STUDYID|DOMAIN|USUBJID|SSSEQ|SSTESTCD|SSTEST|SSCAT|SSORRES|SSSTRESC|SSEVAL|VISITNUM|VISIT|VISITDY|TAETORD|EPOCH|SSDTC|SSDY
e|SS|35f5401f-575a-44dc-9141-8084716a5b70|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|1|TREATMENT|2020-10-20|10
e|SS|35f5401f-575a-44dc-9141-8084716a5b70|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|1|TREATMENT|2020-10-20|10
e|SS|35f5401f-575a-44dc-9141-8084716a5b70|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|3|WASHOUT|2020-11-04|25
e|SS|35f5401f-575a-44dc-9141-8084716a5b70|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|4|TREATMENT|2020-11-04|25
e|SS|35f5401f-575a-44dc-9141-8084716a5b70|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|3|WASHOUT|2020-11-19|40
e|SS|35f5401f-575a-44dc-9141-8084716a5b70|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|6|SCREENING|2020-11-19|40
e|SS|35f5401f-575a-44dc-9141-8084716a5b70|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|5|SCREENING|2020-12-14|65
e|SS|35f5401f-575a-44dc-9141-8084716a5b70|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|5|TREATMENT|2020-12-14|65
e|SS|35f5401f-575a-44dc-9141-8084716a5b70|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2021-01-08|90
e|SS|35f5401f-575a-44dc-9141-8084716a5b70|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|2|TREATMENT|2021-01-08|90
e|SS|8a863a88-67d8-4e50-bafa-c3146591f046|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|4|FOLLOW-UP|2020-12-29|10
e|SS|8a863a88-67d8-4e50-bafa-c3146591f046|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|4|FOLLOW-UP|2020-12-29|10
e|SS|8a863a88-67d8-4e50-bafa-c3146591f046|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|6|SCREENING|2021-01-13|25
e|SS|8a863a88-67d8-4e50-bafa-c3146591f046|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|4|TREATMENT|2021-01-13|25
e|SS|8a863a88-67d8-4e50-bafa-c3146591f046|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|2|TREATMENT|2021-01-28|40
e|SS|8a863a88-67d8-4e50-bafa-c3146591f046|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|3|TREATMENT|2021-01-28|40
e|SS|8a863a88-67d8-4e50-bafa-c3146591f046|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|1|FOLLOW-UP|2021-02-22|65
e|SS|8a863a88-67d8-4e50-bafa-c3146591f046|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|5|TREATMENT|2021-02-22|65
e|SS|8a863a88-67d8-4e50-bafa-c3146591f046|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|1|SCREENING|2021-03-19|90
e|SS|8a863a88-67d8-4e50-bafa-c3146591f046|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|5|TREATMENT|2021-03-19|90
e|SS|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|4|TREATMENT|2020-08-03|10
e|SS|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|7|TREATMENT|2020-08-03|10
e|SS|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|4|TREATMENT|2020-08-18|25
e|SS|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|6|TREATMENT|2020-08-18|25
e|SS|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|TREATMENT|2020-09-02|40
e|SS|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|3|TREATMENT|2020-09-02|40
e|SS|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2020-09-27|65
e|SS|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|TREATMENT|2020-09-27|65
e|SS|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|1|FOLLOW-UP|2020-10-22|90
e|SS|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|3|TREATMENT|2020-10-22|90
e|SS|0558cb35-f542-4f9a-a7e7-18b1d71be69c|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|5|WASHOUT|2020-12-20|10
e|SS|0558cb35-f542-4f9a-a7e7-18b1d71be69c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|1|TREATMENT|2020-12-20|10
e|SS|0558cb35-f542-4f9a-a7e7-18b1d71be69c|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|4|TREATMENT|2021-01-04|25
e|SS|0558cb35-f542-4f9a-a7e7-18b1d71be69c|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|SCREENING|2021-01-04|25
e|SS|0558cb35-f542-4f9a-a7e7-18b1d71be69c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|3|TREATMENT|2021-01-19|40
e|SS|0558cb35-f542-4f9a-a7e7-18b1d71be69c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2021-01-19|40
e|SS|0558cb35-f542-4f9a-a7e7-18b1d71be69c|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|3|SCREENING|2021-02-13|65
e|SS|0558cb35-f542-4f9a-a7e7-18b1d71be69c|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2021-02-13|65
e|SS|0558cb35-f542-4f9a-a7e7-18b1d71be69c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|7|FOLLOW-UP|2021-03-10|90
e|SS|0558cb35-f542-4f9a-a7e7-18b1d71be69c|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|4|SCREENING|2021-03-10|90
e|SS|a9cf4d21-c2a8-4f32-b932-f05d2d317400|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|1|WASHOUT|2020-07-03|10
e|SS|a9cf4d21-c2a8-4f32-b932-f05d2d317400|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|1|WASHOUT|2020-07-03|10
e|SS|a9cf4d21-c2a8-4f32-b932-f05d2d317400|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-07-18|25
e|SS|a9cf4d21-c2a8-4f32-b932-f05d2d317400|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|3|TREATMENT|2020-07-18|25
e|SS|a9cf4d21-c2a8-4f32-b932-f05d2d317400|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|6|FOLLOW-UP|2020-08-02|40
e|SS|a9cf4d21-c2a8-4f32-b932-f05d2d317400|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|6|TREATMENT|2020-08-02|40
e|SS|a9cf4d21-c2a8-4f32-b932-f05d2d317400|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|TREATMENT|2020-08-27|65
e|SS|a9cf4d21-c2a8-4f32-b932-f05d2d317400|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|4|SCREENING|2020-08-27|65
e|SS|a9cf4d21-c2a8-4f32-b932-f05d2d317400|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|6|FOLLOW-UP|2020-09-21|90
e|SS|a9cf4d21-c2a8-4f32-b932-f05d2d317400|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|SCREENING|2020-09-21|90
e|SS|0389257f-50de-4a05-8f2a-69c068374337|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|5|WASHOUT|2020-10-08|10
e|SS|0389257f-50de-4a05-8f2a-69c068374337|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|7|WASHOUT|2020-10-08|10
e|SS|0389257f-50de-4a05-8f2a-69c068374337|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|4|SCREENING|2020-10-23|25
e|SS|0389257f-50de-4a05-8f2a-69c068374337|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|1|WASHOUT|2020-10-23|25
e|SS|0389257f-50de-4a05-8f2a-69c068374337|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|5|SCREENING|2020-11-07|40
e|SS|0389257f-50de-4a05-8f2a-69c068374337|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|4|TREATMENT|2020-11-07|40
e|SS|0389257f-50de-4a05-8f2a-69c068374337|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|7|TREATMENT|2020-12-02|65
e|SS|0389257f-50de-4a05-8f2a-69c068374337|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|7|FOLLOW-UP|2020-12-02|65
e|SS|0389257f-50de-4a05-8f2a-69c068374337|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|6|WASHOUT|2020-12-27|90
e|SS|0389257f-50de-4a05-8f2a-69c068374337|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|3|TREATMENT|2020-12-27|90
e|SS|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|5|TREATMENT|2020-12-15|10
e|SS|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|4|WASHOUT|2020-12-15|10
e|SS|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|1|FOLLOW-UP|2020-12-30|25
e|SS|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|7|SCREENING|2020-12-30|25
e|SS|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|7|TREATMENT|2021-01-14|40
e|SS|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|7|WASHOUT|2021-01-14|40
e|SS|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|3|SCREENING|2021-02-08|65
e|SS|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|SCREENING|2021-02-08|65
e|SS|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|6|FOLLOW-UP|2021-03-05|90
e|SS|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|5|TREATMENT|2021-03-05|90
e|SS|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|6|TREATMENT|2020-12-22|10
e|SS|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|4|WASHOUT|2020-12-22|10
e|SS|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|3|FOLLOW-UP|2021-01-06|25
e|SS|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|5|TREATMENT|2021-01-06|25
e|SS|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|SCREENING|2021-01-21|40
e|SS|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|1|TREATMENT|2021-01-21|40
e|SS|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|3|TREATMENT|2021-02-15|65
e|SS|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|2|TREATMENT|2021-02-15|65
e|SS|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|6|TREATMENT|2021-03-12|90
e|SS|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|1|TREATMENT|2021-03-12|90
e|SS|ad402b62-0625-431b-9bd7-ffd6124610f3|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|1|FOLLOW-UP|2020-09-25|10
e|SS|ad402b62-0625-431b-9bd7-ffd6124610f3|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|5|WASHOUT|2020-09-25|10
e|SS|ad402b62-0625-431b-9bd7-ffd6124610f3|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|5|TREATMENT|2020-10-10|25
e|SS|ad402b62-0625-431b-9bd7-ffd6124610f3|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|6|WASHOUT|2020-10-10|25
e|SS|ad402b62-0625-431b-9bd7-ffd6124610f3|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|TREATMENT|2020-10-25|40
e|SS|ad402b62-0625-431b-9bd7-ffd6124610f3|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|3|TREATMENT|2020-10-25|40
e|SS|ad402b62-0625-431b-9bd7-ffd6124610f3|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|3|TREATMENT|2020-11-19|65
e|SS|ad402b62-0625-431b-9bd7-ffd6124610f3|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|4|SCREENING|2020-11-19|65
e|SS|ad402b62-0625-431b-9bd7-ffd6124610f3|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|6|TREATMENT|2020-12-14|90
e|SS|ad402b62-0625-431b-9bd7-ffd6124610f3|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|TREATMENT|2020-12-14|90
e|SS|d76b0f55-541c-491d-9162-4c133c9509f1|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|6|TREATMENT|2020-05-24|10
e|SS|d76b0f55-541c-491d-9162-4c133c9509f1|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|SCREENING|2020-05-24|10
e|SS|d76b0f55-541c-491d-9162-4c133c9509f1|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|2|WASHOUT|2020-06-08|25
e|SS|d76b0f55-541c-491d-9162-4c133c9509f1|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|1|FOLLOW-UP|2020-06-08|25
e|SS|d76b0f55-541c-491d-9162-4c133c9509f1|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|7|SCREENING|2020-06-23|40
e|SS|d76b0f55-541c-491d-9162-4c133c9509f1|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|7|TREATMENT|2020-06-23|40
e|SS|d76b0f55-541c-491d-9162-4c133c9509f1|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|3|SCREENING|2020-07-18|65
e|SS|d76b0f55-541c-491d-9162-4c133c9509f1|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|3|SCREENING|2020-07-18|65
e|SS|d76b0f55-541c-491d-9162-4c133c9509f1|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|1|FOLLOW-UP|2020-08-12|90
e|SS|d76b0f55-541c-491d-9162-4c133c9509f1|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|6|TREATMENT|2020-08-12|90
e|SS|146059d8-5652-41cd-b484-c6e5d8ea540f|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|SCREENING|2020-08-26|10
e|SS|146059d8-5652-41cd-b484-c6e5d8ea540f|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|WASHOUT|2020-08-26|10
e|SS|146059d8-5652-41cd-b484-c6e5d8ea540f|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|2|FOLLOW-UP|2020-09-10|25
e|SS|146059d8-5652-41cd-b484-c6e5d8ea540f|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|3|SCREENING|2020-09-10|25
e|SS|146059d8-5652-41cd-b484-c6e5d8ea540f|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|2|FOLLOW-UP|2020-09-25|40
e|SS|146059d8-5652-41cd-b484-c6e5d8ea540f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|5|WASHOUT|2020-09-25|40
e|SS|146059d8-5652-41cd-b484-c6e5d8ea540f|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|6|TREATMENT|2020-10-20|65
e|SS|146059d8-5652-41cd-b484-c6e5d8ea540f|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|7|WASHOUT|2020-10-20|65
e|SS|146059d8-5652-41cd-b484-c6e5d8ea540f|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|7|FOLLOW-UP|2020-11-14|90
e|SS|146059d8-5652-41cd-b484-c6e5d8ea540f|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|4|TREATMENT|2020-11-14|90
e|SS|3d5f1964-b65c-4a0a-bb5b-1689308754d8|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|4|TREATMENT|2020-11-04|10
e|SS|3d5f1964-b65c-4a0a-bb5b-1689308754d8|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|TREATMENT|2020-11-04|10
e|SS|3d5f1964-b65c-4a0a-bb5b-1689308754d8|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|5|SCREENING|2020-11-19|25
e|SS|3d5f1964-b65c-4a0a-bb5b-1689308754d8|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|FOLLOW-UP|2020-11-19|25
e|SS|3d5f1964-b65c-4a0a-bb5b-1689308754d8|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|3|SCREENING|2020-12-04|40
e|SS|3d5f1964-b65c-4a0a-bb5b-1689308754d8|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|2|TREATMENT|2020-12-04|40
e|SS|3d5f1964-b65c-4a0a-bb5b-1689308754d8|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|1|TREATMENT|2020-12-29|65
e|SS|3d5f1964-b65c-4a0a-bb5b-1689308754d8|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|7|TREATMENT|2020-12-29|65
e|SS|3d5f1964-b65c-4a0a-bb5b-1689308754d8|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|4|TREATMENT|2021-01-23|90
e|SS|3d5f1964-b65c-4a0a-bb5b-1689308754d8|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|2|TREATMENT|2021-01-23|90
e|SS|129dc836-068a-463e-b789-a0d05c60605d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|2|TREATMENT|2020-07-06|10
e|SS|129dc836-068a-463e-b789-a0d05c60605d|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|FOLLOW-UP|2020-07-06|10
e|SS|129dc836-068a-463e-b789-a0d05c60605d|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|4|TREATMENT|2020-07-21|25
e|SS|129dc836-068a-463e-b789-a0d05c60605d|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|6|WASHOUT|2020-07-21|25
e|SS|129dc836-068a-463e-b789-a0d05c60605d|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|TREATMENT|2020-08-05|40
e|SS|129dc836-068a-463e-b789-a0d05c60605d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|6|TREATMENT|2020-08-05|40
e|SS|129dc836-068a-463e-b789-a0d05c60605d|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|7|FOLLOW-UP|2020-08-30|65
e|SS|129dc836-068a-463e-b789-a0d05c60605d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|6|TREATMENT|2020-08-30|65
e|SS|129dc836-068a-463e-b789-a0d05c60605d|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|2|TREATMENT|2020-09-24|90
e|SS|129dc836-068a-463e-b789-a0d05c60605d|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|5|TREATMENT|2020-09-24|90
e|SS|9ef8a6d4-8326-4050-be85-e9f8983f55c1|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|6|FOLLOW-UP|2020-11-07|10
e|SS|9ef8a6d4-8326-4050-be85-e9f8983f55c1|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|WASHOUT|2020-11-07|10
e|SS|9ef8a6d4-8326-4050-be85-e9f8983f55c1|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-11-22|25
e|SS|9ef8a6d4-8326-4050-be85-e9f8983f55c1|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|WASHOUT|2020-11-22|25
e|SS|9ef8a6d4-8326-4050-be85-e9f8983f55c1|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|2|WASHOUT|2020-12-07|40
e|SS|9ef8a6d4-8326-4050-be85-e9f8983f55c1|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|7|WASHOUT|2020-12-07|40
e|SS|9ef8a6d4-8326-4050-be85-e9f8983f55c1|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|1|SCREENING|2021-01-01|65
e|SS|9ef8a6d4-8326-4050-be85-e9f8983f55c1|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|4|TREATMENT|2021-01-01|65
e|SS|9ef8a6d4-8326-4050-be85-e9f8983f55c1|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|1|TREATMENT|2021-01-26|90
e|SS|9ef8a6d4-8326-4050-be85-e9f8983f55c1|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|1|FOLLOW-UP|2021-01-26|90
e|SS|b91c4469-b3be-467f-8512-b73cf561e168|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|4|TREATMENT|2020-05-18|10
e|SS|b91c4469-b3be-467f-8512-b73cf561e168|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|1|TREATMENT|2020-05-18|10
e|SS|b91c4469-b3be-467f-8512-b73cf561e168|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|2|TREATMENT|2020-06-02|25
e|SS|b91c4469-b3be-467f-8512-b73cf561e168|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|4|FOLLOW-UP|2020-06-02|25
e|SS|b91c4469-b3be-467f-8512-b73cf561e168|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|1|FOLLOW-UP|2020-06-17|40
e|SS|b91c4469-b3be-467f-8512-b73cf561e168|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|6|FOLLOW-UP|2020-06-17|40
e|SS|b91c4469-b3be-467f-8512-b73cf561e168|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|6|SCREENING|2020-07-12|65
e|SS|b91c4469-b3be-467f-8512-b73cf561e168|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|7|TREATMENT|2020-07-12|65
e|SS|b91c4469-b3be-467f-8512-b73cf561e168|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|7|WASHOUT|2020-08-06|90
e|SS|b91c4469-b3be-467f-8512-b73cf561e168|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2020-08-06|90
e|SS|3637e1e0-8c0c-45cc-b139-e812a589f940|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|7|TREATMENT|2020-08-30|10
e|SS|3637e1e0-8c0c-45cc-b139-e812a589f940|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2020-08-30|10
e|SS|3637e1e0-8c0c-45cc-b139-e812a589f940|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|FOLLOW-UP|2020-09-14|25
e|SS|3637e1e0-8c0c-45cc-b139-e812a589f940|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|4|TREATMENT|2020-09-14|25
e|SS|3637e1e0-8c0c-45cc-b139-e812a589f940|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|6|FOLLOW-UP|2020-09-29|40
e|SS|3637e1e0-8c0c-45cc-b139-e812a589f940|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|6|TREATMENT|2020-09-29|40
e|SS|3637e1e0-8c0c-45cc-b139-e812a589f940|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|3|TREATMENT|2020-10-24|65
e|SS|3637e1e0-8c0c-45cc-b139-e812a589f940|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|3|SCREENING|2020-10-24|65
e|SS|3637e1e0-8c0c-45cc-b139-e812a589f940|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|1|TREATMENT|2020-11-18|90
e|SS|3637e1e0-8c0c-45cc-b139-e812a589f940|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2020-11-18|90
e|SS|23385974-5fcd-4c36-b9fa-2fbb3841f182|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|4|FOLLOW-UP|2020-11-27|10
e|SS|23385974-5fcd-4c36-b9fa-2fbb3841f182|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|SCREENING|2020-11-27|10
e|SS|23385974-5fcd-4c36-b9fa-2fbb3841f182|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2020-12-12|25
e|SS|23385974-5fcd-4c36-b9fa-2fbb3841f182|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|3|FOLLOW-UP|2020-12-12|25
e|SS|23385974-5fcd-4c36-b9fa-2fbb3841f182|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|3|SCREENING|2020-12-27|40
e|SS|23385974-5fcd-4c36-b9fa-2fbb3841f182|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|5|WASHOUT|2020-12-27|40
e|SS|23385974-5fcd-4c36-b9fa-2fbb3841f182|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|7|SCREENING|2021-01-21|65
e|SS|23385974-5fcd-4c36-b9fa-2fbb3841f182|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|3|FOLLOW-UP|2021-01-21|65
e|SS|23385974-5fcd-4c36-b9fa-2fbb3841f182|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|2|WASHOUT|2021-02-15|90
e|SS|23385974-5fcd-4c36-b9fa-2fbb3841f182|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|FOLLOW-UP|2021-02-15|90
e|SS|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|5|FOLLOW-UP|2020-12-06|10
e|SS|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|2|WASHOUT|2020-12-06|10
e|SS|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|3|SCREENING|2020-12-21|25
e|SS|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|2|WASHOUT|2020-12-21|25
e|SS|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2021-01-05|40
e|SS|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|1|TREATMENT|2021-01-05|40
e|SS|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|5|SCREENING|2021-01-30|65
e|SS|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2021-01-30|65
e|SS|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|3|TREATMENT|2021-02-24|90
e|SS|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|4|TREATMENT|2021-02-24|90
e|SS|f1327e16-08c6-4ef0-852e-13c095a94c00|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|2|TREATMENT|2020-05-26|10
e|SS|f1327e16-08c6-4ef0-852e-13c095a94c00|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|7|TREATMENT|2020-05-26|10
e|SS|f1327e16-08c6-4ef0-852e-13c095a94c00|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|7|TREATMENT|2020-06-10|25
e|SS|f1327e16-08c6-4ef0-852e-13c095a94c00|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|7|SCREENING|2020-06-10|25
e|SS|f1327e16-08c6-4ef0-852e-13c095a94c00|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|5|WASHOUT|2020-06-25|40
e|SS|f1327e16-08c6-4ef0-852e-13c095a94c00|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|SCREENING|2020-06-25|40
e|SS|f1327e16-08c6-4ef0-852e-13c095a94c00|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|6|TREATMENT|2020-07-20|65
e|SS|f1327e16-08c6-4ef0-852e-13c095a94c00|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|1|TREATMENT|2020-07-20|65
e|SS|f1327e16-08c6-4ef0-852e-13c095a94c00|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|6|FOLLOW-UP|2020-08-14|90
e|SS|f1327e16-08c6-4ef0-852e-13c095a94c00|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|4|TREATMENT|2020-08-14|90
e|SS|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|TREATMENT|2021-01-15|10
e|SS|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|7|TREATMENT|2021-01-15|10
e|SS|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|3|WASHOUT|2021-01-30|25
e|SS|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|4|FOLLOW-UP|2021-01-30|25
e|SS|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|FOLLOW-UP|2021-02-14|40
e|SS|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|SCREENING|2021-02-14|40
e|SS|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|7|TREATMENT|2021-03-11|65
e|SS|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|2|TREATMENT|2021-03-11|65
e|SS|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|2|WASHOUT|2021-04-05|90
e|SS|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|2|WASHOUT|2021-04-05|90
e|SS|e8065021-c163-41c8-8a76-5f0c1c3a06c4|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|1|TREATMENT|2020-12-08|10
e|SS|e8065021-c163-41c8-8a76-5f0c1c3a06c4|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|6|TREATMENT|2020-12-08|10
e|SS|e8065021-c163-41c8-8a76-5f0c1c3a06c4|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|TREATMENT|2020-12-23|25
e|SS|e8065021-c163-41c8-8a76-5f0c1c3a06c4|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|4|FOLLOW-UP|2020-12-23|25
e|SS|e8065021-c163-41c8-8a76-5f0c1c3a06c4|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|4|TREATMENT|2021-01-07|40
e|SS|e8065021-c163-41c8-8a76-5f0c1c3a06c4|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|4|WASHOUT|2021-01-07|40
e|SS|e8065021-c163-41c8-8a76-5f0c1c3a06c4|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|3|FOLLOW-UP|2021-02-01|65
e|SS|e8065021-c163-41c8-8a76-5f0c1c3a06c4|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|WASHOUT|2021-02-01|65
e|SS|e8065021-c163-41c8-8a76-5f0c1c3a06c4|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|4|TREATMENT|2021-02-26|90
e|SS|e8065021-c163-41c8-8a76-5f0c1c3a06c4|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|7|SCREENING|2021-02-26|90
e|SS|854a9218-995e-47f4-87ab-e58d20f56d19|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|WASHOUT|2021-02-21|100
e|SS|854a9218-995e-47f4-87ab-e58d20f56d19|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATOR|1|Visit_1|10|3|TREATMENT|2021-02-21|100
e|SS|854a9218-995e-47f4-87ab-e58d20f56d19|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|FOLLOW-UP|2021-02-21|100
e|SS|854a9218-995e-47f4-87ab-e58d20f56d19|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|PROXY|2|Visit_2|25|2|FOLLOW-UP|2021-02-21|100
e|SS|854a9218-995e-47f4-87ab-e58d20f56d19|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|FAMILY MEMBER|3|Visit_3|40|6|FOLLOW-UP|2021-02-21|100
e|SS|854a9218-995e-47f4-87ab-e58d20f56d19|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIGNIFICANT OTHER|3|Visit_3|40|1|TREATMENT|2021-02-21|100
e|SS|854a9218-995e-47f4-87ab-e58d20f56d19|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIBLING|4|Visit_4|65|1|SCREENING|2021-02-21|100
e|SS|854a9218-995e-47f4-87ab-e58d20f56d19|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|CAREGIVER|4|Visit_4|65|5|FOLLOW-UP|2021-02-21|100
e|SS|854a9218-995e-47f4-87ab-e58d20f56d19|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|CHILD|5|Visit_5|90|7|SCREENING|2021-02-21|100
e|SS|854a9218-995e-47f4-87ab-e58d20f56d19|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATOR|5|Visit_5|90|5|WASHOUT|2021-02-21|100
e|SS|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|4|TREATMENT|2020-06-21|10
e|SS|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|SCREENING|2020-06-21|10
e|SS|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|SCREENING|2020-07-06|25
e|SS|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|6|SCREENING|2020-07-06|25
e|SS|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|3|TREATMENT|2020-07-21|40
e|SS|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|5|FOLLOW-UP|2020-07-21|40
e|SS|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|2|FOLLOW-UP|2020-08-15|65
e|SS|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|1|FOLLOW-UP|2020-08-15|65
e|SS|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|1|FOLLOW-UP|2020-09-09|90
e|SS|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|3|WASHOUT|2020-09-09|90
e|SS|08944dcd-a62d-4932-bb15-a8f15cc73229|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|3|TREATMENT|2020-12-23|10
e|SS|08944dcd-a62d-4932-bb15-a8f15cc73229|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|5|TREATMENT|2020-12-23|10
e|SS|08944dcd-a62d-4932-bb15-a8f15cc73229|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|1|TREATMENT|2021-01-07|25
e|SS|08944dcd-a62d-4932-bb15-a8f15cc73229|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2021-01-07|25
e|SS|08944dcd-a62d-4932-bb15-a8f15cc73229|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|WASHOUT|2021-01-22|40
e|SS|08944dcd-a62d-4932-bb15-a8f15cc73229|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|FOLLOW-UP|2021-01-22|40
e|SS|08944dcd-a62d-4932-bb15-a8f15cc73229|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|7|WASHOUT|2021-02-16|65
e|SS|08944dcd-a62d-4932-bb15-a8f15cc73229|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2021-02-16|65
e|SS|08944dcd-a62d-4932-bb15-a8f15cc73229|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|6|WASHOUT|2021-03-13|90
e|SS|08944dcd-a62d-4932-bb15-a8f15cc73229|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|1|TREATMENT|2021-03-13|90
e|SS|1d7df560-695a-41fe-9226-4cc206b05f48|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|TREATMENT|2020-12-09|10
e|SS|1d7df560-695a-41fe-9226-4cc206b05f48|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|2|FOLLOW-UP|2020-12-09|10
e|SS|1d7df560-695a-41fe-9226-4cc206b05f48|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|TREATMENT|2020-12-24|25
e|SS|1d7df560-695a-41fe-9226-4cc206b05f48|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|1|FOLLOW-UP|2020-12-24|25
e|SS|1d7df560-695a-41fe-9226-4cc206b05f48|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|6|SCREENING|2021-01-08|40
e|SS|1d7df560-695a-41fe-9226-4cc206b05f48|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|2|SCREENING|2021-01-08|40
e|SS|1d7df560-695a-41fe-9226-4cc206b05f48|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|6|TREATMENT|2021-02-02|65
e|SS|1d7df560-695a-41fe-9226-4cc206b05f48|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|4|SCREENING|2021-02-02|65
e|SS|1d7df560-695a-41fe-9226-4cc206b05f48|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|1|FOLLOW-UP|2021-02-27|90
e|SS|1d7df560-695a-41fe-9226-4cc206b05f48|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|4|SCREENING|2021-02-27|90
e|SS|12c802a8-862c-45a4-b12c-a6f920772534|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|INVESTIGATOR|1|Visit_1|10|4|TREATMENT|2020-09-15|100
e|SS|12c802a8-862c-45a4-b12c-a6f920772534|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|SPOUSE|1|Visit_1|10|7|TREATMENT|2020-09-15|100
e|SS|12c802a8-862c-45a4-b12c-a6f920772534|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIBLING|2|Visit_2|25|4|FOLLOW-UP|2020-09-15|100
e|SS|12c802a8-862c-45a4-b12c-a6f920772534|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|INDEPENDENT ASSESSOR|2|Visit_2|25|2|TREATMENT|2020-09-15|100
e|SS|12c802a8-862c-45a4-b12c-a6f920772534|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|DOMESTIC PARTNER|3|Visit_3|40|4|WASHOUT|2020-09-15|100
e|SS|12c802a8-862c-45a4-b12c-a6f920772534|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|1|TREATMENT|2020-09-15|100
e|SS|12c802a8-862c-45a4-b12c-a6f920772534|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|FAMILY MEMBER|4|Visit_4|65|4|TREATMENT|2020-09-15|100
e|SS|12c802a8-862c-45a4-b12c-a6f920772534|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|PROXY|4|Visit_4|65|6|FOLLOW-UP|2020-09-15|100
e|SS|12c802a8-862c-45a4-b12c-a6f920772534|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIBLING|5|Visit_5|90|3|WASHOUT|2020-09-15|100
e|SS|12c802a8-862c-45a4-b12c-a6f920772534|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|PARENT|5|Visit_5|90|6|WASHOUT|2020-09-15|100
e|SS|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|5|TREATMENT|2020-11-23|10
e|SS|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|6|SCREENING|2020-11-23|10
e|SS|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|6|TREATMENT|2020-12-08|25
e|SS|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|3|TREATMENT|2020-12-08|25
e|SS|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|4|WASHOUT|2020-12-23|40
e|SS|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|1|TREATMENT|2020-12-23|40
e|SS|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|1|SCREENING|2021-01-17|65
e|SS|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|6|FOLLOW-UP|2021-01-17|65
e|SS|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|7|TREATMENT|2021-02-11|90
e|SS|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|4|FOLLOW-UP|2021-02-11|90
e|SS|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|6|FOLLOW-UP|2020-08-16|10
e|SS|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|6|TREATMENT|2020-08-16|10
e|SS|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|6|TREATMENT|2020-08-31|25
e|SS|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|4|FOLLOW-UP|2020-08-31|25
e|SS|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|4|TREATMENT|2020-09-15|40
e|SS|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|2|TREATMENT|2020-09-15|40
e|SS|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|1|SCREENING|2020-10-10|65
e|SS|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|3|FOLLOW-UP|2020-10-10|65
e|SS|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|7|TREATMENT|2020-11-04|90
e|SS|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|7|TREATMENT|2020-11-04|90
e|SS|96114171-59a0-4543-b3ec-c7796ae8ee92|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|1|TREATMENT|2020-11-24|10
e|SS|96114171-59a0-4543-b3ec-c7796ae8ee92|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|4|TREATMENT|2020-11-24|10
e|SS|96114171-59a0-4543-b3ec-c7796ae8ee92|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|7|WASHOUT|2020-12-09|25
e|SS|96114171-59a0-4543-b3ec-c7796ae8ee92|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|1|TREATMENT|2020-12-09|25
e|SS|96114171-59a0-4543-b3ec-c7796ae8ee92|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|6|SCREENING|2020-12-24|40
e|SS|96114171-59a0-4543-b3ec-c7796ae8ee92|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|4|TREATMENT|2020-12-24|40
e|SS|96114171-59a0-4543-b3ec-c7796ae8ee92|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|7|SCREENING|2021-01-18|65
e|SS|96114171-59a0-4543-b3ec-c7796ae8ee92|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2021-01-18|65
e|SS|96114171-59a0-4543-b3ec-c7796ae8ee92|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|6|TREATMENT|2021-02-12|90
e|SS|96114171-59a0-4543-b3ec-c7796ae8ee92|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|6|FOLLOW-UP|2021-02-12|90
e|SS|0070d42d-c864-4a83-a3c9-4c8ca7de51de|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATOR|1|Visit_1|10|6|WASHOUT|2020-11-13|100
e|SS|0070d42d-c864-4a83-a3c9-4c8ca7de51de|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATION COMMITTEE|1|Visit_1|10|5|SCREENING|2020-11-13|100
e|SS|0070d42d-c864-4a83-a3c9-4c8ca7de51de|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|SPOUSE|2|Visit_2|25|4|FOLLOW-UP|2020-11-13|100
e|SS|0070d42d-c864-4a83-a3c9-4c8ca7de51de|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|CAREGIVER|2|Visit_2|25|5|WASHOUT|2020-11-13|100
e|SS|0070d42d-c864-4a83-a3c9-4c8ca7de51de|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|PROXY|3|Visit_3|40|5|WASHOUT|2020-11-13|100
e|SS|0070d42d-c864-4a83-a3c9-4c8ca7de51de|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|3|FOLLOW-UP|2020-11-13|100
e|SS|0070d42d-c864-4a83-a3c9-4c8ca7de51de|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|CHILD|4|Visit_4|65|1|SCREENING|2020-11-13|100
e|SS|0070d42d-c864-4a83-a3c9-4c8ca7de51de|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|STUDY SUBJECT|4|Visit_4|65|2|WASHOUT|2020-11-13|100
e|SS|0070d42d-c864-4a83-a3c9-4c8ca7de51de|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|CAREGIVER|5|Visit_5|90|4|TREATMENT|2020-11-13|100
e|SS|0070d42d-c864-4a83-a3c9-4c8ca7de51de|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|INVESTIGATOR|5|Visit_5|90|7|FOLLOW-UP|2020-11-13|100
e|SS|a2ec3389-6f5f-44a3-a6dd-f6177a805791|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|2|TREATMENT|2020-10-17|10
e|SS|a2ec3389-6f5f-44a3-a6dd-f6177a805791|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|2|TREATMENT|2020-10-17|10
e|SS|a2ec3389-6f5f-44a3-a6dd-f6177a805791|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|4|TREATMENT|2020-11-01|25
e|SS|a2ec3389-6f5f-44a3-a6dd-f6177a805791|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|2|SCREENING|2020-11-01|25
e|SS|a2ec3389-6f5f-44a3-a6dd-f6177a805791|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|1|TREATMENT|2020-11-16|40
e|SS|a2ec3389-6f5f-44a3-a6dd-f6177a805791|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|6|SCREENING|2020-11-16|40
e|SS|a2ec3389-6f5f-44a3-a6dd-f6177a805791|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|7|SCREENING|2020-12-11|65
e|SS|a2ec3389-6f5f-44a3-a6dd-f6177a805791|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|TREATMENT|2020-12-11|65
e|SS|a2ec3389-6f5f-44a3-a6dd-f6177a805791|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|3|FOLLOW-UP|2021-01-05|90
e|SS|a2ec3389-6f5f-44a3-a6dd-f6177a805791|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|1|FOLLOW-UP|2021-01-05|90
e|SS|cc562042-9641-460d-862e-d6923dd4207d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|5|TREATMENT|2020-05-27|10
e|SS|cc562042-9641-460d-862e-d6923dd4207d|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|6|FOLLOW-UP|2020-05-27|10
e|SS|cc562042-9641-460d-862e-d6923dd4207d|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|FOLLOW-UP|2020-06-11|25
e|SS|cc562042-9641-460d-862e-d6923dd4207d|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|6|SCREENING|2020-06-11|25
e|SS|cc562042-9641-460d-862e-d6923dd4207d|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|4|TREATMENT|2020-06-26|40
e|SS|cc562042-9641-460d-862e-d6923dd4207d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|7|TREATMENT|2020-06-26|40
e|SS|cc562042-9641-460d-862e-d6923dd4207d|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|6|TREATMENT|2020-07-21|65
e|SS|cc562042-9641-460d-862e-d6923dd4207d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|2|TREATMENT|2020-07-21|65
e|SS|cc562042-9641-460d-862e-d6923dd4207d|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|7|TREATMENT|2020-08-15|90
e|SS|cc562042-9641-460d-862e-d6923dd4207d|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|4|TREATMENT|2020-08-15|90
e|SS|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|2|WASHOUT|2020-07-30|10
e|SS|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|5|SCREENING|2020-07-30|10
e|SS|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|6|FOLLOW-UP|2020-08-14|25
e|SS|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|4|TREATMENT|2020-08-14|25
e|SS|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|4|TREATMENT|2020-08-29|40
e|SS|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|6|SCREENING|2020-08-29|40
e|SS|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|1|SCREENING|2020-09-23|65
e|SS|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2020-09-23|65
e|SS|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|2|SCREENING|2020-10-18|90
e|SS|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|4|WASHOUT|2020-10-18|90
e|SS|d90f2824-692e-403f-b1ca-5b6462c93a75|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|TREATMENT|2020-07-15|10
e|SS|d90f2824-692e-403f-b1ca-5b6462c93a75|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|3|TREATMENT|2020-07-15|10
e|SS|d90f2824-692e-403f-b1ca-5b6462c93a75|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|3|WASHOUT|2020-07-30|25
e|SS|d90f2824-692e-403f-b1ca-5b6462c93a75|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|WASHOUT|2020-07-30|25
e|SS|d90f2824-692e-403f-b1ca-5b6462c93a75|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|6|TREATMENT|2020-08-14|40
e|SS|d90f2824-692e-403f-b1ca-5b6462c93a75|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|5|FOLLOW-UP|2020-08-14|40
e|SS|d90f2824-692e-403f-b1ca-5b6462c93a75|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|7|FOLLOW-UP|2020-09-08|65
e|SS|d90f2824-692e-403f-b1ca-5b6462c93a75|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|7|WASHOUT|2020-09-08|65
e|SS|d90f2824-692e-403f-b1ca-5b6462c93a75|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|FOLLOW-UP|2020-10-03|90
e|SS|d90f2824-692e-403f-b1ca-5b6462c93a75|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|4|TREATMENT|2020-10-03|90
e|SS|ee0e55e1-6107-4a3c-85b4-cb48300153e8|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|7|SCREENING|2020-05-25|10
e|SS|ee0e55e1-6107-4a3c-85b4-cb48300153e8|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|2|TREATMENT|2020-05-25|10
e|SS|ee0e55e1-6107-4a3c-85b4-cb48300153e8|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|2|TREATMENT|2020-06-09|25
e|SS|ee0e55e1-6107-4a3c-85b4-cb48300153e8|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|4|TREATMENT|2020-06-09|25
e|SS|ee0e55e1-6107-4a3c-85b4-cb48300153e8|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|3|WASHOUT|2020-06-24|40
e|SS|ee0e55e1-6107-4a3c-85b4-cb48300153e8|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|7|SCREENING|2020-06-24|40
e|SS|ee0e55e1-6107-4a3c-85b4-cb48300153e8|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|7|SCREENING|2020-07-19|65
e|SS|ee0e55e1-6107-4a3c-85b4-cb48300153e8|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|WASHOUT|2020-07-19|65
e|SS|ee0e55e1-6107-4a3c-85b4-cb48300153e8|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|7|TREATMENT|2020-08-13|90
e|SS|ee0e55e1-6107-4a3c-85b4-cb48300153e8|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|5|WASHOUT|2020-08-13|90
e|SS|6aa37bb3-85aa-427f-9e56-a776257f1548|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|5|TREATMENT|2020-11-14|10
e|SS|6aa37bb3-85aa-427f-9e56-a776257f1548|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|SCREENING|2020-11-14|10
e|SS|6aa37bb3-85aa-427f-9e56-a776257f1548|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|FOLLOW-UP|2020-11-29|25
e|SS|6aa37bb3-85aa-427f-9e56-a776257f1548|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|1|TREATMENT|2020-11-29|25
e|SS|6aa37bb3-85aa-427f-9e56-a776257f1548|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|2|FOLLOW-UP|2020-12-14|40
e|SS|6aa37bb3-85aa-427f-9e56-a776257f1548|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|4|TREATMENT|2020-12-14|40
e|SS|6aa37bb3-85aa-427f-9e56-a776257f1548|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|4|TREATMENT|2021-01-08|65
e|SS|6aa37bb3-85aa-427f-9e56-a776257f1548|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2021-01-08|65
e|SS|6aa37bb3-85aa-427f-9e56-a776257f1548|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|SCREENING|2021-02-02|90
e|SS|6aa37bb3-85aa-427f-9e56-a776257f1548|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|1|WASHOUT|2021-02-02|90
e|SS|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|1|SCREENING|2020-05-18|10
e|SS|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|5|TREATMENT|2020-05-18|10
e|SS|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|7|WASHOUT|2020-06-02|25
e|SS|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|5|SCREENING|2020-06-02|25
e|SS|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|7|FOLLOW-UP|2020-06-17|40
e|SS|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2020-06-17|40
e|SS|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|7|TREATMENT|2020-07-12|65
e|SS|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|7|TREATMENT|2020-07-12|65
e|SS|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|4|SCREENING|2020-08-06|90
e|SS|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|4|SCREENING|2020-08-06|90
e|SS|940d4614-b41a-44d3-b878-6e19ee22f24b|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|1|SCREENING|2020-07-06|10
e|SS|940d4614-b41a-44d3-b878-6e19ee22f24b|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|5|FOLLOW-UP|2020-07-06|10
e|SS|940d4614-b41a-44d3-b878-6e19ee22f24b|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|1|SCREENING|2020-07-21|25
e|SS|940d4614-b41a-44d3-b878-6e19ee22f24b|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|3|TREATMENT|2020-07-21|25
e|SS|940d4614-b41a-44d3-b878-6e19ee22f24b|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|4|WASHOUT|2020-08-05|40
e|SS|940d4614-b41a-44d3-b878-6e19ee22f24b|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2020-08-05|40
e|SS|940d4614-b41a-44d3-b878-6e19ee22f24b|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|7|TREATMENT|2020-08-30|65
e|SS|940d4614-b41a-44d3-b878-6e19ee22f24b|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|7|TREATMENT|2020-08-30|65
e|SS|940d4614-b41a-44d3-b878-6e19ee22f24b|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|6|TREATMENT|2020-09-24|90
e|SS|940d4614-b41a-44d3-b878-6e19ee22f24b|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|4|FOLLOW-UP|2020-09-24|90
e|SS|e2edd4f0-926b-4514-bf3f-7449f248343f|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|2|FOLLOW-UP|2020-11-01|10
e|SS|e2edd4f0-926b-4514-bf3f-7449f248343f|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|5|TREATMENT|2020-11-01|10
e|SS|e2edd4f0-926b-4514-bf3f-7449f248343f|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|7|TREATMENT|2020-11-16|25
e|SS|e2edd4f0-926b-4514-bf3f-7449f248343f|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|2|TREATMENT|2020-11-16|25
e|SS|e2edd4f0-926b-4514-bf3f-7449f248343f|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|5|SCREENING|2020-12-01|40
e|SS|e2edd4f0-926b-4514-bf3f-7449f248343f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|3|TREATMENT|2020-12-01|40
e|SS|e2edd4f0-926b-4514-bf3f-7449f248343f|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|5|TREATMENT|2020-12-26|65
e|SS|e2edd4f0-926b-4514-bf3f-7449f248343f|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|3|TREATMENT|2020-12-26|65
e|SS|e2edd4f0-926b-4514-bf3f-7449f248343f|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|4|TREATMENT|2021-01-20|90
e|SS|e2edd4f0-926b-4514-bf3f-7449f248343f|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|3|TREATMENT|2021-01-20|90
e|SS|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|1|TREATMENT|2020-06-28|10
e|SS|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|5|SCREENING|2020-06-28|10
e|SS|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|4|WASHOUT|2020-07-13|25
e|SS|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|WASHOUT|2020-07-13|25
e|SS|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|6|WASHOUT|2020-07-28|40
e|SS|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|3|WASHOUT|2020-07-28|40
e|SS|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|2|TREATMENT|2020-08-22|65
e|SS|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|FOLLOW-UP|2020-08-22|65
e|SS|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|6|TREATMENT|2020-09-16|90
e|SS|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|7|TREATMENT|2020-09-16|90
e|SS|493a53ef-01ab-470c-9bbe-7c2aa48b946b|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|6|TREATMENT|2020-07-13|10
e|SS|493a53ef-01ab-470c-9bbe-7c2aa48b946b|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|WASHOUT|2020-07-13|10
e|SS|493a53ef-01ab-470c-9bbe-7c2aa48b946b|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|2|FOLLOW-UP|2020-07-28|25
e|SS|493a53ef-01ab-470c-9bbe-7c2aa48b946b|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|TREATMENT|2020-07-28|25
e|SS|493a53ef-01ab-470c-9bbe-7c2aa48b946b|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|TREATMENT|2020-08-12|40
e|SS|493a53ef-01ab-470c-9bbe-7c2aa48b946b|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|6|TREATMENT|2020-08-12|40
e|SS|493a53ef-01ab-470c-9bbe-7c2aa48b946b|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|6|TREATMENT|2020-09-06|65
e|SS|493a53ef-01ab-470c-9bbe-7c2aa48b946b|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|2|TREATMENT|2020-09-06|65
e|SS|493a53ef-01ab-470c-9bbe-7c2aa48b946b|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|FOLLOW-UP|2020-10-01|90
e|SS|493a53ef-01ab-470c-9bbe-7c2aa48b946b|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|2|FOLLOW-UP|2020-10-01|90
e|SS|ba33de14-b676-4389-a863-a7fa3edb8543|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|2|WASHOUT|2020-11-03|10
e|SS|ba33de14-b676-4389-a863-a7fa3edb8543|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|1|WASHOUT|2020-11-03|10
e|SS|ba33de14-b676-4389-a863-a7fa3edb8543|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|2|SCREENING|2020-11-18|25
e|SS|ba33de14-b676-4389-a863-a7fa3edb8543|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|3|SCREENING|2020-11-18|25
e|SS|ba33de14-b676-4389-a863-a7fa3edb8543|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|6|TREATMENT|2020-12-03|40
e|SS|ba33de14-b676-4389-a863-a7fa3edb8543|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|SCREENING|2020-12-03|40
e|SS|ba33de14-b676-4389-a863-a7fa3edb8543|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2020-12-28|65
e|SS|ba33de14-b676-4389-a863-a7fa3edb8543|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|TREATMENT|2020-12-28|65
e|SS|ba33de14-b676-4389-a863-a7fa3edb8543|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|4|FOLLOW-UP|2021-01-22|90
e|SS|ba33de14-b676-4389-a863-a7fa3edb8543|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|1|TREATMENT|2021-01-22|90
e|SS|24801f05-79be-433d-8124-85580bc14c4f|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|4|SCREENING|2020-09-09|10
e|SS|24801f05-79be-433d-8124-85580bc14c4f|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|TREATMENT|2020-09-09|10
e|SS|24801f05-79be-433d-8124-85580bc14c4f|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|5|TREATMENT|2020-09-24|25
e|SS|24801f05-79be-433d-8124-85580bc14c4f|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|1|TREATMENT|2020-09-24|25
e|SS|24801f05-79be-433d-8124-85580bc14c4f|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|3|TREATMENT|2020-10-09|40
e|SS|24801f05-79be-433d-8124-85580bc14c4f|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|7|FOLLOW-UP|2020-10-09|40
e|SS|24801f05-79be-433d-8124-85580bc14c4f|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|WASHOUT|2020-11-03|65
e|SS|24801f05-79be-433d-8124-85580bc14c4f|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|3|TREATMENT|2020-11-03|65
e|SS|24801f05-79be-433d-8124-85580bc14c4f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|3|TREATMENT|2020-11-28|90
e|SS|24801f05-79be-433d-8124-85580bc14c4f|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|4|TREATMENT|2020-11-28|90
e|SS|02df80f9-2337-4abd-9452-41cd83dec8ba|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|5|TREATMENT|2020-08-04|10
e|SS|02df80f9-2337-4abd-9452-41cd83dec8ba|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|2|WASHOUT|2020-08-04|10
e|SS|02df80f9-2337-4abd-9452-41cd83dec8ba|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|4|FOLLOW-UP|2020-08-19|25
e|SS|02df80f9-2337-4abd-9452-41cd83dec8ba|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|5|WASHOUT|2020-08-19|25
e|SS|02df80f9-2337-4abd-9452-41cd83dec8ba|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|6|WASHOUT|2020-09-03|40
e|SS|02df80f9-2337-4abd-9452-41cd83dec8ba|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|4|TREATMENT|2020-09-03|40
e|SS|02df80f9-2337-4abd-9452-41cd83dec8ba|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|5|FOLLOW-UP|2020-09-28|65
e|SS|02df80f9-2337-4abd-9452-41cd83dec8ba|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|2|TREATMENT|2020-09-28|65
e|SS|02df80f9-2337-4abd-9452-41cd83dec8ba|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|6|TREATMENT|2020-10-23|90
e|SS|02df80f9-2337-4abd-9452-41cd83dec8ba|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|1|WASHOUT|2020-10-23|90
e|SS|d9eea93b-f9f9-466c-aa8a-a250baff18ef|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|4|FOLLOW-UP|2020-08-03|10
e|SS|d9eea93b-f9f9-466c-aa8a-a250baff18ef|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|1|TREATMENT|2020-08-03|10
e|SS|d9eea93b-f9f9-466c-aa8a-a250baff18ef|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|5|WASHOUT|2020-08-18|25
e|SS|d9eea93b-f9f9-466c-aa8a-a250baff18ef|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|5|SCREENING|2020-08-18|25
e|SS|d9eea93b-f9f9-466c-aa8a-a250baff18ef|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|FOLLOW-UP|2020-09-02|40
e|SS|d9eea93b-f9f9-466c-aa8a-a250baff18ef|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|6|WASHOUT|2020-09-02|40
e|SS|d9eea93b-f9f9-466c-aa8a-a250baff18ef|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|4|TREATMENT|2020-09-27|65
e|SS|d9eea93b-f9f9-466c-aa8a-a250baff18ef|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|7|TREATMENT|2020-09-27|65
e|SS|d9eea93b-f9f9-466c-aa8a-a250baff18ef|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|3|FOLLOW-UP|2020-10-22|90
e|SS|d9eea93b-f9f9-466c-aa8a-a250baff18ef|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|3|SCREENING|2020-10-22|90
e|SS|35a59f6a-2712-4d1b-a954-f1418d4b9168|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|7|TREATMENT|2020-11-05|10
e|SS|35a59f6a-2712-4d1b-a954-f1418d4b9168|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|1|TREATMENT|2020-11-05|10
e|SS|35a59f6a-2712-4d1b-a954-f1418d4b9168|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|7|TREATMENT|2020-11-20|25
e|SS|35a59f6a-2712-4d1b-a954-f1418d4b9168|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|7|TREATMENT|2020-11-20|25
e|SS|35a59f6a-2712-4d1b-a954-f1418d4b9168|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|1|WASHOUT|2020-12-05|40
e|SS|35a59f6a-2712-4d1b-a954-f1418d4b9168|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|5|TREATMENT|2020-12-05|40
e|SS|35a59f6a-2712-4d1b-a954-f1418d4b9168|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|7|FOLLOW-UP|2020-12-30|65
e|SS|35a59f6a-2712-4d1b-a954-f1418d4b9168|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|2|TREATMENT|2020-12-30|65
e|SS|35a59f6a-2712-4d1b-a954-f1418d4b9168|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2021-01-24|90
e|SS|35a59f6a-2712-4d1b-a954-f1418d4b9168|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|1|WASHOUT|2021-01-24|90
e|SS|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|7|FOLLOW-UP|2020-11-10|10
e|SS|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|FOLLOW-UP|2020-11-10|10
e|SS|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|5|TREATMENT|2020-11-25|25
e|SS|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|WASHOUT|2020-11-25|25
e|SS|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|TREATMENT|2020-12-10|40
e|SS|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|3|FOLLOW-UP|2020-12-10|40
e|SS|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|6|WASHOUT|2021-01-04|65
e|SS|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|5|TREATMENT|2021-01-04|65
e|SS|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|1|TREATMENT|2021-01-29|90
e|SS|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|4|SCREENING|2021-01-29|90
e|SS|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|2|FOLLOW-UP|2020-05-13|10
e|SS|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|7|TREATMENT|2020-05-13|10
e|SS|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|1|FOLLOW-UP|2020-05-28|25
e|SS|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|FOLLOW-UP|2020-05-28|25
e|SS|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|6|TREATMENT|2020-06-12|40
e|SS|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-06-12|40
e|SS|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|6|WASHOUT|2020-07-07|65
e|SS|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|4|SCREENING|2020-07-07|65
e|SS|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|2|WASHOUT|2020-08-01|90
e|SS|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|2|SCREENING|2020-08-01|90
e|SS|d041952e-4aa6-4b37-9cec-127adce2eabb|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|6|FOLLOW-UP|2020-10-09|10
e|SS|d041952e-4aa6-4b37-9cec-127adce2eabb|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|6|WASHOUT|2020-10-09|10
e|SS|d041952e-4aa6-4b37-9cec-127adce2eabb|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|WASHOUT|2020-10-24|25
e|SS|d041952e-4aa6-4b37-9cec-127adce2eabb|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|4|FOLLOW-UP|2020-10-24|25
e|SS|d041952e-4aa6-4b37-9cec-127adce2eabb|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-11-08|40
e|SS|d041952e-4aa6-4b37-9cec-127adce2eabb|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-11-08|40
e|SS|d041952e-4aa6-4b37-9cec-127adce2eabb|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|1|SCREENING|2020-12-03|65
e|SS|d041952e-4aa6-4b37-9cec-127adce2eabb|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|6|TREATMENT|2020-12-03|65
e|SS|d041952e-4aa6-4b37-9cec-127adce2eabb|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|5|TREATMENT|2020-12-28|90
e|SS|d041952e-4aa6-4b37-9cec-127adce2eabb|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|3|WASHOUT|2020-12-28|90
e|SS|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|1|TREATMENT|2020-06-09|10
e|SS|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|WASHOUT|2020-06-09|10
e|SS|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|5|TREATMENT|2020-06-24|25
e|SS|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2020-06-24|25
e|SS|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|2|FOLLOW-UP|2020-07-09|40
e|SS|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|FOLLOW-UP|2020-07-09|40
e|SS|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|6|FOLLOW-UP|2020-08-03|65
e|SS|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2020-08-03|65
e|SS|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|5|TREATMENT|2020-08-28|90
e|SS|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|7|SCREENING|2020-08-28|90
e|SS|9fc393da-4665-4be5-a869-856c45ddcf13|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|1|WASHOUT|2020-06-18|10
e|SS|9fc393da-4665-4be5-a869-856c45ddcf13|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|5|TREATMENT|2020-06-18|10
e|SS|9fc393da-4665-4be5-a869-856c45ddcf13|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|FOLLOW-UP|2020-07-03|25
e|SS|9fc393da-4665-4be5-a869-856c45ddcf13|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|3|FOLLOW-UP|2020-07-03|25
e|SS|9fc393da-4665-4be5-a869-856c45ddcf13|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|7|TREATMENT|2020-07-18|40
e|SS|9fc393da-4665-4be5-a869-856c45ddcf13|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|1|TREATMENT|2020-07-18|40
e|SS|9fc393da-4665-4be5-a869-856c45ddcf13|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|5|TREATMENT|2020-08-12|65
e|SS|9fc393da-4665-4be5-a869-856c45ddcf13|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2020-08-12|65
e|SS|9fc393da-4665-4be5-a869-856c45ddcf13|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2020-09-06|90
e|SS|9fc393da-4665-4be5-a869-856c45ddcf13|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|3|TREATMENT|2020-09-06|90
e|SS|cddc1541-4de9-45e7-bb61-15a2d5baca6f|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|5|TREATMENT|2021-01-19|10
e|SS|cddc1541-4de9-45e7-bb61-15a2d5baca6f|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|4|TREATMENT|2021-01-19|10
e|SS|cddc1541-4de9-45e7-bb61-15a2d5baca6f|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|TREATMENT|2021-02-03|25
e|SS|cddc1541-4de9-45e7-bb61-15a2d5baca6f|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|3|TREATMENT|2021-02-03|25
e|SS|cddc1541-4de9-45e7-bb61-15a2d5baca6f|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|3|FOLLOW-UP|2021-02-18|40
e|SS|cddc1541-4de9-45e7-bb61-15a2d5baca6f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|2|TREATMENT|2021-02-18|40
e|SS|cddc1541-4de9-45e7-bb61-15a2d5baca6f|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|4|TREATMENT|2021-03-15|65
e|SS|cddc1541-4de9-45e7-bb61-15a2d5baca6f|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|FOLLOW-UP|2021-03-15|65
e|SS|cddc1541-4de9-45e7-bb61-15a2d5baca6f|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|2|WASHOUT|2021-04-09|90
e|SS|cddc1541-4de9-45e7-bb61-15a2d5baca6f|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|2|TREATMENT|2021-04-09|90
e|SS|303c6dbe-59f9-4016-baa1-8506c0c1ee09|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|5|WASHOUT|2020-12-26|10
e|SS|303c6dbe-59f9-4016-baa1-8506c0c1ee09|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|TREATMENT|2020-12-26|10
e|SS|303c6dbe-59f9-4016-baa1-8506c0c1ee09|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|1|FOLLOW-UP|2021-01-10|25
e|SS|303c6dbe-59f9-4016-baa1-8506c0c1ee09|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|4|WASHOUT|2021-01-10|25
e|SS|303c6dbe-59f9-4016-baa1-8506c0c1ee09|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|4|TREATMENT|2021-01-25|40
e|SS|303c6dbe-59f9-4016-baa1-8506c0c1ee09|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|4|WASHOUT|2021-01-25|40
e|SS|303c6dbe-59f9-4016-baa1-8506c0c1ee09|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|1|TREATMENT|2021-02-19|65
e|SS|303c6dbe-59f9-4016-baa1-8506c0c1ee09|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|6|TREATMENT|2021-02-19|65
e|SS|303c6dbe-59f9-4016-baa1-8506c0c1ee09|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|2|WASHOUT|2021-03-16|90
e|SS|303c6dbe-59f9-4016-baa1-8506c0c1ee09|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|5|WASHOUT|2021-03-16|90
e|SS|fee3c810-3d76-4db4-9272-6b4e8fd14088|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|3|TREATMENT|2020-12-15|10
e|SS|fee3c810-3d76-4db4-9272-6b4e8fd14088|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|2|WASHOUT|2020-12-15|10
e|SS|fee3c810-3d76-4db4-9272-6b4e8fd14088|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|3|FOLLOW-UP|2020-12-30|25
e|SS|fee3c810-3d76-4db4-9272-6b4e8fd14088|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|6|FOLLOW-UP|2020-12-30|25
e|SS|fee3c810-3d76-4db4-9272-6b4e8fd14088|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|6|TREATMENT|2021-01-14|40
e|SS|fee3c810-3d76-4db4-9272-6b4e8fd14088|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|7|WASHOUT|2021-01-14|40
e|SS|fee3c810-3d76-4db4-9272-6b4e8fd14088|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|3|SCREENING|2021-02-08|65
e|SS|fee3c810-3d76-4db4-9272-6b4e8fd14088|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|4|TREATMENT|2021-02-08|65
e|SS|fee3c810-3d76-4db4-9272-6b4e8fd14088|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|4|WASHOUT|2021-03-05|90
e|SS|fee3c810-3d76-4db4-9272-6b4e8fd14088|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|5|WASHOUT|2021-03-05|90
e|SS|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|1|TREATMENT|2020-07-08|10
e|SS|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|1|WASHOUT|2020-07-08|10
e|SS|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|5|SCREENING|2020-07-23|25
e|SS|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|7|TREATMENT|2020-07-23|25
e|SS|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|1|TREATMENT|2020-08-07|40
e|SS|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|5|FOLLOW-UP|2020-08-07|40
e|SS|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|5|TREATMENT|2020-09-01|65
e|SS|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|5|TREATMENT|2020-09-01|65
e|SS|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|5|SCREENING|2020-09-26|90
e|SS|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|2|TREATMENT|2020-09-26|90
e|SS|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|6|SCREENING|2020-08-01|10
e|SS|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|FOLLOW-UP|2020-08-01|10
e|SS|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|7|SCREENING|2020-08-16|25
e|SS|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|7|TREATMENT|2020-08-16|25
e|SS|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|2|FOLLOW-UP|2020-08-31|40
e|SS|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|6|SCREENING|2020-08-31|40
e|SS|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|4|TREATMENT|2020-09-25|65
e|SS|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|1|FOLLOW-UP|2020-09-25|65
e|SS|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|6|TREATMENT|2020-10-20|90
e|SS|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|FOLLOW-UP|2020-10-20|90
e|SS|47fad45a-9a4c-47ee-a863-089d979523b5|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|5|TREATMENT|2020-10-07|10
e|SS|47fad45a-9a4c-47ee-a863-089d979523b5|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|1|TREATMENT|2020-10-07|10
e|SS|47fad45a-9a4c-47ee-a863-089d979523b5|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|4|SCREENING|2020-10-22|25
e|SS|47fad45a-9a4c-47ee-a863-089d979523b5|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|7|WASHOUT|2020-10-22|25
e|SS|47fad45a-9a4c-47ee-a863-089d979523b5|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|1|TREATMENT|2020-11-06|40
e|SS|47fad45a-9a4c-47ee-a863-089d979523b5|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|1|TREATMENT|2020-11-06|40
e|SS|47fad45a-9a4c-47ee-a863-089d979523b5|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|3|FOLLOW-UP|2020-12-01|65
e|SS|47fad45a-9a4c-47ee-a863-089d979523b5|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|2|SCREENING|2020-12-01|65
e|SS|47fad45a-9a4c-47ee-a863-089d979523b5|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2020-12-26|90
e|SS|47fad45a-9a4c-47ee-a863-089d979523b5|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|2|WASHOUT|2020-12-26|90
e|SS|317b8b6d-9638-44a3-816f-7f3fca1e01a3|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|3|SCREENING|2020-05-23|10
e|SS|317b8b6d-9638-44a3-816f-7f3fca1e01a3|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|5|SCREENING|2020-05-23|10
e|SS|317b8b6d-9638-44a3-816f-7f3fca1e01a3|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|1|WASHOUT|2020-06-07|25
e|SS|317b8b6d-9638-44a3-816f-7f3fca1e01a3|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|7|WASHOUT|2020-06-07|25
e|SS|317b8b6d-9638-44a3-816f-7f3fca1e01a3|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|5|TREATMENT|2020-06-22|40
e|SS|317b8b6d-9638-44a3-816f-7f3fca1e01a3|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|1|TREATMENT|2020-06-22|40
e|SS|317b8b6d-9638-44a3-816f-7f3fca1e01a3|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|3|TREATMENT|2020-07-17|65
e|SS|317b8b6d-9638-44a3-816f-7f3fca1e01a3|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2020-07-17|65
e|SS|317b8b6d-9638-44a3-816f-7f3fca1e01a3|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|1|WASHOUT|2020-08-11|90
e|SS|317b8b6d-9638-44a3-816f-7f3fca1e01a3|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|2|TREATMENT|2020-08-11|90
e|SS|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|TREATMENT|2020-07-10|10
e|SS|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|6|TREATMENT|2020-07-10|10
e|SS|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|3|FOLLOW-UP|2020-07-25|25
e|SS|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|3|SCREENING|2020-07-25|25
e|SS|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|SCREENING|2020-08-09|40
e|SS|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|6|FOLLOW-UP|2020-08-09|40
e|SS|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2020-09-03|65
e|SS|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|5|TREATMENT|2020-09-03|65
e|SS|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|3|SCREENING|2020-09-28|90
e|SS|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|6|TREATMENT|2020-09-28|90
e|SS|e7cee930-54f6-482e-b782-01aed0f0db06|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|5|TREATMENT|2021-01-07|10
e|SS|e7cee930-54f6-482e-b782-01aed0f0db06|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|2|WASHOUT|2021-01-07|10
e|SS|e7cee930-54f6-482e-b782-01aed0f0db06|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|5|TREATMENT|2021-01-22|25
e|SS|e7cee930-54f6-482e-b782-01aed0f0db06|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|5|TREATMENT|2021-01-22|25
e|SS|e7cee930-54f6-482e-b782-01aed0f0db06|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2021-02-06|40
e|SS|e7cee930-54f6-482e-b782-01aed0f0db06|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|WASHOUT|2021-02-06|40
e|SS|e7cee930-54f6-482e-b782-01aed0f0db06|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|5|SCREENING|2021-03-03|65
e|SS|e7cee930-54f6-482e-b782-01aed0f0db06|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2021-03-03|65
e|SS|e7cee930-54f6-482e-b782-01aed0f0db06|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|6|WASHOUT|2021-03-28|90
e|SS|e7cee930-54f6-482e-b782-01aed0f0db06|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|5|FOLLOW-UP|2021-03-28|90
e|SS|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|SCREENING|2021-04-21|100
e|SS|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL STUDY SPONSOR|1|Visit_1|10|4|TREATMENT|2021-04-21|100
e|SS|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2021-04-21|100
e|SS|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|GUARDIAN|2|Visit_2|25|1|FOLLOW-UP|2021-04-21|100
e|SS|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|DOMESTIC PARTNER|3|Visit_3|40|5|WASHOUT|2021-04-21|100
e|SS|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|INTERVIEWER|3|Visit_3|40|7|TREATMENT|2021-04-21|100
e|SS|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL STUDY SPONSOR|4|Visit_4|65|2|WASHOUT|2021-04-21|100
e|SS|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIBLING|4|Visit_4|65|6|FOLLOW-UP|2021-04-21|100
e|SS|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|GUARDIAN|5|Visit_5|90|1|SCREENING|2021-04-21|100
e|SS|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|FOLLOW-UP|2021-04-21|100
e|SS|f754ae7d-0776-41c0-988c-8cf2879d85da|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|1|TREATMENT|2020-09-17|10
e|SS|f754ae7d-0776-41c0-988c-8cf2879d85da|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|FOLLOW-UP|2020-09-17|10
e|SS|f754ae7d-0776-41c0-988c-8cf2879d85da|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|7|TREATMENT|2020-10-02|25
e|SS|f754ae7d-0776-41c0-988c-8cf2879d85da|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|6|WASHOUT|2020-10-02|25
e|SS|f754ae7d-0776-41c0-988c-8cf2879d85da|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|FOLLOW-UP|2020-10-17|40
e|SS|f754ae7d-0776-41c0-988c-8cf2879d85da|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|4|SCREENING|2020-10-17|40
e|SS|f754ae7d-0776-41c0-988c-8cf2879d85da|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|2|TREATMENT|2020-11-11|65
e|SS|f754ae7d-0776-41c0-988c-8cf2879d85da|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|2|FOLLOW-UP|2020-11-11|65
e|SS|f754ae7d-0776-41c0-988c-8cf2879d85da|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|5|TREATMENT|2020-12-06|90
e|SS|f754ae7d-0776-41c0-988c-8cf2879d85da|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|7|TREATMENT|2020-12-06|90
e|SS|8a8d8c31-ae36-4a64-90da-ba5eb473e420|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|WASHOUT|2020-06-25|10
e|SS|8a8d8c31-ae36-4a64-90da-ba5eb473e420|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|3|WASHOUT|2020-06-25|10
e|SS|8a8d8c31-ae36-4a64-90da-ba5eb473e420|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|SCREENING|2020-07-10|25
e|SS|8a8d8c31-ae36-4a64-90da-ba5eb473e420|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|4|FOLLOW-UP|2020-07-10|25
e|SS|8a8d8c31-ae36-4a64-90da-ba5eb473e420|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|1|TREATMENT|2020-07-25|40
e|SS|8a8d8c31-ae36-4a64-90da-ba5eb473e420|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|6|WASHOUT|2020-07-25|40
e|SS|8a8d8c31-ae36-4a64-90da-ba5eb473e420|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|7|WASHOUT|2020-08-19|65
e|SS|8a8d8c31-ae36-4a64-90da-ba5eb473e420|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|FOLLOW-UP|2020-08-19|65
e|SS|8a8d8c31-ae36-4a64-90da-ba5eb473e420|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|4|TREATMENT|2020-09-13|90
e|SS|8a8d8c31-ae36-4a64-90da-ba5eb473e420|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2020-09-13|90
e|SS|482e40c9-2908-4269-b93c-61c311e9fde3|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|1|SCREENING|2020-07-16|10
e|SS|482e40c9-2908-4269-b93c-61c311e9fde3|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|5|TREATMENT|2020-07-16|10
e|SS|482e40c9-2908-4269-b93c-61c311e9fde3|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|1|TREATMENT|2020-07-31|25
e|SS|482e40c9-2908-4269-b93c-61c311e9fde3|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|1|TREATMENT|2020-07-31|25
e|SS|482e40c9-2908-4269-b93c-61c311e9fde3|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|3|TREATMENT|2020-08-15|40
e|SS|482e40c9-2908-4269-b93c-61c311e9fde3|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|6|TREATMENT|2020-08-15|40
e|SS|482e40c9-2908-4269-b93c-61c311e9fde3|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|6|TREATMENT|2020-09-09|65
e|SS|482e40c9-2908-4269-b93c-61c311e9fde3|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|7|TREATMENT|2020-09-09|65
e|SS|482e40c9-2908-4269-b93c-61c311e9fde3|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|5|FOLLOW-UP|2020-10-04|90
e|SS|482e40c9-2908-4269-b93c-61c311e9fde3|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|7|TREATMENT|2020-10-04|90
e|SS|f7cfb281-0556-4316-9373-65edf63c4b23|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|TREATMENT|2020-06-29|10
e|SS|f7cfb281-0556-4316-9373-65edf63c4b23|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|6|SCREENING|2020-06-29|10
e|SS|f7cfb281-0556-4316-9373-65edf63c4b23|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|6|TREATMENT|2020-07-14|25
e|SS|f7cfb281-0556-4316-9373-65edf63c4b23|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|1|TREATMENT|2020-07-14|25
e|SS|f7cfb281-0556-4316-9373-65edf63c4b23|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|7|SCREENING|2020-07-29|40
e|SS|f7cfb281-0556-4316-9373-65edf63c4b23|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|6|SCREENING|2020-07-29|40
e|SS|f7cfb281-0556-4316-9373-65edf63c4b23|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|4|TREATMENT|2020-08-23|65
e|SS|f7cfb281-0556-4316-9373-65edf63c4b23|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2020-08-23|65
e|SS|f7cfb281-0556-4316-9373-65edf63c4b23|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|6|WASHOUT|2020-09-17|90
e|SS|f7cfb281-0556-4316-9373-65edf63c4b23|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|5|WASHOUT|2020-09-17|90
e|SS|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|3|TREATMENT|2021-01-10|10
e|SS|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|4|TREATMENT|2021-01-10|10
e|SS|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|6|TREATMENT|2021-01-25|25
e|SS|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|4|TREATMENT|2021-01-25|25
e|SS|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|7|TREATMENT|2021-02-09|40
e|SS|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|6|SCREENING|2021-02-09|40
e|SS|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|5|FOLLOW-UP|2021-03-06|65
e|SS|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|2|FOLLOW-UP|2021-03-06|65
e|SS|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|3|TREATMENT|2021-03-31|90
e|SS|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|7|TREATMENT|2021-03-31|90
e|SS|9ed8a578-a82a-423a-81ca-ee87f98d62f7|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|1|TREATMENT|2020-09-02|10
e|SS|9ed8a578-a82a-423a-81ca-ee87f98d62f7|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|6|TREATMENT|2020-09-02|10
e|SS|9ed8a578-a82a-423a-81ca-ee87f98d62f7|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|7|WASHOUT|2020-09-17|25
e|SS|9ed8a578-a82a-423a-81ca-ee87f98d62f7|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|SCREENING|2020-09-17|25
e|SS|9ed8a578-a82a-423a-81ca-ee87f98d62f7|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|TREATMENT|2020-10-02|40
e|SS|9ed8a578-a82a-423a-81ca-ee87f98d62f7|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|6|FOLLOW-UP|2020-10-02|40
e|SS|9ed8a578-a82a-423a-81ca-ee87f98d62f7|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|3|FOLLOW-UP|2020-10-27|65
e|SS|9ed8a578-a82a-423a-81ca-ee87f98d62f7|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|4|WASHOUT|2020-10-27|65
e|SS|9ed8a578-a82a-423a-81ca-ee87f98d62f7|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|2|SCREENING|2020-11-21|90
e|SS|9ed8a578-a82a-423a-81ca-ee87f98d62f7|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|2|SCREENING|2020-11-21|90
e|SS|2214af46-1072-4328-bf3d-f4fe9cd97d9b|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|4|TREATMENT|2020-10-18|10
e|SS|2214af46-1072-4328-bf3d-f4fe9cd97d9b|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|4|TREATMENT|2020-10-18|10
e|SS|2214af46-1072-4328-bf3d-f4fe9cd97d9b|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2020-11-02|25
e|SS|2214af46-1072-4328-bf3d-f4fe9cd97d9b|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|5|FOLLOW-UP|2020-11-02|25
e|SS|2214af46-1072-4328-bf3d-f4fe9cd97d9b|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|4|FOLLOW-UP|2020-11-17|40
e|SS|2214af46-1072-4328-bf3d-f4fe9cd97d9b|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|1|TREATMENT|2020-11-17|40
e|SS|2214af46-1072-4328-bf3d-f4fe9cd97d9b|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|2|TREATMENT|2020-12-12|65
e|SS|2214af46-1072-4328-bf3d-f4fe9cd97d9b|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|FOLLOW-UP|2020-12-12|65
e|SS|2214af46-1072-4328-bf3d-f4fe9cd97d9b|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|6|TREATMENT|2021-01-06|90
e|SS|2214af46-1072-4328-bf3d-f4fe9cd97d9b|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|4|TREATMENT|2021-01-06|90
e|SS|7e56eb43-62a6-45ac-9476-1d0655595a04|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|4|SCREENING|2021-01-24|10
e|SS|7e56eb43-62a6-45ac-9476-1d0655595a04|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|1|WASHOUT|2021-01-24|10
e|SS|7e56eb43-62a6-45ac-9476-1d0655595a04|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|3|TREATMENT|2021-02-08|25
e|SS|7e56eb43-62a6-45ac-9476-1d0655595a04|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|6|WASHOUT|2021-02-08|25
e|SS|7e56eb43-62a6-45ac-9476-1d0655595a04|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|4|SCREENING|2021-02-23|40
e|SS|7e56eb43-62a6-45ac-9476-1d0655595a04|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|7|TREATMENT|2021-02-23|40
e|SS|7e56eb43-62a6-45ac-9476-1d0655595a04|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|7|TREATMENT|2021-03-20|65
e|SS|7e56eb43-62a6-45ac-9476-1d0655595a04|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|1|SCREENING|2021-03-20|65
e|SS|7e56eb43-62a6-45ac-9476-1d0655595a04|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|1|WASHOUT|2021-04-14|90
e|SS|7e56eb43-62a6-45ac-9476-1d0655595a04|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|4|SCREENING|2021-04-14|90
e|SS|73a8e85a-0b5f-496b-b164-afc4d1f02de2|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|TREATMENT|2020-06-29|10
e|SS|73a8e85a-0b5f-496b-b164-afc4d1f02de2|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|7|WASHOUT|2020-06-29|10
e|SS|73a8e85a-0b5f-496b-b164-afc4d1f02de2|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|4|FOLLOW-UP|2020-07-14|25
e|SS|73a8e85a-0b5f-496b-b164-afc4d1f02de2|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|5|TREATMENT|2020-07-14|25
e|SS|73a8e85a-0b5f-496b-b164-afc4d1f02de2|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|1|WASHOUT|2020-07-29|40
e|SS|73a8e85a-0b5f-496b-b164-afc4d1f02de2|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2020-07-29|40
e|SS|73a8e85a-0b5f-496b-b164-afc4d1f02de2|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|1|FOLLOW-UP|2020-08-23|65
e|SS|73a8e85a-0b5f-496b-b164-afc4d1f02de2|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|7|TREATMENT|2020-08-23|65
e|SS|73a8e85a-0b5f-496b-b164-afc4d1f02de2|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|2|FOLLOW-UP|2020-09-17|90
e|SS|73a8e85a-0b5f-496b-b164-afc4d1f02de2|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|5|FOLLOW-UP|2020-09-17|90
e|SS|84f74359-c79b-4f1c-8119-a4993b071973|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|6|FOLLOW-UP|2020-05-12|10
e|SS|84f74359-c79b-4f1c-8119-a4993b071973|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|TREATMENT|2020-05-12|10
e|SS|84f74359-c79b-4f1c-8119-a4993b071973|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|4|TREATMENT|2020-05-27|25
e|SS|84f74359-c79b-4f1c-8119-a4993b071973|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|2|FOLLOW-UP|2020-05-27|25
e|SS|84f74359-c79b-4f1c-8119-a4993b071973|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|4|SCREENING|2020-06-11|40
e|SS|84f74359-c79b-4f1c-8119-a4993b071973|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|2|SCREENING|2020-06-11|40
e|SS|84f74359-c79b-4f1c-8119-a4993b071973|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|6|FOLLOW-UP|2020-07-06|65
e|SS|84f74359-c79b-4f1c-8119-a4993b071973|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|7|TREATMENT|2020-07-06|65
e|SS|84f74359-c79b-4f1c-8119-a4993b071973|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|7|WASHOUT|2020-07-31|90
e|SS|84f74359-c79b-4f1c-8119-a4993b071973|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|2|TREATMENT|2020-07-31|90
e|SS|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|4|SCREENING|2020-11-06|10
e|SS|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|7|WASHOUT|2020-11-06|10
e|SS|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|TREATMENT|2020-11-21|25
e|SS|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|4|WASHOUT|2020-11-21|25
e|SS|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|3|FOLLOW-UP|2020-12-06|40
e|SS|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|1|WASHOUT|2020-12-06|40
e|SS|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|FOLLOW-UP|2020-12-31|65
e|SS|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|FOLLOW-UP|2020-12-31|65
e|SS|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|1|SCREENING|2021-01-25|90
e|SS|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|4|SCREENING|2021-01-25|90
e|SS|cd0c969e-61c6-4c65-ac19-4ee247f5009a|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|TREATMENT|2020-09-09|10
e|SS|cd0c969e-61c6-4c65-ac19-4ee247f5009a|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|1|FOLLOW-UP|2020-09-09|10
e|SS|cd0c969e-61c6-4c65-ac19-4ee247f5009a|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|1|WASHOUT|2020-09-24|25
e|SS|cd0c969e-61c6-4c65-ac19-4ee247f5009a|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|1|TREATMENT|2020-09-24|25
e|SS|cd0c969e-61c6-4c65-ac19-4ee247f5009a|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|2|TREATMENT|2020-10-09|40
e|SS|cd0c969e-61c6-4c65-ac19-4ee247f5009a|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|1|TREATMENT|2020-10-09|40
e|SS|cd0c969e-61c6-4c65-ac19-4ee247f5009a|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|4|TREATMENT|2020-11-03|65
e|SS|cd0c969e-61c6-4c65-ac19-4ee247f5009a|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|6|TREATMENT|2020-11-03|65
e|SS|cd0c969e-61c6-4c65-ac19-4ee247f5009a|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|4|FOLLOW-UP|2020-11-28|90
e|SS|cd0c969e-61c6-4c65-ac19-4ee247f5009a|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|1|WASHOUT|2020-11-28|90
e|SS|1fff484d-0a68-42cd-8eff-bc4fe4da945c|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|7|WASHOUT|2021-01-28|10
e|SS|1fff484d-0a68-42cd-8eff-bc4fe4da945c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|WASHOUT|2021-01-28|10
e|SS|1fff484d-0a68-42cd-8eff-bc4fe4da945c|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|1|WASHOUT|2021-02-12|25
e|SS|1fff484d-0a68-42cd-8eff-bc4fe4da945c|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|5|TREATMENT|2021-02-12|25
e|SS|1fff484d-0a68-42cd-8eff-bc4fe4da945c|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|2|TREATMENT|2021-02-27|40
e|SS|1fff484d-0a68-42cd-8eff-bc4fe4da945c|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|2|FOLLOW-UP|2021-02-27|40
e|SS|1fff484d-0a68-42cd-8eff-bc4fe4da945c|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|7|WASHOUT|2021-03-24|65
e|SS|1fff484d-0a68-42cd-8eff-bc4fe4da945c|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|5|SCREENING|2021-03-24|65
e|SS|1fff484d-0a68-42cd-8eff-bc4fe4da945c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|FOLLOW-UP|2021-04-18|90
e|SS|1fff484d-0a68-42cd-8eff-bc4fe4da945c|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|3|TREATMENT|2021-04-18|90
e|SS|e2c20e9a-0ac5-4907-96de-472bee70bd79|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|6|SCREENING|2020-12-04|10
e|SS|e2c20e9a-0ac5-4907-96de-472bee70bd79|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|7|FOLLOW-UP|2020-12-04|10
e|SS|e2c20e9a-0ac5-4907-96de-472bee70bd79|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|7|WASHOUT|2020-12-19|25
e|SS|e2c20e9a-0ac5-4907-96de-472bee70bd79|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|6|TREATMENT|2020-12-19|25
e|SS|e2c20e9a-0ac5-4907-96de-472bee70bd79|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|5|TREATMENT|2021-01-03|40
e|SS|e2c20e9a-0ac5-4907-96de-472bee70bd79|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|4|TREATMENT|2021-01-03|40
e|SS|e2c20e9a-0ac5-4907-96de-472bee70bd79|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|6|TREATMENT|2021-01-28|65
e|SS|e2c20e9a-0ac5-4907-96de-472bee70bd79|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|5|FOLLOW-UP|2021-01-28|65
e|SS|e2c20e9a-0ac5-4907-96de-472bee70bd79|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|2|SCREENING|2021-02-22|90
e|SS|e2c20e9a-0ac5-4907-96de-472bee70bd79|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|4|TREATMENT|2021-02-22|90
e|SS|6064ca8c-b723-4d05-914a-bb547d86fcc5|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|TREATMENT|2020-06-02|10
e|SS|6064ca8c-b723-4d05-914a-bb547d86fcc5|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|2|TREATMENT|2020-06-02|10
e|SS|6064ca8c-b723-4d05-914a-bb547d86fcc5|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|5|SCREENING|2020-06-17|25
e|SS|6064ca8c-b723-4d05-914a-bb547d86fcc5|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|2|TREATMENT|2020-06-17|25
e|SS|6064ca8c-b723-4d05-914a-bb547d86fcc5|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|1|TREATMENT|2020-07-02|40
e|SS|6064ca8c-b723-4d05-914a-bb547d86fcc5|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|7|WASHOUT|2020-07-02|40
e|SS|6064ca8c-b723-4d05-914a-bb547d86fcc5|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|TREATMENT|2020-07-27|65
e|SS|6064ca8c-b723-4d05-914a-bb547d86fcc5|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|WASHOUT|2020-07-27|65
e|SS|6064ca8c-b723-4d05-914a-bb547d86fcc5|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|2|WASHOUT|2020-08-21|90
e|SS|6064ca8c-b723-4d05-914a-bb547d86fcc5|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|5|WASHOUT|2020-08-21|90
e|SS|8effbbff-acda-4718-89f1-e30a418f6bae|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|3|TREATMENT|2020-11-06|10
e|SS|8effbbff-acda-4718-89f1-e30a418f6bae|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|5|TREATMENT|2020-11-06|10
e|SS|8effbbff-acda-4718-89f1-e30a418f6bae|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|2|TREATMENT|2020-11-21|25
e|SS|8effbbff-acda-4718-89f1-e30a418f6bae|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|7|TREATMENT|2020-11-21|25
e|SS|8effbbff-acda-4718-89f1-e30a418f6bae|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|2|FOLLOW-UP|2020-12-06|40
e|SS|8effbbff-acda-4718-89f1-e30a418f6bae|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|FOLLOW-UP|2020-12-06|40
e|SS|8effbbff-acda-4718-89f1-e30a418f6bae|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|TREATMENT|2020-12-31|65
e|SS|8effbbff-acda-4718-89f1-e30a418f6bae|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|6|FOLLOW-UP|2020-12-31|65
e|SS|8effbbff-acda-4718-89f1-e30a418f6bae|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|5|TREATMENT|2021-01-25|90
e|SS|8effbbff-acda-4718-89f1-e30a418f6bae|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2021-01-25|90
e|SS|859b16a5-f6a2-40cc-8e01-18c112b1969e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|4|FOLLOW-UP|2020-08-18|10
e|SS|859b16a5-f6a2-40cc-8e01-18c112b1969e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|7|TREATMENT|2020-08-18|10
e|SS|859b16a5-f6a2-40cc-8e01-18c112b1969e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|6|TREATMENT|2020-09-02|25
e|SS|859b16a5-f6a2-40cc-8e01-18c112b1969e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|7|TREATMENT|2020-09-02|25
e|SS|859b16a5-f6a2-40cc-8e01-18c112b1969e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|5|TREATMENT|2020-09-17|40
e|SS|859b16a5-f6a2-40cc-8e01-18c112b1969e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|1|TREATMENT|2020-09-17|40
e|SS|859b16a5-f6a2-40cc-8e01-18c112b1969e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|6|WASHOUT|2020-10-12|65
e|SS|859b16a5-f6a2-40cc-8e01-18c112b1969e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|4|SCREENING|2020-10-12|65
e|SS|859b16a5-f6a2-40cc-8e01-18c112b1969e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|1|WASHOUT|2020-11-06|90
e|SS|859b16a5-f6a2-40cc-8e01-18c112b1969e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|5|SCREENING|2020-11-06|90
e|SS|36b457ef-4cf6-4043-a836-49368ebf3f1c|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIGNIFICANT OTHER|1|Visit_1|10|5|TREATMENT|2020-11-14|100
e|SS|36b457ef-4cf6-4043-a836-49368ebf3f1c|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|TREATMENT|2020-11-14|100
e|SS|36b457ef-4cf6-4043-a836-49368ebf3f1c|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|SPOUSE|2|Visit_2|25|3|TREATMENT|2020-11-14|100
e|SS|36b457ef-4cf6-4043-a836-49368ebf3f1c|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|FRIEND|2|Visit_2|25|2|TREATMENT|2020-11-14|100
e|SS|36b457ef-4cf6-4043-a836-49368ebf3f1c|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|VENDOR|3|Visit_3|40|6|TREATMENT|2020-11-14|100
e|SS|36b457ef-4cf6-4043-a836-49368ebf3f1c|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|PROXY|3|Visit_3|40|2|FOLLOW-UP|2020-11-14|100
e|SS|36b457ef-4cf6-4043-a836-49368ebf3f1c|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|SPOUSE|4|Visit_4|65|3|WASHOUT|2020-11-14|100
e|SS|36b457ef-4cf6-4043-a836-49368ebf3f1c|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIBLING|4|Visit_4|65|4|SCREENING|2020-11-14|100
e|SS|36b457ef-4cf6-4043-a836-49368ebf3f1c|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|SPOUSE|5|Visit_5|90|3|SCREENING|2020-11-14|100
e|SS|36b457ef-4cf6-4043-a836-49368ebf3f1c|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|7|SCREENING|2020-11-14|100
e|SS|31f33e38-bba6-4c8a-b563-14afaabae5d7|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|4|TREATMENT|2020-07-01|10
e|SS|31f33e38-bba6-4c8a-b563-14afaabae5d7|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|6|WASHOUT|2020-07-01|10
e|SS|31f33e38-bba6-4c8a-b563-14afaabae5d7|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|6|SCREENING|2020-07-16|25
e|SS|31f33e38-bba6-4c8a-b563-14afaabae5d7|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|1|FOLLOW-UP|2020-07-16|25
e|SS|31f33e38-bba6-4c8a-b563-14afaabae5d7|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|7|TREATMENT|2020-07-31|40
e|SS|31f33e38-bba6-4c8a-b563-14afaabae5d7|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|4|TREATMENT|2020-07-31|40
e|SS|31f33e38-bba6-4c8a-b563-14afaabae5d7|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|3|TREATMENT|2020-08-25|65
e|SS|31f33e38-bba6-4c8a-b563-14afaabae5d7|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|2|TREATMENT|2020-08-25|65
e|SS|31f33e38-bba6-4c8a-b563-14afaabae5d7|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|2|WASHOUT|2020-09-19|90
e|SS|31f33e38-bba6-4c8a-b563-14afaabae5d7|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|1|TREATMENT|2020-09-19|90
e|SS|6794dffe-333b-425b-8883-26f6e5ba0797|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|6|WASHOUT|2020-07-09|10
e|SS|6794dffe-333b-425b-8883-26f6e5ba0797|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|6|TREATMENT|2020-07-09|10
e|SS|6794dffe-333b-425b-8883-26f6e5ba0797|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|TREATMENT|2020-07-24|25
e|SS|6794dffe-333b-425b-8883-26f6e5ba0797|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|WASHOUT|2020-07-24|25
e|SS|6794dffe-333b-425b-8883-26f6e5ba0797|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|7|FOLLOW-UP|2020-08-08|40
e|SS|6794dffe-333b-425b-8883-26f6e5ba0797|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|2|SCREENING|2020-08-08|40
e|SS|6794dffe-333b-425b-8883-26f6e5ba0797|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2020-09-02|65
e|SS|6794dffe-333b-425b-8883-26f6e5ba0797|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|7|TREATMENT|2020-09-02|65
e|SS|6794dffe-333b-425b-8883-26f6e5ba0797|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2020-09-27|90
e|SS|6794dffe-333b-425b-8883-26f6e5ba0797|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|3|TREATMENT|2020-09-27|90
e|SS|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|6|TREATMENT|2020-06-07|10
e|SS|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|5|TREATMENT|2020-06-07|10
e|SS|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|3|FOLLOW-UP|2020-06-22|25
e|SS|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|SCREENING|2020-06-22|25
e|SS|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|1|TREATMENT|2020-07-07|40
e|SS|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|2|TREATMENT|2020-07-07|40
e|SS|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|2|TREATMENT|2020-08-01|65
e|SS|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|4|SCREENING|2020-08-01|65
e|SS|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|1|SCREENING|2020-08-26|90
e|SS|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|5|SCREENING|2020-08-26|90
e|SS|45897452-8f5a-458d-9a43-13237460ba48|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|6|TREATMENT|2020-11-11|10
e|SS|45897452-8f5a-458d-9a43-13237460ba48|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|1|FOLLOW-UP|2020-11-11|10
e|SS|45897452-8f5a-458d-9a43-13237460ba48|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|6|SCREENING|2020-11-26|25
e|SS|45897452-8f5a-458d-9a43-13237460ba48|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|3|FOLLOW-UP|2020-11-26|25
e|SS|45897452-8f5a-458d-9a43-13237460ba48|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|4|TREATMENT|2020-12-11|40
e|SS|45897452-8f5a-458d-9a43-13237460ba48|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-12-11|40
e|SS|45897452-8f5a-458d-9a43-13237460ba48|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|1|SCREENING|2021-01-05|65
e|SS|45897452-8f5a-458d-9a43-13237460ba48|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|5|SCREENING|2021-01-05|65
e|SS|45897452-8f5a-458d-9a43-13237460ba48|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|6|TREATMENT|2021-01-30|90
e|SS|45897452-8f5a-458d-9a43-13237460ba48|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|2|TREATMENT|2021-01-30|90
e|SS|16eb981f-2118-4658-a83f-93d925c410c9|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|SCREENING|2020-12-16|10
e|SS|16eb981f-2118-4658-a83f-93d925c410c9|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2020-12-16|10
e|SS|16eb981f-2118-4658-a83f-93d925c410c9|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|7|WASHOUT|2020-12-31|25
e|SS|16eb981f-2118-4658-a83f-93d925c410c9|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|5|WASHOUT|2020-12-31|25
e|SS|16eb981f-2118-4658-a83f-93d925c410c9|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|2|TREATMENT|2021-01-15|40
e|SS|16eb981f-2118-4658-a83f-93d925c410c9|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|4|TREATMENT|2021-01-15|40
e|SS|16eb981f-2118-4658-a83f-93d925c410c9|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|2|TREATMENT|2021-02-09|65
e|SS|16eb981f-2118-4658-a83f-93d925c410c9|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|3|SCREENING|2021-02-09|65
e|SS|16eb981f-2118-4658-a83f-93d925c410c9|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|1|TREATMENT|2021-03-06|90
e|SS|16eb981f-2118-4658-a83f-93d925c410c9|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|FOLLOW-UP|2021-03-06|90
e|SS|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|3|TREATMENT|2021-01-11|10
e|SS|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|3|SCREENING|2021-01-11|10
e|SS|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|6|TREATMENT|2021-01-26|25
e|SS|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|6|TREATMENT|2021-01-26|25
e|SS|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|7|SCREENING|2021-02-10|40
e|SS|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|2|SCREENING|2021-02-10|40
e|SS|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|2|TREATMENT|2021-03-07|65
e|SS|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|6|SCREENING|2021-03-07|65
e|SS|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|4|FOLLOW-UP|2021-04-01|90
e|SS|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|6|FOLLOW-UP|2021-04-01|90
e|SS|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2021-01-29|10
e|SS|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|7|TREATMENT|2021-01-29|10
e|SS|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|6|TREATMENT|2021-02-13|25
e|SS|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|2|TREATMENT|2021-02-13|25
e|SS|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|5|WASHOUT|2021-02-28|40
e|SS|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|6|SCREENING|2021-02-28|40
e|SS|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|1|SCREENING|2021-03-25|65
e|SS|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|2|SCREENING|2021-03-25|65
e|SS|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|2|TREATMENT|2021-04-19|90
e|SS|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2021-04-19|90
e|SS|874f491c-5d55-4738-86b7-b1200b16d106|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|3|TREATMENT|2021-01-08|10
e|SS|874f491c-5d55-4738-86b7-b1200b16d106|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|3|TREATMENT|2021-01-08|10
e|SS|874f491c-5d55-4738-86b7-b1200b16d106|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|3|WASHOUT|2021-01-23|25
e|SS|874f491c-5d55-4738-86b7-b1200b16d106|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|4|FOLLOW-UP|2021-01-23|25
e|SS|874f491c-5d55-4738-86b7-b1200b16d106|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|4|TREATMENT|2021-02-07|40
e|SS|874f491c-5d55-4738-86b7-b1200b16d106|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|1|WASHOUT|2021-02-07|40
e|SS|874f491c-5d55-4738-86b7-b1200b16d106|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|FOLLOW-UP|2021-03-04|65
e|SS|874f491c-5d55-4738-86b7-b1200b16d106|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|2|TREATMENT|2021-03-04|65
e|SS|874f491c-5d55-4738-86b7-b1200b16d106|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|3|TREATMENT|2021-03-29|90
e|SS|874f491c-5d55-4738-86b7-b1200b16d106|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|FOLLOW-UP|2021-03-29|90
e|SS|281ccdef-794c-49ad-9616-6f6f68dd4543|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|2|SCREENING|2020-06-04|10
e|SS|281ccdef-794c-49ad-9616-6f6f68dd4543|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|5|SCREENING|2020-06-04|10
e|SS|281ccdef-794c-49ad-9616-6f6f68dd4543|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|7|TREATMENT|2020-06-19|25
e|SS|281ccdef-794c-49ad-9616-6f6f68dd4543|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|1|TREATMENT|2020-06-19|25
e|SS|281ccdef-794c-49ad-9616-6f6f68dd4543|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|1|WASHOUT|2020-07-04|40
e|SS|281ccdef-794c-49ad-9616-6f6f68dd4543|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|2|FOLLOW-UP|2020-07-04|40
e|SS|281ccdef-794c-49ad-9616-6f6f68dd4543|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|6|TREATMENT|2020-07-29|65
e|SS|281ccdef-794c-49ad-9616-6f6f68dd4543|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|5|SCREENING|2020-07-29|65
e|SS|281ccdef-794c-49ad-9616-6f6f68dd4543|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|4|TREATMENT|2020-08-23|90
e|SS|281ccdef-794c-49ad-9616-6f6f68dd4543|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|2|FOLLOW-UP|2020-08-23|90
e|SS|b1179e10-e8fe-472c-a511-d6d460571857|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|3|SCREENING|2020-08-02|10
e|SS|b1179e10-e8fe-472c-a511-d6d460571857|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|3|TREATMENT|2020-08-02|10
e|SS|b1179e10-e8fe-472c-a511-d6d460571857|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|3|TREATMENT|2020-08-17|25
e|SS|b1179e10-e8fe-472c-a511-d6d460571857|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|1|TREATMENT|2020-08-17|25
e|SS|b1179e10-e8fe-472c-a511-d6d460571857|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|2|TREATMENT|2020-09-01|40
e|SS|b1179e10-e8fe-472c-a511-d6d460571857|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|SCREENING|2020-09-01|40
e|SS|b1179e10-e8fe-472c-a511-d6d460571857|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|7|SCREENING|2020-09-26|65
e|SS|b1179e10-e8fe-472c-a511-d6d460571857|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|5|FOLLOW-UP|2020-09-26|65
e|SS|b1179e10-e8fe-472c-a511-d6d460571857|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|2|SCREENING|2020-10-21|90
e|SS|b1179e10-e8fe-472c-a511-d6d460571857|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|3|SCREENING|2020-10-21|90
e|SS|6362cf42-f286-4151-bdf7-38fcc5639eed|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|3|FOLLOW-UP|2020-09-07|10
e|SS|6362cf42-f286-4151-bdf7-38fcc5639eed|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|3|SCREENING|2020-09-07|10
e|SS|6362cf42-f286-4151-bdf7-38fcc5639eed|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|1|TREATMENT|2020-09-22|25
e|SS|6362cf42-f286-4151-bdf7-38fcc5639eed|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|3|WASHOUT|2020-09-22|25
e|SS|6362cf42-f286-4151-bdf7-38fcc5639eed|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|1|TREATMENT|2020-10-07|40
e|SS|6362cf42-f286-4151-bdf7-38fcc5639eed|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|TREATMENT|2020-10-07|40
e|SS|6362cf42-f286-4151-bdf7-38fcc5639eed|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|7|FOLLOW-UP|2020-11-01|65
e|SS|6362cf42-f286-4151-bdf7-38fcc5639eed|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|1|FOLLOW-UP|2020-11-01|65
e|SS|6362cf42-f286-4151-bdf7-38fcc5639eed|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2020-11-26|90
e|SS|6362cf42-f286-4151-bdf7-38fcc5639eed|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|2|TREATMENT|2020-11-26|90
e|SS|8e28e3ab-0060-43f7-b033-c16bd77c0e29|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|4|TREATMENT|2020-11-30|10
e|SS|8e28e3ab-0060-43f7-b033-c16bd77c0e29|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|5|SCREENING|2020-11-30|10
e|SS|8e28e3ab-0060-43f7-b033-c16bd77c0e29|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|2|TREATMENT|2020-12-15|25
e|SS|8e28e3ab-0060-43f7-b033-c16bd77c0e29|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|2|FOLLOW-UP|2020-12-15|25
e|SS|8e28e3ab-0060-43f7-b033-c16bd77c0e29|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|7|SCREENING|2020-12-30|40
e|SS|8e28e3ab-0060-43f7-b033-c16bd77c0e29|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|1|TREATMENT|2020-12-30|40
e|SS|8e28e3ab-0060-43f7-b033-c16bd77c0e29|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|3|SCREENING|2021-01-24|65
e|SS|8e28e3ab-0060-43f7-b033-c16bd77c0e29|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|6|TREATMENT|2021-01-24|65
e|SS|8e28e3ab-0060-43f7-b033-c16bd77c0e29|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|5|FOLLOW-UP|2021-02-18|90
e|SS|8e28e3ab-0060-43f7-b033-c16bd77c0e29|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|3|SCREENING|2021-02-18|90
e|SS|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|1|TREATMENT|2020-06-27|10
e|SS|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|3|WASHOUT|2020-06-27|10
e|SS|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|4|WASHOUT|2020-07-12|25
e|SS|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|4|TREATMENT|2020-07-12|25
e|SS|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|1|TREATMENT|2020-07-27|40
e|SS|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|2|FOLLOW-UP|2020-07-27|40
e|SS|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|3|WASHOUT|2020-08-21|65
e|SS|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|7|WASHOUT|2020-08-21|65
e|SS|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|1|WASHOUT|2020-09-15|90
e|SS|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|7|SCREENING|2020-09-15|90
e|SS|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|4|TREATMENT|2020-06-22|10
e|SS|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|4|TREATMENT|2020-06-22|10
e|SS|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|5|WASHOUT|2020-07-07|25
e|SS|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|2|TREATMENT|2020-07-07|25
e|SS|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|5|SCREENING|2020-07-22|40
e|SS|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-07-22|40
e|SS|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|5|TREATMENT|2020-08-16|65
e|SS|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|3|TREATMENT|2020-08-16|65
e|SS|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|7|TREATMENT|2020-09-10|90
e|SS|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|WASHOUT|2020-09-10|90
e|SS|43880587-c397-402d-886b-9b666e3fe455|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|3|TREATMENT|2020-07-21|10
e|SS|43880587-c397-402d-886b-9b666e3fe455|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|3|SCREENING|2020-07-21|10
e|SS|43880587-c397-402d-886b-9b666e3fe455|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|7|TREATMENT|2020-08-05|25
e|SS|43880587-c397-402d-886b-9b666e3fe455|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|6|WASHOUT|2020-08-05|25
e|SS|43880587-c397-402d-886b-9b666e3fe455|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|TREATMENT|2020-08-20|40
e|SS|43880587-c397-402d-886b-9b666e3fe455|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|FOLLOW-UP|2020-08-20|40
e|SS|43880587-c397-402d-886b-9b666e3fe455|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|2|TREATMENT|2020-09-14|65
e|SS|43880587-c397-402d-886b-9b666e3fe455|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2020-09-14|65
e|SS|43880587-c397-402d-886b-9b666e3fe455|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|6|SCREENING|2020-10-09|90
e|SS|43880587-c397-402d-886b-9b666e3fe455|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|6|TREATMENT|2020-10-09|90
e|SS|807f83d2-9364-4ee4-855d-304f3e252555|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|WASHOUT|2020-05-14|10
e|SS|807f83d2-9364-4ee4-855d-304f3e252555|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2020-05-14|10
e|SS|807f83d2-9364-4ee4-855d-304f3e252555|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|1|TREATMENT|2020-05-29|25
e|SS|807f83d2-9364-4ee4-855d-304f3e252555|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|2|SCREENING|2020-05-29|25
e|SS|807f83d2-9364-4ee4-855d-304f3e252555|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|3|TREATMENT|2020-06-13|40
e|SS|807f83d2-9364-4ee4-855d-304f3e252555|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|3|TREATMENT|2020-06-13|40
e|SS|807f83d2-9364-4ee4-855d-304f3e252555|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|TREATMENT|2020-07-08|65
e|SS|807f83d2-9364-4ee4-855d-304f3e252555|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|7|WASHOUT|2020-07-08|65
e|SS|807f83d2-9364-4ee4-855d-304f3e252555|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|7|TREATMENT|2020-08-02|90
e|SS|807f83d2-9364-4ee4-855d-304f3e252555|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|SCREENING|2020-08-02|90
e|SS|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-12-09|10
e|SS|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|TREATMENT|2020-12-09|10
e|SS|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|4|TREATMENT|2020-12-24|25
e|SS|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|1|TREATMENT|2020-12-24|25
e|SS|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|5|TREATMENT|2021-01-08|40
e|SS|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|7|TREATMENT|2021-01-08|40
e|SS|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|2|FOLLOW-UP|2021-02-02|65
e|SS|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|4|FOLLOW-UP|2021-02-02|65
e|SS|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|5|WASHOUT|2021-02-27|90
e|SS|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|2|TREATMENT|2021-02-27|90
e|SS|81c33633-6ade-45fe-a78e-0e853d8aa9c2|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|2|WASHOUT|2020-08-15|10
e|SS|81c33633-6ade-45fe-a78e-0e853d8aa9c2|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|5|WASHOUT|2020-08-15|10
e|SS|81c33633-6ade-45fe-a78e-0e853d8aa9c2|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|2|TREATMENT|2020-08-30|25
e|SS|81c33633-6ade-45fe-a78e-0e853d8aa9c2|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|5|TREATMENT|2020-08-30|25
e|SS|81c33633-6ade-45fe-a78e-0e853d8aa9c2|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|TREATMENT|2020-09-14|40
e|SS|81c33633-6ade-45fe-a78e-0e853d8aa9c2|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|6|TREATMENT|2020-09-14|40
e|SS|81c33633-6ade-45fe-a78e-0e853d8aa9c2|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|7|TREATMENT|2020-10-09|65
e|SS|81c33633-6ade-45fe-a78e-0e853d8aa9c2|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2020-10-09|65
e|SS|81c33633-6ade-45fe-a78e-0e853d8aa9c2|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|WASHOUT|2020-11-03|90
e|SS|81c33633-6ade-45fe-a78e-0e853d8aa9c2|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|7|SCREENING|2020-11-03|90
e|SS|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|3|TREATMENT|2020-08-01|10
e|SS|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|4|TREATMENT|2020-08-01|10
e|SS|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|1|WASHOUT|2020-08-16|25
e|SS|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|3|TREATMENT|2020-08-16|25
e|SS|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|FOLLOW-UP|2020-08-31|40
e|SS|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2020-08-31|40
e|SS|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|4|TREATMENT|2020-09-25|65
e|SS|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|6|FOLLOW-UP|2020-09-25|65
e|SS|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|5|TREATMENT|2020-10-20|90
e|SS|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|7|TREATMENT|2020-10-20|90
e|SS|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|1|WASHOUT|2020-09-01|10
e|SS|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|1|TREATMENT|2020-09-01|10
e|SS|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|6|TREATMENT|2020-09-16|25
e|SS|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|4|TREATMENT|2020-09-16|25
e|SS|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|3|SCREENING|2020-10-01|40
e|SS|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|7|TREATMENT|2020-10-01|40
e|SS|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|2|TREATMENT|2020-10-26|65
e|SS|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|1|TREATMENT|2020-10-26|65
e|SS|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|2|SCREENING|2020-11-20|90
e|SS|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|1|TREATMENT|2020-11-20|90
e|SS|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|7|SCREENING|2021-01-27|10
e|SS|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|2|WASHOUT|2021-01-27|10
e|SS|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|3|SCREENING|2021-02-11|25
e|SS|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|FOLLOW-UP|2021-02-11|25
e|SS|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|5|TREATMENT|2021-02-26|40
e|SS|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|1|SCREENING|2021-02-26|40
e|SS|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|4|WASHOUT|2021-03-23|65
e|SS|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|4|FOLLOW-UP|2021-03-23|65
e|SS|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|7|TREATMENT|2021-04-17|90
e|SS|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|3|TREATMENT|2021-04-17|90
e|SS|21740641-69bb-49a9-a86d-2444914f6d12|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|7|SCREENING|2020-05-17|10
e|SS|21740641-69bb-49a9-a86d-2444914f6d12|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|1|TREATMENT|2020-05-17|10
e|SS|21740641-69bb-49a9-a86d-2444914f6d12|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|5|WASHOUT|2020-06-01|25
e|SS|21740641-69bb-49a9-a86d-2444914f6d12|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|7|TREATMENT|2020-06-01|25
e|SS|21740641-69bb-49a9-a86d-2444914f6d12|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|4|TREATMENT|2020-06-16|40
e|SS|21740641-69bb-49a9-a86d-2444914f6d12|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|2|SCREENING|2020-06-16|40
e|SS|21740641-69bb-49a9-a86d-2444914f6d12|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|2|FOLLOW-UP|2020-07-11|65
e|SS|21740641-69bb-49a9-a86d-2444914f6d12|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|TREATMENT|2020-07-11|65
e|SS|21740641-69bb-49a9-a86d-2444914f6d12|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|7|FOLLOW-UP|2020-08-05|90
e|SS|21740641-69bb-49a9-a86d-2444914f6d12|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|7|TREATMENT|2020-08-05|90
e|SS|c3984f41-30a0-49a4-a8bd-f36fad4621a8|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|7|TREATMENT|2020-06-18|10
e|SS|c3984f41-30a0-49a4-a8bd-f36fad4621a8|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|5|TREATMENT|2020-06-18|10
e|SS|c3984f41-30a0-49a4-a8bd-f36fad4621a8|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|2|WASHOUT|2020-07-03|25
e|SS|c3984f41-30a0-49a4-a8bd-f36fad4621a8|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|5|TREATMENT|2020-07-03|25
e|SS|c3984f41-30a0-49a4-a8bd-f36fad4621a8|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|3|TREATMENT|2020-07-18|40
e|SS|c3984f41-30a0-49a4-a8bd-f36fad4621a8|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|4|WASHOUT|2020-07-18|40
e|SS|c3984f41-30a0-49a4-a8bd-f36fad4621a8|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|1|FOLLOW-UP|2020-08-12|65
e|SS|c3984f41-30a0-49a4-a8bd-f36fad4621a8|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|7|TREATMENT|2020-08-12|65
e|SS|c3984f41-30a0-49a4-a8bd-f36fad4621a8|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|4|SCREENING|2020-09-06|90
e|SS|c3984f41-30a0-49a4-a8bd-f36fad4621a8|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|3|SCREENING|2020-09-06|90
e|SS|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|1|SCREENING|2021-01-21|10
e|SS|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|6|WASHOUT|2021-01-21|10
e|SS|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|7|SCREENING|2021-02-05|25
e|SS|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|3|TREATMENT|2021-02-05|25
e|SS|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|1|TREATMENT|2021-02-20|40
e|SS|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|7|FOLLOW-UP|2021-02-20|40
e|SS|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|7|SCREENING|2021-03-17|65
e|SS|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2021-03-17|65
e|SS|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|2|WASHOUT|2021-04-11|90
e|SS|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|1|FOLLOW-UP|2021-04-11|90
e|SS|0f85b859-187d-4c6b-8873-33c0f18d3e3c|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|1|FOLLOW-UP|2020-07-24|10
e|SS|0f85b859-187d-4c6b-8873-33c0f18d3e3c|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|3|FOLLOW-UP|2020-07-24|10
e|SS|0f85b859-187d-4c6b-8873-33c0f18d3e3c|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|3|WASHOUT|2020-08-08|25
e|SS|0f85b859-187d-4c6b-8873-33c0f18d3e3c|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|1|TREATMENT|2020-08-08|25
e|SS|0f85b859-187d-4c6b-8873-33c0f18d3e3c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|6|TREATMENT|2020-08-23|40
e|SS|0f85b859-187d-4c6b-8873-33c0f18d3e3c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-08-23|40
e|SS|0f85b859-187d-4c6b-8873-33c0f18d3e3c|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|5|TREATMENT|2020-09-17|65
e|SS|0f85b859-187d-4c6b-8873-33c0f18d3e3c|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|7|FOLLOW-UP|2020-09-17|65
e|SS|0f85b859-187d-4c6b-8873-33c0f18d3e3c|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|7|TREATMENT|2020-10-12|90
e|SS|0f85b859-187d-4c6b-8873-33c0f18d3e3c|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|4|TREATMENT|2020-10-12|90
e|SS|5e383a9d-dc97-4352-8add-d55a1a566b9f|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|4|WASHOUT|2020-09-27|10
e|SS|5e383a9d-dc97-4352-8add-d55a1a566b9f|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|2|TREATMENT|2020-09-27|10
e|SS|5e383a9d-dc97-4352-8add-d55a1a566b9f|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|4|WASHOUT|2020-10-12|25
e|SS|5e383a9d-dc97-4352-8add-d55a1a566b9f|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-10-12|25
e|SS|5e383a9d-dc97-4352-8add-d55a1a566b9f|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|7|WASHOUT|2020-10-27|40
e|SS|5e383a9d-dc97-4352-8add-d55a1a566b9f|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|TREATMENT|2020-10-27|40
e|SS|5e383a9d-dc97-4352-8add-d55a1a566b9f|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|2|TREATMENT|2020-11-21|65
e|SS|5e383a9d-dc97-4352-8add-d55a1a566b9f|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|6|TREATMENT|2020-11-21|65
e|SS|5e383a9d-dc97-4352-8add-d55a1a566b9f|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|7|TREATMENT|2020-12-16|90
e|SS|5e383a9d-dc97-4352-8add-d55a1a566b9f|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|2|SCREENING|2020-12-16|90
e|SS|3eda746b-fb97-4950-a528-1d4ae5d3653a|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|2|TREATMENT|2020-06-13|10
e|SS|3eda746b-fb97-4950-a528-1d4ae5d3653a|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|1|TREATMENT|2020-06-13|10
e|SS|3eda746b-fb97-4950-a528-1d4ae5d3653a|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|7|TREATMENT|2020-06-28|25
e|SS|3eda746b-fb97-4950-a528-1d4ae5d3653a|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|6|SCREENING|2020-06-28|25
e|SS|3eda746b-fb97-4950-a528-1d4ae5d3653a|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|3|SCREENING|2020-07-13|40
e|SS|3eda746b-fb97-4950-a528-1d4ae5d3653a|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|1|WASHOUT|2020-07-13|40
e|SS|3eda746b-fb97-4950-a528-1d4ae5d3653a|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|6|WASHOUT|2020-08-07|65
e|SS|3eda746b-fb97-4950-a528-1d4ae5d3653a|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|3|TREATMENT|2020-08-07|65
e|SS|3eda746b-fb97-4950-a528-1d4ae5d3653a|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|4|TREATMENT|2020-09-01|90
e|SS|3eda746b-fb97-4950-a528-1d4ae5d3653a|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|4|SCREENING|2020-09-01|90
e|SS|a3b72841-3401-4dcc-9d06-75438b408d0b|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|7|TREATMENT|2020-11-05|10
e|SS|a3b72841-3401-4dcc-9d06-75438b408d0b|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|3|SCREENING|2020-11-05|10
e|SS|a3b72841-3401-4dcc-9d06-75438b408d0b|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|7|TREATMENT|2020-11-20|25
e|SS|a3b72841-3401-4dcc-9d06-75438b408d0b|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|2|TREATMENT|2020-11-20|25
e|SS|a3b72841-3401-4dcc-9d06-75438b408d0b|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|6|WASHOUT|2020-12-05|40
e|SS|a3b72841-3401-4dcc-9d06-75438b408d0b|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-12-05|40
e|SS|a3b72841-3401-4dcc-9d06-75438b408d0b|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|SCREENING|2020-12-30|65
e|SS|a3b72841-3401-4dcc-9d06-75438b408d0b|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|7|TREATMENT|2020-12-30|65
e|SS|a3b72841-3401-4dcc-9d06-75438b408d0b|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|1|TREATMENT|2021-01-24|90
e|SS|a3b72841-3401-4dcc-9d06-75438b408d0b|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|1|TREATMENT|2021-01-24|90
e|SS|4393406e-bda5-42e4-a752-a8121004b7ef|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|FOLLOW-UP|2020-10-28|10
e|SS|4393406e-bda5-42e4-a752-a8121004b7ef|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|7|TREATMENT|2020-10-28|10
e|SS|4393406e-bda5-42e4-a752-a8121004b7ef|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|6|WASHOUT|2020-11-12|25
e|SS|4393406e-bda5-42e4-a752-a8121004b7ef|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|7|SCREENING|2020-11-12|25
e|SS|4393406e-bda5-42e4-a752-a8121004b7ef|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|6|WASHOUT|2020-11-27|40
e|SS|4393406e-bda5-42e4-a752-a8121004b7ef|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|7|TREATMENT|2020-11-27|40
e|SS|4393406e-bda5-42e4-a752-a8121004b7ef|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|7|TREATMENT|2020-12-22|65
e|SS|4393406e-bda5-42e4-a752-a8121004b7ef|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2020-12-22|65
e|SS|4393406e-bda5-42e4-a752-a8121004b7ef|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|3|TREATMENT|2021-01-16|90
e|SS|4393406e-bda5-42e4-a752-a8121004b7ef|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2021-01-16|90
e|SS|d70f5903-3d94-422b-8f69-212f015b54c9|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|TREATMENT|2020-08-17|100
e|SS|d70f5903-3d94-422b-8f69-212f015b54c9|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|STUDY SUBJECT|1|Visit_1|10|2|WASHOUT|2020-08-17|100
e|SS|d70f5903-3d94-422b-8f69-212f015b54c9|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|7|SCREENING|2020-08-17|100
e|SS|d70f5903-3d94-422b-8f69-212f015b54c9|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|STUDY SUBJECT|2|Visit_2|25|6|SCREENING|2020-08-17|100
e|SS|d70f5903-3d94-422b-8f69-212f015b54c9|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|CAREGIVER|3|Visit_3|40|2|TREATMENT|2020-08-17|100
e|SS|d70f5903-3d94-422b-8f69-212f015b54c9|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATION COMMITTEE|3|Visit_3|40|5|FOLLOW-UP|2020-08-17|100
e|SS|d70f5903-3d94-422b-8f69-212f015b54c9|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIGNIFICANT OTHER|4|Visit_4|65|5|WASHOUT|2020-08-17|100
e|SS|d70f5903-3d94-422b-8f69-212f015b54c9|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATOR|4|Visit_4|65|5|TREATMENT|2020-08-17|100
e|SS|d70f5903-3d94-422b-8f69-212f015b54c9|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|FOLLOW-UP|2020-08-17|100
e|SS|d70f5903-3d94-422b-8f69-212f015b54c9|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIBLING|5|Visit_5|90|1|TREATMENT|2020-08-17|100
e|SS|ef772266-faf1-4904-8ac3-19cbc3ea7d36|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|1|TREATMENT|2021-01-06|10
e|SS|ef772266-faf1-4904-8ac3-19cbc3ea7d36|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|5|WASHOUT|2021-01-06|10
e|SS|ef772266-faf1-4904-8ac3-19cbc3ea7d36|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|3|SCREENING|2021-01-21|25
e|SS|ef772266-faf1-4904-8ac3-19cbc3ea7d36|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|3|WASHOUT|2021-01-21|25
e|SS|ef772266-faf1-4904-8ac3-19cbc3ea7d36|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2021-02-05|40
e|SS|ef772266-faf1-4904-8ac3-19cbc3ea7d36|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|4|TREATMENT|2021-02-05|40
e|SS|ef772266-faf1-4904-8ac3-19cbc3ea7d36|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|5|FOLLOW-UP|2021-03-02|65
e|SS|ef772266-faf1-4904-8ac3-19cbc3ea7d36|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|5|TREATMENT|2021-03-02|65
e|SS|ef772266-faf1-4904-8ac3-19cbc3ea7d36|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|6|TREATMENT|2021-03-27|90
e|SS|ef772266-faf1-4904-8ac3-19cbc3ea7d36|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|3|TREATMENT|2021-03-27|90
e|SS|c0f9c36c-1ae5-4f80-b936-0afe3f661746|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|4|TREATMENT|2020-07-14|10
e|SS|c0f9c36c-1ae5-4f80-b936-0afe3f661746|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|6|FOLLOW-UP|2020-07-14|10
e|SS|c0f9c36c-1ae5-4f80-b936-0afe3f661746|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|3|TREATMENT|2020-07-29|25
e|SS|c0f9c36c-1ae5-4f80-b936-0afe3f661746|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|5|FOLLOW-UP|2020-07-29|25
e|SS|c0f9c36c-1ae5-4f80-b936-0afe3f661746|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|FOLLOW-UP|2020-08-13|40
e|SS|c0f9c36c-1ae5-4f80-b936-0afe3f661746|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|2|TREATMENT|2020-08-13|40
e|SS|c0f9c36c-1ae5-4f80-b936-0afe3f661746|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|2|WASHOUT|2020-09-07|65
e|SS|c0f9c36c-1ae5-4f80-b936-0afe3f661746|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|1|FOLLOW-UP|2020-09-07|65
e|SS|c0f9c36c-1ae5-4f80-b936-0afe3f661746|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|4|SCREENING|2020-10-02|90
e|SS|c0f9c36c-1ae5-4f80-b936-0afe3f661746|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|6|TREATMENT|2020-10-02|90
e|SS|f17b5630-e782-4135-8a50-4a9bb2fe63b1|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|6|WASHOUT|2020-11-29|10
e|SS|f17b5630-e782-4135-8a50-4a9bb2fe63b1|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|5|SCREENING|2020-11-29|10
e|SS|f17b5630-e782-4135-8a50-4a9bb2fe63b1|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|1|TREATMENT|2020-12-14|25
e|SS|f17b5630-e782-4135-8a50-4a9bb2fe63b1|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|1|FOLLOW-UP|2020-12-14|25
e|SS|f17b5630-e782-4135-8a50-4a9bb2fe63b1|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|4|FOLLOW-UP|2020-12-29|40
e|SS|f17b5630-e782-4135-8a50-4a9bb2fe63b1|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|1|FOLLOW-UP|2020-12-29|40
e|SS|f17b5630-e782-4135-8a50-4a9bb2fe63b1|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|4|SCREENING|2021-01-23|65
e|SS|f17b5630-e782-4135-8a50-4a9bb2fe63b1|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|3|TREATMENT|2021-01-23|65
e|SS|f17b5630-e782-4135-8a50-4a9bb2fe63b1|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|4|TREATMENT|2021-02-17|90
e|SS|f17b5630-e782-4135-8a50-4a9bb2fe63b1|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|5|TREATMENT|2021-02-17|90
e|SS|8bdb40c9-1e44-45ae-bf08-81ea635fd762|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|FOLLOW-UP|2021-01-02|10
e|SS|8bdb40c9-1e44-45ae-bf08-81ea635fd762|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|3|SCREENING|2021-01-02|10
e|SS|8bdb40c9-1e44-45ae-bf08-81ea635fd762|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|6|FOLLOW-UP|2021-01-17|25
e|SS|8bdb40c9-1e44-45ae-bf08-81ea635fd762|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|5|WASHOUT|2021-01-17|25
e|SS|8bdb40c9-1e44-45ae-bf08-81ea635fd762|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|4|TREATMENT|2021-02-01|40
e|SS|8bdb40c9-1e44-45ae-bf08-81ea635fd762|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|WASHOUT|2021-02-01|40
e|SS|8bdb40c9-1e44-45ae-bf08-81ea635fd762|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|4|WASHOUT|2021-02-26|65
e|SS|8bdb40c9-1e44-45ae-bf08-81ea635fd762|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|5|SCREENING|2021-02-26|65
e|SS|8bdb40c9-1e44-45ae-bf08-81ea635fd762|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|5|WASHOUT|2021-03-23|90
e|SS|8bdb40c9-1e44-45ae-bf08-81ea635fd762|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|1|TREATMENT|2021-03-23|90
e|SS|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|5|TREATMENT|2021-01-16|10
e|SS|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|5|TREATMENT|2021-01-16|10
e|SS|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|6|SCREENING|2021-01-31|25
e|SS|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|4|TREATMENT|2021-01-31|25
e|SS|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|6|FOLLOW-UP|2021-02-15|40
e|SS|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|4|WASHOUT|2021-02-15|40
e|SS|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|2|TREATMENT|2021-03-12|65
e|SS|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|6|TREATMENT|2021-03-12|65
e|SS|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|5|WASHOUT|2021-04-06|90
e|SS|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|5|TREATMENT|2021-04-06|90
e|SS|296f8314-5a07-47b5-8796-31afe709b379|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|5|TREATMENT|2020-07-08|10
e|SS|296f8314-5a07-47b5-8796-31afe709b379|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|1|WASHOUT|2020-07-08|10
e|SS|296f8314-5a07-47b5-8796-31afe709b379|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|TREATMENT|2020-07-23|25
e|SS|296f8314-5a07-47b5-8796-31afe709b379|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|2|TREATMENT|2020-07-23|25
e|SS|296f8314-5a07-47b5-8796-31afe709b379|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|1|TREATMENT|2020-08-07|40
e|SS|296f8314-5a07-47b5-8796-31afe709b379|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|6|WASHOUT|2020-08-07|40
e|SS|296f8314-5a07-47b5-8796-31afe709b379|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|7|FOLLOW-UP|2020-09-01|65
e|SS|296f8314-5a07-47b5-8796-31afe709b379|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|7|SCREENING|2020-09-01|65
e|SS|296f8314-5a07-47b5-8796-31afe709b379|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|6|TREATMENT|2020-09-26|90
e|SS|296f8314-5a07-47b5-8796-31afe709b379|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|7|TREATMENT|2020-09-26|90
e|SS|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|FOLLOW-UP|2020-12-13|10
e|SS|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|1|TREATMENT|2020-12-13|10
e|SS|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|TREATMENT|2020-12-28|25
e|SS|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|6|TREATMENT|2020-12-28|25
e|SS|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|6|SCREENING|2021-01-12|40
e|SS|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|4|TREATMENT|2021-01-12|40
e|SS|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|7|TREATMENT|2021-02-06|65
e|SS|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|4|TREATMENT|2021-02-06|65
e|SS|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|TREATMENT|2021-03-03|90
e|SS|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|7|TREATMENT|2021-03-03|90
e|SS|b06043ae-8251-4df8-ab6d-0ceb269c1a42|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|7|WASHOUT|2021-01-25|10
e|SS|b06043ae-8251-4df8-ab6d-0ceb269c1a42|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|6|WASHOUT|2021-01-25|10
e|SS|b06043ae-8251-4df8-ab6d-0ceb269c1a42|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|3|WASHOUT|2021-02-09|25
e|SS|b06043ae-8251-4df8-ab6d-0ceb269c1a42|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|1|WASHOUT|2021-02-09|25
e|SS|b06043ae-8251-4df8-ab6d-0ceb269c1a42|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|2|TREATMENT|2021-02-24|40
e|SS|b06043ae-8251-4df8-ab6d-0ceb269c1a42|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|2|WASHOUT|2021-02-24|40
e|SS|b06043ae-8251-4df8-ab6d-0ceb269c1a42|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|3|TREATMENT|2021-03-21|65
e|SS|b06043ae-8251-4df8-ab6d-0ceb269c1a42|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|3|SCREENING|2021-03-21|65
e|SS|b06043ae-8251-4df8-ab6d-0ceb269c1a42|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|6|TREATMENT|2021-04-15|90
e|SS|b06043ae-8251-4df8-ab6d-0ceb269c1a42|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|3|WASHOUT|2021-04-15|90
e|SS|d4fb5b9e-e244-4818-be3d-dbb57faacd43|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|2|WASHOUT|2020-11-07|10
e|SS|d4fb5b9e-e244-4818-be3d-dbb57faacd43|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|6|TREATMENT|2020-11-07|10
e|SS|d4fb5b9e-e244-4818-be3d-dbb57faacd43|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|3|WASHOUT|2020-11-22|25
e|SS|d4fb5b9e-e244-4818-be3d-dbb57faacd43|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|3|SCREENING|2020-11-22|25
e|SS|d4fb5b9e-e244-4818-be3d-dbb57faacd43|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|5|TREATMENT|2020-12-07|40
e|SS|d4fb5b9e-e244-4818-be3d-dbb57faacd43|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|1|TREATMENT|2020-12-07|40
e|SS|d4fb5b9e-e244-4818-be3d-dbb57faacd43|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|3|FOLLOW-UP|2021-01-01|65
e|SS|d4fb5b9e-e244-4818-be3d-dbb57faacd43|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|4|TREATMENT|2021-01-01|65
e|SS|d4fb5b9e-e244-4818-be3d-dbb57faacd43|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|7|FOLLOW-UP|2021-01-26|90
e|SS|d4fb5b9e-e244-4818-be3d-dbb57faacd43|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|6|FOLLOW-UP|2021-01-26|90
e|SS|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|5|TREATMENT|2020-07-13|10
e|SS|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|3|TREATMENT|2020-07-13|10
e|SS|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|3|SCREENING|2020-07-28|25
e|SS|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|3|SCREENING|2020-07-28|25
e|SS|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-08-12|40
e|SS|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|6|TREATMENT|2020-08-12|40
e|SS|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|1|TREATMENT|2020-09-06|65
e|SS|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|2|TREATMENT|2020-09-06|65
e|SS|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|3|SCREENING|2020-10-01|90
e|SS|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|4|WASHOUT|2020-10-01|90
e|SS|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|1|TREATMENT|2021-01-14|10
e|SS|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|1|FOLLOW-UP|2021-01-14|10
e|SS|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|FOLLOW-UP|2021-01-29|25
e|SS|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|7|TREATMENT|2021-01-29|25
e|SS|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|3|FOLLOW-UP|2021-02-13|40
e|SS|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|3|TREATMENT|2021-02-13|40
e|SS|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2021-03-10|65
e|SS|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|1|TREATMENT|2021-03-10|65
e|SS|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|4|FOLLOW-UP|2021-04-04|90
e|SS|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|2|FOLLOW-UP|2021-04-04|90
e|SS|b1215705-4c22-43bd-aa65-58bd8745f081|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|4|TREATMENT|2020-07-15|10
e|SS|b1215705-4c22-43bd-aa65-58bd8745f081|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|2|TREATMENT|2020-07-15|10
e|SS|b1215705-4c22-43bd-aa65-58bd8745f081|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|5|SCREENING|2020-07-30|25
e|SS|b1215705-4c22-43bd-aa65-58bd8745f081|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|2|TREATMENT|2020-07-30|25
e|SS|b1215705-4c22-43bd-aa65-58bd8745f081|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|WASHOUT|2020-08-14|40
e|SS|b1215705-4c22-43bd-aa65-58bd8745f081|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|2|TREATMENT|2020-08-14|40
e|SS|b1215705-4c22-43bd-aa65-58bd8745f081|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|6|WASHOUT|2020-09-08|65
e|SS|b1215705-4c22-43bd-aa65-58bd8745f081|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|6|SCREENING|2020-09-08|65
e|SS|b1215705-4c22-43bd-aa65-58bd8745f081|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|2|TREATMENT|2020-10-03|90
e|SS|b1215705-4c22-43bd-aa65-58bd8745f081|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|TREATMENT|2020-10-03|90
e|SS|b99c6528-af4e-42f5-8d2d-18943b57d55a|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|6|SCREENING|2020-10-25|10
e|SS|b99c6528-af4e-42f5-8d2d-18943b57d55a|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|5|TREATMENT|2020-10-25|10
e|SS|b99c6528-af4e-42f5-8d2d-18943b57d55a|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|6|FOLLOW-UP|2020-11-09|25
e|SS|b99c6528-af4e-42f5-8d2d-18943b57d55a|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|2|FOLLOW-UP|2020-11-09|25
e|SS|b99c6528-af4e-42f5-8d2d-18943b57d55a|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|5|SCREENING|2020-11-24|40
e|SS|b99c6528-af4e-42f5-8d2d-18943b57d55a|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2020-11-24|40
e|SS|b99c6528-af4e-42f5-8d2d-18943b57d55a|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|5|TREATMENT|2020-12-19|65
e|SS|b99c6528-af4e-42f5-8d2d-18943b57d55a|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|4|TREATMENT|2020-12-19|65
e|SS|b99c6528-af4e-42f5-8d2d-18943b57d55a|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|4|TREATMENT|2021-01-13|90
e|SS|b99c6528-af4e-42f5-8d2d-18943b57d55a|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|2|TREATMENT|2021-01-13|90
e|SS|6848e438-51ca-4a7d-8f81-26c375969a64|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|FOLLOW-UP|2020-11-12|10
e|SS|6848e438-51ca-4a7d-8f81-26c375969a64|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|1|TREATMENT|2020-11-12|10
e|SS|6848e438-51ca-4a7d-8f81-26c375969a64|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|2|SCREENING|2020-11-27|25
e|SS|6848e438-51ca-4a7d-8f81-26c375969a64|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|1|FOLLOW-UP|2020-11-27|25
e|SS|6848e438-51ca-4a7d-8f81-26c375969a64|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|1|WASHOUT|2020-12-12|40
e|SS|6848e438-51ca-4a7d-8f81-26c375969a64|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|7|FOLLOW-UP|2020-12-12|40
e|SS|6848e438-51ca-4a7d-8f81-26c375969a64|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|6|TREATMENT|2021-01-06|65
e|SS|6848e438-51ca-4a7d-8f81-26c375969a64|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|5|WASHOUT|2021-01-06|65
e|SS|6848e438-51ca-4a7d-8f81-26c375969a64|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|5|TREATMENT|2021-01-31|90
e|SS|6848e438-51ca-4a7d-8f81-26c375969a64|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|3|FOLLOW-UP|2021-01-31|90
e|SS|a6e11c33-7905-42d2-bda9-671d756d4c51|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|PARENT|1|Visit_1|10|6|FOLLOW-UP|2020-11-04|100
e|SS|a6e11c33-7905-42d2-bda9-671d756d4c51|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|STUDY SUBJECT|1|Visit_1|10|7|TREATMENT|2020-11-04|100
e|SS|a6e11c33-7905-42d2-bda9-671d756d4c51|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|CAREGIVER|2|Visit_2|25|5|TREATMENT|2020-11-04|100
e|SS|a6e11c33-7905-42d2-bda9-671d756d4c51|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL STUDY SPONSOR|2|Visit_2|25|7|TREATMENT|2020-11-04|100
e|SS|a6e11c33-7905-42d2-bda9-671d756d4c51|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|FAMILY MEMBER|3|Visit_3|40|1|TREATMENT|2020-11-04|100
e|SS|a6e11c33-7905-42d2-bda9-671d756d4c51|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATION COMMITTEE|3|Visit_3|40|2|TREATMENT|2020-11-04|100
e|SS|a6e11c33-7905-42d2-bda9-671d756d4c51|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|TREATMENT|2020-11-04|100
e|SS|a6e11c33-7905-42d2-bda9-671d756d4c51|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|FAMILY MEMBER|4|Visit_4|65|3|TREATMENT|2020-11-04|100
e|SS|a6e11c33-7905-42d2-bda9-671d756d4c51|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|VENDOR|5|Visit_5|90|2|SCREENING|2020-11-04|100
e|SS|a6e11c33-7905-42d2-bda9-671d756d4c51|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATOR|5|Visit_5|90|1|SCREENING|2020-11-04|100
e|SS|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|5|FOLLOW-UP|2020-11-12|10
e|SS|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|5|SCREENING|2020-11-12|10
e|SS|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|5|TREATMENT|2020-11-27|25
e|SS|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|1|TREATMENT|2020-11-27|25
e|SS|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|5|FOLLOW-UP|2020-12-12|40
e|SS|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|1|FOLLOW-UP|2020-12-12|40
e|SS|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2021-01-06|65
e|SS|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|2|TREATMENT|2021-01-06|65
e|SS|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|5|TREATMENT|2021-01-31|90
e|SS|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|3|WASHOUT|2021-01-31|90
e|SS|8ef37b54-b463-43a4-879f-3ad653c4fef4|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|2|TREATMENT|2020-09-11|10
e|SS|8ef37b54-b463-43a4-879f-3ad653c4fef4|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|6|TREATMENT|2020-09-11|10
e|SS|8ef37b54-b463-43a4-879f-3ad653c4fef4|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|6|FOLLOW-UP|2020-09-26|25
e|SS|8ef37b54-b463-43a4-879f-3ad653c4fef4|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|SCREENING|2020-09-26|25
e|SS|8ef37b54-b463-43a4-879f-3ad653c4fef4|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|1|FOLLOW-UP|2020-10-11|40
e|SS|8ef37b54-b463-43a4-879f-3ad653c4fef4|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|4|SCREENING|2020-10-11|40
e|SS|8ef37b54-b463-43a4-879f-3ad653c4fef4|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|3|TREATMENT|2020-11-05|65
e|SS|8ef37b54-b463-43a4-879f-3ad653c4fef4|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|1|TREATMENT|2020-11-05|65
e|SS|8ef37b54-b463-43a4-879f-3ad653c4fef4|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|3|SCREENING|2020-11-30|90
e|SS|8ef37b54-b463-43a4-879f-3ad653c4fef4|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|7|FOLLOW-UP|2020-11-30|90
e|SS|cf10035c-4d44-4512-810b-c267d1c8821b|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|2|TREATMENT|2020-05-27|10
e|SS|cf10035c-4d44-4512-810b-c267d1c8821b|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|6|TREATMENT|2020-05-27|10
e|SS|cf10035c-4d44-4512-810b-c267d1c8821b|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|4|SCREENING|2020-06-11|25
e|SS|cf10035c-4d44-4512-810b-c267d1c8821b|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|4|TREATMENT|2020-06-11|25
e|SS|cf10035c-4d44-4512-810b-c267d1c8821b|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|6|WASHOUT|2020-06-26|40
e|SS|cf10035c-4d44-4512-810b-c267d1c8821b|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|1|TREATMENT|2020-06-26|40
e|SS|cf10035c-4d44-4512-810b-c267d1c8821b|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|4|FOLLOW-UP|2020-07-21|65
e|SS|cf10035c-4d44-4512-810b-c267d1c8821b|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|4|TREATMENT|2020-07-21|65
e|SS|cf10035c-4d44-4512-810b-c267d1c8821b|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|6|FOLLOW-UP|2020-08-15|90
e|SS|cf10035c-4d44-4512-810b-c267d1c8821b|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|6|TREATMENT|2020-08-15|90
e|SS|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|7|SCREENING|2020-08-01|10
e|SS|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|4|FOLLOW-UP|2020-08-01|10
e|SS|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|6|WASHOUT|2020-08-16|25
e|SS|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|6|TREATMENT|2020-08-16|25
e|SS|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|5|TREATMENT|2020-08-31|40
e|SS|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|3|WASHOUT|2020-08-31|40
e|SS|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|6|WASHOUT|2020-09-25|65
e|SS|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|2|TREATMENT|2020-09-25|65
e|SS|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|5|TREATMENT|2020-10-20|90
e|SS|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|3|TREATMENT|2020-10-20|90
e|SS|a1e0035a-3328-4966-8664-82e53a44eb59|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|6|TREATMENT|2020-08-10|10
e|SS|a1e0035a-3328-4966-8664-82e53a44eb59|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|1|FOLLOW-UP|2020-08-10|10
e|SS|a1e0035a-3328-4966-8664-82e53a44eb59|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|1|TREATMENT|2020-08-25|25
e|SS|a1e0035a-3328-4966-8664-82e53a44eb59|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|WASHOUT|2020-08-25|25
e|SS|a1e0035a-3328-4966-8664-82e53a44eb59|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2020-09-09|40
e|SS|a1e0035a-3328-4966-8664-82e53a44eb59|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|2|TREATMENT|2020-09-09|40
e|SS|a1e0035a-3328-4966-8664-82e53a44eb59|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|6|TREATMENT|2020-10-04|65
e|SS|a1e0035a-3328-4966-8664-82e53a44eb59|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|1|FOLLOW-UP|2020-10-04|65
e|SS|a1e0035a-3328-4966-8664-82e53a44eb59|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|1|TREATMENT|2020-10-29|90
e|SS|a1e0035a-3328-4966-8664-82e53a44eb59|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|6|TREATMENT|2020-10-29|90
e|SS|771377fd-724f-4056-b2ea-84e1adab1f47|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|SCREENING|2020-11-08|10
e|SS|771377fd-724f-4056-b2ea-84e1adab1f47|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|7|TREATMENT|2020-11-08|10
e|SS|771377fd-724f-4056-b2ea-84e1adab1f47|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|7|FOLLOW-UP|2020-11-23|25
e|SS|771377fd-724f-4056-b2ea-84e1adab1f47|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|6|TREATMENT|2020-11-23|25
e|SS|771377fd-724f-4056-b2ea-84e1adab1f47|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|5|TREATMENT|2020-12-08|40
e|SS|771377fd-724f-4056-b2ea-84e1adab1f47|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|5|SCREENING|2020-12-08|40
e|SS|771377fd-724f-4056-b2ea-84e1adab1f47|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|2|FOLLOW-UP|2021-01-02|65
e|SS|771377fd-724f-4056-b2ea-84e1adab1f47|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|3|TREATMENT|2021-01-02|65
e|SS|771377fd-724f-4056-b2ea-84e1adab1f47|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|3|TREATMENT|2021-01-27|90
e|SS|771377fd-724f-4056-b2ea-84e1adab1f47|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|6|SCREENING|2021-01-27|90
e|SS|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|2|TREATMENT|2020-08-23|10
e|SS|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|7|TREATMENT|2020-08-23|10
e|SS|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|3|WASHOUT|2020-09-07|25
e|SS|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|4|TREATMENT|2020-09-07|25
e|SS|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|6|TREATMENT|2020-09-22|40
e|SS|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|1|TREATMENT|2020-09-22|40
e|SS|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|5|FOLLOW-UP|2020-10-17|65
e|SS|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|5|TREATMENT|2020-10-17|65
e|SS|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|2|FOLLOW-UP|2020-11-11|90
e|SS|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|1|FOLLOW-UP|2020-11-11|90
e|SS|3aea0861-8f67-4717-93ce-c1e322f151d9|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|7|SCREENING|2020-08-14|10
e|SS|3aea0861-8f67-4717-93ce-c1e322f151d9|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|6|SCREENING|2020-08-14|10
e|SS|3aea0861-8f67-4717-93ce-c1e322f151d9|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|7|SCREENING|2020-08-29|25
e|SS|3aea0861-8f67-4717-93ce-c1e322f151d9|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|2|TREATMENT|2020-08-29|25
e|SS|3aea0861-8f67-4717-93ce-c1e322f151d9|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|3|TREATMENT|2020-09-13|40
e|SS|3aea0861-8f67-4717-93ce-c1e322f151d9|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|7|FOLLOW-UP|2020-09-13|40
e|SS|3aea0861-8f67-4717-93ce-c1e322f151d9|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|1|TREATMENT|2020-10-08|65
e|SS|3aea0861-8f67-4717-93ce-c1e322f151d9|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|4|TREATMENT|2020-10-08|65
e|SS|3aea0861-8f67-4717-93ce-c1e322f151d9|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|4|TREATMENT|2020-11-02|90
e|SS|3aea0861-8f67-4717-93ce-c1e322f151d9|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|2|TREATMENT|2020-11-02|90
e|SS|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|7|TREATMENT|2020-10-05|10
e|SS|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|6|SCREENING|2020-10-05|10
e|SS|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|5|TREATMENT|2020-10-20|25
e|SS|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|3|FOLLOW-UP|2020-10-20|25
e|SS|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|TREATMENT|2020-11-04|40
e|SS|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|FOLLOW-UP|2020-11-04|40
e|SS|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|5|TREATMENT|2020-11-29|65
e|SS|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|3|WASHOUT|2020-11-29|65
e|SS|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|5|SCREENING|2020-12-24|90
e|SS|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|4|WASHOUT|2020-12-24|90
e|SS|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|3|TREATMENT|2020-12-30|10
e|SS|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|FOLLOW-UP|2020-12-30|10
e|SS|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|4|TREATMENT|2021-01-14|25
e|SS|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|5|TREATMENT|2021-01-14|25
e|SS|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|1|FOLLOW-UP|2021-01-29|40
e|SS|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|2|SCREENING|2021-01-29|40
e|SS|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|2|FOLLOW-UP|2021-02-23|65
e|SS|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|6|TREATMENT|2021-02-23|65
e|SS|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|5|WASHOUT|2021-03-20|90
e|SS|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|4|TREATMENT|2021-03-20|90
e|SS|39f51bd8-5edc-4434-92d4-7d8b683a6c32|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|3|SCREENING|2020-09-19|10
e|SS|39f51bd8-5edc-4434-92d4-7d8b683a6c32|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|1|SCREENING|2020-09-19|10
e|SS|39f51bd8-5edc-4434-92d4-7d8b683a6c32|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-10-04|25
e|SS|39f51bd8-5edc-4434-92d4-7d8b683a6c32|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|3|SCREENING|2020-10-04|25
e|SS|39f51bd8-5edc-4434-92d4-7d8b683a6c32|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|3|TREATMENT|2020-10-19|40
e|SS|39f51bd8-5edc-4434-92d4-7d8b683a6c32|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|3|TREATMENT|2020-10-19|40
e|SS|39f51bd8-5edc-4434-92d4-7d8b683a6c32|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|6|TREATMENT|2020-11-13|65
e|SS|39f51bd8-5edc-4434-92d4-7d8b683a6c32|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|6|TREATMENT|2020-11-13|65
e|SS|39f51bd8-5edc-4434-92d4-7d8b683a6c32|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|WASHOUT|2020-12-08|90
e|SS|39f51bd8-5edc-4434-92d4-7d8b683a6c32|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|2|TREATMENT|2020-12-08|90
e|SS|80565a22-8cec-46a2-abd7-91daf0767035|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|2|TREATMENT|2021-01-28|10
e|SS|80565a22-8cec-46a2-abd7-91daf0767035|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|FOLLOW-UP|2021-01-28|10
e|SS|80565a22-8cec-46a2-abd7-91daf0767035|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|1|SCREENING|2021-02-12|25
e|SS|80565a22-8cec-46a2-abd7-91daf0767035|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|3|TREATMENT|2021-02-12|25
e|SS|80565a22-8cec-46a2-abd7-91daf0767035|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|3|SCREENING|2021-02-27|40
e|SS|80565a22-8cec-46a2-abd7-91daf0767035|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|5|WASHOUT|2021-02-27|40
e|SS|80565a22-8cec-46a2-abd7-91daf0767035|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|7|TREATMENT|2021-03-24|65
e|SS|80565a22-8cec-46a2-abd7-91daf0767035|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|7|WASHOUT|2021-03-24|65
e|SS|80565a22-8cec-46a2-abd7-91daf0767035|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|2|FOLLOW-UP|2021-04-18|90
e|SS|80565a22-8cec-46a2-abd7-91daf0767035|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|FOLLOW-UP|2021-04-18|90
e|SS|585a254e-c36b-44cf-b8a9-335fb98e0fd2|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|5|WASHOUT|2020-10-19|10
e|SS|585a254e-c36b-44cf-b8a9-335fb98e0fd2|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|2|SCREENING|2020-10-19|10
e|SS|585a254e-c36b-44cf-b8a9-335fb98e0fd2|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|FOLLOW-UP|2020-11-03|25
e|SS|585a254e-c36b-44cf-b8a9-335fb98e0fd2|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|5|SCREENING|2020-11-03|25
e|SS|585a254e-c36b-44cf-b8a9-335fb98e0fd2|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|2|FOLLOW-UP|2020-11-18|40
e|SS|585a254e-c36b-44cf-b8a9-335fb98e0fd2|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|5|FOLLOW-UP|2020-11-18|40
e|SS|585a254e-c36b-44cf-b8a9-335fb98e0fd2|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|2|WASHOUT|2020-12-13|65
e|SS|585a254e-c36b-44cf-b8a9-335fb98e0fd2|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|4|FOLLOW-UP|2020-12-13|65
e|SS|585a254e-c36b-44cf-b8a9-335fb98e0fd2|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|4|TREATMENT|2021-01-07|90
e|SS|585a254e-c36b-44cf-b8a9-335fb98e0fd2|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|3|TREATMENT|2021-01-07|90
e|SS|9ee3632d-4e99-4a46-b0b9-237467d97ca0|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|4|TREATMENT|2020-09-09|10
e|SS|9ee3632d-4e99-4a46-b0b9-237467d97ca0|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|7|FOLLOW-UP|2020-09-09|10
e|SS|9ee3632d-4e99-4a46-b0b9-237467d97ca0|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|7|FOLLOW-UP|2020-09-24|25
e|SS|9ee3632d-4e99-4a46-b0b9-237467d97ca0|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|1|FOLLOW-UP|2020-09-24|25
e|SS|9ee3632d-4e99-4a46-b0b9-237467d97ca0|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|3|TREATMENT|2020-10-09|40
e|SS|9ee3632d-4e99-4a46-b0b9-237467d97ca0|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|3|TREATMENT|2020-10-09|40
e|SS|9ee3632d-4e99-4a46-b0b9-237467d97ca0|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|2|TREATMENT|2020-11-03|65
e|SS|9ee3632d-4e99-4a46-b0b9-237467d97ca0|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|5|TREATMENT|2020-11-03|65
e|SS|9ee3632d-4e99-4a46-b0b9-237467d97ca0|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|6|FOLLOW-UP|2020-11-28|90
e|SS|9ee3632d-4e99-4a46-b0b9-237467d97ca0|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|4|FOLLOW-UP|2020-11-28|90
e|SS|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|4|TREATMENT|2020-06-16|10
e|SS|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|SCREENING|2020-06-16|10
e|SS|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|5|TREATMENT|2020-07-01|25
e|SS|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|5|TREATMENT|2020-07-01|25
e|SS|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|7|FOLLOW-UP|2020-07-16|40
e|SS|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|4|WASHOUT|2020-07-16|40
e|SS|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|5|WASHOUT|2020-08-10|65
e|SS|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|3|FOLLOW-UP|2020-08-10|65
e|SS|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|4|FOLLOW-UP|2020-09-04|90
e|SS|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|3|TREATMENT|2020-09-04|90
e|SS|34b2090b-13ac-4fb2-8d87-eca2839a62f2|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|4|TREATMENT|2020-06-07|10
e|SS|34b2090b-13ac-4fb2-8d87-eca2839a62f2|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|3|WASHOUT|2020-06-07|10
e|SS|34b2090b-13ac-4fb2-8d87-eca2839a62f2|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|3|WASHOUT|2020-06-22|25
e|SS|34b2090b-13ac-4fb2-8d87-eca2839a62f2|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|6|TREATMENT|2020-06-22|25
e|SS|34b2090b-13ac-4fb2-8d87-eca2839a62f2|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|2|WASHOUT|2020-07-07|40
e|SS|34b2090b-13ac-4fb2-8d87-eca2839a62f2|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|WASHOUT|2020-07-07|40
e|SS|34b2090b-13ac-4fb2-8d87-eca2839a62f2|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|TREATMENT|2020-08-01|65
e|SS|34b2090b-13ac-4fb2-8d87-eca2839a62f2|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|1|WASHOUT|2020-08-01|65
e|SS|34b2090b-13ac-4fb2-8d87-eca2839a62f2|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|1|TREATMENT|2020-08-26|90
e|SS|34b2090b-13ac-4fb2-8d87-eca2839a62f2|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|3|TREATMENT|2020-08-26|90
e|SS|bfc19b4b-51bb-4056-9195-8bd2db53a497|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|2|TREATMENT|2020-07-26|10
e|SS|bfc19b4b-51bb-4056-9195-8bd2db53a497|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|6|TREATMENT|2020-07-26|10
e|SS|bfc19b4b-51bb-4056-9195-8bd2db53a497|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|4|TREATMENT|2020-08-10|25
e|SS|bfc19b4b-51bb-4056-9195-8bd2db53a497|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|7|SCREENING|2020-08-10|25
e|SS|bfc19b4b-51bb-4056-9195-8bd2db53a497|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|2|TREATMENT|2020-08-25|40
e|SS|bfc19b4b-51bb-4056-9195-8bd2db53a497|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|2|FOLLOW-UP|2020-08-25|40
e|SS|bfc19b4b-51bb-4056-9195-8bd2db53a497|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|3|WASHOUT|2020-09-19|65
e|SS|bfc19b4b-51bb-4056-9195-8bd2db53a497|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|FOLLOW-UP|2020-09-19|65
e|SS|bfc19b4b-51bb-4056-9195-8bd2db53a497|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|6|TREATMENT|2020-10-14|90
e|SS|bfc19b4b-51bb-4056-9195-8bd2db53a497|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|7|TREATMENT|2020-10-14|90
e|SS|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|4|TREATMENT|2020-09-21|10
e|SS|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|2|TREATMENT|2020-09-21|10
e|SS|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|2|TREATMENT|2020-10-06|25
e|SS|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|7|FOLLOW-UP|2020-10-06|25
e|SS|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|4|TREATMENT|2020-10-21|40
e|SS|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-10-21|40
e|SS|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|4|TREATMENT|2020-11-15|65
e|SS|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|1|SCREENING|2020-11-15|65
e|SS|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|7|TREATMENT|2020-12-10|90
e|SS|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|WASHOUT|2020-12-10|90
e|SS|64a70103-14bf-42f4-808b-fbdecec8bd4f|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|2|TREATMENT|2020-09-09|10
e|SS|64a70103-14bf-42f4-808b-fbdecec8bd4f|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|2|TREATMENT|2020-09-09|10
e|SS|64a70103-14bf-42f4-808b-fbdecec8bd4f|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|WASHOUT|2020-09-24|25
e|SS|64a70103-14bf-42f4-808b-fbdecec8bd4f|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|1|TREATMENT|2020-09-24|25
e|SS|64a70103-14bf-42f4-808b-fbdecec8bd4f|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-10-09|40
e|SS|64a70103-14bf-42f4-808b-fbdecec8bd4f|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|1|TREATMENT|2020-10-09|40
e|SS|64a70103-14bf-42f4-808b-fbdecec8bd4f|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|5|TREATMENT|2020-11-03|65
e|SS|64a70103-14bf-42f4-808b-fbdecec8bd4f|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|5|WASHOUT|2020-11-03|65
e|SS|64a70103-14bf-42f4-808b-fbdecec8bd4f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|SCREENING|2020-11-28|90
e|SS|64a70103-14bf-42f4-808b-fbdecec8bd4f|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|SCREENING|2020-11-28|90
e|SS|00f3949b-b14a-47c5-942c-2ab71e03e40f|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|6|SCREENING|2021-01-19|10
e|SS|00f3949b-b14a-47c5-942c-2ab71e03e40f|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|7|TREATMENT|2021-01-19|10
e|SS|00f3949b-b14a-47c5-942c-2ab71e03e40f|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|6|TREATMENT|2021-02-03|25
e|SS|00f3949b-b14a-47c5-942c-2ab71e03e40f|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|5|TREATMENT|2021-02-03|25
e|SS|00f3949b-b14a-47c5-942c-2ab71e03e40f|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|2|TREATMENT|2021-02-18|40
e|SS|00f3949b-b14a-47c5-942c-2ab71e03e40f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|4|WASHOUT|2021-02-18|40
e|SS|00f3949b-b14a-47c5-942c-2ab71e03e40f|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|SCREENING|2021-03-15|65
e|SS|00f3949b-b14a-47c5-942c-2ab71e03e40f|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|6|TREATMENT|2021-03-15|65
e|SS|00f3949b-b14a-47c5-942c-2ab71e03e40f|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|2|SCREENING|2021-04-09|90
e|SS|00f3949b-b14a-47c5-942c-2ab71e03e40f|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|4|FOLLOW-UP|2021-04-09|90
e|SS|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|4|TREATMENT|2020-12-27|10
e|SS|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|5|TREATMENT|2020-12-27|10
e|SS|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|4|WASHOUT|2021-01-11|25
e|SS|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|3|TREATMENT|2021-01-11|25
e|SS|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|2|TREATMENT|2021-01-26|40
e|SS|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|5|TREATMENT|2021-01-26|40
e|SS|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|4|WASHOUT|2021-02-20|65
e|SS|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|7|TREATMENT|2021-02-20|65
e|SS|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|WASHOUT|2021-03-17|90
e|SS|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|3|TREATMENT|2021-03-17|90
e|SS|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|1|TREATMENT|2020-07-19|10
e|SS|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|3|TREATMENT|2020-07-19|10
e|SS|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|7|TREATMENT|2020-08-03|25
e|SS|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-08-03|25
e|SS|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|2|SCREENING|2020-08-18|40
e|SS|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|2|TREATMENT|2020-08-18|40
e|SS|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|1|WASHOUT|2020-09-12|65
e|SS|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|5|FOLLOW-UP|2020-09-12|65
e|SS|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|3|TREATMENT|2020-10-07|90
e|SS|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|7|SCREENING|2020-10-07|90
e|SS|44ca1fe6-76d2-4a94-9854-1ddbde638803|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|5|WASHOUT|2020-07-19|10
e|SS|44ca1fe6-76d2-4a94-9854-1ddbde638803|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|FOLLOW-UP|2020-07-19|10
e|SS|44ca1fe6-76d2-4a94-9854-1ddbde638803|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|1|TREATMENT|2020-08-03|25
e|SS|44ca1fe6-76d2-4a94-9854-1ddbde638803|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|7|TREATMENT|2020-08-03|25
e|SS|44ca1fe6-76d2-4a94-9854-1ddbde638803|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|5|TREATMENT|2020-08-18|40
e|SS|44ca1fe6-76d2-4a94-9854-1ddbde638803|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|FOLLOW-UP|2020-08-18|40
e|SS|44ca1fe6-76d2-4a94-9854-1ddbde638803|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|5|SCREENING|2020-09-12|65
e|SS|44ca1fe6-76d2-4a94-9854-1ddbde638803|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|WASHOUT|2020-09-12|65
e|SS|44ca1fe6-76d2-4a94-9854-1ddbde638803|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|5|TREATMENT|2020-10-07|90
e|SS|44ca1fe6-76d2-4a94-9854-1ddbde638803|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|3|TREATMENT|2020-10-07|90
e|SS|edc935ed-3b94-43fa-9b7f-facf6eb6780e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|5|WASHOUT|2020-12-04|10
e|SS|edc935ed-3b94-43fa-9b7f-facf6eb6780e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|3|TREATMENT|2020-12-04|10
e|SS|edc935ed-3b94-43fa-9b7f-facf6eb6780e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|2|FOLLOW-UP|2020-12-19|25
e|SS|edc935ed-3b94-43fa-9b7f-facf6eb6780e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|5|FOLLOW-UP|2020-12-19|25
e|SS|edc935ed-3b94-43fa-9b7f-facf6eb6780e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2021-01-03|40
e|SS|edc935ed-3b94-43fa-9b7f-facf6eb6780e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|7|TREATMENT|2021-01-03|40
e|SS|edc935ed-3b94-43fa-9b7f-facf6eb6780e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|6|WASHOUT|2021-01-28|65
e|SS|edc935ed-3b94-43fa-9b7f-facf6eb6780e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|2|TREATMENT|2021-01-28|65
e|SS|edc935ed-3b94-43fa-9b7f-facf6eb6780e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|4|TREATMENT|2021-02-22|90
e|SS|edc935ed-3b94-43fa-9b7f-facf6eb6780e|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|WASHOUT|2021-02-22|90
e|SS|f997ad2a-e9b1-4341-96d5-caef4bcb7196|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|4|FOLLOW-UP|2020-06-08|10
e|SS|f997ad2a-e9b1-4341-96d5-caef4bcb7196|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|6|SCREENING|2020-06-08|10
e|SS|f997ad2a-e9b1-4341-96d5-caef4bcb7196|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|SCREENING|2020-06-23|25
e|SS|f997ad2a-e9b1-4341-96d5-caef4bcb7196|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|1|FOLLOW-UP|2020-06-23|25
e|SS|f997ad2a-e9b1-4341-96d5-caef4bcb7196|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|6|WASHOUT|2020-07-08|40
e|SS|f997ad2a-e9b1-4341-96d5-caef4bcb7196|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|4|FOLLOW-UP|2020-07-08|40
e|SS|f997ad2a-e9b1-4341-96d5-caef4bcb7196|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|2|TREATMENT|2020-08-02|65
e|SS|f997ad2a-e9b1-4341-96d5-caef4bcb7196|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|6|SCREENING|2020-08-02|65
e|SS|f997ad2a-e9b1-4341-96d5-caef4bcb7196|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|5|FOLLOW-UP|2020-08-27|90
e|SS|f997ad2a-e9b1-4341-96d5-caef4bcb7196|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|7|SCREENING|2020-08-27|90
e|SS|5a56874f-10e4-4cd0-842f-19552a04d1bd|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|7|SCREENING|2020-06-20|10
e|SS|5a56874f-10e4-4cd0-842f-19552a04d1bd|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|2|TREATMENT|2020-06-20|10
e|SS|5a56874f-10e4-4cd0-842f-19552a04d1bd|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|1|TREATMENT|2020-07-05|25
e|SS|5a56874f-10e4-4cd0-842f-19552a04d1bd|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|FOLLOW-UP|2020-07-05|25
e|SS|5a56874f-10e4-4cd0-842f-19552a04d1bd|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|6|FOLLOW-UP|2020-07-20|40
e|SS|5a56874f-10e4-4cd0-842f-19552a04d1bd|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|2|WASHOUT|2020-07-20|40
e|SS|5a56874f-10e4-4cd0-842f-19552a04d1bd|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|6|TREATMENT|2020-08-14|65
e|SS|5a56874f-10e4-4cd0-842f-19552a04d1bd|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|6|TREATMENT|2020-08-14|65
e|SS|5a56874f-10e4-4cd0-842f-19552a04d1bd|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|6|TREATMENT|2020-09-08|90
e|SS|5a56874f-10e4-4cd0-842f-19552a04d1bd|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|6|SCREENING|2020-09-08|90
e|SS|f1d4ebe5-fc72-447b-8872-67e971ff471b|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|2|TREATMENT|2020-11-08|10
e|SS|f1d4ebe5-fc72-447b-8872-67e971ff471b|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|7|SCREENING|2020-11-08|10
e|SS|f1d4ebe5-fc72-447b-8872-67e971ff471b|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|2|SCREENING|2020-11-23|25
e|SS|f1d4ebe5-fc72-447b-8872-67e971ff471b|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|1|TREATMENT|2020-11-23|25
e|SS|f1d4ebe5-fc72-447b-8872-67e971ff471b|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|2|WASHOUT|2020-12-08|40
e|SS|f1d4ebe5-fc72-447b-8872-67e971ff471b|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|7|FOLLOW-UP|2020-12-08|40
e|SS|f1d4ebe5-fc72-447b-8872-67e971ff471b|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|6|TREATMENT|2021-01-02|65
e|SS|f1d4ebe5-fc72-447b-8872-67e971ff471b|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|7|TREATMENT|2021-01-02|65
e|SS|f1d4ebe5-fc72-447b-8872-67e971ff471b|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|6|SCREENING|2021-01-27|90
e|SS|f1d4ebe5-fc72-447b-8872-67e971ff471b|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|6|SCREENING|2021-01-27|90
e|SS|2a141b73-e336-4701-9067-8d51d532596b|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|4|TREATMENT|2020-06-12|10
e|SS|2a141b73-e336-4701-9067-8d51d532596b|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|4|TREATMENT|2020-06-12|10
e|SS|2a141b73-e336-4701-9067-8d51d532596b|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|2|FOLLOW-UP|2020-06-27|25
e|SS|2a141b73-e336-4701-9067-8d51d532596b|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|2|TREATMENT|2020-06-27|25
e|SS|2a141b73-e336-4701-9067-8d51d532596b|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|4|WASHOUT|2020-07-12|40
e|SS|2a141b73-e336-4701-9067-8d51d532596b|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|6|TREATMENT|2020-07-12|40
e|SS|2a141b73-e336-4701-9067-8d51d532596b|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|2|FOLLOW-UP|2020-08-06|65
e|SS|2a141b73-e336-4701-9067-8d51d532596b|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|5|WASHOUT|2020-08-06|65
e|SS|2a141b73-e336-4701-9067-8d51d532596b|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|1|TREATMENT|2020-08-31|90
e|SS|2a141b73-e336-4701-9067-8d51d532596b|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|4|TREATMENT|2020-08-31|90
e|SS|4adf9a2c-3c43-4289-8156-1a109791580c|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|4|TREATMENT|2020-11-22|10
e|SS|4adf9a2c-3c43-4289-8156-1a109791580c|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|6|TREATMENT|2020-11-22|10
e|SS|4adf9a2c-3c43-4289-8156-1a109791580c|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|4|TREATMENT|2020-12-07|25
e|SS|4adf9a2c-3c43-4289-8156-1a109791580c|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|3|TREATMENT|2020-12-07|25
e|SS|4adf9a2c-3c43-4289-8156-1a109791580c|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-12-22|40
e|SS|4adf9a2c-3c43-4289-8156-1a109791580c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|TREATMENT|2020-12-22|40
e|SS|4adf9a2c-3c43-4289-8156-1a109791580c|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|TREATMENT|2021-01-16|65
e|SS|4adf9a2c-3c43-4289-8156-1a109791580c|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|3|TREATMENT|2021-01-16|65
e|SS|4adf9a2c-3c43-4289-8156-1a109791580c|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|1|SCREENING|2021-02-10|90
e|SS|4adf9a2c-3c43-4289-8156-1a109791580c|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|1|TREATMENT|2021-02-10|90
e|SS|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|1|TREATMENT|2020-05-23|10
e|SS|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|6|TREATMENT|2020-05-23|10
e|SS|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|TREATMENT|2020-06-07|25
e|SS|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|7|SCREENING|2020-06-07|25
e|SS|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|2|TREATMENT|2020-06-22|40
e|SS|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|1|WASHOUT|2020-06-22|40
e|SS|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|6|SCREENING|2020-07-17|65
e|SS|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|2|FOLLOW-UP|2020-07-17|65
e|SS|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|6|TREATMENT|2020-08-11|90
e|SS|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|7|SCREENING|2020-08-11|90
e|SS|1b2eda86-2d2c-4fdc-a88e-409ea5180603|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|7|FOLLOW-UP|2020-05-19|10
e|SS|1b2eda86-2d2c-4fdc-a88e-409ea5180603|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|2|WASHOUT|2020-05-19|10
e|SS|1b2eda86-2d2c-4fdc-a88e-409ea5180603|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|6|SCREENING|2020-06-03|25
e|SS|1b2eda86-2d2c-4fdc-a88e-409ea5180603|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|4|TREATMENT|2020-06-03|25
e|SS|1b2eda86-2d2c-4fdc-a88e-409ea5180603|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|3|WASHOUT|2020-06-18|40
e|SS|1b2eda86-2d2c-4fdc-a88e-409ea5180603|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|6|WASHOUT|2020-06-18|40
e|SS|1b2eda86-2d2c-4fdc-a88e-409ea5180603|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|WASHOUT|2020-07-13|65
e|SS|1b2eda86-2d2c-4fdc-a88e-409ea5180603|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|2|TREATMENT|2020-07-13|65
e|SS|1b2eda86-2d2c-4fdc-a88e-409ea5180603|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|2|TREATMENT|2020-08-07|90
e|SS|1b2eda86-2d2c-4fdc-a88e-409ea5180603|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|7|TREATMENT|2020-08-07|90
e|SS|fc02184a-dfba-4964-be3a-cfa5f5d7200e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|7|TREATMENT|2020-05-26|10
e|SS|fc02184a-dfba-4964-be3a-cfa5f5d7200e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|3|WASHOUT|2020-05-26|10
e|SS|fc02184a-dfba-4964-be3a-cfa5f5d7200e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|5|FOLLOW-UP|2020-06-10|25
e|SS|fc02184a-dfba-4964-be3a-cfa5f5d7200e|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|1|TREATMENT|2020-06-10|25
e|SS|fc02184a-dfba-4964-be3a-cfa5f5d7200e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|5|TREATMENT|2020-06-25|40
e|SS|fc02184a-dfba-4964-be3a-cfa5f5d7200e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|2|WASHOUT|2020-06-25|40
e|SS|fc02184a-dfba-4964-be3a-cfa5f5d7200e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|2|FOLLOW-UP|2020-07-20|65
e|SS|fc02184a-dfba-4964-be3a-cfa5f5d7200e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|3|WASHOUT|2020-07-20|65
e|SS|fc02184a-dfba-4964-be3a-cfa5f5d7200e|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|6|TREATMENT|2020-08-14|90
e|SS|fc02184a-dfba-4964-be3a-cfa5f5d7200e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2020-08-14|90
e|SS|37c59cfa-b952-4d16-a675-5e3b3a2e0288|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|TREATMENT|2020-05-29|10
e|SS|37c59cfa-b952-4d16-a675-5e3b3a2e0288|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2020-05-29|10
e|SS|37c59cfa-b952-4d16-a675-5e3b3a2e0288|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|2|TREATMENT|2020-06-13|25
e|SS|37c59cfa-b952-4d16-a675-5e3b3a2e0288|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|5|FOLLOW-UP|2020-06-13|25
e|SS|37c59cfa-b952-4d16-a675-5e3b3a2e0288|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|1|SCREENING|2020-06-28|40
e|SS|37c59cfa-b952-4d16-a675-5e3b3a2e0288|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|TREATMENT|2020-06-28|40
e|SS|37c59cfa-b952-4d16-a675-5e3b3a2e0288|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|3|TREATMENT|2020-07-23|65
e|SS|37c59cfa-b952-4d16-a675-5e3b3a2e0288|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|2|TREATMENT|2020-07-23|65
e|SS|37c59cfa-b952-4d16-a675-5e3b3a2e0288|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|6|FOLLOW-UP|2020-08-17|90
e|SS|37c59cfa-b952-4d16-a675-5e3b3a2e0288|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|1|FOLLOW-UP|2020-08-17|90
e|SS|11130b2c-e9fd-4a50-87ee-5dfa19199eba|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIGNIFICANT OTHER|1|Visit_1|10|4|TREATMENT|2021-03-03|100
e|SS|11130b2c-e9fd-4a50-87ee-5dfa19199eba|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATION COMMITTEE|1|Visit_1|10|5|SCREENING|2021-03-03|100
e|SS|11130b2c-e9fd-4a50-87ee-5dfa19199eba|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|INVESTIGATOR|2|Visit_2|25|4|TREATMENT|2021-03-03|100
e|SS|11130b2c-e9fd-4a50-87ee-5dfa19199eba|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATOR|2|Visit_2|25|2|SCREENING|2021-03-03|100
e|SS|11130b2c-e9fd-4a50-87ee-5dfa19199eba|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|FRIEND|3|Visit_3|40|1|TREATMENT|2021-03-03|100
e|SS|11130b2c-e9fd-4a50-87ee-5dfa19199eba|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATION COMMITTEE|3|Visit_3|40|4|SCREENING|2021-03-03|100
e|SS|11130b2c-e9fd-4a50-87ee-5dfa19199eba|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|FAMILY MEMBER|4|Visit_4|65|7|SCREENING|2021-03-03|100
e|SS|11130b2c-e9fd-4a50-87ee-5dfa19199eba|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|DOMESTIC PARTNER|4|Visit_4|65|2|SCREENING|2021-03-03|100
e|SS|11130b2c-e9fd-4a50-87ee-5dfa19199eba|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|GUARDIAN|5|Visit_5|90|1|WASHOUT|2021-03-03|100
e|SS|11130b2c-e9fd-4a50-87ee-5dfa19199eba|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|DOMESTIC PARTNER|5|Visit_5|90|4|TREATMENT|2021-03-03|100
e|SS|08e4310f-f868-4858-a321-f33a21a771e8|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|5|WASHOUT|2020-05-15|10
e|SS|08e4310f-f868-4858-a321-f33a21a771e8|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|WASHOUT|2020-05-15|10
e|SS|08e4310f-f868-4858-a321-f33a21a771e8|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|6|SCREENING|2020-05-30|25
e|SS|08e4310f-f868-4858-a321-f33a21a771e8|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|6|TREATMENT|2020-05-30|25
e|SS|08e4310f-f868-4858-a321-f33a21a771e8|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|7|TREATMENT|2020-06-14|40
e|SS|08e4310f-f868-4858-a321-f33a21a771e8|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|7|TREATMENT|2020-06-14|40
e|SS|08e4310f-f868-4858-a321-f33a21a771e8|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|6|FOLLOW-UP|2020-07-09|65
e|SS|08e4310f-f868-4858-a321-f33a21a771e8|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|6|WASHOUT|2020-07-09|65
e|SS|08e4310f-f868-4858-a321-f33a21a771e8|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|2|TREATMENT|2020-08-03|90
e|SS|08e4310f-f868-4858-a321-f33a21a771e8|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|6|FOLLOW-UP|2020-08-03|90
e|SS|29edf133-8b5b-46d5-bf7a-f75af4658417|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|2|TREATMENT|2020-08-22|10
e|SS|29edf133-8b5b-46d5-bf7a-f75af4658417|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|5|TREATMENT|2020-08-22|10
e|SS|29edf133-8b5b-46d5-bf7a-f75af4658417|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|6|SCREENING|2020-09-06|25
e|SS|29edf133-8b5b-46d5-bf7a-f75af4658417|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|6|TREATMENT|2020-09-06|25
e|SS|29edf133-8b5b-46d5-bf7a-f75af4658417|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|7|TREATMENT|2020-09-21|40
e|SS|29edf133-8b5b-46d5-bf7a-f75af4658417|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|2|FOLLOW-UP|2020-09-21|40
e|SS|29edf133-8b5b-46d5-bf7a-f75af4658417|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|7|TREATMENT|2020-10-16|65
e|SS|29edf133-8b5b-46d5-bf7a-f75af4658417|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|4|TREATMENT|2020-10-16|65
e|SS|29edf133-8b5b-46d5-bf7a-f75af4658417|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|1|TREATMENT|2020-11-10|90
e|SS|29edf133-8b5b-46d5-bf7a-f75af4658417|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|6|SCREENING|2020-11-10|90
e|SS|49756233-e18f-4187-8d48-3b6b4fa7e5c2|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|5|WASHOUT|2020-08-09|10
e|SS|49756233-e18f-4187-8d48-3b6b4fa7e5c2|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|6|WASHOUT|2020-08-09|10
e|SS|49756233-e18f-4187-8d48-3b6b4fa7e5c2|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|WASHOUT|2020-08-24|25
e|SS|49756233-e18f-4187-8d48-3b6b4fa7e5c2|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|2|TREATMENT|2020-08-24|25
e|SS|49756233-e18f-4187-8d48-3b6b4fa7e5c2|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|5|TREATMENT|2020-09-08|40
e|SS|49756233-e18f-4187-8d48-3b6b4fa7e5c2|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|4|FOLLOW-UP|2020-09-08|40
e|SS|49756233-e18f-4187-8d48-3b6b4fa7e5c2|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|1|SCREENING|2020-10-03|65
e|SS|49756233-e18f-4187-8d48-3b6b4fa7e5c2|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|1|WASHOUT|2020-10-03|65
e|SS|49756233-e18f-4187-8d48-3b6b4fa7e5c2|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|5|TREATMENT|2020-10-28|90
e|SS|49756233-e18f-4187-8d48-3b6b4fa7e5c2|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2020-10-28|90
e|SS|7a046104-7215-4708-9d85-66683ceb8fe8|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|3|WASHOUT|2020-10-16|10
e|SS|7a046104-7215-4708-9d85-66683ceb8fe8|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|6|TREATMENT|2020-10-16|10
e|SS|7a046104-7215-4708-9d85-66683ceb8fe8|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|1|TREATMENT|2020-10-31|25
e|SS|7a046104-7215-4708-9d85-66683ceb8fe8|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|4|TREATMENT|2020-10-31|25
e|SS|7a046104-7215-4708-9d85-66683ceb8fe8|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|1|SCREENING|2020-11-15|40
e|SS|7a046104-7215-4708-9d85-66683ceb8fe8|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|7|WASHOUT|2020-11-15|40
e|SS|7a046104-7215-4708-9d85-66683ceb8fe8|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|1|WASHOUT|2020-12-10|65
e|SS|7a046104-7215-4708-9d85-66683ceb8fe8|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|6|FOLLOW-UP|2020-12-10|65
e|SS|7a046104-7215-4708-9d85-66683ceb8fe8|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|1|FOLLOW-UP|2021-01-04|90
e|SS|7a046104-7215-4708-9d85-66683ceb8fe8|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|1|SCREENING|2021-01-04|90
e|SS|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|5|TREATMENT|2021-01-26|10
e|SS|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|7|TREATMENT|2021-01-26|10
e|SS|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|2|SCREENING|2021-02-10|25
e|SS|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|1|WASHOUT|2021-02-10|25
e|SS|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|1|SCREENING|2021-02-25|40
e|SS|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|5|TREATMENT|2021-02-25|40
e|SS|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|5|SCREENING|2021-03-22|65
e|SS|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|5|TREATMENT|2021-03-22|65
e|SS|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|1|WASHOUT|2021-04-16|90
e|SS|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|5|TREATMENT|2021-04-16|90
e|SS|bcbe7d50-2ebe-483a-9d71-dce4094f864e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|5|TREATMENT|2020-05-25|10
e|SS|bcbe7d50-2ebe-483a-9d71-dce4094f864e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|1|SCREENING|2020-05-25|10
e|SS|bcbe7d50-2ebe-483a-9d71-dce4094f864e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|4|SCREENING|2020-06-09|25
e|SS|bcbe7d50-2ebe-483a-9d71-dce4094f864e|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2020-06-09|25
e|SS|bcbe7d50-2ebe-483a-9d71-dce4094f864e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|5|TREATMENT|2020-06-24|40
e|SS|bcbe7d50-2ebe-483a-9d71-dce4094f864e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|6|SCREENING|2020-06-24|40
e|SS|bcbe7d50-2ebe-483a-9d71-dce4094f864e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|6|WASHOUT|2020-07-19|65
e|SS|bcbe7d50-2ebe-483a-9d71-dce4094f864e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|4|TREATMENT|2020-07-19|65
e|SS|bcbe7d50-2ebe-483a-9d71-dce4094f864e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|1|TREATMENT|2020-08-13|90
e|SS|bcbe7d50-2ebe-483a-9d71-dce4094f864e|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|2|TREATMENT|2020-08-13|90
e|SS|2550ba24-7bcf-41e2-9eae-536e13d4b345|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|5|WASHOUT|2021-01-20|10
e|SS|2550ba24-7bcf-41e2-9eae-536e13d4b345|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|4|TREATMENT|2021-01-20|10
e|SS|2550ba24-7bcf-41e2-9eae-536e13d4b345|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|7|TREATMENT|2021-02-04|25
e|SS|2550ba24-7bcf-41e2-9eae-536e13d4b345|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|3|FOLLOW-UP|2021-02-04|25
e|SS|2550ba24-7bcf-41e2-9eae-536e13d4b345|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|1|FOLLOW-UP|2021-02-19|40
e|SS|2550ba24-7bcf-41e2-9eae-536e13d4b345|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|4|TREATMENT|2021-02-19|40
e|SS|2550ba24-7bcf-41e2-9eae-536e13d4b345|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|WASHOUT|2021-03-16|65
e|SS|2550ba24-7bcf-41e2-9eae-536e13d4b345|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|7|TREATMENT|2021-03-16|65
e|SS|2550ba24-7bcf-41e2-9eae-536e13d4b345|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|WASHOUT|2021-04-10|90
e|SS|2550ba24-7bcf-41e2-9eae-536e13d4b345|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|2|TREATMENT|2021-04-10|90
e|SS|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|7|TREATMENT|2020-08-14|10
e|SS|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|2|SCREENING|2020-08-14|10
e|SS|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|WASHOUT|2020-08-29|25
e|SS|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|4|SCREENING|2020-08-29|25
e|SS|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|4|TREATMENT|2020-09-13|40
e|SS|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|1|TREATMENT|2020-09-13|40
e|SS|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|4|WASHOUT|2020-10-08|65
e|SS|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|3|SCREENING|2020-10-08|65
e|SS|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|3|TREATMENT|2020-11-02|90
e|SS|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|5|TREATMENT|2020-11-02|90
e|SS|6ec23671-252e-4dc9-b919-88254fce68a5|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|3|WASHOUT|2020-07-28|10
e|SS|6ec23671-252e-4dc9-b919-88254fce68a5|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|7|TREATMENT|2020-07-28|10
e|SS|6ec23671-252e-4dc9-b919-88254fce68a5|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|7|WASHOUT|2020-08-12|25
e|SS|6ec23671-252e-4dc9-b919-88254fce68a5|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-08-12|25
e|SS|6ec23671-252e-4dc9-b919-88254fce68a5|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|1|TREATMENT|2020-08-27|40
e|SS|6ec23671-252e-4dc9-b919-88254fce68a5|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|3|SCREENING|2020-08-27|40
e|SS|6ec23671-252e-4dc9-b919-88254fce68a5|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|5|TREATMENT|2020-09-21|65
e|SS|6ec23671-252e-4dc9-b919-88254fce68a5|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|4|WASHOUT|2020-09-21|65
e|SS|6ec23671-252e-4dc9-b919-88254fce68a5|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|3|SCREENING|2020-10-16|90
e|SS|6ec23671-252e-4dc9-b919-88254fce68a5|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|3|TREATMENT|2020-10-16|90
e|SS|db59e5e1-ccda-480b-8955-da5157e16c4a|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|TREATMENT|2020-05-14|10
e|SS|db59e5e1-ccda-480b-8955-da5157e16c4a|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|4|TREATMENT|2020-05-14|10
e|SS|db59e5e1-ccda-480b-8955-da5157e16c4a|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|4|TREATMENT|2020-05-29|25
e|SS|db59e5e1-ccda-480b-8955-da5157e16c4a|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|3|WASHOUT|2020-05-29|25
e|SS|db59e5e1-ccda-480b-8955-da5157e16c4a|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|2|TREATMENT|2020-06-13|40
e|SS|db59e5e1-ccda-480b-8955-da5157e16c4a|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|2|WASHOUT|2020-06-13|40
e|SS|db59e5e1-ccda-480b-8955-da5157e16c4a|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|2|TREATMENT|2020-07-08|65
e|SS|db59e5e1-ccda-480b-8955-da5157e16c4a|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|4|TREATMENT|2020-07-08|65
e|SS|db59e5e1-ccda-480b-8955-da5157e16c4a|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|WASHOUT|2020-08-02|90
e|SS|db59e5e1-ccda-480b-8955-da5157e16c4a|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|1|TREATMENT|2020-08-02|90
e|SS|1dce856e-b7cb-4899-b27f-87ab8d918df4|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|FOLLOW-UP|2020-09-12|10
e|SS|1dce856e-b7cb-4899-b27f-87ab8d918df4|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|5|WASHOUT|2020-09-12|10
e|SS|1dce856e-b7cb-4899-b27f-87ab8d918df4|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|5|WASHOUT|2020-09-27|25
e|SS|1dce856e-b7cb-4899-b27f-87ab8d918df4|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|4|SCREENING|2020-09-27|25
e|SS|1dce856e-b7cb-4899-b27f-87ab8d918df4|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|4|WASHOUT|2020-10-12|40
e|SS|1dce856e-b7cb-4899-b27f-87ab8d918df4|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|4|SCREENING|2020-10-12|40
e|SS|1dce856e-b7cb-4899-b27f-87ab8d918df4|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2020-11-06|65
e|SS|1dce856e-b7cb-4899-b27f-87ab8d918df4|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|3|TREATMENT|2020-11-06|65
e|SS|1dce856e-b7cb-4899-b27f-87ab8d918df4|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|FOLLOW-UP|2020-12-01|90
e|SS|1dce856e-b7cb-4899-b27f-87ab8d918df4|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|5|TREATMENT|2020-12-01|90
e|SS|7449180b-e226-4e97-a059-8760f6523f77|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|4|TREATMENT|2020-07-04|10
e|SS|7449180b-e226-4e97-a059-8760f6523f77|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|4|TREATMENT|2020-07-04|10
e|SS|7449180b-e226-4e97-a059-8760f6523f77|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|2|FOLLOW-UP|2020-07-19|25
e|SS|7449180b-e226-4e97-a059-8760f6523f77|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|3|SCREENING|2020-07-19|25
e|SS|7449180b-e226-4e97-a059-8760f6523f77|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|6|SCREENING|2020-08-03|40
e|SS|7449180b-e226-4e97-a059-8760f6523f77|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|5|TREATMENT|2020-08-03|40
e|SS|7449180b-e226-4e97-a059-8760f6523f77|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|5|TREATMENT|2020-08-28|65
e|SS|7449180b-e226-4e97-a059-8760f6523f77|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|TREATMENT|2020-08-28|65
e|SS|7449180b-e226-4e97-a059-8760f6523f77|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|7|TREATMENT|2020-09-22|90
e|SS|7449180b-e226-4e97-a059-8760f6523f77|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|2|FOLLOW-UP|2020-09-22|90
e|SS|f077c497-b0f0-4a20-b448-608b0cc6ab36|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|3|TREATMENT|2020-06-08|10
e|SS|f077c497-b0f0-4a20-b448-608b0cc6ab36|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|WASHOUT|2020-06-08|10
e|SS|f077c497-b0f0-4a20-b448-608b0cc6ab36|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|1|FOLLOW-UP|2020-06-23|25
e|SS|f077c497-b0f0-4a20-b448-608b0cc6ab36|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|1|FOLLOW-UP|2020-06-23|25
e|SS|f077c497-b0f0-4a20-b448-608b0cc6ab36|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|4|TREATMENT|2020-07-08|40
e|SS|f077c497-b0f0-4a20-b448-608b0cc6ab36|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|2|FOLLOW-UP|2020-07-08|40
e|SS|f077c497-b0f0-4a20-b448-608b0cc6ab36|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|SCREENING|2020-08-02|65
e|SS|f077c497-b0f0-4a20-b448-608b0cc6ab36|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|5|TREATMENT|2020-08-02|65
e|SS|f077c497-b0f0-4a20-b448-608b0cc6ab36|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|7|FOLLOW-UP|2020-08-27|90
e|SS|f077c497-b0f0-4a20-b448-608b0cc6ab36|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|5|FOLLOW-UP|2020-08-27|90
e|SS|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-06-12|10
e|SS|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|2|WASHOUT|2020-06-12|10
e|SS|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|2|WASHOUT|2020-06-27|25
e|SS|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|7|TREATMENT|2020-06-27|25
e|SS|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|1|WASHOUT|2020-07-12|40
e|SS|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|WASHOUT|2020-07-12|40
e|SS|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|SCREENING|2020-08-06|65
e|SS|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|3|TREATMENT|2020-08-06|65
e|SS|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2020-08-31|90
e|SS|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|TREATMENT|2020-08-31|90
e|SS|3f7c46ac-fe30-4ef3-a581-99c064a85efa|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|7|TREATMENT|2021-01-11|10
e|SS|3f7c46ac-fe30-4ef3-a581-99c064a85efa|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|2|WASHOUT|2021-01-11|10
e|SS|3f7c46ac-fe30-4ef3-a581-99c064a85efa|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|6|TREATMENT|2021-01-26|25
e|SS|3f7c46ac-fe30-4ef3-a581-99c064a85efa|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|SCREENING|2021-01-26|25
e|SS|3f7c46ac-fe30-4ef3-a581-99c064a85efa|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|3|FOLLOW-UP|2021-02-10|40
e|SS|3f7c46ac-fe30-4ef3-a581-99c064a85efa|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|6|WASHOUT|2021-02-10|40
e|SS|3f7c46ac-fe30-4ef3-a581-99c064a85efa|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2021-03-07|65
e|SS|3f7c46ac-fe30-4ef3-a581-99c064a85efa|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|7|TREATMENT|2021-03-07|65
e|SS|3f7c46ac-fe30-4ef3-a581-99c064a85efa|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2021-04-01|90
e|SS|3f7c46ac-fe30-4ef3-a581-99c064a85efa|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2021-04-01|90
e|SS|8d944400-df75-4ec7-8fb4-239eb0f6de9d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|7|TREATMENT|2020-09-22|10
e|SS|8d944400-df75-4ec7-8fb4-239eb0f6de9d|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|1|SCREENING|2020-09-22|10
e|SS|8d944400-df75-4ec7-8fb4-239eb0f6de9d|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|5|FOLLOW-UP|2020-10-07|25
e|SS|8d944400-df75-4ec7-8fb4-239eb0f6de9d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|6|FOLLOW-UP|2020-10-07|25
e|SS|8d944400-df75-4ec7-8fb4-239eb0f6de9d|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|6|TREATMENT|2020-10-22|40
e|SS|8d944400-df75-4ec7-8fb4-239eb0f6de9d|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|5|TREATMENT|2020-10-22|40
e|SS|8d944400-df75-4ec7-8fb4-239eb0f6de9d|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|1|TREATMENT|2020-11-16|65
e|SS|8d944400-df75-4ec7-8fb4-239eb0f6de9d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|FOLLOW-UP|2020-11-16|65
e|SS|8d944400-df75-4ec7-8fb4-239eb0f6de9d|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|WASHOUT|2020-12-11|90
e|SS|8d944400-df75-4ec7-8fb4-239eb0f6de9d|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|TREATMENT|2020-12-11|90
e|SS|7b201f93-bd8c-4507-a7b7-27a02e364647|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|2|SCREENING|2020-12-23|10
e|SS|7b201f93-bd8c-4507-a7b7-27a02e364647|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|2|TREATMENT|2020-12-23|10
e|SS|7b201f93-bd8c-4507-a7b7-27a02e364647|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|7|WASHOUT|2021-01-07|25
e|SS|7b201f93-bd8c-4507-a7b7-27a02e364647|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2021-01-07|25
e|SS|7b201f93-bd8c-4507-a7b7-27a02e364647|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|2|TREATMENT|2021-01-22|40
e|SS|7b201f93-bd8c-4507-a7b7-27a02e364647|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|5|WASHOUT|2021-01-22|40
e|SS|7b201f93-bd8c-4507-a7b7-27a02e364647|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|5|FOLLOW-UP|2021-02-16|65
e|SS|7b201f93-bd8c-4507-a7b7-27a02e364647|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|2|TREATMENT|2021-02-16|65
e|SS|7b201f93-bd8c-4507-a7b7-27a02e364647|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|2|WASHOUT|2021-03-13|90
e|SS|7b201f93-bd8c-4507-a7b7-27a02e364647|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|3|TREATMENT|2021-03-13|90
e|SS|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|7|SCREENING|2020-08-05|10
e|SS|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|3|TREATMENT|2020-08-05|10
e|SS|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|3|FOLLOW-UP|2020-08-20|25
e|SS|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|6|SCREENING|2020-08-20|25
e|SS|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|7|WASHOUT|2020-09-04|40
e|SS|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|3|WASHOUT|2020-09-04|40
e|SS|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|2|FOLLOW-UP|2020-09-29|65
e|SS|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|3|SCREENING|2020-09-29|65
e|SS|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|7|TREATMENT|2020-10-24|90
e|SS|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|4|TREATMENT|2020-10-24|90
e|SS|3611b798-9b3d-4173-b23e-3017939847e0|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|FOLLOW-UP|2020-08-03|10
e|SS|3611b798-9b3d-4173-b23e-3017939847e0|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|2|WASHOUT|2020-08-03|10
e|SS|3611b798-9b3d-4173-b23e-3017939847e0|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|5|TREATMENT|2020-08-18|25
e|SS|3611b798-9b3d-4173-b23e-3017939847e0|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|4|SCREENING|2020-08-18|25
e|SS|3611b798-9b3d-4173-b23e-3017939847e0|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|1|TREATMENT|2020-09-02|40
e|SS|3611b798-9b3d-4173-b23e-3017939847e0|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-09-02|40
e|SS|3611b798-9b3d-4173-b23e-3017939847e0|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|4|SCREENING|2020-09-27|65
e|SS|3611b798-9b3d-4173-b23e-3017939847e0|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|4|SCREENING|2020-09-27|65
e|SS|3611b798-9b3d-4173-b23e-3017939847e0|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|4|FOLLOW-UP|2020-10-22|90
e|SS|3611b798-9b3d-4173-b23e-3017939847e0|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|4|TREATMENT|2020-10-22|90
e|SS|f651799b-9723-4c2c-88d1-de2f347e9a69|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|TREATMENT|2020-06-24|10
e|SS|f651799b-9723-4c2c-88d1-de2f347e9a69|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|SCREENING|2020-06-24|10
e|SS|f651799b-9723-4c2c-88d1-de2f347e9a69|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|4|WASHOUT|2020-07-09|25
e|SS|f651799b-9723-4c2c-88d1-de2f347e9a69|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|1|TREATMENT|2020-07-09|25
e|SS|f651799b-9723-4c2c-88d1-de2f347e9a69|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|7|FOLLOW-UP|2020-07-24|40
e|SS|f651799b-9723-4c2c-88d1-de2f347e9a69|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|7|TREATMENT|2020-07-24|40
e|SS|f651799b-9723-4c2c-88d1-de2f347e9a69|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|3|TREATMENT|2020-08-18|65
e|SS|f651799b-9723-4c2c-88d1-de2f347e9a69|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|2|FOLLOW-UP|2020-08-18|65
e|SS|f651799b-9723-4c2c-88d1-de2f347e9a69|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|5|SCREENING|2020-09-12|90
e|SS|f651799b-9723-4c2c-88d1-de2f347e9a69|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|5|TREATMENT|2020-09-12|90
e|SS|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|6|TREATMENT|2020-10-19|10
e|SS|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|1|SCREENING|2020-10-19|10
e|SS|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|1|SCREENING|2020-11-03|25
e|SS|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|5|FOLLOW-UP|2020-11-03|25
e|SS|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|7|TREATMENT|2020-11-18|40
e|SS|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|7|WASHOUT|2020-11-18|40
e|SS|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|4|TREATMENT|2020-12-13|65
e|SS|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|3|TREATMENT|2020-12-13|65
e|SS|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|6|FOLLOW-UP|2021-01-07|90
e|SS|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|1|TREATMENT|2021-01-07|90
e|SS|29b16c31-df0e-493c-a777-46113b904879|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|5|TREATMENT|2020-06-07|10
e|SS|29b16c31-df0e-493c-a777-46113b904879|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|6|TREATMENT|2020-06-07|10
e|SS|29b16c31-df0e-493c-a777-46113b904879|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|4|WASHOUT|2020-06-22|25
e|SS|29b16c31-df0e-493c-a777-46113b904879|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|7|WASHOUT|2020-06-22|25
e|SS|29b16c31-df0e-493c-a777-46113b904879|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|3|TREATMENT|2020-07-07|40
e|SS|29b16c31-df0e-493c-a777-46113b904879|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|FOLLOW-UP|2020-07-07|40
e|SS|29b16c31-df0e-493c-a777-46113b904879|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|TREATMENT|2020-08-01|65
e|SS|29b16c31-df0e-493c-a777-46113b904879|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|4|TREATMENT|2020-08-01|65
e|SS|29b16c31-df0e-493c-a777-46113b904879|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|2|TREATMENT|2020-08-26|90
e|SS|29b16c31-df0e-493c-a777-46113b904879|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|6|SCREENING|2020-08-26|90
e|SS|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|1|FOLLOW-UP|2020-07-31|10
e|SS|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|3|TREATMENT|2020-07-31|10
e|SS|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|2|SCREENING|2020-08-15|25
e|SS|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|5|TREATMENT|2020-08-15|25
e|SS|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|4|FOLLOW-UP|2020-08-30|40
e|SS|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|5|TREATMENT|2020-08-30|40
e|SS|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|5|FOLLOW-UP|2020-09-24|65
e|SS|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|4|WASHOUT|2020-09-24|65
e|SS|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|1|WASHOUT|2020-10-19|90
e|SS|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|1|FOLLOW-UP|2020-10-19|90
e|SS|118914c8-9f6a-47c8-b427-296a99547756|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|6|FOLLOW-UP|2020-10-25|10
e|SS|118914c8-9f6a-47c8-b427-296a99547756|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|WASHOUT|2020-10-25|10
e|SS|118914c8-9f6a-47c8-b427-296a99547756|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|FOLLOW-UP|2020-11-09|25
e|SS|118914c8-9f6a-47c8-b427-296a99547756|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|6|TREATMENT|2020-11-09|25
e|SS|118914c8-9f6a-47c8-b427-296a99547756|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|3|TREATMENT|2020-11-24|40
e|SS|118914c8-9f6a-47c8-b427-296a99547756|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|6|TREATMENT|2020-11-24|40
e|SS|118914c8-9f6a-47c8-b427-296a99547756|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|FOLLOW-UP|2020-12-19|65
e|SS|118914c8-9f6a-47c8-b427-296a99547756|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|FOLLOW-UP|2020-12-19|65
e|SS|118914c8-9f6a-47c8-b427-296a99547756|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|2|TREATMENT|2021-01-13|90
e|SS|118914c8-9f6a-47c8-b427-296a99547756|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|6|WASHOUT|2021-01-13|90
e|SS|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|3|WASHOUT|2020-12-09|10
e|SS|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|TREATMENT|2020-12-09|10
e|SS|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|1|TREATMENT|2020-12-24|25
e|SS|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|5|TREATMENT|2020-12-24|25
e|SS|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|7|WASHOUT|2021-01-08|40
e|SS|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|4|WASHOUT|2021-01-08|40
e|SS|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|6|TREATMENT|2021-02-02|65
e|SS|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|TREATMENT|2021-02-02|65
e|SS|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|5|TREATMENT|2021-02-27|90
e|SS|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|1|TREATMENT|2021-02-27|90
e|SS|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|3|WASHOUT|2021-01-08|10
e|SS|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|2|FOLLOW-UP|2021-01-08|10
e|SS|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|3|WASHOUT|2021-01-23|25
e|SS|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|2|TREATMENT|2021-01-23|25
e|SS|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|7|SCREENING|2021-02-07|40
e|SS|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|7|FOLLOW-UP|2021-02-07|40
e|SS|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|7|TREATMENT|2021-03-04|65
e|SS|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|SCREENING|2021-03-04|65
e|SS|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|1|TREATMENT|2021-03-29|90
e|SS|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|2|WASHOUT|2021-03-29|90
e|SS|7a5ae465-03b9-4006-a29e-94822ed857aa|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|5|TREATMENT|2020-07-02|10
e|SS|7a5ae465-03b9-4006-a29e-94822ed857aa|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|2|TREATMENT|2020-07-02|10
e|SS|7a5ae465-03b9-4006-a29e-94822ed857aa|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|1|TREATMENT|2020-07-17|25
e|SS|7a5ae465-03b9-4006-a29e-94822ed857aa|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|6|TREATMENT|2020-07-17|25
e|SS|7a5ae465-03b9-4006-a29e-94822ed857aa|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|5|TREATMENT|2020-08-01|40
e|SS|7a5ae465-03b9-4006-a29e-94822ed857aa|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|3|WASHOUT|2020-08-01|40
e|SS|7a5ae465-03b9-4006-a29e-94822ed857aa|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|7|WASHOUT|2020-08-26|65
e|SS|7a5ae465-03b9-4006-a29e-94822ed857aa|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|5|WASHOUT|2020-08-26|65
e|SS|7a5ae465-03b9-4006-a29e-94822ed857aa|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|6|SCREENING|2020-09-20|90
e|SS|7a5ae465-03b9-4006-a29e-94822ed857aa|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|7|SCREENING|2020-09-20|90
e|SS|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|4|WASHOUT|2020-09-22|10
e|SS|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|5|SCREENING|2020-09-22|10
e|SS|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|TREATMENT|2020-10-07|25
e|SS|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|4|TREATMENT|2020-10-07|25
e|SS|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|2|TREATMENT|2020-10-22|40
e|SS|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|2|SCREENING|2020-10-22|40
e|SS|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|FOLLOW-UP|2020-11-16|65
e|SS|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|FOLLOW-UP|2020-11-16|65
e|SS|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|4|TREATMENT|2020-12-11|90
e|SS|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|7|FOLLOW-UP|2020-12-11|90
e|SS|2e4cd860-734a-40b0-bde5-ca08297415a9|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|3|WASHOUT|2020-11-25|10
e|SS|2e4cd860-734a-40b0-bde5-ca08297415a9|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|6|SCREENING|2020-11-25|10
e|SS|2e4cd860-734a-40b0-bde5-ca08297415a9|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|SCREENING|2020-12-10|25
e|SS|2e4cd860-734a-40b0-bde5-ca08297415a9|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|6|TREATMENT|2020-12-10|25
e|SS|2e4cd860-734a-40b0-bde5-ca08297415a9|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|4|SCREENING|2020-12-25|40
e|SS|2e4cd860-734a-40b0-bde5-ca08297415a9|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|2|SCREENING|2020-12-25|40
e|SS|2e4cd860-734a-40b0-bde5-ca08297415a9|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|4|WASHOUT|2021-01-19|65
e|SS|2e4cd860-734a-40b0-bde5-ca08297415a9|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|2|TREATMENT|2021-01-19|65
e|SS|2e4cd860-734a-40b0-bde5-ca08297415a9|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|5|SCREENING|2021-02-13|90
e|SS|2e4cd860-734a-40b0-bde5-ca08297415a9|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|FOLLOW-UP|2021-02-13|90
e|SS|3f1854fb-d14e-4699-888b-d5042fa9327c|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|WASHOUT|2020-08-04|10
e|SS|3f1854fb-d14e-4699-888b-d5042fa9327c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|1|SCREENING|2020-08-04|10
e|SS|3f1854fb-d14e-4699-888b-d5042fa9327c|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|1|TREATMENT|2020-08-19|25
e|SS|3f1854fb-d14e-4699-888b-d5042fa9327c|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|3|TREATMENT|2020-08-19|25
e|SS|3f1854fb-d14e-4699-888b-d5042fa9327c|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|6|WASHOUT|2020-09-03|40
e|SS|3f1854fb-d14e-4699-888b-d5042fa9327c|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|5|TREATMENT|2020-09-03|40
e|SS|3f1854fb-d14e-4699-888b-d5042fa9327c|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|4|TREATMENT|2020-09-28|65
e|SS|3f1854fb-d14e-4699-888b-d5042fa9327c|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|2|FOLLOW-UP|2020-09-28|65
e|SS|3f1854fb-d14e-4699-888b-d5042fa9327c|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|2|TREATMENT|2020-10-23|90
e|SS|3f1854fb-d14e-4699-888b-d5042fa9327c|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2020-10-23|90
e|SS|f6e37eba-e224-47f3-baa0-59dfdfb47b70|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2020-12-10|10
e|SS|f6e37eba-e224-47f3-baa0-59dfdfb47b70|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|1|TREATMENT|2020-12-10|10
e|SS|f6e37eba-e224-47f3-baa0-59dfdfb47b70|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|1|TREATMENT|2020-12-25|25
e|SS|f6e37eba-e224-47f3-baa0-59dfdfb47b70|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-12-25|25
e|SS|f6e37eba-e224-47f3-baa0-59dfdfb47b70|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|6|SCREENING|2021-01-09|40
e|SS|f6e37eba-e224-47f3-baa0-59dfdfb47b70|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|6|TREATMENT|2021-01-09|40
e|SS|f6e37eba-e224-47f3-baa0-59dfdfb47b70|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|3|TREATMENT|2021-02-03|65
e|SS|f6e37eba-e224-47f3-baa0-59dfdfb47b70|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|4|TREATMENT|2021-02-03|65
e|SS|f6e37eba-e224-47f3-baa0-59dfdfb47b70|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|3|TREATMENT|2021-02-28|90
e|SS|f6e37eba-e224-47f3-baa0-59dfdfb47b70|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|TREATMENT|2021-02-28|90
e|SS|8298b45d-16ff-42ef-8404-0f3ce628f9e5|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|2|FOLLOW-UP|2020-07-31|10
e|SS|8298b45d-16ff-42ef-8404-0f3ce628f9e5|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|WASHOUT|2020-07-31|10
e|SS|8298b45d-16ff-42ef-8404-0f3ce628f9e5|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|FOLLOW-UP|2020-08-15|25
e|SS|8298b45d-16ff-42ef-8404-0f3ce628f9e5|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|3|TREATMENT|2020-08-15|25
e|SS|8298b45d-16ff-42ef-8404-0f3ce628f9e5|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|5|TREATMENT|2020-08-30|40
e|SS|8298b45d-16ff-42ef-8404-0f3ce628f9e5|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|2|WASHOUT|2020-08-30|40
e|SS|8298b45d-16ff-42ef-8404-0f3ce628f9e5|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|4|WASHOUT|2020-09-24|65
e|SS|8298b45d-16ff-42ef-8404-0f3ce628f9e5|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|1|TREATMENT|2020-09-24|65
e|SS|8298b45d-16ff-42ef-8404-0f3ce628f9e5|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|3|SCREENING|2020-10-19|90
e|SS|8298b45d-16ff-42ef-8404-0f3ce628f9e5|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|6|FOLLOW-UP|2020-10-19|90
e|SS|ee5c6623-5cb4-4f18-99b0-6373328abc1d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|1|TREATMENT|2020-06-11|10
e|SS|ee5c6623-5cb4-4f18-99b0-6373328abc1d|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|1|TREATMENT|2020-06-11|10
e|SS|ee5c6623-5cb4-4f18-99b0-6373328abc1d|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|3|WASHOUT|2020-06-26|25
e|SS|ee5c6623-5cb4-4f18-99b0-6373328abc1d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2020-06-26|25
e|SS|ee5c6623-5cb4-4f18-99b0-6373328abc1d|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|TREATMENT|2020-07-11|40
e|SS|ee5c6623-5cb4-4f18-99b0-6373328abc1d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|5|FOLLOW-UP|2020-07-11|40
e|SS|ee5c6623-5cb4-4f18-99b0-6373328abc1d|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|5|FOLLOW-UP|2020-08-05|65
e|SS|ee5c6623-5cb4-4f18-99b0-6373328abc1d|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|1|SCREENING|2020-08-05|65
e|SS|ee5c6623-5cb4-4f18-99b0-6373328abc1d|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|3|SCREENING|2020-08-30|90
e|SS|ee5c6623-5cb4-4f18-99b0-6373328abc1d|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|FOLLOW-UP|2020-08-30|90
e|SS|f8d6576b-b300-4c5f-8f5a-6bb35250d576|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|5|TREATMENT|2020-06-25|10
e|SS|f8d6576b-b300-4c5f-8f5a-6bb35250d576|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|2|TREATMENT|2020-06-25|10
e|SS|f8d6576b-b300-4c5f-8f5a-6bb35250d576|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|1|TREATMENT|2020-07-10|25
e|SS|f8d6576b-b300-4c5f-8f5a-6bb35250d576|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|4|TREATMENT|2020-07-10|25
e|SS|f8d6576b-b300-4c5f-8f5a-6bb35250d576|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|1|FOLLOW-UP|2020-07-25|40
e|SS|f8d6576b-b300-4c5f-8f5a-6bb35250d576|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|7|TREATMENT|2020-07-25|40
e|SS|f8d6576b-b300-4c5f-8f5a-6bb35250d576|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|5|TREATMENT|2020-08-19|65
e|SS|f8d6576b-b300-4c5f-8f5a-6bb35250d576|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|7|WASHOUT|2020-08-19|65
e|SS|f8d6576b-b300-4c5f-8f5a-6bb35250d576|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|4|TREATMENT|2020-09-13|90
e|SS|f8d6576b-b300-4c5f-8f5a-6bb35250d576|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|5|TREATMENT|2020-09-13|90
e|SS|8635a6b3-d16e-432c-90bf-53f1494dbe5e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|6|TREATMENT|2020-10-26|10
e|SS|8635a6b3-d16e-432c-90bf-53f1494dbe5e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|2|TREATMENT|2020-10-26|10
e|SS|8635a6b3-d16e-432c-90bf-53f1494dbe5e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|3|SCREENING|2020-11-10|25
e|SS|8635a6b3-d16e-432c-90bf-53f1494dbe5e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|3|FOLLOW-UP|2020-11-10|25
e|SS|8635a6b3-d16e-432c-90bf-53f1494dbe5e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|2|TREATMENT|2020-11-25|40
e|SS|8635a6b3-d16e-432c-90bf-53f1494dbe5e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|SCREENING|2020-11-25|40
e|SS|8635a6b3-d16e-432c-90bf-53f1494dbe5e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2020-12-20|65
e|SS|8635a6b3-d16e-432c-90bf-53f1494dbe5e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|4|TREATMENT|2020-12-20|65
e|SS|8635a6b3-d16e-432c-90bf-53f1494dbe5e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|1|WASHOUT|2021-01-14|90
e|SS|8635a6b3-d16e-432c-90bf-53f1494dbe5e|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|4|TREATMENT|2021-01-14|90
e|SS|2cda4297-410a-49e4-949c-deb3dc4c6656|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|3|WASHOUT|2020-06-20|10
e|SS|2cda4297-410a-49e4-949c-deb3dc4c6656|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|1|TREATMENT|2020-06-20|10
e|SS|2cda4297-410a-49e4-949c-deb3dc4c6656|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|5|TREATMENT|2020-07-05|25
e|SS|2cda4297-410a-49e4-949c-deb3dc4c6656|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|TREATMENT|2020-07-05|25
e|SS|2cda4297-410a-49e4-949c-deb3dc4c6656|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|5|FOLLOW-UP|2020-07-20|40
e|SS|2cda4297-410a-49e4-949c-deb3dc4c6656|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|SCREENING|2020-07-20|40
e|SS|2cda4297-410a-49e4-949c-deb3dc4c6656|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|1|TREATMENT|2020-08-14|65
e|SS|2cda4297-410a-49e4-949c-deb3dc4c6656|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|4|TREATMENT|2020-08-14|65
e|SS|2cda4297-410a-49e4-949c-deb3dc4c6656|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|7|TREATMENT|2020-09-08|90
e|SS|2cda4297-410a-49e4-949c-deb3dc4c6656|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|TREATMENT|2020-09-08|90
e|SS|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|1|FOLLOW-UP|2021-01-29|10
e|SS|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|2|SCREENING|2021-01-29|10
e|SS|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|2|WASHOUT|2021-02-13|25
e|SS|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|1|SCREENING|2021-02-13|25
e|SS|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|2|SCREENING|2021-02-28|40
e|SS|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|1|WASHOUT|2021-02-28|40
e|SS|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|3|WASHOUT|2021-03-25|65
e|SS|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|1|TREATMENT|2021-03-25|65
e|SS|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|4|WASHOUT|2021-04-19|90
e|SS|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|3|TREATMENT|2021-04-19|90
e|SS|9e82141b-e2b9-42c7-b813-b79bda2bd216|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|6|TREATMENT|2020-05-31|10
e|SS|9e82141b-e2b9-42c7-b813-b79bda2bd216|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|1|FOLLOW-UP|2020-05-31|10
e|SS|9e82141b-e2b9-42c7-b813-b79bda2bd216|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|4|TREATMENT|2020-06-15|25
e|SS|9e82141b-e2b9-42c7-b813-b79bda2bd216|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|3|FOLLOW-UP|2020-06-15|25
e|SS|9e82141b-e2b9-42c7-b813-b79bda2bd216|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|7|FOLLOW-UP|2020-06-30|40
e|SS|9e82141b-e2b9-42c7-b813-b79bda2bd216|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|5|SCREENING|2020-06-30|40
e|SS|9e82141b-e2b9-42c7-b813-b79bda2bd216|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|7|WASHOUT|2020-07-25|65
e|SS|9e82141b-e2b9-42c7-b813-b79bda2bd216|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|1|SCREENING|2020-07-25|65
e|SS|9e82141b-e2b9-42c7-b813-b79bda2bd216|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|4|TREATMENT|2020-08-19|90
e|SS|9e82141b-e2b9-42c7-b813-b79bda2bd216|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|2|TREATMENT|2020-08-19|90
e|SS|4b432c61-c620-4c5e-8aad-411facc0f4db|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|6|TREATMENT|2020-09-14|10
e|SS|4b432c61-c620-4c5e-8aad-411facc0f4db|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|6|FOLLOW-UP|2020-09-14|10
e|SS|4b432c61-c620-4c5e-8aad-411facc0f4db|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|6|TREATMENT|2020-09-29|25
e|SS|4b432c61-c620-4c5e-8aad-411facc0f4db|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|1|TREATMENT|2020-09-29|25
e|SS|4b432c61-c620-4c5e-8aad-411facc0f4db|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|7|FOLLOW-UP|2020-10-14|40
e|SS|4b432c61-c620-4c5e-8aad-411facc0f4db|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|3|TREATMENT|2020-10-14|40
e|SS|4b432c61-c620-4c5e-8aad-411facc0f4db|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|4|TREATMENT|2020-11-08|65
e|SS|4b432c61-c620-4c5e-8aad-411facc0f4db|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|TREATMENT|2020-11-08|65
e|SS|4b432c61-c620-4c5e-8aad-411facc0f4db|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|WASHOUT|2020-12-03|90
e|SS|4b432c61-c620-4c5e-8aad-411facc0f4db|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2020-12-03|90
e|SS|1a1e6863-26da-4b5d-b82a-5703e3e9056e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|7|TREATMENT|2020-12-26|10
e|SS|1a1e6863-26da-4b5d-b82a-5703e3e9056e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|2|SCREENING|2020-12-26|10
e|SS|1a1e6863-26da-4b5d-b82a-5703e3e9056e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|7|TREATMENT|2021-01-10|25
e|SS|1a1e6863-26da-4b5d-b82a-5703e3e9056e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|6|TREATMENT|2021-01-10|25
e|SS|1a1e6863-26da-4b5d-b82a-5703e3e9056e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|3|WASHOUT|2021-01-25|40
e|SS|1a1e6863-26da-4b5d-b82a-5703e3e9056e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|TREATMENT|2021-01-25|40
e|SS|1a1e6863-26da-4b5d-b82a-5703e3e9056e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|7|TREATMENT|2021-02-19|65
e|SS|1a1e6863-26da-4b5d-b82a-5703e3e9056e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|3|SCREENING|2021-02-19|65
e|SS|1a1e6863-26da-4b5d-b82a-5703e3e9056e|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2021-03-16|90
e|SS|1a1e6863-26da-4b5d-b82a-5703e3e9056e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|2|FOLLOW-UP|2021-03-16|90
e|SS|8c8053d1-adae-4d45-870e-cf4ad2475c74|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|1|WASHOUT|2020-05-11|10
e|SS|8c8053d1-adae-4d45-870e-cf4ad2475c74|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|6|TREATMENT|2020-05-11|10
e|SS|8c8053d1-adae-4d45-870e-cf4ad2475c74|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|WASHOUT|2020-05-26|25
e|SS|8c8053d1-adae-4d45-870e-cf4ad2475c74|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|4|FOLLOW-UP|2020-05-26|25
e|SS|8c8053d1-adae-4d45-870e-cf4ad2475c74|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|5|SCREENING|2020-06-10|40
e|SS|8c8053d1-adae-4d45-870e-cf4ad2475c74|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|FOLLOW-UP|2020-06-10|40
e|SS|8c8053d1-adae-4d45-870e-cf4ad2475c74|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|5|SCREENING|2020-07-05|65
e|SS|8c8053d1-adae-4d45-870e-cf4ad2475c74|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|2|WASHOUT|2020-07-05|65
e|SS|8c8053d1-adae-4d45-870e-cf4ad2475c74|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|WASHOUT|2020-07-30|90
e|SS|8c8053d1-adae-4d45-870e-cf4ad2475c74|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|7|WASHOUT|2020-07-30|90
e|SS|c3b911a8-116e-4940-80a2-7128db004f4a|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|4|TREATMENT|2020-11-19|10
e|SS|c3b911a8-116e-4940-80a2-7128db004f4a|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|2|TREATMENT|2020-11-19|10
e|SS|c3b911a8-116e-4940-80a2-7128db004f4a|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|TREATMENT|2020-12-04|25
e|SS|c3b911a8-116e-4940-80a2-7128db004f4a|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2020-12-04|25
e|SS|c3b911a8-116e-4940-80a2-7128db004f4a|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|2|SCREENING|2020-12-19|40
e|SS|c3b911a8-116e-4940-80a2-7128db004f4a|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|2|TREATMENT|2020-12-19|40
e|SS|c3b911a8-116e-4940-80a2-7128db004f4a|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|2|WASHOUT|2021-01-13|65
e|SS|c3b911a8-116e-4940-80a2-7128db004f4a|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|6|WASHOUT|2021-01-13|65
e|SS|c3b911a8-116e-4940-80a2-7128db004f4a|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|4|TREATMENT|2021-02-07|90
e|SS|c3b911a8-116e-4940-80a2-7128db004f4a|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|1|TREATMENT|2021-02-07|90
e|SS|401d66ba-bc00-4495-ba5d-796068dd1fd6|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|FOLLOW-UP|2020-06-11|10
e|SS|401d66ba-bc00-4495-ba5d-796068dd1fd6|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|TREATMENT|2020-06-11|10
e|SS|401d66ba-bc00-4495-ba5d-796068dd1fd6|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|1|SCREENING|2020-06-26|25
e|SS|401d66ba-bc00-4495-ba5d-796068dd1fd6|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|1|TREATMENT|2020-06-26|25
e|SS|401d66ba-bc00-4495-ba5d-796068dd1fd6|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|2|TREATMENT|2020-07-11|40
e|SS|401d66ba-bc00-4495-ba5d-796068dd1fd6|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|3|SCREENING|2020-07-11|40
e|SS|401d66ba-bc00-4495-ba5d-796068dd1fd6|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|5|TREATMENT|2020-08-05|65
e|SS|401d66ba-bc00-4495-ba5d-796068dd1fd6|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|4|FOLLOW-UP|2020-08-05|65
e|SS|401d66ba-bc00-4495-ba5d-796068dd1fd6|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|2|WASHOUT|2020-08-30|90
e|SS|401d66ba-bc00-4495-ba5d-796068dd1fd6|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|6|FOLLOW-UP|2020-08-30|90
e|SS|f8113725-4deb-48a1-876a-ba168a6d2cee|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|FOLLOW-UP|2021-01-22|10
e|SS|f8113725-4deb-48a1-876a-ba168a6d2cee|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|4|SCREENING|2021-01-22|10
e|SS|f8113725-4deb-48a1-876a-ba168a6d2cee|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2021-02-06|25
e|SS|f8113725-4deb-48a1-876a-ba168a6d2cee|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|3|FOLLOW-UP|2021-02-06|25
e|SS|f8113725-4deb-48a1-876a-ba168a6d2cee|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|6|TREATMENT|2021-02-21|40
e|SS|f8113725-4deb-48a1-876a-ba168a6d2cee|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|7|TREATMENT|2021-02-21|40
e|SS|f8113725-4deb-48a1-876a-ba168a6d2cee|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|5|TREATMENT|2021-03-18|65
e|SS|f8113725-4deb-48a1-876a-ba168a6d2cee|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|5|WASHOUT|2021-03-18|65
e|SS|f8113725-4deb-48a1-876a-ba168a6d2cee|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|6|TREATMENT|2021-04-12|90
e|SS|f8113725-4deb-48a1-876a-ba168a6d2cee|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|7|TREATMENT|2021-04-12|90
e|SS|f056c174-b6da-4df6-bf95-2e31911939fb|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|6|TREATMENT|2020-12-16|10
e|SS|f056c174-b6da-4df6-bf95-2e31911939fb|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|6|TREATMENT|2020-12-16|10
e|SS|f056c174-b6da-4df6-bf95-2e31911939fb|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|7|TREATMENT|2020-12-31|25
e|SS|f056c174-b6da-4df6-bf95-2e31911939fb|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|3|TREATMENT|2020-12-31|25
e|SS|f056c174-b6da-4df6-bf95-2e31911939fb|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|TREATMENT|2021-01-15|40
e|SS|f056c174-b6da-4df6-bf95-2e31911939fb|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|FOLLOW-UP|2021-01-15|40
e|SS|f056c174-b6da-4df6-bf95-2e31911939fb|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|2|TREATMENT|2021-02-09|65
e|SS|f056c174-b6da-4df6-bf95-2e31911939fb|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|6|WASHOUT|2021-02-09|65
e|SS|f056c174-b6da-4df6-bf95-2e31911939fb|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|1|TREATMENT|2021-03-06|90
e|SS|f056c174-b6da-4df6-bf95-2e31911939fb|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|7|WASHOUT|2021-03-06|90
e|SS|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2020-09-16|10
e|SS|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|5|TREATMENT|2020-09-16|10
e|SS|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|3|SCREENING|2020-10-01|25
e|SS|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|7|TREATMENT|2020-10-01|25
e|SS|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|6|TREATMENT|2020-10-16|40
e|SS|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|7|SCREENING|2020-10-16|40
e|SS|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|3|TREATMENT|2020-11-10|65
e|SS|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|6|FOLLOW-UP|2020-11-10|65
e|SS|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|4|TREATMENT|2020-12-05|90
e|SS|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|6|WASHOUT|2020-12-05|90
e|SS|57b7f30f-5f2a-425d-8bf2-fd5915cac481|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|6|SCREENING|2021-01-18|10
e|SS|57b7f30f-5f2a-425d-8bf2-fd5915cac481|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|FOLLOW-UP|2021-01-18|10
e|SS|57b7f30f-5f2a-425d-8bf2-fd5915cac481|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|6|SCREENING|2021-02-02|25
e|SS|57b7f30f-5f2a-425d-8bf2-fd5915cac481|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|3|FOLLOW-UP|2021-02-02|25
e|SS|57b7f30f-5f2a-425d-8bf2-fd5915cac481|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|5|TREATMENT|2021-02-17|40
e|SS|57b7f30f-5f2a-425d-8bf2-fd5915cac481|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|WASHOUT|2021-02-17|40
e|SS|57b7f30f-5f2a-425d-8bf2-fd5915cac481|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|1|WASHOUT|2021-03-14|65
e|SS|57b7f30f-5f2a-425d-8bf2-fd5915cac481|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|3|WASHOUT|2021-03-14|65
e|SS|57b7f30f-5f2a-425d-8bf2-fd5915cac481|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|2|TREATMENT|2021-04-08|90
e|SS|57b7f30f-5f2a-425d-8bf2-fd5915cac481|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|1|TREATMENT|2021-04-08|90
e|SS|02d9a74a-abc8-4b47-a4d4-a196d339f621|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|WASHOUT|2020-09-14|10
e|SS|02d9a74a-abc8-4b47-a4d4-a196d339f621|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|6|TREATMENT|2020-09-14|10
e|SS|02d9a74a-abc8-4b47-a4d4-a196d339f621|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|2|WASHOUT|2020-09-29|25
e|SS|02d9a74a-abc8-4b47-a4d4-a196d339f621|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2020-09-29|25
e|SS|02d9a74a-abc8-4b47-a4d4-a196d339f621|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|3|TREATMENT|2020-10-14|40
e|SS|02d9a74a-abc8-4b47-a4d4-a196d339f621|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|6|SCREENING|2020-10-14|40
e|SS|02d9a74a-abc8-4b47-a4d4-a196d339f621|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|1|FOLLOW-UP|2020-11-08|65
e|SS|02d9a74a-abc8-4b47-a4d4-a196d339f621|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|2|WASHOUT|2020-11-08|65
e|SS|02d9a74a-abc8-4b47-a4d4-a196d339f621|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|3|WASHOUT|2020-12-03|90
e|SS|02d9a74a-abc8-4b47-a4d4-a196d339f621|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|3|TREATMENT|2020-12-03|90
e|SS|81480f83-206f-40c0-a5a4-f75b31cda363|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|2|TREATMENT|2020-11-22|10
e|SS|81480f83-206f-40c0-a5a4-f75b31cda363|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|5|TREATMENT|2020-11-22|10
e|SS|81480f83-206f-40c0-a5a4-f75b31cda363|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|2|FOLLOW-UP|2020-12-07|25
e|SS|81480f83-206f-40c0-a5a4-f75b31cda363|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|WASHOUT|2020-12-07|25
e|SS|81480f83-206f-40c0-a5a4-f75b31cda363|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|6|SCREENING|2020-12-22|40
e|SS|81480f83-206f-40c0-a5a4-f75b31cda363|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|1|TREATMENT|2020-12-22|40
e|SS|81480f83-206f-40c0-a5a4-f75b31cda363|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2021-01-16|65
e|SS|81480f83-206f-40c0-a5a4-f75b31cda363|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|7|FOLLOW-UP|2021-01-16|65
e|SS|81480f83-206f-40c0-a5a4-f75b31cda363|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|1|TREATMENT|2021-02-10|90
e|SS|81480f83-206f-40c0-a5a4-f75b31cda363|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|6|FOLLOW-UP|2021-02-10|90
e|SS|2b183b69-3ed8-4356-b9e2-0988128de3f2|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|7|TREATMENT|2020-10-16|10
e|SS|2b183b69-3ed8-4356-b9e2-0988128de3f2|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|WASHOUT|2020-10-16|10
e|SS|2b183b69-3ed8-4356-b9e2-0988128de3f2|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|WASHOUT|2020-10-31|25
e|SS|2b183b69-3ed8-4356-b9e2-0988128de3f2|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|2|FOLLOW-UP|2020-10-31|25
e|SS|2b183b69-3ed8-4356-b9e2-0988128de3f2|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|2|SCREENING|2020-11-15|40
e|SS|2b183b69-3ed8-4356-b9e2-0988128de3f2|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|4|TREATMENT|2020-11-15|40
e|SS|2b183b69-3ed8-4356-b9e2-0988128de3f2|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|5|FOLLOW-UP|2020-12-10|65
e|SS|2b183b69-3ed8-4356-b9e2-0988128de3f2|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|4|TREATMENT|2020-12-10|65
e|SS|2b183b69-3ed8-4356-b9e2-0988128de3f2|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|2|TREATMENT|2021-01-04|90
e|SS|2b183b69-3ed8-4356-b9e2-0988128de3f2|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|2|SCREENING|2021-01-04|90
e|SS|6ed8a749-81c0-4998-817d-efc86cfaa091|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|5|TREATMENT|2020-06-05|10
e|SS|6ed8a749-81c0-4998-817d-efc86cfaa091|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|1|WASHOUT|2020-06-05|10
e|SS|6ed8a749-81c0-4998-817d-efc86cfaa091|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|4|WASHOUT|2020-06-20|25
e|SS|6ed8a749-81c0-4998-817d-efc86cfaa091|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2020-06-20|25
e|SS|6ed8a749-81c0-4998-817d-efc86cfaa091|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|1|SCREENING|2020-07-05|40
e|SS|6ed8a749-81c0-4998-817d-efc86cfaa091|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|6|TREATMENT|2020-07-05|40
e|SS|6ed8a749-81c0-4998-817d-efc86cfaa091|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|TREATMENT|2020-07-30|65
e|SS|6ed8a749-81c0-4998-817d-efc86cfaa091|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|1|TREATMENT|2020-07-30|65
e|SS|6ed8a749-81c0-4998-817d-efc86cfaa091|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|5|SCREENING|2020-08-24|90
e|SS|6ed8a749-81c0-4998-817d-efc86cfaa091|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|1|FOLLOW-UP|2020-08-24|90
e|SS|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|1|TREATMENT|2021-01-18|10
e|SS|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|7|TREATMENT|2021-01-18|10
e|SS|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|4|WASHOUT|2021-02-02|25
e|SS|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|3|FOLLOW-UP|2021-02-02|25
e|SS|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|3|SCREENING|2021-02-17|40
e|SS|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|3|WASHOUT|2021-02-17|40
e|SS|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|1|TREATMENT|2021-03-14|65
e|SS|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|6|SCREENING|2021-03-14|65
e|SS|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|1|TREATMENT|2021-04-08|90
e|SS|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|4|TREATMENT|2021-04-08|90
e|SS|e6162980-e240-4924-a13a-dde28b2345cd|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|4|SCREENING|2020-08-11|10
e|SS|e6162980-e240-4924-a13a-dde28b2345cd|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|TREATMENT|2020-08-11|10
e|SS|e6162980-e240-4924-a13a-dde28b2345cd|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|2|WASHOUT|2020-08-26|25
e|SS|e6162980-e240-4924-a13a-dde28b2345cd|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|4|FOLLOW-UP|2020-08-26|25
e|SS|e6162980-e240-4924-a13a-dde28b2345cd|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|4|SCREENING|2020-09-10|40
e|SS|e6162980-e240-4924-a13a-dde28b2345cd|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|1|TREATMENT|2020-09-10|40
e|SS|e6162980-e240-4924-a13a-dde28b2345cd|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|5|TREATMENT|2020-10-05|65
e|SS|e6162980-e240-4924-a13a-dde28b2345cd|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|SCREENING|2020-10-05|65
e|SS|e6162980-e240-4924-a13a-dde28b2345cd|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|6|WASHOUT|2020-10-30|90
e|SS|e6162980-e240-4924-a13a-dde28b2345cd|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|WASHOUT|2020-10-30|90
e|SS|3dc9c666-8be3-4cfa-88d4-b18647e08d00|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|5|TREATMENT|2020-06-13|10
e|SS|3dc9c666-8be3-4cfa-88d4-b18647e08d00|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|3|WASHOUT|2020-06-13|10
e|SS|3dc9c666-8be3-4cfa-88d4-b18647e08d00|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|5|WASHOUT|2020-06-28|25
e|SS|3dc9c666-8be3-4cfa-88d4-b18647e08d00|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|1|TREATMENT|2020-06-28|25
e|SS|3dc9c666-8be3-4cfa-88d4-b18647e08d00|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|1|WASHOUT|2020-07-13|40
e|SS|3dc9c666-8be3-4cfa-88d4-b18647e08d00|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|5|TREATMENT|2020-07-13|40
e|SS|3dc9c666-8be3-4cfa-88d4-b18647e08d00|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|6|SCREENING|2020-08-07|65
e|SS|3dc9c666-8be3-4cfa-88d4-b18647e08d00|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|1|SCREENING|2020-08-07|65
e|SS|3dc9c666-8be3-4cfa-88d4-b18647e08d00|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|6|TREATMENT|2020-09-01|90
e|SS|3dc9c666-8be3-4cfa-88d4-b18647e08d00|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|4|TREATMENT|2020-09-01|90
e|SS|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|7|TREATMENT|2021-01-23|10
e|SS|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|TREATMENT|2021-01-23|10
e|SS|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|7|TREATMENT|2021-02-07|25
e|SS|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|2|SCREENING|2021-02-07|25
e|SS|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|7|FOLLOW-UP|2021-02-22|40
e|SS|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|TREATMENT|2021-02-22|40
e|SS|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|5|FOLLOW-UP|2021-03-19|65
e|SS|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|6|TREATMENT|2021-03-19|65
e|SS|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|5|WASHOUT|2021-04-13|90
e|SS|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|7|TREATMENT|2021-04-13|90
e|SS|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|WASHOUT|2020-11-19|10
e|SS|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|1|TREATMENT|2020-11-19|10
e|SS|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|5|TREATMENT|2020-12-04|25
e|SS|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|2|WASHOUT|2020-12-04|25
e|SS|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|4|TREATMENT|2020-12-19|40
e|SS|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|1|TREATMENT|2020-12-19|40
e|SS|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|2|TREATMENT|2021-01-13|65
e|SS|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|1|TREATMENT|2021-01-13|65
e|SS|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|4|TREATMENT|2021-02-07|90
e|SS|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|6|TREATMENT|2021-02-07|90
e|SS|2738b933-c71d-4239-a093-6b4aa7cc41df|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|6|TREATMENT|2020-05-28|10
e|SS|2738b933-c71d-4239-a093-6b4aa7cc41df|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|5|TREATMENT|2020-05-28|10
e|SS|2738b933-c71d-4239-a093-6b4aa7cc41df|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|7|FOLLOW-UP|2020-06-12|25
e|SS|2738b933-c71d-4239-a093-6b4aa7cc41df|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|6|TREATMENT|2020-06-12|25
e|SS|2738b933-c71d-4239-a093-6b4aa7cc41df|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|5|TREATMENT|2020-06-27|40
e|SS|2738b933-c71d-4239-a093-6b4aa7cc41df|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-06-27|40
e|SS|2738b933-c71d-4239-a093-6b4aa7cc41df|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|6|FOLLOW-UP|2020-07-22|65
e|SS|2738b933-c71d-4239-a093-6b4aa7cc41df|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|3|SCREENING|2020-07-22|65
e|SS|2738b933-c71d-4239-a093-6b4aa7cc41df|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|3|SCREENING|2020-08-16|90
e|SS|2738b933-c71d-4239-a093-6b4aa7cc41df|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|TREATMENT|2020-08-16|90
e|SS|68b9ff4e-9694-4545-a752-4d3ac0e89fda|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|3|SCREENING|2021-01-08|10
e|SS|68b9ff4e-9694-4545-a752-4d3ac0e89fda|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|5|TREATMENT|2021-01-08|10
e|SS|68b9ff4e-9694-4545-a752-4d3ac0e89fda|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|7|TREATMENT|2021-01-23|25
e|SS|68b9ff4e-9694-4545-a752-4d3ac0e89fda|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|WASHOUT|2021-01-23|25
e|SS|68b9ff4e-9694-4545-a752-4d3ac0e89fda|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|3|SCREENING|2021-02-07|40
e|SS|68b9ff4e-9694-4545-a752-4d3ac0e89fda|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|3|WASHOUT|2021-02-07|40
e|SS|68b9ff4e-9694-4545-a752-4d3ac0e89fda|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|4|WASHOUT|2021-03-04|65
e|SS|68b9ff4e-9694-4545-a752-4d3ac0e89fda|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|1|FOLLOW-UP|2021-03-04|65
e|SS|68b9ff4e-9694-4545-a752-4d3ac0e89fda|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|7|WASHOUT|2021-03-29|90
e|SS|68b9ff4e-9694-4545-a752-4d3ac0e89fda|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|3|WASHOUT|2021-03-29|90
e|SS|0f0ec179-5100-4a3d-9f93-54140aca7d30|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|DOMESTIC PARTNER|1|Visit_1|10|3|TREATMENT|2020-11-23|100
e|SS|0f0ec179-5100-4a3d-9f93-54140aca7d30|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|CHILD|1|Visit_1|10|3|WASHOUT|2020-11-23|100
e|SS|0f0ec179-5100-4a3d-9f93-54140aca7d30|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|WASHOUT|2020-11-23|100
e|SS|0f0ec179-5100-4a3d-9f93-54140aca7d30|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATOR|2|Visit_2|25|2|TREATMENT|2020-11-23|100
e|SS|0f0ec179-5100-4a3d-9f93-54140aca7d30|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|VENDOR|3|Visit_3|40|1|FOLLOW-UP|2020-11-23|100
e|SS|0f0ec179-5100-4a3d-9f93-54140aca7d30|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|INTERVIEWER|3|Visit_3|40|7|TREATMENT|2020-11-23|100
e|SS|0f0ec179-5100-4a3d-9f93-54140aca7d30|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|FRIEND|4|Visit_4|65|4|SCREENING|2020-11-23|100
e|SS|0f0ec179-5100-4a3d-9f93-54140aca7d30|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|FRIEND|4|Visit_4|65|1|TREATMENT|2020-11-23|100
e|SS|0f0ec179-5100-4a3d-9f93-54140aca7d30|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|INVESTIGATOR|5|Visit_5|90|5|WASHOUT|2020-11-23|100
e|SS|0f0ec179-5100-4a3d-9f93-54140aca7d30|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|FAMILY MEMBER|5|Visit_5|90|4|TREATMENT|2020-11-23|100
e|SS|6affe43d-e455-40af-8478-dc38019e89e1|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|5|WASHOUT|2020-06-17|10
e|SS|6affe43d-e455-40af-8478-dc38019e89e1|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|7|TREATMENT|2020-06-17|10
e|SS|6affe43d-e455-40af-8478-dc38019e89e1|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|4|TREATMENT|2020-07-02|25
e|SS|6affe43d-e455-40af-8478-dc38019e89e1|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|2|WASHOUT|2020-07-02|25
e|SS|6affe43d-e455-40af-8478-dc38019e89e1|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|5|SCREENING|2020-07-17|40
e|SS|6affe43d-e455-40af-8478-dc38019e89e1|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|5|TREATMENT|2020-07-17|40
e|SS|6affe43d-e455-40af-8478-dc38019e89e1|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|2|TREATMENT|2020-08-11|65
e|SS|6affe43d-e455-40af-8478-dc38019e89e1|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2020-08-11|65
e|SS|6affe43d-e455-40af-8478-dc38019e89e1|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|5|TREATMENT|2020-09-05|90
e|SS|6affe43d-e455-40af-8478-dc38019e89e1|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|1|TREATMENT|2020-09-05|90
e|SS|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|4|FOLLOW-UP|2020-06-07|10
e|SS|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|2|FOLLOW-UP|2020-06-07|10
e|SS|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|3|SCREENING|2020-06-22|25
e|SS|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|2|TREATMENT|2020-06-22|25
e|SS|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|6|TREATMENT|2020-07-07|40
e|SS|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-07-07|40
e|SS|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|2|TREATMENT|2020-08-01|65
e|SS|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|5|WASHOUT|2020-08-01|65
e|SS|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|SCREENING|2020-08-26|90
e|SS|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|4|WASHOUT|2020-08-26|90
e|SS|e0258c95-7bcc-4b54-895c-f290a1364b5c|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|7|TREATMENT|2020-12-27|10
e|SS|e0258c95-7bcc-4b54-895c-f290a1364b5c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|FOLLOW-UP|2020-12-27|10
e|SS|e0258c95-7bcc-4b54-895c-f290a1364b5c|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|6|TREATMENT|2021-01-11|25
e|SS|e0258c95-7bcc-4b54-895c-f290a1364b5c|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|5|SCREENING|2021-01-11|25
e|SS|e0258c95-7bcc-4b54-895c-f290a1364b5c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|5|SCREENING|2021-01-26|40
e|SS|e0258c95-7bcc-4b54-895c-f290a1364b5c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|5|SCREENING|2021-01-26|40
e|SS|e0258c95-7bcc-4b54-895c-f290a1364b5c|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|1|SCREENING|2021-02-20|65
e|SS|e0258c95-7bcc-4b54-895c-f290a1364b5c|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2021-02-20|65
e|SS|e0258c95-7bcc-4b54-895c-f290a1364b5c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|1|TREATMENT|2021-03-17|90
e|SS|e0258c95-7bcc-4b54-895c-f290a1364b5c|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|6|TREATMENT|2021-03-17|90
e|SS|7218f9ae-0119-4633-a8d3-7d98b2ae1671|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|3|SCREENING|2021-01-13|10
e|SS|7218f9ae-0119-4633-a8d3-7d98b2ae1671|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|5|FOLLOW-UP|2021-01-13|10
e|SS|7218f9ae-0119-4633-a8d3-7d98b2ae1671|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|6|WASHOUT|2021-01-28|25
e|SS|7218f9ae-0119-4633-a8d3-7d98b2ae1671|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|WASHOUT|2021-01-28|25
e|SS|7218f9ae-0119-4633-a8d3-7d98b2ae1671|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|3|WASHOUT|2021-02-12|40
e|SS|7218f9ae-0119-4633-a8d3-7d98b2ae1671|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|WASHOUT|2021-02-12|40
e|SS|7218f9ae-0119-4633-a8d3-7d98b2ae1671|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|TREATMENT|2021-03-09|65
e|SS|7218f9ae-0119-4633-a8d3-7d98b2ae1671|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|7|SCREENING|2021-03-09|65
e|SS|7218f9ae-0119-4633-a8d3-7d98b2ae1671|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|1|SCREENING|2021-04-03|90
e|SS|7218f9ae-0119-4633-a8d3-7d98b2ae1671|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|2|TREATMENT|2021-04-03|90
e|SS|f8c938ff-21c8-4d0b-9335-08d2865543ab|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|7|TREATMENT|2020-05-11|10
e|SS|f8c938ff-21c8-4d0b-9335-08d2865543ab|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|1|TREATMENT|2020-05-11|10
e|SS|f8c938ff-21c8-4d0b-9335-08d2865543ab|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|WASHOUT|2020-05-26|25
e|SS|f8c938ff-21c8-4d0b-9335-08d2865543ab|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|7|SCREENING|2020-05-26|25
e|SS|f8c938ff-21c8-4d0b-9335-08d2865543ab|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|3|SCREENING|2020-06-10|40
e|SS|f8c938ff-21c8-4d0b-9335-08d2865543ab|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|3|TREATMENT|2020-06-10|40
e|SS|f8c938ff-21c8-4d0b-9335-08d2865543ab|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|2|WASHOUT|2020-07-05|65
e|SS|f8c938ff-21c8-4d0b-9335-08d2865543ab|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|3|WASHOUT|2020-07-05|65
e|SS|f8c938ff-21c8-4d0b-9335-08d2865543ab|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|4|SCREENING|2020-07-30|90
e|SS|f8c938ff-21c8-4d0b-9335-08d2865543ab|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|1|TREATMENT|2020-07-30|90
e|SS|7176f852-7392-4636-800f-3aad48e93065|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|4|SCREENING|2021-01-16|10
e|SS|7176f852-7392-4636-800f-3aad48e93065|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|6|TREATMENT|2021-01-16|10
e|SS|7176f852-7392-4636-800f-3aad48e93065|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|4|SCREENING|2021-01-31|25
e|SS|7176f852-7392-4636-800f-3aad48e93065|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|4|TREATMENT|2021-01-31|25
e|SS|7176f852-7392-4636-800f-3aad48e93065|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|2|FOLLOW-UP|2021-02-15|40
e|SS|7176f852-7392-4636-800f-3aad48e93065|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|2|WASHOUT|2021-02-15|40
e|SS|7176f852-7392-4636-800f-3aad48e93065|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|6|TREATMENT|2021-03-12|65
e|SS|7176f852-7392-4636-800f-3aad48e93065|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|6|FOLLOW-UP|2021-03-12|65
e|SS|7176f852-7392-4636-800f-3aad48e93065|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|4|FOLLOW-UP|2021-04-06|90
e|SS|7176f852-7392-4636-800f-3aad48e93065|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2021-04-06|90
e|SS|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|7|SCREENING|2020-10-08|10
e|SS|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|3|TREATMENT|2020-10-08|10
e|SS|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|TREATMENT|2020-10-23|25
e|SS|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|4|TREATMENT|2020-10-23|25
e|SS|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|1|FOLLOW-UP|2020-11-07|40
e|SS|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|6|TREATMENT|2020-11-07|40
e|SS|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|6|FOLLOW-UP|2020-12-02|65
e|SS|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|4|FOLLOW-UP|2020-12-02|65
e|SS|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|5|TREATMENT|2020-12-27|90
e|SS|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|4|TREATMENT|2020-12-27|90
e|SS|69e41d6b-57f7-48b0-be7a-29fca953f8d9|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|2|TREATMENT|2020-10-28|10
e|SS|69e41d6b-57f7-48b0-be7a-29fca953f8d9|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|6|TREATMENT|2020-10-28|10
e|SS|69e41d6b-57f7-48b0-be7a-29fca953f8d9|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|5|TREATMENT|2020-11-12|25
e|SS|69e41d6b-57f7-48b0-be7a-29fca953f8d9|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|1|TREATMENT|2020-11-12|25
e|SS|69e41d6b-57f7-48b0-be7a-29fca953f8d9|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|1|WASHOUT|2020-11-27|40
e|SS|69e41d6b-57f7-48b0-be7a-29fca953f8d9|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|2|TREATMENT|2020-11-27|40
e|SS|69e41d6b-57f7-48b0-be7a-29fca953f8d9|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|5|FOLLOW-UP|2020-12-22|65
e|SS|69e41d6b-57f7-48b0-be7a-29fca953f8d9|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|7|TREATMENT|2020-12-22|65
e|SS|69e41d6b-57f7-48b0-be7a-29fca953f8d9|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|3|WASHOUT|2021-01-16|90
e|SS|69e41d6b-57f7-48b0-be7a-29fca953f8d9|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|WASHOUT|2021-01-16|90
e|SS|a38eb4fc-2422-4d4a-a435-58ae9bf42589|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|3|WASHOUT|2020-11-23|10
e|SS|a38eb4fc-2422-4d4a-a435-58ae9bf42589|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|1|TREATMENT|2020-11-23|10
e|SS|a38eb4fc-2422-4d4a-a435-58ae9bf42589|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|1|TREATMENT|2020-12-08|25
e|SS|a38eb4fc-2422-4d4a-a435-58ae9bf42589|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|3|TREATMENT|2020-12-08|25
e|SS|a38eb4fc-2422-4d4a-a435-58ae9bf42589|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|1|WASHOUT|2020-12-23|40
e|SS|a38eb4fc-2422-4d4a-a435-58ae9bf42589|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|2|TREATMENT|2020-12-23|40
e|SS|a38eb4fc-2422-4d4a-a435-58ae9bf42589|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|4|SCREENING|2021-01-17|65
e|SS|a38eb4fc-2422-4d4a-a435-58ae9bf42589|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|SCREENING|2021-01-17|65
e|SS|a38eb4fc-2422-4d4a-a435-58ae9bf42589|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|5|FOLLOW-UP|2021-02-11|90
e|SS|a38eb4fc-2422-4d4a-a435-58ae9bf42589|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|7|FOLLOW-UP|2021-02-11|90
e|SS|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIBLING|1|Visit_1|10|5|FOLLOW-UP|2020-12-25|100
e|SS|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|TREATMENT|2020-12-25|100
e|SS|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|PROXY|2|Visit_2|25|2|WASHOUT|2020-12-25|100
e|SS|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|VENDOR|2|Visit_2|25|6|TREATMENT|2020-12-25|100
e|SS|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|VENDOR|3|Visit_3|40|4|TREATMENT|2020-12-25|100
e|SS|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|FRIEND|3|Visit_3|40|4|TREATMENT|2020-12-25|100
e|SS|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|STUDY SUBJECT|4|Visit_4|65|5|SCREENING|2020-12-25|100
e|SS|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|FAMILY MEMBER|4|Visit_4|65|2|TREATMENT|2020-12-25|100
e|SS|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|SPOUSE|5|Visit_5|90|5|TREATMENT|2020-12-25|100
e|SS|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|CAREGIVER|5|Visit_5|90|6|TREATMENT|2020-12-25|100
e|SS|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|3|TREATMENT|2021-01-01|10
e|SS|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|6|TREATMENT|2021-01-01|10
e|SS|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|2|FOLLOW-UP|2021-01-16|25
e|SS|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|5|SCREENING|2021-01-16|25
e|SS|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|1|TREATMENT|2021-01-31|40
e|SS|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|4|SCREENING|2021-01-31|40
e|SS|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|5|FOLLOW-UP|2021-02-25|65
e|SS|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|TREATMENT|2021-02-25|65
e|SS|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|2|SCREENING|2021-03-22|90
e|SS|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|2|SCREENING|2021-03-22|90
e|SS|dd518f55-0280-445d-a29f-10f09b21fd53|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|2|FOLLOW-UP|2020-05-18|10
e|SS|dd518f55-0280-445d-a29f-10f09b21fd53|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|1|TREATMENT|2020-05-18|10
e|SS|dd518f55-0280-445d-a29f-10f09b21fd53|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-06-02|25
e|SS|dd518f55-0280-445d-a29f-10f09b21fd53|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|3|TREATMENT|2020-06-02|25
e|SS|dd518f55-0280-445d-a29f-10f09b21fd53|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|1|TREATMENT|2020-06-17|40
e|SS|dd518f55-0280-445d-a29f-10f09b21fd53|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|3|FOLLOW-UP|2020-06-17|40
e|SS|dd518f55-0280-445d-a29f-10f09b21fd53|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|6|SCREENING|2020-07-12|65
e|SS|dd518f55-0280-445d-a29f-10f09b21fd53|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|4|TREATMENT|2020-07-12|65
e|SS|dd518f55-0280-445d-a29f-10f09b21fd53|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|5|TREATMENT|2020-08-06|90
e|SS|dd518f55-0280-445d-a29f-10f09b21fd53|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|2|WASHOUT|2020-08-06|90
e|SS|49a972da-dfad-438e-b5bc-26ee6b955a59|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|5|TREATMENT|2020-06-24|10
e|SS|49a972da-dfad-438e-b5bc-26ee6b955a59|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|3|WASHOUT|2020-06-24|10
e|SS|49a972da-dfad-438e-b5bc-26ee6b955a59|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|6|TREATMENT|2020-07-09|25
e|SS|49a972da-dfad-438e-b5bc-26ee6b955a59|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|3|TREATMENT|2020-07-09|25
e|SS|49a972da-dfad-438e-b5bc-26ee6b955a59|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|3|FOLLOW-UP|2020-07-24|40
e|SS|49a972da-dfad-438e-b5bc-26ee6b955a59|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|2|WASHOUT|2020-07-24|40
e|SS|49a972da-dfad-438e-b5bc-26ee6b955a59|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|1|SCREENING|2020-08-18|65
e|SS|49a972da-dfad-438e-b5bc-26ee6b955a59|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|3|WASHOUT|2020-08-18|65
e|SS|49a972da-dfad-438e-b5bc-26ee6b955a59|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|1|TREATMENT|2020-09-12|90
e|SS|49a972da-dfad-438e-b5bc-26ee6b955a59|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|1|TREATMENT|2020-09-12|90
e|SS|502a42a7-2ed6-46b9-9b10-728f849334b6|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|6|TREATMENT|2020-11-21|10
e|SS|502a42a7-2ed6-46b9-9b10-728f849334b6|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|5|WASHOUT|2020-11-21|10
e|SS|502a42a7-2ed6-46b9-9b10-728f849334b6|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|2|FOLLOW-UP|2020-12-06|25
e|SS|502a42a7-2ed6-46b9-9b10-728f849334b6|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|7|SCREENING|2020-12-06|25
e|SS|502a42a7-2ed6-46b9-9b10-728f849334b6|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|6|TREATMENT|2020-12-21|40
e|SS|502a42a7-2ed6-46b9-9b10-728f849334b6|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2020-12-21|40
e|SS|502a42a7-2ed6-46b9-9b10-728f849334b6|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|4|TREATMENT|2021-01-15|65
e|SS|502a42a7-2ed6-46b9-9b10-728f849334b6|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2021-01-15|65
e|SS|502a42a7-2ed6-46b9-9b10-728f849334b6|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|7|TREATMENT|2021-02-09|90
e|SS|502a42a7-2ed6-46b9-9b10-728f849334b6|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|1|WASHOUT|2021-02-09|90
e|SS|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|2|SCREENING|2020-10-26|10
e|SS|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|7|TREATMENT|2020-10-26|10
e|SS|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|7|TREATMENT|2020-11-10|25
e|SS|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|5|TREATMENT|2020-11-10|25
e|SS|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|5|TREATMENT|2020-11-25|40
e|SS|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|5|SCREENING|2020-11-25|40
e|SS|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|2|TREATMENT|2020-12-20|65
e|SS|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|WASHOUT|2020-12-20|65
e|SS|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|1|TREATMENT|2021-01-14|90
e|SS|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|7|FOLLOW-UP|2021-01-14|90
e|SS|40c048ea-d637-426b-8afe-2da3a6961528|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|2|TREATMENT|2020-07-13|10
e|SS|40c048ea-d637-426b-8afe-2da3a6961528|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|4|TREATMENT|2020-07-13|10
e|SS|40c048ea-d637-426b-8afe-2da3a6961528|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|3|FOLLOW-UP|2020-07-28|25
e|SS|40c048ea-d637-426b-8afe-2da3a6961528|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|5|TREATMENT|2020-07-28|25
e|SS|40c048ea-d637-426b-8afe-2da3a6961528|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|5|FOLLOW-UP|2020-08-12|40
e|SS|40c048ea-d637-426b-8afe-2da3a6961528|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|6|TREATMENT|2020-08-12|40
e|SS|40c048ea-d637-426b-8afe-2da3a6961528|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|2|TREATMENT|2020-09-06|65
e|SS|40c048ea-d637-426b-8afe-2da3a6961528|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|1|TREATMENT|2020-09-06|65
e|SS|40c048ea-d637-426b-8afe-2da3a6961528|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|2|TREATMENT|2020-10-01|90
e|SS|40c048ea-d637-426b-8afe-2da3a6961528|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|7|TREATMENT|2020-10-01|90
e|SS|4d03b209-bd53-47f5-8251-f9fb2074bc38|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|7|WASHOUT|2021-01-02|10
e|SS|4d03b209-bd53-47f5-8251-f9fb2074bc38|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|FOLLOW-UP|2021-01-02|10
e|SS|4d03b209-bd53-47f5-8251-f9fb2074bc38|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|6|WASHOUT|2021-01-17|25
e|SS|4d03b209-bd53-47f5-8251-f9fb2074bc38|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|6|SCREENING|2021-01-17|25
e|SS|4d03b209-bd53-47f5-8251-f9fb2074bc38|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|6|TREATMENT|2021-02-01|40
e|SS|4d03b209-bd53-47f5-8251-f9fb2074bc38|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|2|TREATMENT|2021-02-01|40
e|SS|4d03b209-bd53-47f5-8251-f9fb2074bc38|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|4|SCREENING|2021-02-26|65
e|SS|4d03b209-bd53-47f5-8251-f9fb2074bc38|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|1|FOLLOW-UP|2021-02-26|65
e|SS|4d03b209-bd53-47f5-8251-f9fb2074bc38|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|1|FOLLOW-UP|2021-03-23|90
e|SS|4d03b209-bd53-47f5-8251-f9fb2074bc38|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|7|FOLLOW-UP|2021-03-23|90
e|SS|35f01eda-1acb-4700-8285-c8cd4b69b524|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|2|TREATMENT|2020-09-30|10
e|SS|35f01eda-1acb-4700-8285-c8cd4b69b524|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|1|TREATMENT|2020-09-30|10
e|SS|35f01eda-1acb-4700-8285-c8cd4b69b524|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|4|TREATMENT|2020-10-15|25
e|SS|35f01eda-1acb-4700-8285-c8cd4b69b524|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|3|WASHOUT|2020-10-15|25
e|SS|35f01eda-1acb-4700-8285-c8cd4b69b524|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|4|WASHOUT|2020-10-30|40
e|SS|35f01eda-1acb-4700-8285-c8cd4b69b524|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|1|TREATMENT|2020-10-30|40
e|SS|35f01eda-1acb-4700-8285-c8cd4b69b524|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2020-11-24|65
e|SS|35f01eda-1acb-4700-8285-c8cd4b69b524|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|2|TREATMENT|2020-11-24|65
e|SS|35f01eda-1acb-4700-8285-c8cd4b69b524|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|2|TREATMENT|2020-12-19|90
e|SS|35f01eda-1acb-4700-8285-c8cd4b69b524|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|6|FOLLOW-UP|2020-12-19|90
e|SS|9df97277-7d07-4020-bae0-dfa982f21c8d|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|7|WASHOUT|2020-11-02|10
e|SS|9df97277-7d07-4020-bae0-dfa982f21c8d|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|2|TREATMENT|2020-11-02|10
e|SS|9df97277-7d07-4020-bae0-dfa982f21c8d|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|1|WASHOUT|2020-11-17|25
e|SS|9df97277-7d07-4020-bae0-dfa982f21c8d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|2|TREATMENT|2020-11-17|25
e|SS|9df97277-7d07-4020-bae0-dfa982f21c8d|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|7|TREATMENT|2020-12-02|40
e|SS|9df97277-7d07-4020-bae0-dfa982f21c8d|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|1|TREATMENT|2020-12-02|40
e|SS|9df97277-7d07-4020-bae0-dfa982f21c8d|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|5|TREATMENT|2020-12-27|65
e|SS|9df97277-7d07-4020-bae0-dfa982f21c8d|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2020-12-27|65
e|SS|9df97277-7d07-4020-bae0-dfa982f21c8d|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|2|FOLLOW-UP|2021-01-21|90
e|SS|9df97277-7d07-4020-bae0-dfa982f21c8d|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|7|TREATMENT|2021-01-21|90
e|SS|d1b522d5-557a-4361-a9da-292aa601fbc3|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|4|SCREENING|2020-10-09|10
e|SS|d1b522d5-557a-4361-a9da-292aa601fbc3|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|5|TREATMENT|2020-10-09|10
e|SS|d1b522d5-557a-4361-a9da-292aa601fbc3|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|3|FOLLOW-UP|2020-10-24|25
e|SS|d1b522d5-557a-4361-a9da-292aa601fbc3|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|4|TREATMENT|2020-10-24|25
e|SS|d1b522d5-557a-4361-a9da-292aa601fbc3|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|6|TREATMENT|2020-11-08|40
e|SS|d1b522d5-557a-4361-a9da-292aa601fbc3|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|7|WASHOUT|2020-11-08|40
e|SS|d1b522d5-557a-4361-a9da-292aa601fbc3|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|1|FOLLOW-UP|2020-12-03|65
e|SS|d1b522d5-557a-4361-a9da-292aa601fbc3|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|6|FOLLOW-UP|2020-12-03|65
e|SS|d1b522d5-557a-4361-a9da-292aa601fbc3|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|2|TREATMENT|2020-12-28|90
e|SS|d1b522d5-557a-4361-a9da-292aa601fbc3|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2020-12-28|90
e|SS|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|5|FOLLOW-UP|2020-07-27|10
e|SS|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|3|SCREENING|2020-07-27|10
e|SS|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|3|FOLLOW-UP|2020-08-11|25
e|SS|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|2|SCREENING|2020-08-11|25
e|SS|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|4|FOLLOW-UP|2020-08-26|40
e|SS|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|5|WASHOUT|2020-08-26|40
e|SS|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|4|TREATMENT|2020-09-20|65
e|SS|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|5|FOLLOW-UP|2020-09-20|65
e|SS|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|2|WASHOUT|2020-10-15|90
e|SS|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|4|TREATMENT|2020-10-15|90
e|SS|da2d0844-3608-4927-9103-cb7c52dd2c96|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|5|TREATMENT|2021-01-26|10
e|SS|da2d0844-3608-4927-9103-cb7c52dd2c96|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|2|SCREENING|2021-01-26|10
e|SS|da2d0844-3608-4927-9103-cb7c52dd2c96|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|3|TREATMENT|2021-02-10|25
e|SS|da2d0844-3608-4927-9103-cb7c52dd2c96|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|4|TREATMENT|2021-02-10|25
e|SS|da2d0844-3608-4927-9103-cb7c52dd2c96|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|3|TREATMENT|2021-02-25|40
e|SS|da2d0844-3608-4927-9103-cb7c52dd2c96|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2021-02-25|40
e|SS|da2d0844-3608-4927-9103-cb7c52dd2c96|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|1|FOLLOW-UP|2021-03-22|65
e|SS|da2d0844-3608-4927-9103-cb7c52dd2c96|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|1|WASHOUT|2021-03-22|65
e|SS|da2d0844-3608-4927-9103-cb7c52dd2c96|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|2|TREATMENT|2021-04-16|90
e|SS|da2d0844-3608-4927-9103-cb7c52dd2c96|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|1|WASHOUT|2021-04-16|90
e|SS|30b6f8a7-4512-462d-a162-45c3dad853e5|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|4|TREATMENT|2020-12-02|10
e|SS|30b6f8a7-4512-462d-a162-45c3dad853e5|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|2|FOLLOW-UP|2020-12-02|10
e|SS|30b6f8a7-4512-462d-a162-45c3dad853e5|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|6|SCREENING|2020-12-17|25
e|SS|30b6f8a7-4512-462d-a162-45c3dad853e5|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|TREATMENT|2020-12-17|25
e|SS|30b6f8a7-4512-462d-a162-45c3dad853e5|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|4|SCREENING|2021-01-01|40
e|SS|30b6f8a7-4512-462d-a162-45c3dad853e5|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|4|WASHOUT|2021-01-01|40
e|SS|30b6f8a7-4512-462d-a162-45c3dad853e5|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|6|TREATMENT|2021-01-26|65
e|SS|30b6f8a7-4512-462d-a162-45c3dad853e5|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|6|TREATMENT|2021-01-26|65
e|SS|30b6f8a7-4512-462d-a162-45c3dad853e5|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|3|TREATMENT|2021-02-20|90
e|SS|30b6f8a7-4512-462d-a162-45c3dad853e5|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|4|TREATMENT|2021-02-20|90
e|SS|1a3808b9-6004-4133-8f59-49905d04655e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|3|TREATMENT|2020-11-07|10
e|SS|1a3808b9-6004-4133-8f59-49905d04655e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|1|TREATMENT|2020-11-07|10
e|SS|1a3808b9-6004-4133-8f59-49905d04655e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|SCREENING|2020-11-22|25
e|SS|1a3808b9-6004-4133-8f59-49905d04655e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|6|FOLLOW-UP|2020-11-22|25
e|SS|1a3808b9-6004-4133-8f59-49905d04655e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|4|FOLLOW-UP|2020-12-07|40
e|SS|1a3808b9-6004-4133-8f59-49905d04655e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|TREATMENT|2020-12-07|40
e|SS|1a3808b9-6004-4133-8f59-49905d04655e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|6|WASHOUT|2021-01-01|65
e|SS|1a3808b9-6004-4133-8f59-49905d04655e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|2|SCREENING|2021-01-01|65
e|SS|1a3808b9-6004-4133-8f59-49905d04655e|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|6|TREATMENT|2021-01-26|90
e|SS|1a3808b9-6004-4133-8f59-49905d04655e|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|2|TREATMENT|2021-01-26|90
e|SS|5c91894d-c756-4ade-9fc4-2a64d4acc53f|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|4|TREATMENT|2021-01-19|10
e|SS|5c91894d-c756-4ade-9fc4-2a64d4acc53f|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|TREATMENT|2021-01-19|10
e|SS|5c91894d-c756-4ade-9fc4-2a64d4acc53f|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|5|SCREENING|2021-02-03|25
e|SS|5c91894d-c756-4ade-9fc4-2a64d4acc53f|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|1|FOLLOW-UP|2021-02-03|25
e|SS|5c91894d-c756-4ade-9fc4-2a64d4acc53f|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|2|TREATMENT|2021-02-18|40
e|SS|5c91894d-c756-4ade-9fc4-2a64d4acc53f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|3|FOLLOW-UP|2021-02-18|40
e|SS|5c91894d-c756-4ade-9fc4-2a64d4acc53f|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|2|WASHOUT|2021-03-15|65
e|SS|5c91894d-c756-4ade-9fc4-2a64d4acc53f|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|7|FOLLOW-UP|2021-03-15|65
e|SS|5c91894d-c756-4ade-9fc4-2a64d4acc53f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|3|WASHOUT|2021-04-09|90
e|SS|5c91894d-c756-4ade-9fc4-2a64d4acc53f|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|5|SCREENING|2021-04-09|90
e|SS|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|1|TREATMENT|2020-07-15|10
e|SS|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|5|FOLLOW-UP|2020-07-15|10
e|SS|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|5|FOLLOW-UP|2020-07-30|25
e|SS|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|2|TREATMENT|2020-07-30|25
e|SS|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|5|WASHOUT|2020-08-14|40
e|SS|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|1|SCREENING|2020-08-14|40
e|SS|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|6|FOLLOW-UP|2020-09-08|65
e|SS|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|3|TREATMENT|2020-09-08|65
e|SS|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|3|TREATMENT|2020-10-03|90
e|SS|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|2|FOLLOW-UP|2020-10-03|90
e|SS|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|1|TREATMENT|2020-09-15|10
e|SS|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|FOLLOW-UP|2020-09-15|10
e|SS|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|7|TREATMENT|2020-09-30|25
e|SS|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|3|SCREENING|2020-09-30|25
e|SS|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|6|FOLLOW-UP|2020-10-15|40
e|SS|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|1|WASHOUT|2020-10-15|40
e|SS|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|1|TREATMENT|2020-11-09|65
e|SS|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|3|TREATMENT|2020-11-09|65
e|SS|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|1|SCREENING|2020-12-04|90
e|SS|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|1|FOLLOW-UP|2020-12-04|90
e|SS|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|4|WASHOUT|2020-06-10|10
e|SS|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|TREATMENT|2020-06-10|10
e|SS|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|6|WASHOUT|2020-06-25|25
e|SS|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|3|TREATMENT|2020-06-25|25
e|SS|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|2|TREATMENT|2020-07-10|40
e|SS|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|5|TREATMENT|2020-07-10|40
e|SS|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|5|SCREENING|2020-08-04|65
e|SS|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|6|TREATMENT|2020-08-04|65
e|SS|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|4|WASHOUT|2020-08-29|90
e|SS|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|7|TREATMENT|2020-08-29|90
e|SS|37610314-f803-4ffa-a584-ebfe09267a0d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|4|SCREENING|2020-06-30|10
e|SS|37610314-f803-4ffa-a584-ebfe09267a0d|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|6|SCREENING|2020-06-30|10
e|SS|37610314-f803-4ffa-a584-ebfe09267a0d|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|1|TREATMENT|2020-07-15|25
e|SS|37610314-f803-4ffa-a584-ebfe09267a0d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|3|TREATMENT|2020-07-15|25
e|SS|37610314-f803-4ffa-a584-ebfe09267a0d|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|4|TREATMENT|2020-07-30|40
e|SS|37610314-f803-4ffa-a584-ebfe09267a0d|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|7|SCREENING|2020-07-30|40
e|SS|37610314-f803-4ffa-a584-ebfe09267a0d|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|7|TREATMENT|2020-08-24|65
e|SS|37610314-f803-4ffa-a584-ebfe09267a0d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|5|TREATMENT|2020-08-24|65
e|SS|37610314-f803-4ffa-a584-ebfe09267a0d|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|4|TREATMENT|2020-09-18|90
e|SS|37610314-f803-4ffa-a584-ebfe09267a0d|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|5|TREATMENT|2020-09-18|90
e|SS|760ec5ce-3ae7-4268-9f76-b83085ad3754|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|7|TREATMENT|2020-09-24|10
e|SS|760ec5ce-3ae7-4268-9f76-b83085ad3754|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|3|SCREENING|2020-09-24|10
e|SS|760ec5ce-3ae7-4268-9f76-b83085ad3754|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|7|FOLLOW-UP|2020-10-09|25
e|SS|760ec5ce-3ae7-4268-9f76-b83085ad3754|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|5|FOLLOW-UP|2020-10-09|25
e|SS|760ec5ce-3ae7-4268-9f76-b83085ad3754|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|5|FOLLOW-UP|2020-10-24|40
e|SS|760ec5ce-3ae7-4268-9f76-b83085ad3754|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|2|TREATMENT|2020-10-24|40
e|SS|760ec5ce-3ae7-4268-9f76-b83085ad3754|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|SCREENING|2020-11-18|65
e|SS|760ec5ce-3ae7-4268-9f76-b83085ad3754|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|SCREENING|2020-11-18|65
e|SS|760ec5ce-3ae7-4268-9f76-b83085ad3754|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|4|TREATMENT|2020-12-13|90
e|SS|760ec5ce-3ae7-4268-9f76-b83085ad3754|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|2|TREATMENT|2020-12-13|90
e|SS|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|4|TREATMENT|2020-06-15|10
e|SS|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|7|FOLLOW-UP|2020-06-15|10
e|SS|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|2|TREATMENT|2020-06-30|25
e|SS|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2020-06-30|25
e|SS|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|FOLLOW-UP|2020-07-15|40
e|SS|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|6|TREATMENT|2020-07-15|40
e|SS|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|3|WASHOUT|2020-08-09|65
e|SS|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|1|TREATMENT|2020-08-09|65
e|SS|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|7|WASHOUT|2020-09-03|90
e|SS|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|3|TREATMENT|2020-09-03|90
e|SS|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|TREATMENT|2021-01-24|10
e|SS|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|2|FOLLOW-UP|2021-01-24|10
e|SS|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|6|TREATMENT|2021-02-08|25
e|SS|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|5|TREATMENT|2021-02-08|25
e|SS|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|6|FOLLOW-UP|2021-02-23|40
e|SS|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|5|TREATMENT|2021-02-23|40
e|SS|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|FOLLOW-UP|2021-03-20|65
e|SS|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|3|SCREENING|2021-03-20|65
e|SS|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|2|TREATMENT|2021-04-14|90
e|SS|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|6|TREATMENT|2021-04-14|90
e|SS|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|6|TREATMENT|2020-11-13|10
e|SS|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|4|TREATMENT|2020-11-13|10
e|SS|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|3|TREATMENT|2020-11-28|25
e|SS|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|SCREENING|2020-11-28|25
e|SS|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|2|TREATMENT|2020-12-13|40
e|SS|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|2|TREATMENT|2020-12-13|40
e|SS|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|6|TREATMENT|2021-01-07|65
e|SS|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|2|TREATMENT|2021-01-07|65
e|SS|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|SCREENING|2021-02-01|90
e|SS|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|3|TREATMENT|2021-02-01|90
e|SS|d7b41e15-6725-4433-8a35-72629e342b47|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|6|SCREENING|2020-09-14|10
e|SS|d7b41e15-6725-4433-8a35-72629e342b47|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|3|SCREENING|2020-09-14|10
e|SS|d7b41e15-6725-4433-8a35-72629e342b47|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|1|WASHOUT|2020-09-29|25
e|SS|d7b41e15-6725-4433-8a35-72629e342b47|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|2|TREATMENT|2020-09-29|25
e|SS|d7b41e15-6725-4433-8a35-72629e342b47|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|1|SCREENING|2020-10-14|40
e|SS|d7b41e15-6725-4433-8a35-72629e342b47|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|TREATMENT|2020-10-14|40
e|SS|d7b41e15-6725-4433-8a35-72629e342b47|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2020-11-08|65
e|SS|d7b41e15-6725-4433-8a35-72629e342b47|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|SCREENING|2020-11-08|65
e|SS|d7b41e15-6725-4433-8a35-72629e342b47|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|4|TREATMENT|2020-12-03|90
e|SS|d7b41e15-6725-4433-8a35-72629e342b47|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|2|TREATMENT|2020-12-03|90
e|SS|aeddc1ed-545c-405e-b1f7-08131961f5ff|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|2|SCREENING|2020-10-15|10
e|SS|aeddc1ed-545c-405e-b1f7-08131961f5ff|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|7|WASHOUT|2020-10-15|10
e|SS|aeddc1ed-545c-405e-b1f7-08131961f5ff|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|2|FOLLOW-UP|2020-10-30|25
e|SS|aeddc1ed-545c-405e-b1f7-08131961f5ff|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|1|TREATMENT|2020-10-30|25
e|SS|aeddc1ed-545c-405e-b1f7-08131961f5ff|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|7|TREATMENT|2020-11-14|40
e|SS|aeddc1ed-545c-405e-b1f7-08131961f5ff|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|1|TREATMENT|2020-11-14|40
e|SS|aeddc1ed-545c-405e-b1f7-08131961f5ff|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|7|SCREENING|2020-12-09|65
e|SS|aeddc1ed-545c-405e-b1f7-08131961f5ff|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|7|TREATMENT|2020-12-09|65
e|SS|aeddc1ed-545c-405e-b1f7-08131961f5ff|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|2|SCREENING|2021-01-03|90
e|SS|aeddc1ed-545c-405e-b1f7-08131961f5ff|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|3|SCREENING|2021-01-03|90
e|SS|3effe272-6a68-4163-a4f3-bd269af6061c|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|TREATMENT|2021-01-15|10
e|SS|3effe272-6a68-4163-a4f3-bd269af6061c|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|6|FOLLOW-UP|2021-01-15|10
e|SS|3effe272-6a68-4163-a4f3-bd269af6061c|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|7|TREATMENT|2021-01-30|25
e|SS|3effe272-6a68-4163-a4f3-bd269af6061c|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|5|TREATMENT|2021-01-30|25
e|SS|3effe272-6a68-4163-a4f3-bd269af6061c|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|4|TREATMENT|2021-02-14|40
e|SS|3effe272-6a68-4163-a4f3-bd269af6061c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|3|TREATMENT|2021-02-14|40
e|SS|3effe272-6a68-4163-a4f3-bd269af6061c|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|2|TREATMENT|2021-03-11|65
e|SS|3effe272-6a68-4163-a4f3-bd269af6061c|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|SCREENING|2021-03-11|65
e|SS|3effe272-6a68-4163-a4f3-bd269af6061c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|2|TREATMENT|2021-04-05|90
e|SS|3effe272-6a68-4163-a4f3-bd269af6061c|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|6|WASHOUT|2021-04-05|90
e|SS|8153c765-a92a-4b0f-9ef3-6ca925337f54|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|FOLLOW-UP|2020-09-29|10
e|SS|8153c765-a92a-4b0f-9ef3-6ca925337f54|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|6|SCREENING|2020-09-29|10
e|SS|8153c765-a92a-4b0f-9ef3-6ca925337f54|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|5|SCREENING|2020-10-14|25
e|SS|8153c765-a92a-4b0f-9ef3-6ca925337f54|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|SCREENING|2020-10-14|25
e|SS|8153c765-a92a-4b0f-9ef3-6ca925337f54|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|1|TREATMENT|2020-10-29|40
e|SS|8153c765-a92a-4b0f-9ef3-6ca925337f54|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|5|TREATMENT|2020-10-29|40
e|SS|8153c765-a92a-4b0f-9ef3-6ca925337f54|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|2|SCREENING|2020-11-23|65
e|SS|8153c765-a92a-4b0f-9ef3-6ca925337f54|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|5|WASHOUT|2020-11-23|65
e|SS|8153c765-a92a-4b0f-9ef3-6ca925337f54|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|2|TREATMENT|2020-12-18|90
e|SS|8153c765-a92a-4b0f-9ef3-6ca925337f54|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|7|SCREENING|2020-12-18|90
e|SS|8d27cdcf-768e-4630-95b5-da554f6f3b56|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|1|TREATMENT|2020-10-30|10
e|SS|8d27cdcf-768e-4630-95b5-da554f6f3b56|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|7|TREATMENT|2020-10-30|10
e|SS|8d27cdcf-768e-4630-95b5-da554f6f3b56|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|7|TREATMENT|2020-11-14|25
e|SS|8d27cdcf-768e-4630-95b5-da554f6f3b56|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|3|TREATMENT|2020-11-14|25
e|SS|8d27cdcf-768e-4630-95b5-da554f6f3b56|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|6|FOLLOW-UP|2020-11-29|40
e|SS|8d27cdcf-768e-4630-95b5-da554f6f3b56|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|4|TREATMENT|2020-11-29|40
e|SS|8d27cdcf-768e-4630-95b5-da554f6f3b56|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|6|TREATMENT|2020-12-24|65
e|SS|8d27cdcf-768e-4630-95b5-da554f6f3b56|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|4|SCREENING|2020-12-24|65
e|SS|8d27cdcf-768e-4630-95b5-da554f6f3b56|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|4|FOLLOW-UP|2021-01-18|90
e|SS|8d27cdcf-768e-4630-95b5-da554f6f3b56|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|WASHOUT|2021-01-18|90
e|SS|5c2791ff-aaf6-413f-9827-6e97e2273388|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|4|TREATMENT|2020-09-06|10
e|SS|5c2791ff-aaf6-413f-9827-6e97e2273388|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|7|TREATMENT|2020-09-06|10
e|SS|5c2791ff-aaf6-413f-9827-6e97e2273388|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|5|SCREENING|2020-09-21|25
e|SS|5c2791ff-aaf6-413f-9827-6e97e2273388|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|2|SCREENING|2020-09-21|25
e|SS|5c2791ff-aaf6-413f-9827-6e97e2273388|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|4|TREATMENT|2020-10-06|40
e|SS|5c2791ff-aaf6-413f-9827-6e97e2273388|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|7|SCREENING|2020-10-06|40
e|SS|5c2791ff-aaf6-413f-9827-6e97e2273388|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|2|WASHOUT|2020-10-31|65
e|SS|5c2791ff-aaf6-413f-9827-6e97e2273388|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|2|SCREENING|2020-10-31|65
e|SS|5c2791ff-aaf6-413f-9827-6e97e2273388|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2020-11-25|90
e|SS|5c2791ff-aaf6-413f-9827-6e97e2273388|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|7|TREATMENT|2020-11-25|90
e|SS|b336d8c2-7bca-404e-aea3-5148d559ea99|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|TREATMENT|2020-09-19|10
e|SS|b336d8c2-7bca-404e-aea3-5148d559ea99|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|3|SCREENING|2020-09-19|10
e|SS|b336d8c2-7bca-404e-aea3-5148d559ea99|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|7|TREATMENT|2020-10-04|25
e|SS|b336d8c2-7bca-404e-aea3-5148d559ea99|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|3|TREATMENT|2020-10-04|25
e|SS|b336d8c2-7bca-404e-aea3-5148d559ea99|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|1|SCREENING|2020-10-19|40
e|SS|b336d8c2-7bca-404e-aea3-5148d559ea99|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|4|SCREENING|2020-10-19|40
e|SS|b336d8c2-7bca-404e-aea3-5148d559ea99|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|FOLLOW-UP|2020-11-13|65
e|SS|b336d8c2-7bca-404e-aea3-5148d559ea99|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|7|TREATMENT|2020-11-13|65
e|SS|b336d8c2-7bca-404e-aea3-5148d559ea99|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|1|TREATMENT|2020-12-08|90
e|SS|b336d8c2-7bca-404e-aea3-5148d559ea99|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|5|TREATMENT|2020-12-08|90
e|SS|702b2f8f-63b9-44c1-a46d-1a41bc837c32|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|6|TREATMENT|2020-06-17|10
e|SS|702b2f8f-63b9-44c1-a46d-1a41bc837c32|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|3|WASHOUT|2020-06-17|10
e|SS|702b2f8f-63b9-44c1-a46d-1a41bc837c32|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|2|TREATMENT|2020-07-02|25
e|SS|702b2f8f-63b9-44c1-a46d-1a41bc837c32|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|4|TREATMENT|2020-07-02|25
e|SS|702b2f8f-63b9-44c1-a46d-1a41bc837c32|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|TREATMENT|2020-07-17|40
e|SS|702b2f8f-63b9-44c1-a46d-1a41bc837c32|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|4|FOLLOW-UP|2020-07-17|40
e|SS|702b2f8f-63b9-44c1-a46d-1a41bc837c32|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|3|TREATMENT|2020-08-11|65
e|SS|702b2f8f-63b9-44c1-a46d-1a41bc837c32|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|2|TREATMENT|2020-08-11|65
e|SS|702b2f8f-63b9-44c1-a46d-1a41bc837c32|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2020-09-05|90
e|SS|702b2f8f-63b9-44c1-a46d-1a41bc837c32|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|5|TREATMENT|2020-09-05|90
e|SS|1261eee1-f073-4419-b0b7-28abd0ec1513|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|3|WASHOUT|2020-10-01|10
e|SS|1261eee1-f073-4419-b0b7-28abd0ec1513|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|WASHOUT|2020-10-01|10
e|SS|1261eee1-f073-4419-b0b7-28abd0ec1513|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|5|TREATMENT|2020-10-16|25
e|SS|1261eee1-f073-4419-b0b7-28abd0ec1513|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|SCREENING|2020-10-16|25
e|SS|1261eee1-f073-4419-b0b7-28abd0ec1513|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|4|TREATMENT|2020-10-31|40
e|SS|1261eee1-f073-4419-b0b7-28abd0ec1513|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|3|TREATMENT|2020-10-31|40
e|SS|1261eee1-f073-4419-b0b7-28abd0ec1513|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|1|WASHOUT|2020-11-25|65
e|SS|1261eee1-f073-4419-b0b7-28abd0ec1513|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|1|TREATMENT|2020-11-25|65
e|SS|1261eee1-f073-4419-b0b7-28abd0ec1513|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|5|FOLLOW-UP|2020-12-20|90
e|SS|1261eee1-f073-4419-b0b7-28abd0ec1513|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|1|SCREENING|2020-12-20|90
e|SS|46eefdf3-c314-4e61-963c-ce7f48c636e5|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|7|SCREENING|2020-12-29|10
e|SS|46eefdf3-c314-4e61-963c-ce7f48c636e5|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2020-12-29|10
e|SS|46eefdf3-c314-4e61-963c-ce7f48c636e5|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|2|TREATMENT|2021-01-13|25
e|SS|46eefdf3-c314-4e61-963c-ce7f48c636e5|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|5|SCREENING|2021-01-13|25
e|SS|46eefdf3-c314-4e61-963c-ce7f48c636e5|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|7|FOLLOW-UP|2021-01-28|40
e|SS|46eefdf3-c314-4e61-963c-ce7f48c636e5|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|WASHOUT|2021-01-28|40
e|SS|46eefdf3-c314-4e61-963c-ce7f48c636e5|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|FOLLOW-UP|2021-02-22|65
e|SS|46eefdf3-c314-4e61-963c-ce7f48c636e5|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|2|WASHOUT|2021-02-22|65
e|SS|46eefdf3-c314-4e61-963c-ce7f48c636e5|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|3|SCREENING|2021-03-19|90
e|SS|46eefdf3-c314-4e61-963c-ce7f48c636e5|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|5|TREATMENT|2021-03-19|90
e|SS|f632159b-8c91-4f0d-81cb-e5b9195588c9|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|5|SCREENING|2021-01-12|10
e|SS|f632159b-8c91-4f0d-81cb-e5b9195588c9|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|7|TREATMENT|2021-01-12|10
e|SS|f632159b-8c91-4f0d-81cb-e5b9195588c9|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|3|WASHOUT|2021-01-27|25
e|SS|f632159b-8c91-4f0d-81cb-e5b9195588c9|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|FOLLOW-UP|2021-01-27|25
e|SS|f632159b-8c91-4f0d-81cb-e5b9195588c9|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|5|TREATMENT|2021-02-11|40
e|SS|f632159b-8c91-4f0d-81cb-e5b9195588c9|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|4|FOLLOW-UP|2021-02-11|40
e|SS|f632159b-8c91-4f0d-81cb-e5b9195588c9|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|3|TREATMENT|2021-03-08|65
e|SS|f632159b-8c91-4f0d-81cb-e5b9195588c9|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|4|SCREENING|2021-03-08|65
e|SS|f632159b-8c91-4f0d-81cb-e5b9195588c9|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|3|TREATMENT|2021-04-02|90
e|SS|f632159b-8c91-4f0d-81cb-e5b9195588c9|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|4|TREATMENT|2021-04-02|90
e|SS|898a9d2f-338b-41bf-8ac0-c4a025481349|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIGNIFICANT OTHER|1|Visit_1|10|3|SCREENING|2020-08-22|100
e|SS|898a9d2f-338b-41bf-8ac0-c4a025481349|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIGNIFICANT OTHER|1|Visit_1|10|4|TREATMENT|2020-08-22|100
e|SS|898a9d2f-338b-41bf-8ac0-c4a025481349|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|FRIEND|2|Visit_2|25|1|FOLLOW-UP|2020-08-22|100
e|SS|898a9d2f-338b-41bf-8ac0-c4a025481349|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL STUDY SPONSOR|2|Visit_2|25|4|TREATMENT|2020-08-22|100
e|SS|898a9d2f-338b-41bf-8ac0-c4a025481349|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|PARENT|3|Visit_3|40|4|WASHOUT|2020-08-22|100
e|SS|898a9d2f-338b-41bf-8ac0-c4a025481349|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATION COMMITTEE|3|Visit_3|40|4|SCREENING|2020-08-22|100
e|SS|898a9d2f-338b-41bf-8ac0-c4a025481349|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|FAMILY MEMBER|4|Visit_4|65|6|SCREENING|2020-08-22|100
e|SS|898a9d2f-338b-41bf-8ac0-c4a025481349|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIBLING|4|Visit_4|65|2|FOLLOW-UP|2020-08-22|100
e|SS|898a9d2f-338b-41bf-8ac0-c4a025481349|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|DOMESTIC PARTNER|5|Visit_5|90|6|WASHOUT|2020-08-22|100
e|SS|898a9d2f-338b-41bf-8ac0-c4a025481349|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|STUDY SUBJECT|5|Visit_5|90|3|WASHOUT|2020-08-22|100
e|SS|db3824aa-375d-4e40-a14b-af0e4460914e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|7|WASHOUT|2020-05-20|10
e|SS|db3824aa-375d-4e40-a14b-af0e4460914e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|4|TREATMENT|2020-05-20|10
e|SS|db3824aa-375d-4e40-a14b-af0e4460914e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|4|SCREENING|2020-06-04|25
e|SS|db3824aa-375d-4e40-a14b-af0e4460914e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|1|TREATMENT|2020-06-04|25
e|SS|db3824aa-375d-4e40-a14b-af0e4460914e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|5|TREATMENT|2020-06-19|40
e|SS|db3824aa-375d-4e40-a14b-af0e4460914e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|TREATMENT|2020-06-19|40
e|SS|db3824aa-375d-4e40-a14b-af0e4460914e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|2|TREATMENT|2020-07-14|65
e|SS|db3824aa-375d-4e40-a14b-af0e4460914e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|7|TREATMENT|2020-07-14|65
e|SS|db3824aa-375d-4e40-a14b-af0e4460914e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|TREATMENT|2020-08-08|90
e|SS|db3824aa-375d-4e40-a14b-af0e4460914e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|4|TREATMENT|2020-08-08|90
e|SS|0ea6be64-32f8-4e10-b993-687ea200e4e9|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|6|SCREENING|2021-01-28|10
e|SS|0ea6be64-32f8-4e10-b993-687ea200e4e9|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|1|SCREENING|2021-01-28|10
e|SS|0ea6be64-32f8-4e10-b993-687ea200e4e9|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|5|TREATMENT|2021-02-12|25
e|SS|0ea6be64-32f8-4e10-b993-687ea200e4e9|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|WASHOUT|2021-02-12|25
e|SS|0ea6be64-32f8-4e10-b993-687ea200e4e9|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|7|SCREENING|2021-02-27|40
e|SS|0ea6be64-32f8-4e10-b993-687ea200e4e9|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|4|TREATMENT|2021-02-27|40
e|SS|0ea6be64-32f8-4e10-b993-687ea200e4e9|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|2|TREATMENT|2021-03-24|65
e|SS|0ea6be64-32f8-4e10-b993-687ea200e4e9|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|3|WASHOUT|2021-03-24|65
e|SS|0ea6be64-32f8-4e10-b993-687ea200e4e9|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|1|TREATMENT|2021-04-18|90
e|SS|0ea6be64-32f8-4e10-b993-687ea200e4e9|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|1|FOLLOW-UP|2021-04-18|90
e|SS|18504c4e-41c8-4c1a-a479-d179ccd318e3|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|4|FOLLOW-UP|2020-06-22|10
e|SS|18504c4e-41c8-4c1a-a479-d179ccd318e3|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|6|TREATMENT|2020-06-22|10
e|SS|18504c4e-41c8-4c1a-a479-d179ccd318e3|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|1|WASHOUT|2020-07-07|25
e|SS|18504c4e-41c8-4c1a-a479-d179ccd318e3|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|1|FOLLOW-UP|2020-07-07|25
e|SS|18504c4e-41c8-4c1a-a479-d179ccd318e3|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|2|SCREENING|2020-07-22|40
e|SS|18504c4e-41c8-4c1a-a479-d179ccd318e3|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|3|TREATMENT|2020-07-22|40
e|SS|18504c4e-41c8-4c1a-a479-d179ccd318e3|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|3|TREATMENT|2020-08-16|65
e|SS|18504c4e-41c8-4c1a-a479-d179ccd318e3|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|6|TREATMENT|2020-08-16|65
e|SS|18504c4e-41c8-4c1a-a479-d179ccd318e3|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|2|SCREENING|2020-09-10|90
e|SS|18504c4e-41c8-4c1a-a479-d179ccd318e3|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|3|TREATMENT|2020-09-10|90
e|SS|7f211d8a-7478-4082-8d95-4ace9ceee919|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|4|FOLLOW-UP|2020-08-19|10
e|SS|7f211d8a-7478-4082-8d95-4ace9ceee919|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|TREATMENT|2020-08-19|10
e|SS|7f211d8a-7478-4082-8d95-4ace9ceee919|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|3|TREATMENT|2020-09-03|25
e|SS|7f211d8a-7478-4082-8d95-4ace9ceee919|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|6|SCREENING|2020-09-03|25
e|SS|7f211d8a-7478-4082-8d95-4ace9ceee919|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|2|SCREENING|2020-09-18|40
e|SS|7f211d8a-7478-4082-8d95-4ace9ceee919|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|6|TREATMENT|2020-09-18|40
e|SS|7f211d8a-7478-4082-8d95-4ace9ceee919|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|5|FOLLOW-UP|2020-10-13|65
e|SS|7f211d8a-7478-4082-8d95-4ace9ceee919|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|6|WASHOUT|2020-10-13|65
e|SS|7f211d8a-7478-4082-8d95-4ace9ceee919|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|4|TREATMENT|2020-11-07|90
e|SS|7f211d8a-7478-4082-8d95-4ace9ceee919|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|5|TREATMENT|2020-11-07|90
e|SS|0739e140-bcac-4df9-9629-bd0748d1fdd6|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|5|FOLLOW-UP|2020-10-09|10
e|SS|0739e140-bcac-4df9-9629-bd0748d1fdd6|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|2|TREATMENT|2020-10-09|10
e|SS|0739e140-bcac-4df9-9629-bd0748d1fdd6|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|5|TREATMENT|2020-10-24|25
e|SS|0739e140-bcac-4df9-9629-bd0748d1fdd6|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|4|FOLLOW-UP|2020-10-24|25
e|SS|0739e140-bcac-4df9-9629-bd0748d1fdd6|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|5|SCREENING|2020-11-08|40
e|SS|0739e140-bcac-4df9-9629-bd0748d1fdd6|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|6|SCREENING|2020-11-08|40
e|SS|0739e140-bcac-4df9-9629-bd0748d1fdd6|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|3|TREATMENT|2020-12-03|65
e|SS|0739e140-bcac-4df9-9629-bd0748d1fdd6|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|7|TREATMENT|2020-12-03|65
e|SS|0739e140-bcac-4df9-9629-bd0748d1fdd6|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|7|TREATMENT|2020-12-28|90
e|SS|0739e140-bcac-4df9-9629-bd0748d1fdd6|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|2|SCREENING|2020-12-28|90
e|SS|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|7|WASHOUT|2020-12-21|10
e|SS|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|7|WASHOUT|2020-12-21|10
e|SS|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|5|FOLLOW-UP|2021-01-05|25
e|SS|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|6|TREATMENT|2021-01-05|25
e|SS|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|6|TREATMENT|2021-01-20|40
e|SS|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|5|TREATMENT|2021-01-20|40
e|SS|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|1|TREATMENT|2021-02-14|65
e|SS|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|2|FOLLOW-UP|2021-02-14|65
e|SS|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|3|TREATMENT|2021-03-11|90
e|SS|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|7|FOLLOW-UP|2021-03-11|90
e|SS|f24b931a-2cdd-4432-a1dd-69c7286f4690|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|FAMILY MEMBER|1|Visit_1|10|7|WASHOUT|2020-08-13|100
e|SS|f24b931a-2cdd-4432-a1dd-69c7286f4690|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|CHILD|1|Visit_1|10|2|SCREENING|2020-08-13|100
e|SS|f24b931a-2cdd-4432-a1dd-69c7286f4690|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|PROXY|2|Visit_2|25|5|FOLLOW-UP|2020-08-13|100
e|SS|f24b931a-2cdd-4432-a1dd-69c7286f4690|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|CHILD|2|Visit_2|25|5|TREATMENT|2020-08-13|100
e|SS|f24b931a-2cdd-4432-a1dd-69c7286f4690|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|SPOUSE|3|Visit_3|40|2|TREATMENT|2020-08-13|100
e|SS|f24b931a-2cdd-4432-a1dd-69c7286f4690|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|DOMESTIC PARTNER|3|Visit_3|40|7|TREATMENT|2020-08-13|100
e|SS|f24b931a-2cdd-4432-a1dd-69c7286f4690|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATION COMMITTEE|4|Visit_4|65|6|TREATMENT|2020-08-13|100
e|SS|f24b931a-2cdd-4432-a1dd-69c7286f4690|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|FRIEND|4|Visit_4|65|1|TREATMENT|2020-08-13|100
e|SS|f24b931a-2cdd-4432-a1dd-69c7286f4690|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|PROXY|5|Visit_5|90|6|WASHOUT|2020-08-13|100
e|SS|f24b931a-2cdd-4432-a1dd-69c7286f4690|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|SCREENING|2020-08-13|100
e|SS|d394120d-7630-4fcf-a336-482599d88296|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|3|WASHOUT|2021-01-22|10
e|SS|d394120d-7630-4fcf-a336-482599d88296|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|5|TREATMENT|2021-01-22|10
e|SS|d394120d-7630-4fcf-a336-482599d88296|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|4|TREATMENT|2021-02-06|25
e|SS|d394120d-7630-4fcf-a336-482599d88296|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|7|TREATMENT|2021-02-06|25
e|SS|d394120d-7630-4fcf-a336-482599d88296|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|2|SCREENING|2021-02-21|40
e|SS|d394120d-7630-4fcf-a336-482599d88296|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|6|TREATMENT|2021-02-21|40
e|SS|d394120d-7630-4fcf-a336-482599d88296|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|TREATMENT|2021-03-18|65
e|SS|d394120d-7630-4fcf-a336-482599d88296|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|5|FOLLOW-UP|2021-03-18|65
e|SS|d394120d-7630-4fcf-a336-482599d88296|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|2|SCREENING|2021-04-12|90
e|SS|d394120d-7630-4fcf-a336-482599d88296|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|7|TREATMENT|2021-04-12|90
e|SS|bcda1d95-58ed-4991-9395-0b98efc1d9a1|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|4|SCREENING|2020-10-21|10
e|SS|bcda1d95-58ed-4991-9395-0b98efc1d9a1|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|4|TREATMENT|2020-10-21|10
e|SS|bcda1d95-58ed-4991-9395-0b98efc1d9a1|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|5|FOLLOW-UP|2020-11-05|25
e|SS|bcda1d95-58ed-4991-9395-0b98efc1d9a1|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|7|TREATMENT|2020-11-05|25
e|SS|bcda1d95-58ed-4991-9395-0b98efc1d9a1|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|1|WASHOUT|2020-11-20|40
e|SS|bcda1d95-58ed-4991-9395-0b98efc1d9a1|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|4|FOLLOW-UP|2020-11-20|40
e|SS|bcda1d95-58ed-4991-9395-0b98efc1d9a1|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|2|WASHOUT|2020-12-15|65
e|SS|bcda1d95-58ed-4991-9395-0b98efc1d9a1|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2020-12-15|65
e|SS|bcda1d95-58ed-4991-9395-0b98efc1d9a1|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|7|TREATMENT|2021-01-09|90
e|SS|bcda1d95-58ed-4991-9395-0b98efc1d9a1|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|6|SCREENING|2021-01-09|90
e|SS|6999bd5c-0790-42b8-a4ff-e538776b0fb0|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|TREATMENT|2020-08-15|10
e|SS|6999bd5c-0790-42b8-a4ff-e538776b0fb0|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|1|TREATMENT|2020-08-15|10
e|SS|6999bd5c-0790-42b8-a4ff-e538776b0fb0|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|1|WASHOUT|2020-08-30|25
e|SS|6999bd5c-0790-42b8-a4ff-e538776b0fb0|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|1|TREATMENT|2020-08-30|25
e|SS|6999bd5c-0790-42b8-a4ff-e538776b0fb0|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|TREATMENT|2020-09-14|40
e|SS|6999bd5c-0790-42b8-a4ff-e538776b0fb0|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|5|SCREENING|2020-09-14|40
e|SS|6999bd5c-0790-42b8-a4ff-e538776b0fb0|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|3|TREATMENT|2020-10-09|65
e|SS|6999bd5c-0790-42b8-a4ff-e538776b0fb0|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|6|FOLLOW-UP|2020-10-09|65
e|SS|6999bd5c-0790-42b8-a4ff-e538776b0fb0|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|5|TREATMENT|2020-11-03|90
e|SS|6999bd5c-0790-42b8-a4ff-e538776b0fb0|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|7|WASHOUT|2020-11-03|90
e|SS|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|1|SCREENING|2020-12-21|10
e|SS|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|SCREENING|2020-12-21|10
e|SS|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|6|FOLLOW-UP|2021-01-05|25
e|SS|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|3|SCREENING|2021-01-05|25
e|SS|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|4|TREATMENT|2021-01-20|40
e|SS|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|2|TREATMENT|2021-01-20|40
e|SS|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|2|TREATMENT|2021-02-14|65
e|SS|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|WASHOUT|2021-02-14|65
e|SS|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|3|TREATMENT|2021-03-11|90
e|SS|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|4|FOLLOW-UP|2021-03-11|90
e|SS|59b0fee3-2294-448e-9837-38bd6b5c794b|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|7|TREATMENT|2021-01-01|10
e|SS|59b0fee3-2294-448e-9837-38bd6b5c794b|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|6|TREATMENT|2021-01-01|10
e|SS|59b0fee3-2294-448e-9837-38bd6b5c794b|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|6|TREATMENT|2021-01-16|25
e|SS|59b0fee3-2294-448e-9837-38bd6b5c794b|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|1|TREATMENT|2021-01-16|25
e|SS|59b0fee3-2294-448e-9837-38bd6b5c794b|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|5|WASHOUT|2021-01-31|40
e|SS|59b0fee3-2294-448e-9837-38bd6b5c794b|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|WASHOUT|2021-01-31|40
e|SS|59b0fee3-2294-448e-9837-38bd6b5c794b|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|5|WASHOUT|2021-02-25|65
e|SS|59b0fee3-2294-448e-9837-38bd6b5c794b|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|3|WASHOUT|2021-02-25|65
e|SS|59b0fee3-2294-448e-9837-38bd6b5c794b|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|4|SCREENING|2021-03-22|90
e|SS|59b0fee3-2294-448e-9837-38bd6b5c794b|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|2|TREATMENT|2021-03-22|90
e|SS|d9bdb1e3-4630-423f-be01-4873bce30422|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|SCREENING|2020-12-22|10
e|SS|d9bdb1e3-4630-423f-be01-4873bce30422|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|7|TREATMENT|2020-12-22|10
e|SS|d9bdb1e3-4630-423f-be01-4873bce30422|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|6|TREATMENT|2021-01-06|25
e|SS|d9bdb1e3-4630-423f-be01-4873bce30422|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|3|TREATMENT|2021-01-06|25
e|SS|d9bdb1e3-4630-423f-be01-4873bce30422|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|3|SCREENING|2021-01-21|40
e|SS|d9bdb1e3-4630-423f-be01-4873bce30422|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|3|SCREENING|2021-01-21|40
e|SS|d9bdb1e3-4630-423f-be01-4873bce30422|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|3|TREATMENT|2021-02-15|65
e|SS|d9bdb1e3-4630-423f-be01-4873bce30422|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|4|TREATMENT|2021-02-15|65
e|SS|d9bdb1e3-4630-423f-be01-4873bce30422|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|3|WASHOUT|2021-03-12|90
e|SS|d9bdb1e3-4630-423f-be01-4873bce30422|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|6|TREATMENT|2021-03-12|90
e|SS|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|5|FOLLOW-UP|2020-06-25|10
e|SS|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|7|SCREENING|2020-06-25|10
e|SS|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|5|TREATMENT|2020-07-10|25
e|SS|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|7|TREATMENT|2020-07-10|25
e|SS|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|6|FOLLOW-UP|2020-07-25|40
e|SS|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|FOLLOW-UP|2020-07-25|40
e|SS|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|FOLLOW-UP|2020-08-19|65
e|SS|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|2|FOLLOW-UP|2020-08-19|65
e|SS|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|3|TREATMENT|2020-09-13|90
e|SS|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2020-09-13|90
e|SS|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|FRIEND|1|Visit_1|10|2|WASHOUT|2020-11-02|100
e|SS|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|CAREGIVER|1|Visit_1|10|7|WASHOUT|2020-11-02|100
e|SS|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|CHILD|2|Visit_2|25|2|TREATMENT|2020-11-02|100
e|SS|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|CHILD|2|Visit_2|25|7|SCREENING|2020-11-02|100
e|SS|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|1|WASHOUT|2020-11-02|100
e|SS|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|FAMILY MEMBER|3|Visit_3|40|3|TREATMENT|2020-11-02|100
e|SS|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|CAREGIVER|4|Visit_4|65|5|TREATMENT|2020-11-02|100
e|SS|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|WASHOUT|2020-11-02|100
e|SS|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|CAREGIVER|5|Visit_5|90|4|TREATMENT|2020-11-02|100
e|SS|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL STUDY SPONSOR|5|Visit_5|90|3|WASHOUT|2020-11-02|100
e|SS|933c3a61-59a0-4cfb-ae17-45bc48229323|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|FOLLOW-UP|2020-09-09|10
e|SS|933c3a61-59a0-4cfb-ae17-45bc48229323|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|3|TREATMENT|2020-09-09|10
e|SS|933c3a61-59a0-4cfb-ae17-45bc48229323|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|6|TREATMENT|2020-09-24|25
e|SS|933c3a61-59a0-4cfb-ae17-45bc48229323|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-09-24|25
e|SS|933c3a61-59a0-4cfb-ae17-45bc48229323|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|6|TREATMENT|2020-10-09|40
e|SS|933c3a61-59a0-4cfb-ae17-45bc48229323|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|3|TREATMENT|2020-10-09|40
e|SS|933c3a61-59a0-4cfb-ae17-45bc48229323|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|1|WASHOUT|2020-11-03|65
e|SS|933c3a61-59a0-4cfb-ae17-45bc48229323|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|2|TREATMENT|2020-11-03|65
e|SS|933c3a61-59a0-4cfb-ae17-45bc48229323|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|6|SCREENING|2020-11-28|90
e|SS|933c3a61-59a0-4cfb-ae17-45bc48229323|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|2|WASHOUT|2020-11-28|90
e|SS|58d871e3-ef99-48da-ab12-fdfdc2e01da6|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|6|WASHOUT|2020-10-26|10
e|SS|58d871e3-ef99-48da-ab12-fdfdc2e01da6|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|1|WASHOUT|2020-10-26|10
e|SS|58d871e3-ef99-48da-ab12-fdfdc2e01da6|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|6|WASHOUT|2020-11-10|25
e|SS|58d871e3-ef99-48da-ab12-fdfdc2e01da6|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|1|WASHOUT|2020-11-10|25
e|SS|58d871e3-ef99-48da-ab12-fdfdc2e01da6|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|TREATMENT|2020-11-25|40
e|SS|58d871e3-ef99-48da-ab12-fdfdc2e01da6|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|7|TREATMENT|2020-11-25|40
e|SS|58d871e3-ef99-48da-ab12-fdfdc2e01da6|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|4|SCREENING|2020-12-20|65
e|SS|58d871e3-ef99-48da-ab12-fdfdc2e01da6|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|4|WASHOUT|2020-12-20|65
e|SS|58d871e3-ef99-48da-ab12-fdfdc2e01da6|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|1|TREATMENT|2021-01-14|90
e|SS|58d871e3-ef99-48da-ab12-fdfdc2e01da6|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|2|WASHOUT|2021-01-14|90
e|SS|ac66129e-3244-4cd8-a235-43b4bfb7dace|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|3|TREATMENT|2020-10-29|10
e|SS|ac66129e-3244-4cd8-a235-43b4bfb7dace|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|1|TREATMENT|2020-10-29|10
e|SS|ac66129e-3244-4cd8-a235-43b4bfb7dace|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|1|TREATMENT|2020-11-13|25
e|SS|ac66129e-3244-4cd8-a235-43b4bfb7dace|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|TREATMENT|2020-11-13|25
e|SS|ac66129e-3244-4cd8-a235-43b4bfb7dace|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-11-28|40
e|SS|ac66129e-3244-4cd8-a235-43b4bfb7dace|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|3|TREATMENT|2020-11-28|40
e|SS|ac66129e-3244-4cd8-a235-43b4bfb7dace|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|1|FOLLOW-UP|2020-12-23|65
e|SS|ac66129e-3244-4cd8-a235-43b4bfb7dace|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|6|TREATMENT|2020-12-23|65
e|SS|ac66129e-3244-4cd8-a235-43b4bfb7dace|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|7|WASHOUT|2021-01-17|90
e|SS|ac66129e-3244-4cd8-a235-43b4bfb7dace|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|5|TREATMENT|2021-01-17|90
e|SS|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|3|TREATMENT|2020-09-02|10
e|SS|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|3|SCREENING|2020-09-02|10
e|SS|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|4|TREATMENT|2020-09-17|25
e|SS|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|6|TREATMENT|2020-09-17|25
e|SS|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|7|TREATMENT|2020-10-02|40
e|SS|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|5|SCREENING|2020-10-02|40
e|SS|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|4|FOLLOW-UP|2020-10-27|65
e|SS|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|1|WASHOUT|2020-10-27|65
e|SS|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|3|WASHOUT|2020-11-21|90
e|SS|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|6|SCREENING|2020-11-21|90
e|SS|3d59a754-10bb-4847-93ea-433b43265a2f|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|4|FOLLOW-UP|2020-10-24|10
e|SS|3d59a754-10bb-4847-93ea-433b43265a2f|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|5|TREATMENT|2020-10-24|10
e|SS|3d59a754-10bb-4847-93ea-433b43265a2f|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|4|SCREENING|2020-11-08|25
e|SS|3d59a754-10bb-4847-93ea-433b43265a2f|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|4|TREATMENT|2020-11-08|25
e|SS|3d59a754-10bb-4847-93ea-433b43265a2f|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|TREATMENT|2020-11-23|40
e|SS|3d59a754-10bb-4847-93ea-433b43265a2f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|7|TREATMENT|2020-11-23|40
e|SS|3d59a754-10bb-4847-93ea-433b43265a2f|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|1|FOLLOW-UP|2020-12-18|65
e|SS|3d59a754-10bb-4847-93ea-433b43265a2f|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|5|WASHOUT|2020-12-18|65
e|SS|3d59a754-10bb-4847-93ea-433b43265a2f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2021-01-12|90
e|SS|3d59a754-10bb-4847-93ea-433b43265a2f|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|5|TREATMENT|2021-01-12|90
e|SS|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|2|TREATMENT|2021-01-20|10
e|SS|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|7|SCREENING|2021-01-20|10
e|SS|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|5|SCREENING|2021-02-04|25
e|SS|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|3|TREATMENT|2021-02-04|25
e|SS|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|6|TREATMENT|2021-02-19|40
e|SS|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|3|TREATMENT|2021-02-19|40
e|SS|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|6|SCREENING|2021-03-16|65
e|SS|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|5|SCREENING|2021-03-16|65
e|SS|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|1|TREATMENT|2021-04-10|90
e|SS|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|2|FOLLOW-UP|2021-04-10|90
e|SS|89209495-c485-4eb7-b858-8dc5490d2b64|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|7|FOLLOW-UP|2020-09-07|10
e|SS|89209495-c485-4eb7-b858-8dc5490d2b64|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|6|TREATMENT|2020-09-07|10
e|SS|89209495-c485-4eb7-b858-8dc5490d2b64|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|4|SCREENING|2020-09-22|25
e|SS|89209495-c485-4eb7-b858-8dc5490d2b64|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|6|SCREENING|2020-09-22|25
e|SS|89209495-c485-4eb7-b858-8dc5490d2b64|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|3|TREATMENT|2020-10-07|40
e|SS|89209495-c485-4eb7-b858-8dc5490d2b64|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|FOLLOW-UP|2020-10-07|40
e|SS|89209495-c485-4eb7-b858-8dc5490d2b64|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|1|WASHOUT|2020-11-01|65
e|SS|89209495-c485-4eb7-b858-8dc5490d2b64|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|5|WASHOUT|2020-11-01|65
e|SS|89209495-c485-4eb7-b858-8dc5490d2b64|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|6|SCREENING|2020-11-26|90
e|SS|89209495-c485-4eb7-b858-8dc5490d2b64|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2020-11-26|90
e|SS|d80522bb-f146-4270-a6e1-326fde50d9ca|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|5|TREATMENT|2020-12-31|10
e|SS|d80522bb-f146-4270-a6e1-326fde50d9ca|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|1|SCREENING|2020-12-31|10
e|SS|d80522bb-f146-4270-a6e1-326fde50d9ca|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|6|TREATMENT|2021-01-15|25
e|SS|d80522bb-f146-4270-a6e1-326fde50d9ca|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|3|SCREENING|2021-01-15|25
e|SS|d80522bb-f146-4270-a6e1-326fde50d9ca|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|1|TREATMENT|2021-01-30|40
e|SS|d80522bb-f146-4270-a6e1-326fde50d9ca|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|FOLLOW-UP|2021-01-30|40
e|SS|d80522bb-f146-4270-a6e1-326fde50d9ca|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|6|TREATMENT|2021-02-24|65
e|SS|d80522bb-f146-4270-a6e1-326fde50d9ca|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|7|TREATMENT|2021-02-24|65
e|SS|d80522bb-f146-4270-a6e1-326fde50d9ca|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|7|SCREENING|2021-03-21|90
e|SS|d80522bb-f146-4270-a6e1-326fde50d9ca|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|3|TREATMENT|2021-03-21|90
e|SS|3982a462-95f6-4e71-93e5-9df777770067|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|4|TREATMENT|2020-12-25|10
e|SS|3982a462-95f6-4e71-93e5-9df777770067|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|3|TREATMENT|2020-12-25|10
e|SS|3982a462-95f6-4e71-93e5-9df777770067|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|7|TREATMENT|2021-01-09|25
e|SS|3982a462-95f6-4e71-93e5-9df777770067|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|1|TREATMENT|2021-01-09|25
e|SS|3982a462-95f6-4e71-93e5-9df777770067|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|SCREENING|2021-01-24|40
e|SS|3982a462-95f6-4e71-93e5-9df777770067|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|3|TREATMENT|2021-01-24|40
e|SS|3982a462-95f6-4e71-93e5-9df777770067|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|6|FOLLOW-UP|2021-02-18|65
e|SS|3982a462-95f6-4e71-93e5-9df777770067|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2021-02-18|65
e|SS|3982a462-95f6-4e71-93e5-9df777770067|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|6|FOLLOW-UP|2021-03-15|90
e|SS|3982a462-95f6-4e71-93e5-9df777770067|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|3|TREATMENT|2021-03-15|90
e|SS|f3a3a6ca-2344-4cee-a6a5-59beee9304df|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|3|FOLLOW-UP|2020-11-09|10
e|SS|f3a3a6ca-2344-4cee-a6a5-59beee9304df|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|7|TREATMENT|2020-11-09|10
e|SS|f3a3a6ca-2344-4cee-a6a5-59beee9304df|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|5|FOLLOW-UP|2020-11-24|25
e|SS|f3a3a6ca-2344-4cee-a6a5-59beee9304df|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|1|WASHOUT|2020-11-24|25
e|SS|f3a3a6ca-2344-4cee-a6a5-59beee9304df|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|FOLLOW-UP|2020-12-09|40
e|SS|f3a3a6ca-2344-4cee-a6a5-59beee9304df|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|WASHOUT|2020-12-09|40
e|SS|f3a3a6ca-2344-4cee-a6a5-59beee9304df|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|3|SCREENING|2021-01-03|65
e|SS|f3a3a6ca-2344-4cee-a6a5-59beee9304df|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2021-01-03|65
e|SS|f3a3a6ca-2344-4cee-a6a5-59beee9304df|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2021-01-28|90
e|SS|f3a3a6ca-2344-4cee-a6a5-59beee9304df|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|1|TREATMENT|2021-01-28|90
e|SS|175cfd82-a6fe-463b-81e5-07ae9e1253db|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|4|TREATMENT|2020-05-26|10
e|SS|175cfd82-a6fe-463b-81e5-07ae9e1253db|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|5|TREATMENT|2020-05-26|10
e|SS|175cfd82-a6fe-463b-81e5-07ae9e1253db|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|6|TREATMENT|2020-06-10|25
e|SS|175cfd82-a6fe-463b-81e5-07ae9e1253db|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|2|TREATMENT|2020-06-10|25
e|SS|175cfd82-a6fe-463b-81e5-07ae9e1253db|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|1|TREATMENT|2020-06-25|40
e|SS|175cfd82-a6fe-463b-81e5-07ae9e1253db|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|1|TREATMENT|2020-06-25|40
e|SS|175cfd82-a6fe-463b-81e5-07ae9e1253db|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|TREATMENT|2020-07-20|65
e|SS|175cfd82-a6fe-463b-81e5-07ae9e1253db|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|7|WASHOUT|2020-07-20|65
e|SS|175cfd82-a6fe-463b-81e5-07ae9e1253db|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|7|FOLLOW-UP|2020-08-14|90
e|SS|175cfd82-a6fe-463b-81e5-07ae9e1253db|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|7|SCREENING|2020-08-14|90
e|SS|e19b469c-40d5-4506-8233-a86bebde880d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|1|SCREENING|2021-01-22|10
e|SS|e19b469c-40d5-4506-8233-a86bebde880d|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|6|TREATMENT|2021-01-22|10
e|SS|e19b469c-40d5-4506-8233-a86bebde880d|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|3|TREATMENT|2021-02-06|25
e|SS|e19b469c-40d5-4506-8233-a86bebde880d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|2|TREATMENT|2021-02-06|25
e|SS|e19b469c-40d5-4506-8233-a86bebde880d|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|6|FOLLOW-UP|2021-02-21|40
e|SS|e19b469c-40d5-4506-8233-a86bebde880d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|5|TREATMENT|2021-02-21|40
e|SS|e19b469c-40d5-4506-8233-a86bebde880d|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|7|TREATMENT|2021-03-18|65
e|SS|e19b469c-40d5-4506-8233-a86bebde880d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|4|TREATMENT|2021-03-18|65
e|SS|e19b469c-40d5-4506-8233-a86bebde880d|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|2|FOLLOW-UP|2021-04-12|90
e|SS|e19b469c-40d5-4506-8233-a86bebde880d|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|3|TREATMENT|2021-04-12|90
e|SS|f280a4a5-9826-4d77-adf1-992284cb3314|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|1|TREATMENT|2020-12-19|10
e|SS|f280a4a5-9826-4d77-adf1-992284cb3314|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-12-19|10
e|SS|f280a4a5-9826-4d77-adf1-992284cb3314|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|SCREENING|2021-01-03|25
e|SS|f280a4a5-9826-4d77-adf1-992284cb3314|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|6|TREATMENT|2021-01-03|25
e|SS|f280a4a5-9826-4d77-adf1-992284cb3314|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|2|WASHOUT|2021-01-18|40
e|SS|f280a4a5-9826-4d77-adf1-992284cb3314|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|4|TREATMENT|2021-01-18|40
e|SS|f280a4a5-9826-4d77-adf1-992284cb3314|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|7|WASHOUT|2021-02-12|65
e|SS|f280a4a5-9826-4d77-adf1-992284cb3314|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|5|SCREENING|2021-02-12|65
e|SS|f280a4a5-9826-4d77-adf1-992284cb3314|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|3|TREATMENT|2021-03-09|90
e|SS|f280a4a5-9826-4d77-adf1-992284cb3314|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|1|FOLLOW-UP|2021-03-09|90
e|SS|82840929-7800-4254-b60a-8af4786664f6|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|FRIEND|1|Visit_1|10|7|TREATMENT|2020-09-02|100
e|SS|82840929-7800-4254-b60a-8af4786664f6|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|INVESTIGATOR|1|Visit_1|10|6|TREATMENT|2020-09-02|100
e|SS|82840929-7800-4254-b60a-8af4786664f6|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|PARENT|2|Visit_2|25|7|TREATMENT|2020-09-02|100
e|SS|82840929-7800-4254-b60a-8af4786664f6|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATION COMMITTEE|2|Visit_2|25|4|TREATMENT|2020-09-02|100
e|SS|82840929-7800-4254-b60a-8af4786664f6|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|DOMESTIC PARTNER|3|Visit_3|40|6|TREATMENT|2020-09-02|100
e|SS|82840929-7800-4254-b60a-8af4786664f6|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|FAMILY MEMBER|3|Visit_3|40|7|SCREENING|2020-09-02|100
e|SS|82840929-7800-4254-b60a-8af4786664f6|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2020-09-02|100
e|SS|82840929-7800-4254-b60a-8af4786664f6|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|WASHOUT|2020-09-02|100
e|SS|82840929-7800-4254-b60a-8af4786664f6|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|3|TREATMENT|2020-09-02|100
e|SS|82840929-7800-4254-b60a-8af4786664f6|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|INTERVIEWER|5|Visit_5|90|6|WASHOUT|2020-09-02|100
e|SS|dae25bdb-38fd-4852-9a9a-7627368e9497|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|1|SCREENING|2020-09-02|10
e|SS|dae25bdb-38fd-4852-9a9a-7627368e9497|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|3|TREATMENT|2020-09-02|10
e|SS|dae25bdb-38fd-4852-9a9a-7627368e9497|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|3|TREATMENT|2020-09-17|25
e|SS|dae25bdb-38fd-4852-9a9a-7627368e9497|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|SCREENING|2020-09-17|25
e|SS|dae25bdb-38fd-4852-9a9a-7627368e9497|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|5|TREATMENT|2020-10-02|40
e|SS|dae25bdb-38fd-4852-9a9a-7627368e9497|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|4|TREATMENT|2020-10-02|40
e|SS|dae25bdb-38fd-4852-9a9a-7627368e9497|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|1|WASHOUT|2020-10-27|65
e|SS|dae25bdb-38fd-4852-9a9a-7627368e9497|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|3|TREATMENT|2020-10-27|65
e|SS|dae25bdb-38fd-4852-9a9a-7627368e9497|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|6|FOLLOW-UP|2020-11-21|90
e|SS|dae25bdb-38fd-4852-9a9a-7627368e9497|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|FOLLOW-UP|2020-11-21|90
e|SS|9e009737-cd77-4b96-a4af-e9731ef7e9d0|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|7|TREATMENT|2020-10-05|10
e|SS|9e009737-cd77-4b96-a4af-e9731ef7e9d0|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|1|FOLLOW-UP|2020-10-05|10
e|SS|9e009737-cd77-4b96-a4af-e9731ef7e9d0|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|1|TREATMENT|2020-10-20|25
e|SS|9e009737-cd77-4b96-a4af-e9731ef7e9d0|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|6|TREATMENT|2020-10-20|25
e|SS|9e009737-cd77-4b96-a4af-e9731ef7e9d0|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|2|TREATMENT|2020-11-04|40
e|SS|9e009737-cd77-4b96-a4af-e9731ef7e9d0|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|7|TREATMENT|2020-11-04|40
e|SS|9e009737-cd77-4b96-a4af-e9731ef7e9d0|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|3|TREATMENT|2020-11-29|65
e|SS|9e009737-cd77-4b96-a4af-e9731ef7e9d0|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2020-11-29|65
e|SS|9e009737-cd77-4b96-a4af-e9731ef7e9d0|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|3|TREATMENT|2020-12-24|90
e|SS|9e009737-cd77-4b96-a4af-e9731ef7e9d0|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|7|TREATMENT|2020-12-24|90
e|SS|e7468d01-71b3-47c4-9715-62fe143364cb|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|7|WASHOUT|2020-10-15|10
e|SS|e7468d01-71b3-47c4-9715-62fe143364cb|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|FOLLOW-UP|2020-10-15|10
e|SS|e7468d01-71b3-47c4-9715-62fe143364cb|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|6|SCREENING|2020-10-30|25
e|SS|e7468d01-71b3-47c4-9715-62fe143364cb|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|7|FOLLOW-UP|2020-10-30|25
e|SS|e7468d01-71b3-47c4-9715-62fe143364cb|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|2|WASHOUT|2020-11-14|40
e|SS|e7468d01-71b3-47c4-9715-62fe143364cb|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|7|TREATMENT|2020-11-14|40
e|SS|e7468d01-71b3-47c4-9715-62fe143364cb|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|2|SCREENING|2020-12-09|65
e|SS|e7468d01-71b3-47c4-9715-62fe143364cb|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|6|TREATMENT|2020-12-09|65
e|SS|e7468d01-71b3-47c4-9715-62fe143364cb|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|7|WASHOUT|2021-01-03|90
e|SS|e7468d01-71b3-47c4-9715-62fe143364cb|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|7|SCREENING|2021-01-03|90
e|SS|6a021859-1b18-4eb5-9548-0e32c0c1edf7|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|5|TREATMENT|2020-05-18|10
e|SS|6a021859-1b18-4eb5-9548-0e32c0c1edf7|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|1|TREATMENT|2020-05-18|10
e|SS|6a021859-1b18-4eb5-9548-0e32c0c1edf7|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|3|FOLLOW-UP|2020-06-02|25
e|SS|6a021859-1b18-4eb5-9548-0e32c0c1edf7|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|3|TREATMENT|2020-06-02|25
e|SS|6a021859-1b18-4eb5-9548-0e32c0c1edf7|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|3|TREATMENT|2020-06-17|40
e|SS|6a021859-1b18-4eb5-9548-0e32c0c1edf7|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|2|TREATMENT|2020-06-17|40
e|SS|6a021859-1b18-4eb5-9548-0e32c0c1edf7|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|6|TREATMENT|2020-07-12|65
e|SS|6a021859-1b18-4eb5-9548-0e32c0c1edf7|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|4|TREATMENT|2020-07-12|65
e|SS|6a021859-1b18-4eb5-9548-0e32c0c1edf7|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|FOLLOW-UP|2020-08-06|90
e|SS|6a021859-1b18-4eb5-9548-0e32c0c1edf7|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|4|WASHOUT|2020-08-06|90
e|SS|eb409ec5-4c02-41c8-a11f-03d990818c2a|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|7|TREATMENT|2020-12-09|10
e|SS|eb409ec5-4c02-41c8-a11f-03d990818c2a|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|1|SCREENING|2020-12-09|10
e|SS|eb409ec5-4c02-41c8-a11f-03d990818c2a|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|7|TREATMENT|2020-12-24|25
e|SS|eb409ec5-4c02-41c8-a11f-03d990818c2a|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|7|TREATMENT|2020-12-24|25
e|SS|eb409ec5-4c02-41c8-a11f-03d990818c2a|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|6|TREATMENT|2021-01-08|40
e|SS|eb409ec5-4c02-41c8-a11f-03d990818c2a|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|1|TREATMENT|2021-01-08|40
e|SS|eb409ec5-4c02-41c8-a11f-03d990818c2a|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|6|SCREENING|2021-02-02|65
e|SS|eb409ec5-4c02-41c8-a11f-03d990818c2a|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|TREATMENT|2021-02-02|65
e|SS|eb409ec5-4c02-41c8-a11f-03d990818c2a|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|6|TREATMENT|2021-02-27|90
e|SS|eb409ec5-4c02-41c8-a11f-03d990818c2a|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|7|TREATMENT|2021-02-27|90
e|SS|2178f542-809d-4306-84e4-26d3b3b370b0|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|7|FOLLOW-UP|2020-11-06|10
e|SS|2178f542-809d-4306-84e4-26d3b3b370b0|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|4|TREATMENT|2020-11-06|10
e|SS|2178f542-809d-4306-84e4-26d3b3b370b0|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-11-21|25
e|SS|2178f542-809d-4306-84e4-26d3b3b370b0|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|6|TREATMENT|2020-11-21|25
e|SS|2178f542-809d-4306-84e4-26d3b3b370b0|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|3|SCREENING|2020-12-06|40
e|SS|2178f542-809d-4306-84e4-26d3b3b370b0|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|7|TREATMENT|2020-12-06|40
e|SS|2178f542-809d-4306-84e4-26d3b3b370b0|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|7|FOLLOW-UP|2020-12-31|65
e|SS|2178f542-809d-4306-84e4-26d3b3b370b0|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|4|SCREENING|2020-12-31|65
e|SS|2178f542-809d-4306-84e4-26d3b3b370b0|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|1|SCREENING|2021-01-25|90
e|SS|2178f542-809d-4306-84e4-26d3b3b370b0|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|SCREENING|2021-01-25|90
e|SS|da7423fb-461e-43a6-bcb9-aa87051bda0a|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|6|SCREENING|2020-10-04|10
e|SS|da7423fb-461e-43a6-bcb9-aa87051bda0a|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|3|WASHOUT|2020-10-04|10
e|SS|da7423fb-461e-43a6-bcb9-aa87051bda0a|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|3|TREATMENT|2020-10-19|25
e|SS|da7423fb-461e-43a6-bcb9-aa87051bda0a|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|7|TREATMENT|2020-10-19|25
e|SS|da7423fb-461e-43a6-bcb9-aa87051bda0a|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|5|FOLLOW-UP|2020-11-03|40
e|SS|da7423fb-461e-43a6-bcb9-aa87051bda0a|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|6|TREATMENT|2020-11-03|40
e|SS|da7423fb-461e-43a6-bcb9-aa87051bda0a|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|4|TREATMENT|2020-11-28|65
e|SS|da7423fb-461e-43a6-bcb9-aa87051bda0a|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|6|TREATMENT|2020-11-28|65
e|SS|da7423fb-461e-43a6-bcb9-aa87051bda0a|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|2|TREATMENT|2020-12-23|90
e|SS|da7423fb-461e-43a6-bcb9-aa87051bda0a|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|TREATMENT|2020-12-23|90
e|SS|40e4c69f-6115-4f0e-8555-45b12b222801|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|2|TREATMENT|2021-01-30|10
e|SS|40e4c69f-6115-4f0e-8555-45b12b222801|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|1|WASHOUT|2021-01-30|10
e|SS|40e4c69f-6115-4f0e-8555-45b12b222801|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|5|TREATMENT|2021-02-14|25
e|SS|40e4c69f-6115-4f0e-8555-45b12b222801|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|2|FOLLOW-UP|2021-02-14|25
e|SS|40e4c69f-6115-4f0e-8555-45b12b222801|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|3|WASHOUT|2021-03-01|40
e|SS|40e4c69f-6115-4f0e-8555-45b12b222801|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|7|TREATMENT|2021-03-01|40
e|SS|40e4c69f-6115-4f0e-8555-45b12b222801|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|3|TREATMENT|2021-03-26|65
e|SS|40e4c69f-6115-4f0e-8555-45b12b222801|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|4|TREATMENT|2021-03-26|65
e|SS|40e4c69f-6115-4f0e-8555-45b12b222801|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|SCREENING|2021-04-20|90
e|SS|40e4c69f-6115-4f0e-8555-45b12b222801|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|7|TREATMENT|2021-04-20|90
e|SS|1307d7f6-acb6-4096-a907-08345548a82b|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|3|FOLLOW-UP|2020-05-28|10
e|SS|1307d7f6-acb6-4096-a907-08345548a82b|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|FOLLOW-UP|2020-05-28|10
e|SS|1307d7f6-acb6-4096-a907-08345548a82b|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|4|SCREENING|2020-06-12|25
e|SS|1307d7f6-acb6-4096-a907-08345548a82b|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|5|TREATMENT|2020-06-12|25
e|SS|1307d7f6-acb6-4096-a907-08345548a82b|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|6|TREATMENT|2020-06-27|40
e|SS|1307d7f6-acb6-4096-a907-08345548a82b|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|4|WASHOUT|2020-06-27|40
e|SS|1307d7f6-acb6-4096-a907-08345548a82b|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|1|TREATMENT|2020-07-22|65
e|SS|1307d7f6-acb6-4096-a907-08345548a82b|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|2|FOLLOW-UP|2020-07-22|65
e|SS|1307d7f6-acb6-4096-a907-08345548a82b|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|7|SCREENING|2020-08-16|90
e|SS|1307d7f6-acb6-4096-a907-08345548a82b|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|7|TREATMENT|2020-08-16|90
e|SS|bac23835-1120-43b2-9d99-694bef97f44b|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|7|TREATMENT|2020-05-21|10
e|SS|bac23835-1120-43b2-9d99-694bef97f44b|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|7|TREATMENT|2020-05-21|10
e|SS|bac23835-1120-43b2-9d99-694bef97f44b|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|3|TREATMENT|2020-06-05|25
e|SS|bac23835-1120-43b2-9d99-694bef97f44b|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|7|TREATMENT|2020-06-05|25
e|SS|bac23835-1120-43b2-9d99-694bef97f44b|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|7|TREATMENT|2020-06-20|40
e|SS|bac23835-1120-43b2-9d99-694bef97f44b|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|6|TREATMENT|2020-06-20|40
e|SS|bac23835-1120-43b2-9d99-694bef97f44b|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|TREATMENT|2020-07-15|65
e|SS|bac23835-1120-43b2-9d99-694bef97f44b|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|WASHOUT|2020-07-15|65
e|SS|bac23835-1120-43b2-9d99-694bef97f44b|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|6|SCREENING|2020-08-09|90
e|SS|bac23835-1120-43b2-9d99-694bef97f44b|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|2|TREATMENT|2020-08-09|90
e|SS|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|7|TREATMENT|2020-09-24|10
e|SS|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|3|WASHOUT|2020-09-24|10
e|SS|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|7|TREATMENT|2020-10-09|25
e|SS|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|6|FOLLOW-UP|2020-10-09|25
e|SS|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|1|TREATMENT|2020-10-24|40
e|SS|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|6|TREATMENT|2020-10-24|40
e|SS|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|2|FOLLOW-UP|2020-11-18|65
e|SS|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|3|SCREENING|2020-11-18|65
e|SS|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|2|SCREENING|2020-12-13|90
e|SS|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|TREATMENT|2020-12-13|90
e|SS|14cd64f5-f3c8-47a4-b40e-9c5090890870|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|SCREENING|2020-09-24|10
e|SS|14cd64f5-f3c8-47a4-b40e-9c5090890870|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|2|TREATMENT|2020-09-24|10
e|SS|14cd64f5-f3c8-47a4-b40e-9c5090890870|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|2|TREATMENT|2020-10-09|25
e|SS|14cd64f5-f3c8-47a4-b40e-9c5090890870|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|4|TREATMENT|2020-10-09|25
e|SS|14cd64f5-f3c8-47a4-b40e-9c5090890870|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|WASHOUT|2020-10-24|40
e|SS|14cd64f5-f3c8-47a4-b40e-9c5090890870|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|3|WASHOUT|2020-10-24|40
e|SS|14cd64f5-f3c8-47a4-b40e-9c5090890870|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|3|TREATMENT|2020-11-18|65
e|SS|14cd64f5-f3c8-47a4-b40e-9c5090890870|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|4|WASHOUT|2020-11-18|65
e|SS|14cd64f5-f3c8-47a4-b40e-9c5090890870|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|WASHOUT|2020-12-13|90
e|SS|14cd64f5-f3c8-47a4-b40e-9c5090890870|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|3|SCREENING|2020-12-13|90
e|SS|ca4a06be-5e6a-4220-9854-e5fe02b384af|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|WASHOUT|2020-10-03|10
e|SS|ca4a06be-5e6a-4220-9854-e5fe02b384af|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|5|TREATMENT|2020-10-03|10
e|SS|ca4a06be-5e6a-4220-9854-e5fe02b384af|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|3|WASHOUT|2020-10-18|25
e|SS|ca4a06be-5e6a-4220-9854-e5fe02b384af|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|1|TREATMENT|2020-10-18|25
e|SS|ca4a06be-5e6a-4220-9854-e5fe02b384af|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|WASHOUT|2020-11-02|40
e|SS|ca4a06be-5e6a-4220-9854-e5fe02b384af|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|6|SCREENING|2020-11-02|40
e|SS|ca4a06be-5e6a-4220-9854-e5fe02b384af|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|1|WASHOUT|2020-11-27|65
e|SS|ca4a06be-5e6a-4220-9854-e5fe02b384af|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|5|TREATMENT|2020-11-27|65
e|SS|ca4a06be-5e6a-4220-9854-e5fe02b384af|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|3|TREATMENT|2020-12-22|90
e|SS|ca4a06be-5e6a-4220-9854-e5fe02b384af|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|2|SCREENING|2020-12-22|90
e|SS|55504c69-a659-402b-a0cb-95ab4e08c086|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|3|SCREENING|2021-01-14|10
e|SS|55504c69-a659-402b-a0cb-95ab4e08c086|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|5|SCREENING|2021-01-14|10
e|SS|55504c69-a659-402b-a0cb-95ab4e08c086|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|2|TREATMENT|2021-01-29|25
e|SS|55504c69-a659-402b-a0cb-95ab4e08c086|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|7|TREATMENT|2021-01-29|25
e|SS|55504c69-a659-402b-a0cb-95ab4e08c086|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|2|SCREENING|2021-02-13|40
e|SS|55504c69-a659-402b-a0cb-95ab4e08c086|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|3|TREATMENT|2021-02-13|40
e|SS|55504c69-a659-402b-a0cb-95ab4e08c086|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|4|FOLLOW-UP|2021-03-10|65
e|SS|55504c69-a659-402b-a0cb-95ab4e08c086|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|TREATMENT|2021-03-10|65
e|SS|55504c69-a659-402b-a0cb-95ab4e08c086|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|6|SCREENING|2021-04-04|90
e|SS|55504c69-a659-402b-a0cb-95ab4e08c086|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|6|TREATMENT|2021-04-04|90
e|SS|bffa468a-a27b-4e87-a60d-b5787a03c6f6|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|TREATMENT|2020-11-30|10
e|SS|bffa468a-a27b-4e87-a60d-b5787a03c6f6|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|7|WASHOUT|2020-11-30|10
e|SS|bffa468a-a27b-4e87-a60d-b5787a03c6f6|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|1|FOLLOW-UP|2020-12-15|25
e|SS|bffa468a-a27b-4e87-a60d-b5787a03c6f6|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|7|TREATMENT|2020-12-15|25
e|SS|bffa468a-a27b-4e87-a60d-b5787a03c6f6|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|4|TREATMENT|2020-12-30|40
e|SS|bffa468a-a27b-4e87-a60d-b5787a03c6f6|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|3|TREATMENT|2020-12-30|40
e|SS|bffa468a-a27b-4e87-a60d-b5787a03c6f6|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|2|WASHOUT|2021-01-24|65
e|SS|bffa468a-a27b-4e87-a60d-b5787a03c6f6|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|7|WASHOUT|2021-01-24|65
e|SS|bffa468a-a27b-4e87-a60d-b5787a03c6f6|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|7|SCREENING|2021-02-18|90
e|SS|bffa468a-a27b-4e87-a60d-b5787a03c6f6|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|1|FOLLOW-UP|2021-02-18|90
e|SS|2e25aa76-914f-41e3-82ce-7c56ba2f6271|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|7|FOLLOW-UP|2020-12-11|10
e|SS|2e25aa76-914f-41e3-82ce-7c56ba2f6271|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|6|TREATMENT|2020-12-11|10
e|SS|2e25aa76-914f-41e3-82ce-7c56ba2f6271|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|7|TREATMENT|2020-12-26|25
e|SS|2e25aa76-914f-41e3-82ce-7c56ba2f6271|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|6|TREATMENT|2020-12-26|25
e|SS|2e25aa76-914f-41e3-82ce-7c56ba2f6271|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|3|WASHOUT|2021-01-10|40
e|SS|2e25aa76-914f-41e3-82ce-7c56ba2f6271|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|1|TREATMENT|2021-01-10|40
e|SS|2e25aa76-914f-41e3-82ce-7c56ba2f6271|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|7|SCREENING|2021-02-04|65
e|SS|2e25aa76-914f-41e3-82ce-7c56ba2f6271|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|6|WASHOUT|2021-02-04|65
e|SS|2e25aa76-914f-41e3-82ce-7c56ba2f6271|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|4|SCREENING|2021-03-01|90
e|SS|2e25aa76-914f-41e3-82ce-7c56ba2f6271|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|FOLLOW-UP|2021-03-01|90
e|SS|12c24fff-080b-4889-a455-ff55d5c0536c|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|7|WASHOUT|2021-01-27|10
e|SS|12c24fff-080b-4889-a455-ff55d5c0536c|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|2|TREATMENT|2021-01-27|10
e|SS|12c24fff-080b-4889-a455-ff55d5c0536c|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|3|FOLLOW-UP|2021-02-11|25
e|SS|12c24fff-080b-4889-a455-ff55d5c0536c|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|7|WASHOUT|2021-02-11|25
e|SS|12c24fff-080b-4889-a455-ff55d5c0536c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|FOLLOW-UP|2021-02-26|40
e|SS|12c24fff-080b-4889-a455-ff55d5c0536c|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|3|FOLLOW-UP|2021-02-26|40
e|SS|12c24fff-080b-4889-a455-ff55d5c0536c|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|5|FOLLOW-UP|2021-03-23|65
e|SS|12c24fff-080b-4889-a455-ff55d5c0536c|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|7|TREATMENT|2021-03-23|65
e|SS|12c24fff-080b-4889-a455-ff55d5c0536c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|7|TREATMENT|2021-04-17|90
e|SS|12c24fff-080b-4889-a455-ff55d5c0536c|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2021-04-17|90
e|SS|aecfe062-4e0d-4c91-8b67-1f304c5765ae|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|6|TREATMENT|2021-01-21|10
e|SS|aecfe062-4e0d-4c91-8b67-1f304c5765ae|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|5|WASHOUT|2021-01-21|10
e|SS|aecfe062-4e0d-4c91-8b67-1f304c5765ae|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|5|TREATMENT|2021-02-05|25
e|SS|aecfe062-4e0d-4c91-8b67-1f304c5765ae|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|TREATMENT|2021-02-05|25
e|SS|aecfe062-4e0d-4c91-8b67-1f304c5765ae|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|2|TREATMENT|2021-02-20|40
e|SS|aecfe062-4e0d-4c91-8b67-1f304c5765ae|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|5|SCREENING|2021-02-20|40
e|SS|aecfe062-4e0d-4c91-8b67-1f304c5765ae|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|1|TREATMENT|2021-03-17|65
e|SS|aecfe062-4e0d-4c91-8b67-1f304c5765ae|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|3|FOLLOW-UP|2021-03-17|65
e|SS|aecfe062-4e0d-4c91-8b67-1f304c5765ae|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|5|FOLLOW-UP|2021-04-11|90
e|SS|aecfe062-4e0d-4c91-8b67-1f304c5765ae|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|7|TREATMENT|2021-04-11|90
e|SS|05a142dc-a779-44cb-ab2e-f961676a3940|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|5|SCREENING|2020-11-18|10
e|SS|05a142dc-a779-44cb-ab2e-f961676a3940|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|7|TREATMENT|2020-11-18|10
e|SS|05a142dc-a779-44cb-ab2e-f961676a3940|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|4|TREATMENT|2020-12-03|25
e|SS|05a142dc-a779-44cb-ab2e-f961676a3940|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2020-12-03|25
e|SS|05a142dc-a779-44cb-ab2e-f961676a3940|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|2|SCREENING|2020-12-18|40
e|SS|05a142dc-a779-44cb-ab2e-f961676a3940|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|TREATMENT|2020-12-18|40
e|SS|05a142dc-a779-44cb-ab2e-f961676a3940|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|7|WASHOUT|2021-01-12|65
e|SS|05a142dc-a779-44cb-ab2e-f961676a3940|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|7|TREATMENT|2021-01-12|65
e|SS|05a142dc-a779-44cb-ab2e-f961676a3940|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|2|WASHOUT|2021-02-06|90
e|SS|05a142dc-a779-44cb-ab2e-f961676a3940|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|2|TREATMENT|2021-02-06|90
e|SS|498524c5-08c4-41a4-af81-876ab2452f64|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|3|TREATMENT|2020-12-09|10
e|SS|498524c5-08c4-41a4-af81-876ab2452f64|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|3|FOLLOW-UP|2020-12-09|10
e|SS|498524c5-08c4-41a4-af81-876ab2452f64|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|2|TREATMENT|2020-12-24|25
e|SS|498524c5-08c4-41a4-af81-876ab2452f64|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|3|SCREENING|2020-12-24|25
e|SS|498524c5-08c4-41a4-af81-876ab2452f64|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|SCREENING|2021-01-08|40
e|SS|498524c5-08c4-41a4-af81-876ab2452f64|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|5|SCREENING|2021-01-08|40
e|SS|498524c5-08c4-41a4-af81-876ab2452f64|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|4|FOLLOW-UP|2021-02-02|65
e|SS|498524c5-08c4-41a4-af81-876ab2452f64|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|6|WASHOUT|2021-02-02|65
e|SS|498524c5-08c4-41a4-af81-876ab2452f64|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2021-02-27|90
e|SS|498524c5-08c4-41a4-af81-876ab2452f64|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|7|TREATMENT|2021-02-27|90
e|SS|93490930-01cd-470e-81a3-bcd7a140ccc1|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|6|TREATMENT|2020-11-17|10
e|SS|93490930-01cd-470e-81a3-bcd7a140ccc1|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|7|FOLLOW-UP|2020-11-17|10
e|SS|93490930-01cd-470e-81a3-bcd7a140ccc1|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|5|TREATMENT|2020-12-02|25
e|SS|93490930-01cd-470e-81a3-bcd7a140ccc1|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|7|TREATMENT|2020-12-02|25
e|SS|93490930-01cd-470e-81a3-bcd7a140ccc1|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|6|FOLLOW-UP|2020-12-17|40
e|SS|93490930-01cd-470e-81a3-bcd7a140ccc1|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|1|SCREENING|2020-12-17|40
e|SS|93490930-01cd-470e-81a3-bcd7a140ccc1|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|5|FOLLOW-UP|2021-01-11|65
e|SS|93490930-01cd-470e-81a3-bcd7a140ccc1|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|6|TREATMENT|2021-01-11|65
e|SS|93490930-01cd-470e-81a3-bcd7a140ccc1|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|7|FOLLOW-UP|2021-02-05|90
e|SS|93490930-01cd-470e-81a3-bcd7a140ccc1|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|4|SCREENING|2021-02-05|90
e|SS|fd588c97-c57f-432f-81a0-a116a017c5dd|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|2|WASHOUT|2020-06-03|10
e|SS|fd588c97-c57f-432f-81a0-a116a017c5dd|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|3|TREATMENT|2020-06-03|10
e|SS|fd588c97-c57f-432f-81a0-a116a017c5dd|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|3|SCREENING|2020-06-18|25
e|SS|fd588c97-c57f-432f-81a0-a116a017c5dd|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|6|TREATMENT|2020-06-18|25
e|SS|fd588c97-c57f-432f-81a0-a116a017c5dd|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|7|TREATMENT|2020-07-03|40
e|SS|fd588c97-c57f-432f-81a0-a116a017c5dd|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|TREATMENT|2020-07-03|40
e|SS|fd588c97-c57f-432f-81a0-a116a017c5dd|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|FOLLOW-UP|2020-07-28|65
e|SS|fd588c97-c57f-432f-81a0-a116a017c5dd|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|1|TREATMENT|2020-07-28|65
e|SS|fd588c97-c57f-432f-81a0-a116a017c5dd|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|6|SCREENING|2020-08-22|90
e|SS|fd588c97-c57f-432f-81a0-a116a017c5dd|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|6|FOLLOW-UP|2020-08-22|90
e|SS|18028efc-33b9-4741-a47a-8fdac0a90e6e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|3|WASHOUT|2020-12-22|10
e|SS|18028efc-33b9-4741-a47a-8fdac0a90e6e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|4|TREATMENT|2020-12-22|10
e|SS|18028efc-33b9-4741-a47a-8fdac0a90e6e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|7|FOLLOW-UP|2021-01-06|25
e|SS|18028efc-33b9-4741-a47a-8fdac0a90e6e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|TREATMENT|2021-01-06|25
e|SS|18028efc-33b9-4741-a47a-8fdac0a90e6e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|SCREENING|2021-01-21|40
e|SS|18028efc-33b9-4741-a47a-8fdac0a90e6e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|6|SCREENING|2021-01-21|40
e|SS|18028efc-33b9-4741-a47a-8fdac0a90e6e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|2|TREATMENT|2021-02-15|65
e|SS|18028efc-33b9-4741-a47a-8fdac0a90e6e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|7|FOLLOW-UP|2021-02-15|65
e|SS|18028efc-33b9-4741-a47a-8fdac0a90e6e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|6|TREATMENT|2021-03-12|90
e|SS|18028efc-33b9-4741-a47a-8fdac0a90e6e|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|6|FOLLOW-UP|2021-03-12|90
e|SS|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|6|TREATMENT|2020-06-04|10
e|SS|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|2|WASHOUT|2020-06-04|10
e|SS|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|3|WASHOUT|2020-06-19|25
e|SS|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|TREATMENT|2020-06-19|25
e|SS|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|WASHOUT|2020-07-04|40
e|SS|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|SCREENING|2020-07-04|40
e|SS|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|1|SCREENING|2020-07-29|65
e|SS|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|2|TREATMENT|2020-07-29|65
e|SS|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|3|FOLLOW-UP|2020-08-23|90
e|SS|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|4|SCREENING|2020-08-23|90
e|SS|08fccce4-64bf-431e-81b0-a96566e77df6|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|1|TREATMENT|2021-01-20|10
e|SS|08fccce4-64bf-431e-81b0-a96566e77df6|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|1|FOLLOW-UP|2021-01-20|10
e|SS|08fccce4-64bf-431e-81b0-a96566e77df6|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|4|WASHOUT|2021-02-04|25
e|SS|08fccce4-64bf-431e-81b0-a96566e77df6|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|3|FOLLOW-UP|2021-02-04|25
e|SS|08fccce4-64bf-431e-81b0-a96566e77df6|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|6|TREATMENT|2021-02-19|40
e|SS|08fccce4-64bf-431e-81b0-a96566e77df6|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|1|FOLLOW-UP|2021-02-19|40
e|SS|08fccce4-64bf-431e-81b0-a96566e77df6|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|TREATMENT|2021-03-16|65
e|SS|08fccce4-64bf-431e-81b0-a96566e77df6|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|7|TREATMENT|2021-03-16|65
e|SS|08fccce4-64bf-431e-81b0-a96566e77df6|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|6|FOLLOW-UP|2021-04-10|90
e|SS|08fccce4-64bf-431e-81b0-a96566e77df6|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|4|TREATMENT|2021-04-10|90
e|SS|0354fab5-5636-4504-8345-af060ad4c90c|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|5|SCREENING|2021-01-23|10
e|SS|0354fab5-5636-4504-8345-af060ad4c90c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|FOLLOW-UP|2021-01-23|10
e|SS|0354fab5-5636-4504-8345-af060ad4c90c|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|1|WASHOUT|2021-02-07|25
e|SS|0354fab5-5636-4504-8345-af060ad4c90c|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|1|SCREENING|2021-02-07|25
e|SS|0354fab5-5636-4504-8345-af060ad4c90c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|2|SCREENING|2021-02-22|40
e|SS|0354fab5-5636-4504-8345-af060ad4c90c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|1|FOLLOW-UP|2021-02-22|40
e|SS|0354fab5-5636-4504-8345-af060ad4c90c|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|3|SCREENING|2021-03-19|65
e|SS|0354fab5-5636-4504-8345-af060ad4c90c|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|2|TREATMENT|2021-03-19|65
e|SS|0354fab5-5636-4504-8345-af060ad4c90c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|3|TREATMENT|2021-04-13|90
e|SS|0354fab5-5636-4504-8345-af060ad4c90c|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2021-04-13|90
e|SS|f4f1a53a-d621-4f75-b44e-96b959aed03d|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|5|TREATMENT|2021-01-09|10
e|SS|f4f1a53a-d621-4f75-b44e-96b959aed03d|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|4|TREATMENT|2021-01-09|10
e|SS|f4f1a53a-d621-4f75-b44e-96b959aed03d|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|7|TREATMENT|2021-01-24|25
e|SS|f4f1a53a-d621-4f75-b44e-96b959aed03d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|2|WASHOUT|2021-01-24|25
e|SS|f4f1a53a-d621-4f75-b44e-96b959aed03d|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|3|TREATMENT|2021-02-08|40
e|SS|f4f1a53a-d621-4f75-b44e-96b959aed03d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|4|WASHOUT|2021-02-08|40
e|SS|f4f1a53a-d621-4f75-b44e-96b959aed03d|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|7|TREATMENT|2021-03-05|65
e|SS|f4f1a53a-d621-4f75-b44e-96b959aed03d|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|2|WASHOUT|2021-03-05|65
e|SS|f4f1a53a-d621-4f75-b44e-96b959aed03d|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|6|FOLLOW-UP|2021-03-30|90
e|SS|f4f1a53a-d621-4f75-b44e-96b959aed03d|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|6|WASHOUT|2021-03-30|90
e|SS|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|4|TREATMENT|2020-10-01|10
e|SS|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|2|TREATMENT|2020-10-01|10
e|SS|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|3|FOLLOW-UP|2020-10-16|25
e|SS|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|6|TREATMENT|2020-10-16|25
e|SS|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|5|FOLLOW-UP|2020-10-31|40
e|SS|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|3|FOLLOW-UP|2020-10-31|40
e|SS|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|4|SCREENING|2020-11-25|65
e|SS|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|1|TREATMENT|2020-11-25|65
e|SS|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|FOLLOW-UP|2020-12-20|90
e|SS|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|5|TREATMENT|2020-12-20|90
e|SS|679423a4-92cf-4a93-8277-282f9b43f2ed|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|6|TREATMENT|2020-08-03|10
e|SS|679423a4-92cf-4a93-8277-282f9b43f2ed|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|6|WASHOUT|2020-08-03|10
e|SS|679423a4-92cf-4a93-8277-282f9b43f2ed|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|7|TREATMENT|2020-08-18|25
e|SS|679423a4-92cf-4a93-8277-282f9b43f2ed|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|7|TREATMENT|2020-08-18|25
e|SS|679423a4-92cf-4a93-8277-282f9b43f2ed|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|1|TREATMENT|2020-09-02|40
e|SS|679423a4-92cf-4a93-8277-282f9b43f2ed|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|2|WASHOUT|2020-09-02|40
e|SS|679423a4-92cf-4a93-8277-282f9b43f2ed|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|6|TREATMENT|2020-09-27|65
e|SS|679423a4-92cf-4a93-8277-282f9b43f2ed|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|3|TREATMENT|2020-09-27|65
e|SS|679423a4-92cf-4a93-8277-282f9b43f2ed|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|4|TREATMENT|2020-10-22|90
e|SS|679423a4-92cf-4a93-8277-282f9b43f2ed|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|1|TREATMENT|2020-10-22|90
e|SS|fb686cda-337b-46aa-b67b-790414201d9a|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|1|TREATMENT|2020-05-26|10
e|SS|fb686cda-337b-46aa-b67b-790414201d9a|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|6|TREATMENT|2020-05-26|10
e|SS|fb686cda-337b-46aa-b67b-790414201d9a|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|6|TREATMENT|2020-06-10|25
e|SS|fb686cda-337b-46aa-b67b-790414201d9a|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|SCREENING|2020-06-10|25
e|SS|fb686cda-337b-46aa-b67b-790414201d9a|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|7|TREATMENT|2020-06-25|40
e|SS|fb686cda-337b-46aa-b67b-790414201d9a|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|4|TREATMENT|2020-06-25|40
e|SS|fb686cda-337b-46aa-b67b-790414201d9a|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|6|TREATMENT|2020-07-20|65
e|SS|fb686cda-337b-46aa-b67b-790414201d9a|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|SCREENING|2020-07-20|65
e|SS|fb686cda-337b-46aa-b67b-790414201d9a|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|3|SCREENING|2020-08-14|90
e|SS|fb686cda-337b-46aa-b67b-790414201d9a|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|1|TREATMENT|2020-08-14|90
e|SS|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|2|FOLLOW-UP|2020-10-05|10
e|SS|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-10-05|10
e|SS|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|6|TREATMENT|2020-10-20|25
e|SS|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|3|TREATMENT|2020-10-20|25
e|SS|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|6|SCREENING|2020-11-04|40
e|SS|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-11-04|40
e|SS|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2020-11-29|65
e|SS|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|7|TREATMENT|2020-11-29|65
e|SS|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|5|TREATMENT|2020-12-24|90
e|SS|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|4|TREATMENT|2020-12-24|90
e|SS|92d7a180-9353-41f8-93e2-ebcee32a1c63|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|7|TREATMENT|2020-12-06|10
e|SS|92d7a180-9353-41f8-93e2-ebcee32a1c63|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|3|SCREENING|2020-12-06|10
e|SS|92d7a180-9353-41f8-93e2-ebcee32a1c63|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|6|WASHOUT|2020-12-21|25
e|SS|92d7a180-9353-41f8-93e2-ebcee32a1c63|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|4|TREATMENT|2020-12-21|25
e|SS|92d7a180-9353-41f8-93e2-ebcee32a1c63|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|5|SCREENING|2021-01-05|40
e|SS|92d7a180-9353-41f8-93e2-ebcee32a1c63|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|TREATMENT|2021-01-05|40
e|SS|92d7a180-9353-41f8-93e2-ebcee32a1c63|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|5|TREATMENT|2021-01-30|65
e|SS|92d7a180-9353-41f8-93e2-ebcee32a1c63|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|6|FOLLOW-UP|2021-01-30|65
e|SS|92d7a180-9353-41f8-93e2-ebcee32a1c63|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|3|WASHOUT|2021-02-24|90
e|SS|92d7a180-9353-41f8-93e2-ebcee32a1c63|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2021-02-24|90
e|SS|5da18fbc-1274-4cb3-bb6b-b57872b9815b|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|1|WASHOUT|2020-10-17|10
e|SS|5da18fbc-1274-4cb3-bb6b-b57872b9815b|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|4|WASHOUT|2020-10-17|10
e|SS|5da18fbc-1274-4cb3-bb6b-b57872b9815b|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|4|FOLLOW-UP|2020-11-01|25
e|SS|5da18fbc-1274-4cb3-bb6b-b57872b9815b|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|TREATMENT|2020-11-01|25
e|SS|5da18fbc-1274-4cb3-bb6b-b57872b9815b|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|5|WASHOUT|2020-11-16|40
e|SS|5da18fbc-1274-4cb3-bb6b-b57872b9815b|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|FOLLOW-UP|2020-11-16|40
e|SS|5da18fbc-1274-4cb3-bb6b-b57872b9815b|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|1|TREATMENT|2020-12-11|65
e|SS|5da18fbc-1274-4cb3-bb6b-b57872b9815b|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|6|SCREENING|2020-12-11|65
e|SS|5da18fbc-1274-4cb3-bb6b-b57872b9815b|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|3|WASHOUT|2021-01-05|90
e|SS|5da18fbc-1274-4cb3-bb6b-b57872b9815b|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|2|WASHOUT|2021-01-05|90
e|SS|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|2|FOLLOW-UP|2020-11-21|10
e|SS|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|7|TREATMENT|2020-11-21|10
e|SS|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|7|FOLLOW-UP|2020-12-06|25
e|SS|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2020-12-06|25
e|SS|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|4|TREATMENT|2020-12-21|40
e|SS|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|SCREENING|2020-12-21|40
e|SS|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|1|TREATMENT|2021-01-15|65
e|SS|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|1|TREATMENT|2021-01-15|65
e|SS|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|4|SCREENING|2021-02-09|90
e|SS|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|1|FOLLOW-UP|2021-02-09|90
e|SS|4a195822-d646-4b22-a3b9-f6642442474d|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|4|TREATMENT|2020-07-25|10
e|SS|4a195822-d646-4b22-a3b9-f6642442474d|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|7|SCREENING|2020-07-25|10
e|SS|4a195822-d646-4b22-a3b9-f6642442474d|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2020-08-09|25
e|SS|4a195822-d646-4b22-a3b9-f6642442474d|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|5|TREATMENT|2020-08-09|25
e|SS|4a195822-d646-4b22-a3b9-f6642442474d|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|6|SCREENING|2020-08-24|40
e|SS|4a195822-d646-4b22-a3b9-f6642442474d|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|1|TREATMENT|2020-08-24|40
e|SS|4a195822-d646-4b22-a3b9-f6642442474d|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|6|SCREENING|2020-09-18|65
e|SS|4a195822-d646-4b22-a3b9-f6642442474d|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|2|WASHOUT|2020-09-18|65
e|SS|4a195822-d646-4b22-a3b9-f6642442474d|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|1|TREATMENT|2020-10-13|90
e|SS|4a195822-d646-4b22-a3b9-f6642442474d|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|6|TREATMENT|2020-10-13|90
e|SS|515808c1-fda7-43bb-91dc-28e2d4e308cd|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|TREATMENT|2020-09-07|10
e|SS|515808c1-fda7-43bb-91dc-28e2d4e308cd|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|1|FOLLOW-UP|2020-09-07|10
e|SS|515808c1-fda7-43bb-91dc-28e2d4e308cd|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|FOLLOW-UP|2020-09-22|25
e|SS|515808c1-fda7-43bb-91dc-28e2d4e308cd|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|1|TREATMENT|2020-09-22|25
e|SS|515808c1-fda7-43bb-91dc-28e2d4e308cd|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|2|SCREENING|2020-10-07|40
e|SS|515808c1-fda7-43bb-91dc-28e2d4e308cd|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|4|TREATMENT|2020-10-07|40
e|SS|515808c1-fda7-43bb-91dc-28e2d4e308cd|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|5|TREATMENT|2020-11-01|65
e|SS|515808c1-fda7-43bb-91dc-28e2d4e308cd|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|3|TREATMENT|2020-11-01|65
e|SS|515808c1-fda7-43bb-91dc-28e2d4e308cd|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|3|TREATMENT|2020-11-26|90
e|SS|515808c1-fda7-43bb-91dc-28e2d4e308cd|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|6|TREATMENT|2020-11-26|90
e|SS|18461665-388d-403b-90e4-2b42fcb4a01a|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|3|WASHOUT|2020-10-03|10
e|SS|18461665-388d-403b-90e4-2b42fcb4a01a|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|7|FOLLOW-UP|2020-10-03|10
e|SS|18461665-388d-403b-90e4-2b42fcb4a01a|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-10-18|25
e|SS|18461665-388d-403b-90e4-2b42fcb4a01a|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|4|SCREENING|2020-10-18|25
e|SS|18461665-388d-403b-90e4-2b42fcb4a01a|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|2|TREATMENT|2020-11-02|40
e|SS|18461665-388d-403b-90e4-2b42fcb4a01a|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|6|TREATMENT|2020-11-02|40
e|SS|18461665-388d-403b-90e4-2b42fcb4a01a|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|1|WASHOUT|2020-11-27|65
e|SS|18461665-388d-403b-90e4-2b42fcb4a01a|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2020-11-27|65
e|SS|18461665-388d-403b-90e4-2b42fcb4a01a|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|7|FOLLOW-UP|2020-12-22|90
e|SS|18461665-388d-403b-90e4-2b42fcb4a01a|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|3|WASHOUT|2020-12-22|90
e|SS|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|7|FOLLOW-UP|2020-08-14|10
e|SS|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|SCREENING|2020-08-14|10
e|SS|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|WASHOUT|2020-08-29|25
e|SS|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|5|WASHOUT|2020-08-29|25
e|SS|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|6|WASHOUT|2020-09-13|40
e|SS|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|FOLLOW-UP|2020-09-13|40
e|SS|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|4|TREATMENT|2020-10-08|65
e|SS|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|5|TREATMENT|2020-10-08|65
e|SS|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|7|WASHOUT|2020-11-02|90
e|SS|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|6|TREATMENT|2020-11-02|90
e|SS|e3ce1661-1b72-4835-88d1-5a6d3655b674|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|6|TREATMENT|2020-08-12|10
e|SS|e3ce1661-1b72-4835-88d1-5a6d3655b674|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|5|SCREENING|2020-08-12|10
e|SS|e3ce1661-1b72-4835-88d1-5a6d3655b674|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|4|WASHOUT|2020-08-27|25
e|SS|e3ce1661-1b72-4835-88d1-5a6d3655b674|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|3|TREATMENT|2020-08-27|25
e|SS|e3ce1661-1b72-4835-88d1-5a6d3655b674|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|6|WASHOUT|2020-09-11|40
e|SS|e3ce1661-1b72-4835-88d1-5a6d3655b674|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|1|WASHOUT|2020-09-11|40
e|SS|e3ce1661-1b72-4835-88d1-5a6d3655b674|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|2|TREATMENT|2020-10-06|65
e|SS|e3ce1661-1b72-4835-88d1-5a6d3655b674|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|7|SCREENING|2020-10-06|65
e|SS|e3ce1661-1b72-4835-88d1-5a6d3655b674|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|6|TREATMENT|2020-10-31|90
e|SS|e3ce1661-1b72-4835-88d1-5a6d3655b674|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|4|FOLLOW-UP|2020-10-31|90
e|SS|240844e9-3dda-438e-81b2-8f6aa4e0427e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|3|SCREENING|2020-12-09|10
e|SS|240844e9-3dda-438e-81b2-8f6aa4e0427e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|6|TREATMENT|2020-12-09|10
e|SS|240844e9-3dda-438e-81b2-8f6aa4e0427e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|4|FOLLOW-UP|2020-12-24|25
e|SS|240844e9-3dda-438e-81b2-8f6aa4e0427e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|2|TREATMENT|2020-12-24|25
e|SS|240844e9-3dda-438e-81b2-8f6aa4e0427e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|7|TREATMENT|2021-01-08|40
e|SS|240844e9-3dda-438e-81b2-8f6aa4e0427e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|SCREENING|2021-01-08|40
e|SS|240844e9-3dda-438e-81b2-8f6aa4e0427e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|5|TREATMENT|2021-02-02|65
e|SS|240844e9-3dda-438e-81b2-8f6aa4e0427e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|SCREENING|2021-02-02|65
e|SS|240844e9-3dda-438e-81b2-8f6aa4e0427e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|5|TREATMENT|2021-02-27|90
e|SS|240844e9-3dda-438e-81b2-8f6aa4e0427e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|2|TREATMENT|2021-02-27|90
e|SS|fccf5c5d-deb6-4f13-a485-afcda3556578|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|3|TREATMENT|2020-08-04|10
e|SS|fccf5c5d-deb6-4f13-a485-afcda3556578|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|FOLLOW-UP|2020-08-04|10
e|SS|fccf5c5d-deb6-4f13-a485-afcda3556578|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|6|FOLLOW-UP|2020-08-19|25
e|SS|fccf5c5d-deb6-4f13-a485-afcda3556578|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|WASHOUT|2020-08-19|25
e|SS|fccf5c5d-deb6-4f13-a485-afcda3556578|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|7|TREATMENT|2020-09-03|40
e|SS|fccf5c5d-deb6-4f13-a485-afcda3556578|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|3|FOLLOW-UP|2020-09-03|40
e|SS|fccf5c5d-deb6-4f13-a485-afcda3556578|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|2|TREATMENT|2020-09-28|65
e|SS|fccf5c5d-deb6-4f13-a485-afcda3556578|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|4|TREATMENT|2020-09-28|65
e|SS|fccf5c5d-deb6-4f13-a485-afcda3556578|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|7|TREATMENT|2020-10-23|90
e|SS|fccf5c5d-deb6-4f13-a485-afcda3556578|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|2|WASHOUT|2020-10-23|90
e|SS|94620ed0-1ae8-4fa5-a629-9210860b0be9|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|3|TREATMENT|2020-08-04|10
e|SS|94620ed0-1ae8-4fa5-a629-9210860b0be9|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|7|FOLLOW-UP|2020-08-04|10
e|SS|94620ed0-1ae8-4fa5-a629-9210860b0be9|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|3|TREATMENT|2020-08-19|25
e|SS|94620ed0-1ae8-4fa5-a629-9210860b0be9|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|5|TREATMENT|2020-08-19|25
e|SS|94620ed0-1ae8-4fa5-a629-9210860b0be9|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|WASHOUT|2020-09-03|40
e|SS|94620ed0-1ae8-4fa5-a629-9210860b0be9|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|3|TREATMENT|2020-09-03|40
e|SS|94620ed0-1ae8-4fa5-a629-9210860b0be9|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|6|TREATMENT|2020-09-28|65
e|SS|94620ed0-1ae8-4fa5-a629-9210860b0be9|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|TREATMENT|2020-09-28|65
e|SS|94620ed0-1ae8-4fa5-a629-9210860b0be9|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|5|TREATMENT|2020-10-23|90
e|SS|94620ed0-1ae8-4fa5-a629-9210860b0be9|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|4|TREATMENT|2020-10-23|90
e|SS|9c3b6912-19be-435c-87fc-781a08efb847|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|5|TREATMENT|2021-01-22|10
e|SS|9c3b6912-19be-435c-87fc-781a08efb847|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|6|TREATMENT|2021-01-22|10
e|SS|9c3b6912-19be-435c-87fc-781a08efb847|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|7|WASHOUT|2021-02-06|25
e|SS|9c3b6912-19be-435c-87fc-781a08efb847|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|4|TREATMENT|2021-02-06|25
e|SS|9c3b6912-19be-435c-87fc-781a08efb847|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|3|TREATMENT|2021-02-21|40
e|SS|9c3b6912-19be-435c-87fc-781a08efb847|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|1|SCREENING|2021-02-21|40
e|SS|9c3b6912-19be-435c-87fc-781a08efb847|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|3|WASHOUT|2021-03-18|65
e|SS|9c3b6912-19be-435c-87fc-781a08efb847|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|3|SCREENING|2021-03-18|65
e|SS|9c3b6912-19be-435c-87fc-781a08efb847|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|4|TREATMENT|2021-04-12|90
e|SS|9c3b6912-19be-435c-87fc-781a08efb847|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|5|FOLLOW-UP|2021-04-12|90
e|SS|171a6d85-ba2e-45da-b31b-01651b26e890|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|3|FOLLOW-UP|2020-08-02|10
e|SS|171a6d85-ba2e-45da-b31b-01651b26e890|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|1|FOLLOW-UP|2020-08-02|10
e|SS|171a6d85-ba2e-45da-b31b-01651b26e890|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|5|TREATMENT|2020-08-17|25
e|SS|171a6d85-ba2e-45da-b31b-01651b26e890|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|5|TREATMENT|2020-08-17|25
e|SS|171a6d85-ba2e-45da-b31b-01651b26e890|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|3|TREATMENT|2020-09-01|40
e|SS|171a6d85-ba2e-45da-b31b-01651b26e890|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|3|TREATMENT|2020-09-01|40
e|SS|171a6d85-ba2e-45da-b31b-01651b26e890|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|7|TREATMENT|2020-09-26|65
e|SS|171a6d85-ba2e-45da-b31b-01651b26e890|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|5|TREATMENT|2020-09-26|65
e|SS|171a6d85-ba2e-45da-b31b-01651b26e890|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|6|FOLLOW-UP|2020-10-21|90
e|SS|171a6d85-ba2e-45da-b31b-01651b26e890|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|7|TREATMENT|2020-10-21|90
e|SS|a8338164-1bb5-4474-9432-4d5a81ab30d8|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|1|TREATMENT|2020-12-10|10
e|SS|a8338164-1bb5-4474-9432-4d5a81ab30d8|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|1|SCREENING|2020-12-10|10
e|SS|a8338164-1bb5-4474-9432-4d5a81ab30d8|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|7|FOLLOW-UP|2020-12-25|25
e|SS|a8338164-1bb5-4474-9432-4d5a81ab30d8|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|6|TREATMENT|2020-12-25|25
e|SS|a8338164-1bb5-4474-9432-4d5a81ab30d8|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|2|FOLLOW-UP|2021-01-09|40
e|SS|a8338164-1bb5-4474-9432-4d5a81ab30d8|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|3|SCREENING|2021-01-09|40
e|SS|a8338164-1bb5-4474-9432-4d5a81ab30d8|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|6|WASHOUT|2021-02-03|65
e|SS|a8338164-1bb5-4474-9432-4d5a81ab30d8|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|1|FOLLOW-UP|2021-02-03|65
e|SS|a8338164-1bb5-4474-9432-4d5a81ab30d8|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|3|TREATMENT|2021-02-28|90
e|SS|a8338164-1bb5-4474-9432-4d5a81ab30d8|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|6|TREATMENT|2021-02-28|90
e|SS|6d64077e-1f18-4bd6-ba86-53d90121f7a9|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|6|FOLLOW-UP|2020-06-17|10
e|SS|6d64077e-1f18-4bd6-ba86-53d90121f7a9|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|7|TREATMENT|2020-06-17|10
e|SS|6d64077e-1f18-4bd6-ba86-53d90121f7a9|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|1|TREATMENT|2020-07-02|25
e|SS|6d64077e-1f18-4bd6-ba86-53d90121f7a9|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|5|TREATMENT|2020-07-02|25
e|SS|6d64077e-1f18-4bd6-ba86-53d90121f7a9|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|TREATMENT|2020-07-17|40
e|SS|6d64077e-1f18-4bd6-ba86-53d90121f7a9|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|1|WASHOUT|2020-07-17|40
e|SS|6d64077e-1f18-4bd6-ba86-53d90121f7a9|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|2|FOLLOW-UP|2020-08-11|65
e|SS|6d64077e-1f18-4bd6-ba86-53d90121f7a9|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|2|SCREENING|2020-08-11|65
e|SS|6d64077e-1f18-4bd6-ba86-53d90121f7a9|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|2|SCREENING|2020-09-05|90
e|SS|6d64077e-1f18-4bd6-ba86-53d90121f7a9|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|5|TREATMENT|2020-09-05|90
e|SS|91d08486-3db7-4c71-a63f-fd060f4ae1a4|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|5|SCREENING|2020-12-25|10
e|SS|91d08486-3db7-4c71-a63f-fd060f4ae1a4|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|SCREENING|2020-12-25|10
e|SS|91d08486-3db7-4c71-a63f-fd060f4ae1a4|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|5|WASHOUT|2021-01-09|25
e|SS|91d08486-3db7-4c71-a63f-fd060f4ae1a4|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|4|SCREENING|2021-01-09|25
e|SS|91d08486-3db7-4c71-a63f-fd060f4ae1a4|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|5|TREATMENT|2021-01-24|40
e|SS|91d08486-3db7-4c71-a63f-fd060f4ae1a4|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2021-01-24|40
e|SS|91d08486-3db7-4c71-a63f-fd060f4ae1a4|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|6|TREATMENT|2021-02-18|65
e|SS|91d08486-3db7-4c71-a63f-fd060f4ae1a4|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|3|TREATMENT|2021-02-18|65
e|SS|91d08486-3db7-4c71-a63f-fd060f4ae1a4|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|4|FOLLOW-UP|2021-03-15|90
e|SS|91d08486-3db7-4c71-a63f-fd060f4ae1a4|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|6|FOLLOW-UP|2021-03-15|90
e|SS|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2020-08-14|10
e|SS|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|6|TREATMENT|2020-08-14|10
e|SS|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|3|TREATMENT|2020-08-29|25
e|SS|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|FOLLOW-UP|2020-08-29|25
e|SS|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|5|FOLLOW-UP|2020-09-13|40
e|SS|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|TREATMENT|2020-09-13|40
e|SS|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|2|FOLLOW-UP|2020-10-08|65
e|SS|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|1|TREATMENT|2020-10-08|65
e|SS|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|2|TREATMENT|2020-11-02|90
e|SS|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|3|TREATMENT|2020-11-02|90
e|SS|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|6|WASHOUT|2021-01-09|10
e|SS|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|7|TREATMENT|2021-01-09|10
e|SS|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|5|TREATMENT|2021-01-24|25
e|SS|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|4|WASHOUT|2021-01-24|25
e|SS|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|2|SCREENING|2021-02-08|40
e|SS|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|6|TREATMENT|2021-02-08|40
e|SS|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|6|TREATMENT|2021-03-05|65
e|SS|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|5|TREATMENT|2021-03-05|65
e|SS|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|7|SCREENING|2021-03-30|90
e|SS|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|6|SCREENING|2021-03-30|90
e|SS|87998e13-813a-464d-935c-d5513cd0db5e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|2|TREATMENT|2020-08-31|10
e|SS|87998e13-813a-464d-935c-d5513cd0db5e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|4|WASHOUT|2020-08-31|10
e|SS|87998e13-813a-464d-935c-d5513cd0db5e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|5|TREATMENT|2020-09-15|25
e|SS|87998e13-813a-464d-935c-d5513cd0db5e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|5|TREATMENT|2020-09-15|25
e|SS|87998e13-813a-464d-935c-d5513cd0db5e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|5|TREATMENT|2020-09-30|40
e|SS|87998e13-813a-464d-935c-d5513cd0db5e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|FOLLOW-UP|2020-09-30|40
e|SS|87998e13-813a-464d-935c-d5513cd0db5e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|6|FOLLOW-UP|2020-10-25|65
e|SS|87998e13-813a-464d-935c-d5513cd0db5e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|1|WASHOUT|2020-10-25|65
e|SS|87998e13-813a-464d-935c-d5513cd0db5e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|WASHOUT|2020-11-19|90
e|SS|87998e13-813a-464d-935c-d5513cd0db5e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|4|TREATMENT|2020-11-19|90
e|SS|7812e96e-ea53-4eb0-8160-d4118c567c9d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|1|FOLLOW-UP|2021-01-27|10
e|SS|7812e96e-ea53-4eb0-8160-d4118c567c9d|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|2|WASHOUT|2021-01-27|10
e|SS|7812e96e-ea53-4eb0-8160-d4118c567c9d|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|4|FOLLOW-UP|2021-02-11|25
e|SS|7812e96e-ea53-4eb0-8160-d4118c567c9d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|5|TREATMENT|2021-02-11|25
e|SS|7812e96e-ea53-4eb0-8160-d4118c567c9d|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|SCREENING|2021-02-26|40
e|SS|7812e96e-ea53-4eb0-8160-d4118c567c9d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|4|TREATMENT|2021-02-26|40
e|SS|7812e96e-ea53-4eb0-8160-d4118c567c9d|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|1|WASHOUT|2021-03-23|65
e|SS|7812e96e-ea53-4eb0-8160-d4118c567c9d|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|2|FOLLOW-UP|2021-03-23|65
e|SS|7812e96e-ea53-4eb0-8160-d4118c567c9d|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|4|SCREENING|2021-04-17|90
e|SS|7812e96e-ea53-4eb0-8160-d4118c567c9d|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|5|SCREENING|2021-04-17|90
e|SS|f9c6c448-0e3d-421f-a63f-be4aeb965256|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|5|TREATMENT|2020-11-08|10
e|SS|f9c6c448-0e3d-421f-a63f-be4aeb965256|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|4|FOLLOW-UP|2020-11-08|10
e|SS|f9c6c448-0e3d-421f-a63f-be4aeb965256|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|5|SCREENING|2020-11-23|25
e|SS|f9c6c448-0e3d-421f-a63f-be4aeb965256|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|1|TREATMENT|2020-11-23|25
e|SS|f9c6c448-0e3d-421f-a63f-be4aeb965256|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|TREATMENT|2020-12-08|40
e|SS|f9c6c448-0e3d-421f-a63f-be4aeb965256|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|7|TREATMENT|2020-12-08|40
e|SS|f9c6c448-0e3d-421f-a63f-be4aeb965256|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|7|WASHOUT|2021-01-02|65
e|SS|f9c6c448-0e3d-421f-a63f-be4aeb965256|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|2|TREATMENT|2021-01-02|65
e|SS|f9c6c448-0e3d-421f-a63f-be4aeb965256|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|1|SCREENING|2021-01-27|90
e|SS|f9c6c448-0e3d-421f-a63f-be4aeb965256|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|7|SCREENING|2021-01-27|90
e|SS|e8da815a-b53c-46f4-a546-e8553152719f|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|7|TREATMENT|2020-12-27|10
e|SS|e8da815a-b53c-46f4-a546-e8553152719f|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|6|FOLLOW-UP|2020-12-27|10
e|SS|e8da815a-b53c-46f4-a546-e8553152719f|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|7|TREATMENT|2021-01-11|25
e|SS|e8da815a-b53c-46f4-a546-e8553152719f|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|5|TREATMENT|2021-01-11|25
e|SS|e8da815a-b53c-46f4-a546-e8553152719f|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|4|TREATMENT|2021-01-26|40
e|SS|e8da815a-b53c-46f4-a546-e8553152719f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2021-01-26|40
e|SS|e8da815a-b53c-46f4-a546-e8553152719f|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|6|TREATMENT|2021-02-20|65
e|SS|e8da815a-b53c-46f4-a546-e8553152719f|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|3|TREATMENT|2021-02-20|65
e|SS|e8da815a-b53c-46f4-a546-e8553152719f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|7|TREATMENT|2021-03-17|90
e|SS|e8da815a-b53c-46f4-a546-e8553152719f|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|1|TREATMENT|2021-03-17|90
e|SS|701d794b-07b4-4394-a2a4-d31a9f5b743a|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|7|WASHOUT|2021-01-29|10
e|SS|701d794b-07b4-4394-a2a4-d31a9f5b743a|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|SCREENING|2021-01-29|10
e|SS|701d794b-07b4-4394-a2a4-d31a9f5b743a|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|7|TREATMENT|2021-02-13|25
e|SS|701d794b-07b4-4394-a2a4-d31a9f5b743a|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|1|TREATMENT|2021-02-13|25
e|SS|701d794b-07b4-4394-a2a4-d31a9f5b743a|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|2|TREATMENT|2021-02-28|40
e|SS|701d794b-07b4-4394-a2a4-d31a9f5b743a|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|3|FOLLOW-UP|2021-02-28|40
e|SS|701d794b-07b4-4394-a2a4-d31a9f5b743a|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|4|SCREENING|2021-03-25|65
e|SS|701d794b-07b4-4394-a2a4-d31a9f5b743a|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|3|TREATMENT|2021-03-25|65
e|SS|701d794b-07b4-4394-a2a4-d31a9f5b743a|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|7|TREATMENT|2021-04-19|90
e|SS|701d794b-07b4-4394-a2a4-d31a9f5b743a|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|6|TREATMENT|2021-04-19|90
e|SS|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|4|TREATMENT|2020-12-25|10
e|SS|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|7|TREATMENT|2020-12-25|10
e|SS|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|1|FOLLOW-UP|2021-01-09|25
e|SS|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2021-01-09|25
e|SS|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|5|TREATMENT|2021-01-24|40
e|SS|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|3|WASHOUT|2021-01-24|40
e|SS|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|1|TREATMENT|2021-02-18|65
e|SS|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|2|TREATMENT|2021-02-18|65
e|SS|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|1|TREATMENT|2021-03-15|90
e|SS|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|7|WASHOUT|2021-03-15|90
e|SS|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|7|FOLLOW-UP|2020-08-10|10
e|SS|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|4|FOLLOW-UP|2020-08-10|10
e|SS|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|3|TREATMENT|2020-08-25|25
e|SS|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|WASHOUT|2020-08-25|25
e|SS|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|2|SCREENING|2020-09-09|40
e|SS|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|WASHOUT|2020-09-09|40
e|SS|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|7|TREATMENT|2020-10-04|65
e|SS|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|2|FOLLOW-UP|2020-10-04|65
e|SS|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|6|TREATMENT|2020-10-29|90
e|SS|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|5|TREATMENT|2020-10-29|90
e|SS|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|FOLLOW-UP|2021-01-02|10
e|SS|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|6|TREATMENT|2021-01-02|10
e|SS|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|5|SCREENING|2021-01-17|25
e|SS|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|7|TREATMENT|2021-01-17|25
e|SS|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|1|FOLLOW-UP|2021-02-01|40
e|SS|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|3|SCREENING|2021-02-01|40
e|SS|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|3|TREATMENT|2021-02-26|65
e|SS|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2021-02-26|65
e|SS|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|6|SCREENING|2021-03-23|90
e|SS|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|1|TREATMENT|2021-03-23|90
e|SS|bb2487c3-cc05-48f8-9031-0e433c07e3d6|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|3|FOLLOW-UP|2020-11-29|10
e|SS|bb2487c3-cc05-48f8-9031-0e433c07e3d6|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|WASHOUT|2020-11-29|10
e|SS|bb2487c3-cc05-48f8-9031-0e433c07e3d6|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|7|SCREENING|2020-12-14|25
e|SS|bb2487c3-cc05-48f8-9031-0e433c07e3d6|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|7|FOLLOW-UP|2020-12-14|25
e|SS|bb2487c3-cc05-48f8-9031-0e433c07e3d6|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|SCREENING|2020-12-29|40
e|SS|bb2487c3-cc05-48f8-9031-0e433c07e3d6|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|6|TREATMENT|2020-12-29|40
e|SS|bb2487c3-cc05-48f8-9031-0e433c07e3d6|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|6|SCREENING|2021-01-23|65
e|SS|bb2487c3-cc05-48f8-9031-0e433c07e3d6|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|5|WASHOUT|2021-01-23|65
e|SS|bb2487c3-cc05-48f8-9031-0e433c07e3d6|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|4|TREATMENT|2021-02-17|90
e|SS|bb2487c3-cc05-48f8-9031-0e433c07e3d6|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|4|TREATMENT|2021-02-17|90
e|SS|2661da18-b539-49d8-ac80-9da03c127d21|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|TREATMENT|2020-07-26|10
e|SS|2661da18-b539-49d8-ac80-9da03c127d21|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|2|TREATMENT|2020-07-26|10
e|SS|2661da18-b539-49d8-ac80-9da03c127d21|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|7|FOLLOW-UP|2020-08-10|25
e|SS|2661da18-b539-49d8-ac80-9da03c127d21|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|2|TREATMENT|2020-08-10|25
e|SS|2661da18-b539-49d8-ac80-9da03c127d21|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|2|SCREENING|2020-08-25|40
e|SS|2661da18-b539-49d8-ac80-9da03c127d21|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|3|TREATMENT|2020-08-25|40
e|SS|2661da18-b539-49d8-ac80-9da03c127d21|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|3|TREATMENT|2020-09-19|65
e|SS|2661da18-b539-49d8-ac80-9da03c127d21|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|SCREENING|2020-09-19|65
e|SS|2661da18-b539-49d8-ac80-9da03c127d21|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|3|WASHOUT|2020-10-14|90
e|SS|2661da18-b539-49d8-ac80-9da03c127d21|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|3|TREATMENT|2020-10-14|90
e|SS|f1835786-c567-4235-9bd1-f7ffcec12741|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|1|WASHOUT|2020-08-06|10
e|SS|f1835786-c567-4235-9bd1-f7ffcec12741|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|6|TREATMENT|2020-08-06|10
e|SS|f1835786-c567-4235-9bd1-f7ffcec12741|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|4|TREATMENT|2020-08-21|25
e|SS|f1835786-c567-4235-9bd1-f7ffcec12741|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|1|WASHOUT|2020-08-21|25
e|SS|f1835786-c567-4235-9bd1-f7ffcec12741|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|5|WASHOUT|2020-09-05|40
e|SS|f1835786-c567-4235-9bd1-f7ffcec12741|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|5|TREATMENT|2020-09-05|40
e|SS|f1835786-c567-4235-9bd1-f7ffcec12741|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|7|WASHOUT|2020-09-30|65
e|SS|f1835786-c567-4235-9bd1-f7ffcec12741|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|2|WASHOUT|2020-09-30|65
e|SS|f1835786-c567-4235-9bd1-f7ffcec12741|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|7|TREATMENT|2020-10-25|90
e|SS|f1835786-c567-4235-9bd1-f7ffcec12741|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|6|TREATMENT|2020-10-25|90
e|SS|019eb415-1da3-40fa-b4ba-b1f381ec3cac|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|7|FOLLOW-UP|2020-07-10|10
e|SS|019eb415-1da3-40fa-b4ba-b1f381ec3cac|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|FOLLOW-UP|2020-07-10|10
e|SS|019eb415-1da3-40fa-b4ba-b1f381ec3cac|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|3|WASHOUT|2020-07-25|25
e|SS|019eb415-1da3-40fa-b4ba-b1f381ec3cac|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|5|SCREENING|2020-07-25|25
e|SS|019eb415-1da3-40fa-b4ba-b1f381ec3cac|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|7|FOLLOW-UP|2020-08-09|40
e|SS|019eb415-1da3-40fa-b4ba-b1f381ec3cac|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|1|TREATMENT|2020-08-09|40
e|SS|019eb415-1da3-40fa-b4ba-b1f381ec3cac|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2020-09-03|65
e|SS|019eb415-1da3-40fa-b4ba-b1f381ec3cac|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|7|SCREENING|2020-09-03|65
e|SS|019eb415-1da3-40fa-b4ba-b1f381ec3cac|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|7|TREATMENT|2020-09-28|90
e|SS|019eb415-1da3-40fa-b4ba-b1f381ec3cac|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|3|TREATMENT|2020-09-28|90
e|SS|2506c6e2-018f-4300-b3b5-44ff8d6e13df|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|4|TREATMENT|2020-07-23|10
e|SS|2506c6e2-018f-4300-b3b5-44ff8d6e13df|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|5|FOLLOW-UP|2020-07-23|10
e|SS|2506c6e2-018f-4300-b3b5-44ff8d6e13df|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|6|SCREENING|2020-08-07|25
e|SS|2506c6e2-018f-4300-b3b5-44ff8d6e13df|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|1|SCREENING|2020-08-07|25
e|SS|2506c6e2-018f-4300-b3b5-44ff8d6e13df|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|3|TREATMENT|2020-08-22|40
e|SS|2506c6e2-018f-4300-b3b5-44ff8d6e13df|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|7|TREATMENT|2020-08-22|40
e|SS|2506c6e2-018f-4300-b3b5-44ff8d6e13df|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|3|TREATMENT|2020-09-16|65
e|SS|2506c6e2-018f-4300-b3b5-44ff8d6e13df|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|4|TREATMENT|2020-09-16|65
e|SS|2506c6e2-018f-4300-b3b5-44ff8d6e13df|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|3|WASHOUT|2020-10-11|90
e|SS|2506c6e2-018f-4300-b3b5-44ff8d6e13df|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|1|SCREENING|2020-10-11|90
e|SS|65c439f8-9658-4ac5-9eae-0837182a90fd|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|5|FOLLOW-UP|2020-06-04|10
e|SS|65c439f8-9658-4ac5-9eae-0837182a90fd|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|1|TREATMENT|2020-06-04|10
e|SS|65c439f8-9658-4ac5-9eae-0837182a90fd|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|1|WASHOUT|2020-06-19|25
e|SS|65c439f8-9658-4ac5-9eae-0837182a90fd|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|2|WASHOUT|2020-06-19|25
e|SS|65c439f8-9658-4ac5-9eae-0837182a90fd|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|4|SCREENING|2020-07-04|40
e|SS|65c439f8-9658-4ac5-9eae-0837182a90fd|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|1|SCREENING|2020-07-04|40
e|SS|65c439f8-9658-4ac5-9eae-0837182a90fd|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|1|FOLLOW-UP|2020-07-29|65
e|SS|65c439f8-9658-4ac5-9eae-0837182a90fd|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|7|FOLLOW-UP|2020-07-29|65
e|SS|65c439f8-9658-4ac5-9eae-0837182a90fd|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|2|TREATMENT|2020-08-23|90
e|SS|65c439f8-9658-4ac5-9eae-0837182a90fd|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|2|TREATMENT|2020-08-23|90
e|SS|5b73ad4c-bb28-47d1-a2f6-8508444059a5|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|3|TREATMENT|2020-06-12|10
e|SS|5b73ad4c-bb28-47d1-a2f6-8508444059a5|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|5|WASHOUT|2020-06-12|10
e|SS|5b73ad4c-bb28-47d1-a2f6-8508444059a5|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|2|TREATMENT|2020-06-27|25
e|SS|5b73ad4c-bb28-47d1-a2f6-8508444059a5|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-06-27|25
e|SS|5b73ad4c-bb28-47d1-a2f6-8508444059a5|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|7|SCREENING|2020-07-12|40
e|SS|5b73ad4c-bb28-47d1-a2f6-8508444059a5|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|1|FOLLOW-UP|2020-07-12|40
e|SS|5b73ad4c-bb28-47d1-a2f6-8508444059a5|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|3|FOLLOW-UP|2020-08-06|65
e|SS|5b73ad4c-bb28-47d1-a2f6-8508444059a5|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|FOLLOW-UP|2020-08-06|65
e|SS|5b73ad4c-bb28-47d1-a2f6-8508444059a5|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|7|TREATMENT|2020-08-31|90
e|SS|5b73ad4c-bb28-47d1-a2f6-8508444059a5|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|4|FOLLOW-UP|2020-08-31|90
e|SS|16dcaefa-701c-4863-b010-8ac640aeb55a|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|1|SCREENING|2020-06-17|10
e|SS|16dcaefa-701c-4863-b010-8ac640aeb55a|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|TREATMENT|2020-06-17|10
e|SS|16dcaefa-701c-4863-b010-8ac640aeb55a|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|1|TREATMENT|2020-07-02|25
e|SS|16dcaefa-701c-4863-b010-8ac640aeb55a|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|4|WASHOUT|2020-07-02|25
e|SS|16dcaefa-701c-4863-b010-8ac640aeb55a|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|TREATMENT|2020-07-17|40
e|SS|16dcaefa-701c-4863-b010-8ac640aeb55a|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|SCREENING|2020-07-17|40
e|SS|16dcaefa-701c-4863-b010-8ac640aeb55a|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2020-08-11|65
e|SS|16dcaefa-701c-4863-b010-8ac640aeb55a|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|FOLLOW-UP|2020-08-11|65
e|SS|16dcaefa-701c-4863-b010-8ac640aeb55a|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|2|SCREENING|2020-09-05|90
e|SS|16dcaefa-701c-4863-b010-8ac640aeb55a|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|1|TREATMENT|2020-09-05|90
e|SS|4c19e870-9195-41d8-9c8a-8a54bb428732|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|7|FOLLOW-UP|2020-08-03|10
e|SS|4c19e870-9195-41d8-9c8a-8a54bb428732|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|5|TREATMENT|2020-08-03|10
e|SS|4c19e870-9195-41d8-9c8a-8a54bb428732|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|4|WASHOUT|2020-08-18|25
e|SS|4c19e870-9195-41d8-9c8a-8a54bb428732|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|3|TREATMENT|2020-08-18|25
e|SS|4c19e870-9195-41d8-9c8a-8a54bb428732|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|4|SCREENING|2020-09-02|40
e|SS|4c19e870-9195-41d8-9c8a-8a54bb428732|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|7|TREATMENT|2020-09-02|40
e|SS|4c19e870-9195-41d8-9c8a-8a54bb428732|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|3|SCREENING|2020-09-27|65
e|SS|4c19e870-9195-41d8-9c8a-8a54bb428732|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2020-09-27|65
e|SS|4c19e870-9195-41d8-9c8a-8a54bb428732|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|6|TREATMENT|2020-10-22|90
e|SS|4c19e870-9195-41d8-9c8a-8a54bb428732|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|5|TREATMENT|2020-10-22|90
e|SS|7682184f-0801-4315-9c5f-116f7321a2b0|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|3|FOLLOW-UP|2020-12-22|10
e|SS|7682184f-0801-4315-9c5f-116f7321a2b0|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|4|FOLLOW-UP|2020-12-22|10
e|SS|7682184f-0801-4315-9c5f-116f7321a2b0|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|FOLLOW-UP|2021-01-06|25
e|SS|7682184f-0801-4315-9c5f-116f7321a2b0|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|1|TREATMENT|2021-01-06|25
e|SS|7682184f-0801-4315-9c5f-116f7321a2b0|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|1|TREATMENT|2021-01-21|40
e|SS|7682184f-0801-4315-9c5f-116f7321a2b0|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|1|TREATMENT|2021-01-21|40
e|SS|7682184f-0801-4315-9c5f-116f7321a2b0|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|1|TREATMENT|2021-02-15|65
e|SS|7682184f-0801-4315-9c5f-116f7321a2b0|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|SCREENING|2021-02-15|65
e|SS|7682184f-0801-4315-9c5f-116f7321a2b0|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|5|TREATMENT|2021-03-12|90
e|SS|7682184f-0801-4315-9c5f-116f7321a2b0|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|7|TREATMENT|2021-03-12|90
e|SS|c40f9cb3-b597-4614-8ba5-d40849030ff9|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|5|TREATMENT|2020-12-12|10
e|SS|c40f9cb3-b597-4614-8ba5-d40849030ff9|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|3|TREATMENT|2020-12-12|10
e|SS|c40f9cb3-b597-4614-8ba5-d40849030ff9|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|3|TREATMENT|2020-12-27|25
e|SS|c40f9cb3-b597-4614-8ba5-d40849030ff9|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|3|TREATMENT|2020-12-27|25
e|SS|c40f9cb3-b597-4614-8ba5-d40849030ff9|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|2|TREATMENT|2021-01-11|40
e|SS|c40f9cb3-b597-4614-8ba5-d40849030ff9|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|WASHOUT|2021-01-11|40
e|SS|c40f9cb3-b597-4614-8ba5-d40849030ff9|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|4|SCREENING|2021-02-05|65
e|SS|c40f9cb3-b597-4614-8ba5-d40849030ff9|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|3|SCREENING|2021-02-05|65
e|SS|c40f9cb3-b597-4614-8ba5-d40849030ff9|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|6|TREATMENT|2021-03-02|90
e|SS|c40f9cb3-b597-4614-8ba5-d40849030ff9|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|5|WASHOUT|2021-03-02|90
e|SS|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|TREATMENT|2020-09-09|10
e|SS|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|4|SCREENING|2020-09-09|10
e|SS|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|7|SCREENING|2020-09-24|25
e|SS|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|6|TREATMENT|2020-09-24|25
e|SS|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|2|TREATMENT|2020-10-09|40
e|SS|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|6|FOLLOW-UP|2020-10-09|40
e|SS|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|4|TREATMENT|2020-11-03|65
e|SS|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|1|FOLLOW-UP|2020-11-03|65
e|SS|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|2|FOLLOW-UP|2020-11-28|90
e|SS|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|6|TREATMENT|2020-11-28|90
e|SS|c9308aa7-f38f-4b54-a919-d3f893b18cd1|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|6|TREATMENT|2020-11-07|10
e|SS|c9308aa7-f38f-4b54-a919-d3f893b18cd1|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|TREATMENT|2020-11-07|10
e|SS|c9308aa7-f38f-4b54-a919-d3f893b18cd1|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|5|FOLLOW-UP|2020-11-22|25
e|SS|c9308aa7-f38f-4b54-a919-d3f893b18cd1|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|6|TREATMENT|2020-11-22|25
e|SS|c9308aa7-f38f-4b54-a919-d3f893b18cd1|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|6|TREATMENT|2020-12-07|40
e|SS|c9308aa7-f38f-4b54-a919-d3f893b18cd1|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|5|FOLLOW-UP|2020-12-07|40
e|SS|c9308aa7-f38f-4b54-a919-d3f893b18cd1|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|2|TREATMENT|2021-01-01|65
e|SS|c9308aa7-f38f-4b54-a919-d3f893b18cd1|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|5|WASHOUT|2021-01-01|65
e|SS|c9308aa7-f38f-4b54-a919-d3f893b18cd1|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|1|TREATMENT|2021-01-26|90
e|SS|c9308aa7-f38f-4b54-a919-d3f893b18cd1|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|5|SCREENING|2021-01-26|90
e|SS|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|4|TREATMENT|2020-08-22|10
e|SS|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|2|TREATMENT|2020-08-22|10
e|SS|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|2|TREATMENT|2020-09-06|25
e|SS|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|7|WASHOUT|2020-09-06|25
e|SS|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|1|WASHOUT|2020-09-21|40
e|SS|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|4|TREATMENT|2020-09-21|40
e|SS|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|6|WASHOUT|2020-10-16|65
e|SS|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|FOLLOW-UP|2020-10-16|65
e|SS|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|5|WASHOUT|2020-11-10|90
e|SS|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|7|WASHOUT|2020-11-10|90
e|SS|3da865e8-9680-4112-b6d3-1f5763cfdaae|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|4|FOLLOW-UP|2021-01-20|10
e|SS|3da865e8-9680-4112-b6d3-1f5763cfdaae|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|7|TREATMENT|2021-01-20|10
e|SS|3da865e8-9680-4112-b6d3-1f5763cfdaae|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|4|SCREENING|2021-02-04|25
e|SS|3da865e8-9680-4112-b6d3-1f5763cfdaae|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|2|TREATMENT|2021-02-04|25
e|SS|3da865e8-9680-4112-b6d3-1f5763cfdaae|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|1|SCREENING|2021-02-19|40
e|SS|3da865e8-9680-4112-b6d3-1f5763cfdaae|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|1|SCREENING|2021-02-19|40
e|SS|3da865e8-9680-4112-b6d3-1f5763cfdaae|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|3|SCREENING|2021-03-16|65
e|SS|3da865e8-9680-4112-b6d3-1f5763cfdaae|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|7|WASHOUT|2021-03-16|65
e|SS|3da865e8-9680-4112-b6d3-1f5763cfdaae|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|6|TREATMENT|2021-04-10|90
e|SS|3da865e8-9680-4112-b6d3-1f5763cfdaae|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|1|SCREENING|2021-04-10|90
e|SS|60afc3a3-56b7-4988-9006-e12f3bc1097c|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|3|TREATMENT|2020-08-16|10
e|SS|60afc3a3-56b7-4988-9006-e12f3bc1097c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|3|TREATMENT|2020-08-16|10
e|SS|60afc3a3-56b7-4988-9006-e12f3bc1097c|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|5|SCREENING|2020-08-31|25
e|SS|60afc3a3-56b7-4988-9006-e12f3bc1097c|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|1|SCREENING|2020-08-31|25
e|SS|60afc3a3-56b7-4988-9006-e12f3bc1097c|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|FOLLOW-UP|2020-09-15|40
e|SS|60afc3a3-56b7-4988-9006-e12f3bc1097c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|4|WASHOUT|2020-09-15|40
e|SS|60afc3a3-56b7-4988-9006-e12f3bc1097c|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|3|SCREENING|2020-10-10|65
e|SS|60afc3a3-56b7-4988-9006-e12f3bc1097c|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|4|FOLLOW-UP|2020-10-10|65
e|SS|60afc3a3-56b7-4988-9006-e12f3bc1097c|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2020-11-04|90
e|SS|60afc3a3-56b7-4988-9006-e12f3bc1097c|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|6|WASHOUT|2020-11-04|90
e|SS|440119fb-ad46-4348-b236-8e2979c7bf2e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|4|SCREENING|2020-12-16|10
e|SS|440119fb-ad46-4348-b236-8e2979c7bf2e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|7|SCREENING|2020-12-16|10
e|SS|440119fb-ad46-4348-b236-8e2979c7bf2e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|4|TREATMENT|2020-12-31|25
e|SS|440119fb-ad46-4348-b236-8e2979c7bf2e|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|WASHOUT|2020-12-31|25
e|SS|440119fb-ad46-4348-b236-8e2979c7bf2e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|2|TREATMENT|2021-01-15|40
e|SS|440119fb-ad46-4348-b236-8e2979c7bf2e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|6|TREATMENT|2021-01-15|40
e|SS|440119fb-ad46-4348-b236-8e2979c7bf2e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|7|TREATMENT|2021-02-09|65
e|SS|440119fb-ad46-4348-b236-8e2979c7bf2e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|3|FOLLOW-UP|2021-02-09|65
e|SS|440119fb-ad46-4348-b236-8e2979c7bf2e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|WASHOUT|2021-03-06|90
e|SS|440119fb-ad46-4348-b236-8e2979c7bf2e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|3|TREATMENT|2021-03-06|90
e|SS|af45a9de-c8aa-4602-8e3b-d16998740ebd|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|5|FOLLOW-UP|2020-06-15|10
e|SS|af45a9de-c8aa-4602-8e3b-d16998740ebd|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|4|TREATMENT|2020-06-15|10
e|SS|af45a9de-c8aa-4602-8e3b-d16998740ebd|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|6|WASHOUT|2020-06-30|25
e|SS|af45a9de-c8aa-4602-8e3b-d16998740ebd|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|6|TREATMENT|2020-06-30|25
e|SS|af45a9de-c8aa-4602-8e3b-d16998740ebd|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|7|TREATMENT|2020-07-15|40
e|SS|af45a9de-c8aa-4602-8e3b-d16998740ebd|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|TREATMENT|2020-07-15|40
e|SS|af45a9de-c8aa-4602-8e3b-d16998740ebd|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|4|TREATMENT|2020-08-09|65
e|SS|af45a9de-c8aa-4602-8e3b-d16998740ebd|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|7|TREATMENT|2020-08-09|65
e|SS|af45a9de-c8aa-4602-8e3b-d16998740ebd|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|6|WASHOUT|2020-09-03|90
e|SS|af45a9de-c8aa-4602-8e3b-d16998740ebd|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|7|TREATMENT|2020-09-03|90
e|SS|23306866-3fcb-418d-861b-de3bd779260d|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2020-07-25|10
e|SS|23306866-3fcb-418d-861b-de3bd779260d|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|1|TREATMENT|2020-07-25|10
e|SS|23306866-3fcb-418d-861b-de3bd779260d|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|7|TREATMENT|2020-08-09|25
e|SS|23306866-3fcb-418d-861b-de3bd779260d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|6|WASHOUT|2020-08-09|25
e|SS|23306866-3fcb-418d-861b-de3bd779260d|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|7|TREATMENT|2020-08-24|40
e|SS|23306866-3fcb-418d-861b-de3bd779260d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|6|WASHOUT|2020-08-24|40
e|SS|23306866-3fcb-418d-861b-de3bd779260d|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|1|SCREENING|2020-09-18|65
e|SS|23306866-3fcb-418d-861b-de3bd779260d|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|5|WASHOUT|2020-09-18|65
e|SS|23306866-3fcb-418d-861b-de3bd779260d|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|5|FOLLOW-UP|2020-10-13|90
e|SS|23306866-3fcb-418d-861b-de3bd779260d|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|7|TREATMENT|2020-10-13|90
e|SS|144d2eb9-d79a-4a61-91f5-6a807832d8ca|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|7|TREATMENT|2020-08-04|10
e|SS|144d2eb9-d79a-4a61-91f5-6a807832d8ca|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|5|TREATMENT|2020-08-04|10
e|SS|144d2eb9-d79a-4a61-91f5-6a807832d8ca|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|6|TREATMENT|2020-08-19|25
e|SS|144d2eb9-d79a-4a61-91f5-6a807832d8ca|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|3|TREATMENT|2020-08-19|25
e|SS|144d2eb9-d79a-4a61-91f5-6a807832d8ca|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|5|SCREENING|2020-09-03|40
e|SS|144d2eb9-d79a-4a61-91f5-6a807832d8ca|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|2|FOLLOW-UP|2020-09-03|40
e|SS|144d2eb9-d79a-4a61-91f5-6a807832d8ca|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|7|WASHOUT|2020-09-28|65
e|SS|144d2eb9-d79a-4a61-91f5-6a807832d8ca|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|7|FOLLOW-UP|2020-09-28|65
e|SS|144d2eb9-d79a-4a61-91f5-6a807832d8ca|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|7|WASHOUT|2020-10-23|90
e|SS|144d2eb9-d79a-4a61-91f5-6a807832d8ca|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|2|FOLLOW-UP|2020-10-23|90
e|SS|92855d33-eee6-449f-a9e6-c06a1532571f|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|FOLLOW-UP|2020-11-29|10
e|SS|92855d33-eee6-449f-a9e6-c06a1532571f|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|6|TREATMENT|2020-11-29|10
e|SS|92855d33-eee6-449f-a9e6-c06a1532571f|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|5|TREATMENT|2020-12-14|25
e|SS|92855d33-eee6-449f-a9e6-c06a1532571f|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|4|TREATMENT|2020-12-14|25
e|SS|92855d33-eee6-449f-a9e6-c06a1532571f|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|7|TREATMENT|2020-12-29|40
e|SS|92855d33-eee6-449f-a9e6-c06a1532571f|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|3|TREATMENT|2020-12-29|40
e|SS|92855d33-eee6-449f-a9e6-c06a1532571f|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|6|TREATMENT|2021-01-23|65
e|SS|92855d33-eee6-449f-a9e6-c06a1532571f|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|2|SCREENING|2021-01-23|65
e|SS|92855d33-eee6-449f-a9e6-c06a1532571f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|4|TREATMENT|2021-02-17|90
e|SS|92855d33-eee6-449f-a9e6-c06a1532571f|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|3|TREATMENT|2021-02-17|90
e|SS|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|4|FOLLOW-UP|2021-01-29|10
e|SS|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|2|FOLLOW-UP|2021-01-29|10
e|SS|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|3|SCREENING|2021-02-13|25
e|SS|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|5|FOLLOW-UP|2021-02-13|25
e|SS|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|WASHOUT|2021-02-28|40
e|SS|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|1|SCREENING|2021-02-28|40
e|SS|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|2|WASHOUT|2021-03-25|65
e|SS|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|3|WASHOUT|2021-03-25|65
e|SS|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|TREATMENT|2021-04-19|90
e|SS|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|5|TREATMENT|2021-04-19|90
e|SS|40cb9bc3-abec-4158-bdee-becdeceba727|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|7|WASHOUT|2020-10-19|10
e|SS|40cb9bc3-abec-4158-bdee-becdeceba727|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|7|TREATMENT|2020-10-19|10
e|SS|40cb9bc3-abec-4158-bdee-becdeceba727|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|4|TREATMENT|2020-11-03|25
e|SS|40cb9bc3-abec-4158-bdee-becdeceba727|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|2|TREATMENT|2020-11-03|25
e|SS|40cb9bc3-abec-4158-bdee-becdeceba727|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|4|TREATMENT|2020-11-18|40
e|SS|40cb9bc3-abec-4158-bdee-becdeceba727|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|1|SCREENING|2020-11-18|40
e|SS|40cb9bc3-abec-4158-bdee-becdeceba727|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|2|TREATMENT|2020-12-13|65
e|SS|40cb9bc3-abec-4158-bdee-becdeceba727|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|4|WASHOUT|2020-12-13|65
e|SS|40cb9bc3-abec-4158-bdee-becdeceba727|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|2|SCREENING|2021-01-07|90
e|SS|40cb9bc3-abec-4158-bdee-becdeceba727|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|4|TREATMENT|2021-01-07|90
e|SS|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|4|TREATMENT|2020-10-17|10
e|SS|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|5|TREATMENT|2020-10-17|10
e|SS|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|5|FOLLOW-UP|2020-11-01|25
e|SS|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|2|FOLLOW-UP|2020-11-01|25
e|SS|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|2|TREATMENT|2020-11-16|40
e|SS|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|4|FOLLOW-UP|2020-11-16|40
e|SS|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|1|TREATMENT|2020-12-11|65
e|SS|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|7|TREATMENT|2020-12-11|65
e|SS|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|1|WASHOUT|2021-01-05|90
e|SS|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|1|TREATMENT|2021-01-05|90
e|SS|616b284a-3fed-4009-bafe-7da10acd537e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2020-09-03|10
e|SS|616b284a-3fed-4009-bafe-7da10acd537e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|2|WASHOUT|2020-09-03|10
e|SS|616b284a-3fed-4009-bafe-7da10acd537e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|2|FOLLOW-UP|2020-09-18|25
e|SS|616b284a-3fed-4009-bafe-7da10acd537e|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|WASHOUT|2020-09-18|25
e|SS|616b284a-3fed-4009-bafe-7da10acd537e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|2|TREATMENT|2020-10-03|40
e|SS|616b284a-3fed-4009-bafe-7da10acd537e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|2|FOLLOW-UP|2020-10-03|40
e|SS|616b284a-3fed-4009-bafe-7da10acd537e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|5|TREATMENT|2020-10-28|65
e|SS|616b284a-3fed-4009-bafe-7da10acd537e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|2|WASHOUT|2020-10-28|65
e|SS|616b284a-3fed-4009-bafe-7da10acd537e|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|3|TREATMENT|2020-11-22|90
e|SS|616b284a-3fed-4009-bafe-7da10acd537e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|TREATMENT|2020-11-22|90
e|SS|d39b53da-187f-4da6-9614-2bd301e9ad05|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|6|WASHOUT|2020-10-02|10
e|SS|d39b53da-187f-4da6-9614-2bd301e9ad05|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|7|TREATMENT|2020-10-02|10
e|SS|d39b53da-187f-4da6-9614-2bd301e9ad05|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|4|TREATMENT|2020-10-17|25
e|SS|d39b53da-187f-4da6-9614-2bd301e9ad05|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|2|TREATMENT|2020-10-17|25
e|SS|d39b53da-187f-4da6-9614-2bd301e9ad05|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|FOLLOW-UP|2020-11-01|40
e|SS|d39b53da-187f-4da6-9614-2bd301e9ad05|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|6|TREATMENT|2020-11-01|40
e|SS|d39b53da-187f-4da6-9614-2bd301e9ad05|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|6|WASHOUT|2020-11-26|65
e|SS|d39b53da-187f-4da6-9614-2bd301e9ad05|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|2|WASHOUT|2020-11-26|65
e|SS|d39b53da-187f-4da6-9614-2bd301e9ad05|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|3|SCREENING|2020-12-21|90
e|SS|d39b53da-187f-4da6-9614-2bd301e9ad05|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|1|TREATMENT|2020-12-21|90
e|SS|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|2|WASHOUT|2020-12-04|10
e|SS|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|7|SCREENING|2020-12-04|10
e|SS|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|1|FOLLOW-UP|2020-12-19|25
e|SS|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|5|SCREENING|2020-12-19|25
e|SS|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|7|WASHOUT|2021-01-03|40
e|SS|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|2|FOLLOW-UP|2021-01-03|40
e|SS|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|TREATMENT|2021-01-28|65
e|SS|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|3|TREATMENT|2021-01-28|65
e|SS|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|3|TREATMENT|2021-02-22|90
e|SS|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|5|SCREENING|2021-02-22|90
e|SS|e51cf168-af89-44d9-9e56-14785071f6b0|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|6|FOLLOW-UP|2020-11-27|10
e|SS|e51cf168-af89-44d9-9e56-14785071f6b0|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|TREATMENT|2020-11-27|10
e|SS|e51cf168-af89-44d9-9e56-14785071f6b0|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|3|TREATMENT|2020-12-12|25
e|SS|e51cf168-af89-44d9-9e56-14785071f6b0|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|FOLLOW-UP|2020-12-12|25
e|SS|e51cf168-af89-44d9-9e56-14785071f6b0|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2020-12-27|40
e|SS|e51cf168-af89-44d9-9e56-14785071f6b0|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|7|TREATMENT|2020-12-27|40
e|SS|e51cf168-af89-44d9-9e56-14785071f6b0|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|2|TREATMENT|2021-01-21|65
e|SS|e51cf168-af89-44d9-9e56-14785071f6b0|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|3|SCREENING|2021-01-21|65
e|SS|e51cf168-af89-44d9-9e56-14785071f6b0|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|3|TREATMENT|2021-02-15|90
e|SS|e51cf168-af89-44d9-9e56-14785071f6b0|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|4|TREATMENT|2021-02-15|90
e|SS|8416f8c6-d0e4-43fc-9a66-6a916e853e87|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|6|TREATMENT|2020-06-13|10
e|SS|8416f8c6-d0e4-43fc-9a66-6a916e853e87|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|1|SCREENING|2020-06-13|10
e|SS|8416f8c6-d0e4-43fc-9a66-6a916e853e87|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|1|TREATMENT|2020-06-28|25
e|SS|8416f8c6-d0e4-43fc-9a66-6a916e853e87|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|6|TREATMENT|2020-06-28|25
e|SS|8416f8c6-d0e4-43fc-9a66-6a916e853e87|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|3|TREATMENT|2020-07-13|40
e|SS|8416f8c6-d0e4-43fc-9a66-6a916e853e87|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|4|SCREENING|2020-07-13|40
e|SS|8416f8c6-d0e4-43fc-9a66-6a916e853e87|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|3|FOLLOW-UP|2020-08-07|65
e|SS|8416f8c6-d0e4-43fc-9a66-6a916e853e87|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|6|WASHOUT|2020-08-07|65
e|SS|8416f8c6-d0e4-43fc-9a66-6a916e853e87|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|3|TREATMENT|2020-09-01|90
e|SS|8416f8c6-d0e4-43fc-9a66-6a916e853e87|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|7|TREATMENT|2020-09-01|90
e|SS|a110e924-90a1-4e84-b47a-410f800fa201|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|7|FOLLOW-UP|2020-10-29|10
e|SS|a110e924-90a1-4e84-b47a-410f800fa201|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|5|WASHOUT|2020-10-29|10
e|SS|a110e924-90a1-4e84-b47a-410f800fa201|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|5|SCREENING|2020-11-13|25
e|SS|a110e924-90a1-4e84-b47a-410f800fa201|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|6|TREATMENT|2020-11-13|25
e|SS|a110e924-90a1-4e84-b47a-410f800fa201|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|7|SCREENING|2020-11-28|40
e|SS|a110e924-90a1-4e84-b47a-410f800fa201|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|6|SCREENING|2020-11-28|40
e|SS|a110e924-90a1-4e84-b47a-410f800fa201|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|7|WASHOUT|2020-12-23|65
e|SS|a110e924-90a1-4e84-b47a-410f800fa201|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|2|TREATMENT|2020-12-23|65
e|SS|a110e924-90a1-4e84-b47a-410f800fa201|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|WASHOUT|2021-01-17|90
e|SS|a110e924-90a1-4e84-b47a-410f800fa201|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|5|WASHOUT|2021-01-17|90
e|SS|40681cb8-5d49-4e1d-b893-f5fad62a0885|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|6|WASHOUT|2020-08-08|10
e|SS|40681cb8-5d49-4e1d-b893-f5fad62a0885|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|4|TREATMENT|2020-08-08|10
e|SS|40681cb8-5d49-4e1d-b893-f5fad62a0885|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|6|TREATMENT|2020-08-23|25
e|SS|40681cb8-5d49-4e1d-b893-f5fad62a0885|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|4|TREATMENT|2020-08-23|25
e|SS|40681cb8-5d49-4e1d-b893-f5fad62a0885|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|3|FOLLOW-UP|2020-09-07|40
e|SS|40681cb8-5d49-4e1d-b893-f5fad62a0885|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|TREATMENT|2020-09-07|40
e|SS|40681cb8-5d49-4e1d-b893-f5fad62a0885|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|1|TREATMENT|2020-10-02|65
e|SS|40681cb8-5d49-4e1d-b893-f5fad62a0885|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|2|TREATMENT|2020-10-02|65
e|SS|40681cb8-5d49-4e1d-b893-f5fad62a0885|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|4|TREATMENT|2020-10-27|90
e|SS|40681cb8-5d49-4e1d-b893-f5fad62a0885|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|7|FOLLOW-UP|2020-10-27|90
e|SS|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|3|FOLLOW-UP|2020-12-17|10
e|SS|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|7|TREATMENT|2020-12-17|10
e|SS|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|WASHOUT|2021-01-01|25
e|SS|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|7|FOLLOW-UP|2021-01-01|25
e|SS|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|2|SCREENING|2021-01-16|40
e|SS|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|6|WASHOUT|2021-01-16|40
e|SS|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|1|WASHOUT|2021-02-10|65
e|SS|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|6|TREATMENT|2021-02-10|65
e|SS|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|4|SCREENING|2021-03-07|90
e|SS|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|3|TREATMENT|2021-03-07|90
e|SS|96e65c5c-723c-42d9-8e88-0bcb600e9f88|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|2|TREATMENT|2020-09-10|10
e|SS|96e65c5c-723c-42d9-8e88-0bcb600e9f88|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|4|TREATMENT|2020-09-10|10
e|SS|96e65c5c-723c-42d9-8e88-0bcb600e9f88|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|1|TREATMENT|2020-09-25|25
e|SS|96e65c5c-723c-42d9-8e88-0bcb600e9f88|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|1|FOLLOW-UP|2020-09-25|25
e|SS|96e65c5c-723c-42d9-8e88-0bcb600e9f88|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-10-10|40
e|SS|96e65c5c-723c-42d9-8e88-0bcb600e9f88|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|7|WASHOUT|2020-10-10|40
e|SS|96e65c5c-723c-42d9-8e88-0bcb600e9f88|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|6|TREATMENT|2020-11-04|65
e|SS|96e65c5c-723c-42d9-8e88-0bcb600e9f88|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|6|TREATMENT|2020-11-04|65
e|SS|96e65c5c-723c-42d9-8e88-0bcb600e9f88|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|7|TREATMENT|2020-11-29|90
e|SS|96e65c5c-723c-42d9-8e88-0bcb600e9f88|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|3|TREATMENT|2020-11-29|90
e|SS|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|5|TREATMENT|2020-07-12|10
e|SS|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|5|FOLLOW-UP|2020-07-12|10
e|SS|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|1|FOLLOW-UP|2020-07-27|25
e|SS|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|6|TREATMENT|2020-07-27|25
e|SS|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|2|TREATMENT|2020-08-11|40
e|SS|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|6|TREATMENT|2020-08-11|40
e|SS|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|1|TREATMENT|2020-09-05|65
e|SS|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|3|TREATMENT|2020-09-05|65
e|SS|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2020-09-30|90
e|SS|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|6|TREATMENT|2020-09-30|90
e|SS|f81742a2-5250-43d7-a6e2-8fcb1625a114|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|6|WASHOUT|2020-05-30|10
e|SS|f81742a2-5250-43d7-a6e2-8fcb1625a114|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|6|WASHOUT|2020-05-30|10
e|SS|f81742a2-5250-43d7-a6e2-8fcb1625a114|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|2|TREATMENT|2020-06-14|25
e|SS|f81742a2-5250-43d7-a6e2-8fcb1625a114|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|TREATMENT|2020-06-14|25
e|SS|f81742a2-5250-43d7-a6e2-8fcb1625a114|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|7|TREATMENT|2020-06-29|40
e|SS|f81742a2-5250-43d7-a6e2-8fcb1625a114|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|2|WASHOUT|2020-06-29|40
e|SS|f81742a2-5250-43d7-a6e2-8fcb1625a114|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|1|FOLLOW-UP|2020-07-24|65
e|SS|f81742a2-5250-43d7-a6e2-8fcb1625a114|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|5|FOLLOW-UP|2020-07-24|65
e|SS|f81742a2-5250-43d7-a6e2-8fcb1625a114|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|6|FOLLOW-UP|2020-08-18|90
e|SS|f81742a2-5250-43d7-a6e2-8fcb1625a114|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|2|TREATMENT|2020-08-18|90
e|SS|c6bad1d0-3514-4f98-b229-d093a94dfbc4|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|TREATMENT|2020-06-24|10
e|SS|c6bad1d0-3514-4f98-b229-d093a94dfbc4|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|3|FOLLOW-UP|2020-06-24|10
e|SS|c6bad1d0-3514-4f98-b229-d093a94dfbc4|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|4|TREATMENT|2020-07-09|25
e|SS|c6bad1d0-3514-4f98-b229-d093a94dfbc4|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|3|TREATMENT|2020-07-09|25
e|SS|c6bad1d0-3514-4f98-b229-d093a94dfbc4|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|TREATMENT|2020-07-24|40
e|SS|c6bad1d0-3514-4f98-b229-d093a94dfbc4|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|7|TREATMENT|2020-07-24|40
e|SS|c6bad1d0-3514-4f98-b229-d093a94dfbc4|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|7|TREATMENT|2020-08-18|65
e|SS|c6bad1d0-3514-4f98-b229-d093a94dfbc4|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|4|SCREENING|2020-08-18|65
e|SS|c6bad1d0-3514-4f98-b229-d093a94dfbc4|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|3|WASHOUT|2020-09-12|90
e|SS|c6bad1d0-3514-4f98-b229-d093a94dfbc4|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|6|WASHOUT|2020-09-12|90
e|SS|84d68bcc-dc7a-4366-9630-40ce8885351d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|7|WASHOUT|2020-06-16|10
e|SS|84d68bcc-dc7a-4366-9630-40ce8885351d|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|7|SCREENING|2020-06-16|10
e|SS|84d68bcc-dc7a-4366-9630-40ce8885351d|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|4|TREATMENT|2020-07-01|25
e|SS|84d68bcc-dc7a-4366-9630-40ce8885351d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|4|WASHOUT|2020-07-01|25
e|SS|84d68bcc-dc7a-4366-9630-40ce8885351d|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|1|TREATMENT|2020-07-16|40
e|SS|84d68bcc-dc7a-4366-9630-40ce8885351d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|4|TREATMENT|2020-07-16|40
e|SS|84d68bcc-dc7a-4366-9630-40ce8885351d|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|6|SCREENING|2020-08-10|65
e|SS|84d68bcc-dc7a-4366-9630-40ce8885351d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|6|TREATMENT|2020-08-10|65
e|SS|84d68bcc-dc7a-4366-9630-40ce8885351d|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|4|TREATMENT|2020-09-04|90
e|SS|84d68bcc-dc7a-4366-9630-40ce8885351d|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|7|TREATMENT|2020-09-04|90
e|SS|517f3930-5202-4e0a-b3e1-85ed4bd7e117|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|4|WASHOUT|2021-01-08|10
e|SS|517f3930-5202-4e0a-b3e1-85ed4bd7e117|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|6|TREATMENT|2021-01-08|10
e|SS|517f3930-5202-4e0a-b3e1-85ed4bd7e117|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|7|TREATMENT|2021-01-23|25
e|SS|517f3930-5202-4e0a-b3e1-85ed4bd7e117|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|2|WASHOUT|2021-01-23|25
e|SS|517f3930-5202-4e0a-b3e1-85ed4bd7e117|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|5|WASHOUT|2021-02-07|40
e|SS|517f3930-5202-4e0a-b3e1-85ed4bd7e117|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|4|FOLLOW-UP|2021-02-07|40
e|SS|517f3930-5202-4e0a-b3e1-85ed4bd7e117|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|1|SCREENING|2021-03-04|65
e|SS|517f3930-5202-4e0a-b3e1-85ed4bd7e117|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|1|TREATMENT|2021-03-04|65
e|SS|517f3930-5202-4e0a-b3e1-85ed4bd7e117|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|1|FOLLOW-UP|2021-03-29|90
e|SS|517f3930-5202-4e0a-b3e1-85ed4bd7e117|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|1|TREATMENT|2021-03-29|90
e|SS|edd73650-27bb-474f-bab7-d2c3d57b2dc4|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|7|TREATMENT|2020-12-21|10
e|SS|edd73650-27bb-474f-bab7-d2c3d57b2dc4|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|5|TREATMENT|2020-12-21|10
e|SS|edd73650-27bb-474f-bab7-d2c3d57b2dc4|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|5|FOLLOW-UP|2021-01-05|25
e|SS|edd73650-27bb-474f-bab7-d2c3d57b2dc4|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2021-01-05|25
e|SS|edd73650-27bb-474f-bab7-d2c3d57b2dc4|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|5|TREATMENT|2021-01-20|40
e|SS|edd73650-27bb-474f-bab7-d2c3d57b2dc4|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|1|WASHOUT|2021-01-20|40
e|SS|edd73650-27bb-474f-bab7-d2c3d57b2dc4|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|3|TREATMENT|2021-02-14|65
e|SS|edd73650-27bb-474f-bab7-d2c3d57b2dc4|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|3|TREATMENT|2021-02-14|65
e|SS|edd73650-27bb-474f-bab7-d2c3d57b2dc4|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|4|TREATMENT|2021-03-11|90
e|SS|edd73650-27bb-474f-bab7-d2c3d57b2dc4|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2021-03-11|90
e|SS|98737dfa-0058-4420-a515-38526f01f90d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|WASHOUT|2020-09-09|10
e|SS|98737dfa-0058-4420-a515-38526f01f90d|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|3|WASHOUT|2020-09-09|10
e|SS|98737dfa-0058-4420-a515-38526f01f90d|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|7|SCREENING|2020-09-24|25
e|SS|98737dfa-0058-4420-a515-38526f01f90d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|2|TREATMENT|2020-09-24|25
e|SS|98737dfa-0058-4420-a515-38526f01f90d|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|7|FOLLOW-UP|2020-10-09|40
e|SS|98737dfa-0058-4420-a515-38526f01f90d|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|6|FOLLOW-UP|2020-10-09|40
e|SS|98737dfa-0058-4420-a515-38526f01f90d|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|TREATMENT|2020-11-03|65
e|SS|98737dfa-0058-4420-a515-38526f01f90d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|3|TREATMENT|2020-11-03|65
e|SS|98737dfa-0058-4420-a515-38526f01f90d|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|5|SCREENING|2020-11-28|90
e|SS|98737dfa-0058-4420-a515-38526f01f90d|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|5|FOLLOW-UP|2020-11-28|90
e|SS|e713c631-cdd8-428f-a3a6-0195f6fb80b4|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|6|WASHOUT|2020-10-03|10
e|SS|e713c631-cdd8-428f-a3a6-0195f6fb80b4|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|5|TREATMENT|2020-10-03|10
e|SS|e713c631-cdd8-428f-a3a6-0195f6fb80b4|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|2|TREATMENT|2020-10-18|25
e|SS|e713c631-cdd8-428f-a3a6-0195f6fb80b4|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|4|TREATMENT|2020-10-18|25
e|SS|e713c631-cdd8-428f-a3a6-0195f6fb80b4|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|3|WASHOUT|2020-11-02|40
e|SS|e713c631-cdd8-428f-a3a6-0195f6fb80b4|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|7|TREATMENT|2020-11-02|40
e|SS|e713c631-cdd8-428f-a3a6-0195f6fb80b4|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|7|TREATMENT|2020-11-27|65
e|SS|e713c631-cdd8-428f-a3a6-0195f6fb80b4|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|5|SCREENING|2020-11-27|65
e|SS|e713c631-cdd8-428f-a3a6-0195f6fb80b4|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|5|WASHOUT|2020-12-22|90
e|SS|e713c631-cdd8-428f-a3a6-0195f6fb80b4|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|2|WASHOUT|2020-12-22|90
e|SS|a3964bed-1273-4bce-bbb4-b8d768b30aa3|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|4|TREATMENT|2020-09-20|10
e|SS|a3964bed-1273-4bce-bbb4-b8d768b30aa3|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|7|WASHOUT|2020-09-20|10
e|SS|a3964bed-1273-4bce-bbb4-b8d768b30aa3|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2020-10-05|25
e|SS|a3964bed-1273-4bce-bbb4-b8d768b30aa3|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|3|SCREENING|2020-10-05|25
e|SS|a3964bed-1273-4bce-bbb4-b8d768b30aa3|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|FOLLOW-UP|2020-10-20|40
e|SS|a3964bed-1273-4bce-bbb4-b8d768b30aa3|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|3|FOLLOW-UP|2020-10-20|40
e|SS|a3964bed-1273-4bce-bbb4-b8d768b30aa3|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|4|WASHOUT|2020-11-14|65
e|SS|a3964bed-1273-4bce-bbb4-b8d768b30aa3|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|3|TREATMENT|2020-11-14|65
e|SS|a3964bed-1273-4bce-bbb4-b8d768b30aa3|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|5|TREATMENT|2020-12-09|90
e|SS|a3964bed-1273-4bce-bbb4-b8d768b30aa3|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|5|TREATMENT|2020-12-09|90
e|SS|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|3|FOLLOW-UP|2020-12-21|10
e|SS|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|5|FOLLOW-UP|2020-12-21|10
e|SS|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|7|SCREENING|2021-01-05|25
e|SS|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|2|TREATMENT|2021-01-05|25
e|SS|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|2|SCREENING|2021-01-20|40
e|SS|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|4|FOLLOW-UP|2021-01-20|40
e|SS|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|FOLLOW-UP|2021-02-14|65
e|SS|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|7|TREATMENT|2021-02-14|65
e|SS|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|4|WASHOUT|2021-03-11|90
e|SS|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|7|WASHOUT|2021-03-11|90
e|SS|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|6|FOLLOW-UP|2020-06-09|10
e|SS|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-06-09|10
e|SS|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|2|TREATMENT|2020-06-24|25
e|SS|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|5|SCREENING|2020-06-24|25
e|SS|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|3|WASHOUT|2020-07-09|40
e|SS|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|2|FOLLOW-UP|2020-07-09|40
e|SS|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|3|TREATMENT|2020-08-03|65
e|SS|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|4|WASHOUT|2020-08-03|65
e|SS|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|2|FOLLOW-UP|2020-08-28|90
e|SS|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|6|TREATMENT|2020-08-28|90
e|SS|597ff319-c16e-4aae-a7d9-ed2bc25684dc|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|3|FOLLOW-UP|2020-05-28|10
e|SS|597ff319-c16e-4aae-a7d9-ed2bc25684dc|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|2|SCREENING|2020-05-28|10
e|SS|597ff319-c16e-4aae-a7d9-ed2bc25684dc|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|WASHOUT|2020-06-12|25
e|SS|597ff319-c16e-4aae-a7d9-ed2bc25684dc|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|5|TREATMENT|2020-06-12|25
e|SS|597ff319-c16e-4aae-a7d9-ed2bc25684dc|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|7|TREATMENT|2020-06-27|40
e|SS|597ff319-c16e-4aae-a7d9-ed2bc25684dc|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|4|FOLLOW-UP|2020-06-27|40
e|SS|597ff319-c16e-4aae-a7d9-ed2bc25684dc|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|2|FOLLOW-UP|2020-07-22|65
e|SS|597ff319-c16e-4aae-a7d9-ed2bc25684dc|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|1|TREATMENT|2020-07-22|65
e|SS|597ff319-c16e-4aae-a7d9-ed2bc25684dc|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|7|SCREENING|2020-08-16|90
e|SS|597ff319-c16e-4aae-a7d9-ed2bc25684dc|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|SCREENING|2020-08-16|90
e|SS|7d845e3e-8bd1-4647-a3e8-352a52b585cb|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|1|FOLLOW-UP|2020-11-08|10
e|SS|7d845e3e-8bd1-4647-a3e8-352a52b585cb|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|5|TREATMENT|2020-11-08|10
e|SS|7d845e3e-8bd1-4647-a3e8-352a52b585cb|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|1|TREATMENT|2020-11-23|25
e|SS|7d845e3e-8bd1-4647-a3e8-352a52b585cb|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|1|SCREENING|2020-11-23|25
e|SS|7d845e3e-8bd1-4647-a3e8-352a52b585cb|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|3|SCREENING|2020-12-08|40
e|SS|7d845e3e-8bd1-4647-a3e8-352a52b585cb|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|5|WASHOUT|2020-12-08|40
e|SS|7d845e3e-8bd1-4647-a3e8-352a52b585cb|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|1|SCREENING|2021-01-02|65
e|SS|7d845e3e-8bd1-4647-a3e8-352a52b585cb|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|1|SCREENING|2021-01-02|65
e|SS|7d845e3e-8bd1-4647-a3e8-352a52b585cb|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|7|WASHOUT|2021-01-27|90
e|SS|7d845e3e-8bd1-4647-a3e8-352a52b585cb|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|3|FOLLOW-UP|2021-01-27|90
e|SS|7e9f4283-f90b-4f74-939c-b42648e8373c|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|4|TREATMENT|2020-12-15|10
e|SS|7e9f4283-f90b-4f74-939c-b42648e8373c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|5|TREATMENT|2020-12-15|10
e|SS|7e9f4283-f90b-4f74-939c-b42648e8373c|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|TREATMENT|2020-12-30|25
e|SS|7e9f4283-f90b-4f74-939c-b42648e8373c|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-12-30|25
e|SS|7e9f4283-f90b-4f74-939c-b42648e8373c|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|3|TREATMENT|2021-01-14|40
e|SS|7e9f4283-f90b-4f74-939c-b42648e8373c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|5|SCREENING|2021-01-14|40
e|SS|7e9f4283-f90b-4f74-939c-b42648e8373c|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|1|TREATMENT|2021-02-08|65
e|SS|7e9f4283-f90b-4f74-939c-b42648e8373c|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|4|TREATMENT|2021-02-08|65
e|SS|7e9f4283-f90b-4f74-939c-b42648e8373c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|6|FOLLOW-UP|2021-03-05|90
e|SS|7e9f4283-f90b-4f74-939c-b42648e8373c|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|3|WASHOUT|2021-03-05|90
e|SS|20a637e6-83d2-4a86-9ecc-8ddb0523997f|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|2|TREATMENT|2020-10-31|10
e|SS|20a637e6-83d2-4a86-9ecc-8ddb0523997f|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2020-10-31|10
e|SS|20a637e6-83d2-4a86-9ecc-8ddb0523997f|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|4|TREATMENT|2020-11-15|25
e|SS|20a637e6-83d2-4a86-9ecc-8ddb0523997f|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|5|TREATMENT|2020-11-15|25
e|SS|20a637e6-83d2-4a86-9ecc-8ddb0523997f|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|4|WASHOUT|2020-11-30|40
e|SS|20a637e6-83d2-4a86-9ecc-8ddb0523997f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|1|TREATMENT|2020-11-30|40
e|SS|20a637e6-83d2-4a86-9ecc-8ddb0523997f|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|2|TREATMENT|2020-12-25|65
e|SS|20a637e6-83d2-4a86-9ecc-8ddb0523997f|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|6|TREATMENT|2020-12-25|65
e|SS|20a637e6-83d2-4a86-9ecc-8ddb0523997f|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|3|FOLLOW-UP|2021-01-19|90
e|SS|20a637e6-83d2-4a86-9ecc-8ddb0523997f|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|3|TREATMENT|2021-01-19|90
e|SS|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|3|TREATMENT|2020-05-16|10
e|SS|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|TREATMENT|2020-05-16|10
e|SS|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|6|FOLLOW-UP|2020-05-31|25
e|SS|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|4|SCREENING|2020-05-31|25
e|SS|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|3|TREATMENT|2020-06-15|40
e|SS|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|3|SCREENING|2020-06-15|40
e|SS|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|1|TREATMENT|2020-07-10|65
e|SS|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|WASHOUT|2020-07-10|65
e|SS|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|6|TREATMENT|2020-08-04|90
e|SS|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|4|FOLLOW-UP|2020-08-04|90
e|SS|595aa95c-4378-47c1-96e9-5512d08fb653|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|3|TREATMENT|2020-08-23|10
e|SS|595aa95c-4378-47c1-96e9-5512d08fb653|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|5|TREATMENT|2020-08-23|10
e|SS|595aa95c-4378-47c1-96e9-5512d08fb653|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|2|TREATMENT|2020-09-07|25
e|SS|595aa95c-4378-47c1-96e9-5512d08fb653|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|4|TREATMENT|2020-09-07|25
e|SS|595aa95c-4378-47c1-96e9-5512d08fb653|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|7|WASHOUT|2020-09-22|40
e|SS|595aa95c-4378-47c1-96e9-5512d08fb653|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|7|SCREENING|2020-09-22|40
e|SS|595aa95c-4378-47c1-96e9-5512d08fb653|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|7|FOLLOW-UP|2020-10-17|65
e|SS|595aa95c-4378-47c1-96e9-5512d08fb653|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|2|WASHOUT|2020-10-17|65
e|SS|595aa95c-4378-47c1-96e9-5512d08fb653|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|WASHOUT|2020-11-11|90
e|SS|595aa95c-4378-47c1-96e9-5512d08fb653|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|7|TREATMENT|2020-11-11|90
e|SS|b528dc24-e791-41b1-95b3-fc0be18da47f|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|1|TREATMENT|2020-12-27|10
e|SS|b528dc24-e791-41b1-95b3-fc0be18da47f|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|1|TREATMENT|2020-12-27|10
e|SS|b528dc24-e791-41b1-95b3-fc0be18da47f|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|6|TREATMENT|2021-01-11|25
e|SS|b528dc24-e791-41b1-95b3-fc0be18da47f|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|2|WASHOUT|2021-01-11|25
e|SS|b528dc24-e791-41b1-95b3-fc0be18da47f|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|3|TREATMENT|2021-01-26|40
e|SS|b528dc24-e791-41b1-95b3-fc0be18da47f|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|7|WASHOUT|2021-01-26|40
e|SS|b528dc24-e791-41b1-95b3-fc0be18da47f|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|4|TREATMENT|2021-02-20|65
e|SS|b528dc24-e791-41b1-95b3-fc0be18da47f|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|4|SCREENING|2021-02-20|65
e|SS|b528dc24-e791-41b1-95b3-fc0be18da47f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|6|WASHOUT|2021-03-17|90
e|SS|b528dc24-e791-41b1-95b3-fc0be18da47f|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|2|TREATMENT|2021-03-17|90
e|SS|7a43c892-0e7f-4f33-9130-e175e475531f|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|5|TREATMENT|2020-05-17|10
e|SS|7a43c892-0e7f-4f33-9130-e175e475531f|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|2|FOLLOW-UP|2020-05-17|10
e|SS|7a43c892-0e7f-4f33-9130-e175e475531f|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|1|TREATMENT|2020-06-01|25
e|SS|7a43c892-0e7f-4f33-9130-e175e475531f|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|1|TREATMENT|2020-06-01|25
e|SS|7a43c892-0e7f-4f33-9130-e175e475531f|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|TREATMENT|2020-06-16|40
e|SS|7a43c892-0e7f-4f33-9130-e175e475531f|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|3|TREATMENT|2020-06-16|40
e|SS|7a43c892-0e7f-4f33-9130-e175e475531f|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|3|TREATMENT|2020-07-11|65
e|SS|7a43c892-0e7f-4f33-9130-e175e475531f|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|1|SCREENING|2020-07-11|65
e|SS|7a43c892-0e7f-4f33-9130-e175e475531f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|5|FOLLOW-UP|2020-08-05|90
e|SS|7a43c892-0e7f-4f33-9130-e175e475531f|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|1|TREATMENT|2020-08-05|90
e|SS|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|4|TREATMENT|2020-12-10|10
e|SS|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|5|SCREENING|2020-12-10|10
e|SS|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|3|TREATMENT|2020-12-25|25
e|SS|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|5|TREATMENT|2020-12-25|25
e|SS|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|6|WASHOUT|2021-01-09|40
e|SS|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|5|TREATMENT|2021-01-09|40
e|SS|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|1|FOLLOW-UP|2021-02-03|65
e|SS|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|5|WASHOUT|2021-02-03|65
e|SS|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|6|WASHOUT|2021-02-28|90
e|SS|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|2|WASHOUT|2021-02-28|90
e|SS|bde9096e-9ab9-45fe-8e96-1ec9762824a0|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|4|SCREENING|2020-08-27|10
e|SS|bde9096e-9ab9-45fe-8e96-1ec9762824a0|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|3|TREATMENT|2020-08-27|10
e|SS|bde9096e-9ab9-45fe-8e96-1ec9762824a0|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|2|SCREENING|2020-09-11|25
e|SS|bde9096e-9ab9-45fe-8e96-1ec9762824a0|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|4|SCREENING|2020-09-11|25
e|SS|bde9096e-9ab9-45fe-8e96-1ec9762824a0|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|2|FOLLOW-UP|2020-09-26|40
e|SS|bde9096e-9ab9-45fe-8e96-1ec9762824a0|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|6|SCREENING|2020-09-26|40
e|SS|bde9096e-9ab9-45fe-8e96-1ec9762824a0|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|4|FOLLOW-UP|2020-10-21|65
e|SS|bde9096e-9ab9-45fe-8e96-1ec9762824a0|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|3|TREATMENT|2020-10-21|65
e|SS|bde9096e-9ab9-45fe-8e96-1ec9762824a0|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|6|FOLLOW-UP|2020-11-15|90
e|SS|bde9096e-9ab9-45fe-8e96-1ec9762824a0|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|5|TREATMENT|2020-11-15|90
e|SS|ea7907aa-811e-48ec-9fc6-ab8affde8913|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|4|SCREENING|2020-06-28|10
e|SS|ea7907aa-811e-48ec-9fc6-ab8affde8913|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|4|TREATMENT|2020-06-28|10
e|SS|ea7907aa-811e-48ec-9fc6-ab8affde8913|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|1|TREATMENT|2020-07-13|25
e|SS|ea7907aa-811e-48ec-9fc6-ab8affde8913|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|6|TREATMENT|2020-07-13|25
e|SS|ea7907aa-811e-48ec-9fc6-ab8affde8913|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|5|SCREENING|2020-07-28|40
e|SS|ea7907aa-811e-48ec-9fc6-ab8affde8913|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|4|TREATMENT|2020-07-28|40
e|SS|ea7907aa-811e-48ec-9fc6-ab8affde8913|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|2|TREATMENT|2020-08-22|65
e|SS|ea7907aa-811e-48ec-9fc6-ab8affde8913|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|2|TREATMENT|2020-08-22|65
e|SS|ea7907aa-811e-48ec-9fc6-ab8affde8913|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|3|FOLLOW-UP|2020-09-16|90
e|SS|ea7907aa-811e-48ec-9fc6-ab8affde8913|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|7|TREATMENT|2020-09-16|90
e|SS|3aa9935c-943d-406a-bb6e-fc067fa8a487|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|5|FOLLOW-UP|2020-08-27|10
e|SS|3aa9935c-943d-406a-bb6e-fc067fa8a487|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|SCREENING|2020-08-27|10
e|SS|3aa9935c-943d-406a-bb6e-fc067fa8a487|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|6|SCREENING|2020-09-11|25
e|SS|3aa9935c-943d-406a-bb6e-fc067fa8a487|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|7|TREATMENT|2020-09-11|25
e|SS|3aa9935c-943d-406a-bb6e-fc067fa8a487|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|4|TREATMENT|2020-09-26|40
e|SS|3aa9935c-943d-406a-bb6e-fc067fa8a487|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|6|TREATMENT|2020-09-26|40
e|SS|3aa9935c-943d-406a-bb6e-fc067fa8a487|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|7|WASHOUT|2020-10-21|65
e|SS|3aa9935c-943d-406a-bb6e-fc067fa8a487|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|5|FOLLOW-UP|2020-10-21|65
e|SS|3aa9935c-943d-406a-bb6e-fc067fa8a487|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|1|TREATMENT|2020-11-15|90
e|SS|3aa9935c-943d-406a-bb6e-fc067fa8a487|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|7|TREATMENT|2020-11-15|90
e|SS|0cac2007-ca12-45ba-9b1c-70f753232f05|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|4|SCREENING|2020-12-01|10
e|SS|0cac2007-ca12-45ba-9b1c-70f753232f05|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|FOLLOW-UP|2020-12-01|10
e|SS|0cac2007-ca12-45ba-9b1c-70f753232f05|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|2|SCREENING|2020-12-16|25
e|SS|0cac2007-ca12-45ba-9b1c-70f753232f05|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|TREATMENT|2020-12-16|25
e|SS|0cac2007-ca12-45ba-9b1c-70f753232f05|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|7|FOLLOW-UP|2020-12-31|40
e|SS|0cac2007-ca12-45ba-9b1c-70f753232f05|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|2|FOLLOW-UP|2020-12-31|40
e|SS|0cac2007-ca12-45ba-9b1c-70f753232f05|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|5|TREATMENT|2021-01-25|65
e|SS|0cac2007-ca12-45ba-9b1c-70f753232f05|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|3|TREATMENT|2021-01-25|65
e|SS|0cac2007-ca12-45ba-9b1c-70f753232f05|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|5|WASHOUT|2021-02-19|90
e|SS|0cac2007-ca12-45ba-9b1c-70f753232f05|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|4|TREATMENT|2021-02-19|90
e|SS|2339e91a-b93e-426f-9b60-3d3b6969268d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2020-07-07|10
e|SS|2339e91a-b93e-426f-9b60-3d3b6969268d|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|1|TREATMENT|2020-07-07|10
e|SS|2339e91a-b93e-426f-9b60-3d3b6969268d|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|1|TREATMENT|2020-07-22|25
e|SS|2339e91a-b93e-426f-9b60-3d3b6969268d|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|TREATMENT|2020-07-22|25
e|SS|2339e91a-b93e-426f-9b60-3d3b6969268d|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|4|TREATMENT|2020-08-06|40
e|SS|2339e91a-b93e-426f-9b60-3d3b6969268d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|2|TREATMENT|2020-08-06|40
e|SS|2339e91a-b93e-426f-9b60-3d3b6969268d|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|1|FOLLOW-UP|2020-08-31|65
e|SS|2339e91a-b93e-426f-9b60-3d3b6969268d|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|4|WASHOUT|2020-08-31|65
e|SS|2339e91a-b93e-426f-9b60-3d3b6969268d|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|TREATMENT|2020-09-25|90
e|SS|2339e91a-b93e-426f-9b60-3d3b6969268d|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|3|TREATMENT|2020-09-25|90
e|SS|0d09e35b-e864-4492-a341-21c71d92b551|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|FOLLOW-UP|2020-10-30|10
e|SS|0d09e35b-e864-4492-a341-21c71d92b551|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|2|FOLLOW-UP|2020-10-30|10
e|SS|0d09e35b-e864-4492-a341-21c71d92b551|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|6|TREATMENT|2020-11-14|25
e|SS|0d09e35b-e864-4492-a341-21c71d92b551|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|7|TREATMENT|2020-11-14|25
e|SS|0d09e35b-e864-4492-a341-21c71d92b551|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|2|TREATMENT|2020-11-29|40
e|SS|0d09e35b-e864-4492-a341-21c71d92b551|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|3|WASHOUT|2020-11-29|40
e|SS|0d09e35b-e864-4492-a341-21c71d92b551|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|4|SCREENING|2020-12-24|65
e|SS|0d09e35b-e864-4492-a341-21c71d92b551|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|7|FOLLOW-UP|2020-12-24|65
e|SS|0d09e35b-e864-4492-a341-21c71d92b551|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|6|TREATMENT|2021-01-18|90
e|SS|0d09e35b-e864-4492-a341-21c71d92b551|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|5|TREATMENT|2021-01-18|90
e|SS|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|2|WASHOUT|2020-06-05|10
e|SS|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|1|WASHOUT|2020-06-05|10
e|SS|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|1|TREATMENT|2020-06-20|25
e|SS|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|1|TREATMENT|2020-06-20|25
e|SS|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|5|WASHOUT|2020-07-05|40
e|SS|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|7|FOLLOW-UP|2020-07-05|40
e|SS|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|4|TREATMENT|2020-07-30|65
e|SS|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|3|WASHOUT|2020-07-30|65
e|SS|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|4|WASHOUT|2020-08-24|90
e|SS|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|4|WASHOUT|2020-08-24|90
e|SS|0a5b1036-cd00-4221-b218-ee2664e5a43e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|6|SCREENING|2021-01-02|10
e|SS|0a5b1036-cd00-4221-b218-ee2664e5a43e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|5|SCREENING|2021-01-02|10
e|SS|0a5b1036-cd00-4221-b218-ee2664e5a43e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|6|WASHOUT|2021-01-17|25
e|SS|0a5b1036-cd00-4221-b218-ee2664e5a43e|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|4|SCREENING|2021-01-17|25
e|SS|0a5b1036-cd00-4221-b218-ee2664e5a43e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|2|TREATMENT|2021-02-01|40
e|SS|0a5b1036-cd00-4221-b218-ee2664e5a43e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|1|TREATMENT|2021-02-01|40
e|SS|0a5b1036-cd00-4221-b218-ee2664e5a43e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|2|TREATMENT|2021-02-26|65
e|SS|0a5b1036-cd00-4221-b218-ee2664e5a43e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|1|SCREENING|2021-02-26|65
e|SS|0a5b1036-cd00-4221-b218-ee2664e5a43e|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|2|TREATMENT|2021-03-23|90
e|SS|0a5b1036-cd00-4221-b218-ee2664e5a43e|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|1|TREATMENT|2021-03-23|90
e|SS|a4f74465-7abc-4cc2-a0be-25d1c802af8c|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|TREATMENT|2020-09-30|10
e|SS|a4f74465-7abc-4cc2-a0be-25d1c802af8c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|1|TREATMENT|2020-09-30|10
e|SS|a4f74465-7abc-4cc2-a0be-25d1c802af8c|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|SCREENING|2020-10-15|25
e|SS|a4f74465-7abc-4cc2-a0be-25d1c802af8c|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|1|TREATMENT|2020-10-15|25
e|SS|a4f74465-7abc-4cc2-a0be-25d1c802af8c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|3|FOLLOW-UP|2020-10-30|40
e|SS|a4f74465-7abc-4cc2-a0be-25d1c802af8c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|2|SCREENING|2020-10-30|40
e|SS|a4f74465-7abc-4cc2-a0be-25d1c802af8c|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|6|SCREENING|2020-11-24|65
e|SS|a4f74465-7abc-4cc2-a0be-25d1c802af8c|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2020-11-24|65
e|SS|a4f74465-7abc-4cc2-a0be-25d1c802af8c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2020-12-19|90
e|SS|a4f74465-7abc-4cc2-a0be-25d1c802af8c|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|4|SCREENING|2020-12-19|90
e|SS|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|6|TREATMENT|2020-11-12|10
e|SS|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|SCREENING|2020-11-12|10
e|SS|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|2|SCREENING|2020-11-27|25
e|SS|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|5|FOLLOW-UP|2020-11-27|25
e|SS|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|2|SCREENING|2020-12-12|40
e|SS|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|6|TREATMENT|2020-12-12|40
e|SS|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|2|TREATMENT|2021-01-06|65
e|SS|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|4|FOLLOW-UP|2021-01-06|65
e|SS|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|FOLLOW-UP|2021-01-31|90
e|SS|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|3|TREATMENT|2021-01-31|90
e|SS|e7262592-01e8-4cb3-b967-ec1037505e81|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|2|FOLLOW-UP|2020-09-12|10
e|SS|e7262592-01e8-4cb3-b967-ec1037505e81|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|1|TREATMENT|2020-09-12|10
e|SS|e7262592-01e8-4cb3-b967-ec1037505e81|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|6|TREATMENT|2020-09-27|25
e|SS|e7262592-01e8-4cb3-b967-ec1037505e81|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|7|WASHOUT|2020-09-27|25
e|SS|e7262592-01e8-4cb3-b967-ec1037505e81|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|SCREENING|2020-10-12|40
e|SS|e7262592-01e8-4cb3-b967-ec1037505e81|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|FOLLOW-UP|2020-10-12|40
e|SS|e7262592-01e8-4cb3-b967-ec1037505e81|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|1|FOLLOW-UP|2020-11-06|65
e|SS|e7262592-01e8-4cb3-b967-ec1037505e81|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|7|SCREENING|2020-11-06|65
e|SS|e7262592-01e8-4cb3-b967-ec1037505e81|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|4|TREATMENT|2020-12-01|90
e|SS|e7262592-01e8-4cb3-b967-ec1037505e81|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|2|TREATMENT|2020-12-01|90
e|SS|bf150829-1b25-418a-9bc6-61716984387c|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|1|SCREENING|2020-06-15|10
e|SS|bf150829-1b25-418a-9bc6-61716984387c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|5|TREATMENT|2020-06-15|10
e|SS|bf150829-1b25-418a-9bc6-61716984387c|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|1|TREATMENT|2020-06-30|25
e|SS|bf150829-1b25-418a-9bc6-61716984387c|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|6|TREATMENT|2020-06-30|25
e|SS|bf150829-1b25-418a-9bc6-61716984387c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|6|SCREENING|2020-07-15|40
e|SS|bf150829-1b25-418a-9bc6-61716984387c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|4|TREATMENT|2020-07-15|40
e|SS|bf150829-1b25-418a-9bc6-61716984387c|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|4|FOLLOW-UP|2020-08-09|65
e|SS|bf150829-1b25-418a-9bc6-61716984387c|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|5|TREATMENT|2020-08-09|65
e|SS|bf150829-1b25-418a-9bc6-61716984387c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|3|TREATMENT|2020-09-03|90
e|SS|bf150829-1b25-418a-9bc6-61716984387c|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|2|TREATMENT|2020-09-03|90
e|SS|5c1cc260-97a0-493c-bc11-57f31ffd7455|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|7|TREATMENT|2020-09-06|10
e|SS|5c1cc260-97a0-493c-bc11-57f31ffd7455|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|3|SCREENING|2020-09-06|10
e|SS|5c1cc260-97a0-493c-bc11-57f31ffd7455|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|4|SCREENING|2020-09-21|25
e|SS|5c1cc260-97a0-493c-bc11-57f31ffd7455|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|3|TREATMENT|2020-09-21|25
e|SS|5c1cc260-97a0-493c-bc11-57f31ffd7455|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|5|TREATMENT|2020-10-06|40
e|SS|5c1cc260-97a0-493c-bc11-57f31ffd7455|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|3|TREATMENT|2020-10-06|40
e|SS|5c1cc260-97a0-493c-bc11-57f31ffd7455|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|WASHOUT|2020-10-31|65
e|SS|5c1cc260-97a0-493c-bc11-57f31ffd7455|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|4|TREATMENT|2020-10-31|65
e|SS|5c1cc260-97a0-493c-bc11-57f31ffd7455|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|3|TREATMENT|2020-11-25|90
e|SS|5c1cc260-97a0-493c-bc11-57f31ffd7455|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|TREATMENT|2020-11-25|90
e|SS|cca2835b-ca8d-4db6-89b4-9f2855968a8a|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|3|TREATMENT|2020-07-19|10
e|SS|cca2835b-ca8d-4db6-89b4-9f2855968a8a|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|4|TREATMENT|2020-07-19|10
e|SS|cca2835b-ca8d-4db6-89b4-9f2855968a8a|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|6|SCREENING|2020-08-03|25
e|SS|cca2835b-ca8d-4db6-89b4-9f2855968a8a|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2020-08-03|25
e|SS|cca2835b-ca8d-4db6-89b4-9f2855968a8a|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|3|SCREENING|2020-08-18|40
e|SS|cca2835b-ca8d-4db6-89b4-9f2855968a8a|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|1|FOLLOW-UP|2020-08-18|40
e|SS|cca2835b-ca8d-4db6-89b4-9f2855968a8a|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|4|FOLLOW-UP|2020-09-12|65
e|SS|cca2835b-ca8d-4db6-89b4-9f2855968a8a|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|1|TREATMENT|2020-09-12|65
e|SS|cca2835b-ca8d-4db6-89b4-9f2855968a8a|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|WASHOUT|2020-10-07|90
e|SS|cca2835b-ca8d-4db6-89b4-9f2855968a8a|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|3|TREATMENT|2020-10-07|90
e|SS|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|6|WASHOUT|2020-10-07|10
e|SS|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|3|SCREENING|2020-10-07|10
e|SS|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|7|TREATMENT|2020-10-22|25
e|SS|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|4|TREATMENT|2020-10-22|25
e|SS|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|1|FOLLOW-UP|2020-11-06|40
e|SS|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|2|WASHOUT|2020-11-06|40
e|SS|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|3|WASHOUT|2020-12-01|65
e|SS|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|1|WASHOUT|2020-12-01|65
e|SS|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|3|SCREENING|2020-12-26|90
e|SS|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|TREATMENT|2020-12-26|90
e|SS|74cd0a4f-f9fe-4df9-93b8-7832512d0828|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|2|TREATMENT|2020-05-15|10
e|SS|74cd0a4f-f9fe-4df9-93b8-7832512d0828|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|3|FOLLOW-UP|2020-05-15|10
e|SS|74cd0a4f-f9fe-4df9-93b8-7832512d0828|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|4|TREATMENT|2020-05-30|25
e|SS|74cd0a4f-f9fe-4df9-93b8-7832512d0828|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|3|TREATMENT|2020-05-30|25
e|SS|74cd0a4f-f9fe-4df9-93b8-7832512d0828|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|4|TREATMENT|2020-06-14|40
e|SS|74cd0a4f-f9fe-4df9-93b8-7832512d0828|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|5|WASHOUT|2020-06-14|40
e|SS|74cd0a4f-f9fe-4df9-93b8-7832512d0828|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|5|TREATMENT|2020-07-09|65
e|SS|74cd0a4f-f9fe-4df9-93b8-7832512d0828|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|3|SCREENING|2020-07-09|65
e|SS|74cd0a4f-f9fe-4df9-93b8-7832512d0828|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|7|TREATMENT|2020-08-03|90
e|SS|74cd0a4f-f9fe-4df9-93b8-7832512d0828|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|7|SCREENING|2020-08-03|90
e|SS|09238251-feaf-45a9-b295-dfed9a75fbb2|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|7|TREATMENT|2020-06-26|10
e|SS|09238251-feaf-45a9-b295-dfed9a75fbb2|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|1|FOLLOW-UP|2020-06-26|10
e|SS|09238251-feaf-45a9-b295-dfed9a75fbb2|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|7|TREATMENT|2020-07-11|25
e|SS|09238251-feaf-45a9-b295-dfed9a75fbb2|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|7|TREATMENT|2020-07-11|25
e|SS|09238251-feaf-45a9-b295-dfed9a75fbb2|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|4|FOLLOW-UP|2020-07-26|40
e|SS|09238251-feaf-45a9-b295-dfed9a75fbb2|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|7|SCREENING|2020-07-26|40
e|SS|09238251-feaf-45a9-b295-dfed9a75fbb2|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|2|TREATMENT|2020-08-20|65
e|SS|09238251-feaf-45a9-b295-dfed9a75fbb2|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|2|TREATMENT|2020-08-20|65
e|SS|09238251-feaf-45a9-b295-dfed9a75fbb2|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|5|WASHOUT|2020-09-14|90
e|SS|09238251-feaf-45a9-b295-dfed9a75fbb2|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|4|TREATMENT|2020-09-14|90
e|SS|3e896568-85dc-4a14-ba41-eb3575940a9d|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|7|TREATMENT|2021-01-26|10
e|SS|3e896568-85dc-4a14-ba41-eb3575940a9d|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|FOLLOW-UP|2021-01-26|10
e|SS|3e896568-85dc-4a14-ba41-eb3575940a9d|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|5|TREATMENT|2021-02-10|25
e|SS|3e896568-85dc-4a14-ba41-eb3575940a9d|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|7|TREATMENT|2021-02-10|25
e|SS|3e896568-85dc-4a14-ba41-eb3575940a9d|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|7|TREATMENT|2021-02-25|40
e|SS|3e896568-85dc-4a14-ba41-eb3575940a9d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|6|WASHOUT|2021-02-25|40
e|SS|3e896568-85dc-4a14-ba41-eb3575940a9d|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|3|TREATMENT|2021-03-22|65
e|SS|3e896568-85dc-4a14-ba41-eb3575940a9d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|7|FOLLOW-UP|2021-03-22|65
e|SS|3e896568-85dc-4a14-ba41-eb3575940a9d|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|7|TREATMENT|2021-04-16|90
e|SS|3e896568-85dc-4a14-ba41-eb3575940a9d|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|7|SCREENING|2021-04-16|90
e|SS|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|7|TREATMENT|2020-10-22|10
e|SS|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|2|SCREENING|2020-10-22|10
e|SS|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|5|FOLLOW-UP|2020-11-06|25
e|SS|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|6|TREATMENT|2020-11-06|25
e|SS|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|7|SCREENING|2020-11-21|40
e|SS|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|4|TREATMENT|2020-11-21|40
e|SS|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|5|TREATMENT|2020-12-16|65
e|SS|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|1|TREATMENT|2020-12-16|65
e|SS|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|3|SCREENING|2021-01-10|90
e|SS|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|1|FOLLOW-UP|2021-01-10|90
e|SS|725c5a91-72b0-4b2c-a51a-d1006303373e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|1|FOLLOW-UP|2020-11-23|10
e|SS|725c5a91-72b0-4b2c-a51a-d1006303373e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|5|SCREENING|2020-11-23|10
e|SS|725c5a91-72b0-4b2c-a51a-d1006303373e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|1|SCREENING|2020-12-08|25
e|SS|725c5a91-72b0-4b2c-a51a-d1006303373e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|1|TREATMENT|2020-12-08|25
e|SS|725c5a91-72b0-4b2c-a51a-d1006303373e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|2|WASHOUT|2020-12-23|40
e|SS|725c5a91-72b0-4b2c-a51a-d1006303373e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|1|TREATMENT|2020-12-23|40
e|SS|725c5a91-72b0-4b2c-a51a-d1006303373e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|6|SCREENING|2021-01-17|65
e|SS|725c5a91-72b0-4b2c-a51a-d1006303373e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|3|TREATMENT|2021-01-17|65
e|SS|725c5a91-72b0-4b2c-a51a-d1006303373e|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|3|SCREENING|2021-02-11|90
e|SS|725c5a91-72b0-4b2c-a51a-d1006303373e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|4|WASHOUT|2021-02-11|90
e|SS|5bf5b31d-a59d-46b7-8f8f-97919d449565|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|7|WASHOUT|2021-01-01|10
e|SS|5bf5b31d-a59d-46b7-8f8f-97919d449565|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|4|SCREENING|2021-01-01|10
e|SS|5bf5b31d-a59d-46b7-8f8f-97919d449565|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|6|TREATMENT|2021-01-16|25
e|SS|5bf5b31d-a59d-46b7-8f8f-97919d449565|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|6|SCREENING|2021-01-16|25
e|SS|5bf5b31d-a59d-46b7-8f8f-97919d449565|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|WASHOUT|2021-01-31|40
e|SS|5bf5b31d-a59d-46b7-8f8f-97919d449565|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|7|FOLLOW-UP|2021-01-31|40
e|SS|5bf5b31d-a59d-46b7-8f8f-97919d449565|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|2|TREATMENT|2021-02-25|65
e|SS|5bf5b31d-a59d-46b7-8f8f-97919d449565|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|7|FOLLOW-UP|2021-02-25|65
e|SS|5bf5b31d-a59d-46b7-8f8f-97919d449565|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|3|TREATMENT|2021-03-22|90
e|SS|5bf5b31d-a59d-46b7-8f8f-97919d449565|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|1|SCREENING|2021-03-22|90
e|SS|7fc35880-1672-4e64-ba3b-aa3f1e42764b|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|7|TREATMENT|2020-05-26|10
e|SS|7fc35880-1672-4e64-ba3b-aa3f1e42764b|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|3|SCREENING|2020-05-26|10
e|SS|7fc35880-1672-4e64-ba3b-aa3f1e42764b|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|2|WASHOUT|2020-06-10|25
e|SS|7fc35880-1672-4e64-ba3b-aa3f1e42764b|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|6|SCREENING|2020-06-10|25
e|SS|7fc35880-1672-4e64-ba3b-aa3f1e42764b|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|2|TREATMENT|2020-06-25|40
e|SS|7fc35880-1672-4e64-ba3b-aa3f1e42764b|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|3|TREATMENT|2020-06-25|40
e|SS|7fc35880-1672-4e64-ba3b-aa3f1e42764b|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|4|TREATMENT|2020-07-20|65
e|SS|7fc35880-1672-4e64-ba3b-aa3f1e42764b|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|3|SCREENING|2020-07-20|65
e|SS|7fc35880-1672-4e64-ba3b-aa3f1e42764b|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|6|TREATMENT|2020-08-14|90
e|SS|7fc35880-1672-4e64-ba3b-aa3f1e42764b|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|WASHOUT|2020-08-14|90
e|SS|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|SCREENING|2020-10-14|10
e|SS|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|1|TREATMENT|2020-10-14|10
e|SS|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|3|FOLLOW-UP|2020-10-29|25
e|SS|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|1|WASHOUT|2020-10-29|25
e|SS|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|4|FOLLOW-UP|2020-11-13|40
e|SS|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|3|TREATMENT|2020-11-13|40
e|SS|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|7|TREATMENT|2020-12-08|65
e|SS|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|3|SCREENING|2020-12-08|65
e|SS|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|5|SCREENING|2021-01-02|90
e|SS|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|SCREENING|2021-01-02|90
e|SS|f8878ffd-67af-414c-b346-596dbec640cf|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|TREATMENT|2021-01-04|10
e|SS|f8878ffd-67af-414c-b346-596dbec640cf|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|7|TREATMENT|2021-01-04|10
e|SS|f8878ffd-67af-414c-b346-596dbec640cf|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|5|TREATMENT|2021-01-19|25
e|SS|f8878ffd-67af-414c-b346-596dbec640cf|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|5|TREATMENT|2021-01-19|25
e|SS|f8878ffd-67af-414c-b346-596dbec640cf|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|7|TREATMENT|2021-02-03|40
e|SS|f8878ffd-67af-414c-b346-596dbec640cf|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2021-02-03|40
e|SS|f8878ffd-67af-414c-b346-596dbec640cf|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|2|TREATMENT|2021-02-28|65
e|SS|f8878ffd-67af-414c-b346-596dbec640cf|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|SCREENING|2021-02-28|65
e|SS|f8878ffd-67af-414c-b346-596dbec640cf|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|7|SCREENING|2021-03-25|90
e|SS|f8878ffd-67af-414c-b346-596dbec640cf|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|4|TREATMENT|2021-03-25|90
e|SS|d8212248-cd8c-4404-8ad8-2c89c05bee9e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|6|TREATMENT|2020-05-11|10
e|SS|d8212248-cd8c-4404-8ad8-2c89c05bee9e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|3|TREATMENT|2020-05-11|10
e|SS|d8212248-cd8c-4404-8ad8-2c89c05bee9e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|5|FOLLOW-UP|2020-05-26|25
e|SS|d8212248-cd8c-4404-8ad8-2c89c05bee9e|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|6|WASHOUT|2020-05-26|25
e|SS|d8212248-cd8c-4404-8ad8-2c89c05bee9e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|3|FOLLOW-UP|2020-06-10|40
e|SS|d8212248-cd8c-4404-8ad8-2c89c05bee9e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|6|TREATMENT|2020-06-10|40
e|SS|d8212248-cd8c-4404-8ad8-2c89c05bee9e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|5|TREATMENT|2020-07-05|65
e|SS|d8212248-cd8c-4404-8ad8-2c89c05bee9e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|5|FOLLOW-UP|2020-07-05|65
e|SS|d8212248-cd8c-4404-8ad8-2c89c05bee9e|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|6|SCREENING|2020-07-30|90
e|SS|d8212248-cd8c-4404-8ad8-2c89c05bee9e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|7|TREATMENT|2020-07-30|90
e|SS|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|FOLLOW-UP|2020-07-02|10
e|SS|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|5|TREATMENT|2020-07-02|10
e|SS|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|1|TREATMENT|2020-07-17|25
e|SS|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|4|TREATMENT|2020-07-17|25
e|SS|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|5|SCREENING|2020-08-01|40
e|SS|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|3|TREATMENT|2020-08-01|40
e|SS|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|6|TREATMENT|2020-08-26|65
e|SS|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|2|SCREENING|2020-08-26|65
e|SS|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|3|TREATMENT|2020-09-20|90
e|SS|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|TREATMENT|2020-09-20|90
e|SS|b832144e-88c4-4ad6-b173-abac7802a36c|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|7|FOLLOW-UP|2021-01-14|10
e|SS|b832144e-88c4-4ad6-b173-abac7802a36c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|4|TREATMENT|2021-01-14|10
e|SS|b832144e-88c4-4ad6-b173-abac7802a36c|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|6|TREATMENT|2021-01-29|25
e|SS|b832144e-88c4-4ad6-b173-abac7802a36c|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|3|TREATMENT|2021-01-29|25
e|SS|b832144e-88c4-4ad6-b173-abac7802a36c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|5|SCREENING|2021-02-13|40
e|SS|b832144e-88c4-4ad6-b173-abac7802a36c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|7|FOLLOW-UP|2021-02-13|40
e|SS|b832144e-88c4-4ad6-b173-abac7802a36c|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|2|WASHOUT|2021-03-10|65
e|SS|b832144e-88c4-4ad6-b173-abac7802a36c|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|1|TREATMENT|2021-03-10|65
e|SS|b832144e-88c4-4ad6-b173-abac7802a36c|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|6|TREATMENT|2021-04-04|90
e|SS|b832144e-88c4-4ad6-b173-abac7802a36c|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|WASHOUT|2021-04-04|90
e|SS|6acacd87-c487-401c-8888-76ccf97b640d|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|1|TREATMENT|2020-05-25|10
e|SS|6acacd87-c487-401c-8888-76ccf97b640d|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|FOLLOW-UP|2020-05-25|10
e|SS|6acacd87-c487-401c-8888-76ccf97b640d|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|1|TREATMENT|2020-06-09|25
e|SS|6acacd87-c487-401c-8888-76ccf97b640d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|1|TREATMENT|2020-06-09|25
e|SS|6acacd87-c487-401c-8888-76ccf97b640d|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|4|TREATMENT|2020-06-24|40
e|SS|6acacd87-c487-401c-8888-76ccf97b640d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|4|TREATMENT|2020-06-24|40
e|SS|6acacd87-c487-401c-8888-76ccf97b640d|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|7|TREATMENT|2020-07-19|65
e|SS|6acacd87-c487-401c-8888-76ccf97b640d|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|2|SCREENING|2020-07-19|65
e|SS|6acacd87-c487-401c-8888-76ccf97b640d|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|4|WASHOUT|2020-08-13|90
e|SS|6acacd87-c487-401c-8888-76ccf97b640d|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|6|TREATMENT|2020-08-13|90
e|SS|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|4|TREATMENT|2020-07-16|10
e|SS|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|3|TREATMENT|2020-07-16|10
e|SS|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|3|TREATMENT|2020-07-31|25
e|SS|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|TREATMENT|2020-07-31|25
e|SS|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|5|WASHOUT|2020-08-15|40
e|SS|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|5|WASHOUT|2020-08-15|40
e|SS|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|6|SCREENING|2020-09-09|65
e|SS|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|7|FOLLOW-UP|2020-09-09|65
e|SS|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|2|TREATMENT|2020-10-04|90
e|SS|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|4|TREATMENT|2020-10-04|90
e|SS|73988e01-56c0-4b31-84e2-c23ce0bac5ac|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|7|TREATMENT|2021-01-03|10
e|SS|73988e01-56c0-4b31-84e2-c23ce0bac5ac|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|4|TREATMENT|2021-01-03|10
e|SS|73988e01-56c0-4b31-84e2-c23ce0bac5ac|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|6|TREATMENT|2021-01-18|25
e|SS|73988e01-56c0-4b31-84e2-c23ce0bac5ac|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|4|TREATMENT|2021-01-18|25
e|SS|73988e01-56c0-4b31-84e2-c23ce0bac5ac|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|5|SCREENING|2021-02-02|40
e|SS|73988e01-56c0-4b31-84e2-c23ce0bac5ac|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|TREATMENT|2021-02-02|40
e|SS|73988e01-56c0-4b31-84e2-c23ce0bac5ac|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|7|TREATMENT|2021-02-27|65
e|SS|73988e01-56c0-4b31-84e2-c23ce0bac5ac|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|2|SCREENING|2021-02-27|65
e|SS|73988e01-56c0-4b31-84e2-c23ce0bac5ac|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|4|WASHOUT|2021-03-24|90
e|SS|73988e01-56c0-4b31-84e2-c23ce0bac5ac|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|FOLLOW-UP|2021-03-24|90
e|SS|0670f6a3-18c9-4027-91c1-56f5555589a8|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|TREATMENT|2020-08-11|100
e|SS|0670f6a3-18c9-4027-91c1-56f5555589a8|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|STUDY SUBJECT|1|Visit_1|10|3|TREATMENT|2020-08-11|100
e|SS|0670f6a3-18c9-4027-91c1-56f5555589a8|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|CHILD|2|Visit_2|25|7|TREATMENT|2020-08-11|100
e|SS|0670f6a3-18c9-4027-91c1-56f5555589a8|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATION COMMITTEE|2|Visit_2|25|5|TREATMENT|2020-08-11|100
e|SS|0670f6a3-18c9-4027-91c1-56f5555589a8|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|SPOUSE|3|Visit_3|40|6|TREATMENT|2020-08-11|100
e|SS|0670f6a3-18c9-4027-91c1-56f5555589a8|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|STUDY SUBJECT|3|Visit_3|40|5|TREATMENT|2020-08-11|100
e|SS|0670f6a3-18c9-4027-91c1-56f5555589a8|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIGNIFICANT OTHER|4|Visit_4|65|2|TREATMENT|2020-08-11|100
e|SS|0670f6a3-18c9-4027-91c1-56f5555589a8|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|VENDOR|4|Visit_4|65|1|WASHOUT|2020-08-11|100
e|SS|0670f6a3-18c9-4027-91c1-56f5555589a8|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|FOLLOW-UP|2020-08-11|100
e|SS|0670f6a3-18c9-4027-91c1-56f5555589a8|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|FRIEND|5|Visit_5|90|3|FOLLOW-UP|2020-08-11|100
e|SS|59179734-8784-4a88-aa6b-51b6082ffc1b|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|7|SCREENING|2020-08-11|10
e|SS|59179734-8784-4a88-aa6b-51b6082ffc1b|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|1|WASHOUT|2020-08-11|10
e|SS|59179734-8784-4a88-aa6b-51b6082ffc1b|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|WASHOUT|2020-08-26|25
e|SS|59179734-8784-4a88-aa6b-51b6082ffc1b|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|5|SCREENING|2020-08-26|25
e|SS|59179734-8784-4a88-aa6b-51b6082ffc1b|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|6|WASHOUT|2020-09-10|40
e|SS|59179734-8784-4a88-aa6b-51b6082ffc1b|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|2|TREATMENT|2020-09-10|40
e|SS|59179734-8784-4a88-aa6b-51b6082ffc1b|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|2|SCREENING|2020-10-05|65
e|SS|59179734-8784-4a88-aa6b-51b6082ffc1b|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|2|TREATMENT|2020-10-05|65
e|SS|59179734-8784-4a88-aa6b-51b6082ffc1b|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|6|TREATMENT|2020-10-30|90
e|SS|59179734-8784-4a88-aa6b-51b6082ffc1b|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|7|FOLLOW-UP|2020-10-30|90
e|SS|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-08-22|10
e|SS|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|SCREENING|2020-08-22|10
e|SS|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|3|WASHOUT|2020-09-06|25
e|SS|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|TREATMENT|2020-09-06|25
e|SS|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|1|TREATMENT|2020-09-21|40
e|SS|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|4|WASHOUT|2020-09-21|40
e|SS|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|6|TREATMENT|2020-10-16|65
e|SS|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|7|FOLLOW-UP|2020-10-16|65
e|SS|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|4|FOLLOW-UP|2020-11-10|90
e|SS|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|2|TREATMENT|2020-11-10|90
e|SS|01c642f8-48ef-4375-aa2b-d0940b74e580|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|4|FOLLOW-UP|2020-09-19|10
e|SS|01c642f8-48ef-4375-aa2b-d0940b74e580|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|2|TREATMENT|2020-09-19|10
e|SS|01c642f8-48ef-4375-aa2b-d0940b74e580|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|6|WASHOUT|2020-10-04|25
e|SS|01c642f8-48ef-4375-aa2b-d0940b74e580|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|4|TREATMENT|2020-10-04|25
e|SS|01c642f8-48ef-4375-aa2b-d0940b74e580|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|1|SCREENING|2020-10-19|40
e|SS|01c642f8-48ef-4375-aa2b-d0940b74e580|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2020-10-19|40
e|SS|01c642f8-48ef-4375-aa2b-d0940b74e580|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|1|WASHOUT|2020-11-13|65
e|SS|01c642f8-48ef-4375-aa2b-d0940b74e580|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|3|SCREENING|2020-11-13|65
e|SS|01c642f8-48ef-4375-aa2b-d0940b74e580|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|5|FOLLOW-UP|2020-12-08|90
e|SS|01c642f8-48ef-4375-aa2b-d0940b74e580|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|5|SCREENING|2020-12-08|90
e|SS|c0e7028c-6f5c-410a-afde-e56af2177983|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|2|TREATMENT|2020-07-06|10
e|SS|c0e7028c-6f5c-410a-afde-e56af2177983|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|5|FOLLOW-UP|2020-07-06|10
e|SS|c0e7028c-6f5c-410a-afde-e56af2177983|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|4|SCREENING|2020-07-21|25
e|SS|c0e7028c-6f5c-410a-afde-e56af2177983|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|2|SCREENING|2020-07-21|25
e|SS|c0e7028c-6f5c-410a-afde-e56af2177983|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|3|TREATMENT|2020-08-05|40
e|SS|c0e7028c-6f5c-410a-afde-e56af2177983|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|1|FOLLOW-UP|2020-08-05|40
e|SS|c0e7028c-6f5c-410a-afde-e56af2177983|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|FOLLOW-UP|2020-08-30|65
e|SS|c0e7028c-6f5c-410a-afde-e56af2177983|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|5|WASHOUT|2020-08-30|65
e|SS|c0e7028c-6f5c-410a-afde-e56af2177983|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|2|TREATMENT|2020-09-24|90
e|SS|c0e7028c-6f5c-410a-afde-e56af2177983|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|2|TREATMENT|2020-09-24|90
e|SS|eba928ed-9434-4e75-b49d-169298f966e1|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|4|SCREENING|2020-08-12|10
e|SS|eba928ed-9434-4e75-b49d-169298f966e1|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|5|TREATMENT|2020-08-12|10
e|SS|eba928ed-9434-4e75-b49d-169298f966e1|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|TREATMENT|2020-08-27|25
e|SS|eba928ed-9434-4e75-b49d-169298f966e1|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|6|TREATMENT|2020-08-27|25
e|SS|eba928ed-9434-4e75-b49d-169298f966e1|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|1|TREATMENT|2020-09-11|40
e|SS|eba928ed-9434-4e75-b49d-169298f966e1|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|5|FOLLOW-UP|2020-09-11|40
e|SS|eba928ed-9434-4e75-b49d-169298f966e1|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|4|TREATMENT|2020-10-06|65
e|SS|eba928ed-9434-4e75-b49d-169298f966e1|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|6|WASHOUT|2020-10-06|65
e|SS|eba928ed-9434-4e75-b49d-169298f966e1|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|6|TREATMENT|2020-10-31|90
e|SS|eba928ed-9434-4e75-b49d-169298f966e1|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|5|FOLLOW-UP|2020-10-31|90
e|SS|4772aa80-2097-4867-a549-b6f9b140f141|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|7|WASHOUT|2020-07-12|10
e|SS|4772aa80-2097-4867-a549-b6f9b140f141|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|7|TREATMENT|2020-07-12|10
e|SS|4772aa80-2097-4867-a549-b6f9b140f141|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|6|TREATMENT|2020-07-27|25
e|SS|4772aa80-2097-4867-a549-b6f9b140f141|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|6|TREATMENT|2020-07-27|25
e|SS|4772aa80-2097-4867-a549-b6f9b140f141|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|6|SCREENING|2020-08-11|40
e|SS|4772aa80-2097-4867-a549-b6f9b140f141|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|1|TREATMENT|2020-08-11|40
e|SS|4772aa80-2097-4867-a549-b6f9b140f141|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|3|FOLLOW-UP|2020-09-05|65
e|SS|4772aa80-2097-4867-a549-b6f9b140f141|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|4|FOLLOW-UP|2020-09-05|65
e|SS|4772aa80-2097-4867-a549-b6f9b140f141|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|3|WASHOUT|2020-09-30|90
e|SS|4772aa80-2097-4867-a549-b6f9b140f141|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|7|WASHOUT|2020-09-30|90
e|SS|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|4|TREATMENT|2020-06-07|10
e|SS|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|6|TREATMENT|2020-06-07|10
e|SS|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|3|FOLLOW-UP|2020-06-22|25
e|SS|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|6|TREATMENT|2020-06-22|25
e|SS|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|5|TREATMENT|2020-07-07|40
e|SS|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|4|TREATMENT|2020-07-07|40
e|SS|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|1|FOLLOW-UP|2020-08-01|65
e|SS|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|2|WASHOUT|2020-08-01|65
e|SS|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2020-08-26|90
e|SS|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|SCREENING|2020-08-26|90
e|SS|4d8dd0d0-407d-4374-8345-c11f30603273|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|5|TREATMENT|2021-01-01|10
e|SS|4d8dd0d0-407d-4374-8345-c11f30603273|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|4|FOLLOW-UP|2021-01-01|10
e|SS|4d8dd0d0-407d-4374-8345-c11f30603273|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|4|FOLLOW-UP|2021-01-16|25
e|SS|4d8dd0d0-407d-4374-8345-c11f30603273|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|3|TREATMENT|2021-01-16|25
e|SS|4d8dd0d0-407d-4374-8345-c11f30603273|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|3|TREATMENT|2021-01-31|40
e|SS|4d8dd0d0-407d-4374-8345-c11f30603273|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|5|FOLLOW-UP|2021-01-31|40
e|SS|4d8dd0d0-407d-4374-8345-c11f30603273|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|3|TREATMENT|2021-02-25|65
e|SS|4d8dd0d0-407d-4374-8345-c11f30603273|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|2|WASHOUT|2021-02-25|65
e|SS|4d8dd0d0-407d-4374-8345-c11f30603273|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|1|FOLLOW-UP|2021-03-22|90
e|SS|4d8dd0d0-407d-4374-8345-c11f30603273|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2021-03-22|90
e|SS|6996077b-556a-47b9-bbff-20c1b4df35ea|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|2|TREATMENT|2020-06-08|10
e|SS|6996077b-556a-47b9-bbff-20c1b4df35ea|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|5|WASHOUT|2020-06-08|10
e|SS|6996077b-556a-47b9-bbff-20c1b4df35ea|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|3|WASHOUT|2020-06-23|25
e|SS|6996077b-556a-47b9-bbff-20c1b4df35ea|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|1|WASHOUT|2020-06-23|25
e|SS|6996077b-556a-47b9-bbff-20c1b4df35ea|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|5|TREATMENT|2020-07-08|40
e|SS|6996077b-556a-47b9-bbff-20c1b4df35ea|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-07-08|40
e|SS|6996077b-556a-47b9-bbff-20c1b4df35ea|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|5|SCREENING|2020-08-02|65
e|SS|6996077b-556a-47b9-bbff-20c1b4df35ea|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|SCREENING|2020-08-02|65
e|SS|6996077b-556a-47b9-bbff-20c1b4df35ea|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|6|TREATMENT|2020-08-27|90
e|SS|6996077b-556a-47b9-bbff-20c1b4df35ea|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|1|TREATMENT|2020-08-27|90
e|SS|d79d31c5-d51a-46a7-b22c-20d6d483f46e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|4|TREATMENT|2020-10-23|10
e|SS|d79d31c5-d51a-46a7-b22c-20d6d483f46e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|7|WASHOUT|2020-10-23|10
e|SS|d79d31c5-d51a-46a7-b22c-20d6d483f46e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|4|FOLLOW-UP|2020-11-07|25
e|SS|d79d31c5-d51a-46a7-b22c-20d6d483f46e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|3|SCREENING|2020-11-07|25
e|SS|d79d31c5-d51a-46a7-b22c-20d6d483f46e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|7|SCREENING|2020-11-22|40
e|SS|d79d31c5-d51a-46a7-b22c-20d6d483f46e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|3|FOLLOW-UP|2020-11-22|40
e|SS|d79d31c5-d51a-46a7-b22c-20d6d483f46e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2020-12-17|65
e|SS|d79d31c5-d51a-46a7-b22c-20d6d483f46e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|4|TREATMENT|2020-12-17|65
e|SS|d79d31c5-d51a-46a7-b22c-20d6d483f46e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|FOLLOW-UP|2021-01-11|90
e|SS|d79d31c5-d51a-46a7-b22c-20d6d483f46e|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|5|SCREENING|2021-01-11|90
e|SS|738d539e-a810-4207-8904-fc6a5d055424|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|5|TREATMENT|2021-01-08|10
e|SS|738d539e-a810-4207-8904-fc6a5d055424|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|TREATMENT|2021-01-08|10
e|SS|738d539e-a810-4207-8904-fc6a5d055424|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|2|TREATMENT|2021-01-23|25
e|SS|738d539e-a810-4207-8904-fc6a5d055424|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|4|SCREENING|2021-01-23|25
e|SS|738d539e-a810-4207-8904-fc6a5d055424|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|3|WASHOUT|2021-02-07|40
e|SS|738d539e-a810-4207-8904-fc6a5d055424|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|2|SCREENING|2021-02-07|40
e|SS|738d539e-a810-4207-8904-fc6a5d055424|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|TREATMENT|2021-03-04|65
e|SS|738d539e-a810-4207-8904-fc6a5d055424|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|3|TREATMENT|2021-03-04|65
e|SS|738d539e-a810-4207-8904-fc6a5d055424|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|4|SCREENING|2021-03-29|90
e|SS|738d539e-a810-4207-8904-fc6a5d055424|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|1|TREATMENT|2021-03-29|90
e|SS|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|2|WASHOUT|2020-08-11|10
e|SS|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|2|WASHOUT|2020-08-11|10
e|SS|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|5|FOLLOW-UP|2020-08-26|25
e|SS|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|7|TREATMENT|2020-08-26|25
e|SS|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|7|FOLLOW-UP|2020-09-10|40
e|SS|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|3|SCREENING|2020-09-10|40
e|SS|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|4|TREATMENT|2020-10-05|65
e|SS|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|2|TREATMENT|2020-10-05|65
e|SS|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|6|TREATMENT|2020-10-30|90
e|SS|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|5|WASHOUT|2020-10-30|90
e|SS|20841d37-0444-4d1d-b934-1e805cdacdaf|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|CHILD|1|Visit_1|10|6|WASHOUT|2021-02-20|100
e|SS|20841d37-0444-4d1d-b934-1e805cdacdaf|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL STUDY SPONSOR|1|Visit_1|10|5|TREATMENT|2021-02-20|100
e|SS|20841d37-0444-4d1d-b934-1e805cdacdaf|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|STUDY SUBJECT|2|Visit_2|25|2|TREATMENT|2021-02-20|100
e|SS|20841d37-0444-4d1d-b934-1e805cdacdaf|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|STUDY SUBJECT|2|Visit_2|25|7|WASHOUT|2021-02-20|100
e|SS|20841d37-0444-4d1d-b934-1e805cdacdaf|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|CAREGIVER|3|Visit_3|40|5|TREATMENT|2021-02-20|100
e|SS|20841d37-0444-4d1d-b934-1e805cdacdaf|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|FRIEND|3|Visit_3|40|4|FOLLOW-UP|2021-02-20|100
e|SS|20841d37-0444-4d1d-b934-1e805cdacdaf|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|SPOUSE|4|Visit_4|65|3|TREATMENT|2021-02-20|100
e|SS|20841d37-0444-4d1d-b934-1e805cdacdaf|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|INTERVIEWER|4|Visit_4|65|2|WASHOUT|2021-02-20|100
e|SS|20841d37-0444-4d1d-b934-1e805cdacdaf|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|PARENT|5|Visit_5|90|5|TREATMENT|2021-02-20|100
e|SS|20841d37-0444-4d1d-b934-1e805cdacdaf|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|STUDY SUBJECT|5|Visit_5|90|2|WASHOUT|2021-02-20|100
e|SS|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|TREATMENT|2020-11-01|10
e|SS|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2020-11-01|10
e|SS|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|3|WASHOUT|2020-11-16|25
e|SS|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|1|SCREENING|2020-11-16|25
e|SS|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|7|TREATMENT|2020-12-01|40
e|SS|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|3|TREATMENT|2020-12-01|40
e|SS|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|6|SCREENING|2020-12-26|65
e|SS|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2020-12-26|65
e|SS|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|1|SCREENING|2021-01-20|90
e|SS|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2021-01-20|90
e|SS|d74682f1-824e-449d-bdf1-db517d8fdf2e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|5|FOLLOW-UP|2020-08-08|10
e|SS|d74682f1-824e-449d-bdf1-db517d8fdf2e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|4|TREATMENT|2020-08-08|10
e|SS|d74682f1-824e-449d-bdf1-db517d8fdf2e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|2|TREATMENT|2020-08-23|25
e|SS|d74682f1-824e-449d-bdf1-db517d8fdf2e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|3|WASHOUT|2020-08-23|25
e|SS|d74682f1-824e-449d-bdf1-db517d8fdf2e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|5|WASHOUT|2020-09-07|40
e|SS|d74682f1-824e-449d-bdf1-db517d8fdf2e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|7|TREATMENT|2020-09-07|40
e|SS|d74682f1-824e-449d-bdf1-db517d8fdf2e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|6|TREATMENT|2020-10-02|65
e|SS|d74682f1-824e-449d-bdf1-db517d8fdf2e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|3|TREATMENT|2020-10-02|65
e|SS|d74682f1-824e-449d-bdf1-db517d8fdf2e|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|6|TREATMENT|2020-10-27|90
e|SS|d74682f1-824e-449d-bdf1-db517d8fdf2e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|4|FOLLOW-UP|2020-10-27|90
e|SS|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|5|TREATMENT|2020-12-07|10
e|SS|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2020-12-07|10
e|SS|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|TREATMENT|2020-12-22|25
e|SS|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|6|SCREENING|2020-12-22|25
e|SS|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|3|TREATMENT|2021-01-06|40
e|SS|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|3|FOLLOW-UP|2021-01-06|40
e|SS|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|4|WASHOUT|2021-01-31|65
e|SS|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|FOLLOW-UP|2021-01-31|65
e|SS|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|4|TREATMENT|2021-02-25|90
e|SS|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|1|WASHOUT|2021-02-25|90
e|SS|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|4|SCREENING|2020-07-02|10
e|SS|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|FOLLOW-UP|2020-07-02|10
e|SS|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|5|TREATMENT|2020-07-17|25
e|SS|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|4|TREATMENT|2020-07-17|25
e|SS|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|1|TREATMENT|2020-08-01|40
e|SS|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|3|WASHOUT|2020-08-01|40
e|SS|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|4|TREATMENT|2020-08-26|65
e|SS|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|3|TREATMENT|2020-08-26|65
e|SS|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|2|SCREENING|2020-09-20|90
e|SS|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2020-09-20|90
e|SS|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|3|TREATMENT|2020-11-17|10
e|SS|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|7|TREATMENT|2020-11-17|10
e|SS|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|4|TREATMENT|2020-12-02|25
e|SS|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|TREATMENT|2020-12-02|25
e|SS|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|3|TREATMENT|2020-12-17|40
e|SS|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|3|TREATMENT|2020-12-17|40
e|SS|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|3|FOLLOW-UP|2021-01-11|65
e|SS|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|3|SCREENING|2021-01-11|65
e|SS|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2021-02-05|90
e|SS|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|4|FOLLOW-UP|2021-02-05|90
e|SS|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|4|TREATMENT|2020-10-27|10
e|SS|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|3|TREATMENT|2020-10-27|10
e|SS|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|5|TREATMENT|2020-11-11|25
e|SS|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|SCREENING|2020-11-11|25
e|SS|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|1|SCREENING|2020-11-26|40
e|SS|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|6|SCREENING|2020-11-26|40
e|SS|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|3|FOLLOW-UP|2020-12-21|65
e|SS|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|4|WASHOUT|2020-12-21|65
e|SS|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|2|TREATMENT|2021-01-15|90
e|SS|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|5|FOLLOW-UP|2021-01-15|90
e|SS|b5644705-65e9-4d9b-9f5c-f8f62d26e257|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|5|WASHOUT|2020-12-24|10
e|SS|b5644705-65e9-4d9b-9f5c-f8f62d26e257|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|3|WASHOUT|2020-12-24|10
e|SS|b5644705-65e9-4d9b-9f5c-f8f62d26e257|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|3|WASHOUT|2021-01-08|25
e|SS|b5644705-65e9-4d9b-9f5c-f8f62d26e257|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|SCREENING|2021-01-08|25
e|SS|b5644705-65e9-4d9b-9f5c-f8f62d26e257|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|4|TREATMENT|2021-01-23|40
e|SS|b5644705-65e9-4d9b-9f5c-f8f62d26e257|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|3|FOLLOW-UP|2021-01-23|40
e|SS|b5644705-65e9-4d9b-9f5c-f8f62d26e257|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|7|TREATMENT|2021-02-17|65
e|SS|b5644705-65e9-4d9b-9f5c-f8f62d26e257|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|3|TREATMENT|2021-02-17|65
e|SS|b5644705-65e9-4d9b-9f5c-f8f62d26e257|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|2|TREATMENT|2021-03-14|90
e|SS|b5644705-65e9-4d9b-9f5c-f8f62d26e257|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|3|TREATMENT|2021-03-14|90
e|SS|ec82f59b-197a-4ccc-b5e5-d91627a86a27|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|4|SCREENING|2020-05-16|10
e|SS|ec82f59b-197a-4ccc-b5e5-d91627a86a27|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|1|FOLLOW-UP|2020-05-16|10
e|SS|ec82f59b-197a-4ccc-b5e5-d91627a86a27|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|6|TREATMENT|2020-05-31|25
e|SS|ec82f59b-197a-4ccc-b5e5-d91627a86a27|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|3|WASHOUT|2020-05-31|25
e|SS|ec82f59b-197a-4ccc-b5e5-d91627a86a27|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|5|WASHOUT|2020-06-15|40
e|SS|ec82f59b-197a-4ccc-b5e5-d91627a86a27|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|2|FOLLOW-UP|2020-06-15|40
e|SS|ec82f59b-197a-4ccc-b5e5-d91627a86a27|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|1|WASHOUT|2020-07-10|65
e|SS|ec82f59b-197a-4ccc-b5e5-d91627a86a27|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|5|TREATMENT|2020-07-10|65
e|SS|ec82f59b-197a-4ccc-b5e5-d91627a86a27|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|2|SCREENING|2020-08-04|90
e|SS|ec82f59b-197a-4ccc-b5e5-d91627a86a27|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|2|WASHOUT|2020-08-04|90
e|SS|527fd604-110f-47b1-bd8b-b1de2f5b0d29|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|6|TREATMENT|2020-11-29|10
e|SS|527fd604-110f-47b1-bd8b-b1de2f5b0d29|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|7|TREATMENT|2020-11-29|10
e|SS|527fd604-110f-47b1-bd8b-b1de2f5b0d29|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2020-12-14|25
e|SS|527fd604-110f-47b1-bd8b-b1de2f5b0d29|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|1|FOLLOW-UP|2020-12-14|25
e|SS|527fd604-110f-47b1-bd8b-b1de2f5b0d29|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|6|SCREENING|2020-12-29|40
e|SS|527fd604-110f-47b1-bd8b-b1de2f5b0d29|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|4|FOLLOW-UP|2020-12-29|40
e|SS|527fd604-110f-47b1-bd8b-b1de2f5b0d29|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|SCREENING|2021-01-23|65
e|SS|527fd604-110f-47b1-bd8b-b1de2f5b0d29|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|3|TREATMENT|2021-01-23|65
e|SS|527fd604-110f-47b1-bd8b-b1de2f5b0d29|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2021-02-17|90
e|SS|527fd604-110f-47b1-bd8b-b1de2f5b0d29|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|7|FOLLOW-UP|2021-02-17|90
e|SS|1e1de453-920a-4132-b2f7-6335ee81ec83|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|4|TREATMENT|2020-10-22|10
e|SS|1e1de453-920a-4132-b2f7-6335ee81ec83|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|2|SCREENING|2020-10-22|10
e|SS|1e1de453-920a-4132-b2f7-6335ee81ec83|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-11-06|25
e|SS|1e1de453-920a-4132-b2f7-6335ee81ec83|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|6|TREATMENT|2020-11-06|25
e|SS|1e1de453-920a-4132-b2f7-6335ee81ec83|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|5|WASHOUT|2020-11-21|40
e|SS|1e1de453-920a-4132-b2f7-6335ee81ec83|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|2|TREATMENT|2020-11-21|40
e|SS|1e1de453-920a-4132-b2f7-6335ee81ec83|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|5|TREATMENT|2020-12-16|65
e|SS|1e1de453-920a-4132-b2f7-6335ee81ec83|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|6|TREATMENT|2020-12-16|65
e|SS|1e1de453-920a-4132-b2f7-6335ee81ec83|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|5|FOLLOW-UP|2021-01-10|90
e|SS|1e1de453-920a-4132-b2f7-6335ee81ec83|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|7|TREATMENT|2021-01-10|90
e|SS|e553ad8e-96f4-4cb0-a005-51e9b64513b7|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|3|WASHOUT|2020-06-29|10
e|SS|e553ad8e-96f4-4cb0-a005-51e9b64513b7|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|3|TREATMENT|2020-06-29|10
e|SS|e553ad8e-96f4-4cb0-a005-51e9b64513b7|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|3|FOLLOW-UP|2020-07-14|25
e|SS|e553ad8e-96f4-4cb0-a005-51e9b64513b7|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|3|TREATMENT|2020-07-14|25
e|SS|e553ad8e-96f4-4cb0-a005-51e9b64513b7|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|6|FOLLOW-UP|2020-07-29|40
e|SS|e553ad8e-96f4-4cb0-a005-51e9b64513b7|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|7|TREATMENT|2020-07-29|40
e|SS|e553ad8e-96f4-4cb0-a005-51e9b64513b7|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|7|TREATMENT|2020-08-23|65
e|SS|e553ad8e-96f4-4cb0-a005-51e9b64513b7|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|5|TREATMENT|2020-08-23|65
e|SS|e553ad8e-96f4-4cb0-a005-51e9b64513b7|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2020-09-17|90
e|SS|e553ad8e-96f4-4cb0-a005-51e9b64513b7|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2020-09-17|90
e|SS|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|2|SCREENING|2020-12-16|10
e|SS|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|6|SCREENING|2020-12-16|10
e|SS|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|3|SCREENING|2020-12-31|25
e|SS|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|2|FOLLOW-UP|2020-12-31|25
e|SS|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|5|TREATMENT|2021-01-15|40
e|SS|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|6|FOLLOW-UP|2021-01-15|40
e|SS|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|3|FOLLOW-UP|2021-02-09|65
e|SS|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|5|WASHOUT|2021-02-09|65
e|SS|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|FOLLOW-UP|2021-03-06|90
e|SS|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|1|WASHOUT|2021-03-06|90
e|SS|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2020-06-09|10
e|SS|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|1|TREATMENT|2020-06-09|10
e|SS|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|2|FOLLOW-UP|2020-06-24|25
e|SS|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|3|WASHOUT|2020-06-24|25
e|SS|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|4|WASHOUT|2020-07-09|40
e|SS|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|2|TREATMENT|2020-07-09|40
e|SS|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|FOLLOW-UP|2020-08-03|65
e|SS|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|7|WASHOUT|2020-08-03|65
e|SS|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|3|TREATMENT|2020-08-28|90
e|SS|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|5|SCREENING|2020-08-28|90
e|SS|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|5|SCREENING|2020-10-29|10
e|SS|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|5|WASHOUT|2020-10-29|10
e|SS|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|3|TREATMENT|2020-11-13|25
e|SS|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|TREATMENT|2020-11-13|25
e|SS|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|TREATMENT|2020-11-28|40
e|SS|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|7|FOLLOW-UP|2020-11-28|40
e|SS|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|WASHOUT|2020-12-23|65
e|SS|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|2|SCREENING|2020-12-23|65
e|SS|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|2|WASHOUT|2021-01-17|90
e|SS|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|2|FOLLOW-UP|2021-01-17|90
e|SS|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|2|SCREENING|2020-12-24|10
e|SS|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|3|SCREENING|2020-12-24|10
e|SS|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|2|TREATMENT|2021-01-08|25
e|SS|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|TREATMENT|2021-01-08|25
e|SS|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|4|TREATMENT|2021-01-23|40
e|SS|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|TREATMENT|2021-01-23|40
e|SS|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|WASHOUT|2021-02-17|65
e|SS|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|7|TREATMENT|2021-02-17|65
e|SS|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|6|TREATMENT|2021-03-14|90
e|SS|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|5|TREATMENT|2021-03-14|90
e|SS|ad04ec90-9fd5-49f2-ae23-264273eb0a24|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|FOLLOW-UP|2020-10-17|10
e|SS|ad04ec90-9fd5-49f2-ae23-264273eb0a24|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|5|SCREENING|2020-10-17|10
e|SS|ad04ec90-9fd5-49f2-ae23-264273eb0a24|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|5|SCREENING|2020-11-01|25
e|SS|ad04ec90-9fd5-49f2-ae23-264273eb0a24|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|2|TREATMENT|2020-11-01|25
e|SS|ad04ec90-9fd5-49f2-ae23-264273eb0a24|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|2|TREATMENT|2020-11-16|40
e|SS|ad04ec90-9fd5-49f2-ae23-264273eb0a24|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|6|SCREENING|2020-11-16|40
e|SS|ad04ec90-9fd5-49f2-ae23-264273eb0a24|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|7|FOLLOW-UP|2020-12-11|65
e|SS|ad04ec90-9fd5-49f2-ae23-264273eb0a24|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|5|TREATMENT|2020-12-11|65
e|SS|ad04ec90-9fd5-49f2-ae23-264273eb0a24|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|4|SCREENING|2021-01-05|90
e|SS|ad04ec90-9fd5-49f2-ae23-264273eb0a24|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|FOLLOW-UP|2021-01-05|90
e|SS|a1d203ef-7ee1-4373-988a-370532bae2b1|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|FOLLOW-UP|2021-01-28|10
e|SS|a1d203ef-7ee1-4373-988a-370532bae2b1|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|5|TREATMENT|2021-01-28|10
e|SS|a1d203ef-7ee1-4373-988a-370532bae2b1|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|4|SCREENING|2021-02-12|25
e|SS|a1d203ef-7ee1-4373-988a-370532bae2b1|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|1|TREATMENT|2021-02-12|25
e|SS|a1d203ef-7ee1-4373-988a-370532bae2b1|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|7|TREATMENT|2021-02-27|40
e|SS|a1d203ef-7ee1-4373-988a-370532bae2b1|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|4|TREATMENT|2021-02-27|40
e|SS|a1d203ef-7ee1-4373-988a-370532bae2b1|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|WASHOUT|2021-03-24|65
e|SS|a1d203ef-7ee1-4373-988a-370532bae2b1|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|3|WASHOUT|2021-03-24|65
e|SS|a1d203ef-7ee1-4373-988a-370532bae2b1|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|7|FOLLOW-UP|2021-04-18|90
e|SS|a1d203ef-7ee1-4373-988a-370532bae2b1|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|6|TREATMENT|2021-04-18|90
e|SS|4389d158-cb51-4779-b19a-f38dbef0806a|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|2|FOLLOW-UP|2020-06-22|10
e|SS|4389d158-cb51-4779-b19a-f38dbef0806a|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|4|TREATMENT|2020-06-22|10
e|SS|4389d158-cb51-4779-b19a-f38dbef0806a|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|3|TREATMENT|2020-07-07|25
e|SS|4389d158-cb51-4779-b19a-f38dbef0806a|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|5|FOLLOW-UP|2020-07-07|25
e|SS|4389d158-cb51-4779-b19a-f38dbef0806a|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|WASHOUT|2020-07-22|40
e|SS|4389d158-cb51-4779-b19a-f38dbef0806a|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|7|TREATMENT|2020-07-22|40
e|SS|4389d158-cb51-4779-b19a-f38dbef0806a|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|2|TREATMENT|2020-08-16|65
e|SS|4389d158-cb51-4779-b19a-f38dbef0806a|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|6|TREATMENT|2020-08-16|65
e|SS|4389d158-cb51-4779-b19a-f38dbef0806a|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|1|TREATMENT|2020-09-10|90
e|SS|4389d158-cb51-4779-b19a-f38dbef0806a|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|3|WASHOUT|2020-09-10|90
e|SS|3a973b7a-3583-4383-b59e-3dab51b511bd|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|7|WASHOUT|2021-01-19|10
e|SS|3a973b7a-3583-4383-b59e-3dab51b511bd|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|7|TREATMENT|2021-01-19|10
e|SS|3a973b7a-3583-4383-b59e-3dab51b511bd|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|WASHOUT|2021-02-03|25
e|SS|3a973b7a-3583-4383-b59e-3dab51b511bd|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|1|TREATMENT|2021-02-03|25
e|SS|3a973b7a-3583-4383-b59e-3dab51b511bd|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|TREATMENT|2021-02-18|40
e|SS|3a973b7a-3583-4383-b59e-3dab51b511bd|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|4|FOLLOW-UP|2021-02-18|40
e|SS|3a973b7a-3583-4383-b59e-3dab51b511bd|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|2|TREATMENT|2021-03-15|65
e|SS|3a973b7a-3583-4383-b59e-3dab51b511bd|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|3|SCREENING|2021-03-15|65
e|SS|3a973b7a-3583-4383-b59e-3dab51b511bd|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|FOLLOW-UP|2021-04-09|90
e|SS|3a973b7a-3583-4383-b59e-3dab51b511bd|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|7|TREATMENT|2021-04-09|90
e|SS|d283591c-2085-459e-94f2-d3eb6b81aea7|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|4|TREATMENT|2020-09-28|10
e|SS|d283591c-2085-459e-94f2-d3eb6b81aea7|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|2|SCREENING|2020-09-28|10
e|SS|d283591c-2085-459e-94f2-d3eb6b81aea7|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|6|TREATMENT|2020-10-13|25
e|SS|d283591c-2085-459e-94f2-d3eb6b81aea7|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|FOLLOW-UP|2020-10-13|25
e|SS|d283591c-2085-459e-94f2-d3eb6b81aea7|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|7|TREATMENT|2020-10-28|40
e|SS|d283591c-2085-459e-94f2-d3eb6b81aea7|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|7|FOLLOW-UP|2020-10-28|40
e|SS|d283591c-2085-459e-94f2-d3eb6b81aea7|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|2|TREATMENT|2020-11-22|65
e|SS|d283591c-2085-459e-94f2-d3eb6b81aea7|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|7|TREATMENT|2020-11-22|65
e|SS|d283591c-2085-459e-94f2-d3eb6b81aea7|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|3|TREATMENT|2020-12-17|90
e|SS|d283591c-2085-459e-94f2-d3eb6b81aea7|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|6|TREATMENT|2020-12-17|90
e|SS|da31f695-9f6a-46b2-8002-5c1c21b55cf3|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|6|TREATMENT|2020-10-01|10
e|SS|da31f695-9f6a-46b2-8002-5c1c21b55cf3|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|6|WASHOUT|2020-10-01|10
e|SS|da31f695-9f6a-46b2-8002-5c1c21b55cf3|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|4|FOLLOW-UP|2020-10-16|25
e|SS|da31f695-9f6a-46b2-8002-5c1c21b55cf3|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|WASHOUT|2020-10-16|25
e|SS|da31f695-9f6a-46b2-8002-5c1c21b55cf3|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|WASHOUT|2020-10-31|40
e|SS|da31f695-9f6a-46b2-8002-5c1c21b55cf3|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|1|TREATMENT|2020-10-31|40
e|SS|da31f695-9f6a-46b2-8002-5c1c21b55cf3|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|3|SCREENING|2020-11-25|65
e|SS|da31f695-9f6a-46b2-8002-5c1c21b55cf3|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|5|SCREENING|2020-11-25|65
e|SS|da31f695-9f6a-46b2-8002-5c1c21b55cf3|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|1|TREATMENT|2020-12-20|90
e|SS|da31f695-9f6a-46b2-8002-5c1c21b55cf3|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|6|TREATMENT|2020-12-20|90
e|SS|4cd63e56-3d93-403a-8011-3b4fcf26e445|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|2|WASHOUT|2020-12-27|10
e|SS|4cd63e56-3d93-403a-8011-3b4fcf26e445|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|7|TREATMENT|2020-12-27|10
e|SS|4cd63e56-3d93-403a-8011-3b4fcf26e445|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|4|TREATMENT|2021-01-11|25
e|SS|4cd63e56-3d93-403a-8011-3b4fcf26e445|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|1|TREATMENT|2021-01-11|25
e|SS|4cd63e56-3d93-403a-8011-3b4fcf26e445|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|3|FOLLOW-UP|2021-01-26|40
e|SS|4cd63e56-3d93-403a-8011-3b4fcf26e445|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|7|TREATMENT|2021-01-26|40
e|SS|4cd63e56-3d93-403a-8011-3b4fcf26e445|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|1|TREATMENT|2021-02-20|65
e|SS|4cd63e56-3d93-403a-8011-3b4fcf26e445|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|1|TREATMENT|2021-02-20|65
e|SS|4cd63e56-3d93-403a-8011-3b4fcf26e445|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|5|TREATMENT|2021-03-17|90
e|SS|4cd63e56-3d93-403a-8011-3b4fcf26e445|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|3|TREATMENT|2021-03-17|90
e|SS|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|6|TREATMENT|2020-05-23|10
e|SS|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|4|TREATMENT|2020-05-23|10
e|SS|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2020-06-07|25
e|SS|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|6|TREATMENT|2020-06-07|25
e|SS|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|WASHOUT|2020-06-22|40
e|SS|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|6|SCREENING|2020-06-22|40
e|SS|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|2|FOLLOW-UP|2020-07-17|65
e|SS|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|4|TREATMENT|2020-07-17|65
e|SS|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|6|TREATMENT|2020-08-11|90
e|SS|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|5|TREATMENT|2020-08-11|90
e|SS|f31bab3b-3624-44a5-a62f-f8cf9055eec4|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|7|TREATMENT|2020-08-09|10
e|SS|f31bab3b-3624-44a5-a62f-f8cf9055eec4|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|7|TREATMENT|2020-08-09|10
e|SS|f31bab3b-3624-44a5-a62f-f8cf9055eec4|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|3|TREATMENT|2020-08-24|25
e|SS|f31bab3b-3624-44a5-a62f-f8cf9055eec4|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|4|SCREENING|2020-08-24|25
e|SS|f31bab3b-3624-44a5-a62f-f8cf9055eec4|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|5|TREATMENT|2020-09-08|40
e|SS|f31bab3b-3624-44a5-a62f-f8cf9055eec4|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-09-08|40
e|SS|f31bab3b-3624-44a5-a62f-f8cf9055eec4|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|4|TREATMENT|2020-10-03|65
e|SS|f31bab3b-3624-44a5-a62f-f8cf9055eec4|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|1|SCREENING|2020-10-03|65
e|SS|f31bab3b-3624-44a5-a62f-f8cf9055eec4|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|4|WASHOUT|2020-10-28|90
e|SS|f31bab3b-3624-44a5-a62f-f8cf9055eec4|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|5|FOLLOW-UP|2020-10-28|90
e|SS|0b5675aa-4ec0-4548-9a0b-a13f8de89883|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|5|WASHOUT|2020-06-28|10
e|SS|0b5675aa-4ec0-4548-9a0b-a13f8de89883|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|5|FOLLOW-UP|2020-06-28|10
e|SS|0b5675aa-4ec0-4548-9a0b-a13f8de89883|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|2|TREATMENT|2020-07-13|25
e|SS|0b5675aa-4ec0-4548-9a0b-a13f8de89883|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|5|TREATMENT|2020-07-13|25
e|SS|0b5675aa-4ec0-4548-9a0b-a13f8de89883|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|5|TREATMENT|2020-07-28|40
e|SS|0b5675aa-4ec0-4548-9a0b-a13f8de89883|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|2|FOLLOW-UP|2020-07-28|40
e|SS|0b5675aa-4ec0-4548-9a0b-a13f8de89883|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|7|FOLLOW-UP|2020-08-22|65
e|SS|0b5675aa-4ec0-4548-9a0b-a13f8de89883|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|1|TREATMENT|2020-08-22|65
e|SS|0b5675aa-4ec0-4548-9a0b-a13f8de89883|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|3|SCREENING|2020-09-16|90
e|SS|0b5675aa-4ec0-4548-9a0b-a13f8de89883|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2020-09-16|90
e|SS|9bdf9856-3b2a-43db-b369-3e13868ef413|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|FOLLOW-UP|2021-01-23|10
e|SS|9bdf9856-3b2a-43db-b369-3e13868ef413|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|6|TREATMENT|2021-01-23|10
e|SS|9bdf9856-3b2a-43db-b369-3e13868ef413|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|1|FOLLOW-UP|2021-02-07|25
e|SS|9bdf9856-3b2a-43db-b369-3e13868ef413|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|2|TREATMENT|2021-02-07|25
e|SS|9bdf9856-3b2a-43db-b369-3e13868ef413|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|4|FOLLOW-UP|2021-02-22|40
e|SS|9bdf9856-3b2a-43db-b369-3e13868ef413|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|TREATMENT|2021-02-22|40
e|SS|9bdf9856-3b2a-43db-b369-3e13868ef413|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|2|WASHOUT|2021-03-19|65
e|SS|9bdf9856-3b2a-43db-b369-3e13868ef413|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|5|SCREENING|2021-03-19|65
e|SS|9bdf9856-3b2a-43db-b369-3e13868ef413|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|7|TREATMENT|2021-04-13|90
e|SS|9bdf9856-3b2a-43db-b369-3e13868ef413|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|6|TREATMENT|2021-04-13|90
e|SS|5cc53922-60c0-4bce-8d4a-bc59e9203d63|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|2|WASHOUT|2020-12-28|10
e|SS|5cc53922-60c0-4bce-8d4a-bc59e9203d63|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|4|TREATMENT|2020-12-28|10
e|SS|5cc53922-60c0-4bce-8d4a-bc59e9203d63|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|FOLLOW-UP|2021-01-12|25
e|SS|5cc53922-60c0-4bce-8d4a-bc59e9203d63|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|5|TREATMENT|2021-01-12|25
e|SS|5cc53922-60c0-4bce-8d4a-bc59e9203d63|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|1|WASHOUT|2021-01-27|40
e|SS|5cc53922-60c0-4bce-8d4a-bc59e9203d63|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|2|SCREENING|2021-01-27|40
e|SS|5cc53922-60c0-4bce-8d4a-bc59e9203d63|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|SCREENING|2021-02-21|65
e|SS|5cc53922-60c0-4bce-8d4a-bc59e9203d63|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|2|SCREENING|2021-02-21|65
e|SS|5cc53922-60c0-4bce-8d4a-bc59e9203d63|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|4|SCREENING|2021-03-18|90
e|SS|5cc53922-60c0-4bce-8d4a-bc59e9203d63|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|2|FOLLOW-UP|2021-03-18|90
e|SS|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|5|WASHOUT|2020-12-29|10
e|SS|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|3|TREATMENT|2020-12-29|10
e|SS|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|5|FOLLOW-UP|2021-01-13|25
e|SS|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|6|FOLLOW-UP|2021-01-13|25
e|SS|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|TREATMENT|2021-01-28|40
e|SS|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|5|FOLLOW-UP|2021-01-28|40
e|SS|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|4|TREATMENT|2021-02-22|65
e|SS|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|5|FOLLOW-UP|2021-02-22|65
e|SS|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|6|TREATMENT|2021-03-19|90
e|SS|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|3|WASHOUT|2021-03-19|90
e|SS|066281d3-27b8-439f-8340-f59115f646ef|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|5|FOLLOW-UP|2020-10-21|10
e|SS|066281d3-27b8-439f-8340-f59115f646ef|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|1|SCREENING|2020-10-21|10
e|SS|066281d3-27b8-439f-8340-f59115f646ef|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|5|SCREENING|2020-11-05|25
e|SS|066281d3-27b8-439f-8340-f59115f646ef|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|7|TREATMENT|2020-11-05|25
e|SS|066281d3-27b8-439f-8340-f59115f646ef|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-11-20|40
e|SS|066281d3-27b8-439f-8340-f59115f646ef|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|WASHOUT|2020-11-20|40
e|SS|066281d3-27b8-439f-8340-f59115f646ef|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2020-12-15|65
e|SS|066281d3-27b8-439f-8340-f59115f646ef|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|SCREENING|2020-12-15|65
e|SS|066281d3-27b8-439f-8340-f59115f646ef|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|7|WASHOUT|2021-01-09|90
e|SS|066281d3-27b8-439f-8340-f59115f646ef|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|1|FOLLOW-UP|2021-01-09|90
e|SS|d23cc47e-da96-4042-a69f-60097beaef0e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|5|WASHOUT|2021-01-21|10
e|SS|d23cc47e-da96-4042-a69f-60097beaef0e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|1|TREATMENT|2021-01-21|10
e|SS|d23cc47e-da96-4042-a69f-60097beaef0e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|1|WASHOUT|2021-02-05|25
e|SS|d23cc47e-da96-4042-a69f-60097beaef0e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|1|TREATMENT|2021-02-05|25
e|SS|d23cc47e-da96-4042-a69f-60097beaef0e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|SCREENING|2021-02-20|40
e|SS|d23cc47e-da96-4042-a69f-60097beaef0e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|5|WASHOUT|2021-02-20|40
e|SS|d23cc47e-da96-4042-a69f-60097beaef0e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|3|TREATMENT|2021-03-17|65
e|SS|d23cc47e-da96-4042-a69f-60097beaef0e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|5|TREATMENT|2021-03-17|65
e|SS|d23cc47e-da96-4042-a69f-60097beaef0e|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|6|WASHOUT|2021-04-11|90
e|SS|d23cc47e-da96-4042-a69f-60097beaef0e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|2|TREATMENT|2021-04-11|90
e|SS|b896c679-87d0-4e29-ad27-3944cf09b3ec|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|5|TREATMENT|2021-01-02|10
e|SS|b896c679-87d0-4e29-ad27-3944cf09b3ec|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|6|TREATMENT|2021-01-02|10
e|SS|b896c679-87d0-4e29-ad27-3944cf09b3ec|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|1|SCREENING|2021-01-17|25
e|SS|b896c679-87d0-4e29-ad27-3944cf09b3ec|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|1|SCREENING|2021-01-17|25
e|SS|b896c679-87d0-4e29-ad27-3944cf09b3ec|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|TREATMENT|2021-02-01|40
e|SS|b896c679-87d0-4e29-ad27-3944cf09b3ec|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|6|WASHOUT|2021-02-01|40
e|SS|b896c679-87d0-4e29-ad27-3944cf09b3ec|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|5|TREATMENT|2021-02-26|65
e|SS|b896c679-87d0-4e29-ad27-3944cf09b3ec|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|1|TREATMENT|2021-02-26|65
e|SS|b896c679-87d0-4e29-ad27-3944cf09b3ec|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|3|WASHOUT|2021-03-23|90
e|SS|b896c679-87d0-4e29-ad27-3944cf09b3ec|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|4|SCREENING|2021-03-23|90
e|SS|6d0ec221-6eb6-4fed-806e-2bc700968333|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|2|TREATMENT|2020-07-27|10
e|SS|6d0ec221-6eb6-4fed-806e-2bc700968333|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|TREATMENT|2020-07-27|10
e|SS|6d0ec221-6eb6-4fed-806e-2bc700968333|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|1|FOLLOW-UP|2020-08-11|25
e|SS|6d0ec221-6eb6-4fed-806e-2bc700968333|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|TREATMENT|2020-08-11|25
e|SS|6d0ec221-6eb6-4fed-806e-2bc700968333|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|2|TREATMENT|2020-08-26|40
e|SS|6d0ec221-6eb6-4fed-806e-2bc700968333|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|4|WASHOUT|2020-08-26|40
e|SS|6d0ec221-6eb6-4fed-806e-2bc700968333|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|WASHOUT|2020-09-20|65
e|SS|6d0ec221-6eb6-4fed-806e-2bc700968333|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|4|SCREENING|2020-09-20|65
e|SS|6d0ec221-6eb6-4fed-806e-2bc700968333|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|3|SCREENING|2020-10-15|90
e|SS|6d0ec221-6eb6-4fed-806e-2bc700968333|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|WASHOUT|2020-10-15|90
e|SS|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-10-03|10
e|SS|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|6|WASHOUT|2020-10-03|10
e|SS|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|2|WASHOUT|2020-10-18|25
e|SS|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|6|TREATMENT|2020-10-18|25
e|SS|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|6|TREATMENT|2020-11-02|40
e|SS|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|5|SCREENING|2020-11-02|40
e|SS|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|3|TREATMENT|2020-11-27|65
e|SS|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|WASHOUT|2020-11-27|65
e|SS|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|6|TREATMENT|2020-12-22|90
e|SS|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|1|WASHOUT|2020-12-22|90
e|SS|15e5e7ca-b832-450c-a20c-b21585086328|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|3|WASHOUT|2021-01-05|10
e|SS|15e5e7ca-b832-450c-a20c-b21585086328|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|5|WASHOUT|2021-01-05|10
e|SS|15e5e7ca-b832-450c-a20c-b21585086328|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|1|SCREENING|2021-01-20|25
e|SS|15e5e7ca-b832-450c-a20c-b21585086328|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|6|TREATMENT|2021-01-20|25
e|SS|15e5e7ca-b832-450c-a20c-b21585086328|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|WASHOUT|2021-02-04|40
e|SS|15e5e7ca-b832-450c-a20c-b21585086328|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2021-02-04|40
e|SS|15e5e7ca-b832-450c-a20c-b21585086328|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|4|WASHOUT|2021-03-01|65
e|SS|15e5e7ca-b832-450c-a20c-b21585086328|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|1|SCREENING|2021-03-01|65
e|SS|15e5e7ca-b832-450c-a20c-b21585086328|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|FOLLOW-UP|2021-03-26|90
e|SS|15e5e7ca-b832-450c-a20c-b21585086328|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|5|TREATMENT|2021-03-26|90
e|SS|b46ff3a2-f257-4803-8064-e29bd1114bfc|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|3|SCREENING|2020-10-13|10
e|SS|b46ff3a2-f257-4803-8064-e29bd1114bfc|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|TREATMENT|2020-10-13|10
e|SS|b46ff3a2-f257-4803-8064-e29bd1114bfc|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|TREATMENT|2020-10-28|25
e|SS|b46ff3a2-f257-4803-8064-e29bd1114bfc|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|TREATMENT|2020-10-28|25
e|SS|b46ff3a2-f257-4803-8064-e29bd1114bfc|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|2|FOLLOW-UP|2020-11-12|40
e|SS|b46ff3a2-f257-4803-8064-e29bd1114bfc|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|6|WASHOUT|2020-11-12|40
e|SS|b46ff3a2-f257-4803-8064-e29bd1114bfc|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|1|SCREENING|2020-12-07|65
e|SS|b46ff3a2-f257-4803-8064-e29bd1114bfc|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|6|TREATMENT|2020-12-07|65
e|SS|b46ff3a2-f257-4803-8064-e29bd1114bfc|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|3|FOLLOW-UP|2021-01-01|90
e|SS|b46ff3a2-f257-4803-8064-e29bd1114bfc|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|3|WASHOUT|2021-01-01|90
e|SS|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|WASHOUT|2020-12-06|10
e|SS|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|5|TREATMENT|2020-12-06|10
e|SS|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|2|WASHOUT|2020-12-21|25
e|SS|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|FOLLOW-UP|2020-12-21|25
e|SS|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|WASHOUT|2021-01-05|40
e|SS|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|1|WASHOUT|2021-01-05|40
e|SS|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|4|FOLLOW-UP|2021-01-30|65
e|SS|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|7|TREATMENT|2021-01-30|65
e|SS|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|2|FOLLOW-UP|2021-02-24|90
e|SS|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2021-02-24|90
e|SS|a5c667d1-d2ac-49f7-ad44-bf9a44762025|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|2|WASHOUT|2020-10-06|10
e|SS|a5c667d1-d2ac-49f7-ad44-bf9a44762025|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|WASHOUT|2020-10-06|10
e|SS|a5c667d1-d2ac-49f7-ad44-bf9a44762025|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|6|FOLLOW-UP|2020-10-21|25
e|SS|a5c667d1-d2ac-49f7-ad44-bf9a44762025|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|4|TREATMENT|2020-10-21|25
e|SS|a5c667d1-d2ac-49f7-ad44-bf9a44762025|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|1|TREATMENT|2020-11-05|40
e|SS|a5c667d1-d2ac-49f7-ad44-bf9a44762025|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|5|TREATMENT|2020-11-05|40
e|SS|a5c667d1-d2ac-49f7-ad44-bf9a44762025|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|6|FOLLOW-UP|2020-11-30|65
e|SS|a5c667d1-d2ac-49f7-ad44-bf9a44762025|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|WASHOUT|2020-11-30|65
e|SS|a5c667d1-d2ac-49f7-ad44-bf9a44762025|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|5|TREATMENT|2020-12-25|90
e|SS|a5c667d1-d2ac-49f7-ad44-bf9a44762025|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|2|WASHOUT|2020-12-25|90
e|SS|944a2627-13f1-4ecf-9545-8819a1327138|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|6|TREATMENT|2021-01-17|10
e|SS|944a2627-13f1-4ecf-9545-8819a1327138|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|6|TREATMENT|2021-01-17|10
e|SS|944a2627-13f1-4ecf-9545-8819a1327138|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|2|TREATMENT|2021-02-01|25
e|SS|944a2627-13f1-4ecf-9545-8819a1327138|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|3|FOLLOW-UP|2021-02-01|25
e|SS|944a2627-13f1-4ecf-9545-8819a1327138|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|SCREENING|2021-02-16|40
e|SS|944a2627-13f1-4ecf-9545-8819a1327138|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|TREATMENT|2021-02-16|40
e|SS|944a2627-13f1-4ecf-9545-8819a1327138|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|2|TREATMENT|2021-03-13|65
e|SS|944a2627-13f1-4ecf-9545-8819a1327138|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|SCREENING|2021-03-13|65
e|SS|944a2627-13f1-4ecf-9545-8819a1327138|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2021-04-07|90
e|SS|944a2627-13f1-4ecf-9545-8819a1327138|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|3|FOLLOW-UP|2021-04-07|90
e|SS|7902955a-6336-45e5-a15d-7c368a28ac4f|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|6|FOLLOW-UP|2020-06-01|10
e|SS|7902955a-6336-45e5-a15d-7c368a28ac4f|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|2|WASHOUT|2020-06-01|10
e|SS|7902955a-6336-45e5-a15d-7c368a28ac4f|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|4|TREATMENT|2020-06-16|25
e|SS|7902955a-6336-45e5-a15d-7c368a28ac4f|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|1|TREATMENT|2020-06-16|25
e|SS|7902955a-6336-45e5-a15d-7c368a28ac4f|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|3|TREATMENT|2020-07-01|40
e|SS|7902955a-6336-45e5-a15d-7c368a28ac4f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|7|TREATMENT|2020-07-01|40
e|SS|7902955a-6336-45e5-a15d-7c368a28ac4f|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|1|TREATMENT|2020-07-26|65
e|SS|7902955a-6336-45e5-a15d-7c368a28ac4f|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|5|TREATMENT|2020-07-26|65
e|SS|7902955a-6336-45e5-a15d-7c368a28ac4f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|FOLLOW-UP|2020-08-20|90
e|SS|7902955a-6336-45e5-a15d-7c368a28ac4f|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|2|TREATMENT|2020-08-20|90
e|SS|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|6|TREATMENT|2020-12-20|10
e|SS|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|7|FOLLOW-UP|2020-12-20|10
e|SS|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|5|TREATMENT|2021-01-04|25
e|SS|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|FOLLOW-UP|2021-01-04|25
e|SS|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|6|FOLLOW-UP|2021-01-19|40
e|SS|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|3|WASHOUT|2021-01-19|40
e|SS|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|TREATMENT|2021-02-13|65
e|SS|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|6|TREATMENT|2021-02-13|65
e|SS|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|4|TREATMENT|2021-03-10|90
e|SS|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|2|WASHOUT|2021-03-10|90
e|SS|6071d81f-2f38-414f-90ca-4ad80c971054|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|2|TREATMENT|2020-09-07|10
e|SS|6071d81f-2f38-414f-90ca-4ad80c971054|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|5|TREATMENT|2020-09-07|10
e|SS|6071d81f-2f38-414f-90ca-4ad80c971054|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|FOLLOW-UP|2020-09-22|25
e|SS|6071d81f-2f38-414f-90ca-4ad80c971054|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|5|WASHOUT|2020-09-22|25
e|SS|6071d81f-2f38-414f-90ca-4ad80c971054|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|1|SCREENING|2020-10-07|40
e|SS|6071d81f-2f38-414f-90ca-4ad80c971054|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|7|TREATMENT|2020-10-07|40
e|SS|6071d81f-2f38-414f-90ca-4ad80c971054|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|3|TREATMENT|2020-11-01|65
e|SS|6071d81f-2f38-414f-90ca-4ad80c971054|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|2|TREATMENT|2020-11-01|65
e|SS|6071d81f-2f38-414f-90ca-4ad80c971054|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|7|TREATMENT|2020-11-26|90
e|SS|6071d81f-2f38-414f-90ca-4ad80c971054|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|5|FOLLOW-UP|2020-11-26|90
e|SS|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|3|SCREENING|2020-09-28|10
e|SS|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|3|TREATMENT|2020-09-28|10
e|SS|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|5|WASHOUT|2020-10-13|25
e|SS|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|1|TREATMENT|2020-10-13|25
e|SS|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|4|FOLLOW-UP|2020-10-28|40
e|SS|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|3|FOLLOW-UP|2020-10-28|40
e|SS|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|7|TREATMENT|2020-11-22|65
e|SS|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|7|TREATMENT|2020-11-22|65
e|SS|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|TREATMENT|2020-12-17|90
e|SS|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|6|FOLLOW-UP|2020-12-17|90
e|SS|a046d48d-b1fa-4d46-902e-3984aed00ec7|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|6|WASHOUT|2020-08-01|10
e|SS|a046d48d-b1fa-4d46-902e-3984aed00ec7|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|5|TREATMENT|2020-08-01|10
e|SS|a046d48d-b1fa-4d46-902e-3984aed00ec7|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|3|SCREENING|2020-08-16|25
e|SS|a046d48d-b1fa-4d46-902e-3984aed00ec7|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2020-08-16|25
e|SS|a046d48d-b1fa-4d46-902e-3984aed00ec7|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|TREATMENT|2020-08-31|40
e|SS|a046d48d-b1fa-4d46-902e-3984aed00ec7|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|3|TREATMENT|2020-08-31|40
e|SS|a046d48d-b1fa-4d46-902e-3984aed00ec7|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|FOLLOW-UP|2020-09-25|65
e|SS|a046d48d-b1fa-4d46-902e-3984aed00ec7|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|TREATMENT|2020-09-25|65
e|SS|a046d48d-b1fa-4d46-902e-3984aed00ec7|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|3|FOLLOW-UP|2020-10-20|90
e|SS|a046d48d-b1fa-4d46-902e-3984aed00ec7|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|7|TREATMENT|2020-10-20|90
e|SS|8b60e1b0-2cd9-419d-b345-9006af042932|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|3|TREATMENT|2020-12-16|10
e|SS|8b60e1b0-2cd9-419d-b345-9006af042932|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|FOLLOW-UP|2020-12-16|10
e|SS|8b60e1b0-2cd9-419d-b345-9006af042932|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|1|FOLLOW-UP|2020-12-31|25
e|SS|8b60e1b0-2cd9-419d-b345-9006af042932|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|6|SCREENING|2020-12-31|25
e|SS|8b60e1b0-2cd9-419d-b345-9006af042932|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|1|TREATMENT|2021-01-15|40
e|SS|8b60e1b0-2cd9-419d-b345-9006af042932|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|4|SCREENING|2021-01-15|40
e|SS|8b60e1b0-2cd9-419d-b345-9006af042932|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|5|WASHOUT|2021-02-09|65
e|SS|8b60e1b0-2cd9-419d-b345-9006af042932|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2021-02-09|65
e|SS|8b60e1b0-2cd9-419d-b345-9006af042932|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|5|SCREENING|2021-03-06|90
e|SS|8b60e1b0-2cd9-419d-b345-9006af042932|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|7|TREATMENT|2021-03-06|90
e|SS|712029bc-471a-4e3d-9123-e38b3c38bc6c|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|2|TREATMENT|2021-01-24|10
e|SS|712029bc-471a-4e3d-9123-e38b3c38bc6c|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|1|TREATMENT|2021-01-24|10
e|SS|712029bc-471a-4e3d-9123-e38b3c38bc6c|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|3|TREATMENT|2021-02-08|25
e|SS|712029bc-471a-4e3d-9123-e38b3c38bc6c|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|1|TREATMENT|2021-02-08|25
e|SS|712029bc-471a-4e3d-9123-e38b3c38bc6c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|WASHOUT|2021-02-23|40
e|SS|712029bc-471a-4e3d-9123-e38b3c38bc6c|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|4|SCREENING|2021-02-23|40
e|SS|712029bc-471a-4e3d-9123-e38b3c38bc6c|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|WASHOUT|2021-03-20|65
e|SS|712029bc-471a-4e3d-9123-e38b3c38bc6c|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|TREATMENT|2021-03-20|65
e|SS|712029bc-471a-4e3d-9123-e38b3c38bc6c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|4|TREATMENT|2021-04-14|90
e|SS|712029bc-471a-4e3d-9123-e38b3c38bc6c|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|1|TREATMENT|2021-04-14|90
e|SS|92c0183d-5704-45ad-9aec-e24bc5777b80|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|1|SCREENING|2021-01-20|10
e|SS|92c0183d-5704-45ad-9aec-e24bc5777b80|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2021-01-20|10
e|SS|92c0183d-5704-45ad-9aec-e24bc5777b80|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|7|TREATMENT|2021-02-04|25
e|SS|92c0183d-5704-45ad-9aec-e24bc5777b80|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|1|WASHOUT|2021-02-04|25
e|SS|92c0183d-5704-45ad-9aec-e24bc5777b80|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|7|TREATMENT|2021-02-19|40
e|SS|92c0183d-5704-45ad-9aec-e24bc5777b80|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|6|TREATMENT|2021-02-19|40
e|SS|92c0183d-5704-45ad-9aec-e24bc5777b80|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|1|TREATMENT|2021-03-16|65
e|SS|92c0183d-5704-45ad-9aec-e24bc5777b80|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|WASHOUT|2021-03-16|65
e|SS|92c0183d-5704-45ad-9aec-e24bc5777b80|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|3|FOLLOW-UP|2021-04-10|90
e|SS|92c0183d-5704-45ad-9aec-e24bc5777b80|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|7|TREATMENT|2021-04-10|90
e|SS|52ce3b1f-9500-4323-861d-73c8b96f59de|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|1|FOLLOW-UP|2020-10-26|10
e|SS|52ce3b1f-9500-4323-861d-73c8b96f59de|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|5|SCREENING|2020-10-26|10
e|SS|52ce3b1f-9500-4323-861d-73c8b96f59de|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|4|TREATMENT|2020-11-10|25
e|SS|52ce3b1f-9500-4323-861d-73c8b96f59de|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|2|TREATMENT|2020-11-10|25
e|SS|52ce3b1f-9500-4323-861d-73c8b96f59de|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|3|TREATMENT|2020-11-25|40
e|SS|52ce3b1f-9500-4323-861d-73c8b96f59de|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|6|TREATMENT|2020-11-25|40
e|SS|52ce3b1f-9500-4323-861d-73c8b96f59de|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|3|TREATMENT|2020-12-20|65
e|SS|52ce3b1f-9500-4323-861d-73c8b96f59de|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|3|FOLLOW-UP|2020-12-20|65
e|SS|52ce3b1f-9500-4323-861d-73c8b96f59de|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|6|TREATMENT|2021-01-14|90
e|SS|52ce3b1f-9500-4323-861d-73c8b96f59de|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|5|TREATMENT|2021-01-14|90
e|SS|3655d198-2e7e-419e-8337-d7eea7d795ca|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|3|FOLLOW-UP|2020-11-23|10
e|SS|3655d198-2e7e-419e-8337-d7eea7d795ca|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|2|FOLLOW-UP|2020-11-23|10
e|SS|3655d198-2e7e-419e-8337-d7eea7d795ca|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|SCREENING|2020-12-08|25
e|SS|3655d198-2e7e-419e-8337-d7eea7d795ca|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|6|TREATMENT|2020-12-08|25
e|SS|3655d198-2e7e-419e-8337-d7eea7d795ca|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|2|FOLLOW-UP|2020-12-23|40
e|SS|3655d198-2e7e-419e-8337-d7eea7d795ca|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|2|TREATMENT|2020-12-23|40
e|SS|3655d198-2e7e-419e-8337-d7eea7d795ca|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|7|WASHOUT|2021-01-17|65
e|SS|3655d198-2e7e-419e-8337-d7eea7d795ca|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|5|TREATMENT|2021-01-17|65
e|SS|3655d198-2e7e-419e-8337-d7eea7d795ca|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|6|TREATMENT|2021-02-11|90
e|SS|3655d198-2e7e-419e-8337-d7eea7d795ca|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|6|TREATMENT|2021-02-11|90
e|SS|d47da6bf-8abf-4b62-8bb8-797155981158|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|7|TREATMENT|2020-09-10|10
e|SS|d47da6bf-8abf-4b62-8bb8-797155981158|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|3|TREATMENT|2020-09-10|10
e|SS|d47da6bf-8abf-4b62-8bb8-797155981158|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|7|TREATMENT|2020-09-25|25
e|SS|d47da6bf-8abf-4b62-8bb8-797155981158|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|7|TREATMENT|2020-09-25|25
e|SS|d47da6bf-8abf-4b62-8bb8-797155981158|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|SCREENING|2020-10-10|40
e|SS|d47da6bf-8abf-4b62-8bb8-797155981158|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|TREATMENT|2020-10-10|40
e|SS|d47da6bf-8abf-4b62-8bb8-797155981158|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|6|WASHOUT|2020-11-04|65
e|SS|d47da6bf-8abf-4b62-8bb8-797155981158|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|4|TREATMENT|2020-11-04|65
e|SS|d47da6bf-8abf-4b62-8bb8-797155981158|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|6|FOLLOW-UP|2020-11-29|90
e|SS|d47da6bf-8abf-4b62-8bb8-797155981158|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|FOLLOW-UP|2020-11-29|90
e|SS|25e81c81-8c23-4c9e-be79-35247384dd1f|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|SCREENING|2020-08-08|10
e|SS|25e81c81-8c23-4c9e-be79-35247384dd1f|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|1|SCREENING|2020-08-08|10
e|SS|25e81c81-8c23-4c9e-be79-35247384dd1f|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|1|TREATMENT|2020-08-23|25
e|SS|25e81c81-8c23-4c9e-be79-35247384dd1f|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|7|TREATMENT|2020-08-23|25
e|SS|25e81c81-8c23-4c9e-be79-35247384dd1f|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|3|TREATMENT|2020-09-07|40
e|SS|25e81c81-8c23-4c9e-be79-35247384dd1f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|TREATMENT|2020-09-07|40
e|SS|25e81c81-8c23-4c9e-be79-35247384dd1f|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|1|SCREENING|2020-10-02|65
e|SS|25e81c81-8c23-4c9e-be79-35247384dd1f|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2020-10-02|65
e|SS|25e81c81-8c23-4c9e-be79-35247384dd1f|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|6|TREATMENT|2020-10-27|90
e|SS|25e81c81-8c23-4c9e-be79-35247384dd1f|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|2|SCREENING|2020-10-27|90
e|SS|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|7|TREATMENT|2020-07-27|10
e|SS|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|3|SCREENING|2020-07-27|10
e|SS|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|6|TREATMENT|2020-08-11|25
e|SS|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|TREATMENT|2020-08-11|25
e|SS|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|2|TREATMENT|2020-08-26|40
e|SS|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|1|TREATMENT|2020-08-26|40
e|SS|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|WASHOUT|2020-09-20|65
e|SS|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|5|SCREENING|2020-09-20|65
e|SS|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|7|TREATMENT|2020-10-15|90
e|SS|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|5|SCREENING|2020-10-15|90
e|SS|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|WASHOUT|2020-11-12|10
e|SS|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|2|SCREENING|2020-11-12|10
e|SS|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|3|FOLLOW-UP|2020-11-27|25
e|SS|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|TREATMENT|2020-11-27|25
e|SS|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|FOLLOW-UP|2020-12-12|40
e|SS|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|1|SCREENING|2020-12-12|40
e|SS|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|3|TREATMENT|2021-01-06|65
e|SS|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|5|FOLLOW-UP|2021-01-06|65
e|SS|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|6|TREATMENT|2021-01-31|90
e|SS|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|7|SCREENING|2021-01-31|90
e|SS|5ba70148-c29b-47af-9280-10d1a942380a|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|6|TREATMENT|2020-11-28|10
e|SS|5ba70148-c29b-47af-9280-10d1a942380a|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|1|TREATMENT|2020-11-28|10
e|SS|5ba70148-c29b-47af-9280-10d1a942380a|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|5|WASHOUT|2020-12-13|25
e|SS|5ba70148-c29b-47af-9280-10d1a942380a|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|7|TREATMENT|2020-12-13|25
e|SS|5ba70148-c29b-47af-9280-10d1a942380a|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|4|TREATMENT|2020-12-28|40
e|SS|5ba70148-c29b-47af-9280-10d1a942380a|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|3|TREATMENT|2020-12-28|40
e|SS|5ba70148-c29b-47af-9280-10d1a942380a|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2021-01-22|65
e|SS|5ba70148-c29b-47af-9280-10d1a942380a|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|3|FOLLOW-UP|2021-01-22|65
e|SS|5ba70148-c29b-47af-9280-10d1a942380a|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|7|TREATMENT|2021-02-16|90
e|SS|5ba70148-c29b-47af-9280-10d1a942380a|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|4|SCREENING|2021-02-16|90
e|SS|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|1|WASHOUT|2020-05-27|10
e|SS|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|TREATMENT|2020-05-27|10
e|SS|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|4|FOLLOW-UP|2020-06-11|25
e|SS|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|6|TREATMENT|2020-06-11|25
e|SS|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|4|TREATMENT|2020-06-26|40
e|SS|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|3|TREATMENT|2020-06-26|40
e|SS|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|7|TREATMENT|2020-07-21|65
e|SS|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|7|FOLLOW-UP|2020-07-21|65
e|SS|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|5|SCREENING|2020-08-15|90
e|SS|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|2|WASHOUT|2020-08-15|90
e|SS|2d8f8b1e-7914-400b-afc5-8dc23a626d76|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|5|SCREENING|2020-06-19|10
e|SS|2d8f8b1e-7914-400b-afc5-8dc23a626d76|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|6|FOLLOW-UP|2020-06-19|10
e|SS|2d8f8b1e-7914-400b-afc5-8dc23a626d76|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|WASHOUT|2020-07-04|25
e|SS|2d8f8b1e-7914-400b-afc5-8dc23a626d76|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|TREATMENT|2020-07-04|25
e|SS|2d8f8b1e-7914-400b-afc5-8dc23a626d76|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|1|TREATMENT|2020-07-19|40
e|SS|2d8f8b1e-7914-400b-afc5-8dc23a626d76|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|5|WASHOUT|2020-07-19|40
e|SS|2d8f8b1e-7914-400b-afc5-8dc23a626d76|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|TREATMENT|2020-08-13|65
e|SS|2d8f8b1e-7914-400b-afc5-8dc23a626d76|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|SCREENING|2020-08-13|65
e|SS|2d8f8b1e-7914-400b-afc5-8dc23a626d76|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|4|FOLLOW-UP|2020-09-07|90
e|SS|2d8f8b1e-7914-400b-afc5-8dc23a626d76|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2020-09-07|90
e|SS|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|6|FOLLOW-UP|2020-08-20|10
e|SS|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|7|TREATMENT|2020-08-20|10
e|SS|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|WASHOUT|2020-09-04|25
e|SS|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|6|TREATMENT|2020-09-04|25
e|SS|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|3|TREATMENT|2020-09-19|40
e|SS|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|SCREENING|2020-09-19|40
e|SS|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|6|TREATMENT|2020-10-14|65
e|SS|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2020-10-14|65
e|SS|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|7|FOLLOW-UP|2020-11-08|90
e|SS|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|6|TREATMENT|2020-11-08|90
e|SS|a73142e4-e34b-4144-b95f-7a5562574c1b|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|2|FOLLOW-UP|2020-08-08|10
e|SS|a73142e4-e34b-4144-b95f-7a5562574c1b|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|TREATMENT|2020-08-08|10
e|SS|a73142e4-e34b-4144-b95f-7a5562574c1b|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|2|FOLLOW-UP|2020-08-23|25
e|SS|a73142e4-e34b-4144-b95f-7a5562574c1b|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|3|TREATMENT|2020-08-23|25
e|SS|a73142e4-e34b-4144-b95f-7a5562574c1b|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|7|TREATMENT|2020-09-07|40
e|SS|a73142e4-e34b-4144-b95f-7a5562574c1b|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|3|TREATMENT|2020-09-07|40
e|SS|a73142e4-e34b-4144-b95f-7a5562574c1b|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|5|TREATMENT|2020-10-02|65
e|SS|a73142e4-e34b-4144-b95f-7a5562574c1b|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|5|SCREENING|2020-10-02|65
e|SS|a73142e4-e34b-4144-b95f-7a5562574c1b|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|3|TREATMENT|2020-10-27|90
e|SS|a73142e4-e34b-4144-b95f-7a5562574c1b|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|7|SCREENING|2020-10-27|90
e|SS|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|7|TREATMENT|2020-06-03|10
e|SS|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|TREATMENT|2020-06-03|10
e|SS|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|3|TREATMENT|2020-06-18|25
e|SS|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|6|TREATMENT|2020-06-18|25
e|SS|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|WASHOUT|2020-07-03|40
e|SS|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|1|WASHOUT|2020-07-03|40
e|SS|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|3|FOLLOW-UP|2020-07-28|65
e|SS|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|4|SCREENING|2020-07-28|65
e|SS|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|1|SCREENING|2020-08-22|90
e|SS|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|2|TREATMENT|2020-08-22|90
e|SS|0f682806-b63c-4c3f-9fda-1e59befbd3a3|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|1|TREATMENT|2020-05-29|10
e|SS|0f682806-b63c-4c3f-9fda-1e59befbd3a3|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|5|FOLLOW-UP|2020-05-29|10
e|SS|0f682806-b63c-4c3f-9fda-1e59befbd3a3|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|1|SCREENING|2020-06-13|25
e|SS|0f682806-b63c-4c3f-9fda-1e59befbd3a3|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|3|TREATMENT|2020-06-13|25
e|SS|0f682806-b63c-4c3f-9fda-1e59befbd3a3|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|2|SCREENING|2020-06-28|40
e|SS|0f682806-b63c-4c3f-9fda-1e59befbd3a3|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|1|WASHOUT|2020-06-28|40
e|SS|0f682806-b63c-4c3f-9fda-1e59befbd3a3|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|7|TREATMENT|2020-07-23|65
e|SS|0f682806-b63c-4c3f-9fda-1e59befbd3a3|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|FOLLOW-UP|2020-07-23|65
e|SS|0f682806-b63c-4c3f-9fda-1e59befbd3a3|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|1|TREATMENT|2020-08-17|90
e|SS|0f682806-b63c-4c3f-9fda-1e59befbd3a3|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|3|TREATMENT|2020-08-17|90
e|SS|1d8aba56-f62e-4116-b447-899dedd3d4df|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|1|TREATMENT|2020-09-29|10
e|SS|1d8aba56-f62e-4116-b447-899dedd3d4df|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|7|WASHOUT|2020-09-29|10
e|SS|1d8aba56-f62e-4116-b447-899dedd3d4df|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|1|TREATMENT|2020-10-14|25
e|SS|1d8aba56-f62e-4116-b447-899dedd3d4df|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|3|WASHOUT|2020-10-14|25
e|SS|1d8aba56-f62e-4116-b447-899dedd3d4df|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|7|TREATMENT|2020-10-29|40
e|SS|1d8aba56-f62e-4116-b447-899dedd3d4df|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|FOLLOW-UP|2020-10-29|40
e|SS|1d8aba56-f62e-4116-b447-899dedd3d4df|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|1|TREATMENT|2020-11-23|65
e|SS|1d8aba56-f62e-4116-b447-899dedd3d4df|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|3|TREATMENT|2020-11-23|65
e|SS|1d8aba56-f62e-4116-b447-899dedd3d4df|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|2|SCREENING|2020-12-18|90
e|SS|1d8aba56-f62e-4116-b447-899dedd3d4df|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|5|WASHOUT|2020-12-18|90
e|SS|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|4|WASHOUT|2020-08-14|10
e|SS|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|7|TREATMENT|2020-08-14|10
e|SS|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|6|TREATMENT|2020-08-29|25
e|SS|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|4|TREATMENT|2020-08-29|25
e|SS|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|3|SCREENING|2020-09-13|40
e|SS|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-09-13|40
e|SS|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|3|SCREENING|2020-10-08|65
e|SS|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|5|FOLLOW-UP|2020-10-08|65
e|SS|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|4|TREATMENT|2020-11-02|90
e|SS|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|1|FOLLOW-UP|2020-11-02|90
e|SS|383d3f30-14b7-48c3-b1a8-0f481ef37a50|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|FOLLOW-UP|2020-06-07|10
e|SS|383d3f30-14b7-48c3-b1a8-0f481ef37a50|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|TREATMENT|2020-06-07|10
e|SS|383d3f30-14b7-48c3-b1a8-0f481ef37a50|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|4|WASHOUT|2020-06-22|25
e|SS|383d3f30-14b7-48c3-b1a8-0f481ef37a50|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|1|FOLLOW-UP|2020-06-22|25
e|SS|383d3f30-14b7-48c3-b1a8-0f481ef37a50|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|6|WASHOUT|2020-07-07|40
e|SS|383d3f30-14b7-48c3-b1a8-0f481ef37a50|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|6|SCREENING|2020-07-07|40
e|SS|383d3f30-14b7-48c3-b1a8-0f481ef37a50|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|7|TREATMENT|2020-08-01|65
e|SS|383d3f30-14b7-48c3-b1a8-0f481ef37a50|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|WASHOUT|2020-08-01|65
e|SS|383d3f30-14b7-48c3-b1a8-0f481ef37a50|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|1|WASHOUT|2020-08-26|90
e|SS|383d3f30-14b7-48c3-b1a8-0f481ef37a50|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|WASHOUT|2020-08-26|90
e|SS|b4f81b74-fee9-4544-9404-206d931ed8e5|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|7|TREATMENT|2020-10-18|10
e|SS|b4f81b74-fee9-4544-9404-206d931ed8e5|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|5|TREATMENT|2020-10-18|10
e|SS|b4f81b74-fee9-4544-9404-206d931ed8e5|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|WASHOUT|2020-11-02|25
e|SS|b4f81b74-fee9-4544-9404-206d931ed8e5|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|1|TREATMENT|2020-11-02|25
e|SS|b4f81b74-fee9-4544-9404-206d931ed8e5|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|6|TREATMENT|2020-11-17|40
e|SS|b4f81b74-fee9-4544-9404-206d931ed8e5|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|5|FOLLOW-UP|2020-11-17|40
e|SS|b4f81b74-fee9-4544-9404-206d931ed8e5|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|TREATMENT|2020-12-12|65
e|SS|b4f81b74-fee9-4544-9404-206d931ed8e5|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|5|TREATMENT|2020-12-12|65
e|SS|b4f81b74-fee9-4544-9404-206d931ed8e5|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|3|TREATMENT|2021-01-06|90
e|SS|b4f81b74-fee9-4544-9404-206d931ed8e5|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|7|TREATMENT|2021-01-06|90
e|SS|9e69b457-20db-45e5-a535-0cd8ac102fea|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|5|FOLLOW-UP|2020-06-07|10
e|SS|9e69b457-20db-45e5-a535-0cd8ac102fea|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|1|FOLLOW-UP|2020-06-07|10
e|SS|9e69b457-20db-45e5-a535-0cd8ac102fea|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|7|WASHOUT|2020-06-22|25
e|SS|9e69b457-20db-45e5-a535-0cd8ac102fea|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|6|TREATMENT|2020-06-22|25
e|SS|9e69b457-20db-45e5-a535-0cd8ac102fea|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|SCREENING|2020-07-07|40
e|SS|9e69b457-20db-45e5-a535-0cd8ac102fea|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|1|SCREENING|2020-07-07|40
e|SS|9e69b457-20db-45e5-a535-0cd8ac102fea|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|4|FOLLOW-UP|2020-08-01|65
e|SS|9e69b457-20db-45e5-a535-0cd8ac102fea|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|2|WASHOUT|2020-08-01|65
e|SS|9e69b457-20db-45e5-a535-0cd8ac102fea|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|4|TREATMENT|2020-08-26|90
e|SS|9e69b457-20db-45e5-a535-0cd8ac102fea|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|7|TREATMENT|2020-08-26|90
e|SS|14211798-ddf6-47c8-bd9d-056d95bad8ff|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|4|TREATMENT|2020-09-26|10
e|SS|14211798-ddf6-47c8-bd9d-056d95bad8ff|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|7|TREATMENT|2020-09-26|10
e|SS|14211798-ddf6-47c8-bd9d-056d95bad8ff|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|7|FOLLOW-UP|2020-10-11|25
e|SS|14211798-ddf6-47c8-bd9d-056d95bad8ff|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|7|FOLLOW-UP|2020-10-11|25
e|SS|14211798-ddf6-47c8-bd9d-056d95bad8ff|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|7|TREATMENT|2020-10-26|40
e|SS|14211798-ddf6-47c8-bd9d-056d95bad8ff|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-10-26|40
e|SS|14211798-ddf6-47c8-bd9d-056d95bad8ff|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|3|FOLLOW-UP|2020-11-20|65
e|SS|14211798-ddf6-47c8-bd9d-056d95bad8ff|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|3|SCREENING|2020-11-20|65
e|SS|14211798-ddf6-47c8-bd9d-056d95bad8ff|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|5|FOLLOW-UP|2020-12-15|90
e|SS|14211798-ddf6-47c8-bd9d-056d95bad8ff|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|7|TREATMENT|2020-12-15|90
e|SS|63f3194e-9b88-491a-9a68-19109ed86e2b|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|6|FOLLOW-UP|2020-06-10|10
e|SS|63f3194e-9b88-491a-9a68-19109ed86e2b|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|5|WASHOUT|2020-06-10|10
e|SS|63f3194e-9b88-491a-9a68-19109ed86e2b|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|5|TREATMENT|2020-06-25|25
e|SS|63f3194e-9b88-491a-9a68-19109ed86e2b|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|6|TREATMENT|2020-06-25|25
e|SS|63f3194e-9b88-491a-9a68-19109ed86e2b|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|6|TREATMENT|2020-07-10|40
e|SS|63f3194e-9b88-491a-9a68-19109ed86e2b|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|6|WASHOUT|2020-07-10|40
e|SS|63f3194e-9b88-491a-9a68-19109ed86e2b|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|4|SCREENING|2020-08-04|65
e|SS|63f3194e-9b88-491a-9a68-19109ed86e2b|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|2|FOLLOW-UP|2020-08-04|65
e|SS|63f3194e-9b88-491a-9a68-19109ed86e2b|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|1|TREATMENT|2020-08-29|90
e|SS|63f3194e-9b88-491a-9a68-19109ed86e2b|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|4|TREATMENT|2020-08-29|90
e|SS|b6208258-d7c2-4dde-addf-4677946ab165|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|5|TREATMENT|2020-09-20|10
e|SS|b6208258-d7c2-4dde-addf-4677946ab165|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|2|WASHOUT|2020-09-20|10
e|SS|b6208258-d7c2-4dde-addf-4677946ab165|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|3|WASHOUT|2020-10-05|25
e|SS|b6208258-d7c2-4dde-addf-4677946ab165|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|1|TREATMENT|2020-10-05|25
e|SS|b6208258-d7c2-4dde-addf-4677946ab165|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|5|TREATMENT|2020-10-20|40
e|SS|b6208258-d7c2-4dde-addf-4677946ab165|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|6|TREATMENT|2020-10-20|40
e|SS|b6208258-d7c2-4dde-addf-4677946ab165|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|5|FOLLOW-UP|2020-11-14|65
e|SS|b6208258-d7c2-4dde-addf-4677946ab165|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|TREATMENT|2020-11-14|65
e|SS|b6208258-d7c2-4dde-addf-4677946ab165|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|6|TREATMENT|2020-12-09|90
e|SS|b6208258-d7c2-4dde-addf-4677946ab165|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2020-12-09|90
e|SS|a669a7b9-2034-4bca-aa80-0371c5fb46d3|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|7|TREATMENT|2021-01-26|10
e|SS|a669a7b9-2034-4bca-aa80-0371c5fb46d3|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|7|WASHOUT|2021-01-26|10
e|SS|a669a7b9-2034-4bca-aa80-0371c5fb46d3|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|2|WASHOUT|2021-02-10|25
e|SS|a669a7b9-2034-4bca-aa80-0371c5fb46d3|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|6|SCREENING|2021-02-10|25
e|SS|a669a7b9-2034-4bca-aa80-0371c5fb46d3|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|2|TREATMENT|2021-02-25|40
e|SS|a669a7b9-2034-4bca-aa80-0371c5fb46d3|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|4|SCREENING|2021-02-25|40
e|SS|a669a7b9-2034-4bca-aa80-0371c5fb46d3|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|1|TREATMENT|2021-03-22|65
e|SS|a669a7b9-2034-4bca-aa80-0371c5fb46d3|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|6|TREATMENT|2021-03-22|65
e|SS|a669a7b9-2034-4bca-aa80-0371c5fb46d3|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|TREATMENT|2021-04-16|90
e|SS|a669a7b9-2034-4bca-aa80-0371c5fb46d3|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|1|FOLLOW-UP|2021-04-16|90
e|SS|e148c13d-ee41-4503-a7e5-397dd6155f04|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|1|TREATMENT|2020-07-18|10
e|SS|e148c13d-ee41-4503-a7e5-397dd6155f04|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|SCREENING|2020-07-18|10
e|SS|e148c13d-ee41-4503-a7e5-397dd6155f04|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|2|WASHOUT|2020-08-02|25
e|SS|e148c13d-ee41-4503-a7e5-397dd6155f04|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|3|TREATMENT|2020-08-02|25
e|SS|e148c13d-ee41-4503-a7e5-397dd6155f04|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|5|TREATMENT|2020-08-17|40
e|SS|e148c13d-ee41-4503-a7e5-397dd6155f04|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|7|FOLLOW-UP|2020-08-17|40
e|SS|e148c13d-ee41-4503-a7e5-397dd6155f04|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|2|WASHOUT|2020-09-11|65
e|SS|e148c13d-ee41-4503-a7e5-397dd6155f04|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|4|TREATMENT|2020-09-11|65
e|SS|e148c13d-ee41-4503-a7e5-397dd6155f04|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|FOLLOW-UP|2020-10-06|90
e|SS|e148c13d-ee41-4503-a7e5-397dd6155f04|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|3|FOLLOW-UP|2020-10-06|90
e|SS|815de94a-f259-41ee-8951-8df150184a25|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|6|WASHOUT|2020-07-07|10
e|SS|815de94a-f259-41ee-8951-8df150184a25|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|TREATMENT|2020-07-07|10
e|SS|815de94a-f259-41ee-8951-8df150184a25|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|4|TREATMENT|2020-07-22|25
e|SS|815de94a-f259-41ee-8951-8df150184a25|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|1|WASHOUT|2020-07-22|25
e|SS|815de94a-f259-41ee-8951-8df150184a25|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|2|TREATMENT|2020-08-06|40
e|SS|815de94a-f259-41ee-8951-8df150184a25|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|1|TREATMENT|2020-08-06|40
e|SS|815de94a-f259-41ee-8951-8df150184a25|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|1|SCREENING|2020-08-31|65
e|SS|815de94a-f259-41ee-8951-8df150184a25|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|7|TREATMENT|2020-08-31|65
e|SS|815de94a-f259-41ee-8951-8df150184a25|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|3|TREATMENT|2020-09-25|90
e|SS|815de94a-f259-41ee-8951-8df150184a25|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|2|TREATMENT|2020-09-25|90
e|SS|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|5|TREATMENT|2020-05-16|10
e|SS|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|3|SCREENING|2020-05-16|10
e|SS|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|7|TREATMENT|2020-05-31|25
e|SS|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|7|TREATMENT|2020-05-31|25
e|SS|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|7|FOLLOW-UP|2020-06-15|40
e|SS|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|6|TREATMENT|2020-06-15|40
e|SS|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|6|FOLLOW-UP|2020-07-10|65
e|SS|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|7|WASHOUT|2020-07-10|65
e|SS|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|4|TREATMENT|2020-08-04|90
e|SS|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2020-08-04|90
e|SS|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|2|WASHOUT|2021-01-25|10
e|SS|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|3|SCREENING|2021-01-25|10
e|SS|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|1|TREATMENT|2021-02-09|25
e|SS|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|7|FOLLOW-UP|2021-02-09|25
e|SS|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|3|TREATMENT|2021-02-24|40
e|SS|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|4|TREATMENT|2021-02-24|40
e|SS|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|3|WASHOUT|2021-03-21|65
e|SS|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|6|TREATMENT|2021-03-21|65
e|SS|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|7|TREATMENT|2021-04-15|90
e|SS|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|2|TREATMENT|2021-04-15|90
e|SS|a616ef00-05d6-459a-8474-06ab3eb493b1|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|1|FOLLOW-UP|2020-09-25|10
e|SS|a616ef00-05d6-459a-8474-06ab3eb493b1|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|3|SCREENING|2020-09-25|10
e|SS|a616ef00-05d6-459a-8474-06ab3eb493b1|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|1|TREATMENT|2020-10-10|25
e|SS|a616ef00-05d6-459a-8474-06ab3eb493b1|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|TREATMENT|2020-10-10|25
e|SS|a616ef00-05d6-459a-8474-06ab3eb493b1|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|4|WASHOUT|2020-10-25|40
e|SS|a616ef00-05d6-459a-8474-06ab3eb493b1|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|FOLLOW-UP|2020-10-25|40
e|SS|a616ef00-05d6-459a-8474-06ab3eb493b1|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|4|FOLLOW-UP|2020-11-19|65
e|SS|a616ef00-05d6-459a-8474-06ab3eb493b1|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|4|WASHOUT|2020-11-19|65
e|SS|a616ef00-05d6-459a-8474-06ab3eb493b1|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|6|TREATMENT|2020-12-14|90
e|SS|a616ef00-05d6-459a-8474-06ab3eb493b1|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|2|FOLLOW-UP|2020-12-14|90
e|SS|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|SCREENING|2020-08-20|10
e|SS|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|1|TREATMENT|2020-08-20|10
e|SS|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|7|TREATMENT|2020-09-04|25
e|SS|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2020-09-04|25
e|SS|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2020-09-19|40
e|SS|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|3|SCREENING|2020-09-19|40
e|SS|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|5|TREATMENT|2020-10-14|65
e|SS|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|3|TREATMENT|2020-10-14|65
e|SS|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|6|TREATMENT|2020-11-08|90
e|SS|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|6|SCREENING|2020-11-08|90
e|SS|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|TREATMENT|2020-10-21|10
e|SS|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|4|TREATMENT|2020-10-21|10
e|SS|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|FOLLOW-UP|2020-11-05|25
e|SS|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|WASHOUT|2020-11-05|25
e|SS|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|5|TREATMENT|2020-11-20|40
e|SS|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|7|TREATMENT|2020-11-20|40
e|SS|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|7|FOLLOW-UP|2020-12-15|65
e|SS|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|4|TREATMENT|2020-12-15|65
e|SS|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|SCREENING|2021-01-09|90
e|SS|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|WASHOUT|2021-01-09|90
e|SS|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|5|FOLLOW-UP|2020-07-04|10
e|SS|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|7|TREATMENT|2020-07-04|10
e|SS|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2020-07-19|25
e|SS|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|6|TREATMENT|2020-07-19|25
e|SS|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|2|WASHOUT|2020-08-03|40
e|SS|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|5|TREATMENT|2020-08-03|40
e|SS|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|1|TREATMENT|2020-08-28|65
e|SS|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|2|TREATMENT|2020-08-28|65
e|SS|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|6|WASHOUT|2020-09-22|90
e|SS|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|6|TREATMENT|2020-09-22|90
e|SS|2014bcd0-1430-4096-87f5-650a01dae626|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|4|FOLLOW-UP|2020-05-31|10
e|SS|2014bcd0-1430-4096-87f5-650a01dae626|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|6|WASHOUT|2020-05-31|10
e|SS|2014bcd0-1430-4096-87f5-650a01dae626|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|1|WASHOUT|2020-06-15|25
e|SS|2014bcd0-1430-4096-87f5-650a01dae626|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|5|FOLLOW-UP|2020-06-15|25
e|SS|2014bcd0-1430-4096-87f5-650a01dae626|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|6|TREATMENT|2020-06-30|40
e|SS|2014bcd0-1430-4096-87f5-650a01dae626|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|TREATMENT|2020-06-30|40
e|SS|2014bcd0-1430-4096-87f5-650a01dae626|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|1|TREATMENT|2020-07-25|65
e|SS|2014bcd0-1430-4096-87f5-650a01dae626|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|4|SCREENING|2020-07-25|65
e|SS|2014bcd0-1430-4096-87f5-650a01dae626|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|4|SCREENING|2020-08-19|90
e|SS|2014bcd0-1430-4096-87f5-650a01dae626|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|SCREENING|2020-08-19|90
e|SS|e043f1b3-6b65-45c0-bdae-eb783406c263|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|6|WASHOUT|2020-11-11|10
e|SS|e043f1b3-6b65-45c0-bdae-eb783406c263|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|6|WASHOUT|2020-11-11|10
e|SS|e043f1b3-6b65-45c0-bdae-eb783406c263|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|6|TREATMENT|2020-11-26|25
e|SS|e043f1b3-6b65-45c0-bdae-eb783406c263|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|7|TREATMENT|2020-11-26|25
e|SS|e043f1b3-6b65-45c0-bdae-eb783406c263|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|1|TREATMENT|2020-12-11|40
e|SS|e043f1b3-6b65-45c0-bdae-eb783406c263|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|6|SCREENING|2020-12-11|40
e|SS|e043f1b3-6b65-45c0-bdae-eb783406c263|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|5|WASHOUT|2021-01-05|65
e|SS|e043f1b3-6b65-45c0-bdae-eb783406c263|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|7|TREATMENT|2021-01-05|65
e|SS|e043f1b3-6b65-45c0-bdae-eb783406c263|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|7|FOLLOW-UP|2021-01-30|90
e|SS|e043f1b3-6b65-45c0-bdae-eb783406c263|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2021-01-30|90
e|SS|45623c39-86de-4b2f-bf2d-998d0e941e92|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL STUDY SPONSOR|1|Visit_1|10|1|SCREENING|2020-10-20|100
e|SS|45623c39-86de-4b2f-bf2d-998d0e941e92|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|VENDOR|1|Visit_1|10|5|TREATMENT|2020-10-20|100
e|SS|45623c39-86de-4b2f-bf2d-998d0e941e92|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|SPOUSE|2|Visit_2|25|4|WASHOUT|2020-10-20|100
e|SS|45623c39-86de-4b2f-bf2d-998d0e941e92|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|DOMESTIC PARTNER|2|Visit_2|25|1|TREATMENT|2020-10-20|100
e|SS|45623c39-86de-4b2f-bf2d-998d0e941e92|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|SPOUSE|3|Visit_3|40|1|TREATMENT|2020-10-20|100
e|SS|45623c39-86de-4b2f-bf2d-998d0e941e92|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATION COMMITTEE|3|Visit_3|40|1|TREATMENT|2020-10-20|100
e|SS|45623c39-86de-4b2f-bf2d-998d0e941e92|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|STUDY SUBJECT|4|Visit_4|65|3|TREATMENT|2020-10-20|100
e|SS|45623c39-86de-4b2f-bf2d-998d0e941e92|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|STUDY SUBJECT|4|Visit_4|65|6|SCREENING|2020-10-20|100
e|SS|45623c39-86de-4b2f-bf2d-998d0e941e92|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|DOMESTIC PARTNER|5|Visit_5|90|2|TREATMENT|2020-10-20|100
e|SS|45623c39-86de-4b2f-bf2d-998d0e941e92|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|INTERVIEWER|5|Visit_5|90|5|TREATMENT|2020-10-20|100
e|SS|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|3|FOLLOW-UP|2020-10-18|10
e|SS|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|1|TREATMENT|2020-10-18|10
e|SS|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|FOLLOW-UP|2020-11-02|25
e|SS|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|3|TREATMENT|2020-11-02|25
e|SS|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|4|TREATMENT|2020-11-17|40
e|SS|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|2|SCREENING|2020-11-17|40
e|SS|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|5|WASHOUT|2020-12-12|65
e|SS|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|2|WASHOUT|2020-12-12|65
e|SS|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|7|TREATMENT|2021-01-06|90
e|SS|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|SCREENING|2021-01-06|90
e|SS|e5a105f7-38ac-4f19-aace-4149ed9b1100|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|6|WASHOUT|2020-09-03|10
e|SS|e5a105f7-38ac-4f19-aace-4149ed9b1100|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|4|SCREENING|2020-09-03|10
e|SS|e5a105f7-38ac-4f19-aace-4149ed9b1100|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|7|TREATMENT|2020-09-18|25
e|SS|e5a105f7-38ac-4f19-aace-4149ed9b1100|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|1|FOLLOW-UP|2020-09-18|25
e|SS|e5a105f7-38ac-4f19-aace-4149ed9b1100|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|1|TREATMENT|2020-10-03|40
e|SS|e5a105f7-38ac-4f19-aace-4149ed9b1100|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|4|WASHOUT|2020-10-03|40
e|SS|e5a105f7-38ac-4f19-aace-4149ed9b1100|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|1|TREATMENT|2020-10-28|65
e|SS|e5a105f7-38ac-4f19-aace-4149ed9b1100|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|1|TREATMENT|2020-10-28|65
e|SS|e5a105f7-38ac-4f19-aace-4149ed9b1100|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|WASHOUT|2020-11-22|90
e|SS|e5a105f7-38ac-4f19-aace-4149ed9b1100|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|4|WASHOUT|2020-11-22|90
e|SS|c568ab93-8e7f-4e4e-9685-f0c13f293606|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|3|SCREENING|2021-01-14|10
e|SS|c568ab93-8e7f-4e4e-9685-f0c13f293606|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|SCREENING|2021-01-14|10
e|SS|c568ab93-8e7f-4e4e-9685-f0c13f293606|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|TREATMENT|2021-01-29|25
e|SS|c568ab93-8e7f-4e4e-9685-f0c13f293606|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|7|SCREENING|2021-01-29|25
e|SS|c568ab93-8e7f-4e4e-9685-f0c13f293606|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|5|SCREENING|2021-02-13|40
e|SS|c568ab93-8e7f-4e4e-9685-f0c13f293606|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|2|FOLLOW-UP|2021-02-13|40
e|SS|c568ab93-8e7f-4e4e-9685-f0c13f293606|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|1|TREATMENT|2021-03-10|65
e|SS|c568ab93-8e7f-4e4e-9685-f0c13f293606|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|1|FOLLOW-UP|2021-03-10|65
e|SS|c568ab93-8e7f-4e4e-9685-f0c13f293606|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|WASHOUT|2021-04-04|90
e|SS|c568ab93-8e7f-4e4e-9685-f0c13f293606|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|3|SCREENING|2021-04-04|90
e|SS|bccd8af0-2ecf-4091-92e4-681597b57ca4|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|1|TREATMENT|2020-09-30|10
e|SS|bccd8af0-2ecf-4091-92e4-681597b57ca4|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|4|FOLLOW-UP|2020-09-30|10
e|SS|bccd8af0-2ecf-4091-92e4-681597b57ca4|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|7|WASHOUT|2020-10-15|25
e|SS|bccd8af0-2ecf-4091-92e4-681597b57ca4|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|6|FOLLOW-UP|2020-10-15|25
e|SS|bccd8af0-2ecf-4091-92e4-681597b57ca4|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|1|TREATMENT|2020-10-30|40
e|SS|bccd8af0-2ecf-4091-92e4-681597b57ca4|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|1|FOLLOW-UP|2020-10-30|40
e|SS|bccd8af0-2ecf-4091-92e4-681597b57ca4|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|1|TREATMENT|2020-11-24|65
e|SS|bccd8af0-2ecf-4091-92e4-681597b57ca4|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|6|TREATMENT|2020-11-24|65
e|SS|bccd8af0-2ecf-4091-92e4-681597b57ca4|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|5|SCREENING|2020-12-19|90
e|SS|bccd8af0-2ecf-4091-92e4-681597b57ca4|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|1|WASHOUT|2020-12-19|90
e|SS|bf069a02-03a6-4013-b16d-d7c954a6cc3d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|3|FOLLOW-UP|2020-08-06|10
e|SS|bf069a02-03a6-4013-b16d-d7c954a6cc3d|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|1|TREATMENT|2020-08-06|10
e|SS|bf069a02-03a6-4013-b16d-d7c954a6cc3d|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|2|TREATMENT|2020-08-21|25
e|SS|bf069a02-03a6-4013-b16d-d7c954a6cc3d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|3|TREATMENT|2020-08-21|25
e|SS|bf069a02-03a6-4013-b16d-d7c954a6cc3d|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|WASHOUT|2020-09-05|40
e|SS|bf069a02-03a6-4013-b16d-d7c954a6cc3d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|2|FOLLOW-UP|2020-09-05|40
e|SS|bf069a02-03a6-4013-b16d-d7c954a6cc3d|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|1|TREATMENT|2020-09-30|65
e|SS|bf069a02-03a6-4013-b16d-d7c954a6cc3d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|4|TREATMENT|2020-09-30|65
e|SS|bf069a02-03a6-4013-b16d-d7c954a6cc3d|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|3|TREATMENT|2020-10-25|90
e|SS|bf069a02-03a6-4013-b16d-d7c954a6cc3d|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|SCREENING|2020-10-25|90
e|SS|c40fc52b-2668-4fab-b051-5b258da72f2c|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|4|FOLLOW-UP|2020-10-11|10
e|SS|c40fc52b-2668-4fab-b051-5b258da72f2c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|1|TREATMENT|2020-10-11|10
e|SS|c40fc52b-2668-4fab-b051-5b258da72f2c|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|3|SCREENING|2020-10-26|25
e|SS|c40fc52b-2668-4fab-b051-5b258da72f2c|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|3|SCREENING|2020-10-26|25
e|SS|c40fc52b-2668-4fab-b051-5b258da72f2c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|TREATMENT|2020-11-10|40
e|SS|c40fc52b-2668-4fab-b051-5b258da72f2c|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|3|TREATMENT|2020-11-10|40
e|SS|c40fc52b-2668-4fab-b051-5b258da72f2c|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2020-12-05|65
e|SS|c40fc52b-2668-4fab-b051-5b258da72f2c|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|7|TREATMENT|2020-12-05|65
e|SS|c40fc52b-2668-4fab-b051-5b258da72f2c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|4|TREATMENT|2020-12-30|90
e|SS|c40fc52b-2668-4fab-b051-5b258da72f2c|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|2|TREATMENT|2020-12-30|90
e|SS|d7c792d8-fc98-41ab-8a9e-59de1e186a06|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|7|SCREENING|2020-07-28|10
e|SS|d7c792d8-fc98-41ab-8a9e-59de1e186a06|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|3|WASHOUT|2020-07-28|10
e|SS|d7c792d8-fc98-41ab-8a9e-59de1e186a06|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-08-12|25
e|SS|d7c792d8-fc98-41ab-8a9e-59de1e186a06|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|1|WASHOUT|2020-08-12|25
e|SS|d7c792d8-fc98-41ab-8a9e-59de1e186a06|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|6|TREATMENT|2020-08-27|40
e|SS|d7c792d8-fc98-41ab-8a9e-59de1e186a06|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|3|FOLLOW-UP|2020-08-27|40
e|SS|d7c792d8-fc98-41ab-8a9e-59de1e186a06|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|6|WASHOUT|2020-09-21|65
e|SS|d7c792d8-fc98-41ab-8a9e-59de1e186a06|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|7|TREATMENT|2020-09-21|65
e|SS|d7c792d8-fc98-41ab-8a9e-59de1e186a06|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|6|TREATMENT|2020-10-16|90
e|SS|d7c792d8-fc98-41ab-8a9e-59de1e186a06|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|7|WASHOUT|2020-10-16|90
e|SS|f7773659-f207-4b29-8389-3aa766a6337a|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|5|FOLLOW-UP|2020-10-19|10
e|SS|f7773659-f207-4b29-8389-3aa766a6337a|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|4|TREATMENT|2020-10-19|10
e|SS|f7773659-f207-4b29-8389-3aa766a6337a|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|6|SCREENING|2020-11-03|25
e|SS|f7773659-f207-4b29-8389-3aa766a6337a|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|1|WASHOUT|2020-11-03|25
e|SS|f7773659-f207-4b29-8389-3aa766a6337a|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|3|TREATMENT|2020-11-18|40
e|SS|f7773659-f207-4b29-8389-3aa766a6337a|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|1|FOLLOW-UP|2020-11-18|40
e|SS|f7773659-f207-4b29-8389-3aa766a6337a|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|5|TREATMENT|2020-12-13|65
e|SS|f7773659-f207-4b29-8389-3aa766a6337a|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|1|TREATMENT|2020-12-13|65
e|SS|f7773659-f207-4b29-8389-3aa766a6337a|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|2|SCREENING|2021-01-07|90
e|SS|f7773659-f207-4b29-8389-3aa766a6337a|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|1|SCREENING|2021-01-07|90
e|SS|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|3|SCREENING|2021-01-07|10
e|SS|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|3|WASHOUT|2021-01-07|10
e|SS|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|5|WASHOUT|2021-01-22|25
e|SS|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|6|WASHOUT|2021-01-22|25
e|SS|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|3|FOLLOW-UP|2021-02-06|40
e|SS|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2021-02-06|40
e|SS|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|3|TREATMENT|2021-03-03|65
e|SS|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2021-03-03|65
e|SS|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|5|TREATMENT|2021-03-28|90
e|SS|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|7|SCREENING|2021-03-28|90
e|SS|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|7|TREATMENT|2021-01-26|10
e|SS|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|1|SCREENING|2021-01-26|10
e|SS|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|6|TREATMENT|2021-02-10|25
e|SS|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|3|TREATMENT|2021-02-10|25
e|SS|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|7|TREATMENT|2021-02-25|40
e|SS|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|5|SCREENING|2021-02-25|40
e|SS|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2021-03-22|65
e|SS|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|3|TREATMENT|2021-03-22|65
e|SS|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|WASHOUT|2021-04-16|90
e|SS|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|4|TREATMENT|2021-04-16|90
e|SS|700049a2-ef66-466b-b1d8-f0800bcfde43|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|2|TREATMENT|2020-06-27|10
e|SS|700049a2-ef66-466b-b1d8-f0800bcfde43|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|4|TREATMENT|2020-06-27|10
e|SS|700049a2-ef66-466b-b1d8-f0800bcfde43|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|6|WASHOUT|2020-07-12|25
e|SS|700049a2-ef66-466b-b1d8-f0800bcfde43|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|2|TREATMENT|2020-07-12|25
e|SS|700049a2-ef66-466b-b1d8-f0800bcfde43|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|1|FOLLOW-UP|2020-07-27|40
e|SS|700049a2-ef66-466b-b1d8-f0800bcfde43|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|7|FOLLOW-UP|2020-07-27|40
e|SS|700049a2-ef66-466b-b1d8-f0800bcfde43|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|7|TREATMENT|2020-08-21|65
e|SS|700049a2-ef66-466b-b1d8-f0800bcfde43|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|5|TREATMENT|2020-08-21|65
e|SS|700049a2-ef66-466b-b1d8-f0800bcfde43|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|7|TREATMENT|2020-09-15|90
e|SS|700049a2-ef66-466b-b1d8-f0800bcfde43|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|1|WASHOUT|2020-09-15|90
e|SS|00d906a6-2d14-4199-aff9-524388c5117f|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|1|TREATMENT|2020-11-24|10
e|SS|00d906a6-2d14-4199-aff9-524388c5117f|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|5|TREATMENT|2020-11-24|10
e|SS|00d906a6-2d14-4199-aff9-524388c5117f|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|2|SCREENING|2020-12-09|25
e|SS|00d906a6-2d14-4199-aff9-524388c5117f|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|7|TREATMENT|2020-12-09|25
e|SS|00d906a6-2d14-4199-aff9-524388c5117f|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|4|TREATMENT|2020-12-24|40
e|SS|00d906a6-2d14-4199-aff9-524388c5117f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|3|TREATMENT|2020-12-24|40
e|SS|00d906a6-2d14-4199-aff9-524388c5117f|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|5|WASHOUT|2021-01-18|65
e|SS|00d906a6-2d14-4199-aff9-524388c5117f|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|3|TREATMENT|2021-01-18|65
e|SS|00d906a6-2d14-4199-aff9-524388c5117f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|7|SCREENING|2021-02-12|90
e|SS|00d906a6-2d14-4199-aff9-524388c5117f|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2021-02-12|90
e|SS|2fcc5910-bce0-4510-b17e-3925850d6d32|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|4|FOLLOW-UP|2020-12-16|10
e|SS|2fcc5910-bce0-4510-b17e-3925850d6d32|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|7|SCREENING|2020-12-16|10
e|SS|2fcc5910-bce0-4510-b17e-3925850d6d32|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|5|SCREENING|2020-12-31|25
e|SS|2fcc5910-bce0-4510-b17e-3925850d6d32|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|4|SCREENING|2020-12-31|25
e|SS|2fcc5910-bce0-4510-b17e-3925850d6d32|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|5|TREATMENT|2021-01-15|40
e|SS|2fcc5910-bce0-4510-b17e-3925850d6d32|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|2|SCREENING|2021-01-15|40
e|SS|2fcc5910-bce0-4510-b17e-3925850d6d32|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|5|WASHOUT|2021-02-09|65
e|SS|2fcc5910-bce0-4510-b17e-3925850d6d32|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|3|WASHOUT|2021-02-09|65
e|SS|2fcc5910-bce0-4510-b17e-3925850d6d32|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|3|SCREENING|2021-03-06|90
e|SS|2fcc5910-bce0-4510-b17e-3925850d6d32|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|2|WASHOUT|2021-03-06|90
e|SS|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|6|TREATMENT|2020-08-31|10
e|SS|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|7|FOLLOW-UP|2020-08-31|10
e|SS|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|2|WASHOUT|2020-09-15|25
e|SS|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|3|FOLLOW-UP|2020-09-15|25
e|SS|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|4|TREATMENT|2020-09-30|40
e|SS|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|SCREENING|2020-09-30|40
e|SS|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|5|WASHOUT|2020-10-25|65
e|SS|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|3|TREATMENT|2020-10-25|65
e|SS|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|6|WASHOUT|2020-11-19|90
e|SS|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|TREATMENT|2020-11-19|90
e|SS|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|1|TREATMENT|2020-07-26|10
e|SS|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|7|SCREENING|2020-07-26|10
e|SS|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|7|TREATMENT|2020-08-10|25
e|SS|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|6|FOLLOW-UP|2020-08-10|25
e|SS|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|5|TREATMENT|2020-08-25|40
e|SS|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|6|FOLLOW-UP|2020-08-25|40
e|SS|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|5|SCREENING|2020-09-19|65
e|SS|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|3|SCREENING|2020-09-19|65
e|SS|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|SCREENING|2020-10-14|90
e|SS|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|6|TREATMENT|2020-10-14|90
e|SS|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|6|FOLLOW-UP|2020-10-28|10
e|SS|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|1|TREATMENT|2020-10-28|10
e|SS|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|1|TREATMENT|2020-11-12|25
e|SS|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|6|WASHOUT|2020-11-12|25
e|SS|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|1|WASHOUT|2020-11-27|40
e|SS|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|4|TREATMENT|2020-11-27|40
e|SS|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|4|TREATMENT|2020-12-22|65
e|SS|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|5|SCREENING|2020-12-22|65
e|SS|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|2|TREATMENT|2021-01-16|90
e|SS|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|5|TREATMENT|2021-01-16|90
e|SS|ff163542-abec-4260-b257-f15a11e580ee|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|6|TREATMENT|2020-08-16|10
e|SS|ff163542-abec-4260-b257-f15a11e580ee|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|2|WASHOUT|2020-08-16|10
e|SS|ff163542-abec-4260-b257-f15a11e580ee|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|2|TREATMENT|2020-08-31|25
e|SS|ff163542-abec-4260-b257-f15a11e580ee|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|5|WASHOUT|2020-08-31|25
e|SS|ff163542-abec-4260-b257-f15a11e580ee|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|7|FOLLOW-UP|2020-09-15|40
e|SS|ff163542-abec-4260-b257-f15a11e580ee|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|7|TREATMENT|2020-09-15|40
e|SS|ff163542-abec-4260-b257-f15a11e580ee|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|3|SCREENING|2020-10-10|65
e|SS|ff163542-abec-4260-b257-f15a11e580ee|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|4|SCREENING|2020-10-10|65
e|SS|ff163542-abec-4260-b257-f15a11e580ee|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|5|TREATMENT|2020-11-04|90
e|SS|ff163542-abec-4260-b257-f15a11e580ee|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|3|TREATMENT|2020-11-04|90
e|SS|bb73f732-a52f-4013-9ae6-60ff23b9c224|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|DOMESTIC PARTNER|1|Visit_1|10|3|TREATMENT|2020-11-03|100
e|SS|bb73f732-a52f-4013-9ae6-60ff23b9c224|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|VENDOR|1|Visit_1|10|3|FOLLOW-UP|2020-11-03|100
e|SS|bb73f732-a52f-4013-9ae6-60ff23b9c224|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|WASHOUT|2020-11-03|100
e|SS|bb73f732-a52f-4013-9ae6-60ff23b9c224|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-11-03|100
e|SS|bb73f732-a52f-4013-9ae6-60ff23b9c224|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|INVESTIGATOR|3|Visit_3|40|5|TREATMENT|2020-11-03|100
e|SS|bb73f732-a52f-4013-9ae6-60ff23b9c224|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|STUDY SUBJECT|3|Visit_3|40|1|FOLLOW-UP|2020-11-03|100
e|SS|bb73f732-a52f-4013-9ae6-60ff23b9c224|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIGNIFICANT OTHER|4|Visit_4|65|7|TREATMENT|2020-11-03|100
e|SS|bb73f732-a52f-4013-9ae6-60ff23b9c224|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|INTERVIEWER|4|Visit_4|65|1|TREATMENT|2020-11-03|100
e|SS|bb73f732-a52f-4013-9ae6-60ff23b9c224|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|WASHOUT|2020-11-03|100
e|SS|bb73f732-a52f-4013-9ae6-60ff23b9c224|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIGNIFICANT OTHER|5|Visit_5|90|5|TREATMENT|2020-11-03|100
e|SS|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|4|TREATMENT|2020-07-21|10
e|SS|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|4|TREATMENT|2020-07-21|10
e|SS|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|FOLLOW-UP|2020-08-05|25
e|SS|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|7|SCREENING|2020-08-05|25
e|SS|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|3|TREATMENT|2020-08-20|40
e|SS|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|3|TREATMENT|2020-08-20|40
e|SS|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|6|FOLLOW-UP|2020-09-14|65
e|SS|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|4|WASHOUT|2020-09-14|65
e|SS|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|4|SCREENING|2020-10-09|90
e|SS|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|3|FOLLOW-UP|2020-10-09|90
e|SS|8e056558-ffd2-4c43-bbfa-40914b38af34|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2021-01-29|10
e|SS|8e056558-ffd2-4c43-bbfa-40914b38af34|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|2|TREATMENT|2021-01-29|10
e|SS|8e056558-ffd2-4c43-bbfa-40914b38af34|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|3|TREATMENT|2021-02-13|25
e|SS|8e056558-ffd2-4c43-bbfa-40914b38af34|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|4|WASHOUT|2021-02-13|25
e|SS|8e056558-ffd2-4c43-bbfa-40914b38af34|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|3|TREATMENT|2021-02-28|40
e|SS|8e056558-ffd2-4c43-bbfa-40914b38af34|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|4|WASHOUT|2021-02-28|40
e|SS|8e056558-ffd2-4c43-bbfa-40914b38af34|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2021-03-25|65
e|SS|8e056558-ffd2-4c43-bbfa-40914b38af34|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|2|TREATMENT|2021-03-25|65
e|SS|8e056558-ffd2-4c43-bbfa-40914b38af34|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|3|FOLLOW-UP|2021-04-19|90
e|SS|8e056558-ffd2-4c43-bbfa-40914b38af34|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|5|TREATMENT|2021-04-19|90
e|SS|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|3|TREATMENT|2020-05-29|10
e|SS|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|3|WASHOUT|2020-05-29|10
e|SS|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|WASHOUT|2020-06-13|25
e|SS|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|5|WASHOUT|2020-06-13|25
e|SS|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2020-06-28|40
e|SS|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|1|FOLLOW-UP|2020-06-28|40
e|SS|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|7|SCREENING|2020-07-23|65
e|SS|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|2|TREATMENT|2020-07-23|65
e|SS|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|2|TREATMENT|2020-08-17|90
e|SS|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|2|TREATMENT|2020-08-17|90
e|SS|624c1353-347a-417d-9aab-7f1e7077ba7f|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|7|WASHOUT|2020-08-28|10
e|SS|624c1353-347a-417d-9aab-7f1e7077ba7f|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|6|TREATMENT|2020-08-28|10
e|SS|624c1353-347a-417d-9aab-7f1e7077ba7f|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|2|FOLLOW-UP|2020-09-12|25
e|SS|624c1353-347a-417d-9aab-7f1e7077ba7f|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2020-09-12|25
e|SS|624c1353-347a-417d-9aab-7f1e7077ba7f|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|1|TREATMENT|2020-09-27|40
e|SS|624c1353-347a-417d-9aab-7f1e7077ba7f|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|1|SCREENING|2020-09-27|40
e|SS|624c1353-347a-417d-9aab-7f1e7077ba7f|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|7|TREATMENT|2020-10-22|65
e|SS|624c1353-347a-417d-9aab-7f1e7077ba7f|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|6|TREATMENT|2020-10-22|65
e|SS|624c1353-347a-417d-9aab-7f1e7077ba7f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|1|TREATMENT|2020-11-16|90
e|SS|624c1353-347a-417d-9aab-7f1e7077ba7f|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|1|TREATMENT|2020-11-16|90
e|SS|ef1cddb8-f4ce-45c4-8671-32fe95f00993|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|1|FOLLOW-UP|2020-08-02|10
e|SS|ef1cddb8-f4ce-45c4-8671-32fe95f00993|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|6|WASHOUT|2020-08-02|10
e|SS|ef1cddb8-f4ce-45c4-8671-32fe95f00993|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|2|TREATMENT|2020-08-17|25
e|SS|ef1cddb8-f4ce-45c4-8671-32fe95f00993|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|6|WASHOUT|2020-08-17|25
e|SS|ef1cddb8-f4ce-45c4-8671-32fe95f00993|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|1|SCREENING|2020-09-01|40
e|SS|ef1cddb8-f4ce-45c4-8671-32fe95f00993|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|4|TREATMENT|2020-09-01|40
e|SS|ef1cddb8-f4ce-45c4-8671-32fe95f00993|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|5|FOLLOW-UP|2020-09-26|65
e|SS|ef1cddb8-f4ce-45c4-8671-32fe95f00993|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|4|TREATMENT|2020-09-26|65
e|SS|ef1cddb8-f4ce-45c4-8671-32fe95f00993|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|TREATMENT|2020-10-21|90
e|SS|ef1cddb8-f4ce-45c4-8671-32fe95f00993|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|4|SCREENING|2020-10-21|90
e|SS|da6294b5-de91-4bf7-b160-55d22fefcb07|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-06-28|10
e|SS|da6294b5-de91-4bf7-b160-55d22fefcb07|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|6|SCREENING|2020-06-28|10
e|SS|da6294b5-de91-4bf7-b160-55d22fefcb07|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|5|TREATMENT|2020-07-13|25
e|SS|da6294b5-de91-4bf7-b160-55d22fefcb07|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|5|TREATMENT|2020-07-13|25
e|SS|da6294b5-de91-4bf7-b160-55d22fefcb07|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|3|TREATMENT|2020-07-28|40
e|SS|da6294b5-de91-4bf7-b160-55d22fefcb07|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|SCREENING|2020-07-28|40
e|SS|da6294b5-de91-4bf7-b160-55d22fefcb07|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|4|WASHOUT|2020-08-22|65
e|SS|da6294b5-de91-4bf7-b160-55d22fefcb07|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|5|FOLLOW-UP|2020-08-22|65
e|SS|da6294b5-de91-4bf7-b160-55d22fefcb07|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|4|TREATMENT|2020-09-16|90
e|SS|da6294b5-de91-4bf7-b160-55d22fefcb07|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|SCREENING|2020-09-16|90
e|SS|c01c16d4-7a37-421d-9191-1874eba6a1e3|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|4|SCREENING|2020-10-09|10
e|SS|c01c16d4-7a37-421d-9191-1874eba6a1e3|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|4|FOLLOW-UP|2020-10-09|10
e|SS|c01c16d4-7a37-421d-9191-1874eba6a1e3|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|4|TREATMENT|2020-10-24|25
e|SS|c01c16d4-7a37-421d-9191-1874eba6a1e3|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|7|TREATMENT|2020-10-24|25
e|SS|c01c16d4-7a37-421d-9191-1874eba6a1e3|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|1|TREATMENT|2020-11-08|40
e|SS|c01c16d4-7a37-421d-9191-1874eba6a1e3|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|WASHOUT|2020-11-08|40
e|SS|c01c16d4-7a37-421d-9191-1874eba6a1e3|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|SCREENING|2020-12-03|65
e|SS|c01c16d4-7a37-421d-9191-1874eba6a1e3|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|7|TREATMENT|2020-12-03|65
e|SS|c01c16d4-7a37-421d-9191-1874eba6a1e3|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|3|FOLLOW-UP|2020-12-28|90
e|SS|c01c16d4-7a37-421d-9191-1874eba6a1e3|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|SCREENING|2020-12-28|90
e|SS|6036407d-5ac8-400d-91f7-afd63f3cab88|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|6|SCREENING|2020-06-22|10
e|SS|6036407d-5ac8-400d-91f7-afd63f3cab88|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|7|FOLLOW-UP|2020-06-22|10
e|SS|6036407d-5ac8-400d-91f7-afd63f3cab88|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|6|SCREENING|2020-07-07|25
e|SS|6036407d-5ac8-400d-91f7-afd63f3cab88|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|SCREENING|2020-07-07|25
e|SS|6036407d-5ac8-400d-91f7-afd63f3cab88|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|2|TREATMENT|2020-07-22|40
e|SS|6036407d-5ac8-400d-91f7-afd63f3cab88|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|1|FOLLOW-UP|2020-07-22|40
e|SS|6036407d-5ac8-400d-91f7-afd63f3cab88|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|5|TREATMENT|2020-08-16|65
e|SS|6036407d-5ac8-400d-91f7-afd63f3cab88|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|4|TREATMENT|2020-08-16|65
e|SS|6036407d-5ac8-400d-91f7-afd63f3cab88|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|2|SCREENING|2020-09-10|90
e|SS|6036407d-5ac8-400d-91f7-afd63f3cab88|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|5|SCREENING|2020-09-10|90
e|SS|69cf0c4b-13f6-4955-8046-72a333059d6e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|3|WASHOUT|2020-12-16|10
e|SS|69cf0c4b-13f6-4955-8046-72a333059d6e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|7|FOLLOW-UP|2020-12-16|10
e|SS|69cf0c4b-13f6-4955-8046-72a333059d6e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|6|WASHOUT|2020-12-31|25
e|SS|69cf0c4b-13f6-4955-8046-72a333059d6e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|3|FOLLOW-UP|2020-12-31|25
e|SS|69cf0c4b-13f6-4955-8046-72a333059d6e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|1|WASHOUT|2021-01-15|40
e|SS|69cf0c4b-13f6-4955-8046-72a333059d6e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|2|TREATMENT|2021-01-15|40
e|SS|69cf0c4b-13f6-4955-8046-72a333059d6e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|3|FOLLOW-UP|2021-02-09|65
e|SS|69cf0c4b-13f6-4955-8046-72a333059d6e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|FOLLOW-UP|2021-02-09|65
e|SS|69cf0c4b-13f6-4955-8046-72a333059d6e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|SCREENING|2021-03-06|90
e|SS|69cf0c4b-13f6-4955-8046-72a333059d6e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|2|FOLLOW-UP|2021-03-06|90
e|SS|19829028-595c-4811-90e3-0ca696a04ba3|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|7|SCREENING|2020-07-15|10
e|SS|19829028-595c-4811-90e3-0ca696a04ba3|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|1|TREATMENT|2020-07-15|10
e|SS|19829028-595c-4811-90e3-0ca696a04ba3|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|5|TREATMENT|2020-07-30|25
e|SS|19829028-595c-4811-90e3-0ca696a04ba3|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|4|TREATMENT|2020-07-30|25
e|SS|19829028-595c-4811-90e3-0ca696a04ba3|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|2|WASHOUT|2020-08-14|40
e|SS|19829028-595c-4811-90e3-0ca696a04ba3|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|6|WASHOUT|2020-08-14|40
e|SS|19829028-595c-4811-90e3-0ca696a04ba3|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|1|FOLLOW-UP|2020-09-08|65
e|SS|19829028-595c-4811-90e3-0ca696a04ba3|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|6|WASHOUT|2020-09-08|65
e|SS|19829028-595c-4811-90e3-0ca696a04ba3|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|6|WASHOUT|2020-10-03|90
e|SS|19829028-595c-4811-90e3-0ca696a04ba3|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|2|TREATMENT|2020-10-03|90
e|SS|562a8182-8e9b-4a68-9b95-bc52df58ed46|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|1|TREATMENT|2020-09-05|10
e|SS|562a8182-8e9b-4a68-9b95-bc52df58ed46|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|SCREENING|2020-09-05|10
e|SS|562a8182-8e9b-4a68-9b95-bc52df58ed46|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|2|TREATMENT|2020-09-20|25
e|SS|562a8182-8e9b-4a68-9b95-bc52df58ed46|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|4|FOLLOW-UP|2020-09-20|25
e|SS|562a8182-8e9b-4a68-9b95-bc52df58ed46|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|7|FOLLOW-UP|2020-10-05|40
e|SS|562a8182-8e9b-4a68-9b95-bc52df58ed46|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|3|TREATMENT|2020-10-05|40
e|SS|562a8182-8e9b-4a68-9b95-bc52df58ed46|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2020-10-30|65
e|SS|562a8182-8e9b-4a68-9b95-bc52df58ed46|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|6|FOLLOW-UP|2020-10-30|65
e|SS|562a8182-8e9b-4a68-9b95-bc52df58ed46|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|7|TREATMENT|2020-11-24|90
e|SS|562a8182-8e9b-4a68-9b95-bc52df58ed46|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|4|FOLLOW-UP|2020-11-24|90
e|SS|b29e6912-42f4-471b-ad90-1ec446f89ac0|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|5|SCREENING|2021-01-19|10
e|SS|b29e6912-42f4-471b-ad90-1ec446f89ac0|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|4|WASHOUT|2021-01-19|10
e|SS|b29e6912-42f4-471b-ad90-1ec446f89ac0|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|2|FOLLOW-UP|2021-02-03|25
e|SS|b29e6912-42f4-471b-ad90-1ec446f89ac0|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|5|WASHOUT|2021-02-03|25
e|SS|b29e6912-42f4-471b-ad90-1ec446f89ac0|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|1|SCREENING|2021-02-18|40
e|SS|b29e6912-42f4-471b-ad90-1ec446f89ac0|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|6|TREATMENT|2021-02-18|40
e|SS|b29e6912-42f4-471b-ad90-1ec446f89ac0|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|SCREENING|2021-03-15|65
e|SS|b29e6912-42f4-471b-ad90-1ec446f89ac0|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|6|TREATMENT|2021-03-15|65
e|SS|b29e6912-42f4-471b-ad90-1ec446f89ac0|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|6|WASHOUT|2021-04-09|90
e|SS|b29e6912-42f4-471b-ad90-1ec446f89ac0|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|1|FOLLOW-UP|2021-04-09|90
e|SS|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|TREATMENT|2020-06-09|10
e|SS|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|3|FOLLOW-UP|2020-06-09|10
e|SS|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|TREATMENT|2020-06-24|25
e|SS|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|2|TREATMENT|2020-06-24|25
e|SS|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|3|FOLLOW-UP|2020-07-09|40
e|SS|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|4|TREATMENT|2020-07-09|40
e|SS|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|6|TREATMENT|2020-08-03|65
e|SS|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|5|TREATMENT|2020-08-03|65
e|SS|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|TREATMENT|2020-08-28|90
e|SS|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|2|SCREENING|2020-08-28|90
e|SS|396295ba-9f4c-4689-88c2-f80cb28b567a|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2020-12-31|10
e|SS|396295ba-9f4c-4689-88c2-f80cb28b567a|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|4|WASHOUT|2020-12-31|10
e|SS|396295ba-9f4c-4689-88c2-f80cb28b567a|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2021-01-15|25
e|SS|396295ba-9f4c-4689-88c2-f80cb28b567a|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|3|SCREENING|2021-01-15|25
e|SS|396295ba-9f4c-4689-88c2-f80cb28b567a|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|6|SCREENING|2021-01-30|40
e|SS|396295ba-9f4c-4689-88c2-f80cb28b567a|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|7|FOLLOW-UP|2021-01-30|40
e|SS|396295ba-9f4c-4689-88c2-f80cb28b567a|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|SCREENING|2021-02-24|65
e|SS|396295ba-9f4c-4689-88c2-f80cb28b567a|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|3|TREATMENT|2021-02-24|65
e|SS|396295ba-9f4c-4689-88c2-f80cb28b567a|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|2|WASHOUT|2021-03-21|90
e|SS|396295ba-9f4c-4689-88c2-f80cb28b567a|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|4|SCREENING|2021-03-21|90
e|SS|56072c44-67c3-4c93-8db7-2d1570b2bbbc|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|5|TREATMENT|2020-08-26|10
e|SS|56072c44-67c3-4c93-8db7-2d1570b2bbbc|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|3|TREATMENT|2020-08-26|10
e|SS|56072c44-67c3-4c93-8db7-2d1570b2bbbc|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|5|SCREENING|2020-09-10|25
e|SS|56072c44-67c3-4c93-8db7-2d1570b2bbbc|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|5|FOLLOW-UP|2020-09-10|25
e|SS|56072c44-67c3-4c93-8db7-2d1570b2bbbc|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|WASHOUT|2020-09-25|40
e|SS|56072c44-67c3-4c93-8db7-2d1570b2bbbc|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|4|FOLLOW-UP|2020-09-25|40
e|SS|56072c44-67c3-4c93-8db7-2d1570b2bbbc|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|3|TREATMENT|2020-10-20|65
e|SS|56072c44-67c3-4c93-8db7-2d1570b2bbbc|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|2|TREATMENT|2020-10-20|65
e|SS|56072c44-67c3-4c93-8db7-2d1570b2bbbc|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|5|TREATMENT|2020-11-14|90
e|SS|56072c44-67c3-4c93-8db7-2d1570b2bbbc|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|3|TREATMENT|2020-11-14|90
e|SS|55b23180-01f2-498e-a0af-cb9cd7d81750|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|TREATMENT|2020-07-01|10
e|SS|55b23180-01f2-498e-a0af-cb9cd7d81750|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|2|SCREENING|2020-07-01|10
e|SS|55b23180-01f2-498e-a0af-cb9cd7d81750|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|1|WASHOUT|2020-07-16|25
e|SS|55b23180-01f2-498e-a0af-cb9cd7d81750|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|4|TREATMENT|2020-07-16|25
e|SS|55b23180-01f2-498e-a0af-cb9cd7d81750|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|WASHOUT|2020-07-31|40
e|SS|55b23180-01f2-498e-a0af-cb9cd7d81750|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|7|WASHOUT|2020-07-31|40
e|SS|55b23180-01f2-498e-a0af-cb9cd7d81750|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2020-08-25|65
e|SS|55b23180-01f2-498e-a0af-cb9cd7d81750|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|3|FOLLOW-UP|2020-08-25|65
e|SS|55b23180-01f2-498e-a0af-cb9cd7d81750|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|2|WASHOUT|2020-09-19|90
e|SS|55b23180-01f2-498e-a0af-cb9cd7d81750|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|2|TREATMENT|2020-09-19|90
e|SS|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|1|SCREENING|2020-11-09|10
e|SS|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-11-09|10
e|SS|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|6|TREATMENT|2020-11-24|25
e|SS|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|3|TREATMENT|2020-11-24|25
e|SS|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|1|TREATMENT|2020-12-09|40
e|SS|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|6|TREATMENT|2020-12-09|40
e|SS|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|6|SCREENING|2021-01-03|65
e|SS|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|6|TREATMENT|2021-01-03|65
e|SS|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|WASHOUT|2021-01-28|90
e|SS|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|SCREENING|2021-01-28|90
e|SS|940e4aef-5648-46b3-9c3e-7c40f7930030|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|7|TREATMENT|2020-11-15|10
e|SS|940e4aef-5648-46b3-9c3e-7c40f7930030|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|5|SCREENING|2020-11-15|10
e|SS|940e4aef-5648-46b3-9c3e-7c40f7930030|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|5|FOLLOW-UP|2020-11-30|25
e|SS|940e4aef-5648-46b3-9c3e-7c40f7930030|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|1|TREATMENT|2020-11-30|25
e|SS|940e4aef-5648-46b3-9c3e-7c40f7930030|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|4|TREATMENT|2020-12-15|40
e|SS|940e4aef-5648-46b3-9c3e-7c40f7930030|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-12-15|40
e|SS|940e4aef-5648-46b3-9c3e-7c40f7930030|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|WASHOUT|2021-01-09|65
e|SS|940e4aef-5648-46b3-9c3e-7c40f7930030|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|2|FOLLOW-UP|2021-01-09|65
e|SS|940e4aef-5648-46b3-9c3e-7c40f7930030|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|6|SCREENING|2021-02-03|90
e|SS|940e4aef-5648-46b3-9c3e-7c40f7930030|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2021-02-03|90
e|SS|e4bece1e-6672-4b55-824f-56aa923e60f9|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|TREATMENT|2020-06-22|10
e|SS|e4bece1e-6672-4b55-824f-56aa923e60f9|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|5|TREATMENT|2020-06-22|10
e|SS|e4bece1e-6672-4b55-824f-56aa923e60f9|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|3|SCREENING|2020-07-07|25
e|SS|e4bece1e-6672-4b55-824f-56aa923e60f9|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|2|TREATMENT|2020-07-07|25
e|SS|e4bece1e-6672-4b55-824f-56aa923e60f9|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|2|WASHOUT|2020-07-22|40
e|SS|e4bece1e-6672-4b55-824f-56aa923e60f9|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|6|SCREENING|2020-07-22|40
e|SS|e4bece1e-6672-4b55-824f-56aa923e60f9|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|WASHOUT|2020-08-16|65
e|SS|e4bece1e-6672-4b55-824f-56aa923e60f9|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|3|TREATMENT|2020-08-16|65
e|SS|e4bece1e-6672-4b55-824f-56aa923e60f9|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|3|TREATMENT|2020-09-10|90
e|SS|e4bece1e-6672-4b55-824f-56aa923e60f9|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|7|TREATMENT|2020-09-10|90
e|SS|12e607da-f53c-4078-9742-23a111db6f54|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|SCREENING|2020-10-03|10
e|SS|12e607da-f53c-4078-9742-23a111db6f54|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|1|SCREENING|2020-10-03|10
e|SS|12e607da-f53c-4078-9742-23a111db6f54|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|6|TREATMENT|2020-10-18|25
e|SS|12e607da-f53c-4078-9742-23a111db6f54|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-10-18|25
e|SS|12e607da-f53c-4078-9742-23a111db6f54|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|2|SCREENING|2020-11-02|40
e|SS|12e607da-f53c-4078-9742-23a111db6f54|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|7|WASHOUT|2020-11-02|40
e|SS|12e607da-f53c-4078-9742-23a111db6f54|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|7|FOLLOW-UP|2020-11-27|65
e|SS|12e607da-f53c-4078-9742-23a111db6f54|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|3|TREATMENT|2020-11-27|65
e|SS|12e607da-f53c-4078-9742-23a111db6f54|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|6|FOLLOW-UP|2020-12-22|90
e|SS|12e607da-f53c-4078-9742-23a111db6f54|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|TREATMENT|2020-12-22|90
e|SS|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|3|WASHOUT|2021-01-26|10
e|SS|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|7|TREATMENT|2021-01-26|10
e|SS|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|6|SCREENING|2021-02-10|25
e|SS|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|2|SCREENING|2021-02-10|25
e|SS|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|4|TREATMENT|2021-02-25|40
e|SS|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|4|FOLLOW-UP|2021-02-25|40
e|SS|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|2|WASHOUT|2021-03-22|65
e|SS|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2021-03-22|65
e|SS|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|2|FOLLOW-UP|2021-04-16|90
e|SS|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|6|TREATMENT|2021-04-16|90
e|SS|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|WASHOUT|2020-07-16|10
e|SS|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|TREATMENT|2020-07-16|10
e|SS|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|3|TREATMENT|2020-07-31|25
e|SS|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|1|TREATMENT|2020-07-31|25
e|SS|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|6|TREATMENT|2020-08-15|40
e|SS|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|TREATMENT|2020-08-15|40
e|SS|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|WASHOUT|2020-09-09|65
e|SS|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|4|WASHOUT|2020-09-09|65
e|SS|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|2|TREATMENT|2020-10-04|90
e|SS|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|4|TREATMENT|2020-10-04|90
e|SS|3260122d-3bf4-45ff-a026-2379158721d0|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|5|WASHOUT|2020-06-04|10
e|SS|3260122d-3bf4-45ff-a026-2379158721d0|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|1|FOLLOW-UP|2020-06-04|10
e|SS|3260122d-3bf4-45ff-a026-2379158721d0|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|3|TREATMENT|2020-06-19|25
e|SS|3260122d-3bf4-45ff-a026-2379158721d0|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|4|TREATMENT|2020-06-19|25
e|SS|3260122d-3bf4-45ff-a026-2379158721d0|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|7|SCREENING|2020-07-04|40
e|SS|3260122d-3bf4-45ff-a026-2379158721d0|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|6|WASHOUT|2020-07-04|40
e|SS|3260122d-3bf4-45ff-a026-2379158721d0|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|WASHOUT|2020-07-29|65
e|SS|3260122d-3bf4-45ff-a026-2379158721d0|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|4|WASHOUT|2020-07-29|65
e|SS|3260122d-3bf4-45ff-a026-2379158721d0|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|4|WASHOUT|2020-08-23|90
e|SS|3260122d-3bf4-45ff-a026-2379158721d0|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|TREATMENT|2020-08-23|90
e|SS|05eb4e29-887e-4cdb-8854-49939a8a13d1|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|5|SCREENING|2020-11-05|10
e|SS|05eb4e29-887e-4cdb-8854-49939a8a13d1|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|3|TREATMENT|2020-11-05|10
e|SS|05eb4e29-887e-4cdb-8854-49939a8a13d1|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|3|SCREENING|2020-11-20|25
e|SS|05eb4e29-887e-4cdb-8854-49939a8a13d1|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|5|FOLLOW-UP|2020-11-20|25
e|SS|05eb4e29-887e-4cdb-8854-49939a8a13d1|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|6|FOLLOW-UP|2020-12-05|40
e|SS|05eb4e29-887e-4cdb-8854-49939a8a13d1|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|3|WASHOUT|2020-12-05|40
e|SS|05eb4e29-887e-4cdb-8854-49939a8a13d1|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|6|TREATMENT|2020-12-30|65
e|SS|05eb4e29-887e-4cdb-8854-49939a8a13d1|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|5|TREATMENT|2020-12-30|65
e|SS|05eb4e29-887e-4cdb-8854-49939a8a13d1|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|WASHOUT|2021-01-24|90
e|SS|05eb4e29-887e-4cdb-8854-49939a8a13d1|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|5|TREATMENT|2021-01-24|90
e|SS|c8390c70-766d-4252-9356-39591651bcdf|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|1|SCREENING|2020-08-11|10
e|SS|c8390c70-766d-4252-9356-39591651bcdf|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|FOLLOW-UP|2020-08-11|10
e|SS|c8390c70-766d-4252-9356-39591651bcdf|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|3|FOLLOW-UP|2020-08-26|25
e|SS|c8390c70-766d-4252-9356-39591651bcdf|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|3|TREATMENT|2020-08-26|25
e|SS|c8390c70-766d-4252-9356-39591651bcdf|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|1|WASHOUT|2020-09-10|40
e|SS|c8390c70-766d-4252-9356-39591651bcdf|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|3|SCREENING|2020-09-10|40
e|SS|c8390c70-766d-4252-9356-39591651bcdf|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|6|TREATMENT|2020-10-05|65
e|SS|c8390c70-766d-4252-9356-39591651bcdf|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|4|TREATMENT|2020-10-05|65
e|SS|c8390c70-766d-4252-9356-39591651bcdf|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|4|SCREENING|2020-10-30|90
e|SS|c8390c70-766d-4252-9356-39591651bcdf|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2020-10-30|90
e|SS|a40bf877-c070-40b3-89df-d566b942246e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|2|WASHOUT|2020-06-16|10
e|SS|a40bf877-c070-40b3-89df-d566b942246e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|2|TREATMENT|2020-06-16|10
e|SS|a40bf877-c070-40b3-89df-d566b942246e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|6|TREATMENT|2020-07-01|25
e|SS|a40bf877-c070-40b3-89df-d566b942246e|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|2|WASHOUT|2020-07-01|25
e|SS|a40bf877-c070-40b3-89df-d566b942246e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|1|TREATMENT|2020-07-16|40
e|SS|a40bf877-c070-40b3-89df-d566b942246e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|2|TREATMENT|2020-07-16|40
e|SS|a40bf877-c070-40b3-89df-d566b942246e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|6|TREATMENT|2020-08-10|65
e|SS|a40bf877-c070-40b3-89df-d566b942246e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|1|WASHOUT|2020-08-10|65
e|SS|a40bf877-c070-40b3-89df-d566b942246e|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|WASHOUT|2020-09-04|90
e|SS|a40bf877-c070-40b3-89df-d566b942246e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|4|TREATMENT|2020-09-04|90
e|SS|e9633621-3d08-4b47-b394-5bd3fa47c07f|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|TREATMENT|2021-01-16|10
e|SS|e9633621-3d08-4b47-b394-5bd3fa47c07f|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|3|WASHOUT|2021-01-16|10
e|SS|e9633621-3d08-4b47-b394-5bd3fa47c07f|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|5|FOLLOW-UP|2021-01-31|25
e|SS|e9633621-3d08-4b47-b394-5bd3fa47c07f|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|7|FOLLOW-UP|2021-01-31|25
e|SS|e9633621-3d08-4b47-b394-5bd3fa47c07f|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|6|WASHOUT|2021-02-15|40
e|SS|e9633621-3d08-4b47-b394-5bd3fa47c07f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|6|TREATMENT|2021-02-15|40
e|SS|e9633621-3d08-4b47-b394-5bd3fa47c07f|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|6|TREATMENT|2021-03-12|65
e|SS|e9633621-3d08-4b47-b394-5bd3fa47c07f|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|1|FOLLOW-UP|2021-03-12|65
e|SS|e9633621-3d08-4b47-b394-5bd3fa47c07f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|6|TREATMENT|2021-04-06|90
e|SS|e9633621-3d08-4b47-b394-5bd3fa47c07f|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|5|WASHOUT|2021-04-06|90
e|SS|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|DOMESTIC PARTNER|1|Visit_1|10|7|TREATMENT|2020-09-06|100
e|SS|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|CHILD|1|Visit_1|10|1|TREATMENT|2020-09-06|100
e|SS|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|PROXY|2|Visit_2|25|7|FOLLOW-UP|2020-09-06|100
e|SS|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|PARENT|2|Visit_2|25|1|FOLLOW-UP|2020-09-06|100
e|SS|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATOR|3|Visit_3|40|3|TREATMENT|2020-09-06|100
e|SS|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|INTERVIEWER|3|Visit_3|40|4|TREATMENT|2020-09-06|100
e|SS|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|FRIEND|4|Visit_4|65|2|FOLLOW-UP|2020-09-06|100
e|SS|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|FOLLOW-UP|2020-09-06|100
e|SS|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIBLING|5|Visit_5|90|3|WASHOUT|2020-09-06|100
e|SS|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|4|SCREENING|2020-09-06|100
e|SS|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|5|TREATMENT|2020-07-16|10
e|SS|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|6|TREATMENT|2020-07-16|10
e|SS|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|6|WASHOUT|2020-07-31|25
e|SS|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|6|TREATMENT|2020-07-31|25
e|SS|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|1|WASHOUT|2020-08-15|40
e|SS|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|3|TREATMENT|2020-08-15|40
e|SS|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|7|FOLLOW-UP|2020-09-09|65
e|SS|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|1|TREATMENT|2020-09-09|65
e|SS|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|3|FOLLOW-UP|2020-10-04|90
e|SS|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|2|TREATMENT|2020-10-04|90
e|SS|63f43990-e56e-440c-a445-76e7d114cf26|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|1|FOLLOW-UP|2020-10-02|10
e|SS|63f43990-e56e-440c-a445-76e7d114cf26|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|5|FOLLOW-UP|2020-10-02|10
e|SS|63f43990-e56e-440c-a445-76e7d114cf26|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|2|TREATMENT|2020-10-17|25
e|SS|63f43990-e56e-440c-a445-76e7d114cf26|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|5|TREATMENT|2020-10-17|25
e|SS|63f43990-e56e-440c-a445-76e7d114cf26|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|TREATMENT|2020-11-01|40
e|SS|63f43990-e56e-440c-a445-76e7d114cf26|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|5|SCREENING|2020-11-01|40
e|SS|63f43990-e56e-440c-a445-76e7d114cf26|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|2|TREATMENT|2020-11-26|65
e|SS|63f43990-e56e-440c-a445-76e7d114cf26|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|5|WASHOUT|2020-11-26|65
e|SS|63f43990-e56e-440c-a445-76e7d114cf26|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|5|WASHOUT|2020-12-21|90
e|SS|63f43990-e56e-440c-a445-76e7d114cf26|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|7|TREATMENT|2020-12-21|90
e|SS|380c89f4-2650-4a54-92f5-5e1278b9a91e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|5|SCREENING|2020-10-22|10
e|SS|380c89f4-2650-4a54-92f5-5e1278b9a91e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|7|FOLLOW-UP|2020-10-22|10
e|SS|380c89f4-2650-4a54-92f5-5e1278b9a91e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|7|SCREENING|2020-11-06|25
e|SS|380c89f4-2650-4a54-92f5-5e1278b9a91e|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|5|FOLLOW-UP|2020-11-06|25
e|SS|380c89f4-2650-4a54-92f5-5e1278b9a91e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|2|FOLLOW-UP|2020-11-21|40
e|SS|380c89f4-2650-4a54-92f5-5e1278b9a91e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|6|TREATMENT|2020-11-21|40
e|SS|380c89f4-2650-4a54-92f5-5e1278b9a91e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|4|TREATMENT|2020-12-16|65
e|SS|380c89f4-2650-4a54-92f5-5e1278b9a91e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|FOLLOW-UP|2020-12-16|65
e|SS|380c89f4-2650-4a54-92f5-5e1278b9a91e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|4|TREATMENT|2021-01-10|90
e|SS|380c89f4-2650-4a54-92f5-5e1278b9a91e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|6|TREATMENT|2021-01-10|90
e|SS|84c1f5f4-6415-49d8-b854-22e7529d65b6|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|1|FOLLOW-UP|2020-12-05|10
e|SS|84c1f5f4-6415-49d8-b854-22e7529d65b6|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|6|TREATMENT|2020-12-05|10
e|SS|84c1f5f4-6415-49d8-b854-22e7529d65b6|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|4|TREATMENT|2020-12-20|25
e|SS|84c1f5f4-6415-49d8-b854-22e7529d65b6|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|3|WASHOUT|2020-12-20|25
e|SS|84c1f5f4-6415-49d8-b854-22e7529d65b6|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|7|SCREENING|2021-01-04|40
e|SS|84c1f5f4-6415-49d8-b854-22e7529d65b6|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|4|TREATMENT|2021-01-04|40
e|SS|84c1f5f4-6415-49d8-b854-22e7529d65b6|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|6|SCREENING|2021-01-29|65
e|SS|84c1f5f4-6415-49d8-b854-22e7529d65b6|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|4|TREATMENT|2021-01-29|65
e|SS|84c1f5f4-6415-49d8-b854-22e7529d65b6|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|4|WASHOUT|2021-02-23|90
e|SS|84c1f5f4-6415-49d8-b854-22e7529d65b6|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|6|TREATMENT|2021-02-23|90
e|SS|77c26a0c-0c84-44d7-8351-a50f3236e59a|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|3|TREATMENT|2020-05-14|10
e|SS|77c26a0c-0c84-44d7-8351-a50f3236e59a|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|6|TREATMENT|2020-05-14|10
e|SS|77c26a0c-0c84-44d7-8351-a50f3236e59a|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|6|WASHOUT|2020-05-29|25
e|SS|77c26a0c-0c84-44d7-8351-a50f3236e59a|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|3|SCREENING|2020-05-29|25
e|SS|77c26a0c-0c84-44d7-8351-a50f3236e59a|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|5|WASHOUT|2020-06-13|40
e|SS|77c26a0c-0c84-44d7-8351-a50f3236e59a|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|7|TREATMENT|2020-06-13|40
e|SS|77c26a0c-0c84-44d7-8351-a50f3236e59a|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|7|SCREENING|2020-07-08|65
e|SS|77c26a0c-0c84-44d7-8351-a50f3236e59a|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|2|TREATMENT|2020-07-08|65
e|SS|77c26a0c-0c84-44d7-8351-a50f3236e59a|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|TREATMENT|2020-08-02|90
e|SS|77c26a0c-0c84-44d7-8351-a50f3236e59a|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|1|TREATMENT|2020-08-02|90
e|SS|a201c78a-e826-4f42-a997-7c6a019e2c91|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL STUDY SPONSOR|1|Visit_1|10|4|WASHOUT|2020-11-01|100
e|SS|a201c78a-e826-4f42-a997-7c6a019e2c91|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL STUDY SPONSOR|1|Visit_1|10|3|WASHOUT|2020-11-01|100
e|SS|a201c78a-e826-4f42-a997-7c6a019e2c91|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|VENDOR|2|Visit_2|25|6|FOLLOW-UP|2020-11-01|100
e|SS|a201c78a-e826-4f42-a997-7c6a019e2c91|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|INDEPENDENT ASSESSOR|2|Visit_2|25|6|FOLLOW-UP|2020-11-01|100
e|SS|a201c78a-e826-4f42-a997-7c6a019e2c91|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|PARENT|3|Visit_3|40|6|TREATMENT|2020-11-01|100
e|SS|a201c78a-e826-4f42-a997-7c6a019e2c91|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|WASHOUT|2020-11-01|100
e|SS|a201c78a-e826-4f42-a997-7c6a019e2c91|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|STUDY SUBJECT|4|Visit_4|65|3|TREATMENT|2020-11-01|100
e|SS|a201c78a-e826-4f42-a997-7c6a019e2c91|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|DOMESTIC PARTNER|4|Visit_4|65|7|TREATMENT|2020-11-01|100
e|SS|a201c78a-e826-4f42-a997-7c6a019e2c91|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|WASHOUT|2020-11-01|100
e|SS|a201c78a-e826-4f42-a997-7c6a019e2c91|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|CAREGIVER|5|Visit_5|90|4|TREATMENT|2020-11-01|100
e|SS|c41880bd-1e29-4961-b74d-bb0d979ab00f|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|WASHOUT|2020-09-11|10
e|SS|c41880bd-1e29-4961-b74d-bb0d979ab00f|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|5|TREATMENT|2020-09-11|10
e|SS|c41880bd-1e29-4961-b74d-bb0d979ab00f|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|WASHOUT|2020-09-26|25
e|SS|c41880bd-1e29-4961-b74d-bb0d979ab00f|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|4|FOLLOW-UP|2020-09-26|25
e|SS|c41880bd-1e29-4961-b74d-bb0d979ab00f|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|FOLLOW-UP|2020-10-11|40
e|SS|c41880bd-1e29-4961-b74d-bb0d979ab00f|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|6|WASHOUT|2020-10-11|40
e|SS|c41880bd-1e29-4961-b74d-bb0d979ab00f|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|6|TREATMENT|2020-11-05|65
e|SS|c41880bd-1e29-4961-b74d-bb0d979ab00f|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|WASHOUT|2020-11-05|65
e|SS|c41880bd-1e29-4961-b74d-bb0d979ab00f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|6|TREATMENT|2020-11-30|90
e|SS|c41880bd-1e29-4961-b74d-bb0d979ab00f|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|6|TREATMENT|2020-11-30|90
e|SS|7de60015-fa9d-4a39-bd19-51c718a624e6|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|3|FOLLOW-UP|2020-10-24|10
e|SS|7de60015-fa9d-4a39-bd19-51c718a624e6|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|1|TREATMENT|2020-10-24|10
e|SS|7de60015-fa9d-4a39-bd19-51c718a624e6|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|2|TREATMENT|2020-11-08|25
e|SS|7de60015-fa9d-4a39-bd19-51c718a624e6|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|1|TREATMENT|2020-11-08|25
e|SS|7de60015-fa9d-4a39-bd19-51c718a624e6|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|7|TREATMENT|2020-11-23|40
e|SS|7de60015-fa9d-4a39-bd19-51c718a624e6|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|1|WASHOUT|2020-11-23|40
e|SS|7de60015-fa9d-4a39-bd19-51c718a624e6|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|6|TREATMENT|2020-12-18|65
e|SS|7de60015-fa9d-4a39-bd19-51c718a624e6|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|3|SCREENING|2020-12-18|65
e|SS|7de60015-fa9d-4a39-bd19-51c718a624e6|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|6|TREATMENT|2021-01-12|90
e|SS|7de60015-fa9d-4a39-bd19-51c718a624e6|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|5|TREATMENT|2021-01-12|90
e|SS|34d03f58-155a-4908-bba3-aa979be84610|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|1|SCREENING|2020-06-29|10
e|SS|34d03f58-155a-4908-bba3-aa979be84610|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|7|TREATMENT|2020-06-29|10
e|SS|34d03f58-155a-4908-bba3-aa979be84610|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|3|SCREENING|2020-07-14|25
e|SS|34d03f58-155a-4908-bba3-aa979be84610|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|3|SCREENING|2020-07-14|25
e|SS|34d03f58-155a-4908-bba3-aa979be84610|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|3|TREATMENT|2020-07-29|40
e|SS|34d03f58-155a-4908-bba3-aa979be84610|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|4|TREATMENT|2020-07-29|40
e|SS|34d03f58-155a-4908-bba3-aa979be84610|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|5|TREATMENT|2020-08-23|65
e|SS|34d03f58-155a-4908-bba3-aa979be84610|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|WASHOUT|2020-08-23|65
e|SS|34d03f58-155a-4908-bba3-aa979be84610|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|4|SCREENING|2020-09-17|90
e|SS|34d03f58-155a-4908-bba3-aa979be84610|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|4|SCREENING|2020-09-17|90
e|SS|3818424f-cbc9-4e79-94b8-7edbc706bdbc|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|1|WASHOUT|2020-08-23|10
e|SS|3818424f-cbc9-4e79-94b8-7edbc706bdbc|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|TREATMENT|2020-08-23|10
e|SS|3818424f-cbc9-4e79-94b8-7edbc706bdbc|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|4|FOLLOW-UP|2020-09-07|25
e|SS|3818424f-cbc9-4e79-94b8-7edbc706bdbc|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|6|TREATMENT|2020-09-07|25
e|SS|3818424f-cbc9-4e79-94b8-7edbc706bdbc|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|WASHOUT|2020-09-22|40
e|SS|3818424f-cbc9-4e79-94b8-7edbc706bdbc|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|1|TREATMENT|2020-09-22|40
e|SS|3818424f-cbc9-4e79-94b8-7edbc706bdbc|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|7|TREATMENT|2020-10-17|65
e|SS|3818424f-cbc9-4e79-94b8-7edbc706bdbc|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|TREATMENT|2020-10-17|65
e|SS|3818424f-cbc9-4e79-94b8-7edbc706bdbc|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|4|SCREENING|2020-11-11|90
e|SS|3818424f-cbc9-4e79-94b8-7edbc706bdbc|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|4|FOLLOW-UP|2020-11-11|90
e|SS|4191788e-b2dc-4885-87d8-da9feb6deea5|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|INDEPENDENT ASSESSOR|1|Visit_1|10|5|FOLLOW-UP|2020-12-10|100
e|SS|4191788e-b2dc-4885-87d8-da9feb6deea5|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|FRIEND|1|Visit_1|10|6|FOLLOW-UP|2020-12-10|100
e|SS|4191788e-b2dc-4885-87d8-da9feb6deea5|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|INDEPENDENT ASSESSOR|2|Visit_2|25|2|SCREENING|2020-12-10|100
e|SS|4191788e-b2dc-4885-87d8-da9feb6deea5|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|CAREGIVER|2|Visit_2|25|7|TREATMENT|2020-12-10|100
e|SS|4191788e-b2dc-4885-87d8-da9feb6deea5|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2020-12-10|100
e|SS|4191788e-b2dc-4885-87d8-da9feb6deea5|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|VENDOR|3|Visit_3|40|7|TREATMENT|2020-12-10|100
e|SS|4191788e-b2dc-4885-87d8-da9feb6deea5|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|CAREGIVER|4|Visit_4|65|7|FOLLOW-UP|2020-12-10|100
e|SS|4191788e-b2dc-4885-87d8-da9feb6deea5|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|DOMESTIC PARTNER|4|Visit_4|65|4|FOLLOW-UP|2020-12-10|100
e|SS|4191788e-b2dc-4885-87d8-da9feb6deea5|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|PROXY|5|Visit_5|90|7|SCREENING|2020-12-10|100
e|SS|4191788e-b2dc-4885-87d8-da9feb6deea5|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|INTERVIEWER|5|Visit_5|90|6|FOLLOW-UP|2020-12-10|100
e|SS|8572a9c4-eb87-4745-81b9-8316bc8de69e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|1|SCREENING|2020-12-24|10
e|SS|8572a9c4-eb87-4745-81b9-8316bc8de69e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|3|FOLLOW-UP|2020-12-24|10
e|SS|8572a9c4-eb87-4745-81b9-8316bc8de69e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|6|WASHOUT|2021-01-08|25
e|SS|8572a9c4-eb87-4745-81b9-8316bc8de69e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|4|TREATMENT|2021-01-08|25
e|SS|8572a9c4-eb87-4745-81b9-8316bc8de69e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|7|TREATMENT|2021-01-23|40
e|SS|8572a9c4-eb87-4745-81b9-8316bc8de69e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|4|TREATMENT|2021-01-23|40
e|SS|8572a9c4-eb87-4745-81b9-8316bc8de69e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|3|WASHOUT|2021-02-17|65
e|SS|8572a9c4-eb87-4745-81b9-8316bc8de69e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|4|FOLLOW-UP|2021-02-17|65
e|SS|8572a9c4-eb87-4745-81b9-8316bc8de69e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|3|TREATMENT|2021-03-14|90
e|SS|8572a9c4-eb87-4745-81b9-8316bc8de69e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|7|WASHOUT|2021-03-14|90
e|SS|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|SCREENING|2020-11-26|10
e|SS|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|TREATMENT|2020-11-26|10
e|SS|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|5|TREATMENT|2020-12-11|25
e|SS|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|3|SCREENING|2020-12-11|25
e|SS|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|4|TREATMENT|2020-12-26|40
e|SS|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|7|TREATMENT|2020-12-26|40
e|SS|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|4|TREATMENT|2021-01-20|65
e|SS|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|4|TREATMENT|2021-01-20|65
e|SS|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|TREATMENT|2021-02-14|90
e|SS|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|3|TREATMENT|2021-02-14|90
e|SS|3eceae61-a4a0-49fd-964b-9f142e0da067|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|1|SCREENING|2020-08-28|10
e|SS|3eceae61-a4a0-49fd-964b-9f142e0da067|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|1|TREATMENT|2020-08-28|10
e|SS|3eceae61-a4a0-49fd-964b-9f142e0da067|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|2|TREATMENT|2020-09-12|25
e|SS|3eceae61-a4a0-49fd-964b-9f142e0da067|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|6|WASHOUT|2020-09-12|25
e|SS|3eceae61-a4a0-49fd-964b-9f142e0da067|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|1|WASHOUT|2020-09-27|40
e|SS|3eceae61-a4a0-49fd-964b-9f142e0da067|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|1|WASHOUT|2020-09-27|40
e|SS|3eceae61-a4a0-49fd-964b-9f142e0da067|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|5|TREATMENT|2020-10-22|65
e|SS|3eceae61-a4a0-49fd-964b-9f142e0da067|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|2|WASHOUT|2020-10-22|65
e|SS|3eceae61-a4a0-49fd-964b-9f142e0da067|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|2|SCREENING|2020-11-16|90
e|SS|3eceae61-a4a0-49fd-964b-9f142e0da067|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|2|FOLLOW-UP|2020-11-16|90
e|SS|fe7ad71c-601d-4909-b56a-401c9a10f00c|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|3|TREATMENT|2020-05-21|10
e|SS|fe7ad71c-601d-4909-b56a-401c9a10f00c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|6|FOLLOW-UP|2020-05-21|10
e|SS|fe7ad71c-601d-4909-b56a-401c9a10f00c|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|4|SCREENING|2020-06-05|25
e|SS|fe7ad71c-601d-4909-b56a-401c9a10f00c|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|2|SCREENING|2020-06-05|25
e|SS|fe7ad71c-601d-4909-b56a-401c9a10f00c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|2|TREATMENT|2020-06-20|40
e|SS|fe7ad71c-601d-4909-b56a-401c9a10f00c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|4|FOLLOW-UP|2020-06-20|40
e|SS|fe7ad71c-601d-4909-b56a-401c9a10f00c|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|1|TREATMENT|2020-07-15|65
e|SS|fe7ad71c-601d-4909-b56a-401c9a10f00c|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2020-07-15|65
e|SS|fe7ad71c-601d-4909-b56a-401c9a10f00c|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|4|TREATMENT|2020-08-09|90
e|SS|fe7ad71c-601d-4909-b56a-401c9a10f00c|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|3|FOLLOW-UP|2020-08-09|90
e|SS|cc52d895-5819-46c0-b8e6-b948f1cd2408|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|4|TREATMENT|2020-07-06|10
e|SS|cc52d895-5819-46c0-b8e6-b948f1cd2408|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|3|SCREENING|2020-07-06|10
e|SS|cc52d895-5819-46c0-b8e6-b948f1cd2408|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|4|WASHOUT|2020-07-21|25
e|SS|cc52d895-5819-46c0-b8e6-b948f1cd2408|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|6|SCREENING|2020-07-21|25
e|SS|cc52d895-5819-46c0-b8e6-b948f1cd2408|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|6|TREATMENT|2020-08-05|40
e|SS|cc52d895-5819-46c0-b8e6-b948f1cd2408|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|2|TREATMENT|2020-08-05|40
e|SS|cc52d895-5819-46c0-b8e6-b948f1cd2408|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|3|TREATMENT|2020-08-30|65
e|SS|cc52d895-5819-46c0-b8e6-b948f1cd2408|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|5|SCREENING|2020-08-30|65
e|SS|cc52d895-5819-46c0-b8e6-b948f1cd2408|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|2|TREATMENT|2020-09-24|90
e|SS|cc52d895-5819-46c0-b8e6-b948f1cd2408|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|7|SCREENING|2020-09-24|90
e|SS|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|4|TREATMENT|2021-01-29|10
e|SS|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|4|WASHOUT|2021-01-29|10
e|SS|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|7|WASHOUT|2021-02-13|25
e|SS|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|4|TREATMENT|2021-02-13|25
e|SS|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|2|TREATMENT|2021-02-28|40
e|SS|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|1|TREATMENT|2021-02-28|40
e|SS|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2021-03-25|65
e|SS|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|1|TREATMENT|2021-03-25|65
e|SS|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|2|TREATMENT|2021-04-19|90
e|SS|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|3|FOLLOW-UP|2021-04-19|90
e|SS|1409edea-a372-4938-889b-df6ee93b8543|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|2|TREATMENT|2020-08-27|10
e|SS|1409edea-a372-4938-889b-df6ee93b8543|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|4|SCREENING|2020-08-27|10
e|SS|1409edea-a372-4938-889b-df6ee93b8543|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|7|TREATMENT|2020-09-11|25
e|SS|1409edea-a372-4938-889b-df6ee93b8543|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|6|FOLLOW-UP|2020-09-11|25
e|SS|1409edea-a372-4938-889b-df6ee93b8543|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|1|TREATMENT|2020-09-26|40
e|SS|1409edea-a372-4938-889b-df6ee93b8543|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|2|SCREENING|2020-09-26|40
e|SS|1409edea-a372-4938-889b-df6ee93b8543|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|SCREENING|2020-10-21|65
e|SS|1409edea-a372-4938-889b-df6ee93b8543|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|7|TREATMENT|2020-10-21|65
e|SS|1409edea-a372-4938-889b-df6ee93b8543|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|3|TREATMENT|2020-11-15|90
e|SS|1409edea-a372-4938-889b-df6ee93b8543|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|2|FOLLOW-UP|2020-11-15|90
e|SS|3dc16ad2-d49d-4fad-9823-d0197fb57a42|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|1|TREATMENT|2020-09-04|10
e|SS|3dc16ad2-d49d-4fad-9823-d0197fb57a42|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|6|TREATMENT|2020-09-04|10
e|SS|3dc16ad2-d49d-4fad-9823-d0197fb57a42|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|6|TREATMENT|2020-09-19|25
e|SS|3dc16ad2-d49d-4fad-9823-d0197fb57a42|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|3|WASHOUT|2020-09-19|25
e|SS|3dc16ad2-d49d-4fad-9823-d0197fb57a42|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|1|WASHOUT|2020-10-04|40
e|SS|3dc16ad2-d49d-4fad-9823-d0197fb57a42|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|2|FOLLOW-UP|2020-10-04|40
e|SS|3dc16ad2-d49d-4fad-9823-d0197fb57a42|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|5|TREATMENT|2020-10-29|65
e|SS|3dc16ad2-d49d-4fad-9823-d0197fb57a42|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|5|TREATMENT|2020-10-29|65
e|SS|3dc16ad2-d49d-4fad-9823-d0197fb57a42|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|5|FOLLOW-UP|2020-11-23|90
e|SS|3dc16ad2-d49d-4fad-9823-d0197fb57a42|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|3|TREATMENT|2020-11-23|90
e|SS|7c244128-0508-422f-88ba-ecce68cec054|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|1|TREATMENT|2020-08-05|10
e|SS|7c244128-0508-422f-88ba-ecce68cec054|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|3|FOLLOW-UP|2020-08-05|10
e|SS|7c244128-0508-422f-88ba-ecce68cec054|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|TREATMENT|2020-08-20|25
e|SS|7c244128-0508-422f-88ba-ecce68cec054|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|TREATMENT|2020-08-20|25
e|SS|7c244128-0508-422f-88ba-ecce68cec054|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|4|TREATMENT|2020-09-04|40
e|SS|7c244128-0508-422f-88ba-ecce68cec054|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|2|TREATMENT|2020-09-04|40
e|SS|7c244128-0508-422f-88ba-ecce68cec054|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|1|TREATMENT|2020-09-29|65
e|SS|7c244128-0508-422f-88ba-ecce68cec054|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|5|SCREENING|2020-09-29|65
e|SS|7c244128-0508-422f-88ba-ecce68cec054|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|6|FOLLOW-UP|2020-10-24|90
e|SS|7c244128-0508-422f-88ba-ecce68cec054|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|7|FOLLOW-UP|2020-10-24|90
e|SS|247814c7-9fb3-43f2-9e0a-db70b27b3d95|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|2|FOLLOW-UP|2020-12-16|10
e|SS|247814c7-9fb3-43f2-9e0a-db70b27b3d95|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|5|FOLLOW-UP|2020-12-16|10
e|SS|247814c7-9fb3-43f2-9e0a-db70b27b3d95|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|3|FOLLOW-UP|2020-12-31|25
e|SS|247814c7-9fb3-43f2-9e0a-db70b27b3d95|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-12-31|25
e|SS|247814c7-9fb3-43f2-9e0a-db70b27b3d95|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|2|TREATMENT|2021-01-15|40
e|SS|247814c7-9fb3-43f2-9e0a-db70b27b3d95|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|3|TREATMENT|2021-01-15|40
e|SS|247814c7-9fb3-43f2-9e0a-db70b27b3d95|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|WASHOUT|2021-02-09|65
e|SS|247814c7-9fb3-43f2-9e0a-db70b27b3d95|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|1|TREATMENT|2021-02-09|65
e|SS|247814c7-9fb3-43f2-9e0a-db70b27b3d95|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|2|WASHOUT|2021-03-06|90
e|SS|247814c7-9fb3-43f2-9e0a-db70b27b3d95|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|4|TREATMENT|2021-03-06|90
e|SS|e870fe2f-b08c-41d9-a672-07da09fe2b99|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|3|FOLLOW-UP|2020-08-12|10
e|SS|e870fe2f-b08c-41d9-a672-07da09fe2b99|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|1|TREATMENT|2020-08-12|10
e|SS|e870fe2f-b08c-41d9-a672-07da09fe2b99|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|5|TREATMENT|2020-08-27|25
e|SS|e870fe2f-b08c-41d9-a672-07da09fe2b99|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|7|SCREENING|2020-08-27|25
e|SS|e870fe2f-b08c-41d9-a672-07da09fe2b99|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|5|FOLLOW-UP|2020-09-11|40
e|SS|e870fe2f-b08c-41d9-a672-07da09fe2b99|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|7|TREATMENT|2020-09-11|40
e|SS|e870fe2f-b08c-41d9-a672-07da09fe2b99|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|4|TREATMENT|2020-10-06|65
e|SS|e870fe2f-b08c-41d9-a672-07da09fe2b99|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|1|SCREENING|2020-10-06|65
e|SS|e870fe2f-b08c-41d9-a672-07da09fe2b99|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|5|WASHOUT|2020-10-31|90
e|SS|e870fe2f-b08c-41d9-a672-07da09fe2b99|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|2|TREATMENT|2020-10-31|90
e|SS|32979638-fb88-4cbb-a110-a4d2016e9bc5|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|1|WASHOUT|2020-07-15|10
e|SS|32979638-fb88-4cbb-a110-a4d2016e9bc5|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|7|WASHOUT|2020-07-15|10
e|SS|32979638-fb88-4cbb-a110-a4d2016e9bc5|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|7|TREATMENT|2020-07-30|25
e|SS|32979638-fb88-4cbb-a110-a4d2016e9bc5|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|2|TREATMENT|2020-07-30|25
e|SS|32979638-fb88-4cbb-a110-a4d2016e9bc5|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|2|SCREENING|2020-08-14|40
e|SS|32979638-fb88-4cbb-a110-a4d2016e9bc5|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|5|WASHOUT|2020-08-14|40
e|SS|32979638-fb88-4cbb-a110-a4d2016e9bc5|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|6|WASHOUT|2020-09-08|65
e|SS|32979638-fb88-4cbb-a110-a4d2016e9bc5|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|6|FOLLOW-UP|2020-09-08|65
e|SS|32979638-fb88-4cbb-a110-a4d2016e9bc5|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|4|SCREENING|2020-10-03|90
e|SS|32979638-fb88-4cbb-a110-a4d2016e9bc5|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|3|TREATMENT|2020-10-03|90
e|SS|39b8db88-810b-4402-9ca3-c2bab1939c1c|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|3|TREATMENT|2020-11-15|10
e|SS|39b8db88-810b-4402-9ca3-c2bab1939c1c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|4|TREATMENT|2020-11-15|10
e|SS|39b8db88-810b-4402-9ca3-c2bab1939c1c|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|7|FOLLOW-UP|2020-11-30|25
e|SS|39b8db88-810b-4402-9ca3-c2bab1939c1c|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|2|SCREENING|2020-11-30|25
e|SS|39b8db88-810b-4402-9ca3-c2bab1939c1c|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|1|WASHOUT|2020-12-15|40
e|SS|39b8db88-810b-4402-9ca3-c2bab1939c1c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|SCREENING|2020-12-15|40
e|SS|39b8db88-810b-4402-9ca3-c2bab1939c1c|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|7|TREATMENT|2021-01-09|65
e|SS|39b8db88-810b-4402-9ca3-c2bab1939c1c|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|4|FOLLOW-UP|2021-01-09|65
e|SS|39b8db88-810b-4402-9ca3-c2bab1939c1c|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|7|WASHOUT|2021-02-03|90
e|SS|39b8db88-810b-4402-9ca3-c2bab1939c1c|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|5|TREATMENT|2021-02-03|90
e|SS|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|6|FOLLOW-UP|2020-07-27|10
e|SS|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|2|TREATMENT|2020-07-27|10
e|SS|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|2|FOLLOW-UP|2020-08-11|25
e|SS|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|6|TREATMENT|2020-08-11|25
e|SS|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|3|TREATMENT|2020-08-26|40
e|SS|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2020-08-26|40
e|SS|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|7|WASHOUT|2020-09-20|65
e|SS|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|6|TREATMENT|2020-09-20|65
e|SS|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|7|TREATMENT|2020-10-15|90
e|SS|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|5|TREATMENT|2020-10-15|90
e|SS|bca1f50d-04e6-46f5-afb3-e48aaea1069d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|5|TREATMENT|2020-11-03|10
e|SS|bca1f50d-04e6-46f5-afb3-e48aaea1069d|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|4|SCREENING|2020-11-03|10
e|SS|bca1f50d-04e6-46f5-afb3-e48aaea1069d|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|7|TREATMENT|2020-11-18|25
e|SS|bca1f50d-04e6-46f5-afb3-e48aaea1069d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|2|TREATMENT|2020-11-18|25
e|SS|bca1f50d-04e6-46f5-afb3-e48aaea1069d|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|4|FOLLOW-UP|2020-12-03|40
e|SS|bca1f50d-04e6-46f5-afb3-e48aaea1069d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|6|WASHOUT|2020-12-03|40
e|SS|bca1f50d-04e6-46f5-afb3-e48aaea1069d|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|7|SCREENING|2020-12-28|65
e|SS|bca1f50d-04e6-46f5-afb3-e48aaea1069d|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|6|FOLLOW-UP|2020-12-28|65
e|SS|bca1f50d-04e6-46f5-afb3-e48aaea1069d|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|4|TREATMENT|2021-01-22|90
e|SS|bca1f50d-04e6-46f5-afb3-e48aaea1069d|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|4|FOLLOW-UP|2021-01-22|90
e|SS|6bddadef-13fb-4fab-b281-aa33aa97aa8f|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|5|FOLLOW-UP|2020-05-24|10
e|SS|6bddadef-13fb-4fab-b281-aa33aa97aa8f|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|1|WASHOUT|2020-05-24|10
e|SS|6bddadef-13fb-4fab-b281-aa33aa97aa8f|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|6|TREATMENT|2020-06-08|25
e|SS|6bddadef-13fb-4fab-b281-aa33aa97aa8f|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|2|FOLLOW-UP|2020-06-08|25
e|SS|6bddadef-13fb-4fab-b281-aa33aa97aa8f|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|2|WASHOUT|2020-06-23|40
e|SS|6bddadef-13fb-4fab-b281-aa33aa97aa8f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|2|WASHOUT|2020-06-23|40
e|SS|6bddadef-13fb-4fab-b281-aa33aa97aa8f|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|5|TREATMENT|2020-07-18|65
e|SS|6bddadef-13fb-4fab-b281-aa33aa97aa8f|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|1|TREATMENT|2020-07-18|65
e|SS|6bddadef-13fb-4fab-b281-aa33aa97aa8f|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|FOLLOW-UP|2020-08-12|90
e|SS|6bddadef-13fb-4fab-b281-aa33aa97aa8f|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|2|FOLLOW-UP|2020-08-12|90
e|SS|6edb7414-d8f4-44da-8483-504b93a7e705|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|7|TREATMENT|2020-06-07|10
e|SS|6edb7414-d8f4-44da-8483-504b93a7e705|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|4|SCREENING|2020-06-07|10
e|SS|6edb7414-d8f4-44da-8483-504b93a7e705|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|FOLLOW-UP|2020-06-22|25
e|SS|6edb7414-d8f4-44da-8483-504b93a7e705|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|3|WASHOUT|2020-06-22|25
e|SS|6edb7414-d8f4-44da-8483-504b93a7e705|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|SCREENING|2020-07-07|40
e|SS|6edb7414-d8f4-44da-8483-504b93a7e705|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|3|SCREENING|2020-07-07|40
e|SS|6edb7414-d8f4-44da-8483-504b93a7e705|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|2|TREATMENT|2020-08-01|65
e|SS|6edb7414-d8f4-44da-8483-504b93a7e705|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|6|TREATMENT|2020-08-01|65
e|SS|6edb7414-d8f4-44da-8483-504b93a7e705|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|1|TREATMENT|2020-08-26|90
e|SS|6edb7414-d8f4-44da-8483-504b93a7e705|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|2|TREATMENT|2020-08-26|90
e|SS|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|SCREENING|2020-05-16|10
e|SS|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|3|TREATMENT|2020-05-16|10
e|SS|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|6|SCREENING|2020-05-31|25
e|SS|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-05-31|25
e|SS|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|1|TREATMENT|2020-06-15|40
e|SS|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|2|FOLLOW-UP|2020-06-15|40
e|SS|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|5|SCREENING|2020-07-10|65
e|SS|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|3|TREATMENT|2020-07-10|65
e|SS|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|4|TREATMENT|2020-08-04|90
e|SS|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|3|SCREENING|2020-08-04|90
e|SS|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2020-05-18|10
e|SS|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|4|WASHOUT|2020-05-18|10
e|SS|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|6|SCREENING|2020-06-02|25
e|SS|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|5|TREATMENT|2020-06-02|25
e|SS|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|1|SCREENING|2020-06-17|40
e|SS|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|1|TREATMENT|2020-06-17|40
e|SS|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|4|WASHOUT|2020-07-12|65
e|SS|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|FOLLOW-UP|2020-07-12|65
e|SS|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|7|FOLLOW-UP|2020-08-06|90
e|SS|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|2|TREATMENT|2020-08-06|90
e|SS|47d55e87-e559-424d-a6ad-d533a0d77f39|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|7|WASHOUT|2021-01-12|10
e|SS|47d55e87-e559-424d-a6ad-d533a0d77f39|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|1|WASHOUT|2021-01-12|10
e|SS|47d55e87-e559-424d-a6ad-d533a0d77f39|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|7|TREATMENT|2021-01-27|25
e|SS|47d55e87-e559-424d-a6ad-d533a0d77f39|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2021-01-27|25
e|SS|47d55e87-e559-424d-a6ad-d533a0d77f39|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|6|WASHOUT|2021-02-11|40
e|SS|47d55e87-e559-424d-a6ad-d533a0d77f39|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|1|SCREENING|2021-02-11|40
e|SS|47d55e87-e559-424d-a6ad-d533a0d77f39|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|6|TREATMENT|2021-03-08|65
e|SS|47d55e87-e559-424d-a6ad-d533a0d77f39|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|2|TREATMENT|2021-03-08|65
e|SS|47d55e87-e559-424d-a6ad-d533a0d77f39|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|4|FOLLOW-UP|2021-04-02|90
e|SS|47d55e87-e559-424d-a6ad-d533a0d77f39|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|6|TREATMENT|2021-04-02|90
e|SS|f89c08df-2e24-4c97-a451-1980cecebf14|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|SPOUSE|1|Visit_1|10|4|WASHOUT|2021-03-18|100
e|SS|f89c08df-2e24-4c97-a451-1980cecebf14|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|CAREGIVER|1|Visit_1|10|5|WASHOUT|2021-03-18|100
e|SS|f89c08df-2e24-4c97-a451-1980cecebf14|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|VENDOR|2|Visit_2|25|2|SCREENING|2021-03-18|100
e|SS|f89c08df-2e24-4c97-a451-1980cecebf14|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|INDEPENDENT ASSESSOR|2|Visit_2|25|6|TREATMENT|2021-03-18|100
e|SS|f89c08df-2e24-4c97-a451-1980cecebf14|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|SPOUSE|3|Visit_3|40|5|FOLLOW-UP|2021-03-18|100
e|SS|f89c08df-2e24-4c97-a451-1980cecebf14|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|3|TREATMENT|2021-03-18|100
e|SS|f89c08df-2e24-4c97-a451-1980cecebf14|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|SPOUSE|4|Visit_4|65|4|TREATMENT|2021-03-18|100
e|SS|f89c08df-2e24-4c97-a451-1980cecebf14|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|TREATMENT|2021-03-18|100
e|SS|f89c08df-2e24-4c97-a451-1980cecebf14|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|FAMILY MEMBER|5|Visit_5|90|1|TREATMENT|2021-03-18|100
e|SS|f89c08df-2e24-4c97-a451-1980cecebf14|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2021-03-18|100
e|SS|dbb225ed-e322-4946-a60a-0fafd7e22953|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|3|TREATMENT|2021-01-24|10
e|SS|dbb225ed-e322-4946-a60a-0fafd7e22953|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|WASHOUT|2021-01-24|10
e|SS|dbb225ed-e322-4946-a60a-0fafd7e22953|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|1|TREATMENT|2021-02-08|25
e|SS|dbb225ed-e322-4946-a60a-0fafd7e22953|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|1|FOLLOW-UP|2021-02-08|25
e|SS|dbb225ed-e322-4946-a60a-0fafd7e22953|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|1|FOLLOW-UP|2021-02-23|40
e|SS|dbb225ed-e322-4946-a60a-0fafd7e22953|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|1|WASHOUT|2021-02-23|40
e|SS|dbb225ed-e322-4946-a60a-0fafd7e22953|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|5|WASHOUT|2021-03-20|65
e|SS|dbb225ed-e322-4946-a60a-0fafd7e22953|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2021-03-20|65
e|SS|dbb225ed-e322-4946-a60a-0fafd7e22953|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|7|SCREENING|2021-04-14|90
e|SS|dbb225ed-e322-4946-a60a-0fafd7e22953|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|2|TREATMENT|2021-04-14|90
e|SS|95e61698-43f7-4cc5-aafa-06dac7870743|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|3|TREATMENT|2020-12-25|10
e|SS|95e61698-43f7-4cc5-aafa-06dac7870743|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|WASHOUT|2020-12-25|10
e|SS|95e61698-43f7-4cc5-aafa-06dac7870743|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|3|SCREENING|2021-01-09|25
e|SS|95e61698-43f7-4cc5-aafa-06dac7870743|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|4|SCREENING|2021-01-09|25
e|SS|95e61698-43f7-4cc5-aafa-06dac7870743|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|4|TREATMENT|2021-01-24|40
e|SS|95e61698-43f7-4cc5-aafa-06dac7870743|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2021-01-24|40
e|SS|95e61698-43f7-4cc5-aafa-06dac7870743|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|3|TREATMENT|2021-02-18|65
e|SS|95e61698-43f7-4cc5-aafa-06dac7870743|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|WASHOUT|2021-02-18|65
e|SS|95e61698-43f7-4cc5-aafa-06dac7870743|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|FOLLOW-UP|2021-03-15|90
e|SS|95e61698-43f7-4cc5-aafa-06dac7870743|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|5|TREATMENT|2021-03-15|90
e|SS|151308c7-03aa-4a0b-b13f-9838edb218ef|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|4|WASHOUT|2020-09-13|10
e|SS|151308c7-03aa-4a0b-b13f-9838edb218ef|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|4|WASHOUT|2020-09-13|10
e|SS|151308c7-03aa-4a0b-b13f-9838edb218ef|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|5|WASHOUT|2020-09-28|25
e|SS|151308c7-03aa-4a0b-b13f-9838edb218ef|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|1|TREATMENT|2020-09-28|25
e|SS|151308c7-03aa-4a0b-b13f-9838edb218ef|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|6|SCREENING|2020-10-13|40
e|SS|151308c7-03aa-4a0b-b13f-9838edb218ef|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|7|SCREENING|2020-10-13|40
e|SS|151308c7-03aa-4a0b-b13f-9838edb218ef|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|7|TREATMENT|2020-11-07|65
e|SS|151308c7-03aa-4a0b-b13f-9838edb218ef|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|1|TREATMENT|2020-11-07|65
e|SS|151308c7-03aa-4a0b-b13f-9838edb218ef|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|2|FOLLOW-UP|2020-12-02|90
e|SS|151308c7-03aa-4a0b-b13f-9838edb218ef|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|6|TREATMENT|2020-12-02|90
e|SS|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|1|TREATMENT|2020-06-15|10
e|SS|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|6|SCREENING|2020-06-15|10
e|SS|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|3|TREATMENT|2020-06-30|25
e|SS|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|SCREENING|2020-06-30|25
e|SS|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|4|TREATMENT|2020-07-15|40
e|SS|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|1|TREATMENT|2020-07-15|40
e|SS|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|6|SCREENING|2020-08-09|65
e|SS|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|1|TREATMENT|2020-08-09|65
e|SS|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|7|TREATMENT|2020-09-03|90
e|SS|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|4|TREATMENT|2020-09-03|90
e|SS|23605586-1b30-4f05-bb15-417dd3a79994|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|2|WASHOUT|2020-10-31|10
e|SS|23605586-1b30-4f05-bb15-417dd3a79994|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|4|TREATMENT|2020-10-31|10
e|SS|23605586-1b30-4f05-bb15-417dd3a79994|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|6|FOLLOW-UP|2020-11-15|25
e|SS|23605586-1b30-4f05-bb15-417dd3a79994|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|6|TREATMENT|2020-11-15|25
e|SS|23605586-1b30-4f05-bb15-417dd3a79994|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|3|TREATMENT|2020-11-30|40
e|SS|23605586-1b30-4f05-bb15-417dd3a79994|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|3|FOLLOW-UP|2020-11-30|40
e|SS|23605586-1b30-4f05-bb15-417dd3a79994|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|7|TREATMENT|2020-12-25|65
e|SS|23605586-1b30-4f05-bb15-417dd3a79994|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|3|SCREENING|2020-12-25|65
e|SS|23605586-1b30-4f05-bb15-417dd3a79994|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|FOLLOW-UP|2021-01-19|90
e|SS|23605586-1b30-4f05-bb15-417dd3a79994|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|2|TREATMENT|2021-01-19|90
e|SS|57d15ac0-06a6-40e0-9201-4d947651c9b0|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|3|TREATMENT|2020-08-28|10
e|SS|57d15ac0-06a6-40e0-9201-4d947651c9b0|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|2|TREATMENT|2020-08-28|10
e|SS|57d15ac0-06a6-40e0-9201-4d947651c9b0|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|7|WASHOUT|2020-09-12|25
e|SS|57d15ac0-06a6-40e0-9201-4d947651c9b0|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|4|FOLLOW-UP|2020-09-12|25
e|SS|57d15ac0-06a6-40e0-9201-4d947651c9b0|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|WASHOUT|2020-09-27|40
e|SS|57d15ac0-06a6-40e0-9201-4d947651c9b0|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|SCREENING|2020-09-27|40
e|SS|57d15ac0-06a6-40e0-9201-4d947651c9b0|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|4|TREATMENT|2020-10-22|65
e|SS|57d15ac0-06a6-40e0-9201-4d947651c9b0|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|TREATMENT|2020-10-22|65
e|SS|57d15ac0-06a6-40e0-9201-4d947651c9b0|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|4|WASHOUT|2020-11-16|90
e|SS|57d15ac0-06a6-40e0-9201-4d947651c9b0|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|1|FOLLOW-UP|2020-11-16|90
e|SS|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|5|FOLLOW-UP|2020-08-12|10
e|SS|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|6|TREATMENT|2020-08-12|10
e|SS|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|SCREENING|2020-08-27|25
e|SS|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|5|SCREENING|2020-08-27|25
e|SS|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|TREATMENT|2020-09-11|40
e|SS|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|4|FOLLOW-UP|2020-09-11|40
e|SS|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|1|TREATMENT|2020-10-06|65
e|SS|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|3|TREATMENT|2020-10-06|65
e|SS|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|2|TREATMENT|2020-10-31|90
e|SS|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|5|WASHOUT|2020-10-31|90
e|SS|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|7|SCREENING|2020-08-31|10
e|SS|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|5|WASHOUT|2020-08-31|10
e|SS|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|SCREENING|2020-09-15|25
e|SS|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|5|TREATMENT|2020-09-15|25
e|SS|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|1|TREATMENT|2020-09-30|40
e|SS|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|3|FOLLOW-UP|2020-09-30|40
e|SS|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|4|TREATMENT|2020-10-25|65
e|SS|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|1|TREATMENT|2020-10-25|65
e|SS|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|5|TREATMENT|2020-11-19|90
e|SS|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|3|TREATMENT|2020-11-19|90
e|SS|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|5|FOLLOW-UP|2020-12-24|10
e|SS|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|1|SCREENING|2020-12-24|10
e|SS|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|4|TREATMENT|2021-01-08|25
e|SS|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|1|TREATMENT|2021-01-08|25
e|SS|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|WASHOUT|2021-01-23|40
e|SS|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|5|FOLLOW-UP|2021-01-23|40
e|SS|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|5|SCREENING|2021-02-17|65
e|SS|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|4|TREATMENT|2021-02-17|65
e|SS|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|FOLLOW-UP|2021-03-14|90
e|SS|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|3|FOLLOW-UP|2021-03-14|90
e|SS|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|1|SCREENING|2020-07-02|10
e|SS|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|FOLLOW-UP|2020-07-02|10
e|SS|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|3|TREATMENT|2020-07-17|25
e|SS|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|6|WASHOUT|2020-07-17|25
e|SS|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|4|TREATMENT|2020-08-01|40
e|SS|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|5|FOLLOW-UP|2020-08-01|40
e|SS|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|3|TREATMENT|2020-08-26|65
e|SS|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|WASHOUT|2020-08-26|65
e|SS|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|2|FOLLOW-UP|2020-09-20|90
e|SS|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|5|SCREENING|2020-09-20|90
e|SS|81f62132-123e-4888-abbe-8e289599e965|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|TREATMENT|2020-12-04|10
e|SS|81f62132-123e-4888-abbe-8e289599e965|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|6|SCREENING|2020-12-04|10
e|SS|81f62132-123e-4888-abbe-8e289599e965|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|6|TREATMENT|2020-12-19|25
e|SS|81f62132-123e-4888-abbe-8e289599e965|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|SCREENING|2020-12-19|25
e|SS|81f62132-123e-4888-abbe-8e289599e965|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|7|TREATMENT|2021-01-03|40
e|SS|81f62132-123e-4888-abbe-8e289599e965|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|6|SCREENING|2021-01-03|40
e|SS|81f62132-123e-4888-abbe-8e289599e965|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|7|SCREENING|2021-01-28|65
e|SS|81f62132-123e-4888-abbe-8e289599e965|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|3|SCREENING|2021-01-28|65
e|SS|81f62132-123e-4888-abbe-8e289599e965|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|2|TREATMENT|2021-02-22|90
e|SS|81f62132-123e-4888-abbe-8e289599e965|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|2|TREATMENT|2021-02-22|90
e|SS|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|5|WASHOUT|2020-05-16|10
e|SS|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|1|WASHOUT|2020-05-16|10
e|SS|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|7|TREATMENT|2020-05-31|25
e|SS|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-05-31|25
e|SS|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|5|SCREENING|2020-06-15|40
e|SS|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|2|SCREENING|2020-06-15|40
e|SS|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|6|WASHOUT|2020-07-10|65
e|SS|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|3|TREATMENT|2020-07-10|65
e|SS|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|3|FOLLOW-UP|2020-08-04|90
e|SS|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|6|WASHOUT|2020-08-04|90
e|SS|49282406-97ec-4108-adf9-e01c18ce59c6|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|5|WASHOUT|2020-05-17|10
e|SS|49282406-97ec-4108-adf9-e01c18ce59c6|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|2|TREATMENT|2020-05-17|10
e|SS|49282406-97ec-4108-adf9-e01c18ce59c6|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|6|TREATMENT|2020-06-01|25
e|SS|49282406-97ec-4108-adf9-e01c18ce59c6|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|2|SCREENING|2020-06-01|25
e|SS|49282406-97ec-4108-adf9-e01c18ce59c6|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|7|TREATMENT|2020-06-16|40
e|SS|49282406-97ec-4108-adf9-e01c18ce59c6|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|5|SCREENING|2020-06-16|40
e|SS|49282406-97ec-4108-adf9-e01c18ce59c6|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2020-07-11|65
e|SS|49282406-97ec-4108-adf9-e01c18ce59c6|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|3|SCREENING|2020-07-11|65
e|SS|49282406-97ec-4108-adf9-e01c18ce59c6|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|5|WASHOUT|2020-08-05|90
e|SS|49282406-97ec-4108-adf9-e01c18ce59c6|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|WASHOUT|2020-08-05|90
e|SS|310936c8-7d24-4eea-9892-1cd8bb675421|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|3|SCREENING|2020-07-06|10
e|SS|310936c8-7d24-4eea-9892-1cd8bb675421|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|3|TREATMENT|2020-07-06|10
e|SS|310936c8-7d24-4eea-9892-1cd8bb675421|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|3|TREATMENT|2020-07-21|25
e|SS|310936c8-7d24-4eea-9892-1cd8bb675421|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2020-07-21|25
e|SS|310936c8-7d24-4eea-9892-1cd8bb675421|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|1|TREATMENT|2020-08-05|40
e|SS|310936c8-7d24-4eea-9892-1cd8bb675421|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|4|FOLLOW-UP|2020-08-05|40
e|SS|310936c8-7d24-4eea-9892-1cd8bb675421|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|2|FOLLOW-UP|2020-08-30|65
e|SS|310936c8-7d24-4eea-9892-1cd8bb675421|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|6|TREATMENT|2020-08-30|65
e|SS|310936c8-7d24-4eea-9892-1cd8bb675421|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|1|SCREENING|2020-09-24|90
e|SS|310936c8-7d24-4eea-9892-1cd8bb675421|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|4|FOLLOW-UP|2020-09-24|90
e|SS|034e303b-5675-4188-bcea-fc2e53b155d6|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|TREATMENT|2020-06-01|10
e|SS|034e303b-5675-4188-bcea-fc2e53b155d6|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|7|FOLLOW-UP|2020-06-01|10
e|SS|034e303b-5675-4188-bcea-fc2e53b155d6|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|2|WASHOUT|2020-06-16|25
e|SS|034e303b-5675-4188-bcea-fc2e53b155d6|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|4|TREATMENT|2020-06-16|25
e|SS|034e303b-5675-4188-bcea-fc2e53b155d6|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|4|FOLLOW-UP|2020-07-01|40
e|SS|034e303b-5675-4188-bcea-fc2e53b155d6|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|3|SCREENING|2020-07-01|40
e|SS|034e303b-5675-4188-bcea-fc2e53b155d6|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|2|SCREENING|2020-07-26|65
e|SS|034e303b-5675-4188-bcea-fc2e53b155d6|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|2|WASHOUT|2020-07-26|65
e|SS|034e303b-5675-4188-bcea-fc2e53b155d6|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|4|TREATMENT|2020-08-20|90
e|SS|034e303b-5675-4188-bcea-fc2e53b155d6|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|2|FOLLOW-UP|2020-08-20|90
e|SS|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|PROXY|1|Visit_1|10|6|TREATMENT|2020-10-05|100
e|SS|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|FAMILY MEMBER|1|Visit_1|10|7|TREATMENT|2020-10-05|100
e|SS|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|PARENT|2|Visit_2|25|3|SCREENING|2020-10-05|100
e|SS|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|CAREGIVER|2|Visit_2|25|2|TREATMENT|2020-10-05|100
e|SS|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|GUARDIAN|3|Visit_3|40|6|WASHOUT|2020-10-05|100
e|SS|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|TREATMENT|2020-10-05|100
e|SS|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|SPOUSE|4|Visit_4|65|5|FOLLOW-UP|2020-10-05|100
e|SS|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|INDEPENDENT ASSESSOR|4|Visit_4|65|3|TREATMENT|2020-10-05|100
e|SS|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIBLING|5|Visit_5|90|2|WASHOUT|2020-10-05|100
e|SS|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL STUDY SPONSOR|5|Visit_5|90|5|TREATMENT|2020-10-05|100
e|SS|c912affb-cbc2-4919-81b4-ecaa03908261|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|6|WASHOUT|2020-07-12|10
e|SS|c912affb-cbc2-4919-81b4-ecaa03908261|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|1|FOLLOW-UP|2020-07-12|10
e|SS|c912affb-cbc2-4919-81b4-ecaa03908261|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|6|TREATMENT|2020-07-27|25
e|SS|c912affb-cbc2-4919-81b4-ecaa03908261|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|7|FOLLOW-UP|2020-07-27|25
e|SS|c912affb-cbc2-4919-81b4-ecaa03908261|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|7|FOLLOW-UP|2020-08-11|40
e|SS|c912affb-cbc2-4919-81b4-ecaa03908261|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|TREATMENT|2020-08-11|40
e|SS|c912affb-cbc2-4919-81b4-ecaa03908261|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|3|SCREENING|2020-09-05|65
e|SS|c912affb-cbc2-4919-81b4-ecaa03908261|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|6|TREATMENT|2020-09-05|65
e|SS|c912affb-cbc2-4919-81b4-ecaa03908261|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|6|FOLLOW-UP|2020-09-30|90
e|SS|c912affb-cbc2-4919-81b4-ecaa03908261|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|7|FOLLOW-UP|2020-09-30|90
e|SS|5af817f0-5dfb-4046-ac7c-4bae16a90036|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|SCREENING|2020-07-06|10
e|SS|5af817f0-5dfb-4046-ac7c-4bae16a90036|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|TREATMENT|2020-07-06|10
e|SS|5af817f0-5dfb-4046-ac7c-4bae16a90036|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|5|TREATMENT|2020-07-21|25
e|SS|5af817f0-5dfb-4046-ac7c-4bae16a90036|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-07-21|25
e|SS|5af817f0-5dfb-4046-ac7c-4bae16a90036|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|3|FOLLOW-UP|2020-08-05|40
e|SS|5af817f0-5dfb-4046-ac7c-4bae16a90036|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|4|FOLLOW-UP|2020-08-05|40
e|SS|5af817f0-5dfb-4046-ac7c-4bae16a90036|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|1|SCREENING|2020-08-30|65
e|SS|5af817f0-5dfb-4046-ac7c-4bae16a90036|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|6|FOLLOW-UP|2020-08-30|65
e|SS|5af817f0-5dfb-4046-ac7c-4bae16a90036|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2020-09-24|90
e|SS|5af817f0-5dfb-4046-ac7c-4bae16a90036|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|1|SCREENING|2020-09-24|90
e|SS|dcefd656-a59a-4b71-9260-efcbcecd2132|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|5|SCREENING|2020-06-04|10
e|SS|dcefd656-a59a-4b71-9260-efcbcecd2132|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|6|SCREENING|2020-06-04|10
e|SS|dcefd656-a59a-4b71-9260-efcbcecd2132|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|7|FOLLOW-UP|2020-06-19|25
e|SS|dcefd656-a59a-4b71-9260-efcbcecd2132|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|1|TREATMENT|2020-06-19|25
e|SS|dcefd656-a59a-4b71-9260-efcbcecd2132|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|SCREENING|2020-07-04|40
e|SS|dcefd656-a59a-4b71-9260-efcbcecd2132|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|4|TREATMENT|2020-07-04|40
e|SS|dcefd656-a59a-4b71-9260-efcbcecd2132|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|2|TREATMENT|2020-07-29|65
e|SS|dcefd656-a59a-4b71-9260-efcbcecd2132|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|FOLLOW-UP|2020-07-29|65
e|SS|dcefd656-a59a-4b71-9260-efcbcecd2132|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|6|SCREENING|2020-08-23|90
e|SS|dcefd656-a59a-4b71-9260-efcbcecd2132|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|4|SCREENING|2020-08-23|90
e|SS|641c8067-941a-4f1a-a7b1-4eea0242f1d7|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|SCREENING|2020-12-22|10
e|SS|641c8067-941a-4f1a-a7b1-4eea0242f1d7|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|2|TREATMENT|2020-12-22|10
e|SS|641c8067-941a-4f1a-a7b1-4eea0242f1d7|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2021-01-06|25
e|SS|641c8067-941a-4f1a-a7b1-4eea0242f1d7|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|2|TREATMENT|2021-01-06|25
e|SS|641c8067-941a-4f1a-a7b1-4eea0242f1d7|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|6|TREATMENT|2021-01-21|40
e|SS|641c8067-941a-4f1a-a7b1-4eea0242f1d7|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|7|TREATMENT|2021-01-21|40
e|SS|641c8067-941a-4f1a-a7b1-4eea0242f1d7|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|4|TREATMENT|2021-02-15|65
e|SS|641c8067-941a-4f1a-a7b1-4eea0242f1d7|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|3|TREATMENT|2021-02-15|65
e|SS|641c8067-941a-4f1a-a7b1-4eea0242f1d7|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|4|FOLLOW-UP|2021-03-12|90
e|SS|641c8067-941a-4f1a-a7b1-4eea0242f1d7|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|6|TREATMENT|2021-03-12|90
e|SS|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|7|FOLLOW-UP|2020-09-24|10
e|SS|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|4|TREATMENT|2020-09-24|10
e|SS|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|3|SCREENING|2020-10-09|25
e|SS|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|SCREENING|2020-10-09|25
e|SS|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|1|TREATMENT|2020-10-24|40
e|SS|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|2|FOLLOW-UP|2020-10-24|40
e|SS|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|7|TREATMENT|2020-11-18|65
e|SS|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|7|SCREENING|2020-11-18|65
e|SS|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|3|TREATMENT|2020-12-13|90
e|SS|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|TREATMENT|2020-12-13|90
e|SS|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|7|SCREENING|2020-10-31|10
e|SS|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|4|TREATMENT|2020-10-31|10
e|SS|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|1|SCREENING|2020-11-15|25
e|SS|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|5|SCREENING|2020-11-15|25
e|SS|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|5|TREATMENT|2020-11-30|40
e|SS|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|7|TREATMENT|2020-11-30|40
e|SS|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|6|SCREENING|2020-12-25|65
e|SS|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|1|SCREENING|2020-12-25|65
e|SS|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|4|FOLLOW-UP|2021-01-19|90
e|SS|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|WASHOUT|2021-01-19|90
e|SS|46304edd-0b05-4819-8fcb-35cf9c02764d|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|INVESTIGATOR|1|Visit_1|10|7|FOLLOW-UP|2021-03-03|100
e|SS|46304edd-0b05-4819-8fcb-35cf9c02764d|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|VENDOR|1|Visit_1|10|1|SCREENING|2021-03-03|100
e|SS|46304edd-0b05-4819-8fcb-35cf9c02764d|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATION COMMITTEE|2|Visit_2|25|2|SCREENING|2021-03-03|100
e|SS|46304edd-0b05-4819-8fcb-35cf9c02764d|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|FAMILY MEMBER|2|Visit_2|25|6|TREATMENT|2021-03-03|100
e|SS|46304edd-0b05-4819-8fcb-35cf9c02764d|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|GUARDIAN|3|Visit_3|40|2|FOLLOW-UP|2021-03-03|100
e|SS|46304edd-0b05-4819-8fcb-35cf9c02764d|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|CAREGIVER|3|Visit_3|40|7|FOLLOW-UP|2021-03-03|100
e|SS|46304edd-0b05-4819-8fcb-35cf9c02764d|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|INTERVIEWER|4|Visit_4|65|3|TREATMENT|2021-03-03|100
e|SS|46304edd-0b05-4819-8fcb-35cf9c02764d|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|GUARDIAN|4|Visit_4|65|7|WASHOUT|2021-03-03|100
e|SS|46304edd-0b05-4819-8fcb-35cf9c02764d|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|INTERVIEWER|5|Visit_5|90|5|TREATMENT|2021-03-03|100
e|SS|46304edd-0b05-4819-8fcb-35cf9c02764d|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATION COMMITTEE|5|Visit_5|90|4|TREATMENT|2021-03-03|100
e|SS|3fd6dab2-b35f-4cc5-88dd-b507583d9539|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|TREATMENT|2020-05-26|10
e|SS|3fd6dab2-b35f-4cc5-88dd-b507583d9539|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|7|TREATMENT|2020-05-26|10
e|SS|3fd6dab2-b35f-4cc5-88dd-b507583d9539|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|2|FOLLOW-UP|2020-06-10|25
e|SS|3fd6dab2-b35f-4cc5-88dd-b507583d9539|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|6|SCREENING|2020-06-10|25
e|SS|3fd6dab2-b35f-4cc5-88dd-b507583d9539|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|3|FOLLOW-UP|2020-06-25|40
e|SS|3fd6dab2-b35f-4cc5-88dd-b507583d9539|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|3|TREATMENT|2020-06-25|40
e|SS|3fd6dab2-b35f-4cc5-88dd-b507583d9539|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|2|TREATMENT|2020-07-20|65
e|SS|3fd6dab2-b35f-4cc5-88dd-b507583d9539|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|1|WASHOUT|2020-07-20|65
e|SS|3fd6dab2-b35f-4cc5-88dd-b507583d9539|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|5|WASHOUT|2020-08-14|90
e|SS|3fd6dab2-b35f-4cc5-88dd-b507583d9539|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|2|TREATMENT|2020-08-14|90
e|SS|daa3b89e-637a-43de-86c1-d0db93f00430|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|5|TREATMENT|2020-10-11|10
e|SS|daa3b89e-637a-43de-86c1-d0db93f00430|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|2|TREATMENT|2020-10-11|10
e|SS|daa3b89e-637a-43de-86c1-d0db93f00430|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|FOLLOW-UP|2020-10-26|25
e|SS|daa3b89e-637a-43de-86c1-d0db93f00430|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|3|TREATMENT|2020-10-26|25
e|SS|daa3b89e-637a-43de-86c1-d0db93f00430|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|5|TREATMENT|2020-11-10|40
e|SS|daa3b89e-637a-43de-86c1-d0db93f00430|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|4|SCREENING|2020-11-10|40
e|SS|daa3b89e-637a-43de-86c1-d0db93f00430|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|4|WASHOUT|2020-12-05|65
e|SS|daa3b89e-637a-43de-86c1-d0db93f00430|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|1|TREATMENT|2020-12-05|65
e|SS|daa3b89e-637a-43de-86c1-d0db93f00430|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|6|TREATMENT|2020-12-30|90
e|SS|daa3b89e-637a-43de-86c1-d0db93f00430|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|1|TREATMENT|2020-12-30|90
e|SS|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|4|WASHOUT|2020-07-04|10
e|SS|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|6|FOLLOW-UP|2020-07-04|10
e|SS|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|1|TREATMENT|2020-07-19|25
e|SS|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|SCREENING|2020-07-19|25
e|SS|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-08-03|40
e|SS|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|7|WASHOUT|2020-08-03|40
e|SS|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|6|WASHOUT|2020-08-28|65
e|SS|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|5|FOLLOW-UP|2020-08-28|65
e|SS|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|5|FOLLOW-UP|2020-09-22|90
e|SS|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|5|WASHOUT|2020-09-22|90
e|SS|c22014f2-2d7b-4897-8ad5-e46785e51837|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|TREATMENT|2020-08-13|10
e|SS|c22014f2-2d7b-4897-8ad5-e46785e51837|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|4|TREATMENT|2020-08-13|10
e|SS|c22014f2-2d7b-4897-8ad5-e46785e51837|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|2|WASHOUT|2020-08-28|25
e|SS|c22014f2-2d7b-4897-8ad5-e46785e51837|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-08-28|25
e|SS|c22014f2-2d7b-4897-8ad5-e46785e51837|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|4|FOLLOW-UP|2020-09-12|40
e|SS|c22014f2-2d7b-4897-8ad5-e46785e51837|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|6|FOLLOW-UP|2020-09-12|40
e|SS|c22014f2-2d7b-4897-8ad5-e46785e51837|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|1|TREATMENT|2020-10-07|65
e|SS|c22014f2-2d7b-4897-8ad5-e46785e51837|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|4|WASHOUT|2020-10-07|65
e|SS|c22014f2-2d7b-4897-8ad5-e46785e51837|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|1|FOLLOW-UP|2020-11-01|90
e|SS|c22014f2-2d7b-4897-8ad5-e46785e51837|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|7|FOLLOW-UP|2020-11-01|90
e|SS|987102b2-fe2f-4d72-b8dc-14a71bf034b5|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|6|TREATMENT|2020-10-11|10
e|SS|987102b2-fe2f-4d72-b8dc-14a71bf034b5|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|5|FOLLOW-UP|2020-10-11|10
e|SS|987102b2-fe2f-4d72-b8dc-14a71bf034b5|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|4|TREATMENT|2020-10-26|25
e|SS|987102b2-fe2f-4d72-b8dc-14a71bf034b5|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|WASHOUT|2020-10-26|25
e|SS|987102b2-fe2f-4d72-b8dc-14a71bf034b5|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|TREATMENT|2020-11-10|40
e|SS|987102b2-fe2f-4d72-b8dc-14a71bf034b5|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|6|WASHOUT|2020-11-10|40
e|SS|987102b2-fe2f-4d72-b8dc-14a71bf034b5|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|3|WASHOUT|2020-12-05|65
e|SS|987102b2-fe2f-4d72-b8dc-14a71bf034b5|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|5|TREATMENT|2020-12-05|65
e|SS|987102b2-fe2f-4d72-b8dc-14a71bf034b5|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2020-12-30|90
e|SS|987102b2-fe2f-4d72-b8dc-14a71bf034b5|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|5|TREATMENT|2020-12-30|90
e|SS|24ce0c77-1921-4b87-91da-3627e2afd399|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|5|TREATMENT|2021-01-29|10
e|SS|24ce0c77-1921-4b87-91da-3627e2afd399|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|4|TREATMENT|2021-01-29|10
e|SS|24ce0c77-1921-4b87-91da-3627e2afd399|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|1|WASHOUT|2021-02-13|25
e|SS|24ce0c77-1921-4b87-91da-3627e2afd399|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|7|WASHOUT|2021-02-13|25
e|SS|24ce0c77-1921-4b87-91da-3627e2afd399|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|2|TREATMENT|2021-02-28|40
e|SS|24ce0c77-1921-4b87-91da-3627e2afd399|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|3|TREATMENT|2021-02-28|40
e|SS|24ce0c77-1921-4b87-91da-3627e2afd399|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|4|TREATMENT|2021-03-25|65
e|SS|24ce0c77-1921-4b87-91da-3627e2afd399|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|SCREENING|2021-03-25|65
e|SS|24ce0c77-1921-4b87-91da-3627e2afd399|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|3|WASHOUT|2021-04-19|90
e|SS|24ce0c77-1921-4b87-91da-3627e2afd399|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|3|TREATMENT|2021-04-19|90
e|SS|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-08-20|10
e|SS|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|1|TREATMENT|2020-08-20|10
e|SS|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|SCREENING|2020-09-04|25
e|SS|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|5|TREATMENT|2020-09-04|25
e|SS|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|TREATMENT|2020-09-19|40
e|SS|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|6|WASHOUT|2020-09-19|40
e|SS|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|TREATMENT|2020-10-14|65
e|SS|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|1|TREATMENT|2020-10-14|65
e|SS|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|3|TREATMENT|2020-11-08|90
e|SS|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|7|WASHOUT|2020-11-08|90
e|SS|f4b83a72-7cde-4e02-8883-05e789c617a8|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|5|SCREENING|2020-12-25|10
e|SS|f4b83a72-7cde-4e02-8883-05e789c617a8|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|7|TREATMENT|2020-12-25|10
e|SS|f4b83a72-7cde-4e02-8883-05e789c617a8|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|7|FOLLOW-UP|2021-01-09|25
e|SS|f4b83a72-7cde-4e02-8883-05e789c617a8|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|4|TREATMENT|2021-01-09|25
e|SS|f4b83a72-7cde-4e02-8883-05e789c617a8|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2021-01-24|40
e|SS|f4b83a72-7cde-4e02-8883-05e789c617a8|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|1|TREATMENT|2021-01-24|40
e|SS|f4b83a72-7cde-4e02-8883-05e789c617a8|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|5|TREATMENT|2021-02-18|65
e|SS|f4b83a72-7cde-4e02-8883-05e789c617a8|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|3|TREATMENT|2021-02-18|65
e|SS|f4b83a72-7cde-4e02-8883-05e789c617a8|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|5|TREATMENT|2021-03-15|90
e|SS|f4b83a72-7cde-4e02-8883-05e789c617a8|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|2|TREATMENT|2021-03-15|90
e|SS|c4087538-422a-4bcf-af25-ed4aab36ed4b|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|1|WASHOUT|2021-01-09|10
e|SS|c4087538-422a-4bcf-af25-ed4aab36ed4b|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|4|TREATMENT|2021-01-09|10
e|SS|c4087538-422a-4bcf-af25-ed4aab36ed4b|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|6|FOLLOW-UP|2021-01-24|25
e|SS|c4087538-422a-4bcf-af25-ed4aab36ed4b|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|7|TREATMENT|2021-01-24|25
e|SS|c4087538-422a-4bcf-af25-ed4aab36ed4b|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|5|FOLLOW-UP|2021-02-08|40
e|SS|c4087538-422a-4bcf-af25-ed4aab36ed4b|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2021-02-08|40
e|SS|c4087538-422a-4bcf-af25-ed4aab36ed4b|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|6|TREATMENT|2021-03-05|65
e|SS|c4087538-422a-4bcf-af25-ed4aab36ed4b|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|5|TREATMENT|2021-03-05|65
e|SS|c4087538-422a-4bcf-af25-ed4aab36ed4b|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|5|SCREENING|2021-03-30|90
e|SS|c4087538-422a-4bcf-af25-ed4aab36ed4b|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|4|WASHOUT|2021-03-30|90
e|SS|947aefaf-20c7-47fc-ac56-140f9b6f38f3|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|7|FOLLOW-UP|2020-11-06|10
e|SS|947aefaf-20c7-47fc-ac56-140f9b6f38f3|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|6|SCREENING|2020-11-06|10
e|SS|947aefaf-20c7-47fc-ac56-140f9b6f38f3|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|5|TREATMENT|2020-11-21|25
e|SS|947aefaf-20c7-47fc-ac56-140f9b6f38f3|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|1|FOLLOW-UP|2020-11-21|25
e|SS|947aefaf-20c7-47fc-ac56-140f9b6f38f3|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|5|TREATMENT|2020-12-06|40
e|SS|947aefaf-20c7-47fc-ac56-140f9b6f38f3|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|2|SCREENING|2020-12-06|40
e|SS|947aefaf-20c7-47fc-ac56-140f9b6f38f3|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|1|TREATMENT|2020-12-31|65
e|SS|947aefaf-20c7-47fc-ac56-140f9b6f38f3|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|1|TREATMENT|2020-12-31|65
e|SS|947aefaf-20c7-47fc-ac56-140f9b6f38f3|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|3|SCREENING|2021-01-25|90
e|SS|947aefaf-20c7-47fc-ac56-140f9b6f38f3|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2021-01-25|90
e|SS|3a0c00eb-5614-4053-844d-6bdb71efb1cd|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|4|SCREENING|2020-08-11|10
e|SS|3a0c00eb-5614-4053-844d-6bdb71efb1cd|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|1|SCREENING|2020-08-11|10
e|SS|3a0c00eb-5614-4053-844d-6bdb71efb1cd|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|1|SCREENING|2020-08-26|25
e|SS|3a0c00eb-5614-4053-844d-6bdb71efb1cd|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|5|WASHOUT|2020-08-26|25
e|SS|3a0c00eb-5614-4053-844d-6bdb71efb1cd|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|WASHOUT|2020-09-10|40
e|SS|3a0c00eb-5614-4053-844d-6bdb71efb1cd|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|7|TREATMENT|2020-09-10|40
e|SS|3a0c00eb-5614-4053-844d-6bdb71efb1cd|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|5|SCREENING|2020-10-05|65
e|SS|3a0c00eb-5614-4053-844d-6bdb71efb1cd|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|WASHOUT|2020-10-05|65
e|SS|3a0c00eb-5614-4053-844d-6bdb71efb1cd|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|6|FOLLOW-UP|2020-10-30|90
e|SS|3a0c00eb-5614-4053-844d-6bdb71efb1cd|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|SCREENING|2020-10-30|90
e|SS|dc3ce247-24dd-4255-85a8-ec7a58d30c86|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|7|WASHOUT|2020-10-11|10
e|SS|dc3ce247-24dd-4255-85a8-ec7a58d30c86|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|4|TREATMENT|2020-10-11|10
e|SS|dc3ce247-24dd-4255-85a8-ec7a58d30c86|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|5|SCREENING|2020-10-26|25
e|SS|dc3ce247-24dd-4255-85a8-ec7a58d30c86|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|2|SCREENING|2020-10-26|25
e|SS|dc3ce247-24dd-4255-85a8-ec7a58d30c86|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|7|TREATMENT|2020-11-10|40
e|SS|dc3ce247-24dd-4255-85a8-ec7a58d30c86|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2020-11-10|40
e|SS|dc3ce247-24dd-4255-85a8-ec7a58d30c86|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|WASHOUT|2020-12-05|65
e|SS|dc3ce247-24dd-4255-85a8-ec7a58d30c86|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|3|TREATMENT|2020-12-05|65
e|SS|dc3ce247-24dd-4255-85a8-ec7a58d30c86|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|SCREENING|2020-12-30|90
e|SS|dc3ce247-24dd-4255-85a8-ec7a58d30c86|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|6|FOLLOW-UP|2020-12-30|90
e|SS|61c19f94-bdfc-456d-ba7a-c9097ca1c645|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|5|TREATMENT|2020-07-04|10
e|SS|61c19f94-bdfc-456d-ba7a-c9097ca1c645|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|1|WASHOUT|2020-07-04|10
e|SS|61c19f94-bdfc-456d-ba7a-c9097ca1c645|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|3|TREATMENT|2020-07-19|25
e|SS|61c19f94-bdfc-456d-ba7a-c9097ca1c645|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|2|TREATMENT|2020-07-19|25
e|SS|61c19f94-bdfc-456d-ba7a-c9097ca1c645|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|4|SCREENING|2020-08-03|40
e|SS|61c19f94-bdfc-456d-ba7a-c9097ca1c645|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|7|WASHOUT|2020-08-03|40
e|SS|61c19f94-bdfc-456d-ba7a-c9097ca1c645|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|7|WASHOUT|2020-08-28|65
e|SS|61c19f94-bdfc-456d-ba7a-c9097ca1c645|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|4|SCREENING|2020-08-28|65
e|SS|61c19f94-bdfc-456d-ba7a-c9097ca1c645|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|7|TREATMENT|2020-09-22|90
e|SS|61c19f94-bdfc-456d-ba7a-c9097ca1c645|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|3|TREATMENT|2020-09-22|90
e|SS|1e577f2d-2c45-477d-b74f-af24b81d6d20|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|TREATMENT|2020-09-23|10
e|SS|1e577f2d-2c45-477d-b74f-af24b81d6d20|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|TREATMENT|2020-09-23|10
e|SS|1e577f2d-2c45-477d-b74f-af24b81d6d20|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|2|TREATMENT|2020-10-08|25
e|SS|1e577f2d-2c45-477d-b74f-af24b81d6d20|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|2|TREATMENT|2020-10-08|25
e|SS|1e577f2d-2c45-477d-b74f-af24b81d6d20|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|4|FOLLOW-UP|2020-10-23|40
e|SS|1e577f2d-2c45-477d-b74f-af24b81d6d20|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|7|TREATMENT|2020-10-23|40
e|SS|1e577f2d-2c45-477d-b74f-af24b81d6d20|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|2|TREATMENT|2020-11-17|65
e|SS|1e577f2d-2c45-477d-b74f-af24b81d6d20|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|5|SCREENING|2020-11-17|65
e|SS|1e577f2d-2c45-477d-b74f-af24b81d6d20|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|1|TREATMENT|2020-12-12|90
e|SS|1e577f2d-2c45-477d-b74f-af24b81d6d20|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|4|FOLLOW-UP|2020-12-12|90
e|SS|f845101e-c057-4f84-94b3-6043afb42ac7|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|6|TREATMENT|2020-10-27|10
e|SS|f845101e-c057-4f84-94b3-6043afb42ac7|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|3|WASHOUT|2020-10-27|10
e|SS|f845101e-c057-4f84-94b3-6043afb42ac7|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|4|FOLLOW-UP|2020-11-11|25
e|SS|f845101e-c057-4f84-94b3-6043afb42ac7|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|1|TREATMENT|2020-11-11|25
e|SS|f845101e-c057-4f84-94b3-6043afb42ac7|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|7|SCREENING|2020-11-26|40
e|SS|f845101e-c057-4f84-94b3-6043afb42ac7|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|6|FOLLOW-UP|2020-11-26|40
e|SS|f845101e-c057-4f84-94b3-6043afb42ac7|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|5|TREATMENT|2020-12-21|65
e|SS|f845101e-c057-4f84-94b3-6043afb42ac7|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|2|SCREENING|2020-12-21|65
e|SS|f845101e-c057-4f84-94b3-6043afb42ac7|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|5|FOLLOW-UP|2021-01-15|90
e|SS|f845101e-c057-4f84-94b3-6043afb42ac7|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|5|FOLLOW-UP|2021-01-15|90
e|SS|4ddb2076-6837-4028-81bc-3e8057475977|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|3|TREATMENT|2020-12-27|10
e|SS|4ddb2076-6837-4028-81bc-3e8057475977|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|5|SCREENING|2020-12-27|10
e|SS|4ddb2076-6837-4028-81bc-3e8057475977|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|1|TREATMENT|2021-01-11|25
e|SS|4ddb2076-6837-4028-81bc-3e8057475977|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|1|WASHOUT|2021-01-11|25
e|SS|4ddb2076-6837-4028-81bc-3e8057475977|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|2|TREATMENT|2021-01-26|40
e|SS|4ddb2076-6837-4028-81bc-3e8057475977|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|6|TREATMENT|2021-01-26|40
e|SS|4ddb2076-6837-4028-81bc-3e8057475977|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|7|TREATMENT|2021-02-20|65
e|SS|4ddb2076-6837-4028-81bc-3e8057475977|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|3|WASHOUT|2021-02-20|65
e|SS|4ddb2076-6837-4028-81bc-3e8057475977|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|5|TREATMENT|2021-03-17|90
e|SS|4ddb2076-6837-4028-81bc-3e8057475977|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|3|TREATMENT|2021-03-17|90
e|SS|c165c69c-2ab2-495c-a190-e32d1204bc4e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|4|TREATMENT|2021-01-01|10
e|SS|c165c69c-2ab2-495c-a190-e32d1204bc4e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|3|TREATMENT|2021-01-01|10
e|SS|c165c69c-2ab2-495c-a190-e32d1204bc4e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|4|TREATMENT|2021-01-16|25
e|SS|c165c69c-2ab2-495c-a190-e32d1204bc4e|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|2|TREATMENT|2021-01-16|25
e|SS|c165c69c-2ab2-495c-a190-e32d1204bc4e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|7|TREATMENT|2021-01-31|40
e|SS|c165c69c-2ab2-495c-a190-e32d1204bc4e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|4|TREATMENT|2021-01-31|40
e|SS|c165c69c-2ab2-495c-a190-e32d1204bc4e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|7|SCREENING|2021-02-25|65
e|SS|c165c69c-2ab2-495c-a190-e32d1204bc4e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|3|SCREENING|2021-02-25|65
e|SS|c165c69c-2ab2-495c-a190-e32d1204bc4e|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|4|WASHOUT|2021-03-22|90
e|SS|c165c69c-2ab2-495c-a190-e32d1204bc4e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|5|TREATMENT|2021-03-22|90
e|SS|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|2|TREATMENT|2020-12-29|10
e|SS|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|1|SCREENING|2020-12-29|10
e|SS|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2021-01-13|25
e|SS|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|4|FOLLOW-UP|2021-01-13|25
e|SS|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|2|TREATMENT|2021-01-28|40
e|SS|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|2|FOLLOW-UP|2021-01-28|40
e|SS|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|2|TREATMENT|2021-02-22|65
e|SS|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|4|WASHOUT|2021-02-22|65
e|SS|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|1|SCREENING|2021-03-19|90
e|SS|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|6|TREATMENT|2021-03-19|90
e|SS|024a9f6d-4ff1-4673-8617-3790f831fce7|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|4|SCREENING|2020-06-13|10
e|SS|024a9f6d-4ff1-4673-8617-3790f831fce7|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|2|WASHOUT|2020-06-13|10
e|SS|024a9f6d-4ff1-4673-8617-3790f831fce7|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|3|TREATMENT|2020-06-28|25
e|SS|024a9f6d-4ff1-4673-8617-3790f831fce7|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|5|WASHOUT|2020-06-28|25
e|SS|024a9f6d-4ff1-4673-8617-3790f831fce7|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|1|SCREENING|2020-07-13|40
e|SS|024a9f6d-4ff1-4673-8617-3790f831fce7|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|1|TREATMENT|2020-07-13|40
e|SS|024a9f6d-4ff1-4673-8617-3790f831fce7|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|1|SCREENING|2020-08-07|65
e|SS|024a9f6d-4ff1-4673-8617-3790f831fce7|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|6|WASHOUT|2020-08-07|65
e|SS|024a9f6d-4ff1-4673-8617-3790f831fce7|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|3|TREATMENT|2020-09-01|90
e|SS|024a9f6d-4ff1-4673-8617-3790f831fce7|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|1|FOLLOW-UP|2020-09-01|90
e|SS|40936fc6-251d-4a17-ae9d-3bd1150f8d20|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|6|WASHOUT|2020-11-18|10
e|SS|40936fc6-251d-4a17-ae9d-3bd1150f8d20|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|FOLLOW-UP|2020-11-18|10
e|SS|40936fc6-251d-4a17-ae9d-3bd1150f8d20|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|FOLLOW-UP|2020-12-03|25
e|SS|40936fc6-251d-4a17-ae9d-3bd1150f8d20|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|1|SCREENING|2020-12-03|25
e|SS|40936fc6-251d-4a17-ae9d-3bd1150f8d20|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|3|WASHOUT|2020-12-18|40
e|SS|40936fc6-251d-4a17-ae9d-3bd1150f8d20|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|4|SCREENING|2020-12-18|40
e|SS|40936fc6-251d-4a17-ae9d-3bd1150f8d20|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|7|FOLLOW-UP|2021-01-12|65
e|SS|40936fc6-251d-4a17-ae9d-3bd1150f8d20|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|6|TREATMENT|2021-01-12|65
e|SS|40936fc6-251d-4a17-ae9d-3bd1150f8d20|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|6|WASHOUT|2021-02-06|90
e|SS|40936fc6-251d-4a17-ae9d-3bd1150f8d20|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|1|SCREENING|2021-02-06|90
e|SS|17b9fa7a-f15d-423a-9671-99cd0cbbd362|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|5|FOLLOW-UP|2020-11-11|10
e|SS|17b9fa7a-f15d-423a-9671-99cd0cbbd362|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|2|FOLLOW-UP|2020-11-11|10
e|SS|17b9fa7a-f15d-423a-9671-99cd0cbbd362|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|4|FOLLOW-UP|2020-11-26|25
e|SS|17b9fa7a-f15d-423a-9671-99cd0cbbd362|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|6|TREATMENT|2020-11-26|25
e|SS|17b9fa7a-f15d-423a-9671-99cd0cbbd362|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|5|TREATMENT|2020-12-11|40
e|SS|17b9fa7a-f15d-423a-9671-99cd0cbbd362|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|WASHOUT|2020-12-11|40
e|SS|17b9fa7a-f15d-423a-9671-99cd0cbbd362|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|WASHOUT|2021-01-05|65
e|SS|17b9fa7a-f15d-423a-9671-99cd0cbbd362|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|2|TREATMENT|2021-01-05|65
e|SS|17b9fa7a-f15d-423a-9671-99cd0cbbd362|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|6|TREATMENT|2021-01-30|90
e|SS|17b9fa7a-f15d-423a-9671-99cd0cbbd362|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|6|TREATMENT|2021-01-30|90
e|SS|95c4465b-162a-433d-83c9-6d67dd729c9e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|2|SCREENING|2020-10-22|10
e|SS|95c4465b-162a-433d-83c9-6d67dd729c9e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|2|TREATMENT|2020-10-22|10
e|SS|95c4465b-162a-433d-83c9-6d67dd729c9e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|2|TREATMENT|2020-11-06|25
e|SS|95c4465b-162a-433d-83c9-6d67dd729c9e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|5|TREATMENT|2020-11-06|25
e|SS|95c4465b-162a-433d-83c9-6d67dd729c9e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|4|WASHOUT|2020-11-21|40
e|SS|95c4465b-162a-433d-83c9-6d67dd729c9e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|3|TREATMENT|2020-11-21|40
e|SS|95c4465b-162a-433d-83c9-6d67dd729c9e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|1|FOLLOW-UP|2020-12-16|65
e|SS|95c4465b-162a-433d-83c9-6d67dd729c9e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|3|TREATMENT|2020-12-16|65
e|SS|95c4465b-162a-433d-83c9-6d67dd729c9e|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|4|TREATMENT|2021-01-10|90
e|SS|95c4465b-162a-433d-83c9-6d67dd729c9e|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|SCREENING|2021-01-10|90
e|SS|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|4|TREATMENT|2020-06-27|10
e|SS|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|2|FOLLOW-UP|2020-06-27|10
e|SS|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|6|SCREENING|2020-07-12|25
e|SS|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|2|TREATMENT|2020-07-12|25
e|SS|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|4|SCREENING|2020-07-27|40
e|SS|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|3|TREATMENT|2020-07-27|40
e|SS|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|2|FOLLOW-UP|2020-08-21|65
e|SS|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|1|SCREENING|2020-08-21|65
e|SS|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|4|TREATMENT|2020-09-15|90
e|SS|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|6|WASHOUT|2020-09-15|90
e|SS|beb6b1ab-1264-456a-bf2b-81e28493301d|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|7|SCREENING|2020-06-10|10
e|SS|beb6b1ab-1264-456a-bf2b-81e28493301d|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|1|TREATMENT|2020-06-10|10
e|SS|beb6b1ab-1264-456a-bf2b-81e28493301d|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|2|SCREENING|2020-06-25|25
e|SS|beb6b1ab-1264-456a-bf2b-81e28493301d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|7|SCREENING|2020-06-25|25
e|SS|beb6b1ab-1264-456a-bf2b-81e28493301d|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|3|SCREENING|2020-07-10|40
e|SS|beb6b1ab-1264-456a-bf2b-81e28493301d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|2|WASHOUT|2020-07-10|40
e|SS|beb6b1ab-1264-456a-bf2b-81e28493301d|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|2|SCREENING|2020-08-04|65
e|SS|beb6b1ab-1264-456a-bf2b-81e28493301d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|2|TREATMENT|2020-08-04|65
e|SS|beb6b1ab-1264-456a-bf2b-81e28493301d|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|2|TREATMENT|2020-08-29|90
e|SS|beb6b1ab-1264-456a-bf2b-81e28493301d|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|7|TREATMENT|2020-08-29|90
e|SS|4292c06d-044e-4dff-aea0-830178a6e220|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|4|TREATMENT|2020-12-02|10
e|SS|4292c06d-044e-4dff-aea0-830178a6e220|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|6|TREATMENT|2020-12-02|10
e|SS|4292c06d-044e-4dff-aea0-830178a6e220|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|7|WASHOUT|2020-12-17|25
e|SS|4292c06d-044e-4dff-aea0-830178a6e220|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|7|SCREENING|2020-12-17|25
e|SS|4292c06d-044e-4dff-aea0-830178a6e220|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|3|WASHOUT|2021-01-01|40
e|SS|4292c06d-044e-4dff-aea0-830178a6e220|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|2|WASHOUT|2021-01-01|40
e|SS|4292c06d-044e-4dff-aea0-830178a6e220|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|1|TREATMENT|2021-01-26|65
e|SS|4292c06d-044e-4dff-aea0-830178a6e220|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|5|TREATMENT|2021-01-26|65
e|SS|4292c06d-044e-4dff-aea0-830178a6e220|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|7|TREATMENT|2021-02-20|90
e|SS|4292c06d-044e-4dff-aea0-830178a6e220|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|2|SCREENING|2021-02-20|90
e|SS|050c12d2-cf9f-402b-9332-d6a9771ed115|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|2|FOLLOW-UP|2020-08-18|10
e|SS|050c12d2-cf9f-402b-9332-d6a9771ed115|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|TREATMENT|2020-08-18|10
e|SS|050c12d2-cf9f-402b-9332-d6a9771ed115|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|6|FOLLOW-UP|2020-09-02|25
e|SS|050c12d2-cf9f-402b-9332-d6a9771ed115|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|2|TREATMENT|2020-09-02|25
e|SS|050c12d2-cf9f-402b-9332-d6a9771ed115|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|3|WASHOUT|2020-09-17|40
e|SS|050c12d2-cf9f-402b-9332-d6a9771ed115|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|3|TREATMENT|2020-09-17|40
e|SS|050c12d2-cf9f-402b-9332-d6a9771ed115|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|5|FOLLOW-UP|2020-10-12|65
e|SS|050c12d2-cf9f-402b-9332-d6a9771ed115|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|6|TREATMENT|2020-10-12|65
e|SS|050c12d2-cf9f-402b-9332-d6a9771ed115|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|7|FOLLOW-UP|2020-11-06|90
e|SS|050c12d2-cf9f-402b-9332-d6a9771ed115|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|5|WASHOUT|2020-11-06|90
e|SS|2f1073e4-607f-423f-a5de-f531b828e2d3|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|6|TREATMENT|2020-10-15|10
e|SS|2f1073e4-607f-423f-a5de-f531b828e2d3|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|FOLLOW-UP|2020-10-15|10
e|SS|2f1073e4-607f-423f-a5de-f531b828e2d3|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|7|FOLLOW-UP|2020-10-30|25
e|SS|2f1073e4-607f-423f-a5de-f531b828e2d3|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|4|FOLLOW-UP|2020-10-30|25
e|SS|2f1073e4-607f-423f-a5de-f531b828e2d3|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|2|WASHOUT|2020-11-14|40
e|SS|2f1073e4-607f-423f-a5de-f531b828e2d3|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|5|SCREENING|2020-11-14|40
e|SS|2f1073e4-607f-423f-a5de-f531b828e2d3|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|5|TREATMENT|2020-12-09|65
e|SS|2f1073e4-607f-423f-a5de-f531b828e2d3|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|3|SCREENING|2020-12-09|65
e|SS|2f1073e4-607f-423f-a5de-f531b828e2d3|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|1|TREATMENT|2021-01-03|90
e|SS|2f1073e4-607f-423f-a5de-f531b828e2d3|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|TREATMENT|2021-01-03|90
e|SS|df466903-3212-4e73-bff0-a183447c7408|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|WASHOUT|2020-11-01|10
e|SS|df466903-3212-4e73-bff0-a183447c7408|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|5|WASHOUT|2020-11-01|10
e|SS|df466903-3212-4e73-bff0-a183447c7408|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|5|TREATMENT|2020-11-16|25
e|SS|df466903-3212-4e73-bff0-a183447c7408|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|2|FOLLOW-UP|2020-11-16|25
e|SS|df466903-3212-4e73-bff0-a183447c7408|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|TREATMENT|2020-12-01|40
e|SS|df466903-3212-4e73-bff0-a183447c7408|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|2|TREATMENT|2020-12-01|40
e|SS|df466903-3212-4e73-bff0-a183447c7408|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|5|FOLLOW-UP|2020-12-26|65
e|SS|df466903-3212-4e73-bff0-a183447c7408|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|4|WASHOUT|2020-12-26|65
e|SS|df466903-3212-4e73-bff0-a183447c7408|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|7|TREATMENT|2021-01-20|90
e|SS|df466903-3212-4e73-bff0-a183447c7408|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|3|TREATMENT|2021-01-20|90
e|SS|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|TREATMENT|2020-07-13|10
e|SS|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|7|TREATMENT|2020-07-13|10
e|SS|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|2|TREATMENT|2020-07-28|25
e|SS|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-07-28|25
e|SS|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|2|WASHOUT|2020-08-12|40
e|SS|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|6|SCREENING|2020-08-12|40
e|SS|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|TREATMENT|2020-09-06|65
e|SS|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|FOLLOW-UP|2020-09-06|65
e|SS|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|7|WASHOUT|2020-10-01|90
e|SS|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|4|TREATMENT|2020-10-01|90
e|SS|c37df2f6-be8a-4709-b97d-061ab9754e0d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|5|TREATMENT|2020-08-01|10
e|SS|c37df2f6-be8a-4709-b97d-061ab9754e0d|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|7|FOLLOW-UP|2020-08-01|10
e|SS|c37df2f6-be8a-4709-b97d-061ab9754e0d|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|4|TREATMENT|2020-08-16|25
e|SS|c37df2f6-be8a-4709-b97d-061ab9754e0d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|5|WASHOUT|2020-08-16|25
e|SS|c37df2f6-be8a-4709-b97d-061ab9754e0d|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|7|TREATMENT|2020-08-31|40
e|SS|c37df2f6-be8a-4709-b97d-061ab9754e0d|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|7|SCREENING|2020-08-31|40
e|SS|c37df2f6-be8a-4709-b97d-061ab9754e0d|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|4|FOLLOW-UP|2020-09-25|65
e|SS|c37df2f6-be8a-4709-b97d-061ab9754e0d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|4|TREATMENT|2020-09-25|65
e|SS|c37df2f6-be8a-4709-b97d-061ab9754e0d|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|4|FOLLOW-UP|2020-10-20|90
e|SS|c37df2f6-be8a-4709-b97d-061ab9754e0d|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|4|SCREENING|2020-10-20|90
e|SS|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|FOLLOW-UP|2020-05-13|10
e|SS|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|WASHOUT|2020-05-13|10
e|SS|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|7|TREATMENT|2020-05-28|25
e|SS|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|3|WASHOUT|2020-05-28|25
e|SS|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|FOLLOW-UP|2020-06-12|40
e|SS|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|1|FOLLOW-UP|2020-06-12|40
e|SS|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|4|FOLLOW-UP|2020-07-07|65
e|SS|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2020-07-07|65
e|SS|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|4|TREATMENT|2020-08-01|90
e|SS|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|2|TREATMENT|2020-08-01|90
e|SS|cec9e0ce-4d09-470c-9c26-df661d316a69|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|7|SCREENING|2021-01-05|10
e|SS|cec9e0ce-4d09-470c-9c26-df661d316a69|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|6|TREATMENT|2021-01-05|10
e|SS|cec9e0ce-4d09-470c-9c26-df661d316a69|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|6|TREATMENT|2021-01-20|25
e|SS|cec9e0ce-4d09-470c-9c26-df661d316a69|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|7|TREATMENT|2021-01-20|25
e|SS|cec9e0ce-4d09-470c-9c26-df661d316a69|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|TREATMENT|2021-02-04|40
e|SS|cec9e0ce-4d09-470c-9c26-df661d316a69|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2021-02-04|40
e|SS|cec9e0ce-4d09-470c-9c26-df661d316a69|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|1|WASHOUT|2021-03-01|65
e|SS|cec9e0ce-4d09-470c-9c26-df661d316a69|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|6|TREATMENT|2021-03-01|65
e|SS|cec9e0ce-4d09-470c-9c26-df661d316a69|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|4|TREATMENT|2021-03-26|90
e|SS|cec9e0ce-4d09-470c-9c26-df661d316a69|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|4|WASHOUT|2021-03-26|90
e|SS|b98b4e19-51ac-40cc-80d5-cb6d8000c112|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|5|TREATMENT|2021-01-17|10
e|SS|b98b4e19-51ac-40cc-80d5-cb6d8000c112|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|1|WASHOUT|2021-01-17|10
e|SS|b98b4e19-51ac-40cc-80d5-cb6d8000c112|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|6|TREATMENT|2021-02-01|25
e|SS|b98b4e19-51ac-40cc-80d5-cb6d8000c112|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|4|TREATMENT|2021-02-01|25
e|SS|b98b4e19-51ac-40cc-80d5-cb6d8000c112|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|7|FOLLOW-UP|2021-02-16|40
e|SS|b98b4e19-51ac-40cc-80d5-cb6d8000c112|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|7|TREATMENT|2021-02-16|40
e|SS|b98b4e19-51ac-40cc-80d5-cb6d8000c112|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|6|FOLLOW-UP|2021-03-13|65
e|SS|b98b4e19-51ac-40cc-80d5-cb6d8000c112|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|1|TREATMENT|2021-03-13|65
e|SS|b98b4e19-51ac-40cc-80d5-cb6d8000c112|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|2|WASHOUT|2021-04-07|90
e|SS|b98b4e19-51ac-40cc-80d5-cb6d8000c112|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|4|TREATMENT|2021-04-07|90
e|SS|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|2|TREATMENT|2020-07-07|10
e|SS|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|2|WASHOUT|2020-07-07|10
e|SS|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|7|FOLLOW-UP|2020-07-22|25
e|SS|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|1|SCREENING|2020-07-22|25
e|SS|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|6|FOLLOW-UP|2020-08-06|40
e|SS|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|7|SCREENING|2020-08-06|40
e|SS|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|3|TREATMENT|2020-08-31|65
e|SS|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|1|TREATMENT|2020-08-31|65
e|SS|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|2|FOLLOW-UP|2020-09-25|90
e|SS|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|6|WASHOUT|2020-09-25|90
e|SS|4bc30b18-c8d8-41a3-91d5-33b8b064087b|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|3|TREATMENT|2020-07-12|10
e|SS|4bc30b18-c8d8-41a3-91d5-33b8b064087b|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|2|FOLLOW-UP|2020-07-12|10
e|SS|4bc30b18-c8d8-41a3-91d5-33b8b064087b|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|1|WASHOUT|2020-07-27|25
e|SS|4bc30b18-c8d8-41a3-91d5-33b8b064087b|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|5|TREATMENT|2020-07-27|25
e|SS|4bc30b18-c8d8-41a3-91d5-33b8b064087b|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|WASHOUT|2020-08-11|40
e|SS|4bc30b18-c8d8-41a3-91d5-33b8b064087b|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|4|TREATMENT|2020-08-11|40
e|SS|4bc30b18-c8d8-41a3-91d5-33b8b064087b|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|TREATMENT|2020-09-05|65
e|SS|4bc30b18-c8d8-41a3-91d5-33b8b064087b|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|3|SCREENING|2020-09-05|65
e|SS|4bc30b18-c8d8-41a3-91d5-33b8b064087b|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|1|TREATMENT|2020-09-30|90
e|SS|4bc30b18-c8d8-41a3-91d5-33b8b064087b|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|2|SCREENING|2020-09-30|90
e|SS|7ff27a70-0472-4cc1-b057-6b161ab29568|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|4|TREATMENT|2020-11-19|10
e|SS|7ff27a70-0472-4cc1-b057-6b161ab29568|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|FOLLOW-UP|2020-11-19|10
e|SS|7ff27a70-0472-4cc1-b057-6b161ab29568|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|WASHOUT|2020-12-04|25
e|SS|7ff27a70-0472-4cc1-b057-6b161ab29568|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|3|FOLLOW-UP|2020-12-04|25
e|SS|7ff27a70-0472-4cc1-b057-6b161ab29568|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|6|WASHOUT|2020-12-19|40
e|SS|7ff27a70-0472-4cc1-b057-6b161ab29568|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|6|TREATMENT|2020-12-19|40
e|SS|7ff27a70-0472-4cc1-b057-6b161ab29568|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|1|FOLLOW-UP|2021-01-13|65
e|SS|7ff27a70-0472-4cc1-b057-6b161ab29568|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|4|WASHOUT|2021-01-13|65
e|SS|7ff27a70-0472-4cc1-b057-6b161ab29568|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|3|TREATMENT|2021-02-07|90
e|SS|7ff27a70-0472-4cc1-b057-6b161ab29568|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|2|TREATMENT|2021-02-07|90
e|SS|40529b01-9a80-4ada-a8df-96eec0e65043|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|7|TREATMENT|2020-06-17|10
e|SS|40529b01-9a80-4ada-a8df-96eec0e65043|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|4|FOLLOW-UP|2020-06-17|10
e|SS|40529b01-9a80-4ada-a8df-96eec0e65043|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|1|TREATMENT|2020-07-02|25
e|SS|40529b01-9a80-4ada-a8df-96eec0e65043|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|6|WASHOUT|2020-07-02|25
e|SS|40529b01-9a80-4ada-a8df-96eec0e65043|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|4|WASHOUT|2020-07-17|40
e|SS|40529b01-9a80-4ada-a8df-96eec0e65043|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|5|TREATMENT|2020-07-17|40
e|SS|40529b01-9a80-4ada-a8df-96eec0e65043|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|6|TREATMENT|2020-08-11|65
e|SS|40529b01-9a80-4ada-a8df-96eec0e65043|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|TREATMENT|2020-08-11|65
e|SS|40529b01-9a80-4ada-a8df-96eec0e65043|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|3|TREATMENT|2020-09-05|90
e|SS|40529b01-9a80-4ada-a8df-96eec0e65043|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|4|WASHOUT|2020-09-05|90
e|SS|f3e22efc-0948-4c6e-9173-8e284d342d33|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|4|SCREENING|2020-12-06|10
e|SS|f3e22efc-0948-4c6e-9173-8e284d342d33|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|2|SCREENING|2020-12-06|10
e|SS|f3e22efc-0948-4c6e-9173-8e284d342d33|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|2|FOLLOW-UP|2020-12-21|25
e|SS|f3e22efc-0948-4c6e-9173-8e284d342d33|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|7|FOLLOW-UP|2020-12-21|25
e|SS|f3e22efc-0948-4c6e-9173-8e284d342d33|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|5|WASHOUT|2021-01-05|40
e|SS|f3e22efc-0948-4c6e-9173-8e284d342d33|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|1|SCREENING|2021-01-05|40
e|SS|f3e22efc-0948-4c6e-9173-8e284d342d33|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|2|TREATMENT|2021-01-30|65
e|SS|f3e22efc-0948-4c6e-9173-8e284d342d33|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|WASHOUT|2021-01-30|65
e|SS|f3e22efc-0948-4c6e-9173-8e284d342d33|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|1|FOLLOW-UP|2021-02-24|90
e|SS|f3e22efc-0948-4c6e-9173-8e284d342d33|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|3|TREATMENT|2021-02-24|90
e|SS|919eb5b4-a3df-41c6-86f7-c78501bb4335|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|2|FOLLOW-UP|2020-10-01|10
e|SS|919eb5b4-a3df-41c6-86f7-c78501bb4335|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|SCREENING|2020-10-01|10
e|SS|919eb5b4-a3df-41c6-86f7-c78501bb4335|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|5|WASHOUT|2020-10-16|25
e|SS|919eb5b4-a3df-41c6-86f7-c78501bb4335|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|1|TREATMENT|2020-10-16|25
e|SS|919eb5b4-a3df-41c6-86f7-c78501bb4335|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|5|TREATMENT|2020-10-31|40
e|SS|919eb5b4-a3df-41c6-86f7-c78501bb4335|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|6|WASHOUT|2020-10-31|40
e|SS|919eb5b4-a3df-41c6-86f7-c78501bb4335|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|4|SCREENING|2020-11-25|65
e|SS|919eb5b4-a3df-41c6-86f7-c78501bb4335|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|TREATMENT|2020-11-25|65
e|SS|919eb5b4-a3df-41c6-86f7-c78501bb4335|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|3|FOLLOW-UP|2020-12-20|90
e|SS|919eb5b4-a3df-41c6-86f7-c78501bb4335|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|2|WASHOUT|2020-12-20|90
e|SS|f918d6e0-6fc2-4303-b323-521c5d531773|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|FOLLOW-UP|2020-07-31|10
e|SS|f918d6e0-6fc2-4303-b323-521c5d531773|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|7|FOLLOW-UP|2020-07-31|10
e|SS|f918d6e0-6fc2-4303-b323-521c5d531773|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|3|TREATMENT|2020-08-15|25
e|SS|f918d6e0-6fc2-4303-b323-521c5d531773|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|6|WASHOUT|2020-08-15|25
e|SS|f918d6e0-6fc2-4303-b323-521c5d531773|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|WASHOUT|2020-08-30|40
e|SS|f918d6e0-6fc2-4303-b323-521c5d531773|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|7|TREATMENT|2020-08-30|40
e|SS|f918d6e0-6fc2-4303-b323-521c5d531773|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|3|TREATMENT|2020-09-24|65
e|SS|f918d6e0-6fc2-4303-b323-521c5d531773|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|1|SCREENING|2020-09-24|65
e|SS|f918d6e0-6fc2-4303-b323-521c5d531773|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|4|WASHOUT|2020-10-19|90
e|SS|f918d6e0-6fc2-4303-b323-521c5d531773|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|4|TREATMENT|2020-10-19|90
e|SS|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|FOLLOW-UP|2020-11-24|10
e|SS|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|4|WASHOUT|2020-11-24|10
e|SS|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|TREATMENT|2020-12-09|25
e|SS|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|1|WASHOUT|2020-12-09|25
e|SS|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|7|SCREENING|2020-12-24|40
e|SS|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|3|FOLLOW-UP|2020-12-24|40
e|SS|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|1|TREATMENT|2021-01-18|65
e|SS|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|4|TREATMENT|2021-01-18|65
e|SS|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|4|FOLLOW-UP|2021-02-12|90
e|SS|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|6|WASHOUT|2021-02-12|90
e|SS|4b1e011f-a16d-4ff6-902d-451d5d13ee97|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|TREATMENT|2020-06-21|10
e|SS|4b1e011f-a16d-4ff6-902d-451d5d13ee97|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|5|TREATMENT|2020-06-21|10
e|SS|4b1e011f-a16d-4ff6-902d-451d5d13ee97|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|7|TREATMENT|2020-07-06|25
e|SS|4b1e011f-a16d-4ff6-902d-451d5d13ee97|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|7|TREATMENT|2020-07-06|25
e|SS|4b1e011f-a16d-4ff6-902d-451d5d13ee97|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|7|SCREENING|2020-07-21|40
e|SS|4b1e011f-a16d-4ff6-902d-451d5d13ee97|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|7|TREATMENT|2020-07-21|40
e|SS|4b1e011f-a16d-4ff6-902d-451d5d13ee97|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|1|TREATMENT|2020-08-15|65
e|SS|4b1e011f-a16d-4ff6-902d-451d5d13ee97|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|3|WASHOUT|2020-08-15|65
e|SS|4b1e011f-a16d-4ff6-902d-451d5d13ee97|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|3|TREATMENT|2020-09-09|90
e|SS|4b1e011f-a16d-4ff6-902d-451d5d13ee97|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|6|TREATMENT|2020-09-09|90
e|SS|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|2|TREATMENT|2020-07-19|10
e|SS|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|3|TREATMENT|2020-07-19|10
e|SS|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|6|FOLLOW-UP|2020-08-03|25
e|SS|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|3|TREATMENT|2020-08-03|25
e|SS|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|4|FOLLOW-UP|2020-08-18|40
e|SS|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|6|WASHOUT|2020-08-18|40
e|SS|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|6|WASHOUT|2020-09-12|65
e|SS|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|7|TREATMENT|2020-09-12|65
e|SS|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|FOLLOW-UP|2020-10-07|90
e|SS|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|7|TREATMENT|2020-10-07|90
e|SS|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|3|FOLLOW-UP|2020-11-27|10
e|SS|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|2|TREATMENT|2020-11-27|10
e|SS|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-12-12|25
e|SS|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|3|TREATMENT|2020-12-12|25
e|SS|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|2|FOLLOW-UP|2020-12-27|40
e|SS|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2020-12-27|40
e|SS|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|6|FOLLOW-UP|2021-01-21|65
e|SS|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|3|SCREENING|2021-01-21|65
e|SS|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|1|TREATMENT|2021-02-15|90
e|SS|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|4|TREATMENT|2021-02-15|90
e|SS|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|FOLLOW-UP|2020-12-09|10
e|SS|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|6|TREATMENT|2020-12-09|10
e|SS|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|2|TREATMENT|2020-12-24|25
e|SS|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|2|SCREENING|2020-12-24|25
e|SS|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|3|TREATMENT|2021-01-08|40
e|SS|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|SCREENING|2021-01-08|40
e|SS|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|6|SCREENING|2021-02-02|65
e|SS|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|7|TREATMENT|2021-02-02|65
e|SS|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|1|TREATMENT|2021-02-27|90
e|SS|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|3|TREATMENT|2021-02-27|90
e|SS|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|TREATMENT|2020-07-06|10
e|SS|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|FOLLOW-UP|2020-07-06|10
e|SS|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|5|SCREENING|2020-07-21|25
e|SS|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|5|TREATMENT|2020-07-21|25
e|SS|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|7|TREATMENT|2020-08-05|40
e|SS|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|1|FOLLOW-UP|2020-08-05|40
e|SS|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|7|FOLLOW-UP|2020-08-30|65
e|SS|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2020-08-30|65
e|SS|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|4|TREATMENT|2020-09-24|90
e|SS|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2020-09-24|90
e|SS|7f1e0661-ebbd-4abd-9031-cb6b424977e2|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|5|TREATMENT|2020-12-13|10
e|SS|7f1e0661-ebbd-4abd-9031-cb6b424977e2|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|7|SCREENING|2020-12-13|10
e|SS|7f1e0661-ebbd-4abd-9031-cb6b424977e2|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|3|FOLLOW-UP|2020-12-28|25
e|SS|7f1e0661-ebbd-4abd-9031-cb6b424977e2|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|3|TREATMENT|2020-12-28|25
e|SS|7f1e0661-ebbd-4abd-9031-cb6b424977e2|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|1|TREATMENT|2021-01-12|40
e|SS|7f1e0661-ebbd-4abd-9031-cb6b424977e2|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|1|FOLLOW-UP|2021-01-12|40
e|SS|7f1e0661-ebbd-4abd-9031-cb6b424977e2|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|5|TREATMENT|2021-02-06|65
e|SS|7f1e0661-ebbd-4abd-9031-cb6b424977e2|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|2|SCREENING|2021-02-06|65
e|SS|7f1e0661-ebbd-4abd-9031-cb6b424977e2|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|7|SCREENING|2021-03-03|90
e|SS|7f1e0661-ebbd-4abd-9031-cb6b424977e2|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|6|TREATMENT|2021-03-03|90
e|SS|324a2c67-4802-4806-aff2-04fb9c7394d4|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|7|TREATMENT|2020-05-27|10
e|SS|324a2c67-4802-4806-aff2-04fb9c7394d4|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|1|TREATMENT|2020-05-27|10
e|SS|324a2c67-4802-4806-aff2-04fb9c7394d4|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|7|TREATMENT|2020-06-11|25
e|SS|324a2c67-4802-4806-aff2-04fb9c7394d4|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|WASHOUT|2020-06-11|25
e|SS|324a2c67-4802-4806-aff2-04fb9c7394d4|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|5|FOLLOW-UP|2020-06-26|40
e|SS|324a2c67-4802-4806-aff2-04fb9c7394d4|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|2|SCREENING|2020-06-26|40
e|SS|324a2c67-4802-4806-aff2-04fb9c7394d4|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|1|SCREENING|2020-07-21|65
e|SS|324a2c67-4802-4806-aff2-04fb9c7394d4|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|7|TREATMENT|2020-07-21|65
e|SS|324a2c67-4802-4806-aff2-04fb9c7394d4|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|1|SCREENING|2020-08-15|90
e|SS|324a2c67-4802-4806-aff2-04fb9c7394d4|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|TREATMENT|2020-08-15|90
e|SS|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|2|TREATMENT|2020-12-19|10
e|SS|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|1|TREATMENT|2020-12-19|10
e|SS|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|1|TREATMENT|2021-01-03|25
e|SS|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|4|TREATMENT|2021-01-03|25
e|SS|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|3|TREATMENT|2021-01-18|40
e|SS|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|7|SCREENING|2021-01-18|40
e|SS|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|6|TREATMENT|2021-02-12|65
e|SS|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|2|TREATMENT|2021-02-12|65
e|SS|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|2|FOLLOW-UP|2021-03-09|90
e|SS|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|1|TREATMENT|2021-03-09|90
e|SS|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|WASHOUT|2020-08-24|10
e|SS|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|3|TREATMENT|2020-08-24|10
e|SS|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|1|TREATMENT|2020-09-08|25
e|SS|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|WASHOUT|2020-09-08|25
e|SS|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|7|TREATMENT|2020-09-23|40
e|SS|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|2|WASHOUT|2020-09-23|40
e|SS|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|4|WASHOUT|2020-10-18|65
e|SS|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|4|SCREENING|2020-10-18|65
e|SS|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|2|WASHOUT|2020-11-12|90
e|SS|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|1|FOLLOW-UP|2020-11-12|90
e|SS|911dc297-91cb-42b1-8a26-18f6c83c32a6|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|WASHOUT|2020-12-01|10
e|SS|911dc297-91cb-42b1-8a26-18f6c83c32a6|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|1|TREATMENT|2020-12-01|10
e|SS|911dc297-91cb-42b1-8a26-18f6c83c32a6|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|1|SCREENING|2020-12-16|25
e|SS|911dc297-91cb-42b1-8a26-18f6c83c32a6|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-12-16|25
e|SS|911dc297-91cb-42b1-8a26-18f6c83c32a6|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-12-31|40
e|SS|911dc297-91cb-42b1-8a26-18f6c83c32a6|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|7|TREATMENT|2020-12-31|40
e|SS|911dc297-91cb-42b1-8a26-18f6c83c32a6|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|FOLLOW-UP|2021-01-25|65
e|SS|911dc297-91cb-42b1-8a26-18f6c83c32a6|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|7|WASHOUT|2021-01-25|65
e|SS|911dc297-91cb-42b1-8a26-18f6c83c32a6|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|4|TREATMENT|2021-02-19|90
e|SS|911dc297-91cb-42b1-8a26-18f6c83c32a6|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|2|TREATMENT|2021-02-19|90
e|SS|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|4|TREATMENT|2020-11-25|10
e|SS|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|7|TREATMENT|2020-11-25|10
e|SS|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|7|SCREENING|2020-12-10|25
e|SS|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|1|WASHOUT|2020-12-10|25
e|SS|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|WASHOUT|2020-12-25|40
e|SS|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|3|TREATMENT|2020-12-25|40
e|SS|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|4|TREATMENT|2021-01-19|65
e|SS|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|3|TREATMENT|2021-01-19|65
e|SS|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|3|TREATMENT|2021-02-13|90
e|SS|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|2|TREATMENT|2021-02-13|90
e|SS|9bfcd733-2233-4e54-a6cd-641a59fc8a01|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|5|SCREENING|2020-08-15|10
e|SS|9bfcd733-2233-4e54-a6cd-641a59fc8a01|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|4|SCREENING|2020-08-15|10
e|SS|9bfcd733-2233-4e54-a6cd-641a59fc8a01|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|1|FOLLOW-UP|2020-08-30|25
e|SS|9bfcd733-2233-4e54-a6cd-641a59fc8a01|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|2|FOLLOW-UP|2020-08-30|25
e|SS|9bfcd733-2233-4e54-a6cd-641a59fc8a01|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|3|TREATMENT|2020-09-14|40
e|SS|9bfcd733-2233-4e54-a6cd-641a59fc8a01|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|1|SCREENING|2020-09-14|40
e|SS|9bfcd733-2233-4e54-a6cd-641a59fc8a01|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|4|SCREENING|2020-10-09|65
e|SS|9bfcd733-2233-4e54-a6cd-641a59fc8a01|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|4|TREATMENT|2020-10-09|65
e|SS|9bfcd733-2233-4e54-a6cd-641a59fc8a01|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|3|TREATMENT|2020-11-03|90
e|SS|9bfcd733-2233-4e54-a6cd-641a59fc8a01|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|7|WASHOUT|2020-11-03|90
e|SS|7eb97152-173c-4923-8604-5dad3140cc25|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|3|SCREENING|2020-09-05|10
e|SS|7eb97152-173c-4923-8604-5dad3140cc25|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|4|WASHOUT|2020-09-05|10
e|SS|7eb97152-173c-4923-8604-5dad3140cc25|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|7|FOLLOW-UP|2020-09-20|25
e|SS|7eb97152-173c-4923-8604-5dad3140cc25|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|7|TREATMENT|2020-09-20|25
e|SS|7eb97152-173c-4923-8604-5dad3140cc25|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|WASHOUT|2020-10-05|40
e|SS|7eb97152-173c-4923-8604-5dad3140cc25|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|6|TREATMENT|2020-10-05|40
e|SS|7eb97152-173c-4923-8604-5dad3140cc25|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|2|TREATMENT|2020-10-30|65
e|SS|7eb97152-173c-4923-8604-5dad3140cc25|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|3|SCREENING|2020-10-30|65
e|SS|7eb97152-173c-4923-8604-5dad3140cc25|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|1|SCREENING|2020-11-24|90
e|SS|7eb97152-173c-4923-8604-5dad3140cc25|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|5|SCREENING|2020-11-24|90
e|SS|0b2104d0-e1e3-4516-8c4b-de5d42f82784|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|5|TREATMENT|2020-08-08|10
e|SS|0b2104d0-e1e3-4516-8c4b-de5d42f82784|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|4|WASHOUT|2020-08-08|10
e|SS|0b2104d0-e1e3-4516-8c4b-de5d42f82784|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|4|WASHOUT|2020-08-23|25
e|SS|0b2104d0-e1e3-4516-8c4b-de5d42f82784|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|2|WASHOUT|2020-08-23|25
e|SS|0b2104d0-e1e3-4516-8c4b-de5d42f82784|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|1|TREATMENT|2020-09-07|40
e|SS|0b2104d0-e1e3-4516-8c4b-de5d42f82784|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|2|WASHOUT|2020-09-07|40
e|SS|0b2104d0-e1e3-4516-8c4b-de5d42f82784|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|6|TREATMENT|2020-10-02|65
e|SS|0b2104d0-e1e3-4516-8c4b-de5d42f82784|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|1|FOLLOW-UP|2020-10-02|65
e|SS|0b2104d0-e1e3-4516-8c4b-de5d42f82784|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|6|TREATMENT|2020-10-27|90
e|SS|0b2104d0-e1e3-4516-8c4b-de5d42f82784|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|WASHOUT|2020-10-27|90
e|SS|96f68979-6869-403b-a8bd-78c8f965f98a|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|2|FOLLOW-UP|2020-05-26|10
e|SS|96f68979-6869-403b-a8bd-78c8f965f98a|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|4|TREATMENT|2020-05-26|10
e|SS|96f68979-6869-403b-a8bd-78c8f965f98a|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|SCREENING|2020-06-10|25
e|SS|96f68979-6869-403b-a8bd-78c8f965f98a|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|5|TREATMENT|2020-06-10|25
e|SS|96f68979-6869-403b-a8bd-78c8f965f98a|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|6|TREATMENT|2020-06-25|40
e|SS|96f68979-6869-403b-a8bd-78c8f965f98a|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|7|SCREENING|2020-06-25|40
e|SS|96f68979-6869-403b-a8bd-78c8f965f98a|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|1|FOLLOW-UP|2020-07-20|65
e|SS|96f68979-6869-403b-a8bd-78c8f965f98a|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|7|TREATMENT|2020-07-20|65
e|SS|96f68979-6869-403b-a8bd-78c8f965f98a|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|4|WASHOUT|2020-08-14|90
e|SS|96f68979-6869-403b-a8bd-78c8f965f98a|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|2|WASHOUT|2020-08-14|90
e|SS|e0f67610-b86a-4f5a-88eb-905b1e0aa609|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|4|SCREENING|2020-10-16|10
e|SS|e0f67610-b86a-4f5a-88eb-905b1e0aa609|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-10-16|10
e|SS|e0f67610-b86a-4f5a-88eb-905b1e0aa609|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|6|FOLLOW-UP|2020-10-31|25
e|SS|e0f67610-b86a-4f5a-88eb-905b1e0aa609|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|5|SCREENING|2020-10-31|25
e|SS|e0f67610-b86a-4f5a-88eb-905b1e0aa609|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|1|TREATMENT|2020-11-15|40
e|SS|e0f67610-b86a-4f5a-88eb-905b1e0aa609|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2020-11-15|40
e|SS|e0f67610-b86a-4f5a-88eb-905b1e0aa609|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|2|TREATMENT|2020-12-10|65
e|SS|e0f67610-b86a-4f5a-88eb-905b1e0aa609|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|1|TREATMENT|2020-12-10|65
e|SS|e0f67610-b86a-4f5a-88eb-905b1e0aa609|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|4|TREATMENT|2021-01-04|90
e|SS|e0f67610-b86a-4f5a-88eb-905b1e0aa609|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|7|TREATMENT|2021-01-04|90
e|SS|d62dc655-8865-4592-af0b-744524d9a24c|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|2|TREATMENT|2020-09-29|10
e|SS|d62dc655-8865-4592-af0b-744524d9a24c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|2|FOLLOW-UP|2020-09-29|10
e|SS|d62dc655-8865-4592-af0b-744524d9a24c|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|1|TREATMENT|2020-10-14|25
e|SS|d62dc655-8865-4592-af0b-744524d9a24c|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|3|SCREENING|2020-10-14|25
e|SS|d62dc655-8865-4592-af0b-744524d9a24c|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|6|WASHOUT|2020-10-29|40
e|SS|d62dc655-8865-4592-af0b-744524d9a24c|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|3|SCREENING|2020-10-29|40
e|SS|d62dc655-8865-4592-af0b-744524d9a24c|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|2|TREATMENT|2020-11-23|65
e|SS|d62dc655-8865-4592-af0b-744524d9a24c|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|5|SCREENING|2020-11-23|65
e|SS|d62dc655-8865-4592-af0b-744524d9a24c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|1|TREATMENT|2020-12-18|90
e|SS|d62dc655-8865-4592-af0b-744524d9a24c|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|5|WASHOUT|2020-12-18|90
e|SS|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|5|TREATMENT|2021-01-08|10
e|SS|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|3|SCREENING|2021-01-08|10
e|SS|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|2|TREATMENT|2021-01-23|25
e|SS|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|3|SCREENING|2021-01-23|25
e|SS|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|1|TREATMENT|2021-02-07|40
e|SS|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|3|TREATMENT|2021-02-07|40
e|SS|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|2|FOLLOW-UP|2021-03-04|65
e|SS|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|4|FOLLOW-UP|2021-03-04|65
e|SS|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|4|SCREENING|2021-03-29|90
e|SS|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|3|FOLLOW-UP|2021-03-29|90
e|SS|8005bd56-3bd6-477a-a466-b9a3bd189770|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|1|SCREENING|2020-12-23|10
e|SS|8005bd56-3bd6-477a-a466-b9a3bd189770|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|6|FOLLOW-UP|2020-12-23|10
e|SS|8005bd56-3bd6-477a-a466-b9a3bd189770|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|3|FOLLOW-UP|2021-01-07|25
e|SS|8005bd56-3bd6-477a-a466-b9a3bd189770|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|7|TREATMENT|2021-01-07|25
e|SS|8005bd56-3bd6-477a-a466-b9a3bd189770|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|6|TREATMENT|2021-01-22|40
e|SS|8005bd56-3bd6-477a-a466-b9a3bd189770|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|5|TREATMENT|2021-01-22|40
e|SS|8005bd56-3bd6-477a-a466-b9a3bd189770|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|6|SCREENING|2021-02-16|65
e|SS|8005bd56-3bd6-477a-a466-b9a3bd189770|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|1|TREATMENT|2021-02-16|65
e|SS|8005bd56-3bd6-477a-a466-b9a3bd189770|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|6|FOLLOW-UP|2021-03-13|90
e|SS|8005bd56-3bd6-477a-a466-b9a3bd189770|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|6|TREATMENT|2021-03-13|90
e|SS|078ea33d-4114-4320-9116-740b8385a94e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|3|TREATMENT|2020-07-26|10
e|SS|078ea33d-4114-4320-9116-740b8385a94e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|1|TREATMENT|2020-07-26|10
e|SS|078ea33d-4114-4320-9116-740b8385a94e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|2|TREATMENT|2020-08-10|25
e|SS|078ea33d-4114-4320-9116-740b8385a94e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|3|FOLLOW-UP|2020-08-10|25
e|SS|078ea33d-4114-4320-9116-740b8385a94e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|3|TREATMENT|2020-08-25|40
e|SS|078ea33d-4114-4320-9116-740b8385a94e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|7|TREATMENT|2020-08-25|40
e|SS|078ea33d-4114-4320-9116-740b8385a94e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|2|TREATMENT|2020-09-19|65
e|SS|078ea33d-4114-4320-9116-740b8385a94e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|3|SCREENING|2020-09-19|65
e|SS|078ea33d-4114-4320-9116-740b8385a94e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|1|TREATMENT|2020-10-14|90
e|SS|078ea33d-4114-4320-9116-740b8385a94e|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2020-10-14|90
e|SS|1ca91975-9a42-4f4d-9c55-53f7561d82fa|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|5|FOLLOW-UP|2020-06-03|10
e|SS|1ca91975-9a42-4f4d-9c55-53f7561d82fa|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|6|TREATMENT|2020-06-03|10
e|SS|1ca91975-9a42-4f4d-9c55-53f7561d82fa|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|6|TREATMENT|2020-06-18|25
e|SS|1ca91975-9a42-4f4d-9c55-53f7561d82fa|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|4|TREATMENT|2020-06-18|25
e|SS|1ca91975-9a42-4f4d-9c55-53f7561d82fa|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|1|FOLLOW-UP|2020-07-03|40
e|SS|1ca91975-9a42-4f4d-9c55-53f7561d82fa|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|1|SCREENING|2020-07-03|40
e|SS|1ca91975-9a42-4f4d-9c55-53f7561d82fa|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|3|FOLLOW-UP|2020-07-28|65
e|SS|1ca91975-9a42-4f4d-9c55-53f7561d82fa|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|1|WASHOUT|2020-07-28|65
e|SS|1ca91975-9a42-4f4d-9c55-53f7561d82fa|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|1|FOLLOW-UP|2020-08-22|90
e|SS|1ca91975-9a42-4f4d-9c55-53f7561d82fa|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|5|TREATMENT|2020-08-22|90
e|SS|c5f292ad-1729-402b-820f-83ecd29ba00d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|1|TREATMENT|2020-06-08|10
e|SS|c5f292ad-1729-402b-820f-83ecd29ba00d|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|1|WASHOUT|2020-06-08|10
e|SS|c5f292ad-1729-402b-820f-83ecd29ba00d|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|4|FOLLOW-UP|2020-06-23|25
e|SS|c5f292ad-1729-402b-820f-83ecd29ba00d|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|4|FOLLOW-UP|2020-06-23|25
e|SS|c5f292ad-1729-402b-820f-83ecd29ba00d|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-07-08|40
e|SS|c5f292ad-1729-402b-820f-83ecd29ba00d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|6|SCREENING|2020-07-08|40
e|SS|c5f292ad-1729-402b-820f-83ecd29ba00d|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|WASHOUT|2020-08-02|65
e|SS|c5f292ad-1729-402b-820f-83ecd29ba00d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|FOLLOW-UP|2020-08-02|65
e|SS|c5f292ad-1729-402b-820f-83ecd29ba00d|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|3|TREATMENT|2020-08-27|90
e|SS|c5f292ad-1729-402b-820f-83ecd29ba00d|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|7|TREATMENT|2020-08-27|90
e|SS|a746aefb-16c8-43db-a0c4-8e9a4efdb244|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|3|FOLLOW-UP|2020-06-27|10
e|SS|a746aefb-16c8-43db-a0c4-8e9a4efdb244|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|4|WASHOUT|2020-06-27|10
e|SS|a746aefb-16c8-43db-a0c4-8e9a4efdb244|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|1|FOLLOW-UP|2020-07-12|25
e|SS|a746aefb-16c8-43db-a0c4-8e9a4efdb244|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|TREATMENT|2020-07-12|25
e|SS|a746aefb-16c8-43db-a0c4-8e9a4efdb244|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|2|WASHOUT|2020-07-27|40
e|SS|a746aefb-16c8-43db-a0c4-8e9a4efdb244|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2020-07-27|40
e|SS|a746aefb-16c8-43db-a0c4-8e9a4efdb244|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|3|WASHOUT|2020-08-21|65
e|SS|a746aefb-16c8-43db-a0c4-8e9a4efdb244|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|5|TREATMENT|2020-08-21|65
e|SS|a746aefb-16c8-43db-a0c4-8e9a4efdb244|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|3|WASHOUT|2020-09-15|90
e|SS|a746aefb-16c8-43db-a0c4-8e9a4efdb244|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|3|TREATMENT|2020-09-15|90
e|SS|7f95b9c0-3b77-4c60-8890-ecc955f97122|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|3|FOLLOW-UP|2020-09-25|10
e|SS|7f95b9c0-3b77-4c60-8890-ecc955f97122|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|2|SCREENING|2020-09-25|10
e|SS|7f95b9c0-3b77-4c60-8890-ecc955f97122|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|5|SCREENING|2020-10-10|25
e|SS|7f95b9c0-3b77-4c60-8890-ecc955f97122|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2020-10-10|25
e|SS|7f95b9c0-3b77-4c60-8890-ecc955f97122|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|3|TREATMENT|2020-10-25|40
e|SS|7f95b9c0-3b77-4c60-8890-ecc955f97122|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|3|SCREENING|2020-10-25|40
e|SS|7f95b9c0-3b77-4c60-8890-ecc955f97122|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|2|TREATMENT|2020-11-19|65
e|SS|7f95b9c0-3b77-4c60-8890-ecc955f97122|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|6|TREATMENT|2020-11-19|65
e|SS|7f95b9c0-3b77-4c60-8890-ecc955f97122|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|1|WASHOUT|2020-12-14|90
e|SS|7f95b9c0-3b77-4c60-8890-ecc955f97122|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|1|TREATMENT|2020-12-14|90
e|SS|2be43c56-83f3-4148-9cb1-97c6d191d20e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|6|TREATMENT|2020-10-03|10
e|SS|2be43c56-83f3-4148-9cb1-97c6d191d20e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|4|TREATMENT|2020-10-03|10
e|SS|2be43c56-83f3-4148-9cb1-97c6d191d20e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|1|WASHOUT|2020-10-18|25
e|SS|2be43c56-83f3-4148-9cb1-97c6d191d20e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|3|FOLLOW-UP|2020-10-18|25
e|SS|2be43c56-83f3-4148-9cb1-97c6d191d20e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|1|WASHOUT|2020-11-02|40
e|SS|2be43c56-83f3-4148-9cb1-97c6d191d20e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|4|FOLLOW-UP|2020-11-02|40
e|SS|2be43c56-83f3-4148-9cb1-97c6d191d20e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|4|TREATMENT|2020-11-27|65
e|SS|2be43c56-83f3-4148-9cb1-97c6d191d20e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|3|TREATMENT|2020-11-27|65
e|SS|2be43c56-83f3-4148-9cb1-97c6d191d20e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|2|WASHOUT|2020-12-22|90
e|SS|2be43c56-83f3-4148-9cb1-97c6d191d20e|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|1|FOLLOW-UP|2020-12-22|90
e|SS|e27e0325-5fbe-46c0-8264-982d83124203|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|6|WASHOUT|2020-07-07|10
e|SS|e27e0325-5fbe-46c0-8264-982d83124203|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|TREATMENT|2020-07-07|10
e|SS|e27e0325-5fbe-46c0-8264-982d83124203|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|4|TREATMENT|2020-07-22|25
e|SS|e27e0325-5fbe-46c0-8264-982d83124203|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|5|FOLLOW-UP|2020-07-22|25
e|SS|e27e0325-5fbe-46c0-8264-982d83124203|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|6|SCREENING|2020-08-06|40
e|SS|e27e0325-5fbe-46c0-8264-982d83124203|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|6|TREATMENT|2020-08-06|40
e|SS|e27e0325-5fbe-46c0-8264-982d83124203|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|2|WASHOUT|2020-08-31|65
e|SS|e27e0325-5fbe-46c0-8264-982d83124203|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|SCREENING|2020-08-31|65
e|SS|e27e0325-5fbe-46c0-8264-982d83124203|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|2|WASHOUT|2020-09-25|90
e|SS|e27e0325-5fbe-46c0-8264-982d83124203|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|2|TREATMENT|2020-09-25|90
e|SS|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|4|FOLLOW-UP|2020-12-19|10
e|SS|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|7|WASHOUT|2020-12-19|10
e|SS|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|2|TREATMENT|2021-01-03|25
e|SS|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|FOLLOW-UP|2021-01-03|25
e|SS|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|6|TREATMENT|2021-01-18|40
e|SS|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|7|WASHOUT|2021-01-18|40
e|SS|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|6|TREATMENT|2021-02-12|65
e|SS|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|2|TREATMENT|2021-02-12|65
e|SS|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|7|SCREENING|2021-03-09|90
e|SS|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|SCREENING|2021-03-09|90
e|SS|29e08650-9eae-461f-981e-f2a20d8d4492|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|1|TREATMENT|2020-11-17|10
e|SS|29e08650-9eae-461f-981e-f2a20d8d4492|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|5|FOLLOW-UP|2020-11-17|10
e|SS|29e08650-9eae-461f-981e-f2a20d8d4492|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-12-02|25
e|SS|29e08650-9eae-461f-981e-f2a20d8d4492|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|6|TREATMENT|2020-12-02|25
e|SS|29e08650-9eae-461f-981e-f2a20d8d4492|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|3|FOLLOW-UP|2020-12-17|40
e|SS|29e08650-9eae-461f-981e-f2a20d8d4492|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|2|SCREENING|2020-12-17|40
e|SS|29e08650-9eae-461f-981e-f2a20d8d4492|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|7|FOLLOW-UP|2021-01-11|65
e|SS|29e08650-9eae-461f-981e-f2a20d8d4492|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2021-01-11|65
e|SS|29e08650-9eae-461f-981e-f2a20d8d4492|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|7|SCREENING|2021-02-05|90
e|SS|29e08650-9eae-461f-981e-f2a20d8d4492|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|WASHOUT|2021-02-05|90
e|SS|2b944a62-10bc-475e-a90d-da3f07a2c4df|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2020-09-01|10
e|SS|2b944a62-10bc-475e-a90d-da3f07a2c4df|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|TREATMENT|2020-09-01|10
e|SS|2b944a62-10bc-475e-a90d-da3f07a2c4df|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|5|SCREENING|2020-09-16|25
e|SS|2b944a62-10bc-475e-a90d-da3f07a2c4df|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|3|FOLLOW-UP|2020-09-16|25
e|SS|2b944a62-10bc-475e-a90d-da3f07a2c4df|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|5|SCREENING|2020-10-01|40
e|SS|2b944a62-10bc-475e-a90d-da3f07a2c4df|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|SCREENING|2020-10-01|40
e|SS|2b944a62-10bc-475e-a90d-da3f07a2c4df|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|TREATMENT|2020-10-26|65
e|SS|2b944a62-10bc-475e-a90d-da3f07a2c4df|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|7|TREATMENT|2020-10-26|65
e|SS|2b944a62-10bc-475e-a90d-da3f07a2c4df|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|7|FOLLOW-UP|2020-11-20|90
e|SS|2b944a62-10bc-475e-a90d-da3f07a2c4df|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|4|TREATMENT|2020-11-20|90
e|SS|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|7|TREATMENT|2020-09-09|10
e|SS|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|6|SCREENING|2020-09-09|10
e|SS|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|1|SCREENING|2020-09-24|25
e|SS|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|4|TREATMENT|2020-09-24|25
e|SS|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|2|TREATMENT|2020-10-09|40
e|SS|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|6|SCREENING|2020-10-09|40
e|SS|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|6|FOLLOW-UP|2020-11-03|65
e|SS|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|7|TREATMENT|2020-11-03|65
e|SS|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2020-11-28|90
e|SS|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|2|SCREENING|2020-11-28|90
e|SS|8aa77db3-b078-4073-a7f3-9b9a7fb14570|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|7|WASHOUT|2020-11-12|10
e|SS|8aa77db3-b078-4073-a7f3-9b9a7fb14570|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|3|WASHOUT|2020-11-12|10
e|SS|8aa77db3-b078-4073-a7f3-9b9a7fb14570|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|4|WASHOUT|2020-11-27|25
e|SS|8aa77db3-b078-4073-a7f3-9b9a7fb14570|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2020-11-27|25
e|SS|8aa77db3-b078-4073-a7f3-9b9a7fb14570|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2020-12-12|40
e|SS|8aa77db3-b078-4073-a7f3-9b9a7fb14570|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|1|SCREENING|2020-12-12|40
e|SS|8aa77db3-b078-4073-a7f3-9b9a7fb14570|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|5|FOLLOW-UP|2021-01-06|65
e|SS|8aa77db3-b078-4073-a7f3-9b9a7fb14570|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|7|TREATMENT|2021-01-06|65
e|SS|8aa77db3-b078-4073-a7f3-9b9a7fb14570|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|4|TREATMENT|2021-01-31|90
e|SS|8aa77db3-b078-4073-a7f3-9b9a7fb14570|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|7|TREATMENT|2021-01-31|90
e|SS|1fce031b-680b-414f-9b74-d6383e10091d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|7|SCREENING|2020-05-31|10
e|SS|1fce031b-680b-414f-9b74-d6383e10091d|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|1|WASHOUT|2020-05-31|10
e|SS|1fce031b-680b-414f-9b74-d6383e10091d|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|WASHOUT|2020-06-15|25
e|SS|1fce031b-680b-414f-9b74-d6383e10091d|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|4|SCREENING|2020-06-15|25
e|SS|1fce031b-680b-414f-9b74-d6383e10091d|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|4|TREATMENT|2020-06-30|40
e|SS|1fce031b-680b-414f-9b74-d6383e10091d|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|2|WASHOUT|2020-06-30|40
e|SS|1fce031b-680b-414f-9b74-d6383e10091d|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|7|SCREENING|2020-07-25|65
e|SS|1fce031b-680b-414f-9b74-d6383e10091d|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|4|WASHOUT|2020-07-25|65
e|SS|1fce031b-680b-414f-9b74-d6383e10091d|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|7|TREATMENT|2020-08-19|90
e|SS|1fce031b-680b-414f-9b74-d6383e10091d|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2020-08-19|90
e|SS|dcc67696-e91a-4cef-81dd-f2d2711363ae|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|4|TREATMENT|2020-12-28|10
e|SS|dcc67696-e91a-4cef-81dd-f2d2711363ae|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|6|TREATMENT|2020-12-28|10
e|SS|dcc67696-e91a-4cef-81dd-f2d2711363ae|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|1|TREATMENT|2021-01-12|25
e|SS|dcc67696-e91a-4cef-81dd-f2d2711363ae|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|TREATMENT|2021-01-12|25
e|SS|dcc67696-e91a-4cef-81dd-f2d2711363ae|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|6|WASHOUT|2021-01-27|40
e|SS|dcc67696-e91a-4cef-81dd-f2d2711363ae|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|3|TREATMENT|2021-01-27|40
e|SS|dcc67696-e91a-4cef-81dd-f2d2711363ae|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|7|TREATMENT|2021-02-21|65
e|SS|dcc67696-e91a-4cef-81dd-f2d2711363ae|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|6|TREATMENT|2021-02-21|65
e|SS|dcc67696-e91a-4cef-81dd-f2d2711363ae|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|3|TREATMENT|2021-03-18|90
e|SS|dcc67696-e91a-4cef-81dd-f2d2711363ae|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|4|TREATMENT|2021-03-18|90
e|SS|91e83d7a-186a-4fed-8750-af796d77d356|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|2|SCREENING|2020-06-02|10
e|SS|91e83d7a-186a-4fed-8750-af796d77d356|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|6|TREATMENT|2020-06-02|10
e|SS|91e83d7a-186a-4fed-8750-af796d77d356|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|2|WASHOUT|2020-06-17|25
e|SS|91e83d7a-186a-4fed-8750-af796d77d356|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2020-06-17|25
e|SS|91e83d7a-186a-4fed-8750-af796d77d356|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|2|TREATMENT|2020-07-02|40
e|SS|91e83d7a-186a-4fed-8750-af796d77d356|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|7|TREATMENT|2020-07-02|40
e|SS|91e83d7a-186a-4fed-8750-af796d77d356|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|5|WASHOUT|2020-07-27|65
e|SS|91e83d7a-186a-4fed-8750-af796d77d356|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|7|TREATMENT|2020-07-27|65
e|SS|91e83d7a-186a-4fed-8750-af796d77d356|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|1|SCREENING|2020-08-21|90
e|SS|91e83d7a-186a-4fed-8750-af796d77d356|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2020-08-21|90
e|SS|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|7|TREATMENT|2020-05-13|10
e|SS|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|2|TREATMENT|2020-05-13|10
e|SS|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|3|FOLLOW-UP|2020-05-28|25
e|SS|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|FOLLOW-UP|2020-05-28|25
e|SS|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|2|SCREENING|2020-06-12|40
e|SS|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|3|TREATMENT|2020-06-12|40
e|SS|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|6|TREATMENT|2020-07-07|65
e|SS|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|6|TREATMENT|2020-07-07|65
e|SS|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|WASHOUT|2020-08-01|90
e|SS|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|2|FOLLOW-UP|2020-08-01|90
e|SS|0145dfac-a107-4368-b358-bcd136e1ecb3|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|1|TREATMENT|2021-01-08|10
e|SS|0145dfac-a107-4368-b358-bcd136e1ecb3|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|1|TREATMENT|2021-01-08|10
e|SS|0145dfac-a107-4368-b358-bcd136e1ecb3|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|3|WASHOUT|2021-01-23|25
e|SS|0145dfac-a107-4368-b358-bcd136e1ecb3|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|7|FOLLOW-UP|2021-01-23|25
e|SS|0145dfac-a107-4368-b358-bcd136e1ecb3|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|1|FOLLOW-UP|2021-02-07|40
e|SS|0145dfac-a107-4368-b358-bcd136e1ecb3|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|7|TREATMENT|2021-02-07|40
e|SS|0145dfac-a107-4368-b358-bcd136e1ecb3|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|7|TREATMENT|2021-03-04|65
e|SS|0145dfac-a107-4368-b358-bcd136e1ecb3|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|3|TREATMENT|2021-03-04|65
e|SS|0145dfac-a107-4368-b358-bcd136e1ecb3|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|7|TREATMENT|2021-03-29|90
e|SS|0145dfac-a107-4368-b358-bcd136e1ecb3|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|5|TREATMENT|2021-03-29|90
e|SS|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|7|SCREENING|2020-12-29|10
e|SS|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|6|TREATMENT|2020-12-29|10
e|SS|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|4|TREATMENT|2021-01-13|25
e|SS|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|4|FOLLOW-UP|2021-01-13|25
e|SS|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|4|WASHOUT|2021-01-28|40
e|SS|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|5|TREATMENT|2021-01-28|40
e|SS|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|2|SCREENING|2021-02-22|65
e|SS|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|3|WASHOUT|2021-02-22|65
e|SS|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|4|WASHOUT|2021-03-19|90
e|SS|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|3|TREATMENT|2021-03-19|90
e|SS|d4d79f6a-ba90-4503-934b-8a86286d83d3|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|4|SCREENING|2020-11-17|10
e|SS|d4d79f6a-ba90-4503-934b-8a86286d83d3|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|5|TREATMENT|2020-11-17|10
e|SS|d4d79f6a-ba90-4503-934b-8a86286d83d3|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|4|SCREENING|2020-12-02|25
e|SS|d4d79f6a-ba90-4503-934b-8a86286d83d3|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|7|WASHOUT|2020-12-02|25
e|SS|d4d79f6a-ba90-4503-934b-8a86286d83d3|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|WASHOUT|2020-12-17|40
e|SS|d4d79f6a-ba90-4503-934b-8a86286d83d3|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|6|TREATMENT|2020-12-17|40
e|SS|d4d79f6a-ba90-4503-934b-8a86286d83d3|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|1|FOLLOW-UP|2021-01-11|65
e|SS|d4d79f6a-ba90-4503-934b-8a86286d83d3|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|1|WASHOUT|2021-01-11|65
e|SS|d4d79f6a-ba90-4503-934b-8a86286d83d3|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|7|TREATMENT|2021-02-05|90
e|SS|d4d79f6a-ba90-4503-934b-8a86286d83d3|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|4|FOLLOW-UP|2021-02-05|90
e|SS|a329c350-49e2-415d-ba3c-e1ee929aec86|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|FOLLOW-UP|2020-08-15|10
e|SS|a329c350-49e2-415d-ba3c-e1ee929aec86|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|TREATMENT|2020-08-15|10
e|SS|a329c350-49e2-415d-ba3c-e1ee929aec86|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|SCREENING|2020-08-30|25
e|SS|a329c350-49e2-415d-ba3c-e1ee929aec86|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|3|TREATMENT|2020-08-30|25
e|SS|a329c350-49e2-415d-ba3c-e1ee929aec86|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|FOLLOW-UP|2020-09-14|40
e|SS|a329c350-49e2-415d-ba3c-e1ee929aec86|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|7|WASHOUT|2020-09-14|40
e|SS|a329c350-49e2-415d-ba3c-e1ee929aec86|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|7|TREATMENT|2020-10-09|65
e|SS|a329c350-49e2-415d-ba3c-e1ee929aec86|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|6|WASHOUT|2020-10-09|65
e|SS|a329c350-49e2-415d-ba3c-e1ee929aec86|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|SCREENING|2020-11-03|90
e|SS|a329c350-49e2-415d-ba3c-e1ee929aec86|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|1|TREATMENT|2020-11-03|90
e|SS|ff0e3543-c1f3-47f8-987f-7b00a4a33704|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|6|FOLLOW-UP|2020-12-30|100
e|SS|ff0e3543-c1f3-47f8-987f-7b00a4a33704|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|INTERVIEWER|1|Visit_1|10|2|WASHOUT|2020-12-30|100
e|SS|ff0e3543-c1f3-47f8-987f-7b00a4a33704|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|DOMESTIC PARTNER|2|Visit_2|25|7|SCREENING|2020-12-30|100
e|SS|ff0e3543-c1f3-47f8-987f-7b00a4a33704|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|PARENT|2|Visit_2|25|7|FOLLOW-UP|2020-12-30|100
e|SS|ff0e3543-c1f3-47f8-987f-7b00a4a33704|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|FAMILY MEMBER|3|Visit_3|40|6|TREATMENT|2020-12-30|100
e|SS|ff0e3543-c1f3-47f8-987f-7b00a4a33704|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIGNIFICANT OTHER|3|Visit_3|40|2|TREATMENT|2020-12-30|100
e|SS|ff0e3543-c1f3-47f8-987f-7b00a4a33704|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIBLING|4|Visit_4|65|1|WASHOUT|2020-12-30|100
e|SS|ff0e3543-c1f3-47f8-987f-7b00a4a33704|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|SPOUSE|4|Visit_4|65|5|TREATMENT|2020-12-30|100
e|SS|ff0e3543-c1f3-47f8-987f-7b00a4a33704|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|SPOUSE|5|Visit_5|90|1|WASHOUT|2020-12-30|100
e|SS|ff0e3543-c1f3-47f8-987f-7b00a4a33704|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|FAMILY MEMBER|5|Visit_5|90|1|FOLLOW-UP|2020-12-30|100
e|SS|128153ce-7bee-4f8d-bb60-fb1776370b6d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|2|TREATMENT|2021-01-11|10
e|SS|128153ce-7bee-4f8d-bb60-fb1776370b6d|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|2|TREATMENT|2021-01-11|10
e|SS|128153ce-7bee-4f8d-bb60-fb1776370b6d|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|1|TREATMENT|2021-01-26|25
e|SS|128153ce-7bee-4f8d-bb60-fb1776370b6d|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|7|TREATMENT|2021-01-26|25
e|SS|128153ce-7bee-4f8d-bb60-fb1776370b6d|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|6|SCREENING|2021-02-10|40
e|SS|128153ce-7bee-4f8d-bb60-fb1776370b6d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|1|SCREENING|2021-02-10|40
e|SS|128153ce-7bee-4f8d-bb60-fb1776370b6d|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|FOLLOW-UP|2021-03-07|65
e|SS|128153ce-7bee-4f8d-bb60-fb1776370b6d|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|1|TREATMENT|2021-03-07|65
e|SS|128153ce-7bee-4f8d-bb60-fb1776370b6d|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|4|TREATMENT|2021-04-01|90
e|SS|128153ce-7bee-4f8d-bb60-fb1776370b6d|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|7|TREATMENT|2021-04-01|90
e|SS|22ee2f20-4a66-458f-a153-9d7e871e1db2|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|5|TREATMENT|2020-06-17|10
e|SS|22ee2f20-4a66-458f-a153-9d7e871e1db2|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|6|TREATMENT|2020-06-17|10
e|SS|22ee2f20-4a66-458f-a153-9d7e871e1db2|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|1|SCREENING|2020-07-02|25
e|SS|22ee2f20-4a66-458f-a153-9d7e871e1db2|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|3|FOLLOW-UP|2020-07-02|25
e|SS|22ee2f20-4a66-458f-a153-9d7e871e1db2|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|2|WASHOUT|2020-07-17|40
e|SS|22ee2f20-4a66-458f-a153-9d7e871e1db2|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|1|TREATMENT|2020-07-17|40
e|SS|22ee2f20-4a66-458f-a153-9d7e871e1db2|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|2|TREATMENT|2020-08-11|65
e|SS|22ee2f20-4a66-458f-a153-9d7e871e1db2|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|7|FOLLOW-UP|2020-08-11|65
e|SS|22ee2f20-4a66-458f-a153-9d7e871e1db2|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2020-09-05|90
e|SS|22ee2f20-4a66-458f-a153-9d7e871e1db2|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|6|TREATMENT|2020-09-05|90
e|SS|b7caaa04-bcc7-4350-ad98-85670a19778f|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|6|SCREENING|2020-07-06|10
e|SS|b7caaa04-bcc7-4350-ad98-85670a19778f|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|3|FOLLOW-UP|2020-07-06|10
e|SS|b7caaa04-bcc7-4350-ad98-85670a19778f|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|6|TREATMENT|2020-07-21|25
e|SS|b7caaa04-bcc7-4350-ad98-85670a19778f|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|6|WASHOUT|2020-07-21|25
e|SS|b7caaa04-bcc7-4350-ad98-85670a19778f|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|7|SCREENING|2020-08-05|40
e|SS|b7caaa04-bcc7-4350-ad98-85670a19778f|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|2|SCREENING|2020-08-05|40
e|SS|b7caaa04-bcc7-4350-ad98-85670a19778f|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|7|FOLLOW-UP|2020-08-30|65
e|SS|b7caaa04-bcc7-4350-ad98-85670a19778f|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|3|TREATMENT|2020-08-30|65
e|SS|b7caaa04-bcc7-4350-ad98-85670a19778f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|6|TREATMENT|2020-09-24|90
e|SS|b7caaa04-bcc7-4350-ad98-85670a19778f|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|3|WASHOUT|2020-09-24|90
e|SS|2b58d5fd-3ec8-415b-bb53-a252049f228a|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|4|TREATMENT|2020-12-17|10
e|SS|2b58d5fd-3ec8-415b-bb53-a252049f228a|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|5|WASHOUT|2020-12-17|10
e|SS|2b58d5fd-3ec8-415b-bb53-a252049f228a|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|3|FOLLOW-UP|2021-01-01|25
e|SS|2b58d5fd-3ec8-415b-bb53-a252049f228a|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|4|TREATMENT|2021-01-01|25
e|SS|2b58d5fd-3ec8-415b-bb53-a252049f228a|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|FOLLOW-UP|2021-01-16|40
e|SS|2b58d5fd-3ec8-415b-bb53-a252049f228a|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|4|WASHOUT|2021-01-16|40
e|SS|2b58d5fd-3ec8-415b-bb53-a252049f228a|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2021-02-10|65
e|SS|2b58d5fd-3ec8-415b-bb53-a252049f228a|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|6|WASHOUT|2021-02-10|65
e|SS|2b58d5fd-3ec8-415b-bb53-a252049f228a|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|7|TREATMENT|2021-03-07|90
e|SS|2b58d5fd-3ec8-415b-bb53-a252049f228a|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|1|FOLLOW-UP|2021-03-07|90
e|SS|60b23345-43f6-42eb-9225-5a674456c9b9|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|1|WASHOUT|2021-01-15|10
e|SS|60b23345-43f6-42eb-9225-5a674456c9b9|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|1|TREATMENT|2021-01-15|10
e|SS|60b23345-43f6-42eb-9225-5a674456c9b9|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|SCREENING|2021-01-30|25
e|SS|60b23345-43f6-42eb-9225-5a674456c9b9|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|3|SCREENING|2021-01-30|25
e|SS|60b23345-43f6-42eb-9225-5a674456c9b9|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|5|TREATMENT|2021-02-14|40
e|SS|60b23345-43f6-42eb-9225-5a674456c9b9|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|4|TREATMENT|2021-02-14|40
e|SS|60b23345-43f6-42eb-9225-5a674456c9b9|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|1|TREATMENT|2021-03-11|65
e|SS|60b23345-43f6-42eb-9225-5a674456c9b9|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|4|FOLLOW-UP|2021-03-11|65
e|SS|60b23345-43f6-42eb-9225-5a674456c9b9|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|4|TREATMENT|2021-04-05|90
e|SS|60b23345-43f6-42eb-9225-5a674456c9b9|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|2|TREATMENT|2021-04-05|90
e|SS|7979239e-2a6b-48e3-9d11-41c97b33d229|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|3|TREATMENT|2021-01-15|10
e|SS|7979239e-2a6b-48e3-9d11-41c97b33d229|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|2|WASHOUT|2021-01-15|10
e|SS|7979239e-2a6b-48e3-9d11-41c97b33d229|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|5|FOLLOW-UP|2021-01-30|25
e|SS|7979239e-2a6b-48e3-9d11-41c97b33d229|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|7|TREATMENT|2021-01-30|25
e|SS|7979239e-2a6b-48e3-9d11-41c97b33d229|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|5|TREATMENT|2021-02-14|40
e|SS|7979239e-2a6b-48e3-9d11-41c97b33d229|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|TREATMENT|2021-02-14|40
e|SS|7979239e-2a6b-48e3-9d11-41c97b33d229|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|5|TREATMENT|2021-03-11|65
e|SS|7979239e-2a6b-48e3-9d11-41c97b33d229|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|1|FOLLOW-UP|2021-03-11|65
e|SS|7979239e-2a6b-48e3-9d11-41c97b33d229|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2021-04-05|90
e|SS|7979239e-2a6b-48e3-9d11-41c97b33d229|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|3|WASHOUT|2021-04-05|90
e|SS|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|5|FOLLOW-UP|2020-08-06|10
e|SS|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|4|SCREENING|2020-08-06|10
e|SS|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|FOLLOW-UP|2020-08-21|25
e|SS|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|1|TREATMENT|2020-08-21|25
e|SS|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|7|FOLLOW-UP|2020-09-05|40
e|SS|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|1|WASHOUT|2020-09-05|40
e|SS|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|TREATMENT|2020-09-30|65
e|SS|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|6|WASHOUT|2020-09-30|65
e|SS|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|2|TREATMENT|2020-10-25|90
e|SS|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2020-10-25|90
e|SS|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|7|FOLLOW-UP|2021-01-05|10
e|SS|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|4|FOLLOW-UP|2021-01-05|10
e|SS|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|1|SCREENING|2021-01-20|25
e|SS|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|1|WASHOUT|2021-01-20|25
e|SS|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|6|WASHOUT|2021-02-04|40
e|SS|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|3|SCREENING|2021-02-04|40
e|SS|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|4|SCREENING|2021-03-01|65
e|SS|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|TREATMENT|2021-03-01|65
e|SS|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|1|SCREENING|2021-03-26|90
e|SS|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|TREATMENT|2021-03-26|90
e|SS|da35fc01-4258-4e4d-99d9-4172e84c46e8|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|6|TREATMENT|2020-07-22|10
e|SS|da35fc01-4258-4e4d-99d9-4172e84c46e8|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|SCREENING|2020-07-22|10
e|SS|da35fc01-4258-4e4d-99d9-4172e84c46e8|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|1|TREATMENT|2020-08-06|25
e|SS|da35fc01-4258-4e4d-99d9-4172e84c46e8|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|5|TREATMENT|2020-08-06|25
e|SS|da35fc01-4258-4e4d-99d9-4172e84c46e8|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|6|TREATMENT|2020-08-21|40
e|SS|da35fc01-4258-4e4d-99d9-4172e84c46e8|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|3|TREATMENT|2020-08-21|40
e|SS|da35fc01-4258-4e4d-99d9-4172e84c46e8|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|7|WASHOUT|2020-09-15|65
e|SS|da35fc01-4258-4e4d-99d9-4172e84c46e8|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|3|TREATMENT|2020-09-15|65
e|SS|da35fc01-4258-4e4d-99d9-4172e84c46e8|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|4|FOLLOW-UP|2020-10-10|90
e|SS|da35fc01-4258-4e4d-99d9-4172e84c46e8|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|3|TREATMENT|2020-10-10|90
e|SS|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|1|TREATMENT|2020-08-04|10
e|SS|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|4|TREATMENT|2020-08-04|10
e|SS|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|6|TREATMENT|2020-08-19|25
e|SS|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|1|FOLLOW-UP|2020-08-19|25
e|SS|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|3|TREATMENT|2020-09-03|40
e|SS|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|4|TREATMENT|2020-09-03|40
e|SS|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|7|SCREENING|2020-09-28|65
e|SS|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|1|TREATMENT|2020-09-28|65
e|SS|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|6|TREATMENT|2020-10-23|90
e|SS|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|2|TREATMENT|2020-10-23|90
e|SS|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|3|SCREENING|2020-12-14|10
e|SS|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|3|WASHOUT|2020-12-14|10
e|SS|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|6|TREATMENT|2020-12-29|25
e|SS|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|4|WASHOUT|2020-12-29|25
e|SS|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|1|FOLLOW-UP|2021-01-13|40
e|SS|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|2|TREATMENT|2021-01-13|40
e|SS|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|3|TREATMENT|2021-02-07|65
e|SS|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|2|FOLLOW-UP|2021-02-07|65
e|SS|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|WASHOUT|2021-03-04|90
e|SS|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|4|TREATMENT|2021-03-04|90
e|SS|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|3|WASHOUT|2020-06-09|10
e|SS|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|1|TREATMENT|2020-06-09|10
e|SS|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|7|TREATMENT|2020-06-24|25
e|SS|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|1|WASHOUT|2020-06-24|25
e|SS|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|2|FOLLOW-UP|2020-07-09|40
e|SS|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|1|SCREENING|2020-07-09|40
e|SS|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|FOLLOW-UP|2020-08-03|65
e|SS|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|6|SCREENING|2020-08-03|65
e|SS|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|1|SCREENING|2020-08-28|90
e|SS|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|6|TREATMENT|2020-08-28|90
e|SS|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|6|TREATMENT|2020-05-24|10
e|SS|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|3|TREATMENT|2020-05-24|10
e|SS|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|SCREENING|2020-06-08|25
e|SS|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|3|WASHOUT|2020-06-08|25
e|SS|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|2|TREATMENT|2020-06-23|40
e|SS|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|3|TREATMENT|2020-06-23|40
e|SS|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|2|TREATMENT|2020-07-18|65
e|SS|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|1|SCREENING|2020-07-18|65
e|SS|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|6|SCREENING|2020-08-12|90
e|SS|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|2|FOLLOW-UP|2020-08-12|90
e|SS|136d59c6-9645-447a-a047-68d33dbb708e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|TREATMENT|2020-09-24|10
e|SS|136d59c6-9645-447a-a047-68d33dbb708e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|4|WASHOUT|2020-09-24|10
e|SS|136d59c6-9645-447a-a047-68d33dbb708e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|5|TREATMENT|2020-10-09|25
e|SS|136d59c6-9645-447a-a047-68d33dbb708e|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|7|SCREENING|2020-10-09|25
e|SS|136d59c6-9645-447a-a047-68d33dbb708e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|6|TREATMENT|2020-10-24|40
e|SS|136d59c6-9645-447a-a047-68d33dbb708e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|3|SCREENING|2020-10-24|40
e|SS|136d59c6-9645-447a-a047-68d33dbb708e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|WASHOUT|2020-11-18|65
e|SS|136d59c6-9645-447a-a047-68d33dbb708e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|7|WASHOUT|2020-11-18|65
e|SS|136d59c6-9645-447a-a047-68d33dbb708e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|1|FOLLOW-UP|2020-12-13|90
e|SS|136d59c6-9645-447a-a047-68d33dbb708e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|2|WASHOUT|2020-12-13|90
e|SS|2e393b90-213c-4661-ad55-cabb2008bf14|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|5|WASHOUT|2020-06-26|10
e|SS|2e393b90-213c-4661-ad55-cabb2008bf14|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|3|FOLLOW-UP|2020-06-26|10
e|SS|2e393b90-213c-4661-ad55-cabb2008bf14|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|FOLLOW-UP|2020-07-11|25
e|SS|2e393b90-213c-4661-ad55-cabb2008bf14|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|4|TREATMENT|2020-07-11|25
e|SS|2e393b90-213c-4661-ad55-cabb2008bf14|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|7|WASHOUT|2020-07-26|40
e|SS|2e393b90-213c-4661-ad55-cabb2008bf14|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|7|SCREENING|2020-07-26|40
e|SS|2e393b90-213c-4661-ad55-cabb2008bf14|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|6|TREATMENT|2020-08-20|65
e|SS|2e393b90-213c-4661-ad55-cabb2008bf14|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|1|FOLLOW-UP|2020-08-20|65
e|SS|2e393b90-213c-4661-ad55-cabb2008bf14|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|4|TREATMENT|2020-09-14|90
e|SS|2e393b90-213c-4661-ad55-cabb2008bf14|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|1|FOLLOW-UP|2020-09-14|90
e|SS|f72002d8-262b-49da-84a4-42e6011286f0|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|TREATMENT|2020-10-14|10
e|SS|f72002d8-262b-49da-84a4-42e6011286f0|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|4|TREATMENT|2020-10-14|10
e|SS|f72002d8-262b-49da-84a4-42e6011286f0|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|1|TREATMENT|2020-10-29|25
e|SS|f72002d8-262b-49da-84a4-42e6011286f0|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|3|TREATMENT|2020-10-29|25
e|SS|f72002d8-262b-49da-84a4-42e6011286f0|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|6|TREATMENT|2020-11-13|40
e|SS|f72002d8-262b-49da-84a4-42e6011286f0|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|1|SCREENING|2020-11-13|40
e|SS|f72002d8-262b-49da-84a4-42e6011286f0|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|4|TREATMENT|2020-12-08|65
e|SS|f72002d8-262b-49da-84a4-42e6011286f0|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|1|WASHOUT|2020-12-08|65
e|SS|f72002d8-262b-49da-84a4-42e6011286f0|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|6|TREATMENT|2021-01-02|90
e|SS|f72002d8-262b-49da-84a4-42e6011286f0|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|6|FOLLOW-UP|2021-01-02|90
e|SS|68869dda-531d-4218-b2b0-4f5f46825569|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|1|TREATMENT|2020-12-08|10
e|SS|68869dda-531d-4218-b2b0-4f5f46825569|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|4|SCREENING|2020-12-08|10
e|SS|68869dda-531d-4218-b2b0-4f5f46825569|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|4|SCREENING|2020-12-23|25
e|SS|68869dda-531d-4218-b2b0-4f5f46825569|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|7|WASHOUT|2020-12-23|25
e|SS|68869dda-531d-4218-b2b0-4f5f46825569|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|TREATMENT|2021-01-07|40
e|SS|68869dda-531d-4218-b2b0-4f5f46825569|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|2|TREATMENT|2021-01-07|40
e|SS|68869dda-531d-4218-b2b0-4f5f46825569|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|6|TREATMENT|2021-02-01|65
e|SS|68869dda-531d-4218-b2b0-4f5f46825569|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|5|SCREENING|2021-02-01|65
e|SS|68869dda-531d-4218-b2b0-4f5f46825569|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|2|TREATMENT|2021-02-26|90
e|SS|68869dda-531d-4218-b2b0-4f5f46825569|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|6|TREATMENT|2021-02-26|90
e|SS|68888445-1819-4f4c-bd0c-a445906476fb|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|3|TREATMENT|2021-01-14|10
e|SS|68888445-1819-4f4c-bd0c-a445906476fb|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|5|WASHOUT|2021-01-14|10
e|SS|68888445-1819-4f4c-bd0c-a445906476fb|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|2|TREATMENT|2021-01-29|25
e|SS|68888445-1819-4f4c-bd0c-a445906476fb|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|6|WASHOUT|2021-01-29|25
e|SS|68888445-1819-4f4c-bd0c-a445906476fb|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|3|SCREENING|2021-02-13|40
e|SS|68888445-1819-4f4c-bd0c-a445906476fb|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|1|SCREENING|2021-02-13|40
e|SS|68888445-1819-4f4c-bd0c-a445906476fb|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|2|TREATMENT|2021-03-10|65
e|SS|68888445-1819-4f4c-bd0c-a445906476fb|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|WASHOUT|2021-03-10|65
e|SS|68888445-1819-4f4c-bd0c-a445906476fb|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|5|SCREENING|2021-04-04|90
e|SS|68888445-1819-4f4c-bd0c-a445906476fb|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|5|TREATMENT|2021-04-04|90
e|SS|b2ce31a0-513a-449a-aa2c-7c9668fde275|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|5|TREATMENT|2020-06-24|10
e|SS|b2ce31a0-513a-449a-aa2c-7c9668fde275|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|1|WASHOUT|2020-06-24|10
e|SS|b2ce31a0-513a-449a-aa2c-7c9668fde275|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|6|WASHOUT|2020-07-09|25
e|SS|b2ce31a0-513a-449a-aa2c-7c9668fde275|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|7|SCREENING|2020-07-09|25
e|SS|b2ce31a0-513a-449a-aa2c-7c9668fde275|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|4|TREATMENT|2020-07-24|40
e|SS|b2ce31a0-513a-449a-aa2c-7c9668fde275|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|1|SCREENING|2020-07-24|40
e|SS|b2ce31a0-513a-449a-aa2c-7c9668fde275|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|4|TREATMENT|2020-08-18|65
e|SS|b2ce31a0-513a-449a-aa2c-7c9668fde275|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|4|WASHOUT|2020-08-18|65
e|SS|b2ce31a0-513a-449a-aa2c-7c9668fde275|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|1|SCREENING|2020-09-12|90
e|SS|b2ce31a0-513a-449a-aa2c-7c9668fde275|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|TREATMENT|2020-09-12|90
e|SS|6c1d481b-985a-4be0-97ca-ecd06a81b456|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|1|WASHOUT|2020-10-05|10
e|SS|6c1d481b-985a-4be0-97ca-ecd06a81b456|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|6|TREATMENT|2020-10-05|10
e|SS|6c1d481b-985a-4be0-97ca-ecd06a81b456|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|7|SCREENING|2020-10-20|25
e|SS|6c1d481b-985a-4be0-97ca-ecd06a81b456|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|4|TREATMENT|2020-10-20|25
e|SS|6c1d481b-985a-4be0-97ca-ecd06a81b456|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|5|TREATMENT|2020-11-04|40
e|SS|6c1d481b-985a-4be0-97ca-ecd06a81b456|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|7|TREATMENT|2020-11-04|40
e|SS|6c1d481b-985a-4be0-97ca-ecd06a81b456|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|5|SCREENING|2020-11-29|65
e|SS|6c1d481b-985a-4be0-97ca-ecd06a81b456|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|1|TREATMENT|2020-11-29|65
e|SS|6c1d481b-985a-4be0-97ca-ecd06a81b456|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|SCREENING|2020-12-24|90
e|SS|6c1d481b-985a-4be0-97ca-ecd06a81b456|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|1|FOLLOW-UP|2020-12-24|90
e|SS|645a9247-efcb-4641-9514-58d6e28560e0|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|6|SCREENING|2020-12-21|10
e|SS|645a9247-efcb-4641-9514-58d6e28560e0|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|4|TREATMENT|2020-12-21|10
e|SS|645a9247-efcb-4641-9514-58d6e28560e0|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|2|TREATMENT|2021-01-05|25
e|SS|645a9247-efcb-4641-9514-58d6e28560e0|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|2|TREATMENT|2021-01-05|25
e|SS|645a9247-efcb-4641-9514-58d6e28560e0|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|3|FOLLOW-UP|2021-01-20|40
e|SS|645a9247-efcb-4641-9514-58d6e28560e0|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|4|TREATMENT|2021-01-20|40
e|SS|645a9247-efcb-4641-9514-58d6e28560e0|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|TREATMENT|2021-02-14|65
e|SS|645a9247-efcb-4641-9514-58d6e28560e0|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|5|TREATMENT|2021-02-14|65
e|SS|645a9247-efcb-4641-9514-58d6e28560e0|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|SCREENING|2021-03-11|90
e|SS|645a9247-efcb-4641-9514-58d6e28560e0|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|5|SCREENING|2021-03-11|90
e|SS|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|2|FOLLOW-UP|2020-09-15|10
e|SS|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|6|SCREENING|2020-09-15|10
e|SS|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|7|TREATMENT|2020-09-30|25
e|SS|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|4|FOLLOW-UP|2020-09-30|25
e|SS|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|7|FOLLOW-UP|2020-10-15|40
e|SS|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|2|TREATMENT|2020-10-15|40
e|SS|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|2|TREATMENT|2020-11-09|65
e|SS|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|2|TREATMENT|2020-11-09|65
e|SS|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|1|WASHOUT|2020-12-04|90
e|SS|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|7|TREATMENT|2020-12-04|90
e|SS|05b05951-b1ba-4c51-b50f-9c842532bc4e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|7|FOLLOW-UP|2020-07-28|10
e|SS|05b05951-b1ba-4c51-b50f-9c842532bc4e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|1|SCREENING|2020-07-28|10
e|SS|05b05951-b1ba-4c51-b50f-9c842532bc4e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|4|FOLLOW-UP|2020-08-12|25
e|SS|05b05951-b1ba-4c51-b50f-9c842532bc4e|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|2|SCREENING|2020-08-12|25
e|SS|05b05951-b1ba-4c51-b50f-9c842532bc4e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|4|TREATMENT|2020-08-27|40
e|SS|05b05951-b1ba-4c51-b50f-9c842532bc4e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-08-27|40
e|SS|05b05951-b1ba-4c51-b50f-9c842532bc4e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|4|FOLLOW-UP|2020-09-21|65
e|SS|05b05951-b1ba-4c51-b50f-9c842532bc4e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|SCREENING|2020-09-21|65
e|SS|05b05951-b1ba-4c51-b50f-9c842532bc4e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|1|FOLLOW-UP|2020-10-16|90
e|SS|05b05951-b1ba-4c51-b50f-9c842532bc4e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|4|FOLLOW-UP|2020-10-16|90
e|SS|ab38e976-8c2b-48ff-bdba-5a056637ecdd|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|INTERVIEWER|1|Visit_1|10|2|SCREENING|2021-01-21|100
e|SS|ab38e976-8c2b-48ff-bdba-5a056637ecdd|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|CHILD|1|Visit_1|10|4|TREATMENT|2021-01-21|100
e|SS|ab38e976-8c2b-48ff-bdba-5a056637ecdd|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|TREATMENT|2021-01-21|100
e|SS|ab38e976-8c2b-48ff-bdba-5a056637ecdd|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2021-01-21|100
e|SS|ab38e976-8c2b-48ff-bdba-5a056637ecdd|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|PARENT|3|Visit_3|40|5|SCREENING|2021-01-21|100
e|SS|ab38e976-8c2b-48ff-bdba-5a056637ecdd|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|TREATMENT|2021-01-21|100
e|SS|ab38e976-8c2b-48ff-bdba-5a056637ecdd|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|CHILD|4|Visit_4|65|1|FOLLOW-UP|2021-01-21|100
e|SS|ab38e976-8c2b-48ff-bdba-5a056637ecdd|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|INVESTIGATOR|4|Visit_4|65|6|TREATMENT|2021-01-21|100
e|SS|ab38e976-8c2b-48ff-bdba-5a056637ecdd|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|CHILD|5|Visit_5|90|5|FOLLOW-UP|2021-01-21|100
e|SS|ab38e976-8c2b-48ff-bdba-5a056637ecdd|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|VENDOR|5|Visit_5|90|5|WASHOUT|2021-01-21|100
e|SS|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|7|SCREENING|2020-08-31|10
e|SS|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|3|TREATMENT|2020-08-31|10
e|SS|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|6|TREATMENT|2020-09-15|25
e|SS|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|2|WASHOUT|2020-09-15|25
e|SS|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|1|SCREENING|2020-09-30|40
e|SS|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|FOLLOW-UP|2020-09-30|40
e|SS|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|3|TREATMENT|2020-10-25|65
e|SS|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|7|TREATMENT|2020-10-25|65
e|SS|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|5|TREATMENT|2020-11-19|90
e|SS|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|WASHOUT|2020-11-19|90
e|SS|51a49847-6405-4842-b549-0e2ab99f61b2|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|4|SCREENING|2021-01-16|10
e|SS|51a49847-6405-4842-b549-0e2ab99f61b2|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|4|FOLLOW-UP|2021-01-16|10
e|SS|51a49847-6405-4842-b549-0e2ab99f61b2|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|3|SCREENING|2021-01-31|25
e|SS|51a49847-6405-4842-b549-0e2ab99f61b2|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|1|WASHOUT|2021-01-31|25
e|SS|51a49847-6405-4842-b549-0e2ab99f61b2|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|3|TREATMENT|2021-02-15|40
e|SS|51a49847-6405-4842-b549-0e2ab99f61b2|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|1|WASHOUT|2021-02-15|40
e|SS|51a49847-6405-4842-b549-0e2ab99f61b2|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|2|FOLLOW-UP|2021-03-12|65
e|SS|51a49847-6405-4842-b549-0e2ab99f61b2|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|5|TREATMENT|2021-03-12|65
e|SS|51a49847-6405-4842-b549-0e2ab99f61b2|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|7|WASHOUT|2021-04-06|90
e|SS|51a49847-6405-4842-b549-0e2ab99f61b2|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|5|TREATMENT|2021-04-06|90
e|SS|44dcfb9a-c590-4826-a28c-b5e9f83129d5|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|SPOUSE|1|Visit_1|10|5|TREATMENT|2020-08-19|100
e|SS|44dcfb9a-c590-4826-a28c-b5e9f83129d5|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|DOMESTIC PARTNER|1|Visit_1|10|3|FOLLOW-UP|2020-08-19|100
e|SS|44dcfb9a-c590-4826-a28c-b5e9f83129d5|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIBLING|2|Visit_2|25|5|TREATMENT|2020-08-19|100
e|SS|44dcfb9a-c590-4826-a28c-b5e9f83129d5|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|INVESTIGATOR|2|Visit_2|25|7|SCREENING|2020-08-19|100
e|SS|44dcfb9a-c590-4826-a28c-b5e9f83129d5|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|VENDOR|3|Visit_3|40|5|TREATMENT|2020-08-19|100
e|SS|44dcfb9a-c590-4826-a28c-b5e9f83129d5|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|VENDOR|3|Visit_3|40|7|TREATMENT|2020-08-19|100
e|SS|44dcfb9a-c590-4826-a28c-b5e9f83129d5|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|VENDOR|4|Visit_4|65|4|TREATMENT|2020-08-19|100
e|SS|44dcfb9a-c590-4826-a28c-b5e9f83129d5|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|PROXY|4|Visit_4|65|1|TREATMENT|2020-08-19|100
e|SS|44dcfb9a-c590-4826-a28c-b5e9f83129d5|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|INDEPENDENT ASSESSOR|5|Visit_5|90|7|TREATMENT|2020-08-19|100
e|SS|44dcfb9a-c590-4826-a28c-b5e9f83129d5|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|PROXY|5|Visit_5|90|7|WASHOUT|2020-08-19|100
e|SS|98166d74-caa7-4693-a817-b2cbae947ff8|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|2|TREATMENT|2021-01-11|10
e|SS|98166d74-caa7-4693-a817-b2cbae947ff8|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|7|TREATMENT|2021-01-11|10
e|SS|98166d74-caa7-4693-a817-b2cbae947ff8|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|1|TREATMENT|2021-01-26|25
e|SS|98166d74-caa7-4693-a817-b2cbae947ff8|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|7|TREATMENT|2021-01-26|25
e|SS|98166d74-caa7-4693-a817-b2cbae947ff8|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|SCREENING|2021-02-10|40
e|SS|98166d74-caa7-4693-a817-b2cbae947ff8|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|2|TREATMENT|2021-02-10|40
e|SS|98166d74-caa7-4693-a817-b2cbae947ff8|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2021-03-07|65
e|SS|98166d74-caa7-4693-a817-b2cbae947ff8|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|5|TREATMENT|2021-03-07|65
e|SS|98166d74-caa7-4693-a817-b2cbae947ff8|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|3|FOLLOW-UP|2021-04-01|90
e|SS|98166d74-caa7-4693-a817-b2cbae947ff8|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|6|TREATMENT|2021-04-01|90
e|SS|cb07675a-2042-44da-a1f9-8b7783347e88|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|3|FOLLOW-UP|2020-12-05|10
e|SS|cb07675a-2042-44da-a1f9-8b7783347e88|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|4|TREATMENT|2020-12-05|10
e|SS|cb07675a-2042-44da-a1f9-8b7783347e88|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|WASHOUT|2020-12-20|25
e|SS|cb07675a-2042-44da-a1f9-8b7783347e88|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|4|TREATMENT|2020-12-20|25
e|SS|cb07675a-2042-44da-a1f9-8b7783347e88|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|4|TREATMENT|2021-01-04|40
e|SS|cb07675a-2042-44da-a1f9-8b7783347e88|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|7|TREATMENT|2021-01-04|40
e|SS|cb07675a-2042-44da-a1f9-8b7783347e88|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2021-01-29|65
e|SS|cb07675a-2042-44da-a1f9-8b7783347e88|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|5|SCREENING|2021-01-29|65
e|SS|cb07675a-2042-44da-a1f9-8b7783347e88|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|7|TREATMENT|2021-02-23|90
e|SS|cb07675a-2042-44da-a1f9-8b7783347e88|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|7|TREATMENT|2021-02-23|90
e|SS|a8a14aa1-4484-4bbc-86bf-c44257146a26|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|SCREENING|2020-07-01|10
e|SS|a8a14aa1-4484-4bbc-86bf-c44257146a26|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|3|WASHOUT|2020-07-01|10
e|SS|a8a14aa1-4484-4bbc-86bf-c44257146a26|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|7|TREATMENT|2020-07-16|25
e|SS|a8a14aa1-4484-4bbc-86bf-c44257146a26|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|7|WASHOUT|2020-07-16|25
e|SS|a8a14aa1-4484-4bbc-86bf-c44257146a26|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|7|TREATMENT|2020-07-31|40
e|SS|a8a14aa1-4484-4bbc-86bf-c44257146a26|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|5|TREATMENT|2020-07-31|40
e|SS|a8a14aa1-4484-4bbc-86bf-c44257146a26|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|7|TREATMENT|2020-08-25|65
e|SS|a8a14aa1-4484-4bbc-86bf-c44257146a26|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|2|TREATMENT|2020-08-25|65
e|SS|a8a14aa1-4484-4bbc-86bf-c44257146a26|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|5|FOLLOW-UP|2020-09-19|90
e|SS|a8a14aa1-4484-4bbc-86bf-c44257146a26|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|3|TREATMENT|2020-09-19|90
e|SS|dfa4c661-9317-4bec-b307-a31eeadcaba6|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|4|FOLLOW-UP|2020-06-04|10
e|SS|dfa4c661-9317-4bec-b307-a31eeadcaba6|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|6|TREATMENT|2020-06-04|10
e|SS|dfa4c661-9317-4bec-b307-a31eeadcaba6|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|1|TREATMENT|2020-06-19|25
e|SS|dfa4c661-9317-4bec-b307-a31eeadcaba6|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|7|WASHOUT|2020-06-19|25
e|SS|dfa4c661-9317-4bec-b307-a31eeadcaba6|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|1|WASHOUT|2020-07-04|40
e|SS|dfa4c661-9317-4bec-b307-a31eeadcaba6|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|5|TREATMENT|2020-07-04|40
e|SS|dfa4c661-9317-4bec-b307-a31eeadcaba6|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|2|FOLLOW-UP|2020-07-29|65
e|SS|dfa4c661-9317-4bec-b307-a31eeadcaba6|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|3|TREATMENT|2020-07-29|65
e|SS|dfa4c661-9317-4bec-b307-a31eeadcaba6|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|1|SCREENING|2020-08-23|90
e|SS|dfa4c661-9317-4bec-b307-a31eeadcaba6|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|1|TREATMENT|2020-08-23|90
e|SS|9ed984a9-c153-4729-9dc9-3bb3d9059919|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|WASHOUT|2020-09-01|10
e|SS|9ed984a9-c153-4729-9dc9-3bb3d9059919|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|5|TREATMENT|2020-09-01|10
e|SS|9ed984a9-c153-4729-9dc9-3bb3d9059919|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|1|SCREENING|2020-09-16|25
e|SS|9ed984a9-c153-4729-9dc9-3bb3d9059919|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|4|TREATMENT|2020-09-16|25
e|SS|9ed984a9-c153-4729-9dc9-3bb3d9059919|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|7|TREATMENT|2020-10-01|40
e|SS|9ed984a9-c153-4729-9dc9-3bb3d9059919|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|7|TREATMENT|2020-10-01|40
e|SS|9ed984a9-c153-4729-9dc9-3bb3d9059919|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|4|TREATMENT|2020-10-26|65
e|SS|9ed984a9-c153-4729-9dc9-3bb3d9059919|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|5|TREATMENT|2020-10-26|65
e|SS|9ed984a9-c153-4729-9dc9-3bb3d9059919|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|6|FOLLOW-UP|2020-11-20|90
e|SS|9ed984a9-c153-4729-9dc9-3bb3d9059919|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|5|TREATMENT|2020-11-20|90
e|SS|fb234b67-3c81-4d55-bc63-2389a23d67b2|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|7|TREATMENT|2021-01-11|10
e|SS|fb234b67-3c81-4d55-bc63-2389a23d67b2|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|3|TREATMENT|2021-01-11|10
e|SS|fb234b67-3c81-4d55-bc63-2389a23d67b2|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|3|FOLLOW-UP|2021-01-26|25
e|SS|fb234b67-3c81-4d55-bc63-2389a23d67b2|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|1|TREATMENT|2021-01-26|25
e|SS|fb234b67-3c81-4d55-bc63-2389a23d67b2|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|1|SCREENING|2021-02-10|40
e|SS|fb234b67-3c81-4d55-bc63-2389a23d67b2|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|5|FOLLOW-UP|2021-02-10|40
e|SS|fb234b67-3c81-4d55-bc63-2389a23d67b2|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|5|FOLLOW-UP|2021-03-07|65
e|SS|fb234b67-3c81-4d55-bc63-2389a23d67b2|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2021-03-07|65
e|SS|fb234b67-3c81-4d55-bc63-2389a23d67b2|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|3|TREATMENT|2021-04-01|90
e|SS|fb234b67-3c81-4d55-bc63-2389a23d67b2|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|2|TREATMENT|2021-04-01|90
e|SS|84d7ff44-cbe2-446f-b667-5bc539de519b|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|3|FOLLOW-UP|2020-07-06|10
e|SS|84d7ff44-cbe2-446f-b667-5bc539de519b|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|SCREENING|2020-07-06|10
e|SS|84d7ff44-cbe2-446f-b667-5bc539de519b|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|FOLLOW-UP|2020-07-21|25
e|SS|84d7ff44-cbe2-446f-b667-5bc539de519b|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|7|TREATMENT|2020-07-21|25
e|SS|84d7ff44-cbe2-446f-b667-5bc539de519b|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|1|SCREENING|2020-08-05|40
e|SS|84d7ff44-cbe2-446f-b667-5bc539de519b|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|4|WASHOUT|2020-08-05|40
e|SS|84d7ff44-cbe2-446f-b667-5bc539de519b|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2020-08-30|65
e|SS|84d7ff44-cbe2-446f-b667-5bc539de519b|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|6|TREATMENT|2020-08-30|65
e|SS|84d7ff44-cbe2-446f-b667-5bc539de519b|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|3|FOLLOW-UP|2020-09-24|90
e|SS|84d7ff44-cbe2-446f-b667-5bc539de519b|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|3|FOLLOW-UP|2020-09-24|90
e|SS|c96e4485-4aff-4c18-9c65-5f1a800cc6db|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|5|TREATMENT|2020-09-24|10
e|SS|c96e4485-4aff-4c18-9c65-5f1a800cc6db|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|FOLLOW-UP|2020-09-24|10
e|SS|c96e4485-4aff-4c18-9c65-5f1a800cc6db|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|3|TREATMENT|2020-10-09|25
e|SS|c96e4485-4aff-4c18-9c65-5f1a800cc6db|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|4|TREATMENT|2020-10-09|25
e|SS|c96e4485-4aff-4c18-9c65-5f1a800cc6db|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|3|TREATMENT|2020-10-24|40
e|SS|c96e4485-4aff-4c18-9c65-5f1a800cc6db|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|4|SCREENING|2020-10-24|40
e|SS|c96e4485-4aff-4c18-9c65-5f1a800cc6db|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|3|TREATMENT|2020-11-18|65
e|SS|c96e4485-4aff-4c18-9c65-5f1a800cc6db|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|5|TREATMENT|2020-11-18|65
e|SS|c96e4485-4aff-4c18-9c65-5f1a800cc6db|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|TREATMENT|2020-12-13|90
e|SS|c96e4485-4aff-4c18-9c65-5f1a800cc6db|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|3|TREATMENT|2020-12-13|90
e|SS|955188f1-b434-40ab-94c8-0c0fb7f23e84|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|1|TREATMENT|2020-12-14|10
e|SS|955188f1-b434-40ab-94c8-0c0fb7f23e84|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|7|TREATMENT|2020-12-14|10
e|SS|955188f1-b434-40ab-94c8-0c0fb7f23e84|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|3|TREATMENT|2020-12-29|25
e|SS|955188f1-b434-40ab-94c8-0c0fb7f23e84|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|7|TREATMENT|2020-12-29|25
e|SS|955188f1-b434-40ab-94c8-0c0fb7f23e84|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|5|TREATMENT|2021-01-13|40
e|SS|955188f1-b434-40ab-94c8-0c0fb7f23e84|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|1|TREATMENT|2021-01-13|40
e|SS|955188f1-b434-40ab-94c8-0c0fb7f23e84|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|FOLLOW-UP|2021-02-07|65
e|SS|955188f1-b434-40ab-94c8-0c0fb7f23e84|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|1|TREATMENT|2021-02-07|65
e|SS|955188f1-b434-40ab-94c8-0c0fb7f23e84|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|5|SCREENING|2021-03-04|90
e|SS|955188f1-b434-40ab-94c8-0c0fb7f23e84|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|3|SCREENING|2021-03-04|90
e|SS|5a384b5e-954c-4af9-bd60-96aadc72ca44|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|1|WASHOUT|2020-10-09|10
e|SS|5a384b5e-954c-4af9-bd60-96aadc72ca44|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|1|TREATMENT|2020-10-09|10
e|SS|5a384b5e-954c-4af9-bd60-96aadc72ca44|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|2|TREATMENT|2020-10-24|25
e|SS|5a384b5e-954c-4af9-bd60-96aadc72ca44|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|6|TREATMENT|2020-10-24|25
e|SS|5a384b5e-954c-4af9-bd60-96aadc72ca44|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|5|FOLLOW-UP|2020-11-08|40
e|SS|5a384b5e-954c-4af9-bd60-96aadc72ca44|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|3|TREATMENT|2020-11-08|40
e|SS|5a384b5e-954c-4af9-bd60-96aadc72ca44|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|3|TREATMENT|2020-12-03|65
e|SS|5a384b5e-954c-4af9-bd60-96aadc72ca44|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2020-12-03|65
e|SS|5a384b5e-954c-4af9-bd60-96aadc72ca44|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|2|TREATMENT|2020-12-28|90
e|SS|5a384b5e-954c-4af9-bd60-96aadc72ca44|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|4|FOLLOW-UP|2020-12-28|90
e|SS|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|7|WASHOUT|2020-07-02|10
e|SS|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|3|TREATMENT|2020-07-02|10
e|SS|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|7|TREATMENT|2020-07-17|25
e|SS|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|TREATMENT|2020-07-17|25
e|SS|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|3|TREATMENT|2020-08-01|40
e|SS|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|5|WASHOUT|2020-08-01|40
e|SS|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|4|SCREENING|2020-08-26|65
e|SS|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|2|WASHOUT|2020-08-26|65
e|SS|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|2|WASHOUT|2020-09-20|90
e|SS|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|TREATMENT|2020-09-20|90
e|SS|f9432d72-f7d7-4cdf-a173-2e2029258474|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|3|SCREENING|2020-11-20|10
e|SS|f9432d72-f7d7-4cdf-a173-2e2029258474|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|5|WASHOUT|2020-11-20|10
e|SS|f9432d72-f7d7-4cdf-a173-2e2029258474|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|3|TREATMENT|2020-12-05|25
e|SS|f9432d72-f7d7-4cdf-a173-2e2029258474|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|4|TREATMENT|2020-12-05|25
e|SS|f9432d72-f7d7-4cdf-a173-2e2029258474|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|5|TREATMENT|2020-12-20|40
e|SS|f9432d72-f7d7-4cdf-a173-2e2029258474|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|5|TREATMENT|2020-12-20|40
e|SS|f9432d72-f7d7-4cdf-a173-2e2029258474|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|WASHOUT|2021-01-14|65
e|SS|f9432d72-f7d7-4cdf-a173-2e2029258474|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|2|TREATMENT|2021-01-14|65
e|SS|f9432d72-f7d7-4cdf-a173-2e2029258474|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|2|TREATMENT|2021-02-08|90
e|SS|f9432d72-f7d7-4cdf-a173-2e2029258474|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|4|FOLLOW-UP|2021-02-08|90
e|SS|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|6|TREATMENT|2020-12-19|10
e|SS|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|4|TREATMENT|2020-12-19|10
e|SS|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|5|FOLLOW-UP|2021-01-03|25
e|SS|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|4|TREATMENT|2021-01-03|25
e|SS|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|3|WASHOUT|2021-01-18|40
e|SS|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|5|WASHOUT|2021-01-18|40
e|SS|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|2|TREATMENT|2021-02-12|65
e|SS|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|4|TREATMENT|2021-02-12|65
e|SS|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|WASHOUT|2021-03-09|90
e|SS|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|7|TREATMENT|2021-03-09|90
e|SS|0fc0650f-ed95-422d-b407-dcee93178780|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|5|FOLLOW-UP|2020-08-23|10
e|SS|0fc0650f-ed95-422d-b407-dcee93178780|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|7|TREATMENT|2020-08-23|10
e|SS|0fc0650f-ed95-422d-b407-dcee93178780|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|TREATMENT|2020-09-07|25
e|SS|0fc0650f-ed95-422d-b407-dcee93178780|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|1|TREATMENT|2020-09-07|25
e|SS|0fc0650f-ed95-422d-b407-dcee93178780|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|WASHOUT|2020-09-22|40
e|SS|0fc0650f-ed95-422d-b407-dcee93178780|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|1|WASHOUT|2020-09-22|40
e|SS|0fc0650f-ed95-422d-b407-dcee93178780|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|SCREENING|2020-10-17|65
e|SS|0fc0650f-ed95-422d-b407-dcee93178780|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|5|TREATMENT|2020-10-17|65
e|SS|0fc0650f-ed95-422d-b407-dcee93178780|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|6|SCREENING|2020-11-11|90
e|SS|0fc0650f-ed95-422d-b407-dcee93178780|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|5|FOLLOW-UP|2020-11-11|90
e|SS|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|4|FOLLOW-UP|2020-06-03|10
e|SS|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|7|TREATMENT|2020-06-03|10
e|SS|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|5|TREATMENT|2020-06-18|25
e|SS|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|2|WASHOUT|2020-06-18|25
e|SS|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|3|TREATMENT|2020-07-03|40
e|SS|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|2|WASHOUT|2020-07-03|40
e|SS|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|4|WASHOUT|2020-07-28|65
e|SS|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|1|SCREENING|2020-07-28|65
e|SS|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|WASHOUT|2020-08-22|90
e|SS|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|3|FOLLOW-UP|2020-08-22|90
e|SS|a6f48290-787a-46ad-bee1-ae263ad3c121|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|4|TREATMENT|2021-01-19|10
e|SS|a6f48290-787a-46ad-bee1-ae263ad3c121|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|1|SCREENING|2021-01-19|10
e|SS|a6f48290-787a-46ad-bee1-ae263ad3c121|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|2|TREATMENT|2021-02-03|25
e|SS|a6f48290-787a-46ad-bee1-ae263ad3c121|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|5|SCREENING|2021-02-03|25
e|SS|a6f48290-787a-46ad-bee1-ae263ad3c121|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|4|SCREENING|2021-02-18|40
e|SS|a6f48290-787a-46ad-bee1-ae263ad3c121|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|6|WASHOUT|2021-02-18|40
e|SS|a6f48290-787a-46ad-bee1-ae263ad3c121|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|4|FOLLOW-UP|2021-03-15|65
e|SS|a6f48290-787a-46ad-bee1-ae263ad3c121|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|5|TREATMENT|2021-03-15|65
e|SS|a6f48290-787a-46ad-bee1-ae263ad3c121|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|2|WASHOUT|2021-04-09|90
e|SS|a6f48290-787a-46ad-bee1-ae263ad3c121|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|3|SCREENING|2021-04-09|90
e|SS|565e5c83-9c67-4718-bd54-af34be936427|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|2|SCREENING|2020-06-09|10
e|SS|565e5c83-9c67-4718-bd54-af34be936427|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-06-09|10
e|SS|565e5c83-9c67-4718-bd54-af34be936427|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|5|TREATMENT|2020-06-24|25
e|SS|565e5c83-9c67-4718-bd54-af34be936427|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|2|FOLLOW-UP|2020-06-24|25
e|SS|565e5c83-9c67-4718-bd54-af34be936427|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|1|TREATMENT|2020-07-09|40
e|SS|565e5c83-9c67-4718-bd54-af34be936427|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|6|TREATMENT|2020-07-09|40
e|SS|565e5c83-9c67-4718-bd54-af34be936427|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|3|TREATMENT|2020-08-03|65
e|SS|565e5c83-9c67-4718-bd54-af34be936427|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|3|TREATMENT|2020-08-03|65
e|SS|565e5c83-9c67-4718-bd54-af34be936427|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|7|SCREENING|2020-08-28|90
e|SS|565e5c83-9c67-4718-bd54-af34be936427|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|6|WASHOUT|2020-08-28|90
e|SS|b238304c-15ef-4c6e-a32c-9cd583a233a9|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|2|FOLLOW-UP|2021-01-07|10
e|SS|b238304c-15ef-4c6e-a32c-9cd583a233a9|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|5|SCREENING|2021-01-07|10
e|SS|b238304c-15ef-4c6e-a32c-9cd583a233a9|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2021-01-22|25
e|SS|b238304c-15ef-4c6e-a32c-9cd583a233a9|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|SCREENING|2021-01-22|25
e|SS|b238304c-15ef-4c6e-a32c-9cd583a233a9|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|3|WASHOUT|2021-02-06|40
e|SS|b238304c-15ef-4c6e-a32c-9cd583a233a9|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|6|SCREENING|2021-02-06|40
e|SS|b238304c-15ef-4c6e-a32c-9cd583a233a9|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|6|WASHOUT|2021-03-03|65
e|SS|b238304c-15ef-4c6e-a32c-9cd583a233a9|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|7|TREATMENT|2021-03-03|65
e|SS|b238304c-15ef-4c6e-a32c-9cd583a233a9|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|1|FOLLOW-UP|2021-03-28|90
e|SS|b238304c-15ef-4c6e-a32c-9cd583a233a9|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|4|TREATMENT|2021-03-28|90
e|SS|c273f039-bca9-4d55-8620-5c5db32a6c4b|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|4|FOLLOW-UP|2020-09-23|10
e|SS|c273f039-bca9-4d55-8620-5c5db32a6c4b|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|TREATMENT|2020-09-23|10
e|SS|c273f039-bca9-4d55-8620-5c5db32a6c4b|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|3|SCREENING|2020-10-08|25
e|SS|c273f039-bca9-4d55-8620-5c5db32a6c4b|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|1|SCREENING|2020-10-08|25
e|SS|c273f039-bca9-4d55-8620-5c5db32a6c4b|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|TREATMENT|2020-10-23|40
e|SS|c273f039-bca9-4d55-8620-5c5db32a6c4b|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|1|TREATMENT|2020-10-23|40
e|SS|c273f039-bca9-4d55-8620-5c5db32a6c4b|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|5|TREATMENT|2020-11-17|65
e|SS|c273f039-bca9-4d55-8620-5c5db32a6c4b|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|7|TREATMENT|2020-11-17|65
e|SS|c273f039-bca9-4d55-8620-5c5db32a6c4b|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|7|TREATMENT|2020-12-12|90
e|SS|c273f039-bca9-4d55-8620-5c5db32a6c4b|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|2|SCREENING|2020-12-12|90
e|SS|2cdb5053-2108-4f50-8906-8afabc855a36|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|4|TREATMENT|2020-08-28|10
e|SS|2cdb5053-2108-4f50-8906-8afabc855a36|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|5|TREATMENT|2020-08-28|10
e|SS|2cdb5053-2108-4f50-8906-8afabc855a36|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|6|FOLLOW-UP|2020-09-12|25
e|SS|2cdb5053-2108-4f50-8906-8afabc855a36|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|6|TREATMENT|2020-09-12|25
e|SS|2cdb5053-2108-4f50-8906-8afabc855a36|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|7|FOLLOW-UP|2020-09-27|40
e|SS|2cdb5053-2108-4f50-8906-8afabc855a36|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-09-27|40
e|SS|2cdb5053-2108-4f50-8906-8afabc855a36|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|2|TREATMENT|2020-10-22|65
e|SS|2cdb5053-2108-4f50-8906-8afabc855a36|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|1|FOLLOW-UP|2020-10-22|65
e|SS|2cdb5053-2108-4f50-8906-8afabc855a36|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|1|TREATMENT|2020-11-16|90
e|SS|2cdb5053-2108-4f50-8906-8afabc855a36|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|TREATMENT|2020-11-16|90
e|SS|fce7149a-503e-4209-8c62-8044a2ad1c1c|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|6|WASHOUT|2020-08-06|10
e|SS|fce7149a-503e-4209-8c62-8044a2ad1c1c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|5|TREATMENT|2020-08-06|10
e|SS|fce7149a-503e-4209-8c62-8044a2ad1c1c|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|5|WASHOUT|2020-08-21|25
e|SS|fce7149a-503e-4209-8c62-8044a2ad1c1c|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2020-08-21|25
e|SS|fce7149a-503e-4209-8c62-8044a2ad1c1c|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|2|TREATMENT|2020-09-05|40
e|SS|fce7149a-503e-4209-8c62-8044a2ad1c1c|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|7|WASHOUT|2020-09-05|40
e|SS|fce7149a-503e-4209-8c62-8044a2ad1c1c|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|WASHOUT|2020-09-30|65
e|SS|fce7149a-503e-4209-8c62-8044a2ad1c1c|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|1|TREATMENT|2020-09-30|65
e|SS|fce7149a-503e-4209-8c62-8044a2ad1c1c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|6|WASHOUT|2020-10-25|90
e|SS|fce7149a-503e-4209-8c62-8044a2ad1c1c|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|2|FOLLOW-UP|2020-10-25|90
e|SS|c8aad550-11a1-4473-8b35-79b7dfb08122|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|2|TREATMENT|2020-06-09|10
e|SS|c8aad550-11a1-4473-8b35-79b7dfb08122|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|1|TREATMENT|2020-06-09|10
e|SS|c8aad550-11a1-4473-8b35-79b7dfb08122|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-06-24|25
e|SS|c8aad550-11a1-4473-8b35-79b7dfb08122|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|7|TREATMENT|2020-06-24|25
e|SS|c8aad550-11a1-4473-8b35-79b7dfb08122|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|4|TREATMENT|2020-07-09|40
e|SS|c8aad550-11a1-4473-8b35-79b7dfb08122|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|6|SCREENING|2020-07-09|40
e|SS|c8aad550-11a1-4473-8b35-79b7dfb08122|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|7|TREATMENT|2020-08-03|65
e|SS|c8aad550-11a1-4473-8b35-79b7dfb08122|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|6|TREATMENT|2020-08-03|65
e|SS|c8aad550-11a1-4473-8b35-79b7dfb08122|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|2|SCREENING|2020-08-28|90
e|SS|c8aad550-11a1-4473-8b35-79b7dfb08122|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|2|TREATMENT|2020-08-28|90
e|SS|f1967c6e-c520-4482-be7e-01ada4380d87|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|1|WASHOUT|2021-01-05|10
e|SS|f1967c6e-c520-4482-be7e-01ada4380d87|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|5|SCREENING|2021-01-05|10
e|SS|f1967c6e-c520-4482-be7e-01ada4380d87|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|4|WASHOUT|2021-01-20|25
e|SS|f1967c6e-c520-4482-be7e-01ada4380d87|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|6|WASHOUT|2021-01-20|25
e|SS|f1967c6e-c520-4482-be7e-01ada4380d87|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|4|TREATMENT|2021-02-04|40
e|SS|f1967c6e-c520-4482-be7e-01ada4380d87|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|6|WASHOUT|2021-02-04|40
e|SS|f1967c6e-c520-4482-be7e-01ada4380d87|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2021-03-01|65
e|SS|f1967c6e-c520-4482-be7e-01ada4380d87|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|6|TREATMENT|2021-03-01|65
e|SS|f1967c6e-c520-4482-be7e-01ada4380d87|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|6|TREATMENT|2021-03-26|90
e|SS|f1967c6e-c520-4482-be7e-01ada4380d87|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|5|SCREENING|2021-03-26|90
e|SS|2a5a1c03-f54e-47da-8dda-2104c9423e94|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|1|TREATMENT|2021-01-01|10
e|SS|2a5a1c03-f54e-47da-8dda-2104c9423e94|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|6|FOLLOW-UP|2021-01-01|10
e|SS|2a5a1c03-f54e-47da-8dda-2104c9423e94|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|4|SCREENING|2021-01-16|25
e|SS|2a5a1c03-f54e-47da-8dda-2104c9423e94|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|5|WASHOUT|2021-01-16|25
e|SS|2a5a1c03-f54e-47da-8dda-2104c9423e94|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|5|TREATMENT|2021-01-31|40
e|SS|2a5a1c03-f54e-47da-8dda-2104c9423e94|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|1|WASHOUT|2021-01-31|40
e|SS|2a5a1c03-f54e-47da-8dda-2104c9423e94|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|1|SCREENING|2021-02-25|65
e|SS|2a5a1c03-f54e-47da-8dda-2104c9423e94|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|5|TREATMENT|2021-02-25|65
e|SS|2a5a1c03-f54e-47da-8dda-2104c9423e94|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|7|TREATMENT|2021-03-22|90
e|SS|2a5a1c03-f54e-47da-8dda-2104c9423e94|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|3|WASHOUT|2021-03-22|90
e|SS|8f98bac3-8010-4902-8ae1-783dc5fea72d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|1|WASHOUT|2020-06-29|10
e|SS|8f98bac3-8010-4902-8ae1-783dc5fea72d|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|3|SCREENING|2020-06-29|10
e|SS|8f98bac3-8010-4902-8ae1-783dc5fea72d|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|4|FOLLOW-UP|2020-07-14|25
e|SS|8f98bac3-8010-4902-8ae1-783dc5fea72d|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|4|SCREENING|2020-07-14|25
e|SS|8f98bac3-8010-4902-8ae1-783dc5fea72d|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2020-07-29|40
e|SS|8f98bac3-8010-4902-8ae1-783dc5fea72d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|3|TREATMENT|2020-07-29|40
e|SS|8f98bac3-8010-4902-8ae1-783dc5fea72d|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|2|TREATMENT|2020-08-23|65
e|SS|8f98bac3-8010-4902-8ae1-783dc5fea72d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|FOLLOW-UP|2020-08-23|65
e|SS|8f98bac3-8010-4902-8ae1-783dc5fea72d|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|4|SCREENING|2020-09-17|90
e|SS|8f98bac3-8010-4902-8ae1-783dc5fea72d|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2020-09-17|90
e|SS|0fd7cece-4d9d-4d8c-82e0-df0c75613888|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|6|TREATMENT|2020-12-11|10
e|SS|0fd7cece-4d9d-4d8c-82e0-df0c75613888|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|4|WASHOUT|2020-12-11|10
e|SS|0fd7cece-4d9d-4d8c-82e0-df0c75613888|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|1|TREATMENT|2020-12-26|25
e|SS|0fd7cece-4d9d-4d8c-82e0-df0c75613888|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|3|TREATMENT|2020-12-26|25
e|SS|0fd7cece-4d9d-4d8c-82e0-df0c75613888|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|5|TREATMENT|2021-01-10|40
e|SS|0fd7cece-4d9d-4d8c-82e0-df0c75613888|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|5|SCREENING|2021-01-10|40
e|SS|0fd7cece-4d9d-4d8c-82e0-df0c75613888|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|3|TREATMENT|2021-02-04|65
e|SS|0fd7cece-4d9d-4d8c-82e0-df0c75613888|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|4|TREATMENT|2021-02-04|65
e|SS|0fd7cece-4d9d-4d8c-82e0-df0c75613888|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2021-03-01|90
e|SS|0fd7cece-4d9d-4d8c-82e0-df0c75613888|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|WASHOUT|2021-03-01|90
e|SS|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|5|WASHOUT|2020-06-13|10
e|SS|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|5|TREATMENT|2020-06-13|10
e|SS|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|5|FOLLOW-UP|2020-06-28|25
e|SS|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|3|SCREENING|2020-06-28|25
e|SS|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|4|TREATMENT|2020-07-13|40
e|SS|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|4|TREATMENT|2020-07-13|40
e|SS|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|4|FOLLOW-UP|2020-08-07|65
e|SS|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|1|TREATMENT|2020-08-07|65
e|SS|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|1|WASHOUT|2020-09-01|90
e|SS|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|3|TREATMENT|2020-09-01|90
e|SS|4be1ea69-9baf-45b4-873b-13a879544d9c|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|TREATMENT|2021-01-26|10
e|SS|4be1ea69-9baf-45b4-873b-13a879544d9c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|6|FOLLOW-UP|2021-01-26|10
e|SS|4be1ea69-9baf-45b4-873b-13a879544d9c|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|5|TREATMENT|2021-02-10|25
e|SS|4be1ea69-9baf-45b4-873b-13a879544d9c|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|1|TREATMENT|2021-02-10|25
e|SS|4be1ea69-9baf-45b4-873b-13a879544d9c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|2|TREATMENT|2021-02-25|40
e|SS|4be1ea69-9baf-45b4-873b-13a879544d9c|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|6|TREATMENT|2021-02-25|40
e|SS|4be1ea69-9baf-45b4-873b-13a879544d9c|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|1|WASHOUT|2021-03-22|65
e|SS|4be1ea69-9baf-45b4-873b-13a879544d9c|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|2|WASHOUT|2021-03-22|65
e|SS|4be1ea69-9baf-45b4-873b-13a879544d9c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|7|TREATMENT|2021-04-16|90
e|SS|4be1ea69-9baf-45b4-873b-13a879544d9c|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|2|TREATMENT|2021-04-16|90
e|SS|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|1|FOLLOW-UP|2020-10-29|10
e|SS|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|5|WASHOUT|2020-10-29|10
e|SS|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|5|SCREENING|2020-11-13|25
e|SS|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|3|FOLLOW-UP|2020-11-13|25
e|SS|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|FOLLOW-UP|2020-11-28|40
e|SS|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|6|FOLLOW-UP|2020-11-28|40
e|SS|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|4|TREATMENT|2020-12-23|65
e|SS|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|4|TREATMENT|2020-12-23|65
e|SS|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|2|TREATMENT|2021-01-17|90
e|SS|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|7|WASHOUT|2021-01-17|90
e|SS|16720f71-55b5-478f-b041-00b61ae19ac9|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|1|WASHOUT|2021-01-10|10
e|SS|16720f71-55b5-478f-b041-00b61ae19ac9|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|6|WASHOUT|2021-01-10|10
e|SS|16720f71-55b5-478f-b041-00b61ae19ac9|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|2|TREATMENT|2021-01-25|25
e|SS|16720f71-55b5-478f-b041-00b61ae19ac9|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|5|SCREENING|2021-01-25|25
e|SS|16720f71-55b5-478f-b041-00b61ae19ac9|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|2|SCREENING|2021-02-09|40
e|SS|16720f71-55b5-478f-b041-00b61ae19ac9|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|3|WASHOUT|2021-02-09|40
e|SS|16720f71-55b5-478f-b041-00b61ae19ac9|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|6|TREATMENT|2021-03-06|65
e|SS|16720f71-55b5-478f-b041-00b61ae19ac9|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|2|SCREENING|2021-03-06|65
e|SS|16720f71-55b5-478f-b041-00b61ae19ac9|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2021-03-31|90
e|SS|16720f71-55b5-478f-b041-00b61ae19ac9|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|2|TREATMENT|2021-03-31|90
e|SS|4349f45e-f18b-4606-9a72-fd45e64e17dc|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|1|TREATMENT|2021-01-11|10
e|SS|4349f45e-f18b-4606-9a72-fd45e64e17dc|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|4|TREATMENT|2021-01-11|10
e|SS|4349f45e-f18b-4606-9a72-fd45e64e17dc|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|4|TREATMENT|2021-01-26|25
e|SS|4349f45e-f18b-4606-9a72-fd45e64e17dc|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|2|TREATMENT|2021-01-26|25
e|SS|4349f45e-f18b-4606-9a72-fd45e64e17dc|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|5|FOLLOW-UP|2021-02-10|40
e|SS|4349f45e-f18b-4606-9a72-fd45e64e17dc|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|7|WASHOUT|2021-02-10|40
e|SS|4349f45e-f18b-4606-9a72-fd45e64e17dc|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|WASHOUT|2021-03-07|65
e|SS|4349f45e-f18b-4606-9a72-fd45e64e17dc|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|7|WASHOUT|2021-03-07|65
e|SS|4349f45e-f18b-4606-9a72-fd45e64e17dc|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|6|WASHOUT|2021-04-01|90
e|SS|4349f45e-f18b-4606-9a72-fd45e64e17dc|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|7|TREATMENT|2021-04-01|90
e|SS|32e36ec1-6895-42ff-bf33-52977e72b338|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|6|WASHOUT|2020-09-05|10
e|SS|32e36ec1-6895-42ff-bf33-52977e72b338|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|1|WASHOUT|2020-09-05|10
e|SS|32e36ec1-6895-42ff-bf33-52977e72b338|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-09-20|25
e|SS|32e36ec1-6895-42ff-bf33-52977e72b338|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|SCREENING|2020-09-20|25
e|SS|32e36ec1-6895-42ff-bf33-52977e72b338|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|6|TREATMENT|2020-10-05|40
e|SS|32e36ec1-6895-42ff-bf33-52977e72b338|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|5|WASHOUT|2020-10-05|40
e|SS|32e36ec1-6895-42ff-bf33-52977e72b338|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|6|TREATMENT|2020-10-30|65
e|SS|32e36ec1-6895-42ff-bf33-52977e72b338|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|1|FOLLOW-UP|2020-10-30|65
e|SS|32e36ec1-6895-42ff-bf33-52977e72b338|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|7|TREATMENT|2020-11-24|90
e|SS|32e36ec1-6895-42ff-bf33-52977e72b338|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|6|FOLLOW-UP|2020-11-24|90
e|SS|e546f2d8-baea-4a6e-93cb-c7ec7292b423|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2021-01-23|100
e|SS|e546f2d8-baea-4a6e-93cb-c7ec7292b423|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|FAMILY MEMBER|1|Visit_1|10|3|TREATMENT|2021-01-23|100
e|SS|e546f2d8-baea-4a6e-93cb-c7ec7292b423|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIBLING|2|Visit_2|25|4|TREATMENT|2021-01-23|100
e|SS|e546f2d8-baea-4a6e-93cb-c7ec7292b423|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|VENDOR|2|Visit_2|25|3|TREATMENT|2021-01-23|100
e|SS|e546f2d8-baea-4a6e-93cb-c7ec7292b423|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|INDEPENDENT ASSESSOR|3|Visit_3|40|1|WASHOUT|2021-01-23|100
e|SS|e546f2d8-baea-4a6e-93cb-c7ec7292b423|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATOR|3|Visit_3|40|5|FOLLOW-UP|2021-01-23|100
e|SS|e546f2d8-baea-4a6e-93cb-c7ec7292b423|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|WASHOUT|2021-01-23|100
e|SS|e546f2d8-baea-4a6e-93cb-c7ec7292b423|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|FAMILY MEMBER|4|Visit_4|65|7|FOLLOW-UP|2021-01-23|100
e|SS|e546f2d8-baea-4a6e-93cb-c7ec7292b423|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|PARENT|5|Visit_5|90|1|TREATMENT|2021-01-23|100
e|SS|e546f2d8-baea-4a6e-93cb-c7ec7292b423|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|CHILD|5|Visit_5|90|5|FOLLOW-UP|2021-01-23|100
e|SS|0329de16-fc7a-4941-900c-b390dac637aa|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|1|TREATMENT|2020-09-27|10
e|SS|0329de16-fc7a-4941-900c-b390dac637aa|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|3|SCREENING|2020-09-27|10
e|SS|0329de16-fc7a-4941-900c-b390dac637aa|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|WASHOUT|2020-10-12|25
e|SS|0329de16-fc7a-4941-900c-b390dac637aa|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|1|TREATMENT|2020-10-12|25
e|SS|0329de16-fc7a-4941-900c-b390dac637aa|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2020-10-27|40
e|SS|0329de16-fc7a-4941-900c-b390dac637aa|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|4|WASHOUT|2020-10-27|40
e|SS|0329de16-fc7a-4941-900c-b390dac637aa|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|6|SCREENING|2020-11-21|65
e|SS|0329de16-fc7a-4941-900c-b390dac637aa|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|2|WASHOUT|2020-11-21|65
e|SS|0329de16-fc7a-4941-900c-b390dac637aa|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|5|TREATMENT|2020-12-16|90
e|SS|0329de16-fc7a-4941-900c-b390dac637aa|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|FOLLOW-UP|2020-12-16|90
e|SS|89d364c9-1338-472b-af0b-19280e45508b|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|2|WASHOUT|2020-10-15|10
e|SS|89d364c9-1338-472b-af0b-19280e45508b|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|6|TREATMENT|2020-10-15|10
e|SS|89d364c9-1338-472b-af0b-19280e45508b|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|3|TREATMENT|2020-10-30|25
e|SS|89d364c9-1338-472b-af0b-19280e45508b|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|1|SCREENING|2020-10-30|25
e|SS|89d364c9-1338-472b-af0b-19280e45508b|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|7|WASHOUT|2020-11-14|40
e|SS|89d364c9-1338-472b-af0b-19280e45508b|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|4|TREATMENT|2020-11-14|40
e|SS|89d364c9-1338-472b-af0b-19280e45508b|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|7|TREATMENT|2020-12-09|65
e|SS|89d364c9-1338-472b-af0b-19280e45508b|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|2|FOLLOW-UP|2020-12-09|65
e|SS|89d364c9-1338-472b-af0b-19280e45508b|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|3|TREATMENT|2021-01-03|90
e|SS|89d364c9-1338-472b-af0b-19280e45508b|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|5|TREATMENT|2021-01-03|90
e|SS|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|2|TREATMENT|2020-05-27|10
e|SS|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|6|SCREENING|2020-05-27|10
e|SS|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|7|TREATMENT|2020-06-11|25
e|SS|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|6|TREATMENT|2020-06-11|25
e|SS|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|3|SCREENING|2020-06-26|40
e|SS|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|6|FOLLOW-UP|2020-06-26|40
e|SS|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|SCREENING|2020-07-21|65
e|SS|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|2|SCREENING|2020-07-21|65
e|SS|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|3|TREATMENT|2020-08-15|90
e|SS|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|6|TREATMENT|2020-08-15|90
e|SS|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|TREATMENT|2020-10-12|10
e|SS|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|5|TREATMENT|2020-10-12|10
e|SS|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|5|TREATMENT|2020-10-27|25
e|SS|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|2|TREATMENT|2020-10-27|25
e|SS|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|6|WASHOUT|2020-11-11|40
e|SS|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|6|WASHOUT|2020-11-11|40
e|SS|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2020-12-06|65
e|SS|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|1|TREATMENT|2020-12-06|65
e|SS|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2020-12-31|90
e|SS|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2020-12-31|90
e|SS|0c103005-efae-48ed-91e3-35d38fa1d359|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|5|TREATMENT|2020-05-28|10
e|SS|0c103005-efae-48ed-91e3-35d38fa1d359|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|4|WASHOUT|2020-05-28|10
e|SS|0c103005-efae-48ed-91e3-35d38fa1d359|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|5|TREATMENT|2020-06-12|25
e|SS|0c103005-efae-48ed-91e3-35d38fa1d359|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|7|SCREENING|2020-06-12|25
e|SS|0c103005-efae-48ed-91e3-35d38fa1d359|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|7|TREATMENT|2020-06-27|40
e|SS|0c103005-efae-48ed-91e3-35d38fa1d359|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|6|FOLLOW-UP|2020-06-27|40
e|SS|0c103005-efae-48ed-91e3-35d38fa1d359|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|3|TREATMENT|2020-07-22|65
e|SS|0c103005-efae-48ed-91e3-35d38fa1d359|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|4|SCREENING|2020-07-22|65
e|SS|0c103005-efae-48ed-91e3-35d38fa1d359|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|4|SCREENING|2020-08-16|90
e|SS|0c103005-efae-48ed-91e3-35d38fa1d359|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|7|TREATMENT|2020-08-16|90
e|SS|c9808184-3432-448c-a5e5-50176715effa|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|6|WASHOUT|2020-12-29|10
e|SS|c9808184-3432-448c-a5e5-50176715effa|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|1|SCREENING|2020-12-29|10
e|SS|c9808184-3432-448c-a5e5-50176715effa|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|5|SCREENING|2021-01-13|25
e|SS|c9808184-3432-448c-a5e5-50176715effa|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|3|TREATMENT|2021-01-13|25
e|SS|c9808184-3432-448c-a5e5-50176715effa|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|4|WASHOUT|2021-01-28|40
e|SS|c9808184-3432-448c-a5e5-50176715effa|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|4|TREATMENT|2021-01-28|40
e|SS|c9808184-3432-448c-a5e5-50176715effa|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|1|FOLLOW-UP|2021-02-22|65
e|SS|c9808184-3432-448c-a5e5-50176715effa|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|5|TREATMENT|2021-02-22|65
e|SS|c9808184-3432-448c-a5e5-50176715effa|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|6|SCREENING|2021-03-19|90
e|SS|c9808184-3432-448c-a5e5-50176715effa|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|6|SCREENING|2021-03-19|90
e|SS|c3d7d293-975f-44de-bd35-0168eec40ac9|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|DOMESTIC PARTNER|1|Visit_1|10|3|TREATMENT|2021-04-04|100
e|SS|c3d7d293-975f-44de-bd35-0168eec40ac9|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|PROXY|1|Visit_1|10|4|WASHOUT|2021-04-04|100
e|SS|c3d7d293-975f-44de-bd35-0168eec40ac9|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATOR|2|Visit_2|25|6|SCREENING|2021-04-04|100
e|SS|c3d7d293-975f-44de-bd35-0168eec40ac9|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATOR|2|Visit_2|25|3|WASHOUT|2021-04-04|100
e|SS|c3d7d293-975f-44de-bd35-0168eec40ac9|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|INTERVIEWER|3|Visit_3|40|2|FOLLOW-UP|2021-04-04|100
e|SS|c3d7d293-975f-44de-bd35-0168eec40ac9|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL STUDY SPONSOR|3|Visit_3|40|5|FOLLOW-UP|2021-04-04|100
e|SS|c3d7d293-975f-44de-bd35-0168eec40ac9|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|DOMESTIC PARTNER|4|Visit_4|65|4|SCREENING|2021-04-04|100
e|SS|c3d7d293-975f-44de-bd35-0168eec40ac9|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|INTERVIEWER|4|Visit_4|65|1|TREATMENT|2021-04-04|100
e|SS|c3d7d293-975f-44de-bd35-0168eec40ac9|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|6|TREATMENT|2021-04-04|100
e|SS|c3d7d293-975f-44de-bd35-0168eec40ac9|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|VENDOR|5|Visit_5|90|4|TREATMENT|2021-04-04|100
e|SS|2db1f07d-a7db-4cc3-8943-536e24378f08|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|5|TREATMENT|2020-06-12|10
e|SS|2db1f07d-a7db-4cc3-8943-536e24378f08|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|2|WASHOUT|2020-06-12|10
e|SS|2db1f07d-a7db-4cc3-8943-536e24378f08|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|1|TREATMENT|2020-06-27|25
e|SS|2db1f07d-a7db-4cc3-8943-536e24378f08|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|7|SCREENING|2020-06-27|25
e|SS|2db1f07d-a7db-4cc3-8943-536e24378f08|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|7|FOLLOW-UP|2020-07-12|40
e|SS|2db1f07d-a7db-4cc3-8943-536e24378f08|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|2|TREATMENT|2020-07-12|40
e|SS|2db1f07d-a7db-4cc3-8943-536e24378f08|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|6|WASHOUT|2020-08-06|65
e|SS|2db1f07d-a7db-4cc3-8943-536e24378f08|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|4|SCREENING|2020-08-06|65
e|SS|2db1f07d-a7db-4cc3-8943-536e24378f08|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|1|TREATMENT|2020-08-31|90
e|SS|2db1f07d-a7db-4cc3-8943-536e24378f08|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|2|WASHOUT|2020-08-31|90
e|SS|c343ba98-87d7-40bc-b0e8-b866e42d3a21|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|6|TREATMENT|2020-12-15|10
e|SS|c343ba98-87d7-40bc-b0e8-b866e42d3a21|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|TREATMENT|2020-12-15|10
e|SS|c343ba98-87d7-40bc-b0e8-b866e42d3a21|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|7|FOLLOW-UP|2020-12-30|25
e|SS|c343ba98-87d7-40bc-b0e8-b866e42d3a21|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|FOLLOW-UP|2020-12-30|25
e|SS|c343ba98-87d7-40bc-b0e8-b866e42d3a21|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|3|SCREENING|2021-01-14|40
e|SS|c343ba98-87d7-40bc-b0e8-b866e42d3a21|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|7|FOLLOW-UP|2021-01-14|40
e|SS|c343ba98-87d7-40bc-b0e8-b866e42d3a21|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|3|FOLLOW-UP|2021-02-08|65
e|SS|c343ba98-87d7-40bc-b0e8-b866e42d3a21|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|1|WASHOUT|2021-02-08|65
e|SS|c343ba98-87d7-40bc-b0e8-b866e42d3a21|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|6|WASHOUT|2021-03-05|90
e|SS|c343ba98-87d7-40bc-b0e8-b866e42d3a21|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|5|SCREENING|2021-03-05|90
e|SS|d2b31ba9-9718-43ce-82ca-3276c28ac42a|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|2|TREATMENT|2020-12-04|10
e|SS|d2b31ba9-9718-43ce-82ca-3276c28ac42a|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|2|SCREENING|2020-12-04|10
e|SS|d2b31ba9-9718-43ce-82ca-3276c28ac42a|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|7|TREATMENT|2020-12-19|25
e|SS|d2b31ba9-9718-43ce-82ca-3276c28ac42a|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|2|TREATMENT|2020-12-19|25
e|SS|d2b31ba9-9718-43ce-82ca-3276c28ac42a|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|4|FOLLOW-UP|2021-01-03|40
e|SS|d2b31ba9-9718-43ce-82ca-3276c28ac42a|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|7|TREATMENT|2021-01-03|40
e|SS|d2b31ba9-9718-43ce-82ca-3276c28ac42a|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|1|TREATMENT|2021-01-28|65
e|SS|d2b31ba9-9718-43ce-82ca-3276c28ac42a|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|7|SCREENING|2021-01-28|65
e|SS|d2b31ba9-9718-43ce-82ca-3276c28ac42a|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|7|TREATMENT|2021-02-22|90
e|SS|d2b31ba9-9718-43ce-82ca-3276c28ac42a|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|FOLLOW-UP|2021-02-22|90
e|SS|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|3|WASHOUT|2020-07-23|10
e|SS|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|1|TREATMENT|2020-07-23|10
e|SS|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|1|WASHOUT|2020-08-07|25
e|SS|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|1|TREATMENT|2020-08-07|25
e|SS|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-08-22|40
e|SS|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|2|TREATMENT|2020-08-22|40
e|SS|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|6|SCREENING|2020-09-16|65
e|SS|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|SCREENING|2020-09-16|65
e|SS|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|4|TREATMENT|2020-10-11|90
e|SS|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|7|TREATMENT|2020-10-11|90
e|SS|0a42f96a-49c3-492f-a272-bf9989e53e9d|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|3|FOLLOW-UP|2021-01-26|10
e|SS|0a42f96a-49c3-492f-a272-bf9989e53e9d|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|FOLLOW-UP|2021-01-26|10
e|SS|0a42f96a-49c3-492f-a272-bf9989e53e9d|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|3|TREATMENT|2021-02-10|25
e|SS|0a42f96a-49c3-492f-a272-bf9989e53e9d|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|2|TREATMENT|2021-02-10|25
e|SS|0a42f96a-49c3-492f-a272-bf9989e53e9d|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|WASHOUT|2021-02-25|40
e|SS|0a42f96a-49c3-492f-a272-bf9989e53e9d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|FOLLOW-UP|2021-02-25|40
e|SS|0a42f96a-49c3-492f-a272-bf9989e53e9d|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|4|SCREENING|2021-03-22|65
e|SS|0a42f96a-49c3-492f-a272-bf9989e53e9d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|7|TREATMENT|2021-03-22|65
e|SS|0a42f96a-49c3-492f-a272-bf9989e53e9d|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|1|WASHOUT|2021-04-16|90
e|SS|0a42f96a-49c3-492f-a272-bf9989e53e9d|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|TREATMENT|2021-04-16|90
e|SS|a78e7287-581c-4bf2-b3ca-ad2476c010cd|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|1|WASHOUT|2021-01-08|10
e|SS|a78e7287-581c-4bf2-b3ca-ad2476c010cd|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|6|FOLLOW-UP|2021-01-08|10
e|SS|a78e7287-581c-4bf2-b3ca-ad2476c010cd|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|7|TREATMENT|2021-01-23|25
e|SS|a78e7287-581c-4bf2-b3ca-ad2476c010cd|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|3|SCREENING|2021-01-23|25
e|SS|a78e7287-581c-4bf2-b3ca-ad2476c010cd|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|6|TREATMENT|2021-02-07|40
e|SS|a78e7287-581c-4bf2-b3ca-ad2476c010cd|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|3|TREATMENT|2021-02-07|40
e|SS|a78e7287-581c-4bf2-b3ca-ad2476c010cd|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|3|TREATMENT|2021-03-04|65
e|SS|a78e7287-581c-4bf2-b3ca-ad2476c010cd|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|4|TREATMENT|2021-03-04|65
e|SS|a78e7287-581c-4bf2-b3ca-ad2476c010cd|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|7|TREATMENT|2021-03-29|90
e|SS|a78e7287-581c-4bf2-b3ca-ad2476c010cd|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|7|TREATMENT|2021-03-29|90
e|SS|d3651e5f-bc38-4c96-afbf-5a65873ff306|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|7|SCREENING|2020-07-28|10
e|SS|d3651e5f-bc38-4c96-afbf-5a65873ff306|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|3|TREATMENT|2020-07-28|10
e|SS|d3651e5f-bc38-4c96-afbf-5a65873ff306|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|1|TREATMENT|2020-08-12|25
e|SS|d3651e5f-bc38-4c96-afbf-5a65873ff306|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|WASHOUT|2020-08-12|25
e|SS|d3651e5f-bc38-4c96-afbf-5a65873ff306|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|6|SCREENING|2020-08-27|40
e|SS|d3651e5f-bc38-4c96-afbf-5a65873ff306|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2020-08-27|40
e|SS|d3651e5f-bc38-4c96-afbf-5a65873ff306|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|6|WASHOUT|2020-09-21|65
e|SS|d3651e5f-bc38-4c96-afbf-5a65873ff306|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|4|FOLLOW-UP|2020-09-21|65
e|SS|d3651e5f-bc38-4c96-afbf-5a65873ff306|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|3|TREATMENT|2020-10-16|90
e|SS|d3651e5f-bc38-4c96-afbf-5a65873ff306|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|6|SCREENING|2020-10-16|90
e|SS|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|FOLLOW-UP|2020-06-11|10
e|SS|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|6|SCREENING|2020-06-11|10
e|SS|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|5|WASHOUT|2020-06-26|25
e|SS|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|7|TREATMENT|2020-06-26|25
e|SS|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|WASHOUT|2020-07-11|40
e|SS|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|1|TREATMENT|2020-07-11|40
e|SS|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|TREATMENT|2020-08-05|65
e|SS|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|2|FOLLOW-UP|2020-08-05|65
e|SS|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|4|FOLLOW-UP|2020-08-30|90
e|SS|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|3|TREATMENT|2020-08-30|90
e|SS|f50537d2-e098-4dae-8f91-16f2357d709c|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|DOMESTIC PARTNER|1|Visit_1|10|3|TREATMENT|2021-03-07|100
e|SS|f50537d2-e098-4dae-8f91-16f2357d709c|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|INVESTIGATOR|1|Visit_1|10|3|FOLLOW-UP|2021-03-07|100
e|SS|f50537d2-e098-4dae-8f91-16f2357d709c|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|5|TREATMENT|2021-03-07|100
e|SS|f50537d2-e098-4dae-8f91-16f2357d709c|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|INVESTIGATOR|2|Visit_2|25|7|WASHOUT|2021-03-07|100
e|SS|f50537d2-e098-4dae-8f91-16f2357d709c|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2021-03-07|100
e|SS|f50537d2-e098-4dae-8f91-16f2357d709c|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|FAMILY MEMBER|3|Visit_3|40|2|TREATMENT|2021-03-07|100
e|SS|f50537d2-e098-4dae-8f91-16f2357d709c|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|CAREGIVER|4|Visit_4|65|2|TREATMENT|2021-03-07|100
e|SS|f50537d2-e098-4dae-8f91-16f2357d709c|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|INVESTIGATOR|4|Visit_4|65|4|TREATMENT|2021-03-07|100
e|SS|f50537d2-e098-4dae-8f91-16f2357d709c|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|FAMILY MEMBER|5|Visit_5|90|3|TREATMENT|2021-03-07|100
e|SS|f50537d2-e098-4dae-8f91-16f2357d709c|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|FOLLOW-UP|2021-03-07|100
e|SS|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|1|WASHOUT|2020-07-19|10
e|SS|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|6|TREATMENT|2020-07-19|10
e|SS|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|2|TREATMENT|2020-08-03|25
e|SS|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|2|TREATMENT|2020-08-03|25
e|SS|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|3|WASHOUT|2020-08-18|40
e|SS|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|2|WASHOUT|2020-08-18|40
e|SS|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|2|TREATMENT|2020-09-12|65
e|SS|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|TREATMENT|2020-09-12|65
e|SS|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|5|TREATMENT|2020-10-07|90
e|SS|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|5|TREATMENT|2020-10-07|90
e|SS|489870ed-9da5-4df6-a5ef-17821c449c84|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|1|FOLLOW-UP|2020-07-30|10
e|SS|489870ed-9da5-4df6-a5ef-17821c449c84|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|5|TREATMENT|2020-07-30|10
e|SS|489870ed-9da5-4df6-a5ef-17821c449c84|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|1|TREATMENT|2020-08-14|25
e|SS|489870ed-9da5-4df6-a5ef-17821c449c84|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|WASHOUT|2020-08-14|25
e|SS|489870ed-9da5-4df6-a5ef-17821c449c84|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|4|TREATMENT|2020-08-29|40
e|SS|489870ed-9da5-4df6-a5ef-17821c449c84|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|7|TREATMENT|2020-08-29|40
e|SS|489870ed-9da5-4df6-a5ef-17821c449c84|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|SCREENING|2020-09-23|65
e|SS|489870ed-9da5-4df6-a5ef-17821c449c84|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|1|WASHOUT|2020-09-23|65
e|SS|489870ed-9da5-4df6-a5ef-17821c449c84|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|2|TREATMENT|2020-10-18|90
e|SS|489870ed-9da5-4df6-a5ef-17821c449c84|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|3|TREATMENT|2020-10-18|90
e|SS|90fe992f-5a11-4829-b3b0-1c8314f53012|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|3|TREATMENT|2020-09-23|10
e|SS|90fe992f-5a11-4829-b3b0-1c8314f53012|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|2|SCREENING|2020-09-23|10
e|SS|90fe992f-5a11-4829-b3b0-1c8314f53012|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|5|WASHOUT|2020-10-08|25
e|SS|90fe992f-5a11-4829-b3b0-1c8314f53012|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|1|WASHOUT|2020-10-08|25
e|SS|90fe992f-5a11-4829-b3b0-1c8314f53012|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|5|WASHOUT|2020-10-23|40
e|SS|90fe992f-5a11-4829-b3b0-1c8314f53012|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|3|TREATMENT|2020-10-23|40
e|SS|90fe992f-5a11-4829-b3b0-1c8314f53012|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|1|TREATMENT|2020-11-17|65
e|SS|90fe992f-5a11-4829-b3b0-1c8314f53012|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|4|TREATMENT|2020-11-17|65
e|SS|90fe992f-5a11-4829-b3b0-1c8314f53012|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|SCREENING|2020-12-12|90
e|SS|90fe992f-5a11-4829-b3b0-1c8314f53012|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|2|TREATMENT|2020-12-12|90
e|SS|74be8de0-3307-4cc3-9044-05068b60f7e0|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|2|TREATMENT|2020-10-20|10
e|SS|74be8de0-3307-4cc3-9044-05068b60f7e0|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|3|TREATMENT|2020-10-20|10
e|SS|74be8de0-3307-4cc3-9044-05068b60f7e0|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|6|TREATMENT|2020-11-04|25
e|SS|74be8de0-3307-4cc3-9044-05068b60f7e0|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|2|FOLLOW-UP|2020-11-04|25
e|SS|74be8de0-3307-4cc3-9044-05068b60f7e0|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|4|FOLLOW-UP|2020-11-19|40
e|SS|74be8de0-3307-4cc3-9044-05068b60f7e0|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|3|TREATMENT|2020-11-19|40
e|SS|74be8de0-3307-4cc3-9044-05068b60f7e0|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|1|TREATMENT|2020-12-14|65
e|SS|74be8de0-3307-4cc3-9044-05068b60f7e0|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|6|FOLLOW-UP|2020-12-14|65
e|SS|74be8de0-3307-4cc3-9044-05068b60f7e0|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|5|TREATMENT|2021-01-08|90
e|SS|74be8de0-3307-4cc3-9044-05068b60f7e0|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|5|SCREENING|2021-01-08|90
e|SS|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|4|TREATMENT|2020-06-11|10
e|SS|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|2|WASHOUT|2020-06-11|10
e|SS|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|SCREENING|2020-06-26|25
e|SS|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|6|SCREENING|2020-06-26|25
e|SS|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|5|FOLLOW-UP|2020-07-11|40
e|SS|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|2|TREATMENT|2020-07-11|40
e|SS|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|7|TREATMENT|2020-08-05|65
e|SS|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|2|TREATMENT|2020-08-05|65
e|SS|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|7|WASHOUT|2020-08-30|90
e|SS|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|3|TREATMENT|2020-08-30|90
e|SS|8825b806-fa76-49d7-b281-d36fc42fee1e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|7|TREATMENT|2020-08-29|10
e|SS|8825b806-fa76-49d7-b281-d36fc42fee1e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|3|FOLLOW-UP|2020-08-29|10
e|SS|8825b806-fa76-49d7-b281-d36fc42fee1e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|WASHOUT|2020-09-13|25
e|SS|8825b806-fa76-49d7-b281-d36fc42fee1e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|1|TREATMENT|2020-09-13|25
e|SS|8825b806-fa76-49d7-b281-d36fc42fee1e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|3|TREATMENT|2020-09-28|40
e|SS|8825b806-fa76-49d7-b281-d36fc42fee1e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|3|TREATMENT|2020-09-28|40
e|SS|8825b806-fa76-49d7-b281-d36fc42fee1e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2020-10-23|65
e|SS|8825b806-fa76-49d7-b281-d36fc42fee1e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|WASHOUT|2020-10-23|65
e|SS|8825b806-fa76-49d7-b281-d36fc42fee1e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|4|TREATMENT|2020-11-17|90
e|SS|8825b806-fa76-49d7-b281-d36fc42fee1e|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|4|WASHOUT|2020-11-17|90
e|SS|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|1|WASHOUT|2020-05-19|10
e|SS|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|3|WASHOUT|2020-05-19|10
e|SS|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|2|WASHOUT|2020-06-03|25
e|SS|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|1|TREATMENT|2020-06-03|25
e|SS|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|3|TREATMENT|2020-06-18|40
e|SS|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|1|TREATMENT|2020-06-18|40
e|SS|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|6|WASHOUT|2020-07-13|65
e|SS|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|7|SCREENING|2020-07-13|65
e|SS|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2020-08-07|90
e|SS|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|WASHOUT|2020-08-07|90
e|SS|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|3|WASHOUT|2021-01-14|10
e|SS|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|1|WASHOUT|2021-01-14|10
e|SS|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|4|SCREENING|2021-01-29|25
e|SS|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|7|SCREENING|2021-01-29|25
e|SS|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|4|FOLLOW-UP|2021-02-13|40
e|SS|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|3|SCREENING|2021-02-13|40
e|SS|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|WASHOUT|2021-03-10|65
e|SS|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|4|WASHOUT|2021-03-10|65
e|SS|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2021-04-04|90
e|SS|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|4|TREATMENT|2021-04-04|90
e|SS|b36220d8-c129-48bf-8c41-542a954b819a|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|2|SCREENING|2020-05-24|10
e|SS|b36220d8-c129-48bf-8c41-542a954b819a|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|7|SCREENING|2020-05-24|10
e|SS|b36220d8-c129-48bf-8c41-542a954b819a|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|4|TREATMENT|2020-06-08|25
e|SS|b36220d8-c129-48bf-8c41-542a954b819a|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|5|TREATMENT|2020-06-08|25
e|SS|b36220d8-c129-48bf-8c41-542a954b819a|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|5|TREATMENT|2020-06-23|40
e|SS|b36220d8-c129-48bf-8c41-542a954b819a|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|7|FOLLOW-UP|2020-06-23|40
e|SS|b36220d8-c129-48bf-8c41-542a954b819a|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|5|TREATMENT|2020-07-18|65
e|SS|b36220d8-c129-48bf-8c41-542a954b819a|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2020-07-18|65
e|SS|b36220d8-c129-48bf-8c41-542a954b819a|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|4|TREATMENT|2020-08-12|90
e|SS|b36220d8-c129-48bf-8c41-542a954b819a|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|4|TREATMENT|2020-08-12|90
e|SS|92d3477b-7460-4ce8-b237-38ca4c55fc91|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|1|SCREENING|2020-08-14|10
e|SS|92d3477b-7460-4ce8-b237-38ca4c55fc91|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|1|TREATMENT|2020-08-14|10
e|SS|92d3477b-7460-4ce8-b237-38ca4c55fc91|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|TREATMENT|2020-08-29|25
e|SS|92d3477b-7460-4ce8-b237-38ca4c55fc91|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|3|TREATMENT|2020-08-29|25
e|SS|92d3477b-7460-4ce8-b237-38ca4c55fc91|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|3|TREATMENT|2020-09-13|40
e|SS|92d3477b-7460-4ce8-b237-38ca4c55fc91|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|WASHOUT|2020-09-13|40
e|SS|92d3477b-7460-4ce8-b237-38ca4c55fc91|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2020-10-08|65
e|SS|92d3477b-7460-4ce8-b237-38ca4c55fc91|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|5|SCREENING|2020-10-08|65
e|SS|92d3477b-7460-4ce8-b237-38ca4c55fc91|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2020-11-02|90
e|SS|92d3477b-7460-4ce8-b237-38ca4c55fc91|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|7|TREATMENT|2020-11-02|90
e|SS|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|4|TREATMENT|2020-12-16|10
e|SS|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|3|TREATMENT|2020-12-16|10
e|SS|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|6|TREATMENT|2020-12-31|25
e|SS|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|3|WASHOUT|2020-12-31|25
e|SS|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|2|TREATMENT|2021-01-15|40
e|SS|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|4|TREATMENT|2021-01-15|40
e|SS|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|6|TREATMENT|2021-02-09|65
e|SS|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|6|TREATMENT|2021-02-09|65
e|SS|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|2|TREATMENT|2021-03-06|90
e|SS|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|4|TREATMENT|2021-03-06|90
e|SS|db13afe0-14f6-445b-869a-b0d9fe87e5b9|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATION COMMITTEE|1|Visit_1|10|7|FOLLOW-UP|2020-11-20|100
e|SS|db13afe0-14f6-445b-869a-b0d9fe87e5b9|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATOR|1|Visit_1|10|4|TREATMENT|2020-11-20|100
e|SS|db13afe0-14f6-445b-869a-b0d9fe87e5b9|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|FAMILY MEMBER|2|Visit_2|25|2|TREATMENT|2020-11-20|100
e|SS|db13afe0-14f6-445b-869a-b0d9fe87e5b9|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|PARENT|2|Visit_2|25|2|TREATMENT|2020-11-20|100
e|SS|db13afe0-14f6-445b-869a-b0d9fe87e5b9|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|INVESTIGATOR|3|Visit_3|40|1|TREATMENT|2020-11-20|100
e|SS|db13afe0-14f6-445b-869a-b0d9fe87e5b9|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|CHILD|3|Visit_3|40|6|TREATMENT|2020-11-20|100
e|SS|db13afe0-14f6-445b-869a-b0d9fe87e5b9|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|CAREGIVER|4|Visit_4|65|2|SCREENING|2020-11-20|100
e|SS|db13afe0-14f6-445b-869a-b0d9fe87e5b9|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|SPOUSE|4|Visit_4|65|5|TREATMENT|2020-11-20|100
e|SS|db13afe0-14f6-445b-869a-b0d9fe87e5b9|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|INDEPENDENT ASSESSOR|5|Visit_5|90|7|FOLLOW-UP|2020-11-20|100
e|SS|db13afe0-14f6-445b-869a-b0d9fe87e5b9|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|STUDY SUBJECT|5|Visit_5|90|6|WASHOUT|2020-11-20|100
e|SS|3f75a463-1348-4c7f-8b29-7472d29628c8|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|6|SCREENING|2020-07-12|10
e|SS|3f75a463-1348-4c7f-8b29-7472d29628c8|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|3|WASHOUT|2020-07-12|10
e|SS|3f75a463-1348-4c7f-8b29-7472d29628c8|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|7|SCREENING|2020-07-27|25
e|SS|3f75a463-1348-4c7f-8b29-7472d29628c8|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|5|FOLLOW-UP|2020-07-27|25
e|SS|3f75a463-1348-4c7f-8b29-7472d29628c8|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|3|TREATMENT|2020-08-11|40
e|SS|3f75a463-1348-4c7f-8b29-7472d29628c8|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|5|WASHOUT|2020-08-11|40
e|SS|3f75a463-1348-4c7f-8b29-7472d29628c8|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|7|FOLLOW-UP|2020-09-05|65
e|SS|3f75a463-1348-4c7f-8b29-7472d29628c8|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|3|FOLLOW-UP|2020-09-05|65
e|SS|3f75a463-1348-4c7f-8b29-7472d29628c8|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|5|WASHOUT|2020-09-30|90
e|SS|3f75a463-1348-4c7f-8b29-7472d29628c8|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|1|TREATMENT|2020-09-30|90
e|SS|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|6|SCREENING|2021-01-30|10
e|SS|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|7|SCREENING|2021-01-30|10
e|SS|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|6|WASHOUT|2021-02-14|25
e|SS|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|4|SCREENING|2021-02-14|25
e|SS|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|6|SCREENING|2021-03-01|40
e|SS|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|2|FOLLOW-UP|2021-03-01|40
e|SS|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|6|FOLLOW-UP|2021-03-26|65
e|SS|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|3|TREATMENT|2021-03-26|65
e|SS|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|3|TREATMENT|2021-04-20|90
e|SS|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|7|TREATMENT|2021-04-20|90
e|SS|4b00b9ef-ddc3-4669-8a73-f69c73743bce|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|3|TREATMENT|2020-07-23|10
e|SS|4b00b9ef-ddc3-4669-8a73-f69c73743bce|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|4|TREATMENT|2020-07-23|10
e|SS|4b00b9ef-ddc3-4669-8a73-f69c73743bce|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|1|SCREENING|2020-08-07|25
e|SS|4b00b9ef-ddc3-4669-8a73-f69c73743bce|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-08-07|25
e|SS|4b00b9ef-ddc3-4669-8a73-f69c73743bce|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|7|TREATMENT|2020-08-22|40
e|SS|4b00b9ef-ddc3-4669-8a73-f69c73743bce|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|5|WASHOUT|2020-08-22|40
e|SS|4b00b9ef-ddc3-4669-8a73-f69c73743bce|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|4|WASHOUT|2020-09-16|65
e|SS|4b00b9ef-ddc3-4669-8a73-f69c73743bce|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|1|SCREENING|2020-09-16|65
e|SS|4b00b9ef-ddc3-4669-8a73-f69c73743bce|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|5|SCREENING|2020-10-11|90
e|SS|4b00b9ef-ddc3-4669-8a73-f69c73743bce|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|3|WASHOUT|2020-10-11|90
e|SS|a125efdf-aec8-47a1-b492-cdaf8b619a78|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|3|SCREENING|2020-09-30|10
e|SS|a125efdf-aec8-47a1-b492-cdaf8b619a78|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|WASHOUT|2020-09-30|10
e|SS|a125efdf-aec8-47a1-b492-cdaf8b619a78|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|1|TREATMENT|2020-10-15|25
e|SS|a125efdf-aec8-47a1-b492-cdaf8b619a78|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|4|TREATMENT|2020-10-15|25
e|SS|a125efdf-aec8-47a1-b492-cdaf8b619a78|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|2|TREATMENT|2020-10-30|40
e|SS|a125efdf-aec8-47a1-b492-cdaf8b619a78|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|4|TREATMENT|2020-10-30|40
e|SS|a125efdf-aec8-47a1-b492-cdaf8b619a78|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|6|TREATMENT|2020-11-24|65
e|SS|a125efdf-aec8-47a1-b492-cdaf8b619a78|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|1|FOLLOW-UP|2020-11-24|65
e|SS|a125efdf-aec8-47a1-b492-cdaf8b619a78|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|2|TREATMENT|2020-12-19|90
e|SS|a125efdf-aec8-47a1-b492-cdaf8b619a78|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|5|FOLLOW-UP|2020-12-19|90
e|SS|9171362e-0166-46f2-ab2d-2748d8c291d5|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|6|SCREENING|2021-01-12|10
e|SS|9171362e-0166-46f2-ab2d-2748d8c291d5|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|2|TREATMENT|2021-01-12|10
e|SS|9171362e-0166-46f2-ab2d-2748d8c291d5|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|FOLLOW-UP|2021-01-27|25
e|SS|9171362e-0166-46f2-ab2d-2748d8c291d5|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2021-01-27|25
e|SS|9171362e-0166-46f2-ab2d-2748d8c291d5|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|5|FOLLOW-UP|2021-02-11|40
e|SS|9171362e-0166-46f2-ab2d-2748d8c291d5|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|4|TREATMENT|2021-02-11|40
e|SS|9171362e-0166-46f2-ab2d-2748d8c291d5|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|6|SCREENING|2021-03-08|65
e|SS|9171362e-0166-46f2-ab2d-2748d8c291d5|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|6|FOLLOW-UP|2021-03-08|65
e|SS|9171362e-0166-46f2-ab2d-2748d8c291d5|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|3|TREATMENT|2021-04-02|90
e|SS|9171362e-0166-46f2-ab2d-2748d8c291d5|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|6|TREATMENT|2021-04-02|90
e|SS|9b150e38-dc85-4a28-aad3-43f7620be460|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|7|TREATMENT|2020-07-22|10
e|SS|9b150e38-dc85-4a28-aad3-43f7620be460|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|3|FOLLOW-UP|2020-07-22|10
e|SS|9b150e38-dc85-4a28-aad3-43f7620be460|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|2|SCREENING|2020-08-06|25
e|SS|9b150e38-dc85-4a28-aad3-43f7620be460|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|7|WASHOUT|2020-08-06|25
e|SS|9b150e38-dc85-4a28-aad3-43f7620be460|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|5|TREATMENT|2020-08-21|40
e|SS|9b150e38-dc85-4a28-aad3-43f7620be460|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|1|TREATMENT|2020-08-21|40
e|SS|9b150e38-dc85-4a28-aad3-43f7620be460|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|3|FOLLOW-UP|2020-09-15|65
e|SS|9b150e38-dc85-4a28-aad3-43f7620be460|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|1|TREATMENT|2020-09-15|65
e|SS|9b150e38-dc85-4a28-aad3-43f7620be460|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|1|WASHOUT|2020-10-10|90
e|SS|9b150e38-dc85-4a28-aad3-43f7620be460|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2020-10-10|90
e|SS|2a595fc0-7621-4ec9-bd77-74444886052e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|6|TREATMENT|2020-10-25|10
e|SS|2a595fc0-7621-4ec9-bd77-74444886052e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|2|TREATMENT|2020-10-25|10
e|SS|2a595fc0-7621-4ec9-bd77-74444886052e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|1|TREATMENT|2020-11-09|25
e|SS|2a595fc0-7621-4ec9-bd77-74444886052e|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|7|FOLLOW-UP|2020-11-09|25
e|SS|2a595fc0-7621-4ec9-bd77-74444886052e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|4|SCREENING|2020-11-24|40
e|SS|2a595fc0-7621-4ec9-bd77-74444886052e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|4|TREATMENT|2020-11-24|40
e|SS|2a595fc0-7621-4ec9-bd77-74444886052e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|7|TREATMENT|2020-12-19|65
e|SS|2a595fc0-7621-4ec9-bd77-74444886052e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|2|SCREENING|2020-12-19|65
e|SS|2a595fc0-7621-4ec9-bd77-74444886052e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|4|WASHOUT|2021-01-13|90
e|SS|2a595fc0-7621-4ec9-bd77-74444886052e|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|6|TREATMENT|2021-01-13|90
e|SS|0bab89c8-cf57-4d19-9b95-884a2e9da523|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|5|TREATMENT|2020-12-20|10
e|SS|0bab89c8-cf57-4d19-9b95-884a2e9da523|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|3|WASHOUT|2020-12-20|10
e|SS|0bab89c8-cf57-4d19-9b95-884a2e9da523|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|2|TREATMENT|2021-01-04|25
e|SS|0bab89c8-cf57-4d19-9b95-884a2e9da523|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|2|TREATMENT|2021-01-04|25
e|SS|0bab89c8-cf57-4d19-9b95-884a2e9da523|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|5|SCREENING|2021-01-19|40
e|SS|0bab89c8-cf57-4d19-9b95-884a2e9da523|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|4|WASHOUT|2021-01-19|40
e|SS|0bab89c8-cf57-4d19-9b95-884a2e9da523|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|2|WASHOUT|2021-02-13|65
e|SS|0bab89c8-cf57-4d19-9b95-884a2e9da523|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|2|WASHOUT|2021-02-13|65
e|SS|0bab89c8-cf57-4d19-9b95-884a2e9da523|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|4|TREATMENT|2021-03-10|90
e|SS|0bab89c8-cf57-4d19-9b95-884a2e9da523|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|3|TREATMENT|2021-03-10|90
e|SS|84edaa9d-ce48-4866-ab43-af91bee126ae|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|6|TREATMENT|2020-05-11|10
e|SS|84edaa9d-ce48-4866-ab43-af91bee126ae|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|1|TREATMENT|2020-05-11|10
e|SS|84edaa9d-ce48-4866-ab43-af91bee126ae|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|7|SCREENING|2020-05-26|25
e|SS|84edaa9d-ce48-4866-ab43-af91bee126ae|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|3|FOLLOW-UP|2020-05-26|25
e|SS|84edaa9d-ce48-4866-ab43-af91bee126ae|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|SCREENING|2020-06-10|40
e|SS|84edaa9d-ce48-4866-ab43-af91bee126ae|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|6|TREATMENT|2020-06-10|40
e|SS|84edaa9d-ce48-4866-ab43-af91bee126ae|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|5|WASHOUT|2020-07-05|65
e|SS|84edaa9d-ce48-4866-ab43-af91bee126ae|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|6|SCREENING|2020-07-05|65
e|SS|84edaa9d-ce48-4866-ab43-af91bee126ae|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|5|TREATMENT|2020-07-30|90
e|SS|84edaa9d-ce48-4866-ab43-af91bee126ae|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|2|FOLLOW-UP|2020-07-30|90
e|SS|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|3|TREATMENT|2020-08-03|10
e|SS|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|7|SCREENING|2020-08-03|10
e|SS|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|4|TREATMENT|2020-08-18|25
e|SS|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|4|TREATMENT|2020-08-18|25
e|SS|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|2|TREATMENT|2020-09-02|40
e|SS|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|3|WASHOUT|2020-09-02|40
e|SS|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|1|TREATMENT|2020-09-27|65
e|SS|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|1|WASHOUT|2020-09-27|65
e|SS|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|6|TREATMENT|2020-10-22|90
e|SS|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|WASHOUT|2020-10-22|90
e|SS|9734ec2a-d06b-43e1-82a5-37764af17890|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|6|TREATMENT|2020-09-29|10
e|SS|9734ec2a-d06b-43e1-82a5-37764af17890|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|7|TREATMENT|2020-09-29|10
e|SS|9734ec2a-d06b-43e1-82a5-37764af17890|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|4|TREATMENT|2020-10-14|25
e|SS|9734ec2a-d06b-43e1-82a5-37764af17890|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|7|TREATMENT|2020-10-14|25
e|SS|9734ec2a-d06b-43e1-82a5-37764af17890|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|WASHOUT|2020-10-29|40
e|SS|9734ec2a-d06b-43e1-82a5-37764af17890|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|4|TREATMENT|2020-10-29|40
e|SS|9734ec2a-d06b-43e1-82a5-37764af17890|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|2|FOLLOW-UP|2020-11-23|65
e|SS|9734ec2a-d06b-43e1-82a5-37764af17890|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|5|WASHOUT|2020-11-23|65
e|SS|9734ec2a-d06b-43e1-82a5-37764af17890|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|4|SCREENING|2020-12-18|90
e|SS|9734ec2a-d06b-43e1-82a5-37764af17890|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|4|SCREENING|2020-12-18|90
e|SS|9a0ce525-7f10-4651-885a-f64bd9c8925e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|1|SCREENING|2020-11-28|10
e|SS|9a0ce525-7f10-4651-885a-f64bd9c8925e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|3|TREATMENT|2020-11-28|10
e|SS|9a0ce525-7f10-4651-885a-f64bd9c8925e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|6|TREATMENT|2020-12-13|25
e|SS|9a0ce525-7f10-4651-885a-f64bd9c8925e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|7|SCREENING|2020-12-13|25
e|SS|9a0ce525-7f10-4651-885a-f64bd9c8925e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|6|WASHOUT|2020-12-28|40
e|SS|9a0ce525-7f10-4651-885a-f64bd9c8925e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|SCREENING|2020-12-28|40
e|SS|9a0ce525-7f10-4651-885a-f64bd9c8925e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|7|TREATMENT|2021-01-22|65
e|SS|9a0ce525-7f10-4651-885a-f64bd9c8925e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|6|SCREENING|2021-01-22|65
e|SS|9a0ce525-7f10-4651-885a-f64bd9c8925e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|6|FOLLOW-UP|2021-02-16|90
e|SS|9a0ce525-7f10-4651-885a-f64bd9c8925e|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|5|TREATMENT|2021-02-16|90
e|SS|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|5|WASHOUT|2020-07-15|10
e|SS|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|5|TREATMENT|2020-07-15|10
e|SS|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|2|FOLLOW-UP|2020-07-30|25
e|SS|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|5|TREATMENT|2020-07-30|25
e|SS|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|1|TREATMENT|2020-08-14|40
e|SS|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|5|TREATMENT|2020-08-14|40
e|SS|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|2|FOLLOW-UP|2020-09-08|65
e|SS|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|TREATMENT|2020-09-08|65
e|SS|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|2|SCREENING|2020-10-03|90
e|SS|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|5|FOLLOW-UP|2020-10-03|90
e|SS|4ba88073-0003-461a-a950-4504ef7680e7|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|6|WASHOUT|2020-09-02|10
e|SS|4ba88073-0003-461a-a950-4504ef7680e7|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|4|SCREENING|2020-09-02|10
e|SS|4ba88073-0003-461a-a950-4504ef7680e7|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|4|TREATMENT|2020-09-17|25
e|SS|4ba88073-0003-461a-a950-4504ef7680e7|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|7|FOLLOW-UP|2020-09-17|25
e|SS|4ba88073-0003-461a-a950-4504ef7680e7|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|1|TREATMENT|2020-10-02|40
e|SS|4ba88073-0003-461a-a950-4504ef7680e7|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|6|TREATMENT|2020-10-02|40
e|SS|4ba88073-0003-461a-a950-4504ef7680e7|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|3|SCREENING|2020-10-27|65
e|SS|4ba88073-0003-461a-a950-4504ef7680e7|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|FOLLOW-UP|2020-10-27|65
e|SS|4ba88073-0003-461a-a950-4504ef7680e7|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|6|WASHOUT|2020-11-21|90
e|SS|4ba88073-0003-461a-a950-4504ef7680e7|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|6|SCREENING|2020-11-21|90
e|SS|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|5|TREATMENT|2020-09-01|10
e|SS|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|3|TREATMENT|2020-09-01|10
e|SS|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|2|TREATMENT|2020-09-16|25
e|SS|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|4|TREATMENT|2020-09-16|25
e|SS|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|1|FOLLOW-UP|2020-10-01|40
e|SS|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|7|WASHOUT|2020-10-01|40
e|SS|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2020-10-26|65
e|SS|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|6|FOLLOW-UP|2020-10-26|65
e|SS|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|2|TREATMENT|2020-11-20|90
e|SS|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|2|TREATMENT|2020-11-20|90
e|SS|f552fa78-d78f-44c5-9590-30a737e6652d|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|5|WASHOUT|2020-10-05|10
e|SS|f552fa78-d78f-44c5-9590-30a737e6652d|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|7|TREATMENT|2020-10-05|10
e|SS|f552fa78-d78f-44c5-9590-30a737e6652d|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|FOLLOW-UP|2020-10-20|25
e|SS|f552fa78-d78f-44c5-9590-30a737e6652d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|3|WASHOUT|2020-10-20|25
e|SS|f552fa78-d78f-44c5-9590-30a737e6652d|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|6|SCREENING|2020-11-04|40
e|SS|f552fa78-d78f-44c5-9590-30a737e6652d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|5|WASHOUT|2020-11-04|40
e|SS|f552fa78-d78f-44c5-9590-30a737e6652d|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|WASHOUT|2020-11-29|65
e|SS|f552fa78-d78f-44c5-9590-30a737e6652d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|4|SCREENING|2020-11-29|65
e|SS|f552fa78-d78f-44c5-9590-30a737e6652d|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|3|TREATMENT|2020-12-24|90
e|SS|f552fa78-d78f-44c5-9590-30a737e6652d|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2020-12-24|90
e|SS|38d83f86-d8ce-461a-a288-95aebe498d22|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|4|TREATMENT|2020-08-25|10
e|SS|38d83f86-d8ce-461a-a288-95aebe498d22|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|6|TREATMENT|2020-08-25|10
e|SS|38d83f86-d8ce-461a-a288-95aebe498d22|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2020-09-09|25
e|SS|38d83f86-d8ce-461a-a288-95aebe498d22|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|6|FOLLOW-UP|2020-09-09|25
e|SS|38d83f86-d8ce-461a-a288-95aebe498d22|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|3|TREATMENT|2020-09-24|40
e|SS|38d83f86-d8ce-461a-a288-95aebe498d22|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|2|TREATMENT|2020-09-24|40
e|SS|38d83f86-d8ce-461a-a288-95aebe498d22|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|1|TREATMENT|2020-10-19|65
e|SS|38d83f86-d8ce-461a-a288-95aebe498d22|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|7|TREATMENT|2020-10-19|65
e|SS|38d83f86-d8ce-461a-a288-95aebe498d22|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|4|TREATMENT|2020-11-13|90
e|SS|38d83f86-d8ce-461a-a288-95aebe498d22|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|3|SCREENING|2020-11-13|90
e|SS|b31e8820-cc17-4ce5-af30-358dbeb12ba2|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|7|FOLLOW-UP|2020-08-13|10
e|SS|b31e8820-cc17-4ce5-af30-358dbeb12ba2|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|1|TREATMENT|2020-08-13|10
e|SS|b31e8820-cc17-4ce5-af30-358dbeb12ba2|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|3|SCREENING|2020-08-28|25
e|SS|b31e8820-cc17-4ce5-af30-358dbeb12ba2|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2020-08-28|25
e|SS|b31e8820-cc17-4ce5-af30-358dbeb12ba2|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|4|FOLLOW-UP|2020-09-12|40
e|SS|b31e8820-cc17-4ce5-af30-358dbeb12ba2|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|TREATMENT|2020-09-12|40
e|SS|b31e8820-cc17-4ce5-af30-358dbeb12ba2|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|FOLLOW-UP|2020-10-07|65
e|SS|b31e8820-cc17-4ce5-af30-358dbeb12ba2|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|SCREENING|2020-10-07|65
e|SS|b31e8820-cc17-4ce5-af30-358dbeb12ba2|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|4|FOLLOW-UP|2020-11-01|90
e|SS|b31e8820-cc17-4ce5-af30-358dbeb12ba2|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|6|TREATMENT|2020-11-01|90
e|SS|cf39d5bd-7682-4546-8495-5bcf48600a69|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|4|TREATMENT|2021-01-20|10
e|SS|cf39d5bd-7682-4546-8495-5bcf48600a69|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|3|TREATMENT|2021-01-20|10
e|SS|cf39d5bd-7682-4546-8495-5bcf48600a69|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|6|WASHOUT|2021-02-04|25
e|SS|cf39d5bd-7682-4546-8495-5bcf48600a69|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|2|TREATMENT|2021-02-04|25
e|SS|cf39d5bd-7682-4546-8495-5bcf48600a69|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|5|TREATMENT|2021-02-19|40
e|SS|cf39d5bd-7682-4546-8495-5bcf48600a69|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|6|WASHOUT|2021-02-19|40
e|SS|cf39d5bd-7682-4546-8495-5bcf48600a69|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|3|WASHOUT|2021-03-16|65
e|SS|cf39d5bd-7682-4546-8495-5bcf48600a69|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2021-03-16|65
e|SS|cf39d5bd-7682-4546-8495-5bcf48600a69|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|5|WASHOUT|2021-04-10|90
e|SS|cf39d5bd-7682-4546-8495-5bcf48600a69|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|1|FOLLOW-UP|2021-04-10|90
e|SS|84c17e7b-8d56-4726-96a5-9ca41fb9d894|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|4|TREATMENT|2020-11-24|10
e|SS|84c17e7b-8d56-4726-96a5-9ca41fb9d894|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|6|FOLLOW-UP|2020-11-24|10
e|SS|84c17e7b-8d56-4726-96a5-9ca41fb9d894|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|3|WASHOUT|2020-12-09|25
e|SS|84c17e7b-8d56-4726-96a5-9ca41fb9d894|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|1|TREATMENT|2020-12-09|25
e|SS|84c17e7b-8d56-4726-96a5-9ca41fb9d894|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|4|WASHOUT|2020-12-24|40
e|SS|84c17e7b-8d56-4726-96a5-9ca41fb9d894|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|2|WASHOUT|2020-12-24|40
e|SS|84c17e7b-8d56-4726-96a5-9ca41fb9d894|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|3|TREATMENT|2021-01-18|65
e|SS|84c17e7b-8d56-4726-96a5-9ca41fb9d894|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|7|TREATMENT|2021-01-18|65
e|SS|84c17e7b-8d56-4726-96a5-9ca41fb9d894|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|1|SCREENING|2021-02-12|90
e|SS|84c17e7b-8d56-4726-96a5-9ca41fb9d894|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|7|FOLLOW-UP|2021-02-12|90
e|SS|6e557fd7-efaf-4c86-806d-9bd66c7de7da|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|6|WASHOUT|2021-01-27|10
e|SS|6e557fd7-efaf-4c86-806d-9bd66c7de7da|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|5|SCREENING|2021-01-27|10
e|SS|6e557fd7-efaf-4c86-806d-9bd66c7de7da|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|5|TREATMENT|2021-02-11|25
e|SS|6e557fd7-efaf-4c86-806d-9bd66c7de7da|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|3|TREATMENT|2021-02-11|25
e|SS|6e557fd7-efaf-4c86-806d-9bd66c7de7da|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|1|TREATMENT|2021-02-26|40
e|SS|6e557fd7-efaf-4c86-806d-9bd66c7de7da|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|3|TREATMENT|2021-02-26|40
e|SS|6e557fd7-efaf-4c86-806d-9bd66c7de7da|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|4|WASHOUT|2021-03-23|65
e|SS|6e557fd7-efaf-4c86-806d-9bd66c7de7da|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|5|TREATMENT|2021-03-23|65
e|SS|6e557fd7-efaf-4c86-806d-9bd66c7de7da|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|2|FOLLOW-UP|2021-04-17|90
e|SS|6e557fd7-efaf-4c86-806d-9bd66c7de7da|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|7|FOLLOW-UP|2021-04-17|90
e|SS|2b25e1f9-929c-4bdc-8758-79f33b832026|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|WASHOUT|2020-10-19|10
e|SS|2b25e1f9-929c-4bdc-8758-79f33b832026|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|5|SCREENING|2020-10-19|10
e|SS|2b25e1f9-929c-4bdc-8758-79f33b832026|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|1|TREATMENT|2020-11-03|25
e|SS|2b25e1f9-929c-4bdc-8758-79f33b832026|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|4|TREATMENT|2020-11-03|25
e|SS|2b25e1f9-929c-4bdc-8758-79f33b832026|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|2|TREATMENT|2020-11-18|40
e|SS|2b25e1f9-929c-4bdc-8758-79f33b832026|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|4|WASHOUT|2020-11-18|40
e|SS|2b25e1f9-929c-4bdc-8758-79f33b832026|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|1|TREATMENT|2020-12-13|65
e|SS|2b25e1f9-929c-4bdc-8758-79f33b832026|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|3|TREATMENT|2020-12-13|65
e|SS|2b25e1f9-929c-4bdc-8758-79f33b832026|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|2|TREATMENT|2021-01-07|90
e|SS|2b25e1f9-929c-4bdc-8758-79f33b832026|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|2|TREATMENT|2021-01-07|90
e|SS|d02c7553-17f5-44ec-8c24-469234d080e8|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|3|TREATMENT|2021-01-26|10
e|SS|d02c7553-17f5-44ec-8c24-469234d080e8|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|6|TREATMENT|2021-01-26|10
e|SS|d02c7553-17f5-44ec-8c24-469234d080e8|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|1|TREATMENT|2021-02-10|25
e|SS|d02c7553-17f5-44ec-8c24-469234d080e8|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2021-02-10|25
e|SS|d02c7553-17f5-44ec-8c24-469234d080e8|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|4|TREATMENT|2021-02-25|40
e|SS|d02c7553-17f5-44ec-8c24-469234d080e8|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|WASHOUT|2021-02-25|40
e|SS|d02c7553-17f5-44ec-8c24-469234d080e8|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|6|TREATMENT|2021-03-22|65
e|SS|d02c7553-17f5-44ec-8c24-469234d080e8|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|4|WASHOUT|2021-03-22|65
e|SS|d02c7553-17f5-44ec-8c24-469234d080e8|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|1|SCREENING|2021-04-16|90
e|SS|d02c7553-17f5-44ec-8c24-469234d080e8|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|3|TREATMENT|2021-04-16|90
e|SS|e819939e-548d-4e05-83e3-7976790de7e1|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|7|FOLLOW-UP|2020-09-07|10
e|SS|e819939e-548d-4e05-83e3-7976790de7e1|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|7|WASHOUT|2020-09-07|10
e|SS|e819939e-548d-4e05-83e3-7976790de7e1|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|3|TREATMENT|2020-09-22|25
e|SS|e819939e-548d-4e05-83e3-7976790de7e1|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|2|WASHOUT|2020-09-22|25
e|SS|e819939e-548d-4e05-83e3-7976790de7e1|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|1|WASHOUT|2020-10-07|40
e|SS|e819939e-548d-4e05-83e3-7976790de7e1|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|6|TREATMENT|2020-10-07|40
e|SS|e819939e-548d-4e05-83e3-7976790de7e1|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|5|FOLLOW-UP|2020-11-01|65
e|SS|e819939e-548d-4e05-83e3-7976790de7e1|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|2|SCREENING|2020-11-01|65
e|SS|e819939e-548d-4e05-83e3-7976790de7e1|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|3|TREATMENT|2020-11-26|90
e|SS|e819939e-548d-4e05-83e3-7976790de7e1|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2020-11-26|90
e|SS|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|4|TREATMENT|2020-08-18|10
e|SS|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|5|WASHOUT|2020-08-18|10
e|SS|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|7|WASHOUT|2020-09-02|25
e|SS|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|7|TREATMENT|2020-09-02|25
e|SS|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|1|TREATMENT|2020-09-17|40
e|SS|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|6|TREATMENT|2020-09-17|40
e|SS|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|4|TREATMENT|2020-10-12|65
e|SS|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|1|TREATMENT|2020-10-12|65
e|SS|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|1|TREATMENT|2020-11-06|90
e|SS|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|4|TREATMENT|2020-11-06|90
e|SS|ea5229ad-6469-4147-be40-546d27c04c4c|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|1|WASHOUT|2020-06-09|10
e|SS|ea5229ad-6469-4147-be40-546d27c04c4c|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|2|TREATMENT|2020-06-09|10
e|SS|ea5229ad-6469-4147-be40-546d27c04c4c|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|1|TREATMENT|2020-06-24|25
e|SS|ea5229ad-6469-4147-be40-546d27c04c4c|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|4|FOLLOW-UP|2020-06-24|25
e|SS|ea5229ad-6469-4147-be40-546d27c04c4c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|TREATMENT|2020-07-09|40
e|SS|ea5229ad-6469-4147-be40-546d27c04c4c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|TREATMENT|2020-07-09|40
e|SS|ea5229ad-6469-4147-be40-546d27c04c4c|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|FOLLOW-UP|2020-08-03|65
e|SS|ea5229ad-6469-4147-be40-546d27c04c4c|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|2|TREATMENT|2020-08-03|65
e|SS|ea5229ad-6469-4147-be40-546d27c04c4c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|5|TREATMENT|2020-08-28|90
e|SS|ea5229ad-6469-4147-be40-546d27c04c4c|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|6|FOLLOW-UP|2020-08-28|90
e|SS|0a566742-0f71-4603-85f0-875e2c3395e7|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|7|SCREENING|2021-01-08|10
e|SS|0a566742-0f71-4603-85f0-875e2c3395e7|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|3|SCREENING|2021-01-08|10
e|SS|0a566742-0f71-4603-85f0-875e2c3395e7|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|4|TREATMENT|2021-01-23|25
e|SS|0a566742-0f71-4603-85f0-875e2c3395e7|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|1|SCREENING|2021-01-23|25
e|SS|0a566742-0f71-4603-85f0-875e2c3395e7|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|6|WASHOUT|2021-02-07|40
e|SS|0a566742-0f71-4603-85f0-875e2c3395e7|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|7|TREATMENT|2021-02-07|40
e|SS|0a566742-0f71-4603-85f0-875e2c3395e7|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|3|TREATMENT|2021-03-04|65
e|SS|0a566742-0f71-4603-85f0-875e2c3395e7|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|4|TREATMENT|2021-03-04|65
e|SS|0a566742-0f71-4603-85f0-875e2c3395e7|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|1|SCREENING|2021-03-29|90
e|SS|0a566742-0f71-4603-85f0-875e2c3395e7|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|3|FOLLOW-UP|2021-03-29|90
e|SS|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|6|TREATMENT|2020-05-14|10
e|SS|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|7|TREATMENT|2020-05-14|10
e|SS|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|3|SCREENING|2020-05-29|25
e|SS|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|3|WASHOUT|2020-05-29|25
e|SS|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|1|TREATMENT|2020-06-13|40
e|SS|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|2|TREATMENT|2020-06-13|40
e|SS|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|6|TREATMENT|2020-07-08|65
e|SS|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|5|FOLLOW-UP|2020-07-08|65
e|SS|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2020-08-02|90
e|SS|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|2|TREATMENT|2020-08-02|90
e|SS|48103500-0f3d-4108-9167-6afee1098773|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|4|WASHOUT|2020-05-15|10
e|SS|48103500-0f3d-4108-9167-6afee1098773|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|6|SCREENING|2020-05-15|10
e|SS|48103500-0f3d-4108-9167-6afee1098773|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|TREATMENT|2020-05-30|25
e|SS|48103500-0f3d-4108-9167-6afee1098773|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|4|TREATMENT|2020-05-30|25
e|SS|48103500-0f3d-4108-9167-6afee1098773|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|4|FOLLOW-UP|2020-06-14|40
e|SS|48103500-0f3d-4108-9167-6afee1098773|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2020-06-14|40
e|SS|48103500-0f3d-4108-9167-6afee1098773|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|3|TREATMENT|2020-07-09|65
e|SS|48103500-0f3d-4108-9167-6afee1098773|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|1|TREATMENT|2020-07-09|65
e|SS|48103500-0f3d-4108-9167-6afee1098773|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|7|SCREENING|2020-08-03|90
e|SS|48103500-0f3d-4108-9167-6afee1098773|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|6|FOLLOW-UP|2020-08-03|90
e|SS|9855fc59-f162-48ba-8c51-e8c6c54b72f3|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|3|FOLLOW-UP|2020-07-25|10
e|SS|9855fc59-f162-48ba-8c51-e8c6c54b72f3|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|7|TREATMENT|2020-07-25|10
e|SS|9855fc59-f162-48ba-8c51-e8c6c54b72f3|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|2|FOLLOW-UP|2020-08-09|25
e|SS|9855fc59-f162-48ba-8c51-e8c6c54b72f3|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|2|WASHOUT|2020-08-09|25
e|SS|9855fc59-f162-48ba-8c51-e8c6c54b72f3|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|3|TREATMENT|2020-08-24|40
e|SS|9855fc59-f162-48ba-8c51-e8c6c54b72f3|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|6|TREATMENT|2020-08-24|40
e|SS|9855fc59-f162-48ba-8c51-e8c6c54b72f3|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|6|FOLLOW-UP|2020-09-18|65
e|SS|9855fc59-f162-48ba-8c51-e8c6c54b72f3|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|7|WASHOUT|2020-09-18|65
e|SS|9855fc59-f162-48ba-8c51-e8c6c54b72f3|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|6|TREATMENT|2020-10-13|90
e|SS|9855fc59-f162-48ba-8c51-e8c6c54b72f3|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|1|TREATMENT|2020-10-13|90
e|SS|ceab42b0-3a7e-4aad-b599-5da311398148|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|FOLLOW-UP|2020-06-21|10
e|SS|ceab42b0-3a7e-4aad-b599-5da311398148|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|3|TREATMENT|2020-06-21|10
e|SS|ceab42b0-3a7e-4aad-b599-5da311398148|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|2|SCREENING|2020-07-06|25
e|SS|ceab42b0-3a7e-4aad-b599-5da311398148|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|6|TREATMENT|2020-07-06|25
e|SS|ceab42b0-3a7e-4aad-b599-5da311398148|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|6|SCREENING|2020-07-21|40
e|SS|ceab42b0-3a7e-4aad-b599-5da311398148|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|5|WASHOUT|2020-07-21|40
e|SS|ceab42b0-3a7e-4aad-b599-5da311398148|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|4|WASHOUT|2020-08-15|65
e|SS|ceab42b0-3a7e-4aad-b599-5da311398148|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2020-08-15|65
e|SS|ceab42b0-3a7e-4aad-b599-5da311398148|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|FOLLOW-UP|2020-09-09|90
e|SS|ceab42b0-3a7e-4aad-b599-5da311398148|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|6|WASHOUT|2020-09-09|90
e|SS|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|2|SCREENING|2020-07-09|10
e|SS|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|7|TREATMENT|2020-07-09|10
e|SS|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|6|TREATMENT|2020-07-24|25
e|SS|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2020-07-24|25
e|SS|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|2|TREATMENT|2020-08-08|40
e|SS|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|6|WASHOUT|2020-08-08|40
e|SS|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|TREATMENT|2020-09-02|65
e|SS|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|2|TREATMENT|2020-09-02|65
e|SS|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|6|TREATMENT|2020-09-27|90
e|SS|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|4|WASHOUT|2020-09-27|90
e|SS|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|1|SCREENING|2020-07-10|10
e|SS|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|FOLLOW-UP|2020-07-10|10
e|SS|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|2|TREATMENT|2020-07-25|25
e|SS|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|7|FOLLOW-UP|2020-07-25|25
e|SS|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|3|SCREENING|2020-08-09|40
e|SS|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|WASHOUT|2020-08-09|40
e|SS|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|5|TREATMENT|2020-09-03|65
e|SS|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|6|SCREENING|2020-09-03|65
e|SS|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|4|TREATMENT|2020-09-28|90
e|SS|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|6|WASHOUT|2020-09-28|90
e|SS|36a54b72-6368-460e-ab4c-952923e0fd14|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|1|TREATMENT|2020-05-15|10
e|SS|36a54b72-6368-460e-ab4c-952923e0fd14|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|5|TREATMENT|2020-05-15|10
e|SS|36a54b72-6368-460e-ab4c-952923e0fd14|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|6|TREATMENT|2020-05-30|25
e|SS|36a54b72-6368-460e-ab4c-952923e0fd14|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|TREATMENT|2020-05-30|25
e|SS|36a54b72-6368-460e-ab4c-952923e0fd14|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|TREATMENT|2020-06-14|40
e|SS|36a54b72-6368-460e-ab4c-952923e0fd14|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|6|SCREENING|2020-06-14|40
e|SS|36a54b72-6368-460e-ab4c-952923e0fd14|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|4|SCREENING|2020-07-09|65
e|SS|36a54b72-6368-460e-ab4c-952923e0fd14|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|3|TREATMENT|2020-07-09|65
e|SS|36a54b72-6368-460e-ab4c-952923e0fd14|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|6|TREATMENT|2020-08-03|90
e|SS|36a54b72-6368-460e-ab4c-952923e0fd14|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|5|FOLLOW-UP|2020-08-03|90
e|SS|84e56692-9a33-472a-9ddc-545d3342da34|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|7|TREATMENT|2020-12-19|10
e|SS|84e56692-9a33-472a-9ddc-545d3342da34|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|5|TREATMENT|2020-12-19|10
e|SS|84e56692-9a33-472a-9ddc-545d3342da34|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|1|TREATMENT|2021-01-03|25
e|SS|84e56692-9a33-472a-9ddc-545d3342da34|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|2|TREATMENT|2021-01-03|25
e|SS|84e56692-9a33-472a-9ddc-545d3342da34|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|4|TREATMENT|2021-01-18|40
e|SS|84e56692-9a33-472a-9ddc-545d3342da34|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|6|SCREENING|2021-01-18|40
e|SS|84e56692-9a33-472a-9ddc-545d3342da34|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|WASHOUT|2021-02-12|65
e|SS|84e56692-9a33-472a-9ddc-545d3342da34|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|2|FOLLOW-UP|2021-02-12|65
e|SS|84e56692-9a33-472a-9ddc-545d3342da34|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|3|TREATMENT|2021-03-09|90
e|SS|84e56692-9a33-472a-9ddc-545d3342da34|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|TREATMENT|2021-03-09|90
e|SS|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|6|TREATMENT|2020-05-31|10
e|SS|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|6|TREATMENT|2020-05-31|10
e|SS|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|5|TREATMENT|2020-06-15|25
e|SS|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|1|FOLLOW-UP|2020-06-15|25
e|SS|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|6|WASHOUT|2020-06-30|40
e|SS|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|6|FOLLOW-UP|2020-06-30|40
e|SS|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|1|FOLLOW-UP|2020-07-25|65
e|SS|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|WASHOUT|2020-07-25|65
e|SS|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|2|WASHOUT|2020-08-19|90
e|SS|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|1|TREATMENT|2020-08-19|90
e|SS|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|7|FOLLOW-UP|2020-06-10|10
e|SS|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|5|WASHOUT|2020-06-10|10
e|SS|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|3|TREATMENT|2020-06-25|25
e|SS|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-06-25|25
e|SS|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|1|FOLLOW-UP|2020-07-10|40
e|SS|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|2|TREATMENT|2020-07-10|40
e|SS|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2020-08-04|65
e|SS|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|2|TREATMENT|2020-08-04|65
e|SS|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|4|WASHOUT|2020-08-29|90
e|SS|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|7|SCREENING|2020-08-29|90
e|SS|ae0e05c1-3953-4406-bfae-299295c1fa4c|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|3|FOLLOW-UP|2021-01-12|10
e|SS|ae0e05c1-3953-4406-bfae-299295c1fa4c|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|SCREENING|2021-01-12|10
e|SS|ae0e05c1-3953-4406-bfae-299295c1fa4c|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|5|TREATMENT|2021-01-27|25
e|SS|ae0e05c1-3953-4406-bfae-299295c1fa4c|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|4|WASHOUT|2021-01-27|25
e|SS|ae0e05c1-3953-4406-bfae-299295c1fa4c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|2|TREATMENT|2021-02-11|40
e|SS|ae0e05c1-3953-4406-bfae-299295c1fa4c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|1|TREATMENT|2021-02-11|40
e|SS|ae0e05c1-3953-4406-bfae-299295c1fa4c|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|7|FOLLOW-UP|2021-03-08|65
e|SS|ae0e05c1-3953-4406-bfae-299295c1fa4c|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|3|WASHOUT|2021-03-08|65
e|SS|ae0e05c1-3953-4406-bfae-299295c1fa4c|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|5|FOLLOW-UP|2021-04-02|90
e|SS|ae0e05c1-3953-4406-bfae-299295c1fa4c|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2021-04-02|90
e|SS|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|4|FOLLOW-UP|2021-01-16|10
e|SS|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|5|TREATMENT|2021-01-16|10
e|SS|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|4|TREATMENT|2021-01-31|25
e|SS|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|7|FOLLOW-UP|2021-01-31|25
e|SS|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|5|TREATMENT|2021-02-15|40
e|SS|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|SCREENING|2021-02-15|40
e|SS|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|5|SCREENING|2021-03-12|65
e|SS|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|TREATMENT|2021-03-12|65
e|SS|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|5|SCREENING|2021-04-06|90
e|SS|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|WASHOUT|2021-04-06|90
e|SS|ab09e76d-8bbf-4126-a60d-08d6b5292836|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2020-12-25|10
e|SS|ab09e76d-8bbf-4126-a60d-08d6b5292836|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|WASHOUT|2020-12-25|10
e|SS|ab09e76d-8bbf-4126-a60d-08d6b5292836|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|FOLLOW-UP|2021-01-09|25
e|SS|ab09e76d-8bbf-4126-a60d-08d6b5292836|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|3|TREATMENT|2021-01-09|25
e|SS|ab09e76d-8bbf-4126-a60d-08d6b5292836|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|2|TREATMENT|2021-01-24|40
e|SS|ab09e76d-8bbf-4126-a60d-08d6b5292836|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|5|TREATMENT|2021-01-24|40
e|SS|ab09e76d-8bbf-4126-a60d-08d6b5292836|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|TREATMENT|2021-02-18|65
e|SS|ab09e76d-8bbf-4126-a60d-08d6b5292836|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|SCREENING|2021-02-18|65
e|SS|ab09e76d-8bbf-4126-a60d-08d6b5292836|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|3|FOLLOW-UP|2021-03-15|90
e|SS|ab09e76d-8bbf-4126-a60d-08d6b5292836|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|5|TREATMENT|2021-03-15|90
e|SS|8b7e3909-4115-4736-b07a-e0b6c382aa7e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|1|FOLLOW-UP|2020-07-11|10
e|SS|8b7e3909-4115-4736-b07a-e0b6c382aa7e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|7|FOLLOW-UP|2020-07-11|10
e|SS|8b7e3909-4115-4736-b07a-e0b6c382aa7e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|5|FOLLOW-UP|2020-07-26|25
e|SS|8b7e3909-4115-4736-b07a-e0b6c382aa7e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|5|SCREENING|2020-07-26|25
e|SS|8b7e3909-4115-4736-b07a-e0b6c382aa7e|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|2|SCREENING|2020-08-10|40
e|SS|8b7e3909-4115-4736-b07a-e0b6c382aa7e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|6|FOLLOW-UP|2020-08-10|40
e|SS|8b7e3909-4115-4736-b07a-e0b6c382aa7e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|7|WASHOUT|2020-09-04|65
e|SS|8b7e3909-4115-4736-b07a-e0b6c382aa7e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|1|TREATMENT|2020-09-04|65
e|SS|8b7e3909-4115-4736-b07a-e0b6c382aa7e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|2|TREATMENT|2020-09-29|90
e|SS|8b7e3909-4115-4736-b07a-e0b6c382aa7e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|6|WASHOUT|2020-09-29|90
e|SS|187b2279-526f-4978-89d4-d2da56cc2257|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|2|SCREENING|2020-06-21|10
e|SS|187b2279-526f-4978-89d4-d2da56cc2257|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|3|WASHOUT|2020-06-21|10
e|SS|187b2279-526f-4978-89d4-d2da56cc2257|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|5|FOLLOW-UP|2020-07-06|25
e|SS|187b2279-526f-4978-89d4-d2da56cc2257|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|2|TREATMENT|2020-07-06|25
e|SS|187b2279-526f-4978-89d4-d2da56cc2257|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|FOLLOW-UP|2020-07-21|40
e|SS|187b2279-526f-4978-89d4-d2da56cc2257|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-07-21|40
e|SS|187b2279-526f-4978-89d4-d2da56cc2257|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2020-08-15|65
e|SS|187b2279-526f-4978-89d4-d2da56cc2257|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|1|FOLLOW-UP|2020-08-15|65
e|SS|187b2279-526f-4978-89d4-d2da56cc2257|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|1|SCREENING|2020-09-09|90
e|SS|187b2279-526f-4978-89d4-d2da56cc2257|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|6|FOLLOW-UP|2020-09-09|90
e|SS|53506a04-dedb-495b-8e35-0576cdf1b323|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|7|TREATMENT|2020-11-07|10
e|SS|53506a04-dedb-495b-8e35-0576cdf1b323|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|TREATMENT|2020-11-07|10
e|SS|53506a04-dedb-495b-8e35-0576cdf1b323|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|3|TREATMENT|2020-11-22|25
e|SS|53506a04-dedb-495b-8e35-0576cdf1b323|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|4|FOLLOW-UP|2020-11-22|25
e|SS|53506a04-dedb-495b-8e35-0576cdf1b323|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|6|FOLLOW-UP|2020-12-07|40
e|SS|53506a04-dedb-495b-8e35-0576cdf1b323|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|TREATMENT|2020-12-07|40
e|SS|53506a04-dedb-495b-8e35-0576cdf1b323|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|5|TREATMENT|2021-01-01|65
e|SS|53506a04-dedb-495b-8e35-0576cdf1b323|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2021-01-01|65
e|SS|53506a04-dedb-495b-8e35-0576cdf1b323|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|TREATMENT|2021-01-26|90
e|SS|53506a04-dedb-495b-8e35-0576cdf1b323|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|7|WASHOUT|2021-01-26|90
e|SS|defa600c-4205-476e-a40c-690cb16769b3|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|7|TREATMENT|2021-01-24|10
e|SS|defa600c-4205-476e-a40c-690cb16769b3|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|6|TREATMENT|2021-01-24|10
e|SS|defa600c-4205-476e-a40c-690cb16769b3|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|5|WASHOUT|2021-02-08|25
e|SS|defa600c-4205-476e-a40c-690cb16769b3|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|3|WASHOUT|2021-02-08|25
e|SS|defa600c-4205-476e-a40c-690cb16769b3|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|4|FOLLOW-UP|2021-02-23|40
e|SS|defa600c-4205-476e-a40c-690cb16769b3|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|7|TREATMENT|2021-02-23|40
e|SS|defa600c-4205-476e-a40c-690cb16769b3|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|7|FOLLOW-UP|2021-03-20|65
e|SS|defa600c-4205-476e-a40c-690cb16769b3|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|7|FOLLOW-UP|2021-03-20|65
e|SS|defa600c-4205-476e-a40c-690cb16769b3|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|3|TREATMENT|2021-04-14|90
e|SS|defa600c-4205-476e-a40c-690cb16769b3|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|2|SCREENING|2021-04-14|90
e|SS|e5092583-4259-40ba-a6a2-eeef6607263b|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|6|FOLLOW-UP|2020-09-16|10
e|SS|e5092583-4259-40ba-a6a2-eeef6607263b|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|7|SCREENING|2020-09-16|10
e|SS|e5092583-4259-40ba-a6a2-eeef6607263b|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|6|TREATMENT|2020-10-01|25
e|SS|e5092583-4259-40ba-a6a2-eeef6607263b|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|1|TREATMENT|2020-10-01|25
e|SS|e5092583-4259-40ba-a6a2-eeef6607263b|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|TREATMENT|2020-10-16|40
e|SS|e5092583-4259-40ba-a6a2-eeef6607263b|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|2|WASHOUT|2020-10-16|40
e|SS|e5092583-4259-40ba-a6a2-eeef6607263b|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|5|TREATMENT|2020-11-10|65
e|SS|e5092583-4259-40ba-a6a2-eeef6607263b|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|4|FOLLOW-UP|2020-11-10|65
e|SS|e5092583-4259-40ba-a6a2-eeef6607263b|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|WASHOUT|2020-12-05|90
e|SS|e5092583-4259-40ba-a6a2-eeef6607263b|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|4|TREATMENT|2020-12-05|90
e|SS|461196d1-1213-4e5f-9bac-71f097b6cfdb|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|2|SCREENING|2020-11-13|10
e|SS|461196d1-1213-4e5f-9bac-71f097b6cfdb|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|3|WASHOUT|2020-11-13|10
e|SS|461196d1-1213-4e5f-9bac-71f097b6cfdb|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|1|FOLLOW-UP|2020-11-28|25
e|SS|461196d1-1213-4e5f-9bac-71f097b6cfdb|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|2|TREATMENT|2020-11-28|25
e|SS|461196d1-1213-4e5f-9bac-71f097b6cfdb|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|6|TREATMENT|2020-12-13|40
e|SS|461196d1-1213-4e5f-9bac-71f097b6cfdb|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|7|SCREENING|2020-12-13|40
e|SS|461196d1-1213-4e5f-9bac-71f097b6cfdb|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|2|TREATMENT|2021-01-07|65
e|SS|461196d1-1213-4e5f-9bac-71f097b6cfdb|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|6|FOLLOW-UP|2021-01-07|65
e|SS|461196d1-1213-4e5f-9bac-71f097b6cfdb|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|7|TREATMENT|2021-02-01|90
e|SS|461196d1-1213-4e5f-9bac-71f097b6cfdb|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|5|WASHOUT|2021-02-01|90
e|SS|4c82922a-55d0-45b9-a7bb-4edac32b0f68|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|TREATMENT|2020-12-09|10
e|SS|4c82922a-55d0-45b9-a7bb-4edac32b0f68|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|5|SCREENING|2020-12-09|10
e|SS|4c82922a-55d0-45b9-a7bb-4edac32b0f68|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|6|TREATMENT|2020-12-24|25
e|SS|4c82922a-55d0-45b9-a7bb-4edac32b0f68|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|7|WASHOUT|2020-12-24|25
e|SS|4c82922a-55d0-45b9-a7bb-4edac32b0f68|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|3|FOLLOW-UP|2021-01-08|40
e|SS|4c82922a-55d0-45b9-a7bb-4edac32b0f68|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|6|WASHOUT|2021-01-08|40
e|SS|4c82922a-55d0-45b9-a7bb-4edac32b0f68|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|6|SCREENING|2021-02-02|65
e|SS|4c82922a-55d0-45b9-a7bb-4edac32b0f68|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|6|FOLLOW-UP|2021-02-02|65
e|SS|4c82922a-55d0-45b9-a7bb-4edac32b0f68|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|5|SCREENING|2021-02-27|90
e|SS|4c82922a-55d0-45b9-a7bb-4edac32b0f68|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|1|WASHOUT|2021-02-27|90
e|SS|57971bdc-14df-4d9e-a59a-2665703c12ab|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|6|TREATMENT|2020-05-30|10
e|SS|57971bdc-14df-4d9e-a59a-2665703c12ab|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|1|FOLLOW-UP|2020-05-30|10
e|SS|57971bdc-14df-4d9e-a59a-2665703c12ab|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|7|WASHOUT|2020-06-14|25
e|SS|57971bdc-14df-4d9e-a59a-2665703c12ab|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|5|FOLLOW-UP|2020-06-14|25
e|SS|57971bdc-14df-4d9e-a59a-2665703c12ab|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|2|SCREENING|2020-06-29|40
e|SS|57971bdc-14df-4d9e-a59a-2665703c12ab|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|2|TREATMENT|2020-06-29|40
e|SS|57971bdc-14df-4d9e-a59a-2665703c12ab|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|5|SCREENING|2020-07-24|65
e|SS|57971bdc-14df-4d9e-a59a-2665703c12ab|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|4|FOLLOW-UP|2020-07-24|65
e|SS|57971bdc-14df-4d9e-a59a-2665703c12ab|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|7|TREATMENT|2020-08-18|90
e|SS|57971bdc-14df-4d9e-a59a-2665703c12ab|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|WASHOUT|2020-08-18|90
e|SS|dacea2da-9101-41e9-97aa-1cb8445b1320|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|6|TREATMENT|2020-10-09|10
e|SS|dacea2da-9101-41e9-97aa-1cb8445b1320|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|7|TREATMENT|2020-10-09|10
e|SS|dacea2da-9101-41e9-97aa-1cb8445b1320|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|6|TREATMENT|2020-10-24|25
e|SS|dacea2da-9101-41e9-97aa-1cb8445b1320|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|1|TREATMENT|2020-10-24|25
e|SS|dacea2da-9101-41e9-97aa-1cb8445b1320|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|TREATMENT|2020-11-08|40
e|SS|dacea2da-9101-41e9-97aa-1cb8445b1320|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|6|TREATMENT|2020-11-08|40
e|SS|dacea2da-9101-41e9-97aa-1cb8445b1320|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|3|FOLLOW-UP|2020-12-03|65
e|SS|dacea2da-9101-41e9-97aa-1cb8445b1320|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|2|SCREENING|2020-12-03|65
e|SS|dacea2da-9101-41e9-97aa-1cb8445b1320|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|1|TREATMENT|2020-12-28|90
e|SS|dacea2da-9101-41e9-97aa-1cb8445b1320|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|3|TREATMENT|2020-12-28|90
e|SS|cbf5d05e-e934-4946-b991-5fef63a01888|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|1|WASHOUT|2020-11-06|10
e|SS|cbf5d05e-e934-4946-b991-5fef63a01888|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|7|TREATMENT|2020-11-06|10
e|SS|cbf5d05e-e934-4946-b991-5fef63a01888|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|6|FOLLOW-UP|2020-11-21|25
e|SS|cbf5d05e-e934-4946-b991-5fef63a01888|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|1|WASHOUT|2020-11-21|25
e|SS|cbf5d05e-e934-4946-b991-5fef63a01888|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|7|WASHOUT|2020-12-06|40
e|SS|cbf5d05e-e934-4946-b991-5fef63a01888|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|6|SCREENING|2020-12-06|40
e|SS|cbf5d05e-e934-4946-b991-5fef63a01888|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|TREATMENT|2020-12-31|65
e|SS|cbf5d05e-e934-4946-b991-5fef63a01888|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|4|TREATMENT|2020-12-31|65
e|SS|cbf5d05e-e934-4946-b991-5fef63a01888|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|1|WASHOUT|2021-01-25|90
e|SS|cbf5d05e-e934-4946-b991-5fef63a01888|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|3|TREATMENT|2021-01-25|90
e|SS|be18633c-0ff9-4775-9737-dc8a9524fd2c|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|1|TREATMENT|2020-10-18|10
e|SS|be18633c-0ff9-4775-9737-dc8a9524fd2c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|TREATMENT|2020-10-18|10
e|SS|be18633c-0ff9-4775-9737-dc8a9524fd2c|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|6|FOLLOW-UP|2020-11-02|25
e|SS|be18633c-0ff9-4775-9737-dc8a9524fd2c|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|1|FOLLOW-UP|2020-11-02|25
e|SS|be18633c-0ff9-4775-9737-dc8a9524fd2c|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|1|TREATMENT|2020-11-17|40
e|SS|be18633c-0ff9-4775-9737-dc8a9524fd2c|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|6|TREATMENT|2020-11-17|40
e|SS|be18633c-0ff9-4775-9737-dc8a9524fd2c|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|2|TREATMENT|2020-12-12|65
e|SS|be18633c-0ff9-4775-9737-dc8a9524fd2c|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|6|SCREENING|2020-12-12|65
e|SS|be18633c-0ff9-4775-9737-dc8a9524fd2c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|7|TREATMENT|2021-01-06|90
e|SS|be18633c-0ff9-4775-9737-dc8a9524fd2c|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|6|TREATMENT|2021-01-06|90
e|SS|f7eba9b8-94fb-46b8-842a-0322eb68a355|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|INDEPENDENT ASSESSOR|1|Visit_1|10|5|FOLLOW-UP|2020-08-10|100
e|SS|f7eba9b8-94fb-46b8-842a-0322eb68a355|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|CHILD|1|Visit_1|10|5|SCREENING|2020-08-10|100
e|SS|f7eba9b8-94fb-46b8-842a-0322eb68a355|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|INDEPENDENT ASSESSOR|2|Visit_2|25|5|WASHOUT|2020-08-10|100
e|SS|f7eba9b8-94fb-46b8-842a-0322eb68a355|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|DOMESTIC PARTNER|2|Visit_2|25|1|TREATMENT|2020-08-10|100
e|SS|f7eba9b8-94fb-46b8-842a-0322eb68a355|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|VENDOR|3|Visit_3|40|1|TREATMENT|2020-08-10|100
e|SS|f7eba9b8-94fb-46b8-842a-0322eb68a355|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|PARENT|3|Visit_3|40|7|FOLLOW-UP|2020-08-10|100
e|SS|f7eba9b8-94fb-46b8-842a-0322eb68a355|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|WASHOUT|2020-08-10|100
e|SS|f7eba9b8-94fb-46b8-842a-0322eb68a355|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|FOLLOW-UP|2020-08-10|100
e|SS|f7eba9b8-94fb-46b8-842a-0322eb68a355|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|CHILD|5|Visit_5|90|7|TREATMENT|2020-08-10|100
e|SS|f7eba9b8-94fb-46b8-842a-0322eb68a355|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|INDEPENDENT ASSESSOR|5|Visit_5|90|2|WASHOUT|2020-08-10|100
e|SS|903199e2-56e1-41e4-8904-d33cc6846ee3|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|6|TREATMENT|2021-01-18|10
e|SS|903199e2-56e1-41e4-8904-d33cc6846ee3|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|WASHOUT|2021-01-18|10
e|SS|903199e2-56e1-41e4-8904-d33cc6846ee3|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|3|TREATMENT|2021-02-02|25
e|SS|903199e2-56e1-41e4-8904-d33cc6846ee3|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|3|SCREENING|2021-02-02|25
e|SS|903199e2-56e1-41e4-8904-d33cc6846ee3|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|FOLLOW-UP|2021-02-17|40
e|SS|903199e2-56e1-41e4-8904-d33cc6846ee3|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|3|WASHOUT|2021-02-17|40
e|SS|903199e2-56e1-41e4-8904-d33cc6846ee3|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|7|SCREENING|2021-03-14|65
e|SS|903199e2-56e1-41e4-8904-d33cc6846ee3|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|2|TREATMENT|2021-03-14|65
e|SS|903199e2-56e1-41e4-8904-d33cc6846ee3|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|1|TREATMENT|2021-04-08|90
e|SS|903199e2-56e1-41e4-8904-d33cc6846ee3|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|6|TREATMENT|2021-04-08|90
e|SS|32567f8d-e746-44e1-a269-d95ba3bb0b11|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|7|TREATMENT|2020-11-02|10
e|SS|32567f8d-e746-44e1-a269-d95ba3bb0b11|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|5|FOLLOW-UP|2020-11-02|10
e|SS|32567f8d-e746-44e1-a269-d95ba3bb0b11|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|SCREENING|2020-11-17|25
e|SS|32567f8d-e746-44e1-a269-d95ba3bb0b11|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|7|WASHOUT|2020-11-17|25
e|SS|32567f8d-e746-44e1-a269-d95ba3bb0b11|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|1|FOLLOW-UP|2020-12-02|40
e|SS|32567f8d-e746-44e1-a269-d95ba3bb0b11|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|SCREENING|2020-12-02|40
e|SS|32567f8d-e746-44e1-a269-d95ba3bb0b11|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|5|FOLLOW-UP|2020-12-27|65
e|SS|32567f8d-e746-44e1-a269-d95ba3bb0b11|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|4|TREATMENT|2020-12-27|65
e|SS|32567f8d-e746-44e1-a269-d95ba3bb0b11|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|6|FOLLOW-UP|2021-01-21|90
e|SS|32567f8d-e746-44e1-a269-d95ba3bb0b11|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|6|TREATMENT|2021-01-21|90
e|SS|ecdc54eb-c02f-4112-8e85-8a3352470b3b|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|STUDY SUBJECT|1|Visit_1|10|2|TREATMENT|2021-02-09|100
e|SS|ecdc54eb-c02f-4112-8e85-8a3352470b3b|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|SPOUSE|1|Visit_1|10|3|TREATMENT|2021-02-09|100
e|SS|ecdc54eb-c02f-4112-8e85-8a3352470b3b|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|SCREENING|2021-02-09|100
e|SS|ecdc54eb-c02f-4112-8e85-8a3352470b3b|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATOR|2|Visit_2|25|5|FOLLOW-UP|2021-02-09|100
e|SS|ecdc54eb-c02f-4112-8e85-8a3352470b3b|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATION COMMITTEE|3|Visit_3|40|2|TREATMENT|2021-02-09|100
e|SS|ecdc54eb-c02f-4112-8e85-8a3352470b3b|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|STUDY SUBJECT|3|Visit_3|40|1|FOLLOW-UP|2021-02-09|100
e|SS|ecdc54eb-c02f-4112-8e85-8a3352470b3b|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|SPOUSE|4|Visit_4|65|5|SCREENING|2021-02-09|100
e|SS|ecdc54eb-c02f-4112-8e85-8a3352470b3b|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|STUDY SUBJECT|4|Visit_4|65|4|TREATMENT|2021-02-09|100
e|SS|ecdc54eb-c02f-4112-8e85-8a3352470b3b|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|CAREGIVER|5|Visit_5|90|4|WASHOUT|2021-02-09|100
e|SS|ecdc54eb-c02f-4112-8e85-8a3352470b3b|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|STUDY SUBJECT|5|Visit_5|90|2|SCREENING|2021-02-09|100
e|SS|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|1|TREATMENT|2020-07-09|10
e|SS|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|4|TREATMENT|2020-07-09|10
e|SS|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|5|TREATMENT|2020-07-24|25
e|SS|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|7|TREATMENT|2020-07-24|25
e|SS|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|1|TREATMENT|2020-08-08|40
e|SS|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|5|TREATMENT|2020-08-08|40
e|SS|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|6|TREATMENT|2020-09-02|65
e|SS|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|1|TREATMENT|2020-09-02|65
e|SS|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|7|TREATMENT|2020-09-27|90
e|SS|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|TREATMENT|2020-09-27|90
e|SS|5d7241ec-120d-486d-ab39-b9e14ab4ce90|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|2|TREATMENT|2020-08-01|10
e|SS|5d7241ec-120d-486d-ab39-b9e14ab4ce90|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|5|TREATMENT|2020-08-01|10
e|SS|5d7241ec-120d-486d-ab39-b9e14ab4ce90|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|7|TREATMENT|2020-08-16|25
e|SS|5d7241ec-120d-486d-ab39-b9e14ab4ce90|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|2|TREATMENT|2020-08-16|25
e|SS|5d7241ec-120d-486d-ab39-b9e14ab4ce90|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|5|TREATMENT|2020-08-31|40
e|SS|5d7241ec-120d-486d-ab39-b9e14ab4ce90|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|1|SCREENING|2020-08-31|40
e|SS|5d7241ec-120d-486d-ab39-b9e14ab4ce90|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|5|WASHOUT|2020-09-25|65
e|SS|5d7241ec-120d-486d-ab39-b9e14ab4ce90|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|2|TREATMENT|2020-09-25|65
e|SS|5d7241ec-120d-486d-ab39-b9e14ab4ce90|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2020-10-20|90
e|SS|5d7241ec-120d-486d-ab39-b9e14ab4ce90|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|5|TREATMENT|2020-10-20|90
e|SS|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|1|TREATMENT|2020-06-01|10
e|SS|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|2|WASHOUT|2020-06-01|10
e|SS|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|3|TREATMENT|2020-06-16|25
e|SS|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|4|FOLLOW-UP|2020-06-16|25
e|SS|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|2|FOLLOW-UP|2020-07-01|40
e|SS|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|5|SCREENING|2020-07-01|40
e|SS|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|4|WASHOUT|2020-07-26|65
e|SS|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|1|WASHOUT|2020-07-26|65
e|SS|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|2|TREATMENT|2020-08-20|90
e|SS|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|6|FOLLOW-UP|2020-08-20|90
e|SS|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|2|FOLLOW-UP|2020-07-04|10
e|SS|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|7|TREATMENT|2020-07-04|10
e|SS|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|2|FOLLOW-UP|2020-07-19|25
e|SS|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|1|TREATMENT|2020-07-19|25
e|SS|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|1|TREATMENT|2020-08-03|40
e|SS|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|2|TREATMENT|2020-08-03|40
e|SS|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|6|WASHOUT|2020-08-28|65
e|SS|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|4|TREATMENT|2020-08-28|65
e|SS|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|1|TREATMENT|2020-09-22|90
e|SS|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|7|TREATMENT|2020-09-22|90
e|SS|a69c6182-9c35-4365-b732-b238e0584ba7|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|FOLLOW-UP|2020-08-07|10
e|SS|a69c6182-9c35-4365-b732-b238e0584ba7|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|1|WASHOUT|2020-08-07|10
e|SS|a69c6182-9c35-4365-b732-b238e0584ba7|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|5|TREATMENT|2020-08-22|25
e|SS|a69c6182-9c35-4365-b732-b238e0584ba7|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|4|TREATMENT|2020-08-22|25
e|SS|a69c6182-9c35-4365-b732-b238e0584ba7|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|1|FOLLOW-UP|2020-09-06|40
e|SS|a69c6182-9c35-4365-b732-b238e0584ba7|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|4|WASHOUT|2020-09-06|40
e|SS|a69c6182-9c35-4365-b732-b238e0584ba7|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|5|WASHOUT|2020-10-01|65
e|SS|a69c6182-9c35-4365-b732-b238e0584ba7|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|2|FOLLOW-UP|2020-10-01|65
e|SS|a69c6182-9c35-4365-b732-b238e0584ba7|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|6|TREATMENT|2020-10-26|90
e|SS|a69c6182-9c35-4365-b732-b238e0584ba7|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|SCREENING|2020-10-26|90
e|SS|1b9896cf-160e-4a56-8737-9759cd83e784|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|2|WASHOUT|2020-12-11|10
e|SS|1b9896cf-160e-4a56-8737-9759cd83e784|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|4|SCREENING|2020-12-11|10
e|SS|1b9896cf-160e-4a56-8737-9759cd83e784|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|4|TREATMENT|2020-12-26|25
e|SS|1b9896cf-160e-4a56-8737-9759cd83e784|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|5|FOLLOW-UP|2020-12-26|25
e|SS|1b9896cf-160e-4a56-8737-9759cd83e784|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|6|TREATMENT|2021-01-10|40
e|SS|1b9896cf-160e-4a56-8737-9759cd83e784|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|1|TREATMENT|2021-01-10|40
e|SS|1b9896cf-160e-4a56-8737-9759cd83e784|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|7|TREATMENT|2021-02-04|65
e|SS|1b9896cf-160e-4a56-8737-9759cd83e784|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|4|TREATMENT|2021-02-04|65
e|SS|1b9896cf-160e-4a56-8737-9759cd83e784|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|1|TREATMENT|2021-03-01|90
e|SS|1b9896cf-160e-4a56-8737-9759cd83e784|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|2|TREATMENT|2021-03-01|90
e|SS|ea87b553-e331-40cf-bd86-d2bd22694476|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|1|SCREENING|2020-08-05|10
e|SS|ea87b553-e331-40cf-bd86-d2bd22694476|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|7|TREATMENT|2020-08-05|10
e|SS|ea87b553-e331-40cf-bd86-d2bd22694476|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|5|TREATMENT|2020-08-20|25
e|SS|ea87b553-e331-40cf-bd86-d2bd22694476|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|6|TREATMENT|2020-08-20|25
e|SS|ea87b553-e331-40cf-bd86-d2bd22694476|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|7|TREATMENT|2020-09-04|40
e|SS|ea87b553-e331-40cf-bd86-d2bd22694476|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|3|WASHOUT|2020-09-04|40
e|SS|ea87b553-e331-40cf-bd86-d2bd22694476|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|6|TREATMENT|2020-09-29|65
e|SS|ea87b553-e331-40cf-bd86-d2bd22694476|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|5|TREATMENT|2020-09-29|65
e|SS|ea87b553-e331-40cf-bd86-d2bd22694476|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|5|TREATMENT|2020-10-24|90
e|SS|ea87b553-e331-40cf-bd86-d2bd22694476|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|3|WASHOUT|2020-10-24|90
e|SS|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|5|SCREENING|2020-07-30|10
e|SS|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|6|TREATMENT|2020-07-30|10
e|SS|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|4|WASHOUT|2020-08-14|25
e|SS|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|3|FOLLOW-UP|2020-08-14|25
e|SS|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|WASHOUT|2020-08-29|40
e|SS|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|TREATMENT|2020-08-29|40
e|SS|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|2|TREATMENT|2020-09-23|65
e|SS|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|3|WASHOUT|2020-09-23|65
e|SS|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|2|TREATMENT|2020-10-18|90
e|SS|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|1|TREATMENT|2020-10-18|90
e|SS|051dc064-be6f-43eb-aa51-7ed8634d6e23|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|1|FOLLOW-UP|2020-07-08|10
e|SS|051dc064-be6f-43eb-aa51-7ed8634d6e23|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|3|TREATMENT|2020-07-08|10
e|SS|051dc064-be6f-43eb-aa51-7ed8634d6e23|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|7|TREATMENT|2020-07-23|25
e|SS|051dc064-be6f-43eb-aa51-7ed8634d6e23|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|7|WASHOUT|2020-07-23|25
e|SS|051dc064-be6f-43eb-aa51-7ed8634d6e23|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|4|TREATMENT|2020-08-07|40
e|SS|051dc064-be6f-43eb-aa51-7ed8634d6e23|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|2|TREATMENT|2020-08-07|40
e|SS|051dc064-be6f-43eb-aa51-7ed8634d6e23|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|TREATMENT|2020-09-01|65
e|SS|051dc064-be6f-43eb-aa51-7ed8634d6e23|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|3|TREATMENT|2020-09-01|65
e|SS|051dc064-be6f-43eb-aa51-7ed8634d6e23|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|6|TREATMENT|2020-09-26|90
e|SS|051dc064-be6f-43eb-aa51-7ed8634d6e23|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|4|FOLLOW-UP|2020-09-26|90
e|SS|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|1|TREATMENT|2020-06-03|10
e|SS|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|TREATMENT|2020-06-03|10
e|SS|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|7|TREATMENT|2020-06-18|25
e|SS|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|3|TREATMENT|2020-06-18|25
e|SS|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|1|TREATMENT|2020-07-03|40
e|SS|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|3|WASHOUT|2020-07-03|40
e|SS|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|3|TREATMENT|2020-07-28|65
e|SS|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|6|TREATMENT|2020-07-28|65
e|SS|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|6|SCREENING|2020-08-22|90
e|SS|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|1|TREATMENT|2020-08-22|90
e|SS|7a17fe21-b640-4bc5-bf19-b1bceb393dab|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|6|TREATMENT|2020-09-02|10
e|SS|7a17fe21-b640-4bc5-bf19-b1bceb393dab|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|1|TREATMENT|2020-09-02|10
e|SS|7a17fe21-b640-4bc5-bf19-b1bceb393dab|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|3|TREATMENT|2020-09-17|25
e|SS|7a17fe21-b640-4bc5-bf19-b1bceb393dab|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-09-17|25
e|SS|7a17fe21-b640-4bc5-bf19-b1bceb393dab|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|5|SCREENING|2020-10-02|40
e|SS|7a17fe21-b640-4bc5-bf19-b1bceb393dab|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|1|SCREENING|2020-10-02|40
e|SS|7a17fe21-b640-4bc5-bf19-b1bceb393dab|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|2|TREATMENT|2020-10-27|65
e|SS|7a17fe21-b640-4bc5-bf19-b1bceb393dab|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2020-10-27|65
e|SS|7a17fe21-b640-4bc5-bf19-b1bceb393dab|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|4|FOLLOW-UP|2020-11-21|90
e|SS|7a17fe21-b640-4bc5-bf19-b1bceb393dab|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|1|SCREENING|2020-11-21|90
e|SS|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|6|WASHOUT|2021-01-20|10
e|SS|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|7|SCREENING|2021-01-20|10
e|SS|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|2|SCREENING|2021-02-04|25
e|SS|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|7|TREATMENT|2021-02-04|25
e|SS|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|2|WASHOUT|2021-02-19|40
e|SS|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|6|TREATMENT|2021-02-19|40
e|SS|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|3|TREATMENT|2021-03-16|65
e|SS|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|3|WASHOUT|2021-03-16|65
e|SS|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|7|WASHOUT|2021-04-10|90
e|SS|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|7|SCREENING|2021-04-10|90
e|SS|f1d0daec-aa97-4838-9c53-e16dae3e17b2|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|2|WASHOUT|2020-06-23|10
e|SS|f1d0daec-aa97-4838-9c53-e16dae3e17b2|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|6|WASHOUT|2020-06-23|10
e|SS|f1d0daec-aa97-4838-9c53-e16dae3e17b2|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|FOLLOW-UP|2020-07-08|25
e|SS|f1d0daec-aa97-4838-9c53-e16dae3e17b2|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-07-08|25
e|SS|f1d0daec-aa97-4838-9c53-e16dae3e17b2|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|3|Visit_3|40|6|WASHOUT|2020-07-23|40
e|SS|f1d0daec-aa97-4838-9c53-e16dae3e17b2|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|1|FOLLOW-UP|2020-07-23|40
e|SS|f1d0daec-aa97-4838-9c53-e16dae3e17b2|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|6|FOLLOW-UP|2020-08-17|65
e|SS|f1d0daec-aa97-4838-9c53-e16dae3e17b2|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|6|TREATMENT|2020-08-17|65
e|SS|f1d0daec-aa97-4838-9c53-e16dae3e17b2|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|1|FOLLOW-UP|2020-09-11|90
e|SS|f1d0daec-aa97-4838-9c53-e16dae3e17b2|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2020-09-11|90
e|SS|835594ab-e93c-402b-8129-6af659be5ae1|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|5|TREATMENT|2020-11-01|10
e|SS|835594ab-e93c-402b-8129-6af659be5ae1|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|1|TREATMENT|2020-11-01|10
e|SS|835594ab-e93c-402b-8129-6af659be5ae1|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|2|TREATMENT|2020-11-16|25
e|SS|835594ab-e93c-402b-8129-6af659be5ae1|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-11-16|25
e|SS|835594ab-e93c-402b-8129-6af659be5ae1|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|6|TREATMENT|2020-12-01|40
e|SS|835594ab-e93c-402b-8129-6af659be5ae1|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2020-12-01|40
e|SS|835594ab-e93c-402b-8129-6af659be5ae1|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|3|SCREENING|2020-12-26|65
e|SS|835594ab-e93c-402b-8129-6af659be5ae1|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|3|TREATMENT|2020-12-26|65
e|SS|835594ab-e93c-402b-8129-6af659be5ae1|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2021-01-20|90
e|SS|835594ab-e93c-402b-8129-6af659be5ae1|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|7|FOLLOW-UP|2021-01-20|90
e|SS|c3c85786-d24b-4620-9ee0-c13b1cc4f951|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|7|TREATMENT|2020-10-07|10
e|SS|c3c85786-d24b-4620-9ee0-c13b1cc4f951|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|3|WASHOUT|2020-10-07|10
e|SS|c3c85786-d24b-4620-9ee0-c13b1cc4f951|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|1|TREATMENT|2020-10-22|25
e|SS|c3c85786-d24b-4620-9ee0-c13b1cc4f951|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|1|TREATMENT|2020-10-22|25
e|SS|c3c85786-d24b-4620-9ee0-c13b1cc4f951|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|2|TREATMENT|2020-11-06|40
e|SS|c3c85786-d24b-4620-9ee0-c13b1cc4f951|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|FOLLOW-UP|2020-11-06|40
e|SS|c3c85786-d24b-4620-9ee0-c13b1cc4f951|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|3|FOLLOW-UP|2020-12-01|65
e|SS|c3c85786-d24b-4620-9ee0-c13b1cc4f951|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|6|TREATMENT|2020-12-01|65
e|SS|c3c85786-d24b-4620-9ee0-c13b1cc4f951|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|3|WASHOUT|2020-12-26|90
e|SS|c3c85786-d24b-4620-9ee0-c13b1cc4f951|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|4|TREATMENT|2020-12-26|90
e|SS|5354e3c4-4106-4e4c-85c3-2dbbd001688c|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|TREATMENT|2020-11-15|10
e|SS|5354e3c4-4106-4e4c-85c3-2dbbd001688c|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|1|TREATMENT|2020-11-15|10
e|SS|5354e3c4-4106-4e4c-85c3-2dbbd001688c|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|TREATMENT|2020-11-30|25
e|SS|5354e3c4-4106-4e4c-85c3-2dbbd001688c|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|5|SCREENING|2020-11-30|25
e|SS|5354e3c4-4106-4e4c-85c3-2dbbd001688c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|6|TREATMENT|2020-12-15|40
e|SS|5354e3c4-4106-4e4c-85c3-2dbbd001688c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|6|TREATMENT|2020-12-15|40
e|SS|5354e3c4-4106-4e4c-85c3-2dbbd001688c|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|SCREENING|2021-01-09|65
e|SS|5354e3c4-4106-4e4c-85c3-2dbbd001688c|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|1|FOLLOW-UP|2021-01-09|65
e|SS|5354e3c4-4106-4e4c-85c3-2dbbd001688c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|4|WASHOUT|2021-02-03|90
e|SS|5354e3c4-4106-4e4c-85c3-2dbbd001688c|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|5|FOLLOW-UP|2021-02-03|90
e|SS|f10e9188-ef7b-46f9-a80a-0669436eb4dd|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|TREATMENT|2020-06-24|10
e|SS|f10e9188-ef7b-46f9-a80a-0669436eb4dd|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|1|TREATMENT|2020-06-24|10
e|SS|f10e9188-ef7b-46f9-a80a-0669436eb4dd|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|2|TREATMENT|2020-07-09|25
e|SS|f10e9188-ef7b-46f9-a80a-0669436eb4dd|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|2|TREATMENT|2020-07-09|25
e|SS|f10e9188-ef7b-46f9-a80a-0669436eb4dd|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|7|TREATMENT|2020-07-24|40
e|SS|f10e9188-ef7b-46f9-a80a-0669436eb4dd|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|6|TREATMENT|2020-07-24|40
e|SS|f10e9188-ef7b-46f9-a80a-0669436eb4dd|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|2|TREATMENT|2020-08-18|65
e|SS|f10e9188-ef7b-46f9-a80a-0669436eb4dd|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|4|TREATMENT|2020-08-18|65
e|SS|f10e9188-ef7b-46f9-a80a-0669436eb4dd|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|4|FOLLOW-UP|2020-09-12|90
e|SS|f10e9188-ef7b-46f9-a80a-0669436eb4dd|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|WASHOUT|2020-09-12|90
e|SS|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|7|TREATMENT|2020-08-13|10
e|SS|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|7|FOLLOW-UP|2020-08-13|10
e|SS|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|1|TREATMENT|2020-08-28|25
e|SS|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|3|WASHOUT|2020-08-28|25
e|SS|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|6|FOLLOW-UP|2020-09-12|40
e|SS|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|2|FOLLOW-UP|2020-09-12|40
e|SS|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|1|TREATMENT|2020-10-07|65
e|SS|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|FOLLOW-UP|2020-10-07|65
e|SS|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|7|FOLLOW-UP|2020-11-01|90
e|SS|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|2|TREATMENT|2020-11-01|90
e|SS|000b5b99-a92d-4c84-9edc-ee08930d8a2e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|6|SCREENING|2020-10-15|10
e|SS|000b5b99-a92d-4c84-9edc-ee08930d8a2e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|4|WASHOUT|2020-10-15|10
e|SS|000b5b99-a92d-4c84-9edc-ee08930d8a2e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|2|FOLLOW-UP|2020-10-30|25
e|SS|000b5b99-a92d-4c84-9edc-ee08930d8a2e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|3|TREATMENT|2020-10-30|25
e|SS|000b5b99-a92d-4c84-9edc-ee08930d8a2e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|2|WASHOUT|2020-11-14|40
e|SS|000b5b99-a92d-4c84-9edc-ee08930d8a2e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|7|WASHOUT|2020-11-14|40
e|SS|000b5b99-a92d-4c84-9edc-ee08930d8a2e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|4|TREATMENT|2020-12-09|65
e|SS|000b5b99-a92d-4c84-9edc-ee08930d8a2e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|WASHOUT|2020-12-09|65
e|SS|000b5b99-a92d-4c84-9edc-ee08930d8a2e|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|4|TREATMENT|2021-01-03|90
e|SS|000b5b99-a92d-4c84-9edc-ee08930d8a2e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|6|FOLLOW-UP|2021-01-03|90
e|SS|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|7|SCREENING|2020-06-01|10
e|SS|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|2|FOLLOW-UP|2020-06-01|10
e|SS|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|1|SCREENING|2020-06-16|25
e|SS|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|2|TREATMENT|2020-06-16|25
e|SS|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|7|TREATMENT|2020-07-01|40
e|SS|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|2|TREATMENT|2020-07-01|40
e|SS|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|7|TREATMENT|2020-07-26|65
e|SS|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|3|WASHOUT|2020-07-26|65
e|SS|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|3|WASHOUT|2020-08-20|90
e|SS|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|4|SCREENING|2020-08-20|90
e|SS|11b2b359-d4a1-411d-a676-075b26e1453c|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|4|WASHOUT|2020-09-20|10
e|SS|11b2b359-d4a1-411d-a676-075b26e1453c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|4|SCREENING|2020-09-20|10
e|SS|11b2b359-d4a1-411d-a676-075b26e1453c|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|4|TREATMENT|2020-10-05|25
e|SS|11b2b359-d4a1-411d-a676-075b26e1453c|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|5|SCREENING|2020-10-05|25
e|SS|11b2b359-d4a1-411d-a676-075b26e1453c|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|1|TREATMENT|2020-10-20|40
e|SS|11b2b359-d4a1-411d-a676-075b26e1453c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|1|FOLLOW-UP|2020-10-20|40
e|SS|11b2b359-d4a1-411d-a676-075b26e1453c|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|1|TREATMENT|2020-11-14|65
e|SS|11b2b359-d4a1-411d-a676-075b26e1453c|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|6|TREATMENT|2020-11-14|65
e|SS|11b2b359-d4a1-411d-a676-075b26e1453c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2020-12-09|90
e|SS|11b2b359-d4a1-411d-a676-075b26e1453c|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2020-12-09|90
e|SS|293f673d-af6a-473e-8bce-118bb85bbd9e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|1|Visit_1|10|3|FOLLOW-UP|2020-10-19|10
e|SS|293f673d-af6a-473e-8bce-118bb85bbd9e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|6|WASHOUT|2020-10-19|10
e|SS|293f673d-af6a-473e-8bce-118bb85bbd9e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|5|TREATMENT|2020-11-03|25
e|SS|293f673d-af6a-473e-8bce-118bb85bbd9e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|3|WASHOUT|2020-11-03|25
e|SS|293f673d-af6a-473e-8bce-118bb85bbd9e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|1|WASHOUT|2020-11-18|40
e|SS|293f673d-af6a-473e-8bce-118bb85bbd9e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|WASHOUT|2020-11-18|40
e|SS|293f673d-af6a-473e-8bce-118bb85bbd9e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|1|FOLLOW-UP|2020-12-13|65
e|SS|293f673d-af6a-473e-8bce-118bb85bbd9e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|7|WASHOUT|2020-12-13|65
e|SS|293f673d-af6a-473e-8bce-118bb85bbd9e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|3|WASHOUT|2021-01-07|90
e|SS|293f673d-af6a-473e-8bce-118bb85bbd9e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|3|FOLLOW-UP|2021-01-07|90
e|SS|0f60ab31-ee13-4846-93d2-6bcac139006f|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|1|TREATMENT|2020-07-02|10
e|SS|0f60ab31-ee13-4846-93d2-6bcac139006f|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|7|TREATMENT|2020-07-02|10
e|SS|0f60ab31-ee13-4846-93d2-6bcac139006f|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|2|FOLLOW-UP|2020-07-17|25
e|SS|0f60ab31-ee13-4846-93d2-6bcac139006f|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|7|TREATMENT|2020-07-17|25
e|SS|0f60ab31-ee13-4846-93d2-6bcac139006f|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|3|TREATMENT|2020-08-01|40
e|SS|0f60ab31-ee13-4846-93d2-6bcac139006f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|2|SCREENING|2020-08-01|40
e|SS|0f60ab31-ee13-4846-93d2-6bcac139006f|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2020-08-26|65
e|SS|0f60ab31-ee13-4846-93d2-6bcac139006f|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|5|TREATMENT|2020-08-26|65
e|SS|0f60ab31-ee13-4846-93d2-6bcac139006f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|4|TREATMENT|2020-09-20|90
e|SS|0f60ab31-ee13-4846-93d2-6bcac139006f|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|2|WASHOUT|2020-09-20|90
e|SS|d49f37ce-2d6e-4ebb-91af-7ed32322f824|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|4|SCREENING|2020-08-31|10
e|SS|d49f37ce-2d6e-4ebb-91af-7ed32322f824|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|SCREENING|2020-08-31|10
e|SS|d49f37ce-2d6e-4ebb-91af-7ed32322f824|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|1|WASHOUT|2020-09-15|25
e|SS|d49f37ce-2d6e-4ebb-91af-7ed32322f824|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|6|TREATMENT|2020-09-15|25
e|SS|d49f37ce-2d6e-4ebb-91af-7ed32322f824|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|4|TREATMENT|2020-09-30|40
e|SS|d49f37ce-2d6e-4ebb-91af-7ed32322f824|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|3|WASHOUT|2020-09-30|40
e|SS|d49f37ce-2d6e-4ebb-91af-7ed32322f824|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|5|TREATMENT|2020-10-25|65
e|SS|d49f37ce-2d6e-4ebb-91af-7ed32322f824|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2020-10-25|65
e|SS|d49f37ce-2d6e-4ebb-91af-7ed32322f824|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|6|SCREENING|2020-11-19|90
e|SS|d49f37ce-2d6e-4ebb-91af-7ed32322f824|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|4|SCREENING|2020-11-19|90
e|SS|76dd2fe2-bc9e-48e4-870c-af7ece70009a|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|2|SCREENING|2020-07-06|10
e|SS|76dd2fe2-bc9e-48e4-870c-af7ece70009a|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|5|FOLLOW-UP|2020-07-06|10
e|SS|76dd2fe2-bc9e-48e4-870c-af7ece70009a|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|FOLLOW-UP|2020-07-21|25
e|SS|76dd2fe2-bc9e-48e4-870c-af7ece70009a|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|7|TREATMENT|2020-07-21|25
e|SS|76dd2fe2-bc9e-48e4-870c-af7ece70009a|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|2|WASHOUT|2020-08-05|40
e|SS|76dd2fe2-bc9e-48e4-870c-af7ece70009a|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|5|TREATMENT|2020-08-05|40
e|SS|76dd2fe2-bc9e-48e4-870c-af7ece70009a|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2020-08-30|65
e|SS|76dd2fe2-bc9e-48e4-870c-af7ece70009a|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|3|WASHOUT|2020-08-30|65
e|SS|76dd2fe2-bc9e-48e4-870c-af7ece70009a|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|1|TREATMENT|2020-09-24|90
e|SS|76dd2fe2-bc9e-48e4-870c-af7ece70009a|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|3|SCREENING|2020-09-24|90
e|SS|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|7|TREATMENT|2020-11-24|10
e|SS|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|1|WASHOUT|2020-11-24|10
e|SS|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|2|TREATMENT|2020-12-09|25
e|SS|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|7|WASHOUT|2020-12-09|25
e|SS|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|3|TREATMENT|2020-12-24|40
e|SS|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|SCREENING|2020-12-24|40
e|SS|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|3|TREATMENT|2021-01-18|65
e|SS|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|5|SCREENING|2021-01-18|65
e|SS|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|6|TREATMENT|2021-02-12|90
e|SS|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|4|TREATMENT|2021-02-12|90
e|SS|78778706-6b5b-4ad8-90af-f56d602863ae|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|SCREENING|2020-05-13|10
e|SS|78778706-6b5b-4ad8-90af-f56d602863ae|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|6|TREATMENT|2020-05-13|10
e|SS|78778706-6b5b-4ad8-90af-f56d602863ae|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|3|WASHOUT|2020-05-28|25
e|SS|78778706-6b5b-4ad8-90af-f56d602863ae|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|5|TREATMENT|2020-05-28|25
e|SS|78778706-6b5b-4ad8-90af-f56d602863ae|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|1|FOLLOW-UP|2020-06-12|40
e|SS|78778706-6b5b-4ad8-90af-f56d602863ae|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|4|WASHOUT|2020-06-12|40
e|SS|78778706-6b5b-4ad8-90af-f56d602863ae|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|7|TREATMENT|2020-07-07|65
e|SS|78778706-6b5b-4ad8-90af-f56d602863ae|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|1|TREATMENT|2020-07-07|65
e|SS|78778706-6b5b-4ad8-90af-f56d602863ae|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|TREATMENT|2020-08-01|90
e|SS|78778706-6b5b-4ad8-90af-f56d602863ae|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|7|SCREENING|2020-08-01|90
e|SS|a6954aa1-4860-412a-b988-7f708aca2ab2|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|4|WASHOUT|2020-09-17|10
e|SS|a6954aa1-4860-412a-b988-7f708aca2ab2|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|3|FOLLOW-UP|2020-09-17|10
e|SS|a6954aa1-4860-412a-b988-7f708aca2ab2|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|2|FOLLOW-UP|2020-10-02|25
e|SS|a6954aa1-4860-412a-b988-7f708aca2ab2|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|3|WASHOUT|2020-10-02|25
e|SS|a6954aa1-4860-412a-b988-7f708aca2ab2|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|4|TREATMENT|2020-10-17|40
e|SS|a6954aa1-4860-412a-b988-7f708aca2ab2|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|2|TREATMENT|2020-10-17|40
e|SS|a6954aa1-4860-412a-b988-7f708aca2ab2|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|4|TREATMENT|2020-11-11|65
e|SS|a6954aa1-4860-412a-b988-7f708aca2ab2|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|3|FOLLOW-UP|2020-11-11|65
e|SS|a6954aa1-4860-412a-b988-7f708aca2ab2|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|4|TREATMENT|2020-12-06|90
e|SS|a6954aa1-4860-412a-b988-7f708aca2ab2|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|1|TREATMENT|2020-12-06|90
e|SS|0a970eb4-f958-42ad-ad8b-60bb427c9cba|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|SCREENING|2020-05-14|10
e|SS|0a970eb4-f958-42ad-ad8b-60bb427c9cba|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|4|WASHOUT|2020-05-14|10
e|SS|0a970eb4-f958-42ad-ad8b-60bb427c9cba|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|7|SCREENING|2020-05-29|25
e|SS|0a970eb4-f958-42ad-ad8b-60bb427c9cba|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|1|FOLLOW-UP|2020-05-29|25
e|SS|0a970eb4-f958-42ad-ad8b-60bb427c9cba|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|2|TREATMENT|2020-06-13|40
e|SS|0a970eb4-f958-42ad-ad8b-60bb427c9cba|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|2|FOLLOW-UP|2020-06-13|40
e|SS|0a970eb4-f958-42ad-ad8b-60bb427c9cba|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|6|TREATMENT|2020-07-08|65
e|SS|0a970eb4-f958-42ad-ad8b-60bb427c9cba|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|7|FOLLOW-UP|2020-07-08|65
e|SS|0a970eb4-f958-42ad-ad8b-60bb427c9cba|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|4|SCREENING|2020-08-02|90
e|SS|0a970eb4-f958-42ad-ad8b-60bb427c9cba|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|2|TREATMENT|2020-08-02|90
e|SS|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|3|WASHOUT|2021-01-26|10
e|SS|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|SCREENING|2021-01-26|10
e|SS|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|3|WASHOUT|2021-02-10|25
e|SS|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|3|FOLLOW-UP|2021-02-10|25
e|SS|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|5|TREATMENT|2021-02-25|40
e|SS|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|3|WASHOUT|2021-02-25|40
e|SS|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|4|SCREENING|2021-03-22|65
e|SS|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|3|SCREENING|2021-03-22|65
e|SS|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|4|SCREENING|2021-04-16|90
e|SS|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|6|TREATMENT|2021-04-16|90
e|SS|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|5|TREATMENT|2020-08-24|10
e|SS|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|6|TREATMENT|2020-08-24|10
e|SS|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|7|FOLLOW-UP|2020-09-08|25
e|SS|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|3|TREATMENT|2020-09-08|25
e|SS|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|1|WASHOUT|2020-09-23|40
e|SS|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|7|WASHOUT|2020-09-23|40
e|SS|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|5|TREATMENT|2020-10-18|65
e|SS|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|FOLLOW-UP|2020-10-18|65
e|SS|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|7|WASHOUT|2020-11-12|90
e|SS|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2020-11-12|90
e|SS|9b268a13-dc40-4eb6-8729-c131ac302dd3|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|6|TREATMENT|2020-05-15|10
e|SS|9b268a13-dc40-4eb6-8729-c131ac302dd3|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|6|TREATMENT|2020-05-15|10
e|SS|9b268a13-dc40-4eb6-8729-c131ac302dd3|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|5|SCREENING|2020-05-30|25
e|SS|9b268a13-dc40-4eb6-8729-c131ac302dd3|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|2|SCREENING|2020-05-30|25
e|SS|9b268a13-dc40-4eb6-8729-c131ac302dd3|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|1|FOLLOW-UP|2020-06-14|40
e|SS|9b268a13-dc40-4eb6-8729-c131ac302dd3|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|6|SCREENING|2020-06-14|40
e|SS|9b268a13-dc40-4eb6-8729-c131ac302dd3|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|4|TREATMENT|2020-07-09|65
e|SS|9b268a13-dc40-4eb6-8729-c131ac302dd3|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|7|WASHOUT|2020-07-09|65
e|SS|9b268a13-dc40-4eb6-8729-c131ac302dd3|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|4|TREATMENT|2020-08-03|90
e|SS|9b268a13-dc40-4eb6-8729-c131ac302dd3|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|5|FOLLOW-UP|2020-08-03|90
e|SS|fa11534a-92f9-4887-828b-25b7637b8f57|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|3|FOLLOW-UP|2020-12-13|10
e|SS|fa11534a-92f9-4887-828b-25b7637b8f57|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|2|SCREENING|2020-12-13|10
e|SS|fa11534a-92f9-4887-828b-25b7637b8f57|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|7|SCREENING|2020-12-28|25
e|SS|fa11534a-92f9-4887-828b-25b7637b8f57|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|1|WASHOUT|2020-12-28|25
e|SS|fa11534a-92f9-4887-828b-25b7637b8f57|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|4|FOLLOW-UP|2021-01-12|40
e|SS|fa11534a-92f9-4887-828b-25b7637b8f57|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|6|FOLLOW-UP|2021-01-12|40
e|SS|fa11534a-92f9-4887-828b-25b7637b8f57|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|2|WASHOUT|2021-02-06|65
e|SS|fa11534a-92f9-4887-828b-25b7637b8f57|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|2|TREATMENT|2021-02-06|65
e|SS|fa11534a-92f9-4887-828b-25b7637b8f57|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|7|SCREENING|2021-03-03|90
e|SS|fa11534a-92f9-4887-828b-25b7637b8f57|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|4|WASHOUT|2021-03-03|90
e|SS|f305f7a3-8c8b-4eca-afb2-4a376f811170|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|3|FOLLOW-UP|2020-10-04|10
e|SS|f305f7a3-8c8b-4eca-afb2-4a376f811170|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|6|WASHOUT|2020-10-04|10
e|SS|f305f7a3-8c8b-4eca-afb2-4a376f811170|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|2|FOLLOW-UP|2020-10-19|25
e|SS|f305f7a3-8c8b-4eca-afb2-4a376f811170|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|4|TREATMENT|2020-10-19|25
e|SS|f305f7a3-8c8b-4eca-afb2-4a376f811170|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|1|WASHOUT|2020-11-03|40
e|SS|f305f7a3-8c8b-4eca-afb2-4a376f811170|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|WASHOUT|2020-11-03|40
e|SS|f305f7a3-8c8b-4eca-afb2-4a376f811170|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|SCREENING|2020-11-28|65
e|SS|f305f7a3-8c8b-4eca-afb2-4a376f811170|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|3|TREATMENT|2020-11-28|65
e|SS|f305f7a3-8c8b-4eca-afb2-4a376f811170|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|4|WASHOUT|2020-12-23|90
e|SS|f305f7a3-8c8b-4eca-afb2-4a376f811170|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|5|WASHOUT|2020-12-23|90
e|SS|6e4ed6b3-e419-464c-a40e-f100a6894baa|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|5|FOLLOW-UP|2020-06-07|10
e|SS|6e4ed6b3-e419-464c-a40e-f100a6894baa|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|1|FOLLOW-UP|2020-06-07|10
e|SS|6e4ed6b3-e419-464c-a40e-f100a6894baa|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|4|TREATMENT|2020-06-22|25
e|SS|6e4ed6b3-e419-464c-a40e-f100a6894baa|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|5|WASHOUT|2020-06-22|25
e|SS|6e4ed6b3-e419-464c-a40e-f100a6894baa|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|3|SCREENING|2020-07-07|40
e|SS|6e4ed6b3-e419-464c-a40e-f100a6894baa|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|1|TREATMENT|2020-07-07|40
e|SS|6e4ed6b3-e419-464c-a40e-f100a6894baa|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|1|TREATMENT|2020-08-01|65
e|SS|6e4ed6b3-e419-464c-a40e-f100a6894baa|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|7|WASHOUT|2020-08-01|65
e|SS|6e4ed6b3-e419-464c-a40e-f100a6894baa|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|2|SCREENING|2020-08-26|90
e|SS|6e4ed6b3-e419-464c-a40e-f100a6894baa|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|4|SCREENING|2020-08-26|90
e|SS|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|5|TREATMENT|2020-08-08|10
e|SS|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|3|SCREENING|2020-08-08|10
e|SS|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|3|FOLLOW-UP|2020-08-23|25
e|SS|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|7|SCREENING|2020-08-23|25
e|SS|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|4|SCREENING|2020-09-07|40
e|SS|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|5|TREATMENT|2020-09-07|40
e|SS|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|2|SCREENING|2020-10-02|65
e|SS|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|7|WASHOUT|2020-10-02|65
e|SS|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|1|WASHOUT|2020-10-27|90
e|SS|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|2|TREATMENT|2020-10-27|90
e|SS|5d25ac6d-428d-41eb-9549-c23df035a54e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|1|WASHOUT|2020-05-13|10
e|SS|5d25ac6d-428d-41eb-9549-c23df035a54e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|2|TREATMENT|2020-05-13|10
e|SS|5d25ac6d-428d-41eb-9549-c23df035a54e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|2|FOLLOW-UP|2020-05-28|25
e|SS|5d25ac6d-428d-41eb-9549-c23df035a54e|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|3|WASHOUT|2020-05-28|25
e|SS|5d25ac6d-428d-41eb-9549-c23df035a54e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|1|SCREENING|2020-06-12|40
e|SS|5d25ac6d-428d-41eb-9549-c23df035a54e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|3|TREATMENT|2020-06-12|40
e|SS|5d25ac6d-428d-41eb-9549-c23df035a54e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|5|WASHOUT|2020-07-07|65
e|SS|5d25ac6d-428d-41eb-9549-c23df035a54e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|5|TREATMENT|2020-07-07|65
e|SS|5d25ac6d-428d-41eb-9549-c23df035a54e|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|1|TREATMENT|2020-08-01|90
e|SS|5d25ac6d-428d-41eb-9549-c23df035a54e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|6|WASHOUT|2020-08-01|90
e|SS|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|2|SCREENING|2020-10-30|10
e|SS|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|2|TREATMENT|2020-10-30|10
e|SS|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|4|WASHOUT|2020-11-14|25
e|SS|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|4|TREATMENT|2020-11-14|25
e|SS|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|1|TREATMENT|2020-11-29|40
e|SS|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|4|TREATMENT|2020-11-29|40
e|SS|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|3|TREATMENT|2020-12-24|65
e|SS|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|3|FOLLOW-UP|2020-12-24|65
e|SS|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|3|TREATMENT|2021-01-18|90
e|SS|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|2|SCREENING|2021-01-18|90
e|SS|173aea61-964d-4f4a-8d48-56a1a58de6d8|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|1|SCREENING|2020-10-13|10
e|SS|173aea61-964d-4f4a-8d48-56a1a58de6d8|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|TREATMENT|2020-10-13|10
e|SS|173aea61-964d-4f4a-8d48-56a1a58de6d8|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|4|TREATMENT|2020-10-28|25
e|SS|173aea61-964d-4f4a-8d48-56a1a58de6d8|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|2|FOLLOW-UP|2020-10-28|25
e|SS|173aea61-964d-4f4a-8d48-56a1a58de6d8|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|2|TREATMENT|2020-11-12|40
e|SS|173aea61-964d-4f4a-8d48-56a1a58de6d8|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|6|TREATMENT|2020-11-12|40
e|SS|173aea61-964d-4f4a-8d48-56a1a58de6d8|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|4|TREATMENT|2020-12-07|65
e|SS|173aea61-964d-4f4a-8d48-56a1a58de6d8|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|1|FOLLOW-UP|2020-12-07|65
e|SS|173aea61-964d-4f4a-8d48-56a1a58de6d8|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|1|FOLLOW-UP|2021-01-01|90
e|SS|173aea61-964d-4f4a-8d48-56a1a58de6d8|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|5|TREATMENT|2021-01-01|90
e|SS|45d1adb8-9b3b-4f06-87cb-740205448680|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|5|WASHOUT|2020-07-17|10
e|SS|45d1adb8-9b3b-4f06-87cb-740205448680|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|6|TREATMENT|2020-07-17|10
e|SS|45d1adb8-9b3b-4f06-87cb-740205448680|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|4|TREATMENT|2020-08-01|25
e|SS|45d1adb8-9b3b-4f06-87cb-740205448680|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|2|WASHOUT|2020-08-01|25
e|SS|45d1adb8-9b3b-4f06-87cb-740205448680|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|3|TREATMENT|2020-08-16|40
e|SS|45d1adb8-9b3b-4f06-87cb-740205448680|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|4|SCREENING|2020-08-16|40
e|SS|45d1adb8-9b3b-4f06-87cb-740205448680|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|6|TREATMENT|2020-09-10|65
e|SS|45d1adb8-9b3b-4f06-87cb-740205448680|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2020-09-10|65
e|SS|45d1adb8-9b3b-4f06-87cb-740205448680|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|1|SCREENING|2020-10-05|90
e|SS|45d1adb8-9b3b-4f06-87cb-740205448680|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|6|TREATMENT|2020-10-05|90
e|SS|7403ad67-7ed5-4716-a874-c360429845bc|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|SCREENING|2020-05-30|10
e|SS|7403ad67-7ed5-4716-a874-c360429845bc|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|TREATMENT|2020-05-30|10
e|SS|7403ad67-7ed5-4716-a874-c360429845bc|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|2|WASHOUT|2020-06-14|25
e|SS|7403ad67-7ed5-4716-a874-c360429845bc|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|7|TREATMENT|2020-06-14|25
e|SS|7403ad67-7ed5-4716-a874-c360429845bc|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|3|SCREENING|2020-06-29|40
e|SS|7403ad67-7ed5-4716-a874-c360429845bc|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|7|WASHOUT|2020-06-29|40
e|SS|7403ad67-7ed5-4716-a874-c360429845bc|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|2|WASHOUT|2020-07-24|65
e|SS|7403ad67-7ed5-4716-a874-c360429845bc|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|6|SCREENING|2020-07-24|65
e|SS|7403ad67-7ed5-4716-a874-c360429845bc|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|1|FOLLOW-UP|2020-08-18|90
e|SS|7403ad67-7ed5-4716-a874-c360429845bc|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|2|TREATMENT|2020-08-18|90
e|SS|8be919ce-34da-4e49-ac7a-3679c7af632d|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|4|TREATMENT|2021-01-13|10
e|SS|8be919ce-34da-4e49-ac7a-3679c7af632d|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|7|WASHOUT|2021-01-13|10
e|SS|8be919ce-34da-4e49-ac7a-3679c7af632d|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|7|TREATMENT|2021-01-28|25
e|SS|8be919ce-34da-4e49-ac7a-3679c7af632d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|7|TREATMENT|2021-01-28|25
e|SS|8be919ce-34da-4e49-ac7a-3679c7af632d|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|7|TREATMENT|2021-02-12|40
e|SS|8be919ce-34da-4e49-ac7a-3679c7af632d|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|2|SCREENING|2021-02-12|40
e|SS|8be919ce-34da-4e49-ac7a-3679c7af632d|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|WASHOUT|2021-03-09|65
e|SS|8be919ce-34da-4e49-ac7a-3679c7af632d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|3|TREATMENT|2021-03-09|65
e|SS|8be919ce-34da-4e49-ac7a-3679c7af632d|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|6|TREATMENT|2021-04-03|90
e|SS|8be919ce-34da-4e49-ac7a-3679c7af632d|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|4|TREATMENT|2021-04-03|90
e|SS|9c44967b-914e-43d5-be1e-6829804e04ab|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|6|WASHOUT|2021-01-24|10
e|SS|9c44967b-914e-43d5-be1e-6829804e04ab|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|3|SCREENING|2021-01-24|10
e|SS|9c44967b-914e-43d5-be1e-6829804e04ab|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|2|TREATMENT|2021-02-08|25
e|SS|9c44967b-914e-43d5-be1e-6829804e04ab|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|4|WASHOUT|2021-02-08|25
e|SS|9c44967b-914e-43d5-be1e-6829804e04ab|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|FOLLOW-UP|2021-02-23|40
e|SS|9c44967b-914e-43d5-be1e-6829804e04ab|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|7|FOLLOW-UP|2021-02-23|40
e|SS|9c44967b-914e-43d5-be1e-6829804e04ab|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|2|TREATMENT|2021-03-20|65
e|SS|9c44967b-914e-43d5-be1e-6829804e04ab|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|5|WASHOUT|2021-03-20|65
e|SS|9c44967b-914e-43d5-be1e-6829804e04ab|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|7|TREATMENT|2021-04-14|90
e|SS|9c44967b-914e-43d5-be1e-6829804e04ab|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|6|WASHOUT|2021-04-14|90
e|SS|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|7|TREATMENT|2020-07-31|10
e|SS|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|5|TREATMENT|2020-07-31|10
e|SS|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|1|TREATMENT|2020-08-15|25
e|SS|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|5|TREATMENT|2020-08-15|25
e|SS|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|7|TREATMENT|2020-08-30|40
e|SS|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|WASHOUT|2020-08-30|40
e|SS|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|4|TREATMENT|2020-09-24|65
e|SS|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|7|TREATMENT|2020-09-24|65
e|SS|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|6|TREATMENT|2020-10-19|90
e|SS|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|3|FOLLOW-UP|2020-10-19|90
e|SS|cad8c553-739f-4046-a898-d939eb286dba|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|7|FOLLOW-UP|2020-05-17|10
e|SS|cad8c553-739f-4046-a898-d939eb286dba|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|2|TREATMENT|2020-05-17|10
e|SS|cad8c553-739f-4046-a898-d939eb286dba|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|5|SCREENING|2020-06-01|25
e|SS|cad8c553-739f-4046-a898-d939eb286dba|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|6|WASHOUT|2020-06-01|25
e|SS|cad8c553-739f-4046-a898-d939eb286dba|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|3|TREATMENT|2020-06-16|40
e|SS|cad8c553-739f-4046-a898-d939eb286dba|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|2|WASHOUT|2020-06-16|40
e|SS|cad8c553-739f-4046-a898-d939eb286dba|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|2|SCREENING|2020-07-11|65
e|SS|cad8c553-739f-4046-a898-d939eb286dba|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|3|SCREENING|2020-07-11|65
e|SS|cad8c553-739f-4046-a898-d939eb286dba|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|5|TREATMENT|2020-08-05|90
e|SS|cad8c553-739f-4046-a898-d939eb286dba|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|2|WASHOUT|2020-08-05|90
e|SS|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|TREATMENT|2020-09-11|10
e|SS|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|4|TREATMENT|2020-09-11|10
e|SS|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|1|TREATMENT|2020-09-26|25
e|SS|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|5|TREATMENT|2020-09-26|25
e|SS|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|7|TREATMENT|2020-10-11|40
e|SS|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|7|FOLLOW-UP|2020-10-11|40
e|SS|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|4|SCREENING|2020-11-05|65
e|SS|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|2|TREATMENT|2020-11-05|65
e|SS|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|FOLLOW-UP|2020-11-30|90
e|SS|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|4|TREATMENT|2020-11-30|90
e|SS|81e934f8-7bcc-48d2-8d15-5270e51f2870|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|3|WASHOUT|2021-01-24|10
e|SS|81e934f8-7bcc-48d2-8d15-5270e51f2870|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|4|SCREENING|2021-01-24|10
e|SS|81e934f8-7bcc-48d2-8d15-5270e51f2870|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|3|TREATMENT|2021-02-08|25
e|SS|81e934f8-7bcc-48d2-8d15-5270e51f2870|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|4|TREATMENT|2021-02-08|25
e|SS|81e934f8-7bcc-48d2-8d15-5270e51f2870|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|4|TREATMENT|2021-02-23|40
e|SS|81e934f8-7bcc-48d2-8d15-5270e51f2870|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|6|WASHOUT|2021-02-23|40
e|SS|81e934f8-7bcc-48d2-8d15-5270e51f2870|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|1|FOLLOW-UP|2021-03-20|65
e|SS|81e934f8-7bcc-48d2-8d15-5270e51f2870|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|4|SCREENING|2021-03-20|65
e|SS|81e934f8-7bcc-48d2-8d15-5270e51f2870|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2021-04-14|90
e|SS|81e934f8-7bcc-48d2-8d15-5270e51f2870|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2021-04-14|90
e|SS|5713cabe-4d79-4f77-8ddc-daad1242a837|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|2|WASHOUT|2020-09-09|10
e|SS|5713cabe-4d79-4f77-8ddc-daad1242a837|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|1|WASHOUT|2020-09-09|10
e|SS|5713cabe-4d79-4f77-8ddc-daad1242a837|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|1|TREATMENT|2020-09-24|25
e|SS|5713cabe-4d79-4f77-8ddc-daad1242a837|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|1|TREATMENT|2020-09-24|25
e|SS|5713cabe-4d79-4f77-8ddc-daad1242a837|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|1|SCREENING|2020-10-09|40
e|SS|5713cabe-4d79-4f77-8ddc-daad1242a837|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|5|FOLLOW-UP|2020-10-09|40
e|SS|5713cabe-4d79-4f77-8ddc-daad1242a837|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|TREATMENT|2020-11-03|65
e|SS|5713cabe-4d79-4f77-8ddc-daad1242a837|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|2|TREATMENT|2020-11-03|65
e|SS|5713cabe-4d79-4f77-8ddc-daad1242a837|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|6|TREATMENT|2020-11-28|90
e|SS|5713cabe-4d79-4f77-8ddc-daad1242a837|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|1|FOLLOW-UP|2020-11-28|90
e|SS|414d20c7-8dc8-49ad-8ae9-f113b9610109|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|5|TREATMENT|2020-07-10|10
e|SS|414d20c7-8dc8-49ad-8ae9-f113b9610109|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|2|SCREENING|2020-07-10|10
e|SS|414d20c7-8dc8-49ad-8ae9-f113b9610109|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|TREATMENT|2020-07-25|25
e|SS|414d20c7-8dc8-49ad-8ae9-f113b9610109|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|2|TREATMENT|2020-07-25|25
e|SS|414d20c7-8dc8-49ad-8ae9-f113b9610109|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-08-09|40
e|SS|414d20c7-8dc8-49ad-8ae9-f113b9610109|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|1|FOLLOW-UP|2020-08-09|40
e|SS|414d20c7-8dc8-49ad-8ae9-f113b9610109|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|FOLLOW-UP|2020-09-03|65
e|SS|414d20c7-8dc8-49ad-8ae9-f113b9610109|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|6|WASHOUT|2020-09-03|65
e|SS|414d20c7-8dc8-49ad-8ae9-f113b9610109|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|6|SCREENING|2020-09-28|90
e|SS|414d20c7-8dc8-49ad-8ae9-f113b9610109|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|2|SCREENING|2020-09-28|90
e|SS|21e16094-23bd-4d20-b5f8-10d45858160e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|1|TREATMENT|2020-09-17|10
e|SS|21e16094-23bd-4d20-b5f8-10d45858160e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|6|WASHOUT|2020-09-17|10
e|SS|21e16094-23bd-4d20-b5f8-10d45858160e|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|2|TREATMENT|2020-10-02|25
e|SS|21e16094-23bd-4d20-b5f8-10d45858160e|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|1|FOLLOW-UP|2020-10-02|25
e|SS|21e16094-23bd-4d20-b5f8-10d45858160e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|7|TREATMENT|2020-10-17|40
e|SS|21e16094-23bd-4d20-b5f8-10d45858160e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|7|TREATMENT|2020-10-17|40
e|SS|21e16094-23bd-4d20-b5f8-10d45858160e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|7|TREATMENT|2020-11-11|65
e|SS|21e16094-23bd-4d20-b5f8-10d45858160e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|2|SCREENING|2020-11-11|65
e|SS|21e16094-23bd-4d20-b5f8-10d45858160e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|2|TREATMENT|2020-12-06|90
e|SS|21e16094-23bd-4d20-b5f8-10d45858160e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|2|TREATMENT|2020-12-06|90
e|SS|2346613e-6734-476a-a414-511606c2d753|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|WASHOUT|2020-09-22|10
e|SS|2346613e-6734-476a-a414-511606c2d753|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|7|FOLLOW-UP|2020-09-22|10
e|SS|2346613e-6734-476a-a414-511606c2d753|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|1|TREATMENT|2020-10-07|25
e|SS|2346613e-6734-476a-a414-511606c2d753|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|2|TREATMENT|2020-10-07|25
e|SS|2346613e-6734-476a-a414-511606c2d753|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|2|TREATMENT|2020-10-22|40
e|SS|2346613e-6734-476a-a414-511606c2d753|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|3|WASHOUT|2020-10-22|40
e|SS|2346613e-6734-476a-a414-511606c2d753|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|3|TREATMENT|2020-11-16|65
e|SS|2346613e-6734-476a-a414-511606c2d753|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|5|TREATMENT|2020-11-16|65
e|SS|2346613e-6734-476a-a414-511606c2d753|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|4|TREATMENT|2020-12-11|90
e|SS|2346613e-6734-476a-a414-511606c2d753|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2020-12-11|90
e|SS|6a8bda83-1b5a-481e-af4f-77fe74bc37be|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|6|SCREENING|2020-11-26|10
e|SS|6a8bda83-1b5a-481e-af4f-77fe74bc37be|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|1|TREATMENT|2020-11-26|10
e|SS|6a8bda83-1b5a-481e-af4f-77fe74bc37be|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|1|TREATMENT|2020-12-11|25
e|SS|6a8bda83-1b5a-481e-af4f-77fe74bc37be|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|2|TREATMENT|2020-12-11|25
e|SS|6a8bda83-1b5a-481e-af4f-77fe74bc37be|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|3|WASHOUT|2020-12-26|40
e|SS|6a8bda83-1b5a-481e-af4f-77fe74bc37be|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|5|FOLLOW-UP|2020-12-26|40
e|SS|6a8bda83-1b5a-481e-af4f-77fe74bc37be|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|2|TREATMENT|2021-01-20|65
e|SS|6a8bda83-1b5a-481e-af4f-77fe74bc37be|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|4|FOLLOW-UP|2021-01-20|65
e|SS|6a8bda83-1b5a-481e-af4f-77fe74bc37be|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|6|TREATMENT|2021-02-14|90
e|SS|6a8bda83-1b5a-481e-af4f-77fe74bc37be|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|1|SCREENING|2021-02-14|90
e|SS|748ef401-3def-4674-8d5e-4a198709d672|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|3|SCREENING|2020-06-08|10
e|SS|748ef401-3def-4674-8d5e-4a198709d672|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|7|WASHOUT|2020-06-08|10
e|SS|748ef401-3def-4674-8d5e-4a198709d672|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|3|TREATMENT|2020-06-23|25
e|SS|748ef401-3def-4674-8d5e-4a198709d672|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|5|TREATMENT|2020-06-23|25
e|SS|748ef401-3def-4674-8d5e-4a198709d672|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|3|TREATMENT|2020-07-08|40
e|SS|748ef401-3def-4674-8d5e-4a198709d672|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|2|TREATMENT|2020-07-08|40
e|SS|748ef401-3def-4674-8d5e-4a198709d672|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|6|SCREENING|2020-08-02|65
e|SS|748ef401-3def-4674-8d5e-4a198709d672|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2020-08-02|65
e|SS|748ef401-3def-4674-8d5e-4a198709d672|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|1|TREATMENT|2020-08-27|90
e|SS|748ef401-3def-4674-8d5e-4a198709d672|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|5|TREATMENT|2020-08-27|90
e|SS|03c399c1-77b9-4879-a6e8-42ba58ca68d4|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|1|FOLLOW-UP|2020-07-15|10
e|SS|03c399c1-77b9-4879-a6e8-42ba58ca68d4|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|5|SCREENING|2020-07-15|10
e|SS|03c399c1-77b9-4879-a6e8-42ba58ca68d4|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2020-07-30|25
e|SS|03c399c1-77b9-4879-a6e8-42ba58ca68d4|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|5|TREATMENT|2020-07-30|25
e|SS|03c399c1-77b9-4879-a6e8-42ba58ca68d4|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|1|FOLLOW-UP|2020-08-14|40
e|SS|03c399c1-77b9-4879-a6e8-42ba58ca68d4|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|3|TREATMENT|2020-08-14|40
e|SS|03c399c1-77b9-4879-a6e8-42ba58ca68d4|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|4|TREATMENT|2020-09-08|65
e|SS|03c399c1-77b9-4879-a6e8-42ba58ca68d4|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|3|TREATMENT|2020-09-08|65
e|SS|03c399c1-77b9-4879-a6e8-42ba58ca68d4|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|1|WASHOUT|2020-10-03|90
e|SS|03c399c1-77b9-4879-a6e8-42ba58ca68d4|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2020-10-03|90
e|SS|b8afdaf1-5c4d-408f-b8ba-381461f15bde|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|1|TREATMENT|2020-11-13|10
e|SS|b8afdaf1-5c4d-408f-b8ba-381461f15bde|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|6|TREATMENT|2020-11-13|10
e|SS|b8afdaf1-5c4d-408f-b8ba-381461f15bde|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|4|WASHOUT|2020-11-28|25
e|SS|b8afdaf1-5c4d-408f-b8ba-381461f15bde|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|1|TREATMENT|2020-11-28|25
e|SS|b8afdaf1-5c4d-408f-b8ba-381461f15bde|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|5|TREATMENT|2020-12-13|40
e|SS|b8afdaf1-5c4d-408f-b8ba-381461f15bde|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|5|TREATMENT|2020-12-13|40
e|SS|b8afdaf1-5c4d-408f-b8ba-381461f15bde|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|5|SCREENING|2021-01-07|65
e|SS|b8afdaf1-5c4d-408f-b8ba-381461f15bde|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|6|WASHOUT|2021-01-07|65
e|SS|b8afdaf1-5c4d-408f-b8ba-381461f15bde|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|2|SCREENING|2021-02-01|90
e|SS|b8afdaf1-5c4d-408f-b8ba-381461f15bde|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|1|TREATMENT|2021-02-01|90
e|SS|8115d6e8-0908-4491-a82a-08f43ccf1f0d|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|3|SCREENING|2020-11-28|10
e|SS|8115d6e8-0908-4491-a82a-08f43ccf1f0d|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|5|WASHOUT|2020-11-28|10
e|SS|8115d6e8-0908-4491-a82a-08f43ccf1f0d|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|4|WASHOUT|2020-12-13|25
e|SS|8115d6e8-0908-4491-a82a-08f43ccf1f0d|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|1|FOLLOW-UP|2020-12-13|25
e|SS|8115d6e8-0908-4491-a82a-08f43ccf1f0d|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|2|TREATMENT|2020-12-28|40
e|SS|8115d6e8-0908-4491-a82a-08f43ccf1f0d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|5|WASHOUT|2020-12-28|40
e|SS|8115d6e8-0908-4491-a82a-08f43ccf1f0d|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|7|TREATMENT|2021-01-22|65
e|SS|8115d6e8-0908-4491-a82a-08f43ccf1f0d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|6|TREATMENT|2021-01-22|65
e|SS|8115d6e8-0908-4491-a82a-08f43ccf1f0d|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|3|SCREENING|2021-02-16|90
e|SS|8115d6e8-0908-4491-a82a-08f43ccf1f0d|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|4|WASHOUT|2021-02-16|90
e|SS|fbd7ecb2-905f-40a9-babc-ebaf310cc372|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|4|TREATMENT|2020-06-30|10
e|SS|fbd7ecb2-905f-40a9-babc-ebaf310cc372|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|3|FOLLOW-UP|2020-06-30|10
e|SS|fbd7ecb2-905f-40a9-babc-ebaf310cc372|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|4|TREATMENT|2020-07-15|25
e|SS|fbd7ecb2-905f-40a9-babc-ebaf310cc372|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|2|WASHOUT|2020-07-15|25
e|SS|fbd7ecb2-905f-40a9-babc-ebaf310cc372|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-07-30|40
e|SS|fbd7ecb2-905f-40a9-babc-ebaf310cc372|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|4|FOLLOW-UP|2020-07-30|40
e|SS|fbd7ecb2-905f-40a9-babc-ebaf310cc372|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|1|WASHOUT|2020-08-24|65
e|SS|fbd7ecb2-905f-40a9-babc-ebaf310cc372|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|5|WASHOUT|2020-08-24|65
e|SS|fbd7ecb2-905f-40a9-babc-ebaf310cc372|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|7|TREATMENT|2020-09-18|90
e|SS|fbd7ecb2-905f-40a9-babc-ebaf310cc372|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|5|TREATMENT|2020-09-18|90
e|SS|1a0e1a66-82dd-4945-9c9f-179fba9d781e|1|SURVSTAT|Survival Status|[?]|[?]|DEAD|INDEPENDENT ASSESSOR|1|Visit_1|10|7|WASHOUT|2021-03-09|100
e|SS|1a0e1a66-82dd-4945-9c9f-179fba9d781e|2|SURVSTAT|Survival Status|[?]|[?]|DEAD|SIGNIFICANT OTHER|1|Visit_1|10|5|FOLLOW-UP|2021-03-09|100
e|SS|1a0e1a66-82dd-4945-9c9f-179fba9d781e|3|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATION COMMITTEE|2|Visit_2|25|7|SCREENING|2021-03-09|100
e|SS|1a0e1a66-82dd-4945-9c9f-179fba9d781e|4|SURVSTAT|Survival Status|[?]|[?]|DEAD|INTERVIEWER|2|Visit_2|25|6|FOLLOW-UP|2021-03-09|100
e|SS|1a0e1a66-82dd-4945-9c9f-179fba9d781e|5|SURVSTAT|Survival Status|[?]|[?]|DEAD|PARENT|3|Visit_3|40|7|FOLLOW-UP|2021-03-09|100
e|SS|1a0e1a66-82dd-4945-9c9f-179fba9d781e|6|SURVSTAT|Survival Status|[?]|[?]|DEAD|ADJUDICATOR|3|Visit_3|40|4|WASHOUT|2021-03-09|100
e|SS|1a0e1a66-82dd-4945-9c9f-179fba9d781e|7|SURVSTAT|Survival Status|[?]|[?]|DEAD|INDEPENDENT ASSESSOR|4|Visit_4|65|5|WASHOUT|2021-03-09|100
e|SS|1a0e1a66-82dd-4945-9c9f-179fba9d781e|8|SURVSTAT|Survival Status|[?]|[?]|DEAD|CHILD|4|Visit_4|65|1|FOLLOW-UP|2021-03-09|100
e|SS|1a0e1a66-82dd-4945-9c9f-179fba9d781e|9|SURVSTAT|Survival Status|[?]|[?]|DEAD|CHILD|5|Visit_5|90|3|FOLLOW-UP|2021-03-09|100
e|SS|1a0e1a66-82dd-4945-9c9f-179fba9d781e|10|SURVSTAT|Survival Status|[?]|[?]|DEAD|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|7|FOLLOW-UP|2021-03-09|100
e|SS|b3ab1879-3dc7-41fa-be53-f4484af21fbd|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|7|SCREENING|2020-11-19|10
e|SS|b3ab1879-3dc7-41fa-be53-f4484af21fbd|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|FOLLOW-UP|2020-11-19|10
e|SS|b3ab1879-3dc7-41fa-be53-f4484af21fbd|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|3|TREATMENT|2020-12-04|25
e|SS|b3ab1879-3dc7-41fa-be53-f4484af21fbd|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|4|WASHOUT|2020-12-04|25
e|SS|b3ab1879-3dc7-41fa-be53-f4484af21fbd|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|2|TREATMENT|2020-12-19|40
e|SS|b3ab1879-3dc7-41fa-be53-f4484af21fbd|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|6|WASHOUT|2020-12-19|40
e|SS|b3ab1879-3dc7-41fa-be53-f4484af21fbd|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|6|TREATMENT|2021-01-13|65
e|SS|b3ab1879-3dc7-41fa-be53-f4484af21fbd|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|1|SCREENING|2021-01-13|65
e|SS|b3ab1879-3dc7-41fa-be53-f4484af21fbd|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|SCREENING|2021-02-07|90
e|SS|b3ab1879-3dc7-41fa-be53-f4484af21fbd|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|5|SCREENING|2021-02-07|90
e|SS|bc71ddfa-c71c-447b-9684-005e4c112172|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|4|TREATMENT|2020-07-11|10
e|SS|bc71ddfa-c71c-447b-9684-005e4c112172|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|1|WASHOUT|2020-07-11|10
e|SS|bc71ddfa-c71c-447b-9684-005e4c112172|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|7|TREATMENT|2020-07-26|25
e|SS|bc71ddfa-c71c-447b-9684-005e4c112172|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|7|TREATMENT|2020-07-26|25
e|SS|bc71ddfa-c71c-447b-9684-005e4c112172|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2020-08-10|40
e|SS|bc71ddfa-c71c-447b-9684-005e4c112172|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|1|FOLLOW-UP|2020-08-10|40
e|SS|bc71ddfa-c71c-447b-9684-005e4c112172|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|4|Visit_4|65|4|TREATMENT|2020-09-04|65
e|SS|bc71ddfa-c71c-447b-9684-005e4c112172|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|7|WASHOUT|2020-09-04|65
e|SS|bc71ddfa-c71c-447b-9684-005e4c112172|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|7|FOLLOW-UP|2020-09-29|90
e|SS|bc71ddfa-c71c-447b-9684-005e4c112172|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|2|FOLLOW-UP|2020-09-29|90
e|SS|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|1|TREATMENT|2020-12-09|10
e|SS|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|6|SCREENING|2020-12-09|10
e|SS|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|4|TREATMENT|2020-12-24|25
e|SS|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|4|FOLLOW-UP|2020-12-24|25
e|SS|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|1|TREATMENT|2021-01-08|40
e|SS|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|1|TREATMENT|2021-01-08|40
e|SS|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|4|TREATMENT|2021-02-02|65
e|SS|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|1|TREATMENT|2021-02-02|65
e|SS|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|6|TREATMENT|2021-02-27|90
e|SS|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|6|WASHOUT|2021-02-27|90
e|SS|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|2|TREATMENT|2020-09-06|10
e|SS|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|7|TREATMENT|2020-09-06|10
e|SS|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|WASHOUT|2020-09-21|25
e|SS|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|4|WASHOUT|2020-09-21|25
e|SS|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|2|SCREENING|2020-10-06|40
e|SS|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|5|SCREENING|2020-10-06|40
e|SS|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|7|TREATMENT|2020-10-31|65
e|SS|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|2|TREATMENT|2020-10-31|65
e|SS|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|4|WASHOUT|2020-11-25|90
e|SS|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|1|TREATMENT|2020-11-25|90
e|SS|b1b3e113-8c73-4446-8095-3341f8912bd7|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|1|SCREENING|2021-01-27|10
e|SS|b1b3e113-8c73-4446-8095-3341f8912bd7|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|6|TREATMENT|2021-01-27|10
e|SS|b1b3e113-8c73-4446-8095-3341f8912bd7|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|4|WASHOUT|2021-02-11|25
e|SS|b1b3e113-8c73-4446-8095-3341f8912bd7|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|4|TREATMENT|2021-02-11|25
e|SS|b1b3e113-8c73-4446-8095-3341f8912bd7|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|2|WASHOUT|2021-02-26|40
e|SS|b1b3e113-8c73-4446-8095-3341f8912bd7|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|TREATMENT|2021-02-26|40
e|SS|b1b3e113-8c73-4446-8095-3341f8912bd7|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|4|TREATMENT|2021-03-23|65
e|SS|b1b3e113-8c73-4446-8095-3341f8912bd7|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|5|TREATMENT|2021-03-23|65
e|SS|b1b3e113-8c73-4446-8095-3341f8912bd7|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|1|FOLLOW-UP|2021-04-17|90
e|SS|b1b3e113-8c73-4446-8095-3341f8912bd7|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|5|TREATMENT|2021-04-17|90
e|SS|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|5|FOLLOW-UP|2020-11-22|10
e|SS|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|6|TREATMENT|2020-11-22|10
e|SS|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|7|TREATMENT|2020-12-07|25
e|SS|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|TREATMENT|2020-12-07|25
e|SS|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|2|TREATMENT|2020-12-22|40
e|SS|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|3|TREATMENT|2020-12-22|40
e|SS|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2021-01-16|65
e|SS|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|6|TREATMENT|2021-01-16|65
e|SS|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|6|TREATMENT|2021-02-10|90
e|SS|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2021-02-10|90
e|SS|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|7|TREATMENT|2020-08-06|10
e|SS|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|1|FOLLOW-UP|2020-08-06|10
e|SS|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|6|TREATMENT|2020-08-21|25
e|SS|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|6|FOLLOW-UP|2020-08-21|25
e|SS|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|5|TREATMENT|2020-09-05|40
e|SS|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|1|FOLLOW-UP|2020-09-05|40
e|SS|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|1|TREATMENT|2020-09-30|65
e|SS|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|7|TREATMENT|2020-09-30|65
e|SS|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|3|TREATMENT|2020-10-25|90
e|SS|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|TREATMENT|2020-10-25|90
e|SS|3b83c7a0-e22b-45b1-b065-71971f014039|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|1|FOLLOW-UP|2020-09-01|10
e|SS|3b83c7a0-e22b-45b1-b065-71971f014039|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|3|TREATMENT|2020-09-01|10
e|SS|3b83c7a0-e22b-45b1-b065-71971f014039|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|4|FOLLOW-UP|2020-09-16|25
e|SS|3b83c7a0-e22b-45b1-b065-71971f014039|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|3|TREATMENT|2020-09-16|25
e|SS|3b83c7a0-e22b-45b1-b065-71971f014039|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|4|TREATMENT|2020-10-01|40
e|SS|3b83c7a0-e22b-45b1-b065-71971f014039|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|6|TREATMENT|2020-10-01|40
e|SS|3b83c7a0-e22b-45b1-b065-71971f014039|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|4|SCREENING|2020-10-26|65
e|SS|3b83c7a0-e22b-45b1-b065-71971f014039|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|7|TREATMENT|2020-10-26|65
e|SS|3b83c7a0-e22b-45b1-b065-71971f014039|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|5|TREATMENT|2020-11-20|90
e|SS|3b83c7a0-e22b-45b1-b065-71971f014039|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|3|TREATMENT|2020-11-20|90
e|SS|92c849ce-12b8-4c38-baab-f91c44a007b9|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|1|TREATMENT|2020-11-12|10
e|SS|92c849ce-12b8-4c38-baab-f91c44a007b9|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|3|SCREENING|2020-11-12|10
e|SS|92c849ce-12b8-4c38-baab-f91c44a007b9|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|5|SCREENING|2020-11-27|25
e|SS|92c849ce-12b8-4c38-baab-f91c44a007b9|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|3|WASHOUT|2020-11-27|25
e|SS|92c849ce-12b8-4c38-baab-f91c44a007b9|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|6|WASHOUT|2020-12-12|40
e|SS|92c849ce-12b8-4c38-baab-f91c44a007b9|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|5|TREATMENT|2020-12-12|40
e|SS|92c849ce-12b8-4c38-baab-f91c44a007b9|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|1|FOLLOW-UP|2021-01-06|65
e|SS|92c849ce-12b8-4c38-baab-f91c44a007b9|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|3|TREATMENT|2021-01-06|65
e|SS|92c849ce-12b8-4c38-baab-f91c44a007b9|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|2|TREATMENT|2021-01-31|90
e|SS|92c849ce-12b8-4c38-baab-f91c44a007b9|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|1|SCREENING|2021-01-31|90
e|SS|f2101018-c983-435e-a453-148f182388f7|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|1|TREATMENT|2020-09-01|10
e|SS|f2101018-c983-435e-a453-148f182388f7|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|7|FOLLOW-UP|2020-09-01|10
e|SS|f2101018-c983-435e-a453-148f182388f7|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|WASHOUT|2020-09-16|25
e|SS|f2101018-c983-435e-a453-148f182388f7|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|6|TREATMENT|2020-09-16|25
e|SS|f2101018-c983-435e-a453-148f182388f7|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|4|TREATMENT|2020-10-01|40
e|SS|f2101018-c983-435e-a453-148f182388f7|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|1|TREATMENT|2020-10-01|40
e|SS|f2101018-c983-435e-a453-148f182388f7|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|7|FOLLOW-UP|2020-10-26|65
e|SS|f2101018-c983-435e-a453-148f182388f7|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|3|SCREENING|2020-10-26|65
e|SS|f2101018-c983-435e-a453-148f182388f7|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|1|TREATMENT|2020-11-20|90
e|SS|f2101018-c983-435e-a453-148f182388f7|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|2|WASHOUT|2020-11-20|90
e|SS|613284eb-edbe-446b-b4fe-f96f1510e626|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|2|FOLLOW-UP|2020-11-07|10
e|SS|613284eb-edbe-446b-b4fe-f96f1510e626|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|5|FOLLOW-UP|2020-11-07|10
e|SS|613284eb-edbe-446b-b4fe-f96f1510e626|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|5|FOLLOW-UP|2020-11-22|25
e|SS|613284eb-edbe-446b-b4fe-f96f1510e626|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|2|WASHOUT|2020-11-22|25
e|SS|613284eb-edbe-446b-b4fe-f96f1510e626|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|2|WASHOUT|2020-12-07|40
e|SS|613284eb-edbe-446b-b4fe-f96f1510e626|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|3|TREATMENT|2020-12-07|40
e|SS|613284eb-edbe-446b-b4fe-f96f1510e626|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|1|TREATMENT|2021-01-01|65
e|SS|613284eb-edbe-446b-b4fe-f96f1510e626|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|5|TREATMENT|2021-01-01|65
e|SS|613284eb-edbe-446b-b4fe-f96f1510e626|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|2|FOLLOW-UP|2021-01-26|90
e|SS|613284eb-edbe-446b-b4fe-f96f1510e626|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|7|TREATMENT|2021-01-26|90
e|SS|65e8391b-0c34-4687-a0ab-cb291a4cdf36|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|5|TREATMENT|2020-07-15|10
e|SS|65e8391b-0c34-4687-a0ab-cb291a4cdf36|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|FOLLOW-UP|2020-07-15|10
e|SS|65e8391b-0c34-4687-a0ab-cb291a4cdf36|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|6|FOLLOW-UP|2020-07-30|25
e|SS|65e8391b-0c34-4687-a0ab-cb291a4cdf36|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|5|WASHOUT|2020-07-30|25
e|SS|65e8391b-0c34-4687-a0ab-cb291a4cdf36|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|2|TREATMENT|2020-08-14|40
e|SS|65e8391b-0c34-4687-a0ab-cb291a4cdf36|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|TREATMENT|2020-08-14|40
e|SS|65e8391b-0c34-4687-a0ab-cb291a4cdf36|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|4|WASHOUT|2020-09-08|65
e|SS|65e8391b-0c34-4687-a0ab-cb291a4cdf36|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|2|TREATMENT|2020-09-08|65
e|SS|65e8391b-0c34-4687-a0ab-cb291a4cdf36|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|7|TREATMENT|2020-10-03|90
e|SS|65e8391b-0c34-4687-a0ab-cb291a4cdf36|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|4|FOLLOW-UP|2020-10-03|90
e|SS|2350438a-0bc8-4da5-b6c9-99a6c012b454|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|3|TREATMENT|2020-08-21|10
e|SS|2350438a-0bc8-4da5-b6c9-99a6c012b454|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|3|TREATMENT|2020-08-21|10
e|SS|2350438a-0bc8-4da5-b6c9-99a6c012b454|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|3|TREATMENT|2020-09-05|25
e|SS|2350438a-0bc8-4da5-b6c9-99a6c012b454|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|6|TREATMENT|2020-09-05|25
e|SS|2350438a-0bc8-4da5-b6c9-99a6c012b454|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|2|FOLLOW-UP|2020-09-20|40
e|SS|2350438a-0bc8-4da5-b6c9-99a6c012b454|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|2|WASHOUT|2020-09-20|40
e|SS|2350438a-0bc8-4da5-b6c9-99a6c012b454|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|3|TREATMENT|2020-10-15|65
e|SS|2350438a-0bc8-4da5-b6c9-99a6c012b454|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|7|TREATMENT|2020-10-15|65
e|SS|2350438a-0bc8-4da5-b6c9-99a6c012b454|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|1|TREATMENT|2020-11-09|90
e|SS|2350438a-0bc8-4da5-b6c9-99a6c012b454|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|4|TREATMENT|2020-11-09|90
e|SS|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|6|TREATMENT|2020-11-16|10
e|SS|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|4|FOLLOW-UP|2020-11-16|10
e|SS|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|5|TREATMENT|2020-12-01|25
e|SS|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|7|TREATMENT|2020-12-01|25
e|SS|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|SCREENING|2020-12-16|40
e|SS|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|4|TREATMENT|2020-12-16|40
e|SS|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|3|WASHOUT|2021-01-10|65
e|SS|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|1|SCREENING|2021-01-10|65
e|SS|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|4|WASHOUT|2021-02-04|90
e|SS|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|2|TREATMENT|2021-02-04|90
e|SS|416fe99b-1258-4e72-b1df-48b989f8f8ed|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|7|TREATMENT|2020-08-28|10
e|SS|416fe99b-1258-4e72-b1df-48b989f8f8ed|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|7|FOLLOW-UP|2020-08-28|10
e|SS|416fe99b-1258-4e72-b1df-48b989f8f8ed|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|2|TREATMENT|2020-09-12|25
e|SS|416fe99b-1258-4e72-b1df-48b989f8f8ed|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|7|FOLLOW-UP|2020-09-12|25
e|SS|416fe99b-1258-4e72-b1df-48b989f8f8ed|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|FOLLOW-UP|2020-09-27|40
e|SS|416fe99b-1258-4e72-b1df-48b989f8f8ed|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|1|SCREENING|2020-09-27|40
e|SS|416fe99b-1258-4e72-b1df-48b989f8f8ed|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|1|SCREENING|2020-10-22|65
e|SS|416fe99b-1258-4e72-b1df-48b989f8f8ed|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2020-10-22|65
e|SS|416fe99b-1258-4e72-b1df-48b989f8f8ed|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|7|TREATMENT|2020-11-16|90
e|SS|416fe99b-1258-4e72-b1df-48b989f8f8ed|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|1|TREATMENT|2020-11-16|90
e|SS|16a9e070-3e5d-444c-9ac1-6a1abfac0370|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|5|TREATMENT|2020-05-26|10
e|SS|16a9e070-3e5d-444c-9ac1-6a1abfac0370|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|1|Visit_1|10|6|SCREENING|2020-05-26|10
e|SS|16a9e070-3e5d-444c-9ac1-6a1abfac0370|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|5|TREATMENT|2020-06-10|25
e|SS|16a9e070-3e5d-444c-9ac1-6a1abfac0370|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|7|FOLLOW-UP|2020-06-10|25
e|SS|16a9e070-3e5d-444c-9ac1-6a1abfac0370|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|5|WASHOUT|2020-06-25|40
e|SS|16a9e070-3e5d-444c-9ac1-6a1abfac0370|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|7|TREATMENT|2020-06-25|40
e|SS|16a9e070-3e5d-444c-9ac1-6a1abfac0370|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|4|SCREENING|2020-07-20|65
e|SS|16a9e070-3e5d-444c-9ac1-6a1abfac0370|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|7|TREATMENT|2020-07-20|65
e|SS|16a9e070-3e5d-444c-9ac1-6a1abfac0370|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|7|TREATMENT|2020-08-14|90
e|SS|16a9e070-3e5d-444c-9ac1-6a1abfac0370|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|2|FOLLOW-UP|2020-08-14|90
e|SS|1497a00d-55b1-4e02-a957-cf15e3d15512|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|3|TREATMENT|2021-01-25|10
e|SS|1497a00d-55b1-4e02-a957-cf15e3d15512|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|5|SCREENING|2021-01-25|10
e|SS|1497a00d-55b1-4e02-a957-cf15e3d15512|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|2|Visit_2|25|5|TREATMENT|2021-02-09|25
e|SS|1497a00d-55b1-4e02-a957-cf15e3d15512|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|FOLLOW-UP|2021-02-09|25
e|SS|1497a00d-55b1-4e02-a957-cf15e3d15512|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|FOLLOW-UP|2021-02-24|40
e|SS|1497a00d-55b1-4e02-a957-cf15e3d15512|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|6|TREATMENT|2021-02-24|40
e|SS|1497a00d-55b1-4e02-a957-cf15e3d15512|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|1|TREATMENT|2021-03-21|65
e|SS|1497a00d-55b1-4e02-a957-cf15e3d15512|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|4|TREATMENT|2021-03-21|65
e|SS|1497a00d-55b1-4e02-a957-cf15e3d15512|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|5|TREATMENT|2021-04-15|90
e|SS|1497a00d-55b1-4e02-a957-cf15e3d15512|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|3|TREATMENT|2021-04-15|90
e|SS|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|TREATMENT|2020-07-21|10
e|SS|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|7|WASHOUT|2020-07-21|10
e|SS|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|7|FOLLOW-UP|2020-08-05|25
e|SS|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|2|FOLLOW-UP|2020-08-05|25
e|SS|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|1|SCREENING|2020-08-20|40
e|SS|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|2|SCREENING|2020-08-20|40
e|SS|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|TREATMENT|2020-09-14|65
e|SS|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|5|TREATMENT|2020-09-14|65
e|SS|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|7|WASHOUT|2020-10-09|90
e|SS|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|3|SCREENING|2020-10-09|90
e|SS|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|5|SCREENING|2020-12-09|10
e|SS|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|7|FOLLOW-UP|2020-12-09|10
e|SS|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|6|TREATMENT|2020-12-24|25
e|SS|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|7|SCREENING|2020-12-24|25
e|SS|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|3|SCREENING|2021-01-08|40
e|SS|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|SCREENING|2021-01-08|40
e|SS|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|7|TREATMENT|2021-02-02|65
e|SS|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|4|TREATMENT|2021-02-02|65
e|SS|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|7|SCREENING|2021-02-27|90
e|SS|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|3|TREATMENT|2021-02-27|90
e|SS|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|5|SCREENING|2020-11-05|10
e|SS|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|1|Visit_1|10|2|TREATMENT|2020-11-05|10
e|SS|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|4|TREATMENT|2020-11-20|25
e|SS|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|4|SCREENING|2020-11-20|25
e|SS|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|3|TREATMENT|2020-12-05|40
e|SS|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|4|TREATMENT|2020-12-05|40
e|SS|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|6|TREATMENT|2020-12-30|65
e|SS|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|7|SCREENING|2020-12-30|65
e|SS|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|2|SCREENING|2021-01-24|90
e|SS|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|6|TREATMENT|2021-01-24|90
e|SS|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|7|TREATMENT|2020-05-27|10
e|SS|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|WASHOUT|2020-05-27|10
e|SS|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-06-11|25
e|SS|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|5|TREATMENT|2020-06-11|25
e|SS|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|FOLLOW-UP|2020-06-26|40
e|SS|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|1|TREATMENT|2020-06-26|40
e|SS|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|TREATMENT|2020-07-21|65
e|SS|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|WASHOUT|2020-07-21|65
e|SS|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|2|TREATMENT|2020-08-15|90
e|SS|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|TREATMENT|2020-08-15|90
e|SS|2216086b-197e-4780-8e10-28123eb090c5|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|TREATMENT|2020-12-12|10
e|SS|2216086b-197e-4780-8e10-28123eb090c5|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|TREATMENT|2020-12-12|10
e|SS|2216086b-197e-4780-8e10-28123eb090c5|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|1|TREATMENT|2020-12-27|25
e|SS|2216086b-197e-4780-8e10-28123eb090c5|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|1|FOLLOW-UP|2020-12-27|25
e|SS|2216086b-197e-4780-8e10-28123eb090c5|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|2|WASHOUT|2021-01-11|40
e|SS|2216086b-197e-4780-8e10-28123eb090c5|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|4|FOLLOW-UP|2021-01-11|40
e|SS|2216086b-197e-4780-8e10-28123eb090c5|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|5|TREATMENT|2021-02-05|65
e|SS|2216086b-197e-4780-8e10-28123eb090c5|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|2|TREATMENT|2021-02-05|65
e|SS|2216086b-197e-4780-8e10-28123eb090c5|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|4|WASHOUT|2021-03-02|90
e|SS|2216086b-197e-4780-8e10-28123eb090c5|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|4|TREATMENT|2021-03-02|90
e|SS|7280f69c-a0f4-48b5-b714-1e272193168c|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|7|FOLLOW-UP|2020-08-19|10
e|SS|7280f69c-a0f4-48b5-b714-1e272193168c|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|TREATMENT|2020-08-19|10
e|SS|7280f69c-a0f4-48b5-b714-1e272193168c|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|2|Visit_2|25|1|WASHOUT|2020-09-03|25
e|SS|7280f69c-a0f4-48b5-b714-1e272193168c|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|7|TREATMENT|2020-09-03|25
e|SS|7280f69c-a0f4-48b5-b714-1e272193168c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|2|TREATMENT|2020-09-18|40
e|SS|7280f69c-a0f4-48b5-b714-1e272193168c|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|4|FOLLOW-UP|2020-09-18|40
e|SS|7280f69c-a0f4-48b5-b714-1e272193168c|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|1|SCREENING|2020-10-13|65
e|SS|7280f69c-a0f4-48b5-b714-1e272193168c|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|5|TREATMENT|2020-10-13|65
e|SS|7280f69c-a0f4-48b5-b714-1e272193168c|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|WASHOUT|2020-11-07|90
e|SS|7280f69c-a0f4-48b5-b714-1e272193168c|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|6|WASHOUT|2020-11-07|90
e|SS|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|1|WASHOUT|2020-08-01|10
e|SS|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|5|SCREENING|2020-08-01|10
e|SS|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|1|TREATMENT|2020-08-16|25
e|SS|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|4|TREATMENT|2020-08-16|25
e|SS|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|3|WASHOUT|2020-08-31|40
e|SS|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|5|SCREENING|2020-08-31|40
e|SS|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|4|WASHOUT|2020-09-25|65
e|SS|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|4|Visit_4|65|4|FOLLOW-UP|2020-09-25|65
e|SS|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|1|TREATMENT|2020-10-20|90
e|SS|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|5|WASHOUT|2020-10-20|90
e|SS|25c6812b-9200-4dc4-a954-6879183a2c54|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|7|TREATMENT|2020-12-24|10
e|SS|25c6812b-9200-4dc4-a954-6879183a2c54|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|7|SCREENING|2020-12-24|10
e|SS|25c6812b-9200-4dc4-a954-6879183a2c54|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|3|SCREENING|2021-01-08|25
e|SS|25c6812b-9200-4dc4-a954-6879183a2c54|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|6|TREATMENT|2021-01-08|25
e|SS|25c6812b-9200-4dc4-a954-6879183a2c54|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|3|WASHOUT|2021-01-23|40
e|SS|25c6812b-9200-4dc4-a954-6879183a2c54|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|1|SCREENING|2021-01-23|40
e|SS|25c6812b-9200-4dc4-a954-6879183a2c54|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|6|TREATMENT|2021-02-17|65
e|SS|25c6812b-9200-4dc4-a954-6879183a2c54|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|6|FOLLOW-UP|2021-02-17|65
e|SS|25c6812b-9200-4dc4-a954-6879183a2c54|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|2|WASHOUT|2021-03-14|90
e|SS|25c6812b-9200-4dc4-a954-6879183a2c54|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|2|TREATMENT|2021-03-14|90
e|SS|10dca475-f364-42f3-9192-faf762832adf|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|6|WASHOUT|2020-09-25|10
e|SS|10dca475-f364-42f3-9192-faf762832adf|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|SCREENING|2020-09-25|10
e|SS|10dca475-f364-42f3-9192-faf762832adf|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|3|TREATMENT|2020-10-10|25
e|SS|10dca475-f364-42f3-9192-faf762832adf|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|5|WASHOUT|2020-10-10|25
e|SS|10dca475-f364-42f3-9192-faf762832adf|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|4|SCREENING|2020-10-25|40
e|SS|10dca475-f364-42f3-9192-faf762832adf|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|1|FOLLOW-UP|2020-10-25|40
e|SS|10dca475-f364-42f3-9192-faf762832adf|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|4|Visit_4|65|5|TREATMENT|2020-11-19|65
e|SS|10dca475-f364-42f3-9192-faf762832adf|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|5|WASHOUT|2020-11-19|65
e|SS|10dca475-f364-42f3-9192-faf762832adf|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|1|TREATMENT|2020-12-14|90
e|SS|10dca475-f364-42f3-9192-faf762832adf|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|SCREENING|2020-12-14|90
e|SS|caf54095-56c3-428f-8342-ce45c6c9a287|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|FOLLOW-UP|2020-12-20|10
e|SS|caf54095-56c3-428f-8342-ce45c6c9a287|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|1|SCREENING|2020-12-20|10
e|SS|caf54095-56c3-428f-8342-ce45c6c9a287|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|1|TREATMENT|2021-01-04|25
e|SS|caf54095-56c3-428f-8342-ce45c6c9a287|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|2|Visit_2|25|4|WASHOUT|2021-01-04|25
e|SS|caf54095-56c3-428f-8342-ce45c6c9a287|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|7|SCREENING|2021-01-19|40
e|SS|caf54095-56c3-428f-8342-ce45c6c9a287|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|4|TREATMENT|2021-01-19|40
e|SS|caf54095-56c3-428f-8342-ce45c6c9a287|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|4|SCREENING|2021-02-13|65
e|SS|caf54095-56c3-428f-8342-ce45c6c9a287|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|4|TREATMENT|2021-02-13|65
e|SS|caf54095-56c3-428f-8342-ce45c6c9a287|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|5|Visit_5|90|3|SCREENING|2021-03-10|90
e|SS|caf54095-56c3-428f-8342-ce45c6c9a287|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|3|TREATMENT|2021-03-10|90
e|SS|f833ca56-d426-420b-a6d3-fedeabc02734|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|5|WASHOUT|2020-06-20|10
e|SS|f833ca56-d426-420b-a6d3-fedeabc02734|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|6|FOLLOW-UP|2020-06-20|10
e|SS|f833ca56-d426-420b-a6d3-fedeabc02734|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|6|TREATMENT|2020-07-05|25
e|SS|f833ca56-d426-420b-a6d3-fedeabc02734|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|3|TREATMENT|2020-07-05|25
e|SS|f833ca56-d426-420b-a6d3-fedeabc02734|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|3|TREATMENT|2020-07-20|40
e|SS|f833ca56-d426-420b-a6d3-fedeabc02734|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|3|SCREENING|2020-07-20|40
e|SS|f833ca56-d426-420b-a6d3-fedeabc02734|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|TREATMENT|2020-08-14|65
e|SS|f833ca56-d426-420b-a6d3-fedeabc02734|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|TREATMENT|2020-08-14|65
e|SS|f833ca56-d426-420b-a6d3-fedeabc02734|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|4|TREATMENT|2020-09-08|90
e|SS|f833ca56-d426-420b-a6d3-fedeabc02734|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|1|SCREENING|2020-09-08|90
e|SS|03c8e2c7-b70d-4d46-8064-c99370eab232|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|5|TREATMENT|2020-11-29|10
e|SS|03c8e2c7-b70d-4d46-8064-c99370eab232|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|2|SCREENING|2020-11-29|10
e|SS|03c8e2c7-b70d-4d46-8064-c99370eab232|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|5|TREATMENT|2020-12-14|25
e|SS|03c8e2c7-b70d-4d46-8064-c99370eab232|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|6|TREATMENT|2020-12-14|25
e|SS|03c8e2c7-b70d-4d46-8064-c99370eab232|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|7|WASHOUT|2020-12-29|40
e|SS|03c8e2c7-b70d-4d46-8064-c99370eab232|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|6|WASHOUT|2020-12-29|40
e|SS|03c8e2c7-b70d-4d46-8064-c99370eab232|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|3|TREATMENT|2021-01-23|65
e|SS|03c8e2c7-b70d-4d46-8064-c99370eab232|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|5|TREATMENT|2021-01-23|65
e|SS|03c8e2c7-b70d-4d46-8064-c99370eab232|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|7|WASHOUT|2021-02-17|90
e|SS|03c8e2c7-b70d-4d46-8064-c99370eab232|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|5|TREATMENT|2021-02-17|90
e|SS|944617c7-c5e6-4e06-b114-499c3020dbbd|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|6|SCREENING|2020-10-22|10
e|SS|944617c7-c5e6-4e06-b114-499c3020dbbd|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|7|TREATMENT|2020-10-22|10
e|SS|944617c7-c5e6-4e06-b114-499c3020dbbd|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|3|TREATMENT|2020-11-06|25
e|SS|944617c7-c5e6-4e06-b114-499c3020dbbd|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|1|TREATMENT|2020-11-06|25
e|SS|944617c7-c5e6-4e06-b114-499c3020dbbd|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|3|TREATMENT|2020-11-21|40
e|SS|944617c7-c5e6-4e06-b114-499c3020dbbd|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|7|FOLLOW-UP|2020-11-21|40
e|SS|944617c7-c5e6-4e06-b114-499c3020dbbd|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|5|TREATMENT|2020-12-16|65
e|SS|944617c7-c5e6-4e06-b114-499c3020dbbd|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|FOLLOW-UP|2020-12-16|65
e|SS|944617c7-c5e6-4e06-b114-499c3020dbbd|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|7|TREATMENT|2021-01-10|90
e|SS|944617c7-c5e6-4e06-b114-499c3020dbbd|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|6|FOLLOW-UP|2021-01-10|90
e|SS|e4878c66-1e2b-49bb-838e-85139d160dd4|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|6|WASHOUT|2020-10-21|10
e|SS|e4878c66-1e2b-49bb-838e-85139d160dd4|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|6|SCREENING|2020-10-21|10
e|SS|e4878c66-1e2b-49bb-838e-85139d160dd4|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|2|Visit_2|25|7|TREATMENT|2020-11-05|25
e|SS|e4878c66-1e2b-49bb-838e-85139d160dd4|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|5|TREATMENT|2020-11-05|25
e|SS|e4878c66-1e2b-49bb-838e-85139d160dd4|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|5|WASHOUT|2020-11-20|40
e|SS|e4878c66-1e2b-49bb-838e-85139d160dd4|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|2|WASHOUT|2020-11-20|40
e|SS|e4878c66-1e2b-49bb-838e-85139d160dd4|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|5|TREATMENT|2020-12-15|65
e|SS|e4878c66-1e2b-49bb-838e-85139d160dd4|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|7|TREATMENT|2020-12-15|65
e|SS|e4878c66-1e2b-49bb-838e-85139d160dd4|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|5|TREATMENT|2021-01-09|90
e|SS|e4878c66-1e2b-49bb-838e-85139d160dd4|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|7|TREATMENT|2021-01-09|90
e|SS|6873e227-baef-4d6e-8600-0bb61d60fe49|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|5|WASHOUT|2020-06-06|10
e|SS|6873e227-baef-4d6e-8600-0bb61d60fe49|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|7|TREATMENT|2020-06-06|10
e|SS|6873e227-baef-4d6e-8600-0bb61d60fe49|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|2|Visit_2|25|1|TREATMENT|2020-06-21|25
e|SS|6873e227-baef-4d6e-8600-0bb61d60fe49|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|4|TREATMENT|2020-06-21|25
e|SS|6873e227-baef-4d6e-8600-0bb61d60fe49|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|6|SCREENING|2020-07-06|40
e|SS|6873e227-baef-4d6e-8600-0bb61d60fe49|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|4|TREATMENT|2020-07-06|40
e|SS|6873e227-baef-4d6e-8600-0bb61d60fe49|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|3|TREATMENT|2020-07-31|65
e|SS|6873e227-baef-4d6e-8600-0bb61d60fe49|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|2|WASHOUT|2020-07-31|65
e|SS|6873e227-baef-4d6e-8600-0bb61d60fe49|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|1|FOLLOW-UP|2020-08-25|90
e|SS|6873e227-baef-4d6e-8600-0bb61d60fe49|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|5|TREATMENT|2020-08-25|90
e|SS|bad01879-9b97-4d9c-9eec-58871168bd57|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|2|TREATMENT|2020-10-15|10
e|SS|bad01879-9b97-4d9c-9eec-58871168bd57|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|6|TREATMENT|2020-10-15|10
e|SS|bad01879-9b97-4d9c-9eec-58871168bd57|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|7|FOLLOW-UP|2020-10-30|25
e|SS|bad01879-9b97-4d9c-9eec-58871168bd57|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|7|TREATMENT|2020-10-30|25
e|SS|bad01879-9b97-4d9c-9eec-58871168bd57|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|2|TREATMENT|2020-11-14|40
e|SS|bad01879-9b97-4d9c-9eec-58871168bd57|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|3|TREATMENT|2020-11-14|40
e|SS|bad01879-9b97-4d9c-9eec-58871168bd57|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|2|TREATMENT|2020-12-09|65
e|SS|bad01879-9b97-4d9c-9eec-58871168bd57|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|7|SCREENING|2020-12-09|65
e|SS|bad01879-9b97-4d9c-9eec-58871168bd57|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|5|Visit_5|90|3|SCREENING|2021-01-03|90
e|SS|bad01879-9b97-4d9c-9eec-58871168bd57|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|3|TREATMENT|2021-01-03|90
e|SS|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|3|SCREENING|2020-11-05|10
e|SS|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|1|Visit_1|10|3|TREATMENT|2020-11-05|10
e|SS|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|5|TREATMENT|2020-11-20|25
e|SS|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|7|FOLLOW-UP|2020-11-20|25
e|SS|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|4|TREATMENT|2020-12-05|40
e|SS|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|4|SCREENING|2020-12-05|40
e|SS|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|4|TREATMENT|2020-12-30|65
e|SS|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|TREATMENT|2020-12-30|65
e|SS|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|3|SCREENING|2021-01-24|90
e|SS|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|3|TREATMENT|2021-01-24|90
e|SS|0df77775-6e65-4f77-9f8f-7faaa1471141|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|7|WASHOUT|2020-08-24|10
e|SS|0df77775-6e65-4f77-9f8f-7faaa1471141|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|4|TREATMENT|2020-08-24|10
e|SS|0df77775-6e65-4f77-9f8f-7faaa1471141|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|6|TREATMENT|2020-09-08|25
e|SS|0df77775-6e65-4f77-9f8f-7faaa1471141|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|5|TREATMENT|2020-09-08|25
e|SS|0df77775-6e65-4f77-9f8f-7faaa1471141|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|3|WASHOUT|2020-09-23|40
e|SS|0df77775-6e65-4f77-9f8f-7faaa1471141|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|3|TREATMENT|2020-09-23|40
e|SS|0df77775-6e65-4f77-9f8f-7faaa1471141|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|4|WASHOUT|2020-10-18|65
e|SS|0df77775-6e65-4f77-9f8f-7faaa1471141|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|5|WASHOUT|2020-10-18|65
e|SS|0df77775-6e65-4f77-9f8f-7faaa1471141|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|6|TREATMENT|2020-11-12|90
e|SS|0df77775-6e65-4f77-9f8f-7faaa1471141|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|5|SCREENING|2020-11-12|90
e|SS|adc5359a-f1d5-428b-97d8-fce67cfeeaea|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|6|TREATMENT|2020-08-22|10
e|SS|adc5359a-f1d5-428b-97d8-fce67cfeeaea|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|4|SCREENING|2020-08-22|10
e|SS|adc5359a-f1d5-428b-97d8-fce67cfeeaea|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|7|SCREENING|2020-09-06|25
e|SS|adc5359a-f1d5-428b-97d8-fce67cfeeaea|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|FOLLOW-UP|2020-09-06|25
e|SS|adc5359a-f1d5-428b-97d8-fce67cfeeaea|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|TREATMENT|2020-09-21|40
e|SS|adc5359a-f1d5-428b-97d8-fce67cfeeaea|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|4|SCREENING|2020-09-21|40
e|SS|adc5359a-f1d5-428b-97d8-fce67cfeeaea|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|4|Visit_4|65|1|TREATMENT|2020-10-16|65
e|SS|adc5359a-f1d5-428b-97d8-fce67cfeeaea|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|7|FOLLOW-UP|2020-10-16|65
e|SS|adc5359a-f1d5-428b-97d8-fce67cfeeaea|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|1|TREATMENT|2020-11-10|90
e|SS|adc5359a-f1d5-428b-97d8-fce67cfeeaea|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|5|TREATMENT|2020-11-10|90
e|SS|cd68296c-95d4-489e-8b64-b2404f16316c|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|6|FOLLOW-UP|2020-12-20|10
e|SS|cd68296c-95d4-489e-8b64-b2404f16316c|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|2|TREATMENT|2020-12-20|10
e|SS|cd68296c-95d4-489e-8b64-b2404f16316c|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|FOLLOW-UP|2021-01-04|25
e|SS|cd68296c-95d4-489e-8b64-b2404f16316c|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|1|WASHOUT|2021-01-04|25
e|SS|cd68296c-95d4-489e-8b64-b2404f16316c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|3|Visit_3|40|5|FOLLOW-UP|2021-01-19|40
e|SS|cd68296c-95d4-489e-8b64-b2404f16316c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|FOLLOW-UP|2021-01-19|40
e|SS|cd68296c-95d4-489e-8b64-b2404f16316c|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|3|TREATMENT|2021-02-13|65
e|SS|cd68296c-95d4-489e-8b64-b2404f16316c|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|6|WASHOUT|2021-02-13|65
e|SS|cd68296c-95d4-489e-8b64-b2404f16316c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|7|TREATMENT|2021-03-10|90
e|SS|cd68296c-95d4-489e-8b64-b2404f16316c|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|FOLLOW-UP|2021-03-10|90
e|SS|fe137506-d1ce-4b08-a043-9366d86c421e|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|5|WASHOUT|2020-07-03|10
e|SS|fe137506-d1ce-4b08-a043-9366d86c421e|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|7|WASHOUT|2020-07-03|10
e|SS|fe137506-d1ce-4b08-a043-9366d86c421e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|2|Visit_2|25|1|TREATMENT|2020-07-18|25
e|SS|fe137506-d1ce-4b08-a043-9366d86c421e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|7|TREATMENT|2020-07-18|25
e|SS|fe137506-d1ce-4b08-a043-9366d86c421e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|3|TREATMENT|2020-08-02|40
e|SS|fe137506-d1ce-4b08-a043-9366d86c421e|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|1|FOLLOW-UP|2020-08-02|40
e|SS|fe137506-d1ce-4b08-a043-9366d86c421e|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|2|TREATMENT|2020-08-27|65
e|SS|fe137506-d1ce-4b08-a043-9366d86c421e|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|7|TREATMENT|2020-08-27|65
e|SS|fe137506-d1ce-4b08-a043-9366d86c421e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|6|TREATMENT|2020-09-21|90
e|SS|fe137506-d1ce-4b08-a043-9366d86c421e|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2020-09-21|90
e|SS|b112c524-42c8-4e9e-8699-209e739972a7|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|1|Visit_1|10|4|SCREENING|2021-01-03|10
e|SS|b112c524-42c8-4e9e-8699-209e739972a7|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|4|TREATMENT|2021-01-03|10
e|SS|b112c524-42c8-4e9e-8699-209e739972a7|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|4|WASHOUT|2021-01-18|25
e|SS|b112c524-42c8-4e9e-8699-209e739972a7|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|2|WASHOUT|2021-01-18|25
e|SS|b112c524-42c8-4e9e-8699-209e739972a7|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|5|TREATMENT|2021-02-02|40
e|SS|b112c524-42c8-4e9e-8699-209e739972a7|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|5|FOLLOW-UP|2021-02-02|40
e|SS|b112c524-42c8-4e9e-8699-209e739972a7|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|3|TREATMENT|2021-02-27|65
e|SS|b112c524-42c8-4e9e-8699-209e739972a7|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|3|WASHOUT|2021-02-27|65
e|SS|b112c524-42c8-4e9e-8699-209e739972a7|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|6|TREATMENT|2021-03-24|90
e|SS|b112c524-42c8-4e9e-8699-209e739972a7|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|3|SCREENING|2021-03-24|90
e|SS|e6e32df8-8b66-49a5-a626-fd385297dd6f|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|5|TREATMENT|2020-09-02|10
e|SS|e6e32df8-8b66-49a5-a626-fd385297dd6f|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|7|FOLLOW-UP|2020-09-02|10
e|SS|e6e32df8-8b66-49a5-a626-fd385297dd6f|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|7|WASHOUT|2020-09-17|25
e|SS|e6e32df8-8b66-49a5-a626-fd385297dd6f|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|3|TREATMENT|2020-09-17|25
e|SS|e6e32df8-8b66-49a5-a626-fd385297dd6f|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|2|TREATMENT|2020-10-02|40
e|SS|e6e32df8-8b66-49a5-a626-fd385297dd6f|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|7|SCREENING|2020-10-02|40
e|SS|e6e32df8-8b66-49a5-a626-fd385297dd6f|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|7|TREATMENT|2020-10-27|65
e|SS|e6e32df8-8b66-49a5-a626-fd385297dd6f|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|4|SCREENING|2020-10-27|65
e|SS|e6e32df8-8b66-49a5-a626-fd385297dd6f|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|7|SCREENING|2020-11-21|90
e|SS|e6e32df8-8b66-49a5-a626-fd385297dd6f|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|3|TREATMENT|2020-11-21|90
e|SS|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|3|TREATMENT|2020-09-18|10
e|SS|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|FOLLOW-UP|2020-09-18|10
e|SS|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|3|TREATMENT|2020-10-03|25
e|SS|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|FOLLOW-UP|2020-10-03|25
e|SS|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|SCREENING|2020-10-18|40
e|SS|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|6|TREATMENT|2020-10-18|40
e|SS|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|2|WASHOUT|2020-11-12|65
e|SS|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|1|TREATMENT|2020-11-12|65
e|SS|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|4|WASHOUT|2020-12-07|90
e|SS|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|FOLLOW-UP|2020-12-07|90
e|SS|5002de57-45df-4525-a6b7-b6cc33c22229|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|4|TREATMENT|2021-01-12|10
e|SS|5002de57-45df-4525-a6b7-b6cc33c22229|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|6|SCREENING|2021-01-12|10
e|SS|5002de57-45df-4525-a6b7-b6cc33c22229|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|3|FOLLOW-UP|2021-01-27|25
e|SS|5002de57-45df-4525-a6b7-b6cc33c22229|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|6|TREATMENT|2021-01-27|25
e|SS|5002de57-45df-4525-a6b7-b6cc33c22229|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|1|TREATMENT|2021-02-11|40
e|SS|5002de57-45df-4525-a6b7-b6cc33c22229|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|4|TREATMENT|2021-02-11|40
e|SS|5002de57-45df-4525-a6b7-b6cc33c22229|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|3|TREATMENT|2021-03-08|65
e|SS|5002de57-45df-4525-a6b7-b6cc33c22229|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|5|TREATMENT|2021-03-08|65
e|SS|5002de57-45df-4525-a6b7-b6cc33c22229|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|7|FOLLOW-UP|2021-04-02|90
e|SS|5002de57-45df-4525-a6b7-b6cc33c22229|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|4|SCREENING|2021-04-02|90
e|SS|298f2081-bb11-4856-9e88-4be3b9b2250d|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|1|Visit_1|10|1|TREATMENT|2020-10-05|10
e|SS|298f2081-bb11-4856-9e88-4be3b9b2250d|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|1|Visit_1|10|4|TREATMENT|2020-10-05|10
e|SS|298f2081-bb11-4856-9e88-4be3b9b2250d|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|1|TREATMENT|2020-10-20|25
e|SS|298f2081-bb11-4856-9e88-4be3b9b2250d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|2|FOLLOW-UP|2020-10-20|25
e|SS|298f2081-bb11-4856-9e88-4be3b9b2250d|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|1|FOLLOW-UP|2020-11-04|40
e|SS|298f2081-bb11-4856-9e88-4be3b9b2250d|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|3|TREATMENT|2020-11-04|40
e|SS|298f2081-bb11-4856-9e88-4be3b9b2250d|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|6|SCREENING|2020-11-29|65
e|SS|298f2081-bb11-4856-9e88-4be3b9b2250d|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|3|TREATMENT|2020-11-29|65
e|SS|298f2081-bb11-4856-9e88-4be3b9b2250d|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|6|TREATMENT|2020-12-24|90
e|SS|298f2081-bb11-4856-9e88-4be3b9b2250d|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|2|TREATMENT|2020-12-24|90
e|SS|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|5|WASHOUT|2020-12-29|10
e|SS|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|4|TREATMENT|2020-12-29|10
e|SS|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|1|TREATMENT|2021-01-13|25
e|SS|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|1|WASHOUT|2021-01-13|25
e|SS|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|1|WASHOUT|2021-01-28|40
e|SS|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|WASHOUT|2021-01-28|40
e|SS|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|7|TREATMENT|2021-02-22|65
e|SS|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|2|TREATMENT|2021-02-22|65
e|SS|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|3|TREATMENT|2021-03-19|90
e|SS|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|7|TREATMENT|2021-03-19|90
e|SS|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|6|WASHOUT|2020-05-12|10
e|SS|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|5|TREATMENT|2020-05-12|10
e|SS|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|3|FOLLOW-UP|2020-05-27|25
e|SS|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|4|WASHOUT|2020-05-27|25
e|SS|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|1|WASHOUT|2020-06-11|40
e|SS|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|1|TREATMENT|2020-06-11|40
e|SS|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|TREATMENT|2020-07-06|65
e|SS|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|5|FOLLOW-UP|2020-07-06|65
e|SS|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|TREATMENT|2020-07-31|90
e|SS|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|1|TREATMENT|2020-07-31|90
e|SS|18c21176-db5e-4650-a1af-beb2042c31d8|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|4|WASHOUT|2020-08-30|10
e|SS|18c21176-db5e-4650-a1af-beb2042c31d8|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|6|TREATMENT|2020-08-30|10
e|SS|18c21176-db5e-4650-a1af-beb2042c31d8|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|5|TREATMENT|2020-09-14|25
e|SS|18c21176-db5e-4650-a1af-beb2042c31d8|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|2|Visit_2|25|6|SCREENING|2020-09-14|25
e|SS|18c21176-db5e-4650-a1af-beb2042c31d8|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|4|TREATMENT|2020-09-29|40
e|SS|18c21176-db5e-4650-a1af-beb2042c31d8|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|7|TREATMENT|2020-09-29|40
e|SS|18c21176-db5e-4650-a1af-beb2042c31d8|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|7|WASHOUT|2020-10-24|65
e|SS|18c21176-db5e-4650-a1af-beb2042c31d8|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|4|Visit_4|65|5|WASHOUT|2020-10-24|65
e|SS|18c21176-db5e-4650-a1af-beb2042c31d8|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|7|WASHOUT|2020-11-18|90
e|SS|18c21176-db5e-4650-a1af-beb2042c31d8|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|5|Visit_5|90|1|TREATMENT|2020-11-18|90
e|SS|7808abd1-7d6f-4090-aa08-916a804c95f5|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|4|WASHOUT|2020-06-20|10
e|SS|7808abd1-7d6f-4090-aa08-916a804c95f5|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|1|TREATMENT|2020-06-20|10
e|SS|7808abd1-7d6f-4090-aa08-916a804c95f5|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|6|FOLLOW-UP|2020-07-05|25
e|SS|7808abd1-7d6f-4090-aa08-916a804c95f5|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-07-05|25
e|SS|7808abd1-7d6f-4090-aa08-916a804c95f5|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|2|TREATMENT|2020-07-20|40
e|SS|7808abd1-7d6f-4090-aa08-916a804c95f5|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|3|Visit_3|40|7|TREATMENT|2020-07-20|40
e|SS|7808abd1-7d6f-4090-aa08-916a804c95f5|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|2|FOLLOW-UP|2020-08-14|65
e|SS|7808abd1-7d6f-4090-aa08-916a804c95f5|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|4|SCREENING|2020-08-14|65
e|SS|7808abd1-7d6f-4090-aa08-916a804c95f5|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|1|SCREENING|2020-09-08|90
e|SS|7808abd1-7d6f-4090-aa08-916a804c95f5|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|5|Visit_5|90|2|TREATMENT|2020-09-08|90
e|SS|57553b78-e761-4577-aae2-5c693a2dc303|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|3|FOLLOW-UP|2021-01-01|10
e|SS|57553b78-e761-4577-aae2-5c693a2dc303|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|3|WASHOUT|2021-01-01|10
e|SS|57553b78-e761-4577-aae2-5c693a2dc303|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|4|FOLLOW-UP|2021-01-16|25
e|SS|57553b78-e761-4577-aae2-5c693a2dc303|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|1|SCREENING|2021-01-16|25
e|SS|57553b78-e761-4577-aae2-5c693a2dc303|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|5|WASHOUT|2021-01-31|40
e|SS|57553b78-e761-4577-aae2-5c693a2dc303|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|3|Visit_3|40|6|FOLLOW-UP|2021-01-31|40
e|SS|57553b78-e761-4577-aae2-5c693a2dc303|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|3|TREATMENT|2021-02-25|65
e|SS|57553b78-e761-4577-aae2-5c693a2dc303|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|1|TREATMENT|2021-02-25|65
e|SS|57553b78-e761-4577-aae2-5c693a2dc303|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|6|TREATMENT|2021-03-22|90
e|SS|57553b78-e761-4577-aae2-5c693a2dc303|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|7|TREATMENT|2021-03-22|90
e|SS|40883550-4627-4f92-974a-7eeb5bde74c5|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|4|TREATMENT|2020-10-13|10
e|SS|40883550-4627-4f92-974a-7eeb5bde74c5|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|2|WASHOUT|2020-10-13|10
e|SS|40883550-4627-4f92-974a-7eeb5bde74c5|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|2|Visit_2|25|7|TREATMENT|2020-10-28|25
e|SS|40883550-4627-4f92-974a-7eeb5bde74c5|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|2|Visit_2|25|5|WASHOUT|2020-10-28|25
e|SS|40883550-4627-4f92-974a-7eeb5bde74c5|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|6|TREATMENT|2020-11-12|40
e|SS|40883550-4627-4f92-974a-7eeb5bde74c5|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|3|WASHOUT|2020-11-12|40
e|SS|40883550-4627-4f92-974a-7eeb5bde74c5|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|4|FOLLOW-UP|2020-12-07|65
e|SS|40883550-4627-4f92-974a-7eeb5bde74c5|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|4|Visit_4|65|3|TREATMENT|2020-12-07|65
e|SS|40883550-4627-4f92-974a-7eeb5bde74c5|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|5|Visit_5|90|1|SCREENING|2021-01-01|90
e|SS|40883550-4627-4f92-974a-7eeb5bde74c5|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|WASHOUT|2021-01-01|90
e|SS|4199b549-d021-4bfd-97e6-95630d407183|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2020-12-02|10
e|SS|4199b549-d021-4bfd-97e6-95630d407183|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|1|Visit_1|10|1|WASHOUT|2020-12-02|10
e|SS|4199b549-d021-4bfd-97e6-95630d407183|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|2|Visit_2|25|1|SCREENING|2020-12-17|25
e|SS|4199b549-d021-4bfd-97e6-95630d407183|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|5|FOLLOW-UP|2020-12-17|25
e|SS|4199b549-d021-4bfd-97e6-95630d407183|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|3|Visit_3|40|1|TREATMENT|2021-01-01|40
e|SS|4199b549-d021-4bfd-97e6-95630d407183|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|3|FOLLOW-UP|2021-01-01|40
e|SS|4199b549-d021-4bfd-97e6-95630d407183|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|4|FOLLOW-UP|2021-01-26|65
e|SS|4199b549-d021-4bfd-97e6-95630d407183|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|6|WASHOUT|2021-01-26|65
e|SS|4199b549-d021-4bfd-97e6-95630d407183|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|5|Visit_5|90|6|SCREENING|2021-02-20|90
e|SS|4199b549-d021-4bfd-97e6-95630d407183|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|2|SCREENING|2021-02-20|90
e|SS|6366647f-62fa-48dc-9d77-1677fce62fc7|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|TREATMENT|2020-07-14|10
e|SS|6366647f-62fa-48dc-9d77-1677fce62fc7|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|4|FOLLOW-UP|2020-07-14|10
e|SS|6366647f-62fa-48dc-9d77-1677fce62fc7|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|1|WASHOUT|2020-07-29|25
e|SS|6366647f-62fa-48dc-9d77-1677fce62fc7|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|1|FOLLOW-UP|2020-07-29|25
e|SS|6366647f-62fa-48dc-9d77-1677fce62fc7|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|3|TREATMENT|2020-08-13|40
e|SS|6366647f-62fa-48dc-9d77-1677fce62fc7|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|3|Visit_3|40|3|SCREENING|2020-08-13|40
e|SS|6366647f-62fa-48dc-9d77-1677fce62fc7|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|2|SCREENING|2020-09-07|65
e|SS|6366647f-62fa-48dc-9d77-1677fce62fc7|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|4|TREATMENT|2020-09-07|65
e|SS|6366647f-62fa-48dc-9d77-1677fce62fc7|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|1|SCREENING|2020-10-02|90
e|SS|6366647f-62fa-48dc-9d77-1677fce62fc7|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|3|FOLLOW-UP|2020-10-02|90
e|SS|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|1|Visit_1|10|4|TREATMENT|2020-05-13|10
e|SS|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|FOLLOW-UP|2020-05-13|10
e|SS|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|6|TREATMENT|2020-05-28|25
e|SS|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|6|FOLLOW-UP|2020-05-28|25
e|SS|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|7|SCREENING|2020-06-12|40
e|SS|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|3|Visit_3|40|2|FOLLOW-UP|2020-06-12|40
e|SS|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|FOLLOW-UP|2020-07-07|65
e|SS|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|6|SCREENING|2020-07-07|65
e|SS|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|4|FOLLOW-UP|2020-08-01|90
e|SS|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|1|TREATMENT|2020-08-01|90
e|SS|637d7d5f-78d3-47fb-b6dc-d877d92b9001|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|2|SCREENING|2020-06-03|10
e|SS|637d7d5f-78d3-47fb-b6dc-d877d92b9001|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|1|TREATMENT|2020-06-03|10
e|SS|637d7d5f-78d3-47fb-b6dc-d877d92b9001|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|3|WASHOUT|2020-06-18|25
e|SS|637d7d5f-78d3-47fb-b6dc-d877d92b9001|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|1|TREATMENT|2020-06-18|25
e|SS|637d7d5f-78d3-47fb-b6dc-d877d92b9001|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|3|Visit_3|40|7|TREATMENT|2020-07-03|40
e|SS|637d7d5f-78d3-47fb-b6dc-d877d92b9001|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|1|SCREENING|2020-07-03|40
e|SS|637d7d5f-78d3-47fb-b6dc-d877d92b9001|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|4|Visit_4|65|6|TREATMENT|2020-07-28|65
e|SS|637d7d5f-78d3-47fb-b6dc-d877d92b9001|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|1|WASHOUT|2020-07-28|65
e|SS|637d7d5f-78d3-47fb-b6dc-d877d92b9001|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|7|TREATMENT|2020-08-22|90
e|SS|637d7d5f-78d3-47fb-b6dc-d877d92b9001|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|6|FOLLOW-UP|2020-08-22|90
e|SS|696cd04a-cde7-4481-b5e2-fad1877ec284|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|3|TREATMENT|2020-08-31|10
e|SS|696cd04a-cde7-4481-b5e2-fad1877ec284|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|4|TREATMENT|2020-08-31|10
e|SS|696cd04a-cde7-4481-b5e2-fad1877ec284|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|5|SCREENING|2020-09-15|25
e|SS|696cd04a-cde7-4481-b5e2-fad1877ec284|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|4|TREATMENT|2020-09-15|25
e|SS|696cd04a-cde7-4481-b5e2-fad1877ec284|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|1|TREATMENT|2020-09-30|40
e|SS|696cd04a-cde7-4481-b5e2-fad1877ec284|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|6|FOLLOW-UP|2020-09-30|40
e|SS|696cd04a-cde7-4481-b5e2-fad1877ec284|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|5|FOLLOW-UP|2020-10-25|65
e|SS|696cd04a-cde7-4481-b5e2-fad1877ec284|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|5|TREATMENT|2020-10-25|65
e|SS|696cd04a-cde7-4481-b5e2-fad1877ec284|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|3|WASHOUT|2020-11-19|90
e|SS|696cd04a-cde7-4481-b5e2-fad1877ec284|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|1|TREATMENT|2020-11-19|90
e|SS|ce4699cb-66f1-4c13-8428-84064255b765|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|5|TREATMENT|2020-12-02|10
e|SS|ce4699cb-66f1-4c13-8428-84064255b765|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|1|TREATMENT|2020-12-02|10
e|SS|ce4699cb-66f1-4c13-8428-84064255b765|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|7|TREATMENT|2020-12-17|25
e|SS|ce4699cb-66f1-4c13-8428-84064255b765|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|4|FOLLOW-UP|2020-12-17|25
e|SS|ce4699cb-66f1-4c13-8428-84064255b765|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|3|WASHOUT|2021-01-01|40
e|SS|ce4699cb-66f1-4c13-8428-84064255b765|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|2|TREATMENT|2021-01-01|40
e|SS|ce4699cb-66f1-4c13-8428-84064255b765|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|1|TREATMENT|2021-01-26|65
e|SS|ce4699cb-66f1-4c13-8428-84064255b765|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|3|SCREENING|2021-01-26|65
e|SS|ce4699cb-66f1-4c13-8428-84064255b765|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|5|TREATMENT|2021-02-20|90
e|SS|ce4699cb-66f1-4c13-8428-84064255b765|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|5|TREATMENT|2021-02-20|90
e|SS|015b391b-23c7-478d-b9d1-226d3cb9edcf|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|1|Visit_1|10|2|TREATMENT|2020-11-29|10
e|SS|015b391b-23c7-478d-b9d1-226d3cb9edcf|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|1|Visit_1|10|5|WASHOUT|2020-11-29|10
e|SS|015b391b-23c7-478d-b9d1-226d3cb9edcf|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|2|SCREENING|2020-12-14|25
e|SS|015b391b-23c7-478d-b9d1-226d3cb9edcf|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|2|Visit_2|25|1|TREATMENT|2020-12-14|25
e|SS|015b391b-23c7-478d-b9d1-226d3cb9edcf|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|3|WASHOUT|2020-12-29|40
e|SS|015b391b-23c7-478d-b9d1-226d3cb9edcf|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|3|SCREENING|2020-12-29|40
e|SS|015b391b-23c7-478d-b9d1-226d3cb9edcf|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|TREATMENT|2021-01-23|65
e|SS|015b391b-23c7-478d-b9d1-226d3cb9edcf|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|6|FOLLOW-UP|2021-01-23|65
e|SS|015b391b-23c7-478d-b9d1-226d3cb9edcf|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|5|Visit_5|90|4|FOLLOW-UP|2021-02-17|90
e|SS|015b391b-23c7-478d-b9d1-226d3cb9edcf|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|3|TREATMENT|2021-02-17|90
e|SS|b510a277-c5ee-4a32-b111-b2dbc72c8a27|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|4|SCREENING|2020-06-07|10
e|SS|b510a277-c5ee-4a32-b111-b2dbc72c8a27|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|5|WASHOUT|2020-06-07|10
e|SS|b510a277-c5ee-4a32-b111-b2dbc72c8a27|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|5|TREATMENT|2020-06-22|25
e|SS|b510a277-c5ee-4a32-b111-b2dbc72c8a27|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|5|TREATMENT|2020-06-22|25
e|SS|b510a277-c5ee-4a32-b111-b2dbc72c8a27|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|3|Visit_3|40|6|SCREENING|2020-07-07|40
e|SS|b510a277-c5ee-4a32-b111-b2dbc72c8a27|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|5|TREATMENT|2020-07-07|40
e|SS|b510a277-c5ee-4a32-b111-b2dbc72c8a27|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|3|TREATMENT|2020-08-01|65
e|SS|b510a277-c5ee-4a32-b111-b2dbc72c8a27|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|1|SCREENING|2020-08-01|65
e|SS|b510a277-c5ee-4a32-b111-b2dbc72c8a27|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|2|TREATMENT|2020-08-26|90
e|SS|b510a277-c5ee-4a32-b111-b2dbc72c8a27|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|3|TREATMENT|2020-08-26|90
e|SS|9e9acf6b-d29a-4c11-96d6-b580c721f462|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|6|TREATMENT|2020-08-20|10
e|SS|9e9acf6b-d29a-4c11-96d6-b580c721f462|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|3|TREATMENT|2020-08-20|10
e|SS|9e9acf6b-d29a-4c11-96d6-b580c721f462|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|5|TREATMENT|2020-09-04|25
e|SS|9e9acf6b-d29a-4c11-96d6-b580c721f462|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|6|FOLLOW-UP|2020-09-04|25
e|SS|9e9acf6b-d29a-4c11-96d6-b580c721f462|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|6|SCREENING|2020-09-19|40
e|SS|9e9acf6b-d29a-4c11-96d6-b580c721f462|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|5|WASHOUT|2020-09-19|40
e|SS|9e9acf6b-d29a-4c11-96d6-b580c721f462|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|3|WASHOUT|2020-10-14|65
e|SS|9e9acf6b-d29a-4c11-96d6-b580c721f462|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|4|Visit_4|65|3|SCREENING|2020-10-14|65
e|SS|9e9acf6b-d29a-4c11-96d6-b580c721f462|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|5|Visit_5|90|7|SCREENING|2020-11-08|90
e|SS|9e9acf6b-d29a-4c11-96d6-b580c721f462|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|6|TREATMENT|2020-11-08|90
e|SS|da69b157-7dab-49c5-b8fb-bd312a21fcf0|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|2|TREATMENT|2020-07-18|10
e|SS|da69b157-7dab-49c5-b8fb-bd312a21fcf0|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|5|FOLLOW-UP|2020-07-18|10
e|SS|da69b157-7dab-49c5-b8fb-bd312a21fcf0|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|2|Visit_2|25|1|TREATMENT|2020-08-02|25
e|SS|da69b157-7dab-49c5-b8fb-bd312a21fcf0|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|1|WASHOUT|2020-08-02|25
e|SS|da69b157-7dab-49c5-b8fb-bd312a21fcf0|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|3|TREATMENT|2020-08-17|40
e|SS|da69b157-7dab-49c5-b8fb-bd312a21fcf0|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|FOLLOW-UP|2020-08-17|40
e|SS|da69b157-7dab-49c5-b8fb-bd312a21fcf0|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|7|WASHOUT|2020-09-11|65
e|SS|da69b157-7dab-49c5-b8fb-bd312a21fcf0|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|2|TREATMENT|2020-09-11|65
e|SS|da69b157-7dab-49c5-b8fb-bd312a21fcf0|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|2|TREATMENT|2020-10-06|90
e|SS|da69b157-7dab-49c5-b8fb-bd312a21fcf0|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|3|FOLLOW-UP|2020-10-06|90
e|SS|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|3|WASHOUT|2020-05-29|10
e|SS|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|6|SCREENING|2020-05-29|10
e|SS|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|WASHOUT|2020-06-13|25
e|SS|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|FOLLOW-UP|2020-06-13|25
e|SS|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|FOLLOW-UP|2020-06-28|40
e|SS|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|4|SCREENING|2020-06-28|40
e|SS|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|2|TREATMENT|2020-07-23|65
e|SS|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|4|Visit_4|65|7|TREATMENT|2020-07-23|65
e|SS|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|2|FOLLOW-UP|2020-08-17|90
e|SS|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|5|FOLLOW-UP|2020-08-17|90
e|SS|77c97d1e-e223-4485-b2de-59daa4e5b01f|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|4|TREATMENT|2020-06-19|10
e|SS|77c97d1e-e223-4485-b2de-59daa4e5b01f|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|TREATMENT|2020-06-19|10
e|SS|77c97d1e-e223-4485-b2de-59daa4e5b01f|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|2|SCREENING|2020-07-04|25
e|SS|77c97d1e-e223-4485-b2de-59daa4e5b01f|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|FOLLOW-UP|2020-07-04|25
e|SS|77c97d1e-e223-4485-b2de-59daa4e5b01f|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|5|WASHOUT|2020-07-19|40
e|SS|77c97d1e-e223-4485-b2de-59daa4e5b01f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|3|Visit_3|40|4|TREATMENT|2020-07-19|40
e|SS|77c97d1e-e223-4485-b2de-59daa4e5b01f|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|4|Visit_4|65|2|TREATMENT|2020-08-13|65
e|SS|77c97d1e-e223-4485-b2de-59daa4e5b01f|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|4|Visit_4|65|5|TREATMENT|2020-08-13|65
e|SS|77c97d1e-e223-4485-b2de-59daa4e5b01f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|5|Visit_5|90|6|WASHOUT|2020-09-07|90
e|SS|77c97d1e-e223-4485-b2de-59daa4e5b01f|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|5|FOLLOW-UP|2020-09-07|90
e|SS|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|7|TREATMENT|2020-10-14|10
e|SS|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|7|TREATMENT|2020-10-14|10
e|SS|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|3|SCREENING|2020-10-29|25
e|SS|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|5|TREATMENT|2020-10-29|25
e|SS|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|3|TREATMENT|2020-11-13|40
e|SS|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|1|TREATMENT|2020-11-13|40
e|SS|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|5|WASHOUT|2020-12-08|65
e|SS|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|4|Visit_4|65|4|TREATMENT|2020-12-08|65
e|SS|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|2|TREATMENT|2021-01-02|90
e|SS|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|5|Visit_5|90|2|TREATMENT|2021-01-02|90
e|SS|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|5|TREATMENT|2020-11-01|10
e|SS|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|2|SCREENING|2020-11-01|10
e|SS|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|2|WASHOUT|2020-11-16|25
e|SS|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|2|Visit_2|25|2|TREATMENT|2020-11-16|25
e|SS|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|1|FOLLOW-UP|2020-12-01|40
e|SS|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|WASHOUT|2020-12-01|40
e|SS|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|1|SCREENING|2020-12-26|65
e|SS|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|1|WASHOUT|2020-12-26|65
e|SS|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|4|FOLLOW-UP|2021-01-20|90
e|SS|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|5|Visit_5|90|4|TREATMENT|2021-01-20|90
e|SS|9eb6e591-d266-4e05-85b6-230e8a02d494|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|1|Visit_1|10|5|TREATMENT|2020-06-28|10
e|SS|9eb6e591-d266-4e05-85b6-230e8a02d494|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|6|WASHOUT|2020-06-28|10
e|SS|9eb6e591-d266-4e05-85b6-230e8a02d494|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|2|WASHOUT|2020-07-13|25
e|SS|9eb6e591-d266-4e05-85b6-230e8a02d494|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|2|Visit_2|25|4|TREATMENT|2020-07-13|25
e|SS|9eb6e591-d266-4e05-85b6-230e8a02d494|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|2|SCREENING|2020-07-28|40
e|SS|9eb6e591-d266-4e05-85b6-230e8a02d494|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|1|TREATMENT|2020-07-28|40
e|SS|9eb6e591-d266-4e05-85b6-230e8a02d494|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|4|FOLLOW-UP|2020-08-22|65
e|SS|9eb6e591-d266-4e05-85b6-230e8a02d494|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|7|TREATMENT|2020-08-22|65
e|SS|9eb6e591-d266-4e05-85b6-230e8a02d494|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|5|Visit_5|90|6|TREATMENT|2020-09-16|90
e|SS|9eb6e591-d266-4e05-85b6-230e8a02d494|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|7|SCREENING|2020-09-16|90
e|SS|6a6e040d-6a09-4004-9fab-f4f82ba00eae|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|5|SCREENING|2020-06-30|10
e|SS|6a6e040d-6a09-4004-9fab-f4f82ba00eae|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|7|WASHOUT|2020-06-30|10
e|SS|6a6e040d-6a09-4004-9fab-f4f82ba00eae|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|6|WASHOUT|2020-07-15|25
e|SS|6a6e040d-6a09-4004-9fab-f4f82ba00eae|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|2|TREATMENT|2020-07-15|25
e|SS|6a6e040d-6a09-4004-9fab-f4f82ba00eae|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|3|Visit_3|40|7|SCREENING|2020-07-30|40
e|SS|6a6e040d-6a09-4004-9fab-f4f82ba00eae|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|2|SCREENING|2020-07-30|40
e|SS|6a6e040d-6a09-4004-9fab-f4f82ba00eae|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|5|TREATMENT|2020-08-24|65
e|SS|6a6e040d-6a09-4004-9fab-f4f82ba00eae|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|3|TREATMENT|2020-08-24|65
e|SS|6a6e040d-6a09-4004-9fab-f4f82ba00eae|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|6|TREATMENT|2020-09-18|90
e|SS|6a6e040d-6a09-4004-9fab-f4f82ba00eae|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|3|TREATMENT|2020-09-18|90
e|SS|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|7|SCREENING|2020-08-17|10
e|SS|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|1|SCREENING|2020-08-17|10
e|SS|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|SCREENING|2020-09-01|25
e|SS|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|7|TREATMENT|2020-09-01|25
e|SS|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|4|TREATMENT|2020-09-16|40
e|SS|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|6|FOLLOW-UP|2020-09-16|40
e|SS|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|4|Visit_4|65|4|TREATMENT|2020-10-11|65
e|SS|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|7|WASHOUT|2020-10-11|65
e|SS|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|1|TREATMENT|2020-11-05|90
e|SS|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|3|TREATMENT|2020-11-05|90
e|SS|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|1|TREATMENT|2021-01-19|10
e|SS|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|1|Visit_1|10|3|TREATMENT|2021-01-19|10
e|SS|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|4|TREATMENT|2021-02-03|25
e|SS|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|2|TREATMENT|2021-02-03|25
e|SS|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|3|TREATMENT|2021-02-18|40
e|SS|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|5|WASHOUT|2021-02-18|40
e|SS|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|5|SCREENING|2021-03-15|65
e|SS|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|2|TREATMENT|2021-03-15|65
e|SS|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|3|SCREENING|2021-04-09|90
e|SS|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|3|TREATMENT|2021-04-09|90
e|SS|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|1|Visit_1|10|6|TREATMENT|2020-05-12|10
e|SS|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|1|Visit_1|10|5|TREATMENT|2020-05-12|10
e|SS|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|2|Visit_2|25|6|SCREENING|2020-05-27|25
e|SS|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|2|Visit_2|25|3|WASHOUT|2020-05-27|25
e|SS|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|3|Visit_3|40|4|TREATMENT|2020-06-11|40
e|SS|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|3|Visit_3|40|1|TREATMENT|2020-06-11|40
e|SS|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|2|TREATMENT|2020-07-06|65
e|SS|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|4|Visit_4|65|5|TREATMENT|2020-07-06|65
e|SS|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|6|TREATMENT|2020-07-31|90
e|SS|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|5|Visit_5|90|1|TREATMENT|2020-07-31|90
e|SS|ba99022a-d398-4c60-828c-876f119459e1|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|5|SCREENING|2020-12-01|10
e|SS|ba99022a-d398-4c60-828c-876f119459e1|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|1|TREATMENT|2020-12-01|10
e|SS|ba99022a-d398-4c60-828c-876f119459e1|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|2|Visit_2|25|2|TREATMENT|2020-12-16|25
e|SS|ba99022a-d398-4c60-828c-876f119459e1|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|2|FOLLOW-UP|2020-12-16|25
e|SS|ba99022a-d398-4c60-828c-876f119459e1|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|3|Visit_3|40|3|TREATMENT|2020-12-31|40
e|SS|ba99022a-d398-4c60-828c-876f119459e1|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|3|Visit_3|40|5|FOLLOW-UP|2020-12-31|40
e|SS|ba99022a-d398-4c60-828c-876f119459e1|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|4|TREATMENT|2021-01-25|65
e|SS|ba99022a-d398-4c60-828c-876f119459e1|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|4|Visit_4|65|6|TREATMENT|2021-01-25|65
e|SS|ba99022a-d398-4c60-828c-876f119459e1|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|5|Visit_5|90|7|WASHOUT|2021-02-19|90
e|SS|ba99022a-d398-4c60-828c-876f119459e1|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|1|TREATMENT|2021-02-19|90
e|SS|d713869e-061c-4e95-8a50-da2e1ec47b3c|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|7|FOLLOW-UP|2020-06-06|10
e|SS|d713869e-061c-4e95-8a50-da2e1ec47b3c|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|2|TREATMENT|2020-06-06|10
e|SS|d713869e-061c-4e95-8a50-da2e1ec47b3c|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|5|TREATMENT|2020-06-21|25
e|SS|d713869e-061c-4e95-8a50-da2e1ec47b3c|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|2|Visit_2|25|2|TREATMENT|2020-06-21|25
e|SS|d713869e-061c-4e95-8a50-da2e1ec47b3c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|3|TREATMENT|2020-07-06|40
e|SS|d713869e-061c-4e95-8a50-da2e1ec47b3c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|3|TREATMENT|2020-07-06|40
e|SS|d713869e-061c-4e95-8a50-da2e1ec47b3c|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|5|TREATMENT|2020-07-31|65
e|SS|d713869e-061c-4e95-8a50-da2e1ec47b3c|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|4|Visit_4|65|3|WASHOUT|2020-07-31|65
e|SS|d713869e-061c-4e95-8a50-da2e1ec47b3c|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|5|Visit_5|90|7|TREATMENT|2020-08-25|90
e|SS|d713869e-061c-4e95-8a50-da2e1ec47b3c|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|3|TREATMENT|2020-08-25|90
e|SS|fcebb64c-e0e6-4f29-9c52-15fa91f60018|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|6|FOLLOW-UP|2020-07-11|10
e|SS|fcebb64c-e0e6-4f29-9c52-15fa91f60018|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|1|Visit_1|10|7|TREATMENT|2020-07-11|10
e|SS|fcebb64c-e0e6-4f29-9c52-15fa91f60018|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|2|TREATMENT|2020-07-26|25
e|SS|fcebb64c-e0e6-4f29-9c52-15fa91f60018|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|5|TREATMENT|2020-07-26|25
e|SS|fcebb64c-e0e6-4f29-9c52-15fa91f60018|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATION COMMITTEE|3|Visit_3|40|3|TREATMENT|2020-08-10|40
e|SS|fcebb64c-e0e6-4f29-9c52-15fa91f60018|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|3|Visit_3|40|5|TREATMENT|2020-08-10|40
e|SS|fcebb64c-e0e6-4f29-9c52-15fa91f60018|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|4|SCREENING|2020-09-04|65
e|SS|fcebb64c-e0e6-4f29-9c52-15fa91f60018|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|4|Visit_4|65|2|TREATMENT|2020-09-04|65
e|SS|fcebb64c-e0e6-4f29-9c52-15fa91f60018|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|5|Visit_5|90|4|TREATMENT|2020-09-29|90
e|SS|fcebb64c-e0e6-4f29-9c52-15fa91f60018|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|5|Visit_5|90|1|TREATMENT|2020-09-29|90
e|SS|e443f82e-43a8-4710-bff4-fd2b2f4d512f|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|1|TREATMENT|2021-01-01|10
e|SS|e443f82e-43a8-4710-bff4-fd2b2f4d512f|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|3|SCREENING|2021-01-01|10
e|SS|e443f82e-43a8-4710-bff4-fd2b2f4d512f|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FRIEND|2|Visit_2|25|7|FOLLOW-UP|2021-01-16|25
e|SS|e443f82e-43a8-4710-bff4-fd2b2f4d512f|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|2|Visit_2|25|3|TREATMENT|2021-01-16|25
e|SS|e443f82e-43a8-4710-bff4-fd2b2f4d512f|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|1|TREATMENT|2021-01-31|40
e|SS|e443f82e-43a8-4710-bff4-fd2b2f4d512f|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|TREATMENT|2021-01-31|40
e|SS|e443f82e-43a8-4710-bff4-fd2b2f4d512f|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|4|Visit_4|65|1|WASHOUT|2021-02-25|65
e|SS|e443f82e-43a8-4710-bff4-fd2b2f4d512f|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|TREATMENT|2021-02-25|65
e|SS|e443f82e-43a8-4710-bff4-fd2b2f4d512f|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|2|TREATMENT|2021-03-22|90
e|SS|e443f82e-43a8-4710-bff4-fd2b2f4d512f|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|5|Visit_5|90|6|FOLLOW-UP|2021-03-22|90
e|SS|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|1|Visit_1|10|2|TREATMENT|2020-06-22|10
e|SS|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|5|SCREENING|2020-06-22|10
e|SS|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|5|TREATMENT|2020-07-07|25
e|SS|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|2|Visit_2|25|5|TREATMENT|2020-07-07|25
e|SS|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|3|Visit_3|40|1|FOLLOW-UP|2020-07-22|40
e|SS|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|WASHOUT|2020-07-22|40
e|SS|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|2|TREATMENT|2020-08-16|65
e|SS|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|4|Visit_4|65|1|FOLLOW-UP|2020-08-16|65
e|SS|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|2|WASHOUT|2020-09-10|90
e|SS|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|7|FOLLOW-UP|2020-09-10|90
e|SS|8a2147b1-2deb-410e-a298-d028a5efc555|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|4|TREATMENT|2020-10-30|10
e|SS|8a2147b1-2deb-410e-a298-d028a5efc555|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|6|WASHOUT|2020-10-30|10
e|SS|8a2147b1-2deb-410e-a298-d028a5efc555|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|SCREENING|2020-11-14|25
e|SS|8a2147b1-2deb-410e-a298-d028a5efc555|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|7|TREATMENT|2020-11-14|25
e|SS|8a2147b1-2deb-410e-a298-d028a5efc555|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|5|SCREENING|2020-11-29|40
e|SS|8a2147b1-2deb-410e-a298-d028a5efc555|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|3|Visit_3|40|3|TREATMENT|2020-11-29|40
e|SS|8a2147b1-2deb-410e-a298-d028a5efc555|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|5|FOLLOW-UP|2020-12-24|65
e|SS|8a2147b1-2deb-410e-a298-d028a5efc555|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|4|Visit_4|65|6|TREATMENT|2020-12-24|65
e|SS|8a2147b1-2deb-410e-a298-d028a5efc555|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|7|TREATMENT|2021-01-18|90
e|SS|8a2147b1-2deb-410e-a298-d028a5efc555|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|5|Visit_5|90|6|FOLLOW-UP|2021-01-18|90
e|SS|033db3bf-17fb-4872-afdb-1eea3dac6d85|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|5|TREATMENT|2020-07-05|10
e|SS|033db3bf-17fb-4872-afdb-1eea3dac6d85|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|5|FOLLOW-UP|2020-07-05|10
e|SS|033db3bf-17fb-4872-afdb-1eea3dac6d85|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|2|Visit_2|25|6|TREATMENT|2020-07-20|25
e|SS|033db3bf-17fb-4872-afdb-1eea3dac6d85|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|TREATMENT|2020-07-20|25
e|SS|033db3bf-17fb-4872-afdb-1eea3dac6d85|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|2|TREATMENT|2020-08-04|40
e|SS|033db3bf-17fb-4872-afdb-1eea3dac6d85|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|2|FOLLOW-UP|2020-08-04|40
e|SS|033db3bf-17fb-4872-afdb-1eea3dac6d85|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|4|Visit_4|65|2|WASHOUT|2020-08-29|65
e|SS|033db3bf-17fb-4872-afdb-1eea3dac6d85|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|4|Visit_4|65|7|TREATMENT|2020-08-29|65
e|SS|033db3bf-17fb-4872-afdb-1eea3dac6d85|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|7|TREATMENT|2020-09-23|90
e|SS|033db3bf-17fb-4872-afdb-1eea3dac6d85|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|5|Visit_5|90|3|FOLLOW-UP|2020-09-23|90
e|SS|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|1|Visit_1|10|1|TREATMENT|2020-06-19|10
e|SS|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|1|Visit_1|10|2|WASHOUT|2020-06-19|10
e|SS|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|3|WASHOUT|2020-07-04|25
e|SS|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|5|TREATMENT|2020-07-04|25
e|SS|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|1|SCREENING|2020-07-19|40
e|SS|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|2|TREATMENT|2020-07-19|40
e|SS|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|4|TREATMENT|2020-08-13|65
e|SS|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|4|Visit_4|65|5|TREATMENT|2020-08-13|65
e|SS|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|5|Visit_5|90|5|SCREENING|2020-09-07|90
e|SS|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|5|FOLLOW-UP|2020-09-07|90
e|SS|8dd493b7-a892-4cab-8f69-701471c51d99|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|4|TREATMENT|2021-01-12|10
e|SS|8dd493b7-a892-4cab-8f69-701471c51d99|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|3|FOLLOW-UP|2021-01-12|10
e|SS|8dd493b7-a892-4cab-8f69-701471c51d99|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|6|TREATMENT|2021-01-27|25
e|SS|8dd493b7-a892-4cab-8f69-701471c51d99|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|2|Visit_2|25|7|TREATMENT|2021-01-27|25
e|SS|8dd493b7-a892-4cab-8f69-701471c51d99|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|7|SCREENING|2021-02-11|40
e|SS|8dd493b7-a892-4cab-8f69-701471c51d99|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|3|Visit_3|40|2|TREATMENT|2021-02-11|40
e|SS|8dd493b7-a892-4cab-8f69-701471c51d99|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|4|Visit_4|65|3|WASHOUT|2021-03-08|65
e|SS|8dd493b7-a892-4cab-8f69-701471c51d99|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|SCREENING|2021-03-08|65
e|SS|8dd493b7-a892-4cab-8f69-701471c51d99|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|3|FOLLOW-UP|2021-04-02|90
e|SS|8dd493b7-a892-4cab-8f69-701471c51d99|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|5|SCREENING|2021-04-02|90
e|SS|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|1|Visit_1|10|2|WASHOUT|2020-11-07|10
e|SS|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|3|TREATMENT|2020-11-07|10
e|SS|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|7|WASHOUT|2020-11-22|25
e|SS|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|2|Visit_2|25|2|FOLLOW-UP|2020-11-22|25
e|SS|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|3|Visit_3|40|4|WASHOUT|2020-12-07|40
e|SS|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|2|FOLLOW-UP|2020-12-07|40
e|SS|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|2|TREATMENT|2021-01-01|65
e|SS|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|2|SCREENING|2021-01-01|65
e|SS|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|7|TREATMENT|2021-01-26|90
e|SS|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|5|Visit_5|90|2|WASHOUT|2021-01-26|90
e|SS|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIBLING|1|Visit_1|10|7|SCREENING|2020-09-04|10
e|SS|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INTERVIEWER|1|Visit_1|10|3|FOLLOW-UP|2020-09-04|10
e|SS|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|2|TREATMENT|2020-09-19|25
e|SS|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|2|Visit_2|25|2|TREATMENT|2020-09-19|25
e|SS|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|3|TREATMENT|2020-10-04|40
e|SS|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|3|Visit_3|40|2|SCREENING|2020-10-04|40
e|SS|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|4|Visit_4|65|5|SCREENING|2020-10-29|65
e|SS|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|3|SCREENING|2020-10-29|65
e|SS|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|4|TREATMENT|2020-11-23|90
e|SS|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PARENT|5|Visit_5|90|5|TREATMENT|2020-11-23|90
e|SS|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATION COMMITTEE|1|Visit_1|10|1|WASHOUT|2020-11-20|10
e|SS|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|2|TREATMENT|2020-11-20|10
e|SS|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|2|SCREENING|2020-12-05|25
e|SS|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|2|TREATMENT|2020-12-05|25
e|SS|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|3|Visit_3|40|2|WASHOUT|2020-12-20|40
e|SS|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|3|Visit_3|40|3|SCREENING|2020-12-20|40
e|SS|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|4|Visit_4|65|2|TREATMENT|2021-01-14|65
e|SS|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|1|TREATMENT|2021-01-14|65
e|SS|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|5|Visit_5|90|1|FOLLOW-UP|2021-02-08|90
e|SS|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|TREATMENT|2021-02-08|90
e|SS|b49ef90c-a17e-4554-9fa6-af72b4d56a06|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|TREATMENT|2021-01-05|10
e|SS|b49ef90c-a17e-4554-9fa6-af72b4d56a06|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|6|WASHOUT|2021-01-05|10
e|SS|b49ef90c-a17e-4554-9fa6-af72b4d56a06|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|2|Visit_2|25|7|TREATMENT|2021-01-20|25
e|SS|b49ef90c-a17e-4554-9fa6-af72b4d56a06|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2021-01-20|25
e|SS|b49ef90c-a17e-4554-9fa6-af72b4d56a06|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|3|TREATMENT|2021-02-04|40
e|SS|b49ef90c-a17e-4554-9fa6-af72b4d56a06|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|3|Visit_3|40|2|SCREENING|2021-02-04|40
e|SS|b49ef90c-a17e-4554-9fa6-af72b4d56a06|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|WASHOUT|2021-03-01|65
e|SS|b49ef90c-a17e-4554-9fa6-af72b4d56a06|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|4|Visit_4|65|1|SCREENING|2021-03-01|65
e|SS|b49ef90c-a17e-4554-9fa6-af72b4d56a06|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|7|TREATMENT|2021-03-26|90
e|SS|b49ef90c-a17e-4554-9fa6-af72b4d56a06|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|3|WASHOUT|2021-03-26|90
e|SS|df041193-ee4e-4835-8db9-5be9b832ded0|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|4|WASHOUT|2020-11-25|10
e|SS|df041193-ee4e-4835-8db9-5be9b832ded0|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|2|TREATMENT|2020-11-25|10
e|SS|df041193-ee4e-4835-8db9-5be9b832ded0|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|2|Visit_2|25|7|WASHOUT|2020-12-10|25
e|SS|df041193-ee4e-4835-8db9-5be9b832ded0|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|7|TREATMENT|2020-12-10|25
e|SS|df041193-ee4e-4835-8db9-5be9b832ded0|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|3|Visit_3|40|6|TREATMENT|2020-12-25|40
e|SS|df041193-ee4e-4835-8db9-5be9b832ded0|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|1|SCREENING|2020-12-25|40
e|SS|df041193-ee4e-4835-8db9-5be9b832ded0|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|3|TREATMENT|2021-01-19|65
e|SS|df041193-ee4e-4835-8db9-5be9b832ded0|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|7|SCREENING|2021-01-19|65
e|SS|df041193-ee4e-4835-8db9-5be9b832ded0|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|5|Visit_5|90|2|TREATMENT|2021-02-13|90
e|SS|df041193-ee4e-4835-8db9-5be9b832ded0|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|5|Visit_5|90|1|TREATMENT|2021-02-13|90
e|SS|e41a4505-a5aa-4cac-895b-04fe85737ca9|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|1|Visit_1|10|6|TREATMENT|2021-01-13|10
e|SS|e41a4505-a5aa-4cac-895b-04fe85737ca9|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|1|Visit_1|10|7|TREATMENT|2021-01-13|10
e|SS|e41a4505-a5aa-4cac-895b-04fe85737ca9|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|2|Visit_2|25|5|TREATMENT|2021-01-28|25
e|SS|e41a4505-a5aa-4cac-895b-04fe85737ca9|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|2|Visit_2|25|5|TREATMENT|2021-01-28|25
e|SS|e41a4505-a5aa-4cac-895b-04fe85737ca9|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|3|TREATMENT|2021-02-12|40
e|SS|e41a4505-a5aa-4cac-895b-04fe85737ca9|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|6|WASHOUT|2021-02-12|40
e|SS|e41a4505-a5aa-4cac-895b-04fe85737ca9|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|5|FOLLOW-UP|2021-03-09|65
e|SS|e41a4505-a5aa-4cac-895b-04fe85737ca9|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|2|SCREENING|2021-03-09|65
e|SS|e41a4505-a5aa-4cac-895b-04fe85737ca9|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|5|Visit_5|90|6|WASHOUT|2021-04-03|90
e|SS|e41a4505-a5aa-4cac-895b-04fe85737ca9|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|5|Visit_5|90|2|FOLLOW-UP|2021-04-03|90
e|SS|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|1|TREATMENT|2021-01-15|10
e|SS|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|7|FOLLOW-UP|2021-01-15|10
e|SS|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|4|TREATMENT|2021-01-30|25
e|SS|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|2|Visit_2|25|5|TREATMENT|2021-01-30|25
e|SS|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|3|Visit_3|40|6|WASHOUT|2021-02-14|40
e|SS|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|3|Visit_3|40|3|FOLLOW-UP|2021-02-14|40
e|SS|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|4|Visit_4|65|6|SCREENING|2021-03-11|65
e|SS|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|TREATMENT|2021-03-11|65
e|SS|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|6|WASHOUT|2021-04-05|90
e|SS|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|1|TREATMENT|2021-04-05|90
e|SS|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|1|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|1|Visit_1|10|7|TREATMENT|2020-12-12|10
e|SS|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|1|Visit_1|10|6|SCREENING|2020-12-12|10
e|SS|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|2|Visit_2|25|1|FOLLOW-UP|2020-12-27|25
e|SS|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|5|TREATMENT|2020-12-27|25
e|SS|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|6|WASHOUT|2021-01-11|40
e|SS|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|3|Visit_3|40|3|TREATMENT|2021-01-11|40
e|SS|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|ADJUDICATOR|4|Visit_4|65|1|SCREENING|2021-02-05|65
e|SS|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|TREATMENT|2021-02-05|65
e|SS|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|1|FOLLOW-UP|2021-03-02|90
e|SS|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|5|Visit_5|90|2|TREATMENT|2021-03-02|90
e|SS|5abbbb78-2eeb-4d21-85ac-f5d18294c603|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|1|Visit_1|10|2|TREATMENT|2021-01-25|10
e|SS|5abbbb78-2eeb-4d21-85ac-f5d18294c603|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CHILD|1|Visit_1|10|5|WASHOUT|2021-01-25|10
e|SS|5abbbb78-2eeb-4d21-85ac-f5d18294c603|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|7|WASHOUT|2021-02-09|25
e|SS|5abbbb78-2eeb-4d21-85ac-f5d18294c603|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|ADJUDICATOR|2|Visit_2|25|1|SCREENING|2021-02-09|25
e|SS|5abbbb78-2eeb-4d21-85ac-f5d18294c603|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|3|Visit_3|40|1|WASHOUT|2021-02-24|40
e|SS|5abbbb78-2eeb-4d21-85ac-f5d18294c603|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|3|Visit_3|40|5|WASHOUT|2021-02-24|40
e|SS|5abbbb78-2eeb-4d21-85ac-f5d18294c603|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|4|Visit_4|65|1|FOLLOW-UP|2021-03-21|65
e|SS|5abbbb78-2eeb-4d21-85ac-f5d18294c603|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|3|TREATMENT|2021-03-21|65
e|SS|5abbbb78-2eeb-4d21-85ac-f5d18294c603|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|5|FOLLOW-UP|2021-04-15|90
e|SS|5abbbb78-2eeb-4d21-85ac-f5d18294c603|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|5|Visit_5|90|1|FOLLOW-UP|2021-04-15|90
e|SS|109fe46d-ac1f-47fe-8ecb-6049a577d38c|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|1|Visit_1|10|5|TREATMENT|2020-05-20|10
e|SS|109fe46d-ac1f-47fe-8ecb-6049a577d38c|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|2|TREATMENT|2020-05-20|10
e|SS|109fe46d-ac1f-47fe-8ecb-6049a577d38c|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|6|TREATMENT|2020-06-04|25
e|SS|109fe46d-ac1f-47fe-8ecb-6049a577d38c|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|2|Visit_2|25|2|TREATMENT|2020-06-04|25
e|SS|109fe46d-ac1f-47fe-8ecb-6049a577d38c|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|FAMILY MEMBER|3|Visit_3|40|7|WASHOUT|2020-06-19|40
e|SS|109fe46d-ac1f-47fe-8ecb-6049a577d38c|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|3|Visit_3|40|2|WASHOUT|2020-06-19|40
e|SS|109fe46d-ac1f-47fe-8ecb-6049a577d38c|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|5|TREATMENT|2020-07-14|65
e|SS|109fe46d-ac1f-47fe-8ecb-6049a577d38c|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|4|Visit_4|65|1|TREATMENT|2020-07-14|65
e|SS|109fe46d-ac1f-47fe-8ecb-6049a577d38c|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|5|Visit_5|90|1|TREATMENT|2020-08-08|90
e|SS|109fe46d-ac1f-47fe-8ecb-6049a577d38c|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|7|WASHOUT|2020-08-08|90
e|SS|cdb18d0a-5fca-4437-9b6e-0e46b0930521|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|1|Visit_1|10|3|TREATMENT|2020-09-03|10
e|SS|cdb18d0a-5fca-4437-9b6e-0e46b0930521|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|1|Visit_1|10|6|SCREENING|2020-09-03|10
e|SS|cdb18d0a-5fca-4437-9b6e-0e46b0930521|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|3|SCREENING|2020-09-18|25
e|SS|cdb18d0a-5fca-4437-9b6e-0e46b0930521|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|2|Visit_2|25|6|WASHOUT|2020-09-18|25
e|SS|cdb18d0a-5fca-4437-9b6e-0e46b0930521|5|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|3|Visit_3|40|2|WASHOUT|2020-10-03|40
e|SS|cdb18d0a-5fca-4437-9b6e-0e46b0930521|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|5|TREATMENT|2020-10-03|40
e|SS|cdb18d0a-5fca-4437-9b6e-0e46b0930521|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|4|Visit_4|65|6|TREATMENT|2020-10-28|65
e|SS|cdb18d0a-5fca-4437-9b6e-0e46b0930521|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|4|Visit_4|65|3|SCREENING|2020-10-28|65
e|SS|cdb18d0a-5fca-4437-9b6e-0e46b0930521|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|5|Visit_5|90|5|SCREENING|2020-11-22|90
e|SS|cdb18d0a-5fca-4437-9b6e-0e46b0930521|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|GUARDIAN|5|Visit_5|90|3|TREATMENT|2020-11-22|90
e|SS|e515b916-5d28-4236-8835-2ff43b498ab3|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|DOMESTIC PARTNER|1|Visit_1|10|7|FOLLOW-UP|2020-05-23|10
e|SS|e515b916-5d28-4236-8835-2ff43b498ab3|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SIGNIFICANT OTHER|1|Visit_1|10|5|TREATMENT|2020-05-23|10
e|SS|e515b916-5d28-4236-8835-2ff43b498ab3|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|2|Visit_2|25|5|SCREENING|2020-06-07|25
e|SS|e515b916-5d28-4236-8835-2ff43b498ab3|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|5|TREATMENT|2020-06-07|25
e|SS|e515b916-5d28-4236-8835-2ff43b498ab3|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|7|TREATMENT|2020-06-22|40
e|SS|e515b916-5d28-4236-8835-2ff43b498ab3|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INVESTIGATOR|3|Visit_3|40|4|WASHOUT|2020-06-22|40
e|SS|e515b916-5d28-4236-8835-2ff43b498ab3|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PROXY|4|Visit_4|65|3|TREATMENT|2020-07-17|65
e|SS|e515b916-5d28-4236-8835-2ff43b498ab3|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|4|Visit_4|65|1|WASHOUT|2020-07-17|65
e|SS|e515b916-5d28-4236-8835-2ff43b498ab3|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FAMILY MEMBER|5|Visit_5|90|1|TREATMENT|2020-08-11|90
e|SS|e515b916-5d28-4236-8835-2ff43b498ab3|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SPOUSE|5|Visit_5|90|1|TREATMENT|2020-08-11|90
e|SS|158af2a8-d447-45e5-8c58-3b950f1bd889|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|1|Visit_1|10|3|WASHOUT|2020-05-30|10
e|SS|158af2a8-d447-45e5-8c58-3b950f1bd889|2|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|1|Visit_1|10|4|FOLLOW-UP|2020-05-30|10
e|SS|158af2a8-d447-45e5-8c58-3b950f1bd889|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|5|FOLLOW-UP|2020-06-14|25
e|SS|158af2a8-d447-45e5-8c58-3b950f1bd889|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|2|Visit_2|25|1|WASHOUT|2020-06-14|25
e|SS|158af2a8-d447-45e5-8c58-3b950f1bd889|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|HEALTH CARE PROFESSIONAL|3|Visit_3|40|7|SCREENING|2020-06-29|40
e|SS|158af2a8-d447-45e5-8c58-3b950f1bd889|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|VENDOR|3|Visit_3|40|3|WASHOUT|2020-06-29|40
e|SS|158af2a8-d447-45e5-8c58-3b950f1bd889|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|4|Visit_4|65|1|SCREENING|2020-07-24|65
e|SS|158af2a8-d447-45e5-8c58-3b950f1bd889|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|4|Visit_4|65|7|SCREENING|2020-07-24|65
e|SS|158af2a8-d447-45e5-8c58-3b950f1bd889|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|STUDY SUBJECT|5|Visit_5|90|6|SCREENING|2020-08-18|90
e|SS|158af2a8-d447-45e5-8c58-3b950f1bd889|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CAREGIVER|5|Visit_5|90|7|TREATMENT|2020-08-18|90
e|SS|e9a930d5-ca57-4069-8251-c164273df082|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|GUARDIAN|1|Visit_1|10|4|TREATMENT|2020-05-21|10
e|SS|e9a930d5-ca57-4069-8251-c164273df082|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|PARENT|1|Visit_1|10|2|FOLLOW-UP|2020-05-21|10
e|SS|e9a930d5-ca57-4069-8251-c164273df082|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|2|Visit_2|25|2|TREATMENT|2020-06-05|25
e|SS|e9a930d5-ca57-4069-8251-c164273df082|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CHILD|2|Visit_2|25|5|SCREENING|2020-06-05|25
e|SS|e9a930d5-ca57-4069-8251-c164273df082|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|3|Visit_3|40|6|SCREENING|2020-06-20|40
e|SS|e9a930d5-ca57-4069-8251-c164273df082|6|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INDEPENDENT ASSESSOR|3|Visit_3|40|6|SCREENING|2020-06-20|40
e|SS|e9a930d5-ca57-4069-8251-c164273df082|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|4|SCREENING|2020-07-15|65
e|SS|e9a930d5-ca57-4069-8251-c164273df082|8|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|4|Visit_4|65|6|WASHOUT|2020-07-15|65
e|SS|e9a930d5-ca57-4069-8251-c164273df082|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|5|Visit_5|90|1|TREATMENT|2020-08-09|90
e|SS|e9a930d5-ca57-4069-8251-c164273df082|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|VENDOR|5|Visit_5|90|6|FOLLOW-UP|2020-08-09|90
e|SS|e654e37e-1c95-4f25-83b1-9233186626c6|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|FRIEND|1|Visit_1|10|5|TREATMENT|2020-08-04|10
e|SS|e654e37e-1c95-4f25-83b1-9233186626c6|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|SPOUSE|1|Visit_1|10|4|TREATMENT|2020-08-04|10
e|SS|e654e37e-1c95-4f25-83b1-9233186626c6|3|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIGNIFICANT OTHER|2|Visit_2|25|1|WASHOUT|2020-08-19|25
e|SS|e654e37e-1c95-4f25-83b1-9233186626c6|4|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL STUDY SPONSOR|2|Visit_2|25|3|TREATMENT|2020-08-19|25
e|SS|e654e37e-1c95-4f25-83b1-9233186626c6|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|3|TREATMENT|2020-09-03|40
e|SS|e654e37e-1c95-4f25-83b1-9233186626c6|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|SIBLING|3|Visit_3|40|1|TREATMENT|2020-09-03|40
e|SS|e654e37e-1c95-4f25-83b1-9233186626c6|7|SURVSTAT|Survival Status|[?]|[?]|ALIVE|STUDY SUBJECT|4|Visit_4|65|3|TREATMENT|2020-09-28|65
e|SS|e654e37e-1c95-4f25-83b1-9233186626c6|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL STUDY SPONSOR|4|Visit_4|65|5|WASHOUT|2020-09-28|65
e|SS|e654e37e-1c95-4f25-83b1-9233186626c6|9|SURVSTAT|Survival Status|[?]|[?]|ALIVE|HEALTH CARE PROFESSIONAL|5|Visit_5|90|1|FOLLOW-UP|2020-10-23|90
e|SS|e654e37e-1c95-4f25-83b1-9233186626c6|10|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INTERVIEWER|5|Visit_5|90|7|FOLLOW-UP|2020-10-23|90
e|SS|808ee0ac-e668-4e8e-aa0a-889476cbe631|1|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CAREGIVER|1|Visit_1|10|1|TREATMENT|2020-06-19|10
e|SS|808ee0ac-e668-4e8e-aa0a-889476cbe631|2|SURVSTAT|Survival Status|[?]|[?]|ALIVE|DOMESTIC PARTNER|1|Visit_1|10|1|TREATMENT|2020-06-19|10
e|SS|808ee0ac-e668-4e8e-aa0a-889476cbe631|3|SURVSTAT|Survival Status|[?]|[?]|ALIVE|NON-HEALTH CARE PROFESSIONAL|2|Visit_2|25|7|FOLLOW-UP|2020-07-04|25
e|SS|808ee0ac-e668-4e8e-aa0a-889476cbe631|4|SURVSTAT|Survival Status|[?]|[?]|ALIVE|CLINICAL RESEARCH COORDINATOR|2|Visit_2|25|2|TREATMENT|2020-07-04|25
e|SS|808ee0ac-e668-4e8e-aa0a-889476cbe631|5|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|PROXY|3|Visit_3|40|7|FOLLOW-UP|2020-07-19|40
e|SS|808ee0ac-e668-4e8e-aa0a-889476cbe631|6|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|NON-HEALTH CARE PROFESSIONAL|3|Visit_3|40|5|TREATMENT|2020-07-19|40
e|SS|808ee0ac-e668-4e8e-aa0a-889476cbe631|7|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH ASSOCIATE|4|Visit_4|65|4|SCREENING|2020-08-13|65
e|SS|808ee0ac-e668-4e8e-aa0a-889476cbe631|8|SURVSTAT|Survival Status|[?]|[?]|ALIVE|INVESTIGATOR|4|Visit_4|65|2|FOLLOW-UP|2020-08-13|65
e|SS|808ee0ac-e668-4e8e-aa0a-889476cbe631|9|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|INDEPENDENT ASSESSOR|5|Visit_5|90|1|SCREENING|2020-09-07|90
e|SS|808ee0ac-e668-4e8e-aa0a-889476cbe631|10|SURVSTAT|Survival Status|[?]|[?]|UNKNOWN|CLINICAL RESEARCH COORDINATOR|5|Visit_5|90|2|TREATMENT|2020-09-07|90
